Citrus Sinensis ID: 012392

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460----
Protein Sequence
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Secondary Structure (PSIPRED)
cccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHEEEEccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEcccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccccEEEccccccccccccccccccccccccccccccccEEEEEEEccccccHHHHHccccccccccccHHHHHHHHHHcccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEEEEccHHHHEEEcccccccHcHccHHEEccccccEEEEEEEEccccccHHHHHccccccHHHHHHHHHHHHHHHccccccHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHccccccccccccc
Coil and Loop (DISEMBL)
MIGNEALKRlnggfqfqnnpglcgdgiaslractvydntqinpvkpfgshsndttpidisepsgfkehcnqsqcsnsskfpQIAVLAAVTSVTVILAGTGILIFFRYRRhkqkigntsessdwqlsTDLTLakdfnrngasplvsleychgwdplgdylngtgfsrEHLNSFRLNLEEVESATQCfsevnllgkgnfssvykgtlrdgTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFccsrgrgecfliydfapkgklskyldqeegssnvldwsTRVSIIIGIAKGIgylhssevnkpaivhRNLSVEKVLIDqqfnpliadcgLHKLLADDIVFSVLKTSaamgylapeyvttgrftersdifAFGVIILQILTGSLVLTSSMRLAAESATFENFIDrnlkgkfseseAAKLGKMALVCthedpenrptMEAVIEELTVAAPVMATFLFS
Flexible Loop (DISEMBL)
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKigntsessdwqlSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSevnllgkgnfSSVYKGTLRDGTLVAIRSInvtsckseeaeFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEgssnvldwstRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Low Complexity Region (SEG)
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Disordered region (IsUnstruct)
**********NGGFQFQNNPGLCGDGIASLRACTVYDNTQINPV***********************************FPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKI********WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG*********LGKMALVCT***********AVIEELTVAAPVMATFL**
Disordered Region (DISOPRED)
****EALKRLNGGFQFQNNPGLCGDGIASLRACTV**************************************************LAAVTSVTVILAGTGILIFFRYRR**************************************Y**********************SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAI****************KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Disordered Region (DISEMBL)
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF************SKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQ**********WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Disordered Region (DISPRO)
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSN***************************FPQIAVLAAVTSVTVILAGTGILIFFRYRRHK********************************************************HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIGNEALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	464	2.2.26 [Sep-21-2011]
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.663	0.487	0.304	3e-47
Q9C5S8	659	Cysteine-rich receptor-li	no	no	0.607	0.427	0.343	1e-46
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.782	0.571	0.295	3e-46
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.603	0.455	0.318	5e-46
C0LGU5	614	Probable LRR receptor-lik	no	no	0.588	0.444	0.342	7e-46
C0LGG7	953	Probable LRR receptor-lik	no	no	0.584	0.284	0.331	2e-45
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.603	0.451	0.325	2e-45
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.603	0.445	0.315	3e-45
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.594	0.412	0.340	5e-45
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.607	0.437	0.336	5e-45

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  189 bits (481), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 111/365 (30%), Positives = 182/365 (49%), Gaps = 57/365 (15%)

Query: 99  TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 158
           +G+ +++RYRR+KQ   + +E  D                   P VSL            
Sbjct: 255 SGMFLWWRYRRNKQIFFDVNEQYD-------------------PEVSLG----------- 284

Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 218
                    HL   R   +E+ SAT  F+  N+LG+G +  VYKG L DGTLVA++ +  
Sbjct: 285 ---------HLK--RYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKD 333

Query: 219 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 278
            +    E +F   +  ++   H N++RLRGFC S    E  L+Y + P G ++  L    
Sbjct: 334 CNIAGGEVQFQTEVETISLALHRNLLRLRGFCSS--NQERILVYPYMPNGSVASRLKDNI 391

Query: 279 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
                LDWS R  I +G A+G+ YLH  E   P I+HR++    +L+D+ F  ++ D GL
Sbjct: 392 RGEPALDWSRRKKIAVGTARGLVYLH--EQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 449

Query: 339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL------- 391
            KLL              +G++APEY++TG+ +E++D+F FG+++L+++TG         
Sbjct: 450 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRS 509

Query: 392 -----VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
                V+   ++   +    +  ID++L  KF   E  ++ ++AL+CT  +P +RP M  
Sbjct: 510 AHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSE 569

Query: 447 VIEEL 451
           V++ L
Sbjct: 570 VMKML 574

Involved in defense response to geminivirus infection.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  187 bits (476), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 104/303 (34%), Positives = 174/303 (57%), Gaps = 21/303 (6%)

Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
           S + + + +E+AT  FS  N LG+G F  VYKGTL +G  VA++ ++ TS + E+ EF  
Sbjct: 325 SLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEK-EFKN 383

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + ++  L+H N+++L GFC    R E  L+Y+F     L  +L      S  LDW+TR 
Sbjct: 384 EVVVVAKLQHRNLVKLLGFCLE--REEKILVYEFVSNKSLDYFLFDSRMQSQ-LDWTTRY 440

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA-DDIVFS 349
            II GIA+GI YLH    ++  I+HR+L    +L+D   NP +AD G+ ++   D     
Sbjct: 441 KIIGGIARGILYLHQD--SRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQTEAH 498

Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----SL---------VLTSS 396
             +     GY++PEY   G+F+ +SD+++FGV++L+I++G    SL         ++T +
Sbjct: 499 TRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDASFGNLVTYT 558

Query: 397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
            RL ++ +  +  +D + +  +  +E  +   +AL+C  ED ENRPTM A+++ LT ++ 
Sbjct: 559 WRLWSDGSPLD-LVDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIVQMLTTSSI 617

Query: 457 VMA 459
            +A
Sbjct: 618 ALA 620

Involved in multiple distinct defense responses. May function as a disease resistance (R) protein.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  186 bits (472), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 128/433 (29%), Positives = 209/433 (48%), Gaps = 70/433 (16%)

Query: 35  VYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNS-SKFPQIAVLAAV--TS 91
           V  N+QI P        N T P    +P     + +Q++ S+  +K  +IAV+  V  T 
Sbjct: 203 VMGNSQICPTGT-EKDCNGTQP----KPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTC 257

Query: 92  VTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHG 151
           V +++ G G L+++R R +KQ                  L  D N          E C G
Sbjct: 258 VCLLIIGFGFLLWWRRRHNKQ-----------------VLFFDINEQNKE-----EMCLG 295

Query: 152 WDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLV 211
                             N  R N +E++SAT  FS  NL+GKG F +VYKG L DG+++
Sbjct: 296 ------------------NLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSII 337

Query: 212 AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS 271
           A++ +   +    E +F   L +++   H N++RL GFC +    E  L+Y +   G ++
Sbjct: 338 AVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSS--ERLLVYPYMSNGSVA 395

Query: 272 KYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP 331
             L  +     VLDW TR  I +G  +G+ YLH  E   P I+HR++    +L+D  F  
Sbjct: 396 SRLKAKP----VLDWGTRKRIALGAGRGLLYLH--EQCDPKIIHRDVKAANILLDDYFEA 449

Query: 332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-- 389
           ++ D GL KLL  +           +G++APEY++TG+ +E++D+F FG+++L+++TG  
Sbjct: 450 VVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLR 509

Query: 390 -----------SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP 438
                        +L    +L  E    E  +D++LK  +   E  ++ ++AL+CT   P
Sbjct: 510 ALEFGKAANQRGAILDWVKKLQQEKK-LEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLP 568

Query: 439 ENRPTMEAVIEEL 451
            +RP M  V+  L
Sbjct: 569 IHRPKMSEVVRML 581

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  185 bits (470), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 95/298 (31%), Positives = 162/298 (54%), Gaps = 18/298 (6%)

Query: 168 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 226
           HL    R +L E++ A+  FS  N+LG+G F  VYKG L DGTLVA++ +     +  E 
Sbjct: 270 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 329

Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW
Sbjct: 330 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDW 387

Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
             R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL KL+    
Sbjct: 388 PKRQRIALGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 445

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 393
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 446 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 505

Query: 394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 506 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 563

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  185 bits (469), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 100/292 (34%), Positives = 164/292 (56%), Gaps = 19/292 (6%)

Query: 173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 232
           R +  E+++AT  FS  N+LG+G F  VYKG L +GT+VA++ +      + E +F   +
Sbjct: 287 RFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLK-DPIYTGEVQFQTEV 345

Query: 233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            ++    H N++RL GFC +    E  L+Y + P G ++  L    G    LDW+ R+SI
Sbjct: 346 EMIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISI 403

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
            +G A+G+ YLH  E   P I+HR++    +L+D+ F  ++ D GL KLL          
Sbjct: 404 ALGAARGLVYLH--EQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTA 461

Query: 353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-------------SLVLTSSMRL 399
               +G++APEY++TG+ +E++D+F FGV+IL+++TG              ++L+    L
Sbjct: 462 VRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTL 521

Query: 400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            AE   F   +DR+LKG+F +    ++ ++AL+CT   P  RP M  V++ L
Sbjct: 522 KAEK-RFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVL 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  184 bits (466), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 162/287 (56%), Gaps = 16/287 (5%)

Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           L +++ AT  F   N +G+G F  VYKG L DGT++A++ ++ T  K    EF+  + ++
Sbjct: 614 LRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLS-TGSKQGNREFLNEIGMI 672

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
           ++L H N+++L G CC  G G+  L+Y+F     L++ L   + +   LDW TR  I IG
Sbjct: 673 SALHHPNLVKLYG-CCVEG-GQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIG 730

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +A+G+ YLH  E ++  IVHR++    VL+D+Q NP I+D GL KL  +D      + + 
Sbjct: 731 VARGLAYLH--EESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG 788

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-----------SLVLTSSMRLAAESA 404
             GY+APEY   G  T+++D+++FG++ L+I+ G           +  L   + +  E  
Sbjct: 789 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKN 848

Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +D  L  +++  EA  + ++A++CT  +P  RP+M  V++ L
Sbjct: 849 NLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKML 895

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  184 bits (466), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 161/298 (54%), Gaps = 18/298 (6%)

Query: 168 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 226
           HL    R  L E+  AT  FS  N+LG+G F  VYKG L DG LVA++ +     K  E 
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGEL 334

Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +    +  LDW
Sbjct: 335 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPEGNPALDW 392

Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
             R  I +G A+G+ YLH     K  I+HR++    +L+D++F  ++ D GL KL+  + 
Sbjct: 393 PKRKHIALGSARGLAYLHDHCDQK--IIHRDVKAANILLDEEFEAVVGDFGLAKLMNYND 450

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 393
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 451 SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIML 510

Query: 394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++   +    E+ +D  L+GK+ E+E  +L +MAL+CT      RP M  V+  L
Sbjct: 511 LDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRML 568

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  183 bits (464), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 94/298 (31%), Positives = 162/298 (54%), Gaps = 18/298 (6%)

Query: 168 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 226
           HL    R +L E++ AT  FS  N+LG+G F  VYKG L DGTLVA++ +        E 
Sbjct: 286 HLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGEL 345

Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   L W
Sbjct: 346 QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPPSQLPLAW 403

Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
           S R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL +L+    
Sbjct: 404 SIRQQIALGSARGLSYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKD 461

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 393
                     +G++APEY++TG+ +E++D+F +G+++L+++TG              ++L
Sbjct: 462 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 521

Query: 394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++   +    E  +D +L+  ++E+E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 522 LDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRML 579

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  182 bits (462), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 167/297 (56%), Gaps = 21/297 (7%)

Query: 170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV 229
           +S + + + +E+AT  FS+ N++G+G F  VY+G L  G  VA++ ++ TS +  E EF 
Sbjct: 329 HSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAE-EFK 387

Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
               L++ L+H+N++RL GFC      E  L+Y+F P   L  +L  +      LDW+ R
Sbjct: 388 NEAVLVSKLQHKNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFL-FDPAKQGELDWTRR 444

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA-DDIVF 348
            +II GIA+GI YLH    ++  I+HR+L    +L+D   NP IAD G+ ++   D    
Sbjct: 445 YNIIGGIARGILYLHQD--SRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQA 502

Query: 349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL-------------TGSLVLTS 395
           +  + +   GY++PEY   G F+ +SD+++FGV++L+I+             +GS ++T 
Sbjct: 503 NTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562

Query: 396 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           + RL    +  E  +D  +   +  SEA +   +AL+C  EDP +RP + A+I  LT
Sbjct: 563 AWRLWRNGSPLE-LVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLT 618

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  182 bits (462), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 102/303 (33%), Positives = 172/303 (56%), Gaps = 21/303 (6%)

Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
           S + + + +E+AT CF  +N LG+G F  VYKGTL  G  VA++ ++ TS + E+ EF  
Sbjct: 311 SLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEK-EFEN 369

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + ++  L+H N+++L G+C      E  L+Y+F P   L  +L  +      LDW+ R 
Sbjct: 370 EVVVVAKLQHRNLVKLLGYCLE--GEEKILVYEFVPNKSLDHFL-FDSTMKMKLDWTRRY 426

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
            II GIA+GI YLH    ++  I+HR+L    +L+D   NP IAD G+ ++   D   ++
Sbjct: 427 KIIGGIARGILYLHQD--SRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAM 484

Query: 351 L-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----SL---------VLTSS 396
             +     GY++PEY   G+F+ +SD+++FGV++L+I++G    SL         ++T +
Sbjct: 485 TRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYT 544

Query: 397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
            RL +  +  E  +D +    +  SE  +   +AL+C  ED E+RPTM ++++ LT +  
Sbjct: 545 WRLWSNGSPSE-LVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLI 603

Query: 457 VMA 459
            +A
Sbjct: 604 ALA 606

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	464
255537079	693	leucine rich repeat receptor kinase, put	0.956	0.640	0.701	0.0
255537307	451	leucine rich repeat receptor kinase, put	0.956	0.984	0.683	1e-177
224125098	682	predicted protein [Populus trichocarpa]	0.963	0.655	0.690	1e-175
224071591	646	predicted protein [Populus trichocarpa]	0.950	0.682	0.678	1e-171
296082849	680	unnamed protein product [Vitis vinifera]	0.961	0.655	0.657	1e-163
359474325	813	PREDICTED: probable LRR receptor-like se	0.956	0.546	0.653	1e-161
296084139	659	unnamed protein product [Vitis vinifera]	0.956	0.673	0.618	1e-158
225455531	681	PREDICTED: leucine-rich repeat receptor-	0.956	0.651	0.618	1e-158
297803850	687	hypothetical protein ARALYDRAFT_492596 [	0.950	0.641	0.614	1e-156
449460425	683	PREDICTED: LRR receptor-like serine/thre	0.954	0.648	0.616	1e-155

>gi|255537079|ref|XP_002509606.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223549505|gb|EEF50993.1| leucine rich repeat receptor kinase, putative [Ricinus communis]

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/446 (70%), Positives = 368/446 (82%), Gaps = 2/446 (0%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
           AL++LNGGFQF+NN GLCG G   LRACT +DN  IN V+P GS +N TT  +I   +  
Sbjct: 247 ALQKLNGGFQFENNKGLCGAGFPELRACTAFDNMNINQVEPSGSITNTTTSKNIPVSAIL 306

Query: 66  KEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQL 125
           +  C+Q++CSNSSKFPQ+A+++ VT+ T+IL G   LI F YRR KQKIGN SESS+ +L
Sbjct: 307 QAPCDQTKCSNSSKFPQVAIISGVTTATIILIGVAFLIIFFYRRQKQKIGNISESSEGRL 366

Query: 126 STDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQC 185
           STD   AK+F+R GASPLVSLEY +GWDP     NG G S   LN+FR NLEEVESATQC
Sbjct: 367 STDK--AKEFHRAGASPLVSLEYSNGWDPFRGCRNGVGISEPSLNNFRFNLEEVESATQC 424

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           FSEVNLLGK +FSSVYKG LR G+LVA+RSIN+TSCKSEE EFVKGL LLTSLRH+N++R
Sbjct: 425 FSEVNLLGKSSFSSVYKGILRGGSLVAVRSINITSCKSEEDEFVKGLNLLTSLRHDNLVR 484

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           LRGFCCS+GRGECFLIYDFAP G LS+YLD E+GSS++L+WSTRVSII GIAKGI YLH 
Sbjct: 485 LRGFCCSKGRGECFLIYDFAPMGNLSRYLDLEDGSSHILEWSTRVSIINGIAKGIEYLHR 544

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            EVNKPAI+HR +S+EKVL+DQ+F PL+AD GLHKLLADDIVFS LKTSAAMGYLAPEYV
Sbjct: 545 REVNKPAIIHRRVSIEKVLLDQEFKPLMADSGLHKLLADDIVFSGLKTSAAMGYLAPEYV 604

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           TTG FTE+SDI+AFGVIILQIL+G  +L++ MRLAA S+ +E+FID NLKG FSESEAA 
Sbjct: 605 TTGHFTEKSDIYAFGVIILQILSGQHMLSNLMRLAAASSRYEDFIDTNLKGNFSESEAAM 664

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           L K+AL CT E PE RPTMEAVI+E+
Sbjct: 665 LSKIALDCTQELPEQRPTMEAVIQEM 690

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537307|ref|XP_002509720.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223549619|gb|EEF51107.1| leucine rich repeat receptor kinase, putative [Ricinus communis]

 Score =  627 bits (1616), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 305/446 (68%), Positives = 363/446 (81%), Gaps = 2/446 (0%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
           AL++LNGGFQF+NN GLCG G   LRACT ++N  IN V+P G  +N TT  +I   +  
Sbjct: 5   ALQKLNGGFQFENNKGLCGAGFPELRACTAFNNMNINQVEPSGPITNTTTSKNIPVSAIL 64

Query: 66  KEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQL 125
           +  C+Q++CSNSSKFPQ+A+++ VT+ T+IL G   LI F YRR KQKIGN SESS+ +L
Sbjct: 65  QAPCDQTKCSNSSKFPQVAIISGVTTATIILIGVAFLIIFFYRRQKQKIGNISESSEGRL 124

Query: 126 STDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQC 185
           STD   AK+F+  GASPLVSLEY +GWDP     NG G S   LN+FR NLEEVESATQC
Sbjct: 125 STDQ--AKEFHGAGASPLVSLEYSNGWDPFRGCRNGVGISEPSLNNFRFNLEEVESATQC 182

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           FSEVNLLGK +FSSVYKG LR G+LVA+RSIN+TSCKSEE EF+KGL LLTSLRH+N++R
Sbjct: 183 FSEVNLLGKSSFSSVYKGILRGGSLVAVRSINITSCKSEEDEFMKGLNLLTSLRHDNLVR 242

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           LRGFCCS+GRG+CFLIYDFAP G LS+YLD E+GSS++L+WSTRVSII GIAKGI YLH 
Sbjct: 243 LRGFCCSKGRGKCFLIYDFAPMGNLSRYLDLEDGSSHILEWSTRVSIINGIAKGIEYLHR 302

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            E NKPAI+HR +SVEKVL+DQ+F PL+AD GL K LADDIVFS +KTSAAMGYLAPEYV
Sbjct: 303 GEANKPAIIHRRVSVEKVLLDQEFKPLMADSGLRKFLADDIVFSGIKTSAAMGYLAPEYV 362

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           TTG FTE+SDI+AFGVIILQIL+G  +L++SMRLAA S+ +E+FID NLKG FSESEAA 
Sbjct: 363 TTGHFTEKSDIYAFGVIILQILSGQHMLSNSMRLAAASSRYEDFIDTNLKGNFSESEAAM 422

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           L K+AL CT E  E RPTMEAVI+E+
Sbjct: 423 LSKIALDCTQELLEQRPTMEAVIQEM 448

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125098|ref|XP_002329893.1| predicted protein [Populus trichocarpa] gi|222871130|gb|EEF08261.1| predicted protein [Populus trichocarpa]

 Score =  621 bits (1601), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 310/449 (69%), Positives = 363/449 (80%), Gaps = 2/449 (0%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
           ALKRLNGGFQF+NN GLCG G   LRAC+ +DN  IN V   G  +N++      + +  
Sbjct: 232 ALKRLNGGFQFENNQGLCGTGFHPLRACSAFDNMNINQVGSLGPIANNSAKKVTPQSAIL 291

Query: 66  KEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQL 125
           + HCNQ+ CSNSSK PQ A++A V  VT+ L G G LI F YRR KQKIGNTS+SSD +L
Sbjct: 292 QAHCNQTHCSNSSKLPQAAIVAGVIIVTITLMGAGFLIIFCYRRKKQKIGNTSDSSDGRL 351

Query: 126 STDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQC 185
           STD   AK+F+R GASPL SLEY +GWDPLGD  NG  FS EHLN+FR NLEE+ESATQC
Sbjct: 352 STDQ--AKEFHRAGASPLASLEYSNGWDPLGDSRNGIEFSVEHLNNFRFNLEEIESATQC 409

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           FSEVN+LGK +FS+VYKG LRDG++VAI+SINVTSCK EEAEFVKGL LLTSLRH+N+ R
Sbjct: 410 FSEVNVLGKSSFSTVYKGVLRDGSIVAIKSINVTSCKPEEAEFVKGLNLLTSLRHDNLTR 469

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           LRGFCCSRGRGECFLIYDFAPKG LS+YLD E+GS+ VLDWSTRVSII GIAKGI YLHS
Sbjct: 470 LRGFCCSRGRGECFLIYDFAPKGDLSRYLDLEDGSNQVLDWSTRVSIINGIAKGIRYLHS 529

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            E  KPAI+HR +SVEKVL+DQQ NPLIAD GL KLLADDIVFS +K SAAMGYLAPEYV
Sbjct: 530 IEEKKPAIIHRRISVEKVLLDQQVNPLIADSGLAKLLADDIVFSTIKISAAMGYLAPEYV 589

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           TTG FTE+SDI++FGVIILQIL+G  +L++SMRLAA    + +FID +L+G FSESEAAK
Sbjct: 590 TTGLFTEKSDIYSFGVIILQILSGKQLLSNSMRLAAACCRYNDFIDTSLRGNFSESEAAK 649

Query: 426 LGKMALVCTHEDPENRPTMEAVIEELTVA 454
           L K+AL CT + P+ RPTM+ VI+EL ++
Sbjct: 650 LAKIALACTDDLPDQRPTMKEVIQELNLS 678

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224071591|ref|XP_002303531.1| predicted protein [Populus trichocarpa] gi|222840963|gb|EEE78510.1| predicted protein [Populus trichocarpa]

 Score =  608 bits (1567), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 306/451 (67%), Positives = 358/451 (79%), Gaps = 10/451 (2%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRAC-TVYDNTQINPVKPFGSHSNDTTPIDISEPSG 64
           ALKRLNGGFQF+NNPGLCG G   LRAC  V+D   IN V P G  +N+T    I +   
Sbjct: 200 ALKRLNGGFQFENNPGLCGTGFPLLRACNAVFD---INQVGPLGPIANNTAQKVIPQSEI 256

Query: 65  FKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQ 124
            + HCN + CSNSSK PQ A++A V +VTV L G G LI F YRR KQKIGNTS  S+ +
Sbjct: 257 LQAHCNLTHCSNSSKLPQAAIVAGVITVTVTLMGAGFLIIFLYRRKKQKIGNTSAFSEGR 316

Query: 125 LSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ 184
           LST    AK+F+R GASPLVSLEY +GWDPLGD  NG   S EHLN+FR NLEE+ESAT+
Sbjct: 317 LSTHQ--AKEFHRAGASPLVSLEYSNGWDPLGDSRNGIEISGEHLNNFRFNLEEIESATR 374

Query: 185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           CFSEVN+LGK +FS+VYKG LRDG+LVAIRSIN+TSCK EEAEFVKGL LLTSLRH N+ 
Sbjct: 375 CFSEVNVLGKSSFSTVYKGILRDGSLVAIRSINLTSCKPEEAEFVKGLDLLTSLRHNNLT 434

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           RLRGFCCSRGRGECFLIYDFAP+G LS+YLD E+GS+ VLDWS RV II GIAKGI YLH
Sbjct: 435 RLRGFCCSRGRGECFLIYDFAPRGDLSRYLDLEDGSNQVLDWSARVYIINGIAKGIRYLH 494

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
           SSE NKP ++HR +SVEKVL+DQQFNPLIAD GL KLLADD+VFS +K SAAMGYL+PEY
Sbjct: 495 SSEENKPVMIHRRISVEKVLLDQQFNPLIADSGLAKLLADDVVFSTIKISAAMGYLSPEY 554

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTS-SMRLAAESATFENFIDRNLKGKFSESEA 423
           VTTG FTE+SDI+AFGVIILQIL+G  +L S SMRLAA    +++F+D +L+G FSESEA
Sbjct: 555 VTTGLFTEKSDIYAFGVIILQILSGKQMLYSKSMRLAAACCMYDDFVDTSLQGNFSESEA 614

Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
           AKL K+AL      P++RPTM+ VI+EL ++
Sbjct: 615 AKLAKIALT---RLPDHRPTMKEVIQELNLS 642

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296082849|emb|CBI22150.3| unnamed protein product [Vitis vinifera]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 295/449 (65%), Positives = 355/449 (79%), Gaps = 3/449 (0%)

Query: 6   ALKRLNGGFQFQNN-PGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSG 64
            LK+L  GFQ  NN  GLCG G +SLR C+ +D   IN  + F + + D TP      S 
Sbjct: 234 GLKKLKEGFQHANNSAGLCGVGFSSLRVCSYWDGMNINQSETFPATNTDFTPTIYPVSSN 293

Query: 65  FKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQ 124
           F+ HCNQ+ C N SKFP+I +++ VT+VTV L+  G+L F  YRR KQKIG++ ++S+ Q
Sbjct: 294 FRPHCNQTHCPNVSKFPRIVLVSGVTTVTVTLSAVGLLTFLCYRRRKQKIGSSFDTSECQ 353

Query: 125 LSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ 184
           LSTD ++  D +R  ASPLVSLEY  GWDPL D  NG  FS+E   + R NL+E+ESATQ
Sbjct: 354 LSTDRSI--DCHRKIASPLVSLEYSTGWDPLADGRNGNVFSQEFCQNPRFNLDEIESATQ 411

Query: 185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
            FSEVNLLGK  F SVYKG LRDG+LVAIRSI+ TSCKSEEA+F+KGL LL+SLRHEN++
Sbjct: 412 YFSEVNLLGKSKFWSVYKGILRDGSLVAIRSISATSCKSEEADFLKGLNLLSSLRHENLV 471

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           RLRGFCCS+GRGEC+LI+DF P G LS+YLD EEGSS VL+WSTRVSII GIAKGIGYLH
Sbjct: 472 RLRGFCCSKGRGECYLIHDFVPNGSLSRYLDLEEGSSQVLNWSTRVSIIHGIAKGIGYLH 531

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
           SSE NKP++VHR++S +KVLIDQ+FNPLI+D GL KLLADDIVFS LKTSAA+GYLAPEY
Sbjct: 532 SSEENKPSLVHRSISADKVLIDQRFNPLISDSGLPKLLADDIVFSALKTSAALGYLAPEY 591

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +TTG FTE+SDI+AFGVIILQIL+G   LT+SMRLAAES  F +F+D NLKG+FSESEAA
Sbjct: 592 ITTGSFTEKSDIYAFGVIILQILSGKQQLTNSMRLAAESCRFADFVDTNLKGEFSESEAA 651

Query: 425 KLGKMALVCTHEDPENRPTMEAVIEELTV 453
           KL K+ L CTHE P+NRP ME VI+EL+ 
Sbjct: 652 KLAKIGLACTHELPDNRPIMETVIQELST 680

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474325|ref|XP_002266682.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180 [Vitis vinifera]

 Score =  573 bits (1476), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 292/447 (65%), Positives = 353/447 (78%), Gaps = 3/447 (0%)

Query: 6   ALKRLNGGFQFQNN-PGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSG 64
            LK+L  GFQ  NN  GLCG G +SLR C+ +D   IN  + F + + D TP      S 
Sbjct: 234 GLKKLKEGFQHANNSAGLCGVGFSSLRVCSYWDGMNINQSETFPATNTDFTPTIYPVSSN 293

Query: 65  FKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQ 124
           F+ HCNQ+ C N SKFP+I +++ VT+VTV L+  G+L F  YRR KQKIG++ ++S+ Q
Sbjct: 294 FRPHCNQTHCPNVSKFPRIVLVSGVTTVTVTLSAVGLLTFLCYRRRKQKIGSSFDTSECQ 353

Query: 125 LSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ 184
           LSTD ++  D +R  ASPLVSLEY  GWDPL D  NG  FS+E   + R NL+E+ESATQ
Sbjct: 354 LSTDRSI--DCHRKIASPLVSLEYSTGWDPLADGRNGNVFSQEFCQNPRFNLDEIESATQ 411

Query: 185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
            FSEVNLLGK  F SVYKG LRDG+LVAIRSI+ TSCKSEEA+F+KGL LL+SLRHEN++
Sbjct: 412 YFSEVNLLGKSKFWSVYKGILRDGSLVAIRSISATSCKSEEADFLKGLNLLSSLRHENLV 471

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           RLRGFCCS+GRGEC+LI+DF P G LS+YLD EEGSS VL+WSTRVSII GIAKGIGYLH
Sbjct: 472 RLRGFCCSKGRGECYLIHDFVPNGSLSRYLDLEEGSSQVLNWSTRVSIIHGIAKGIGYLH 531

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
           SSE NKP++VHR++S +KVLIDQ+FNPLI+D GL KLLADDIVFS LKTSAA+GYLAPEY
Sbjct: 532 SSEENKPSLVHRSISADKVLIDQRFNPLISDSGLPKLLADDIVFSALKTSAALGYLAPEY 591

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +TTG FTE+SDI+AFGVIILQIL+G   LT+SMRLAAES  F +F+D NLKG+FSESEAA
Sbjct: 592 ITTGSFTEKSDIYAFGVIILQILSGKQQLTNSMRLAAESCRFADFVDTNLKGEFSESEAA 651

Query: 425 KLGKMALVCTHEDPENRPTMEAVIEEL 451
           KL K+ L CTHE P+NRP ME  +++L
Sbjct: 652 KLAKIGLACTHELPDNRPIMETTLKKL 678

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084139|emb|CBI24527.3| unnamed protein product [Vitis vinifera]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 276/446 (61%), Positives = 340/446 (76%), Gaps = 2/446 (0%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
           ALKRLNGGFQ++NN  LCGDG + L+ C   D T  +  +P+G+ SN  +  DI E +  
Sbjct: 209 ALKRLNGGFQYKNNARLCGDGFSYLKVCNSLDLTNQSRPEPYGAGSNTQSTGDIPETANV 268

Query: 66  KEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQL 125
           + HC+++ CSN SK     V+  +  VT+ L+  GIL F +YRR KQK+G++ + SD +L
Sbjct: 269 QLHCDKAHCSNPSKSSHAPVVVGMVVVTIALSAIGILSFAQYRRRKQKLGSSFDISDSRL 328

Query: 126 STDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQC 185
           STD    K+  R   SPLVSLEY +GWDPL D  N  GF +E   SFR NLEEVESATQ 
Sbjct: 329 STDQ--GKEVYRKNGSPLVSLEYSNGWDPLADGRNYGGFPQEVFQSFRFNLEEVESATQH 386

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           FSEVNLLGK NFS++YKG LRDG+LVAI+SIN TSCKSE+AEF+KGL +LTSLRHEN++R
Sbjct: 387 FSEVNLLGKSNFSAIYKGILRDGSLVAIKSINKTSCKSEDAEFLKGLNILTSLRHENLVR 446

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           LRG CCS+GRGECFLIYDF P G L  YLD ++G S VL+WSTRVS+I GIAKGI YLH 
Sbjct: 447 LRGLCCSKGRGECFLIYDFIPNGNLLSYLDLKDGDSKVLEWSTRVSMISGIAKGIEYLHG 506

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            ++NKPA+VH+N+S EKVLIDQ+ NPL++D GLHKLL DDIVFS LK SAAMGYLAPEY 
Sbjct: 507 YKLNKPALVHQNISAEKVLIDQRLNPLLSDSGLHKLLTDDIVFSALKASAAMGYLAPEYT 566

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           TTGRFTE+SD++AFGV++ QIL+G    TSS+ L AE+  F++FID NL G+FSE EAAK
Sbjct: 567 TTGRFTEKSDLYAFGVLVFQILSGKRKFTSSIHLGAETCRFQDFIDANLHGRFSEYEAAK 626

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           L ++AL+CTHE P  RP+ME VI EL
Sbjct: 627 LARIALMCTHESPIERPSMETVIHEL 652

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455531|ref|XP_002267632.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 [Vitis vinifera]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 276/446 (61%), Positives = 340/446 (76%), Gaps = 2/446 (0%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
           ALKRLNGGFQ++NN  LCGDG + L+ C   D T  +  +P+G+ SN  +  DI E +  
Sbjct: 231 ALKRLNGGFQYKNNARLCGDGFSYLKVCNSLDLTNQSRPEPYGAGSNTQSTGDIPETANV 290

Query: 66  KEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQL 125
           + HC+++ CSN SK     V+  +  VT+ L+  GIL F +YRR KQK+G++ + SD +L
Sbjct: 291 QLHCDKAHCSNPSKSSHAPVVVGMVVVTIALSAIGILSFAQYRRRKQKLGSSFDISDSRL 350

Query: 126 STDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQC 185
           STD    K+  R   SPLVSLEY +GWDPL D  N  GF +E   SFR NLEEVESATQ 
Sbjct: 351 STDQ--GKEVYRKNGSPLVSLEYSNGWDPLADGRNYGGFPQEVFQSFRFNLEEVESATQH 408

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           FSEVNLLGK NFS++YKG LRDG+LVAI+SIN TSCKSE+AEF+KGL +LTSLRHEN++R
Sbjct: 409 FSEVNLLGKSNFSAIYKGILRDGSLVAIKSINKTSCKSEDAEFLKGLNILTSLRHENLVR 468

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           LRG CCS+GRGECFLIYDF P G L  YLD ++G S VL+WSTRVS+I GIAKGI YLH 
Sbjct: 469 LRGLCCSKGRGECFLIYDFIPNGNLLSYLDLKDGDSKVLEWSTRVSMISGIAKGIEYLHG 528

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            ++NKPA+VH+N+S EKVLIDQ+ NPL++D GLHKLL DDIVFS LK SAAMGYLAPEY 
Sbjct: 529 YKLNKPALVHQNISAEKVLIDQRLNPLLSDSGLHKLLTDDIVFSALKASAAMGYLAPEYT 588

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           TTGRFTE+SD++AFGV++ QIL+G    TSS+ L AE+  F++FID NL G+FSE EAAK
Sbjct: 589 TTGRFTEKSDLYAFGVLVFQILSGKRKFTSSIHLGAETCRFQDFIDANLHGRFSEYEAAK 648

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           L ++AL+CTHE P  RP+ME VI EL
Sbjct: 649 LARIALMCTHESPIERPSMETVIHEL 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297803850|ref|XP_002869809.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata] gi|297315645|gb|EFH46068.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata]

 Score =  559 bits (1440), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 280/456 (61%), Positives = 348/456 (76%), Gaps = 15/456 (3%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVK-PFGSHSNDTTPI-DISEPS 63
            LK+LNG FQF+NN GLCG    SLRAC+ +DN  I   K P G    D + + +ISE  
Sbjct: 231 GLKKLNGSFQFENNTGLCGMDFPSLRACSAFDNANIEQFKQPPGEIDTDKSALHNISESV 290

Query: 64  GFKEHCNQSQCS-NSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSD 122
             ++HCN++QC  +SSK PQ+A++++V +VT+ L G GIL FFRYRR KQKI NT E S+
Sbjct: 291 YLQKHCNKTQCKKSSSKLPQVALISSVITVTITLLGAGILTFFRYRRRKQKISNTPEFSE 350

Query: 123 WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSRE-HL----NSFRLNLE 177
            +LSTDL   KDF    ASPLVSL Y   WDPLGD  NG  FS+E HL    +SFR NLE
Sbjct: 351 GRLSTDL--QKDFR---ASPLVSLAYTKEWDPLGDSRNGAEFSQEPHLFVVNSSFRFNLE 405

Query: 178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
           ++ESATQCFSE NLL + +F+SV+KG LRDG+ VAIRSIN++SCK+EE EF+ GL LL+S
Sbjct: 406 DIESATQCFSEANLLSRNSFTSVFKGVLRDGSPVAIRSINISSCKNEEVEFMNGLKLLSS 465

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-QEEGSSNVLDWSTRVSIIIGI 296
           L HEN+++LRGFCCSRGRGECFLIYDFA KGKLS +LD QE  ++ VLDW  R+SII GI
Sbjct: 466 LSHENLMKLRGFCCSRGRGECFLIYDFASKGKLSNFLDIQEHETNQVLDWPARISIIKGI 525

Query: 297 AKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           AKGI YLH S +  KP IVHRN+SVEK+L+D+QFNPLIAD GLH LLADD+VFS LKTSA
Sbjct: 526 AKGIAYLHGSDQQKKPTIVHRNISVEKILLDEQFNPLIADSGLHNLLADDMVFSALKTSA 585

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
           AMGYLAPEYVTTG+FTE++DIFAFGVIILQIL+G L+LTSS+R+AAE+     FID  L+
Sbjct: 586 AMGYLAPEYVTTGKFTEKTDIFAFGVIILQILSGKLMLTSSLRIAAENGEHSGFIDEYLR 645

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            +F + EA  + ++ + CT E P NRP +E ++E++
Sbjct: 646 EEFDKPEAIAMARIGISCTQEIPNNRPNIETLLEDI 681

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449460425|ref|XP_004147946.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] gi|449494315|ref|XP_004159511.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 278/451 (61%), Positives = 343/451 (76%), Gaps = 8/451 (1%)

Query: 6   ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQI--NPVKPFGSHSNDTTPIDISEPS 63
            L++LN GFQ +NNPGLCG G  ++R CTV+DN  I  +  +PF S  N+T     + P 
Sbjct: 233 GLRKLNEGFQGENNPGLCGVGFVTVRKCTVFDNENIKGDGFQPFLSEPNNTATTQKNIPQ 292

Query: 64  G---FKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSES 120
               +  +CNQ  CS S++ P+IAV++AV  V+VIL  + IL  F YRR KQKIGN+S S
Sbjct: 293 SADFYNANCNQLHCSKSTRVPKIAVVSAVLIVSVILMVSMILTVFWYRRRKQKIGNSSLS 352

Query: 121 SDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVE 180
            D +LSTD   A++     ASPLV LEY HGWD L D + G G S ++L  F  N+EEVE
Sbjct: 353 CDDRLSTDQ--ARELYSKSASPLVCLEYSHGWDSLADGIKGLGLS-QYLGKFIFNVEEVE 409

Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           SATQ FSE NLLG+ +FS VYKG L+DG+ VAIRSIN+TSCKSEEAEF++GL LL+SLRH
Sbjct: 410 SATQYFSEANLLGRSSFSMVYKGVLKDGSCVAIRSINMTSCKSEEAEFLRGLNLLSSLRH 469

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
           EN++ LRGFCCSRGRGE FL+YDF  +G LS+YLD E+GSS+VL+WS RVSII GIAKGI
Sbjct: 470 ENLVTLRGFCCSRGRGEFFLVYDFVSRGSLSQYLDVEDGSSHVLEWSKRVSIINGIAKGI 529

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 360
            YLH  E NKPA+VH+++S+EK+LID QFN LI+D GL KLLADDI+FS LK+SAAMGYL
Sbjct: 530 AYLHHEEANKPAMVHKSISIEKILIDHQFNALISDSGLSKLLADDIIFSSLKSSAAMGYL 589

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
           APEY+T GRFTE+SDI+AFGVII QIL+G+  L +S+ L AE   FE+FIDRNLKG FSE
Sbjct: 590 APEYITIGRFTEKSDIYAFGVIIFQILSGTRRLANSLLLQAEVCKFEDFIDRNLKGNFSE 649

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           S+A KL  +AL CT+E P NRPT+E +IEEL
Sbjct: 650 SQATKLANLALSCTNELPINRPTIEDLIEEL 680

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	464
TAIR|locus:2132634	688	AT4G22730 [Arabidopsis thalian	0.948	0.639	0.607	7e-141
TAIR|locus:2153097	680	AT5G51560 [Arabidopsis thalian	0.959	0.654	0.540	7.6e-128
TAIR|locus:2050877	691	AT2G45340 [Arabidopsis thalian	0.956	0.642	0.530	6.5e-122
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.594	0.436	0.335	4.7e-48
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.590	0.446	0.341	2.6e-45
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.607	0.437	0.339	8.1e-44
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.581	0.692	0.347	1e-43
TAIR|locus:2171973	614	AT5G45780 [Arabidopsis thalian	0.599	0.452	0.346	1e-43
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.599	0.268	0.336	1.5e-43
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.594	0.413	0.341	1.7e-43

TAIR|locus:2132634 AT4G22730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
 Identities = 277/456 (60%), Positives = 344/456 (75%)

Query:     7 LKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQ-INPVK-PFGSHSNDTTPI-DISEPS 63
             LK+LNG FQF+NN GLCG    SLRAC+ +DN   I   K P G    D + + +I E  
Sbjct:   232 LKKLNGSFQFENNTGLCGIDFPSLRACSAFDNANNIEQFKQPPGEIDTDKSALHNIPESV 291

Query:    64 GFKEHCNQSQCS-NSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSD 122
               ++HCNQ+ C  +SSK PQ+A++++V +VT+ L G GIL FFRYRR KQKI NT E S+
Sbjct:   292 YLQKHCNQTHCKKSSSKLPQVALISSVITVTITLIGAGILTFFRYRRRKQKISNTPEFSE 351

Query:   123 WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSRE-HL----NSFRLNLE 177
              +LSTD    K+F    ASPLVSL Y   WDPLGD  NG  FS+E HL    +SFR NLE
Sbjct:   352 GRLSTDQQ--KEFR---ASPLVSLAYTKEWDPLGDSRNGAEFSQEPHLFVVNSSFRFNLE 406

Query:   178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
             ++ESATQCFSE NLL + +F+SV+KG LRDG+ VAIRSIN++SCK+EE EF+ GL LL+S
Sbjct:   407 DIESATQCFSEANLLSRNSFTSVFKGVLRDGSPVAIRSINISSCKNEEVEFMNGLKLLSS 466

Query:   238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN-VLDWSTRVSIIIGI 296
             L HEN+++LRGFCCSRGRGECFLIYDFA KGKLS +LD +E  +N VL WS R+SII GI
Sbjct:   467 LSHENLVKLRGFCCSRGRGECFLIYDFASKGKLSNFLDLQERETNLVLAWSARISIIKGI 526

Query:   297 AKGIGYLHSSEVNK-PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
             AKGI YLH S+  K P IVHRN+SVEK+L+D+QFNPLIAD GLH LLADD+VFS LKTSA
Sbjct:   527 AKGIAYLHGSDQQKKPTIVHRNISVEKILLDEQFNPLIADSGLHNLLADDMVFSALKTSA 586

Query:   356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
             AMGYLAPEYVTTG+FTE++DIFAFGVIILQIL+G L+LTSS+R AAE+     FID +L+
Sbjct:   587 AMGYLAPEYVTTGKFTEKTDIFAFGVIILQILSGKLMLTSSLRNAAENGEHNGFIDEDLR 646

Query:   416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              +F + EA  + ++ + CT E P NRP +E ++E +
Sbjct:   647 EEFDKPEATAMARIGISCTQEIPNNRPNIETLLENI 682

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2153097 AT5G51560 [Arabidopsis thaliana (taxid:3702)]

 Score = 1255 (446.8 bits), Expect = 7.6e-128, P = 7.6e-128
 Identities = 245/453 (54%), Positives = 322/453 (71%)

Query:     1 MIGN--EALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPID 58
             + GN    LKRLN GF F+NN GLCG   + L++C   + T     KP+G+        D
Sbjct:   227 LTGNVPPVLKRLNEGFSFENNLGLCGAEFSPLKSC---NGTAPEEPKPYGATVFGFPSRD 283

Query:    59 ISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTS 118
             I E +  +  CN + C+   K  Q A+L  +   T+ L+   IL+F  YRR KQK+  T 
Sbjct:   284 IPESANLRSPCNGTNCNTPPKSHQGAILIGLVVSTIALSAISILLFTHYRRRKQKLSTTY 343

Query:   119 ESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEE 178
             E SD +L+T   +   F +N  SPL SLEY +GWDPL D  N + F++E + SFR NLEE
Sbjct:   344 EMSDNRLNT---VGGGFRKNNGSPLASLEYTNGWDPLSDNRNLSVFAQEVIQSFRFNLEE 400

Query:   179 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL 238
             VE+ATQ FSEVNLLG+ NFS+ YKG LRDG+ VAI+  + TSCKSEE EF+KGL +L SL
Sbjct:   401 VETATQYFSEVNLLGRSNFSATYKGILRDGSAVAIKRFSKTSCKSEEPEFLKGLNMLASL 460

Query:   239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
             +HEN+ +LRGFCCSRGRGECFLIYDFAP G L  YLD ++G ++VLDWSTRVSI  GIAK
Sbjct:   461 KHENLSKLRGFCCSRGRGECFLIYDFAPNGNLLSYLDLKDGDAHVLDWSTRVSIAKGIAK 520

Query:   299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
             GI YLHS + +KPA+VH+N+S EKVLIDQ+++PL+++ GLH LL +DIVFS LK SAAMG
Sbjct:   521 GIAYLHSYKGSKPALVHQNISAEKVLIDQRYSPLLSNSGLHTLLTNDIVFSALKDSAAMG 580

Query:   359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
             YLAPEY TTGRFTE++D++AFG+++ QI++G   +   ++L  E+  F ++ID NL+G+F
Sbjct:   581 YLAPEYTTTGRFTEKTDVYAFGILVFQIISGKQKVRHLVKLGTEACRFNDYIDPNLQGRF 640

Query:   419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              E EA KL ++A +CTHE P  RP++EAV+ EL
Sbjct:   641 FEYEATKLARIAWLCTHESPIERPSVEAVVHEL 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2050877 AT2G45340 [Arabidopsis thaliana (taxid:3702)]

 Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
 Identities = 242/456 (53%), Positives = 316/456 (69%)

Query:     6 ALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF 65
             ALKRLN GFQ+ NN GLCGDG   L+ACT  +    NP +P  ++  + T +D+   S  
Sbjct:   231 ALKRLNNGFQYSNNHGLCGDGFTDLKACTGLNGP--NPNRPDPTNPTNFTTVDVKPESAD 288

Query:    66 --KEHC--NQSQCSNSS-KFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSES 120
               + +C  N   CS+ S K   + ++  +    + +A  G   F  YRR KQKIG++ ++
Sbjct:   289 LQRSNCSNNNGGCSSKSLKSSPLGIVMGLIGSILAVAIFGGSTFTWYRRRKQKIGSSLDA 348

Query:   121 SDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLG---DYLNGTGFSREHLNSFRLNLE 177
              D ++ST+    +   R  +SPL+SLEY  GWDPLG      N +  S+E   SF  NLE
Sbjct:   349 MDGRISTEYNFKEVSRRKSSSPLISLEYASGWDPLGRGQSSNNNSALSQEVFESFMFNLE 408

Query:   178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
             E+E ATQ FSE+NLLGK N SSVYKG LRDG++ AI+ I  +SCKS+E+EF+KGL +LT 
Sbjct:   409 EIERATQSFSEINLLGKSNVSSVYKGILRDGSVAAIKCIAKSSCKSDESEFLKGLKMLTL 468

Query:   238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
             L+HEN+ RLRGFCCS+GRGECFLIY+F P G L +YLD ++ +  VL+W+TRVSII GIA
Sbjct:   469 LKHENLARLRGFCCSKGRGECFLIYEFVPNGNLLQYLDVKDETGEVLEWATRVSIINGIA 528

Query:   298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
             +GI YLH    NKPAIVH+NLS EK+LID  +NP +AD GLHKL  DDIVFS LK SAAM
Sbjct:   529 RGIVYLHGENGNKPAIVHQNLSAEKILIDHWYNPSLADSGLHKLFTDDIVFSKLKASAAM 588

Query:   358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-AAESATF-ENFIDRNLK 415
             GYLAPEY+TTGRFT++SD++AFG+I+LQIL+G   ++  M L A ES    E+F+D NL+
Sbjct:   589 GYLAPEYITTGRFTDKSDVYAFGMILLQILSGKSKISHLMILQAVESGRLNEDFMDPNLR 648

Query:   416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               F E EAA+L ++ L+CTHE    RP+ME VI+EL
Sbjct:   649 KNFPEVEAAQLARLGLLCTHESSNQRPSMEDVIQEL 684

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 460 (167.0 bits), Expect = 4.7e-48, Sum P(2) = 4.7e-48
 Identities = 100/298 (33%), Positives = 166/298 (55%)

Query:   168 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE 227
             HL   R   +E+ SAT  F+  N+LG+G +  VYKG L DGTLVA++ +   +    E +
Sbjct:   285 HLK--RYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQ 342

Query:   228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
             F   +  ++   H N++RLRGFC S    E  L+Y + P G ++  L         LDWS
Sbjct:   343 FQTEVETISLALHRNLLRLRGFCSSNQ--ERILVYPYMPNGSVASRLKDNIRGEPALDWS 400

Query:   288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADD 345
              R  I +G A+G+ YLH  E   P I+HR++    +L+D+ F  ++ D GL KLL   D 
Sbjct:   401 RRKKIAVGTARGLVYLH--EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458

Query:   346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL------------VL 393
              V + ++    +G++APEY++TG+ +E++D+F FG+++L+++TG              V+
Sbjct:   459 HVTTAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM 516

Query:   394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                ++   +    +  ID++L  KF   E  ++ ++AL+CT  +P +RP M  V++ L
Sbjct:   517 LDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 439 (159.6 bits), Expect = 2.6e-45, Sum P(2) = 2.6e-45
 Identities = 100/293 (34%), Positives = 159/293 (54%)

Query:   173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 232
             R    E++ AT  FSE N+LG+G F  VYKG L D T VA++ +        +A F + +
Sbjct:   277 RFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREV 336

Query:   233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
              +++   H N++RL GFC ++   E  L+Y F     L+  L + +    VLDW TR  I
Sbjct:   337 EMISVAVHRNLLRLIGFCTTQT--ERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRI 394

Query:   293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +G A+G  YLH  E   P I+HR++    VL+D+ F  ++ D GL KL+         +
Sbjct:   395 ALGAARGFEYLH--EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQ 452

Query:   353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------ 406
                 MG++APEY++TG+ +ER+D+F +G+++L+++TG   +  S RL  E          
Sbjct:   453 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS-RLEEEDDVLLLDHVK 511

Query:   407 --EN------FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               E        +D+NL G++ + E   + ++AL+CT   PE+RP M  V+  L
Sbjct:   512 KLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRML 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 462 (167.7 bits), Expect = 8.1e-44, P = 8.1e-44
 Identities = 103/303 (33%), Positives = 172/303 (56%)

Query:   171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
             S + + + +E+AT CF  +N LG+G F  VYKGTL  G  VA++ ++ TS + E+ EF  
Sbjct:   311 SLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEK-EFEN 369

Query:   231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
              + ++  L+H N+++L G+C   G  E  L+Y+F P   L  +L         LDW+ R 
Sbjct:   370 EVVVVAKLQHRNLVKLLGYCLE-GE-EKILVYEFVPNKSLDHFLFDSTMKMK-LDWTRRY 426

Query:   291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
              II GIA+GI YLH    ++  I+HR+L    +L+D   NP IAD G+ ++   D   ++
Sbjct:   427 KIIGGIARGILYLHQD--SRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAM 484

Query:   351 LK-TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----SL---------VLTSS 396
              +      GY++PEY   G+F+ +SD+++FGV++L+I++G    SL         ++T +
Sbjct:   485 TRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYT 544

Query:   397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              RL +  +  E  +D +    +  SE  +   +AL+C  ED E+RPTM ++++ LT +  
Sbjct:   545 WRLWSNGSPSE-LVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLI 603

Query:   457 VMA 459
              +A
Sbjct:   604 ALA 606

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 1.0e-43, P = 1.0e-43
 Identities = 100/288 (34%), Positives = 167/288 (57%)

Query:   178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
             E+  AT  FS  N +G+G F SVYKG L+DG L AI+ ++  S +  + EF+  + +++ 
Sbjct:    33 EIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAESRQGVK-EFLTEINVISE 91

Query:   238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIG 295
             ++HEN+++L G CC  G     L+Y+F     L K L       S    DWS+R +I +G
Sbjct:    92 IQHENLVKLYG-CCVEGNHR-ILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRANICVG 149

Query:   296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
             +AKG+ +LH  EV +P I+HR++    +L+D+  +P I+D GL +L+  ++     + + 
Sbjct:   150 VAKGLAFLHE-EV-RPHIIHRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVSTRVAG 207

Query:   356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----SLVLTSSMRLAAESA--TFE-- 407
              +GYLAPEY   G+ T ++DI++FGV++++I++G    +  L +  +   E A   +E  
Sbjct:   208 TIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQYLLERAWELYERN 267

Query:   408 ---NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                + +D  L G F   EA +  K+ L+CT + P+ RP+M  V+  LT
Sbjct:   268 ELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLLT 315

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 1.0e-43, P = 1.0e-43
 Identities = 105/303 (34%), Positives = 173/303 (57%)

Query:   164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 223
             F   HL  F  +  E+++AT  FS  N+LG+G F  VYKG L +GT+VA++ +      +
Sbjct:   280 FEIGHLKRF--SFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLK-DPIYT 336

Query:   224 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV 283
              E +F   + ++    H N++RL GFC +    E  L+Y + P G ++  L    G    
Sbjct:   337 GEVQFQTEVEMIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNYGEKPS 394

Query:   284 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL- 342
             LDW+ R+SI +G A+G+ YLH  + N P I+HR++    +L+D+ F  ++ D GL KLL 
Sbjct:   395 LDWNRRISIALGAARGLVYLHE-QCN-PKIIHRDVKAANILLDESFEAIVGDFGLAKLLD 452

Query:   343 -ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG------------ 389
               D  V + ++    +G++APEY++TG+ +E++D+F FGV+IL+++TG            
Sbjct:   453 QRDSHVTTAVR--GTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVR 510

Query:   390 -SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 448
               ++L+    L AE   F   +DR+LKG+F +    ++ ++AL+CT   P  RP M  V+
Sbjct:   511 KGMILSWVRTLKAEKR-FAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVL 569

Query:   449 EEL 451
             + L
Sbjct:   570 KVL 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009560 "embryo sac egg cell differentiation" evidence=RCA

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 448 (162.8 bits), Expect = 1.5e-43, Sum P(2) = 1.5e-43
 Identities = 99/294 (33%), Positives = 163/294 (55%)

Query:   169 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF 228
             L +    L++++ AT  F   N +G+G F  VYKG L DG  +A++ ++  S K    EF
Sbjct:   650 LQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKS-KQGNREF 708

Query:   229 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
             V  + ++++L+H N+++L G CC  G+ E  L+Y++     L++ L   E     LDWST
Sbjct:   709 VTEIGMISALQHPNLVKLYG-CCIEGK-ELLLVYEYLENNSLARALFGTEKQRLHLDWST 766

Query:   289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 348
             R  + IGIAKG+ YLH  E ++  IVHR++    VL+D   N  I+D GL KL  ++   
Sbjct:   767 RNKVCIGIAKGLAYLH--EESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTH 824

Query:   349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM 397
                + +  +GY+APEY   G  T+++D+++FGV+ L+I++G            + L    
Sbjct:   825 ISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWA 884

Query:   398 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              +  E  +    +D +L   FS+ EA ++  +AL+CT+  P  RP M +V+  L
Sbjct:   885 YVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSML 938

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 416 (151.5 bits), Expect = 1.7e-43, Sum P(2) = 1.7e-43
 Identities = 102/299 (34%), Positives = 159/299 (53%)

Query:   170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV 229
             +S   + + +E+AT  FS  N LG+G F +VYKG L +GT VA++ ++  S +    EF 
Sbjct:   334 DSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTR-EFR 392

Query:   230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
                 L+T L+H N++RL GFC  R   E  LIY+F     L  +L   E  S  LDW+ R
Sbjct:   393 NEAVLVTKLQHRNLVRLLGFCLERE--EQILIYEFVHNKSLDYFLFDPEKQSQ-LDWTRR 449

Query:   290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA-DDIVF 348
               II GIA+GI YLH     K  I+HR+L    +L+D   NP IAD GL  +   +    
Sbjct:   450 YKIIGGIARGILYLHQDSRLK--IIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQG 507

Query:   349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL---------------VL 393
             +  + +    Y++PEY   G+++ +SDI++FGV++L+I++G                 ++
Sbjct:   508 NTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLV 567

Query:   394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
             T + RL    +  E  +D      +  +E  +   +AL+C  E+PE+RP +  +I  LT
Sbjct:   568 TYASRLWRNKSPLE-LVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTIILMLT 625

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_scaffold_127000014 hypothetical protein (682 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	464
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-14
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-09
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-05
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.001
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.002
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.002
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	0.003
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (372), Expect = 5e-41
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 35/280 (12%)

Query: 190 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
             LG+G F  VYKG L+      T VA++++   + + E  +F+K   ++  L H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIGIAKGI 300
           L G C        +L+ ++   G L  YL            + L     +S  I IAKG+
Sbjct: 61  LLGVC--TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--G 358
            YL S    K   VHR+L+    L+ +     I+D GL + + DD  +   KT   +   
Sbjct: 119 EYLAS---KK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIR 172

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---SATFENFIDRNLK 415
           ++APE +  G FT +SD+++FGV++ +I T          L A      + E  ++   K
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEYLRK 222

Query: 416 G---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           G      E    +L ++ L C   DPE+RPT   ++E L 
Sbjct: 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  145 bits (369), Expect = 1e-40
 Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 18/265 (6%)

Query: 192 LGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G F  VYKGTL+         VA++++   + + +  EF++   ++  L H NI++L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G C         ++ ++ P G L  YL +       L  S  +S  + IA+G+ YL S 
Sbjct: 67  LGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES- 121

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              K   +HR+L+    L+ +     I+D GL + L DD  + V      + ++APE + 
Sbjct: 122 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 426
            G+FT +SD+++FGV++ +I T        M     +A    ++ +  +     +   +L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM----SNAEVLEYLKKGYRLPKPPNCPPEL 233

Query: 427 GKMALVCTHEDPENRPTMEAVIEEL 451
            K+ L C  EDPE+RPT   ++E L
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  145 bits (368), Expect = 2e-40
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 192 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G F  VYKG L+         VA++++   + + +  EF++   ++  L H N+++L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G C        +++ ++   G L  YL     +   L  S  +S  + IA+G+ YL S 
Sbjct: 67  LGVCTEEEPL--YIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              K   +HR+L+    L+ +     I+D GL + L DD  +        + ++APE + 
Sbjct: 121 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA--- 423
            G+FT +SD+++FGV++ +I T        M       + E  ++    G          
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-------SNEEVLEYLKNGYRLPQPPNCP 229

Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEEL 451
            +L  + L C  EDPE+RPT   ++E L
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  134 bits (340), Expect = 5e-37
 Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 53/264 (20%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG+G F +VY    +  G  VAI+ I      S   E ++ + +L  L H NI++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                   +L+ ++   G L   L + EG    L     + I++ I +G+ YLHS+    
Sbjct: 61  --EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSNG--- 112

Query: 311 PAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE-YVTT 367
             I+HR+L  E +L+D       +AD GL KLL  D   S+LKT      Y+APE  +  
Sbjct: 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGK 168

Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
           G ++E+SDI++ GVI+ ++                    ++ I +               
Sbjct: 169 GYYSEKSDIWSLGVILYEL-----------------PELKDLIRK--------------- 196

Query: 428 KMALVCTHEDPENRPTMEAVIEEL 451
                   +DPE RP+ + ++E L
Sbjct: 197 -----MLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  124 bits (315), Expect = 7e-33
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 30/271 (11%)

Query: 192 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G F  VYKGTL+       T VA++++   + + E  EF++   ++  L H NI+RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G C        +++ ++ P G L  +L +       L     + + + IAKG+ YL S 
Sbjct: 67  LGVC--TQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLES- 120

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----A 361
              K   VHR+L+    L+ +     I+D GL + + +D  +         G L     A
Sbjct: 121 ---KN-FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMA 172

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-FENFIDRNLKGKFSE 420
           PE +  G+FT +SD+++FGV++ +I T              S       ++   +    E
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL-----GEQPYPGMSNEEVLELLEDGYRLPRPE 227

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +   +L ++ L C   DPE+RPT   ++E+L
Sbjct: 228 NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  120 bits (304), Expect = 2e-31
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 30/275 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 243
           +  +  LG G+F +VYK   +  G +VA++ +   S KS++ +  +  + +L  L H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +RL      +     +L+ ++   G L  YL +       L       I + I +G+ YL
Sbjct: 61  VRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYL 114

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 361
           HS+      I+HR+L  E +L+D+     IAD GL K L   +  S   T+      Y+A
Sbjct: 115 HSN-----GIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMA 166

Query: 362 PEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
           PE +  G  +  + D+++ GVI+ ++LTG    +    L          I R L      
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ-----LIRRILGPPLEF 221

Query: 421 SEAAKLGKMALV------CTHEDPENRPTMEAVIE 449
            E                C ++DP  RPT E +++
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (286), Expect = 1e-28
 Identities = 67/282 (23%), Positives = 127/282 (45%), Gaps = 27/282 (9%)

Query: 189 VNLLGKGNFSSVYKGT---LRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +  LG+G+F  V       L D T   VA++S+N +  +   ++F + + +L +L HENI
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ +G C   G     LI ++ P G L  YL   +   + ++    +     I KG+ YL
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGYL 360
            S        +HR+L+   +L++ +    I+D GL K+L +D  +  +K    S    Y 
Sbjct: 126 GSQRY-----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT----------GSLVLTSSMRLAAESATFENFI 410
           APE + T +F+  SD+++FGV + ++ T            L +    +           +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
               +     S   ++  +  +C   +P++RP+   +I  + 
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  111 bits (281), Expect = 3e-28
 Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  +  LG+G+F  VY     + G LVAI+ I     K +    ++ + +L  L+H NI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           RL          + +L+ ++   G L   L +       L        +  I   + YLH
Sbjct: 61  RLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLH 114

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 363
           S       IVHR+L  E +L+D+  +  +AD GL + L        L T      Y+APE
Sbjct: 115 S---KG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPE 166

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--- 420
            +    + +  DI++ GVI+ ++LTG        +L      F+            E   
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDI 223

Query: 421 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           S  AK  + K+ LV   +DPE R T E  ++
Sbjct: 224 SPEAKDLIRKL-LV---KDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 65/267 (24%), Positives = 122/267 (45%), Gaps = 23/267 (8%)

Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
            +GKGNF  VYKG L+  T VA+++   T     + +F++   +L    H NI++L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               +   +++ +  P G L  +L       N L     + + +  A G+ YL S     
Sbjct: 62  VQ--KQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----YLAPEYV 365
              +HR+L+    L+ +     I+D G+ +   +  +++V   S  +      + APE +
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTV---SDGLKQIPIKWTAPEAL 167

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
             GR+T  SD++++G+++ +  +        M   +   T E  I+   +    +    +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGM---SNQQTRE-RIESGYRMPAPQLCPEE 223

Query: 426 LGKMALVCTHEDPENRPTMEAVIEELT 452
           + ++ L C   DPENRP+   +  EL 
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 6e-26
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 17/255 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+ GT    T VA++++   +   E   F++   ++  LRH+ +++L   C 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVC- 70

Query: 252 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                E  +++ ++  KG L  +L   EG    L     V +   IA+G+ YL S     
Sbjct: 71  --SEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESRNY-- 124

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 370
              +HR+L+   +L+ +     IAD GL +L+ DD   +       + + APE    GRF
Sbjct: 125 ---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 371 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 430
           T +SD+++FG+++ +I+T   V    M         E  ++R  +     +   +L  + 
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQ-VERGYRMPRPPNCPEELYDLM 237

Query: 431 LVCTHEDPENRPTME 445
           L C  +DPE RPT E
Sbjct: 238 LQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (263), Expect = 1e-25
 Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 19/268 (7%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           F+    LG G F  V++G  ++   VAI+ +       ++ +F K +  L  LRH+++I 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLIS 66

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L   C S G    ++I +   KG L  +L   EG   VL  ++ + +   +A+G+ YL  
Sbjct: 67  LFAVC-SVGE-PVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE 122

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                   +HR+L+   +L+ +     +AD GL +L+ +D V+          + APE  
Sbjct: 123 QN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAA 176

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF--IDRNLKGKFSESEA 423
           + G F+ +SD+++FG+++ ++ T   V    M         E +  I    +        
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM------NNHEVYDQITAGYRMPCPAKCP 230

Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEEL 451
            ++ K+ L C   +PE+RP+ +A+ EEL
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (260), Expect = 4e-25
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 16/209 (7%)

Query: 189 VNLLGKGNFSSVYK---GTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +  LGKGNF SV       L+D T  +VA++ +  ++      +F + + +L SL+H+NI
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNI 67

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ +G C S GR    L+ ++ P G L  YL +       LD    +     I KG+ YL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 361
            S        VHR+L+   +L++ +    I D GL K+L  D  +  ++    + + + A
Sbjct: 125 GSKRY-----VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE +T  +F+  SD+++FGV++ ++ T S
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 189 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRL 246
             LLG+G+F SVY    +D G L+A++S+ ++    EE E ++  + +L+SL+H NI+R 
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVSIIIGIAKGIGY 302
            G      +    +  ++   G LS  L +     E    +  ++ +      I +G+ Y
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--PVIRKYTRQ------ILEGLAY 116

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS   N   IVHR++    +L+D      +AD G  K L D        +    G   +
Sbjct: 117 LHS---NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR--GTPYW 169

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           +APE +    +   +DI++ G  ++++ TG
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 9e-24
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 35/280 (12%)

Query: 189 VNLLGKGNFSSVYKGTLR-DGTL----VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           + +LG G F +VYKG    +G      VAI+ +   +      E +   Y++ S+ H ++
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGI 300
           +RL G C S    +  LI    P G L  Y+   +   GS  +L+W  +      IAKG+
Sbjct: 72  VRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGM 122

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--- 357
            YL         +VHR+L+   VL+    +  I D GL KLL  D+              
Sbjct: 123 SYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL--DVDEKEYHAEGGKVPI 175

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
            ++A E +    +T +SD++++GV + +++T        +         E         +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK------GER 229

Query: 418 FSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 455
             +     +   M LV C   D E+RPT + +I E +  A
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 27/267 (10%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 71

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSE 307
              +   ++I +F  KG L  +L  +EGS      ++D+S +      IA+G+ +     
Sbjct: 72  ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF----- 117

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
           + +   +HR+L    +L+       IAD GL +++ D+   +       + + APE +  
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177

Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
           G FT +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L 
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELY 233

Query: 428 KMALVCTHEDPENRPT---MEAVIEEL 451
            + + C    PE RPT   +++V+++ 
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-----EFVKGLYLLTSLRHENIIR 245
            +G+G F  VY+G         I ++ V +CK+  +     +F++  Y++    H +I++
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKI-AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G          +++ + AP G+L  YL         LD ++ +     ++  + YL S
Sbjct: 72  LIGVITEN---PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES 125

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                   VHR+++   VL+       + D GL + L D+  +   K    + ++APE +
Sbjct: 126 KR-----FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 366 TTGRFTERSDIFAFGVIILQIL 387
              RFT  SD++ FGV + +IL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 62/256 (24%), Positives = 120/256 (46%), Gaps = 17/256 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V++G   + T VA++++   +   +  +F+    ++  LRH  +I+L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 252 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                E  +++ +    G L +YL    G +  L     + +   +A G+ YL +     
Sbjct: 72  ---LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN--- 123

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 370
              +HR+L+   VL+ +     +AD GL +++ +DI  +       + + APE     RF
Sbjct: 124 --YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 371 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 430
           + +SD+++FG+++ +I+T   +    M     +A     +D+  +         +L  + 
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGM----TNAEVLQQVDQGYRMPCPPGCPKELYDIM 237

Query: 431 LVCTHEDPENRPTMEA 446
           L C  EDP++RPT E 
Sbjct: 238 LDCWKEDPDDRPTFET 253

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 66/263 (25%), Positives = 123/263 (46%), Gaps = 14/263 (5%)

Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LLGKGNF  V+KGTL+D T VA+++      +  + +F+    +L    H NI++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               R   +++ +  P G    +L +++   + L     V   +  A G+ YL S     
Sbjct: 62  TQ--RQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 370
              +HR+L+    L+ +     I+D G+ +   D I  S       + + APE +  GR+
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 371 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 430
           +  SD++++G+++ +  T SL +     +  + A  +  +++  +    +     + K+ 
Sbjct: 172 SSESDVWSYGILLWE--TFSLGVCPYPGMTNQQAREQ--VEKGYRMSCPQKCPDDVYKVM 227

Query: 431 LVCTHEDPENRPTMEAVIEELTV 453
             C    PENRP    + +EL  
Sbjct: 228 QRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 68/266 (25%), Positives = 127/266 (47%), Gaps = 31/266 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 243
           F  +N +GKG+F  V+K   + D  + A++ I+++   + E  E +    +L  L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIG 301
           IR   +     +G+  ++ ++A  G L K L  + G        W   + I++G+A    
Sbjct: 62  IRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGY 359
           +LHS +     I+HR++    + +D   N  I D G+ KLL+D+  F  +++ T     Y
Sbjct: 116 HLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY---Y 167

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF- 418
           L+PE      + E+SD++A GV++ +  TG     ++ + A         I + ++G F 
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGVFP 219

Query: 419 --SESEAAKLGKMALVCTHEDPENRP 442
             S+  + +L ++   C  +D   RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 5e-21
 Identities = 90/281 (32%), Positives = 138/281 (49%), Gaps = 43/281 (15%)

Query: 188 EVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN-VTSCKSEE-AEFVKGLYLLTSLRHENII 244
           E N++ +G   + YKG ++++G    ++ IN V S  S E A+  K       L+H NI+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK-------LQHPNIV 746

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L G C  R     +LI+++     LS+ L         L W  R  I IGIAK + +LH
Sbjct: 747 KLIGLC--RSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLH 797

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                 PA+V  NLS EK++ID +  P +    L  LL  D       +SA   Y+APE 
Sbjct: 798 CR--CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--TKCFISSA---YVAPET 849

Query: 365 VTTGRFTERSDIFAFGVIILQILTG------------SLVLTSSMRLAAESATFENFIDR 412
             T   TE+SDI+ FG+I++++LTG            S+V     R        + +ID 
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDP 907

Query: 413 NLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +++G  S  ++E  ++  +AL CT  DP  RP    V++ L
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.3 bits (226), Expect = 8e-21
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 16/256 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRH+ ++ L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ +F  KG L  +L  +EG    L     V +   IA G+ Y     + + 
Sbjct: 72  EE---PIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAY-----IERM 121

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L    +L+       IAD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ +++T   V    M         E  ++R  +    +     L ++  
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQ-VERGYRMPCPQGCPESLHELMK 237

Query: 432 VCTHEDPENRPTMEAV 447
           +C  +DP+ RPT E +
Sbjct: 238 LCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 9e-21
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 36/271 (13%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+ G  R    VAI+ I   +  SE+ +F++   ++  L H N+++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SED-DFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F++ ++   G L  YL + +G    L     + +   + + + YL S+     
Sbjct: 70  KQR--PIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGF--- 121

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L+ +     ++D GL + + DD   S   T   + +  PE     RF+
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FGV++ ++ +                 +E F   N +   S S   +L +  L
Sbjct: 180 SKSDVWSFGVLMWEVFSEG------------KMPYERF--SNSEVVESVSAGYRLYRPKL 225

Query: 432 V----------CTHEDPENRPTMEAVIEELT 452
                      C HE PE+RP  + ++ +LT
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 16/254 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+ GT    T VA++++   +   E   F++   ++  LRH+ +++L     
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L   EG +  L     V +   +A G+ Y     + + 
Sbjct: 72  EE---PIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAY-----IERM 121

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L    +L+       IAD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ +++T   V    M         E  ++R  +    +     L ++ L
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ-VERGYRMPCPQDCPISLHELML 237

Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 238 QCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 16/257 (6%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  LG G F  V+ G     T VAI+S+   S       F+    L+  L+H  ++RL  
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                 +   ++I ++   G L  +L   EG    L  +  + +   IA+G+ ++     
Sbjct: 69  VVT---QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY 123

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                +HR+L    +L+ +     IAD GL +L+ D+   +       + + APE +  G
Sbjct: 124 -----IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
            FT +SD+++FG+++ +I+T   +    M         +N ++R  +    ++   +L +
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQN-LERGYRMPRPDNCPEELYE 234

Query: 429 MALVCTHEDPENRPTME 445
           +  +C  E PE RPT E
Sbjct: 235 LMRLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 64/280 (22%), Positives = 128/280 (45%), Gaps = 29/280 (10%)

Query: 187 SEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
            E+  LG+G F  V+    +        TLV ++++  T  ++ ++EF + L +   L H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG 295
           +N++RL G C  R     ++I ++   G L ++L       E+     L    +V++   
Sbjct: 68  KNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           IA G+ +L ++       VHR+L+    L+  Q    ++   L K + +   + +     
Sbjct: 126 IALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--- 412
            + +LAPE V    F+ +SD+++FGV++ ++ T          L     + E  ++R   
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-------QGELPFYGLSDEEVLNRLQA 233

Query: 413 -NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             L+    E   ++L K+   C   +P++RP+   ++  L
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 192 LGKGNFSSVY------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  V       +G    G  VA++S+   S  +  A+  K + +L +L HENI++
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +G C   G     LI +F P G L +YL +   + N ++   ++   + I KG+ YL S
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPE 363
            +      VHR+L+   VL++ +    I D GL K +  D  +  +K    + + + APE
Sbjct: 128 RQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F   SD+++FGV + ++LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 72  EE---PIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAY-----VERM 121

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGYRMPCPPECPESLHDLMC 237

Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 238 QCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 11  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 66

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----DWSTRVSIIIGIAKGIGYLH 304
           +         ++I ++  KG L  +L  +EG   +L    D+S +      IA+G+ Y  
Sbjct: 67  YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAY-- 118

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
              + +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE 
Sbjct: 119 ---IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +  G FT +SD+++FG+++ +I+T   +    M     ++   + + R  +    E+   
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRMPRMENCPD 231

Query: 425 KLGKMALVCTHEDPENRPTME 445
           +L  +   C  E  E RPT +
Sbjct: 232 ELYDIMKTCWKEKAEERPTFD 252

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  VYKG L         T VAI+++   +    + EF +   L++ L+H NI+ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 293
           L G C ++ +  C L +++   G L ++L              +E   + LD S  + I 
Sbjct: 73  LLGVC-TKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
           I IA G+ YL S        VHR+L+    L+ +     I+D GL + +     + V   
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 354 SA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
           S   + ++ PE +  G+FT  SDI++FGV++ +I
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 16/210 (7%)

Query: 185 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
             ++  ++G G F  V++G L    R    VAI+++     + +  +F+    ++    H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            NIIRL G           +I ++   G L KYL   +G  +       V ++ GIA G+
Sbjct: 66  HNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGM 120

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 358
            YL  S++N    VHR+L+   +L++      ++D GL ++L DD    ++       + 
Sbjct: 121 KYL--SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + APE +   +FT  SD+++FG+++ ++++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 32/277 (11%)

Query: 192 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  VY+G  +        T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSII---IGIAKG 299
           L G   S G+    ++ +   KG L  YL     E  ++  L   T    I     IA G
Sbjct: 74  LLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 357
           + YL + +      VHR+L+    ++ +     I D G+      DI  +    K    +
Sbjct: 132 MAYLAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYETDYYRKGGKGL 182

Query: 358 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
               ++APE +  G FT +SD+++FGV++ ++ T  L       L+ E      F+    
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVL--KFVIDGG 238

Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                E+   KL ++  +C   +P+ RPT   ++  L
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 37/287 (12%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTL----VAIRSINVTSCKSEEAEFVKGLYLLTS 237
                ++ LLG G F +V+KG  + +G      VAI++I   S +    E    +  + S
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIII 294
           L H  I+RL G C         L+   +P G L  ++ Q   S +   +L+W  +     
Sbjct: 66  LDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ----- 117

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVL 351
            IAKG+ YL         +VHRNL+   +L+       IAD G+  LL  D     +S  
Sbjct: 118 -IAKGMYYLEEH-----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 411
           KT   + ++A E +  GR+T +SD++++GV + ++++      + MR        E    
Sbjct: 172 KTP--IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---- 225

Query: 412 RNLKG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 455
              KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 226 ---KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 66/275 (24%), Positives = 129/275 (46%), Gaps = 31/275 (11%)

Query: 187 SEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           SE+ L   +G G F  V+ G   +   VAI++I      SEE +F++   ++  L H  +
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEE-DFIEEAQVMMKLSHPKL 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L G C  R      L+++F   G LS YL  + G        T + + + + +G+ YL
Sbjct: 62  VQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
            SS V     +HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE
Sbjct: 117 ESSNV-----IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGK 417
             +  +++ +SD+++FGV++ ++        S  +   E+ +    ++      R  K +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVF-------SEGKTPYENRSNSEVVETINAGFRLYKPR 224

Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
            +     +L +    C  E PE+RP+   ++ +L 
Sbjct: 225 LASQSVYELMQH---CWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 30/274 (10%)

Query: 190 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++GKG+F  VY GTL D        A++S+N  +   E  +F+K   ++    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G C     G   ++  +   G L  ++  E  +  V D    +   + +AKG+ YL S
Sbjct: 61  LLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLAS 116

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLAP 362
            +      VHR+L+    ++D+ F   +AD GL + + D   +SV   + A   + ++A 
Sbjct: 117 KK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGK 417
           E + T +FT +SD+++FGV++ +++T         R A      +S     ++ +  +  
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVDSFDITVYLLQGRRLL 222

Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             E     L ++ L C H  PE RPT   ++  +
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 35/282 (12%)

Query: 190 NLLGKGNFSSVYKGTLRD----GT---LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           N LG G F  VY+GT  D    G+    VA++++   +   E+ EF+K  +L+++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 299
           I++L G C        ++I +    G L  YL     E     +L     + I + +AKG
Sbjct: 61  IVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTS 354
             YL      +   +HR+L+    L+ ++         I D GL    A DI  S     
Sbjct: 119 CVYLE-----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL----ARDIYKSDYYRK 169

Query: 355 AAMG-----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
              G     ++APE +  G+FT +SD+++FGV++ +ILT    L      A  +      
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----LGQQPYPALNNQEVLQH 225

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    + +  E+   K+ ++   C  +DP  RPT + + E L
Sbjct: 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 53/285 (18%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 243
           +  +  +GKG+F  VY      DG L  ++ I++++   +E E     + +L  L H NI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 244 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQ--EEGSS----NVLDWSTRV 290
           I+           E F        + ++A  G LS+ + +  +EG       +LDW  + 
Sbjct: 62  IKYY---------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ- 111

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
                +   + YLHS    K  I+HR++  + + +       + D G+ K+L+      +
Sbjct: 112 -----LCLALKYLHS---RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDL 159

Query: 351 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 407
            KT    G   YL+PE      +  +SDI++ G ++ ++ T        ++   E     
Sbjct: 160 AKTVV--GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT--------LKHPFEGENLL 209

Query: 408 NFIDRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
               + LKG++       +++L  +      +DPE RP++  +++
Sbjct: 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.6 bits (218), Expect = 4e-19
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 29/280 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIR--SINVTSCKSEEAEFVKGLYLLTSLRHE-NIIR 245
           +  LG+G+F  VY    RD  LVA++  +  + S   E   F++ + +L SL H  NI++
Sbjct: 5   LRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L  F   +  G  +L+ ++   G L   L  + G    L  S  + I+  I   + YLHS
Sbjct: 63  LYDFF--QDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKLLADDIVFSVLKTSAA-----MGY 359
                  I+HR++  E +L+D+      + D GL KLL D    S +    +      GY
Sbjct: 120 K-----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 360 LAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------- 409
           +APE +        +  SDI++ G+ + ++LTG          +A S T +         
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           +   L     E  +     +      +DP+NR +  + + 
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 185 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
             +   ++G G F  V +G L    +    VAI+++   S   +  +F+    ++    H
Sbjct: 5   YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64

Query: 241 ENIIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
            NIIRL G      +    +I  ++   G L K+L + +G          V ++ GIA G
Sbjct: 65  PNIIRLEGVVT---KSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASG 118

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMG 358
           + YL  SE+N    VHR+L+   +L++      ++D GL + L D +  ++       + 
Sbjct: 119 MKYL--SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + APE +   +FT  SD+++FG+++ ++++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 64/263 (24%), Positives = 121/263 (46%), Gaps = 18/263 (6%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+GNF  V+ G LR D T VA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               +   +++ +    G    +L + EG    L     + ++   A G+ YL S     
Sbjct: 63  TQ--KQPIYIVMELVQGGDFLTFL-RTEGPR--LKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV--LKTSAAMGYLAPEYVTTG 368
              +HR+L+    L+ ++    I+D G+ +   D +  S   +K    + + APE +  G
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVKWTAPEALNYG 171

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
           R++  SD+++FG+++ +  +    L +       +      I++ ++    E     + +
Sbjct: 172 RYSSESDVWSFGILLWEAFS----LGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227

Query: 429 MALVCTHEDPENRPTMEAVIEEL 451
           +   C   DP  RP+   V +EL
Sbjct: 228 LMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 8e-19
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 28/222 (12%)

Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVK 230
           L+E E        V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+ 
Sbjct: 4   LKETE-----LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD 58

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 287
              ++ S+ H +++RL G C S       L+    P G L  Y+ + +   GS  +L+W 
Sbjct: 59  EALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 346
            +      IAKG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+ 
Sbjct: 116 VQ------IAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            ++       + ++A E +   +FT +SD++++GV I +++T
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 32/218 (14%)

Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+ G         D  LVA++++  T+      +F +   LLT+ +HENI++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 246 LRGFCCSRGRGEC-FLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVS 291
             G C     G+   +++++   G L+K+L             D   G    L  S  + 
Sbjct: 73  FYGVC---TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE---LTLSQLLQ 126

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           I + IA G+ YL S        VHR+L+    L+       I D G+ + +     + V 
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181

Query: 352 -KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
             T   + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 48/275 (17%)

Query: 192 LGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           LG GNF SV KG      G    VA++++      + + EF++   ++  L H  I+RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 248 GFCCSRGRGECF-LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           G C    +GE   L+ + AP G L KYL   +E   S++ + + +V      A G+ YL 
Sbjct: 63  GVC----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE 112

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAP 362
           S        VHR+L+   VL+  +    I+D G+ + L     +    T+    + + AP
Sbjct: 113 SKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167

Query: 363 EYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDR 412
           E +  G+F+ +SD++++GV + +           + G+ V+                ++ 
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA--------------MLES 213

Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
             +    E    ++  + L C    PE+RPT   +
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 28/268 (10%)

Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSI--NVTSCKS--EEAEFVKGLYLLTSLRHENIIRL 246
            +GKG F  V  G  R G  VA++ +  + T+ ++   EA        +T+LRH N+++L
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASV------MTTLRHPNLVQL 65

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G          +++ ++  KG L  YL     +   L    ++   + + +G+ YL   
Sbjct: 66  LGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK 121

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
                  VHR+L+   VL+ +     ++D GL    A +           + + APE + 
Sbjct: 122 N-----FVHRDLAARNVLVSEDLVAKVSDFGL----AKEASQGQDSGKLPVKWTAPEALR 172

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 426
             +F+ +SD+++FG+++ +I +   V    + L       E       + +  E    ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----GYRMEAPEGCPPEV 228

Query: 427 GKMALVCTHEDPENRPTMEAVIEELTVA 454
            K+   C   DP  RPT + + E+L + 
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 186 FSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 243
           F  +  LGKG++ SVYK   L D    A++ +++ S  + E  + V  + +L S+ H NI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 244 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
           I  +         E FL       + ++AP G LSK + + +    ++       I I +
Sbjct: 62  ISYK---------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+  LH  +     I+HR+L    +L+       I D G+ K+L  ++  + + T   
Sbjct: 113 LRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH- 166

Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
             Y+APE V  GR ++ +SDI++ G ++ ++ T             E+ + ++   +  +
Sbjct: 167 --YMAPE-VWKGRPYSYKSDIWSLGCLLYEMATF--------APPFEARSMQDLRYKVQR 215

Query: 416 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVI 448
           GK+       +  L           P+ RP  + ++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 64/264 (24%), Positives = 122/264 (46%), Gaps = 22/264 (8%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+ G  R    VAI++IN     SEE +F++   ++  L H  +++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
            +     +++ +F   G L  YL Q +G  S ++L     +S+   + +G+ YL  +   
Sbjct: 70  QQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN--- 119

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR 369
             + +HR+L+    L+       ++D G+ + + DD   S       + +  PE     +
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 370 FTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
           ++ +SD+++FGV++ ++ T G +                 F  R  + K +   +  + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--RLYRPKLA---SMTVYE 232

Query: 429 MALVCTHEDPENRPTMEAVIEELT 452
           +   C HE PE RPT   ++  +T
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)

Query: 192 LGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  V    Y     DGT  +VA++++     +   + + K + +L +L HENI++
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 246 LRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAKGIGYL 303
            +G CCS   G+   LI ++ P G L  YL + +   + +L ++ +      I +G+ YL
Sbjct: 71  YKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYL 123

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 361
           HS        +HR+L+   VL+D      I D GL K + +   +  ++    + + + A
Sbjct: 124 HSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
            E +   +F+  SD+++FGV + ++LT
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 21/273 (7%)

Query: 191 LLGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIR 245
           +LG+G F SV +G L   DG+   VA++++ +      E E F+     +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 246 LRGFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 299
           L G C      +      +I  F   G L  +L   +  G    L   T +  ++ IA G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 358
           + YL +        +HR+L+    ++ +     +AD GL  K+ + D           + 
Sbjct: 126 MEYLSNRN-----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++A E +    +T +SD++AFGV + +I T       +     E+    +++    + K 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            E    +L  +   C   DP++RPT   + E L
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 39/304 (12%)

Query: 164 FSREHLNSFRLNLEEVESATQCFSEV-NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK 222
           F R+ LN F   L E +       E   L      +           LVA++ +   +  
Sbjct: 2   FPRQPLN-FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--- 279
           +   +F+K + +L+ L   NI RL G C         +I ++   G L+++L +      
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 280 ----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
               +S  L +ST + +   IA G+ YL    +N    VHR+L+    L+ + +   IAD
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYL--ESLN---FVHRDLATRNCLVGKNYTIKIAD 173

Query: 336 CGLHK-LLADDIVFSVLKTSAAMG--YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 392
            G+ + L + D  +  ++  A +   ++A E V  G+FT +SD++AFGV + +I      
Sbjct: 174 FGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI------ 225

Query: 393 LTSSMRLAAESATFENFIDRNLKGKFSESE-----------AAKLGKMALVCTHEDPENR 441
           LT       E  T +  I+ N    F +                + ++ L C   D E+R
Sbjct: 226 LTLCREQPYEHLTDQQVIE-NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284

Query: 442 PTME 445
           PT  
Sbjct: 285 PTFR 288

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 191 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           ++G G F  V +G L    +    VAI+++     + +  +F+    ++    H NII L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G   ++ R    +I +F   G L  +L Q +G   V+     V ++ GIA G+ YL  S
Sbjct: 71  EGVV-TKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL--S 123

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAP 362
           E+N    VHR+L+   +L++      ++D GL + L DD       S L     + + AP
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 363 EYVTTGRFTERSDIFAFGVIILQILT 388
           E +   +FT  SD++++G+++ ++++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 27/241 (11%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE-EAEFVKG-LYLLTSLRHENIIRLRG 248
           LGKG+F  V     +D G L A++ +         E E       +L+ + H  I++L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSE 307
               +   + +L+ ++AP G+L  +L +E           R       I   + YLHS  
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFS-EERARFYAAEIVLALEYLHSLG 113

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 364
                I++R+L  E +L+D   +  + D GL K L+ +      +T+   G   YLAPE 
Sbjct: 114 -----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTNTFCGTPEYLAPEV 164

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +    + +  D ++ GV++ ++LTG     +  R       +E  +   L+     S  A
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPEFLSPEA 220

Query: 425 K 425
           +
Sbjct: 221 R 221

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 57/286 (19%)

Query: 191 LLGKGNFSSVYKGTLRD--GTL--VAI---RSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
            LG G+F  V +G      G +  VA+   +S  ++    +   F+K   ++ SL HEN+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENL 58

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 299
           IRL G   +       ++ + AP G L   L ++       S + D++ +      IA G
Sbjct: 59  IRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANG 109

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAM 357
           + YL S        +HR+L+   +L+       I D GL + L   +D            
Sbjct: 110 MRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFE 407
            + APE + T  F+  SD++ FGV + ++          L+GS +L              
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK------------ 212

Query: 408 NFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVIEEL 451
             ID+  + +    EA    +  + L C   +P +RPT  A+ E L
Sbjct: 213 --IDKEGE-RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)

Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 230
           L+E E     F ++ +LG G F +VYKG  + +G      VAI+ +   +      E + 
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 287
             Y++ S+ + ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W 
Sbjct: 59  EAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 346
            +      IAKG+ YL         +VHR+L+   VL+    +  I D GL KLL AD+ 
Sbjct: 116 VQ------IAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            +        + ++A E +    +T +SD++++GV + +++T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)

Query: 189 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 241
              LG+G F  V K            + VA++ +   + + + ++ V  + ++  + +H+
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD----QEEGSSNVLDWSTR-------- 289
           NII L G  C+   G  +++ ++A  G L  +L       E +S                
Sbjct: 77  NIINLLG-VCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--V 347
           VS    +A+G+ +L S +      +HR+L+   VL+ +     IAD GL    A DI  +
Sbjct: 135 VSFAYQVARGMEFLASKK-----CIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHI 185

Query: 348 FSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAE 402
               KT+     + ++APE +    +T +SD+++FGV++ +I T  GS      +     
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240

Query: 403 SATFENFIDRNLK-GKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
               E      LK G   E       +L  +   C HE P  RPT + ++E+L
Sbjct: 241 ----EELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 48/297 (16%)

Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 230
           L+E E       +V +LG G F +VYKG  + DG      VAI+ +   +      E + 
Sbjct: 4   LKETE-----LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD 58

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 287
             Y++  +    + RL G C +       L+    P G L  Y+ + +   GS ++L+W 
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 346
            +      IAKG+ YL   EV    +VHR+L+   VL+    +  I D GL +LL  D+ 
Sbjct: 116 VQ------IAKGMSYLE--EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 406
            +        + ++A E +   RFT +SD++++GV + +++T              +  +
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG------------AKPY 212

Query: 407 ENFIDRNLKGKFSESE-------AAKLGKMALV-CTHEDPENRPTMEAVIEELTVAA 455
           +    R +     + E             M +V C   D E RP    +++E +  A
Sbjct: 213 DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 21/264 (7%)

Query: 185 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
            F  +  +GKG F  VYK    R G  VAI+ I + S + +E + +  + +L   +H NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNI 59

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++   +     + E +++ +F   G L   L     ++  L  S    +   + KG+ YL
Sbjct: 60  VKY--YGSYLKKDELWIVMEFCSGGSLKDLLK---STNQTLTESQIAYVCKELLKGLEYL 114

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS   N   I+HR++    +L+       + D GL   L+D    +         ++APE
Sbjct: 115 HS---NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMVGTPYWMAPE 167

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--ESATFENFIDRNLKGKFSES 421
            +    +  ++DI++ G+  +++  G    +    + A  + AT      RN + K+S+ 
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPE-KWSDE 226

Query: 422 EAAKLGKMALVCTHEDPENRPTME 445
                      C  ++PE RPT E
Sbjct: 227 ----FKDFLKKCLQKNPEKRPTAE 246

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 46/287 (16%)

Query: 191 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           ++G+G+FS+V     +      AI+ ++   +   K  +   ++   L     H  II+L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +   +     + + ++AP G+L +Y+ ++ GS   LD          I   + YLHS 
Sbjct: 68  --YYTFQDEENLYFVLEYAPNGELLQYI-RKYGS---LDEKCTRFYAAEILLALEYLHSK 121

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-------- 358
                 I+HR+L  E +L+D+  +  I D G  K+L  +      K  A           
Sbjct: 122 -----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 359 -----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 407
                      Y++PE +      + SD++A G II Q+LTG        R + E  TF+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG----KPPFRGSNEYLTFQ 232

Query: 408 NFIDRNLKGKFSE--SEAAK-LGKMALVCTHEDPENRPTMEAVIEEL 451
             +       F       AK L +  LV    DP++R  +    +EL
Sbjct: 233 KILKLEY--SFPPNFPPDAKDLIEKLLV---LDPQDRLGVNEGYDEL 274

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 26/219 (11%)

Query: 192 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+  F  +YKG L         LVAI+++   +   +  EF +   L+  L H NI+ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVSII 293
            G   ++ +  C L +++  +G L ++L             D++    + LD    + I 
Sbjct: 73  LG-VVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-K 352
           I IA G+ YL S        VH++L+   +LI +Q +  I+D GL + +     + V  K
Sbjct: 131 IQIAAGMEYLSSH-----FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           +   + ++ PE +  G+F+  SDI++FGV++ +I +  L
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 191 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
           LLG G+F SVY+G  L DG   A++ +++        E VK L     LL+ L+H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIGYL 303
             G          FL  +  P G L+K L ++ GS    V+   TR      I  G+ YL
Sbjct: 67  YLGTEREEDNLYIFL--ELVPGGSLAKLL-KKYGSFPEPVIRLYTR-----QILLGLEYL 118

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           H         VHR++    +L+D      +AD G+ K + +       K S    ++APE
Sbjct: 119 HDRN-----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY--WMAPE 171

Query: 364 YV-TTGRFTERSDIFAFGVIILQILTG 389
            +   G +   +DI++ G  +L++ TG
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 56/263 (21%), Positives = 120/263 (45%), Gaps = 16/263 (6%)

Query: 190 NLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           + LG G +  VY+G   +    VA++++   + + EE  F+K   ++  ++H N+++L G
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 69

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C        ++I +F   G L  YL   E +   ++    + +   I+  + YL     
Sbjct: 70  VCTREP--PFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +   
Sbjct: 125 ----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
           +F+ +SD++AFGV++ +I T  +    S     + +     +++  + +  E    K+ +
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGM----SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236

Query: 429 MALVCTHEDPENRPTMEAVIEEL 451
           +   C   +P +RP+   + +  
Sbjct: 237 LMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 69/259 (26%), Positives = 120/259 (46%), Gaps = 20/259 (7%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++  L HE +++L G  C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYG-VC 68

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
           ++ R   +++ ++   G L  YL +E G       S  + +   + +G+ YL S +    
Sbjct: 69  TKQR-PIYIVTEYMSNGCLLNYL-REHGKR--FQPSQLLEMCKDVCEGMAYLESKQ---- 120

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L+D Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179

Query: 372 ERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID-RNLKGKFSESEAAKLGKM 429
            +SD++AFGV++ ++ + G +           S T E       L      SE  K+  +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKM----PYERFNNSETVEKVSQGLRLYRPHLASE--KVYAI 233

Query: 430 ALVCTHEDPENRPTMEAVI 448
              C HE  E RPT + ++
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 192 LGKGNFSSVYKGT--LRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF  V KG   +R   + VAI+ +   + KS   E ++   ++  L +  I+R+ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            C +       L+ + A  G L+K+L     E   SNV++   +VS+      G+ YL  
Sbjct: 63  VCEAEA---LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG 113

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPE 363
                   VHR+L+   VL+  Q    I+D GL K L  D  +   +++    + + APE
Sbjct: 114 KN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F+ RSD++++G+ + +  +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 190 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 247
           +L+G+G F  VYKG  L  G  VAI+ I++   K E  + +   + LL +L+H NI++  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI-IIGIAKGIGYLHSS 306
           G          ++I ++A  G L + + +       L     V++ +  + +G+ YLH  
Sbjct: 66  GS--IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-----VAVYVYQVLQGLAYLHEQ 118

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPEY 364
                 ++HR++    +L  +     +AD G+   L D      SV+ T   M   APE 
Sbjct: 119 -----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM---APEV 170

Query: 365 VTTGRFTERSDIFAFGVIILQILTG 389
           +     +  SDI++ G  ++++LTG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 63/268 (23%), Positives = 119/268 (44%), Gaps = 34/268 (12%)

Query: 192 LGKGNFSSVYKG---TLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG     +    VA++ + N  +  + + E ++   ++  L +  I+R+ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 248 GFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRVSIIIGIAKGIGYLH 304
           G C      E + L+ + A  G L+K+L + +  +  N+ +   +VS+      G+ YL 
Sbjct: 63  GIC----EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE 112

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAP 362
            +       VHR+L+   VL+  Q    I+D GL K L  D  +   KT     + + AP
Sbjct: 113 ETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E +   +F+ +SD+++FGV++ +  +        M+    +   E+       G+  E  
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------GERMECP 220

Query: 423 AA---KLGKMALVCTHEDPENRPTMEAV 447
                ++  +  +C     + RP    V
Sbjct: 221 QRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)

Query: 191 LLGKGNFSSVYKGTLR--DGTL--VAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIR 245
           +LGKG F SV +  L+  DG+   VA++ +       S+  EF++    +    H N+I+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 246 LRGFCC-SRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSN--VLDWSTRVSIIIGIAKG 299
           L G    SR +G      +I  F   G L  +L           L   T V  +I IA G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 358
           + YL S        +HR+L+    ++++     +AD GL  K+ + D       +   + 
Sbjct: 126 MEYLSSKN-----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           +LA E +    +T  SD++AFGV + +I+T       +     E++   N++ +  + K 
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                  + ++   C   +P+ RP+ + + ++L
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 28/264 (10%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL ++     
Sbjct: 70  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---- 122

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 370
             VHR+L+   VL+ +     ++D GL K  +     S   T    + + APE +   +F
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 176

Query: 371 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 429
           + +SD+++FG+++ +I        S  R+       ++ + R  KG K    +       
Sbjct: 177 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229

Query: 430 ALV--CTHEDPENRPTMEAVIEEL 451
            ++  C H D   RP+   + E+L
Sbjct: 230 DVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 23/155 (14%)

Query: 192 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLLTSLRHENI 243
           +G+G +  VYK    + G LVA++ I +   ++E+  F       +K   LL  LRH NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIK---LLQKLRHPNI 60

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +RL+    S+G+G  ++++++     L+  LD  E        S     +  + +G+ YL
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYL 116

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           HS+      I+HR++    +LI+      +AD GL
Sbjct: 117 HSN-----GILHRDIKGSNILINNDGVLKLADFGL 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 185 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            NII L G   ++ +    ++ ++   G L  +L + +G   V+     V ++ GIA G+
Sbjct: 65  PNIIHLEG-VVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGM 119

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 358
            YL          VHR+L+   +L++      ++D GL ++L DD    ++       + 
Sbjct: 120 KYLSDM-----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + APE +   +FT  SD++++G+++ ++++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS-----------III 294
             G  C+ GR    +++++   G L+++L      + +L     V+           I  
Sbjct: 72  FYG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 353
            IA G+ YL S        VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 130 QIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++ PE +   +FT  SDI++FGV++ +I T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)

Query: 192 LGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG-IAKG 299
           L G   S+G+    +I +   +G L  YL     + E           ++  + G IA G
Sbjct: 74  LLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 358
           + YL++++      VHR+L+    ++ + F   I D G+ + +   D      K    + 
Sbjct: 132 MAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 23/194 (11%)

Query: 210 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 269
           LVA++ +   + K+   +F+K + +L+ L+  NIIRL G C         +I ++   G 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGD 105

Query: 270 LSKY-----LDQEEGSSN----------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 314
           L+++     LD +E + N           + +S+ + + + IA G+ YL  S +N    V
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLN---FV 160

Query: 315 HRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTER 373
           HR+L+    L+ +     IAD G+ + L A D      +    + ++A E +  G+FT  
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 374 SDIFAFGVIILQIL 387
           SD++AFGV + +IL
Sbjct: 221 SDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 53/215 (24%), Positives = 105/215 (48%), Gaps = 25/215 (11%)

Query: 190 NLLGKGNFSSVYKGTLR-DGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V +  ++ DG  +  AI+ +   + +++  +F   L +L  L  H NII 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 293
           L G C    RG  ++  ++AP G L  +L +            E G+++ L     +   
Sbjct: 68  LLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A G+ YL   +      +HR+L+   VL+ +     IAD GL +   +++       
Sbjct: 126 SDVATGMQYLSEKQ-----FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMG 178

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T +SD+++FGV++ +I++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 190 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 293
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 61  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 119 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 171

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 62/253 (24%), Positives = 119/253 (47%), Gaps = 24/253 (9%)

Query: 210 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 269
           LVA++ +     K+   +F+K + +++ L++ NIIRL G C S       +I ++   G 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGD 103

Query: 270 LSKYLDQEEGSSNV--------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 321
           L+++L Q E  S          +  +  + + + IA G+ YL S        VHR+L+  
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLATR 158

Query: 322 KVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFG 380
             L+   +   IAD G+ + L     + +  +    + ++A E +  G+FT  SD++AFG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 381 VIILQILTGSLVLTSSMRLAAESATFEN----FIDRNLKGKFSESE--AAKLGKMALVCT 434
           V + ++ T  L       L ++    EN    F ++  +   S++    + + K+ + C 
Sbjct: 219 VTLWEMFT--LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276

Query: 435 HEDPENRPTMEAV 447
             D ++RPT   +
Sbjct: 277 SRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 23/259 (8%)

Query: 199 SVYKGTLRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 256
           S+YKG   +   V IR+        K         +  L  +   NI+++ GF       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 257 ECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 314
                LI ++  +G L + LD+E+     L + T++ + I   KG+  L+    NKP   
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY-TNKP--- 145

Query: 315 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTE 372
           ++NL+    L+ + +   I   GL K+L+        K    M Y + + +      +T 
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMVYFSYKMLNDIFSEYTI 201

Query: 373 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV 432
           + DI++ GV++ +I TG +   +          ++  I++N   K       ++  +   
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFEN----LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257

Query: 433 CTHEDPENRPTMEAVIEEL 451
           CT  D   RP ++ ++  L
Sbjct: 258 CTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 191 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           +LG G F  + +G L    +    VAI ++       +   F+     L    H NI+RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 247 RGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            G      RG   +I  ++   G L  +L + EG    L     + ++ G+A G+ YL  
Sbjct: 72  EGVIT---RGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL-- 123

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLAPE 363
           SE+     VH+ L+  KVL++      I+  G  +L  D    +++ +   + + + APE
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +    F+  SD+++FG+++ ++++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 38/287 (13%)

Query: 192 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V K T      R G T VA++ +   +  SE  + +    LL  + H ++I+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTR-------------- 289
           L G C   G     LI ++A  G L  +L +    G S +     R              
Sbjct: 68  LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 290 ----VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 344
               +S    I++G+ YL  +E+    +VHR+L+   VL+ +     I+D GL + +  +
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D      K    + ++A E +    +T +SD+++FGV++ +I+T    L  +        
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIAPE 236

Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              N +    + +  E+ + ++  + L C  ++P+ RPT   + +EL
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 20/271 (7%)

Query: 192 LGKGNFSSVYKGTLR--DGTL-VAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLR 247
           LG+G F SV +G L   D  L VA++++ +  C +SE  +F+     +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 248 GFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           G C      E +    +I  F   G L  +L   +       L     V  +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYL 360
           YL S        +HR+L+    ++++  N  +AD GL K + +   +   + +   + ++
Sbjct: 127 YLSSKS-----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
           A E +    +T +SD+++FGV + +I T       +     E++   +++ +  + K   
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRG----QTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                L  +   C   +P++RP+ E +  EL
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)

Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G  C++  G  ++I ++A KG L +YL            D        + +   V
Sbjct: 83  IINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 141 SCTYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 251

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P +RPT + ++E+L
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 190 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 293
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 73  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 131 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 183

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 49/290 (16%)

Query: 192 LGKGNFSSVYK----GTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V +    G  +        VA++ +   +   + A+ +  + L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L ++L            D  +     L +   V
Sbjct: 80  IINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +A+G+ YL S        +HR+L+   VL+ +     IAD GL + + D   +  
Sbjct: 138 SCAYQVARGMEYLESRRC-----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK- 191

Query: 351 LKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GS----LVLTSSMRLAA 401
            KTS     + ++APE +    +T +SD+++FG+++ +I T  GS    + +    +L  
Sbjct: 192 -KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Query: 402 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           E    +         K S         M   C H  P  RPT + ++E L
Sbjct: 251 EGHRMD---------KPSNCTHELYMLMR-ECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 57/270 (21%), Positives = 123/270 (45%), Gaps = 31/270 (11%)

Query: 189 VNLLGKGNFSS--VYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIR 245
           + +LGKG F    +Y+ T  D +LV  + +N+T    +E       + +L+ L+H NII 
Sbjct: 5   IRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 246 -LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
               F          +  ++A  G L   + +++G   + +    +  +  I   + Y+H
Sbjct: 64  YYNHFMDD---NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIH 118

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAP 362
                K  I+HR++    + + +     + D G+ K+L  +     +V+ T     Y++P
Sbjct: 119 -----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY---YMSP 170

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 419
           E     ++  +SDI+A G ++ ++LT        ++   ++    N + + ++G ++   
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT--------LKRTFDATNPLNLVVKIVQGNYTPVV 222

Query: 420 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
              +++L  +      +DPE RPT + V++
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 59/279 (21%)

Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V +LG+G+   VYK   +  G + A++ I+V   +    + ++ L  L S     +++  
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKGIGYLHS 305
           G       GE  ++ ++   G L+  L +             V   I   I KG+ YLH 
Sbjct: 66  GAFYK--EGEISIVLEYMDGGSLADLLKKVGK------IPEPVLAYIARQILKGLDYLH- 116

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAMGYLAPE 363
               K  I+HR++    +LI+ +    IAD G+ K+L +  D   + + T     Y++PE
Sbjct: 117 ---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT---YMSPE 170

Query: 364 YVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMRLAAE--SA 404
            +    ++  +DI++ G+ +L+   G                 ++       L AE  S 
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230

Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
            F +FI                      C  +DP+ RP+
Sbjct: 231 EFRDFISA--------------------CLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 47/280 (16%)

Query: 192 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G G  + VY    L +   VAI+ I++  C++   E  K +  ++   H N++    + 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---KYY 65

Query: 251 CSRGRGEC-FLIYDFAPKGKL-----SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            S   G+  +L+  +   G L     S Y          LD +   +++  + KG+ YLH
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S+       +HR++    +L+ +  +  IAD G+   LAD    +       +G   ++A
Sbjct: 120 SN-----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 362 PEYVTTGR-FTERSDIFAFGVIILQILTG-----------SLVLTSSMRLAAESATFENF 409
           PE +     +  ++DI++FG+  +++ TG            L+LT    L  +  + E  
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQNDPPSLETG 230

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            D     K+S+S      KM  +C  +DP  RPT E +++
Sbjct: 231 AD---YKKYSKS----FRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)

Query: 192 LGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   +  + + +F +   LLT+L+HE+I++
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 71

Query: 246 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 292
             G C   G G+   +++++   G L+K+L             Q   +   L  S  + I
Sbjct: 72  FYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL- 351
              IA G+ YL S        VHR+L+    L+       I D G+ + +     + V  
Sbjct: 129 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            T   + ++ PE +   +FT  SD+++FGVI+ +I T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           +G+G F  V++            T+VA++ +   +    +A+F +   L+    H NI++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSS----------NVLDWST- 288
           L G  C+ G+  C L++++   G L+++L       Q   S           N L  S  
Sbjct: 73  LLG-VCAVGKPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 289 -RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDI 346
            ++ I   +A G+ YL  SE  K   VHR+L+    L+ +     IAD GL   + + D 
Sbjct: 131 EQLCIAKQVAAGMAYL--SE-RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
             +    +  + ++ PE +   R+T  SD++A+GV++ +I +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 25/214 (11%)

Query: 191 LLGKGNFSSVYKG-TLRDGTLVAIR-----SINVTSCKSEEA--EFVKG-LYLLTSLRHE 241
           L+G G+F SVY G     G L+A++     S++ +S   + +  + +   + LL  L+HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI++  G          FL Y   P G ++  L+         + +   + +  I KG+ 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEY--VPGGSVAALLNN----YGAFEETLVRNFVRQILKGLN 120

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-----AA 356
           YLH+       I+HR++    +L+D +    I+D G+ K L  + + +    +      +
Sbjct: 121 YLHNRG-----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           + ++APE V    +T ++DI++ G +++++LTG 
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 18/197 (9%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +G+G F +V +G    G  VA+++I    C      F++   ++T L H+N++RL G   
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
             G    +++ +   KG L  +L +  G + V      +   + +A+G+ YL S +    
Sbjct: 70  HNG---LYIVMELMSKGNLVNFL-RTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---- 120

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
            +VHR+L+   +L+ +     ++D GL ++ +  +  S L       + APE +   +F+
Sbjct: 121 -LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFS 175

Query: 372 ERSDIFAFGVIILQILT 388
            +SD++++GV++ ++ +
Sbjct: 176 SKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 46/202 (22%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +  LG GN   V K   R  G ++A+++I +   ++ + + ++ L +L       I+   
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G   + G  +  +  ++   G L K L + +G    +       I + + KG+ YLH   
Sbjct: 66  GAFYNNG--DISICMEYMDGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYLHE-- 118

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K  I+HR++    +L++ +    + D G+   L + +  + + TS+   Y+APE +  
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQG 173

Query: 368 GRFTERSDIFAFGVIILQILTG 389
             ++ +SDI++ G+ ++++ TG
Sbjct: 174 NDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 58/208 (27%), Positives = 110/208 (52%), Gaps = 14/208 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F ++  LG+G +++VYKG  R  G +VA++ I++ + +   +  ++ + L+  L+HENI+
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           RL     +  +    L++++  K  L KY+D   G    LD +T  S    + KGI + H
Sbjct: 62  RLHDVIHTENK--LMLVFEYMDK-DLKKYMDT-HGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPE 363
            + V     +HR+L  + +LI+++    +AD GL +     +  FS       + Y AP+
Sbjct: 118 ENRV-----LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS--NEVVTLWYRAPD 170

Query: 364 YVTTGR-FTERSDIFAFGVIILQILTGS 390
            +   R ++   DI++ G I+ +++TG 
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 28/233 (12%)

Query: 178 EVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKG 231
           E+  +T  F E   LG+  F  VYKG L           VAI+++   +      EF   
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 232 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEG 279
             + + L+H NI+ L G           +I+ +     L ++L            D ++ 
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 280 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 339
             + L+ +  V I+  IA G+ +L S  V     VH++L+   VL+  + N  I+D GL 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHV-----VHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 340 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           + +     + ++  S   + +++PE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 192 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  VY+G  RD       T VA++++N ++   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVL-DWSTRVSIIIGIAKG 299
           L G   S+G+    ++ +    G L  YL     + E             + +   IA G
Sbjct: 74  LLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 358
           + YL     N    VHR+L+    ++   F   I D G+ + +   D      K    + 
Sbjct: 132 MAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++APE +  G FT  SD+++FGV++ +I       TS      +  + E  +   + G +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGLSNEQVLKFVMDGGY 239

Query: 419 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++   ++  +  +C   +P+ RPT   ++  L
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 36/270 (13%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENII 244
            +LGKG + +VY G    G L+A++ +     NV + + E  +  + + LL SL+H NI+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYL 303
           +  G C        F+  +F P G +S  L++       V    T+      I  G+ YL
Sbjct: 66  QYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYL 118

Query: 304 HSSEVNKPAIVHRNLSVEKV---------LIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
           H++ V     VHR++    V         LID      +A  GLH   ++     +LK+ 
Sbjct: 119 HNNCV-----VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-----MLKSM 168

Query: 355 AAMGY-LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
               Y +APE +    +  +SDI++ G  + ++ TG   L S  RLA   A F     R 
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHRG 225

Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPT 443
           L  +  +S +A        C   D   RP+
Sbjct: 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.4 bits (167), Expect = 9e-13
 Identities = 51/187 (27%), Positives = 96/187 (51%), Gaps = 15/187 (8%)

Query: 210 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 269
           LVA++ +   + K+   +F+K + +++ L+  NIIRL   C +       +I ++   G 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGD 105

Query: 270 LSKYL-------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 322
           L+++L         E+     + +ST + +   IA G+ YL  S +N    VHR+L+   
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL--SSLN---FVHRDLATRN 160

Query: 323 VLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGV 381
            L+ + +   IAD G+ + L + D      +    + +++ E +  G+FT  SD++AFGV
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 382 IILQILT 388
            + +ILT
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 45/210 (21%), Positives = 95/210 (45%), Gaps = 9/210 (4%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 243
           +  +  +GKG+F +V K     DG ++  + I+  +   +E +  V  + +L  L+H NI
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +R       R     +++ ++   G L++ + + +     ++      I+  +   +   
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           H+       ++HR+L    + +D   N  + D GL K+L  D  F        +G   Y+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF----AKTYVGTPYYM 177

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGS 390
           +PE +    + E+SDI++ G +I ++   S
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 191 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHEN 242
            LG G FSS Y+   RD   GTL+A++ +      S E E V     K + L+  L H +
Sbjct: 7   QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           IIR+ G  C       F+  ++   G +S  L +          +  ++    + +G+ Y
Sbjct: 65  IIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKE----AVIINYTEQLLRGLSY 118

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 358
           LH ++     I+HR++    +LID     L IAD G    LA     +       +G   
Sbjct: 119 LHENQ-----IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           ++APE +   ++    D+++ G +I+++ T   
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLRHENII 244
           +LL +G F  ++ G L D        + V + K   +E      ++   LL  L H+NI+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTR--VSIIIGIAK 298
            +    C       F++Y +   G L  +L Q    E  +   L  ST+  V + I IA 
Sbjct: 72  PILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIAC 128

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVL--KTSA 355
           G+ YLH   V     +H++++    +ID++    I D  L + L   D  +  L    + 
Sbjct: 129 GMSYLHKRGV-----IHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENR 181

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            + ++A E +    ++  SD+++FGV++ +++T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 63/282 (22%), Positives = 131/282 (46%), Gaps = 46/282 (16%)

Query: 185 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTS 237
           CF  V ++GKG++  V   +L     DG    I+ +N+ +    E   AE  +   LL+ 
Sbjct: 3   CF--VRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQ 55

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSII 293
           L+H NI+  R        G  +++  F   G L   L +++G     + V++W       
Sbjct: 56  LKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------F 108

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVL 351
           + IA  + YLH        I+HR+L  + V + +     + D G+ ++L +  D+  +++
Sbjct: 109 VQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 411
            T     Y++PE  +   +  +SD++A G  + ++ T        ++ A  +    + + 
Sbjct: 164 GTPY---YMSPELFSNKPYNYKSDVWALGCCVYEMAT--------LKHAFNAKDMNSLVY 212

Query: 412 RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           R ++GK     +  + +LG++      + PE RP++++++ +
Sbjct: 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 33/261 (12%)

Query: 209 TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAPK 267
           T VA++ +   + + + ++ +  + ++  + +H+NII L G C   G    ++I ++A K
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASK 108

Query: 268 GKLSKYL------------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 315
           G L +YL            +  +     L +   VS    +A+G+ YL S +      +H
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC-----IH 163

Query: 316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAA---MGYLAPEYVTTGRF 370
           R+L+   VL+ +     IAD GL    A DI  +    KT+     + ++APE +    +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGL----ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219

Query: 371 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 430
           T +SD+++FGV++ +I T    L  S             +    +     +   +L  M 
Sbjct: 220 THQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMM 275

Query: 431 LVCTHEDPENRPTMEAVIEEL 451
             C H  P  RPT + ++E+L
Sbjct: 276 RDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 26/214 (12%)

Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S  +   +F +   LLT+L+HE+I++
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 71

Query: 246 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYLDQ---------EEGSSNVLDWSTRVSIIIG 295
             G C     G+   +++++   G L+K+L           E      L  S  + I   
Sbjct: 72  FYGVCV---EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTS 354
           IA G+ YL S        VHR+L+    L+ +     I D G+ + +     + V   T 
Sbjct: 129 IAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
             + ++ PE +   +FT  SD+++ GV++ +I T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 65/273 (23%), Positives = 126/273 (46%), Gaps = 33/273 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 243
           + ++ ++G+G F  V+    + D  LV I+ I V    K E         +L  L H NI
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 244 IR-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I     F   +      ++ ++AP G L++Y+ +   S  +LD  T +   + I   + +
Sbjct: 62  IEYYENFLEDKALM---IVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHH 116

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 358
           +H+       I+HR+L  + +L+D+    + I D G+ K+L+     S  K    +G   
Sbjct: 117 VHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-----SKSKAYTVVGTPC 166

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           Y++PE      + ++SDI+A G ++ ++         S++ A E+A     + + + G F
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELA--------SLKRAFEAANLPALVLKIMSGTF 218

Query: 419 ---SESEAAKLGKMALVCTHEDPENRPTMEAVI 448
              S+  +  L ++ L   + DP  RP +  ++
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHEN 242
           F  + ++GKG F  V     RD   + A++ +N   C  K      +    +L  L H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 243 IIRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGI 300
           ++ L   F         +L+ D    G L  +L Q+   S       +V   I  I   +
Sbjct: 62  LVNLWYSFQ---DEENMYLVVDLLLGGDLRYHLSQKVKFS-----EEQVKFWICEIVLAL 113

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 360
            YLHS       I+HR++  + +L+D+Q +  I D  +   +  D +     TS   GY+
Sbjct: 114 EYLHSK-----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYM 166

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE +    ++   D ++ GV   + L G
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 52/216 (24%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH---E 241
           +  + L+G+G + +VY+G  +  G +VA++ IN+ +   + ++  + + LL+ LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGK---LSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
           NI +  G    +G    ++I ++A  G    L K     E   +V        II  +  
Sbjct: 63  NITKYYG-SYLKGP-RLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLV 112

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            + Y+H        ++HR++    +L+    N  + D G+  LL      +  K S  +G
Sbjct: 113 ALKYIHKV-----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----NSSKRSTFVG 163

Query: 359 ---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS 390
              ++APE +T G+ +  ++DI++ G+ I ++ TG+
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 22/261 (8%)

Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  T+  SE    +  L +++ L  HENI+
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L G  C+ G G   +I ++   G L  +L ++  S   L     +S    +AKG+ +L 
Sbjct: 103 NLLG-ACTIG-GPILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAKGMAFLA 158

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAP 362
           S        +HR+L+   VL+       I D GL + + +D  + V+K +A +   ++AP
Sbjct: 159 SKNC-----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAP 212

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E +    +T  SD++++G+++ +I   SL       +  +S  F   I    +    E  
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIF--SLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHA 269

Query: 423 AAKLGKMALVCTHEDPENRPT 443
            A++  +   C   DP  RPT
Sbjct: 270 PAEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 43/285 (15%)

Query: 192 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +G G F  V  G    G   A   ++ +  ++   E+  F++ +     L H N+++  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            C         L+ +F P G L  YL    G  + +        +   +A G+ +LH   
Sbjct: 63  QCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYVT 366
             +   +H +L++    +    +  I D GL  +   +D   +    +  + +LAPE V 
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 367 -------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
                      T++S+I++ GV + ++ T            A    + +  D  +  +  
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT------------AADQPYPDLSDEQVLKQVV 223

Query: 420 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 452
             +  KL K  L   + D            PE RPT E V E LT
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 27/266 (10%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRLRG 248
           +G+G FS VY+ T L DG  VA++ + +      +A  + +K + LL  L H N+I+   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                   E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS   
Sbjct: 70  SFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLAP 362
               ++HR++    V I       + D GL +  +        KT+AA        Y++P
Sbjct: 127 ----VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMSP 175

Query: 363 EYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           E +    +  +SDI++ G ++ ++    S      M L +     E      L    S+ 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDH 232

Query: 422 EAAKLGKMALVCTHEDPENRPTMEAV 447
            + +L ++  +C + DPE RP +  V
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIR-LR 247
           +GKG FS VYK   L DG +VA++ + +          + +K + LL  L H N+I+ L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            F       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  
Sbjct: 70  SFI---ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 361
                I+HR++    V I       + D GL +  +        KT+AA        Y++
Sbjct: 127 -----IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NL------ 414
           PE +    +  +SDI++ G ++ +             +AA  + F    D+ NL      
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE-------------MAALQSPFYG--DKMNLYSLCKK 219

Query: 415 --KGKF----SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             K  +    ++  + +L  +   C + DPE RP +  V++
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 185 CFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
              E++ LG+G   SV K  L++ G + A+++I        + + ++ L +  S +   I
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS------IIIGIA 297
           ++  G           +  ++   G L            V     R+       I   + 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVL 115

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           KG+ YLHS +     I+HR++    +L+ ++    + D G+   L + +  +   TS   
Sbjct: 116 KGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-- 168

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQI 386
            Y+APE +    ++  SD+++ G+ +L++
Sbjct: 169 -YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRH 240
           ++++  +G+G +  VYKG   + G +VA++ I +   +SEE    +  ++ + LL  L+H
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQH 58

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            NI+ L+       R   +LI++F     L KYLD        +D     S +  I +GI
Sbjct: 59  PNIVCLQDVLMQESR--LYLIFEFLSM-DLKKYLDSL-PKGQYMDAELVKSYLYQILQGI 114

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGY 359
            + HS  V     +HR+L  + +LID +    +AD GL +  A  I   V       + Y
Sbjct: 115 LFCHSRRV-----LHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167

Query: 360 LAPEYVTTG--RFTERSDIFAFGVIILQILT 388
            APE V  G  R++   DI++ G I  ++ T
Sbjct: 168 RAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 38/216 (17%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA-------EFVKGLYLLTS 237
           + E+  +G+G + +VYK   L  G  VA++ + V    SEE        E +  L  L S
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTLRE-IALLKQLES 57

Query: 238 LRHENIIRLRGFC--CSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
             H NI+RL   C      R  +  L+++   +  L+ YL +       L   T   ++ 
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMR 114

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT 353
            + +G+ +LHS       IVHR+L  + +L+       IAD GL ++ + ++   SV+ T
Sbjct: 115 QLLRGVDFLHSH-----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 354 SAAMGYLAPE------YVTTGRFTERSDIFAFGVII 383
              + Y APE      Y T        D+++ G I 
Sbjct: 170 ---LWYRAPEVLLQSSYATP------VDMWSVGCIF 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 242
              +  +G G F  V+    R      A++ + +    + ++ + V     +L  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           IIRL  F     +   +++ ++ P G+L  YL      SN    ST +     I   + Y
Sbjct: 63  IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN----STGLFYASEIVCALEY 116

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS E     IV+R+L  E +L+D++ +  + D G  K L D       +T    G   Y
Sbjct: 117 LHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------RTWTLCGTPEY 164

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           LAPE + +    +  D +A G++I ++L G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 30/227 (13%)

Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTL--RDGTL----VAIRSINVTSCKSEEAEFVKGLY 233
           E      + +  LG G F  VY+G    RDG      VA++++  +  + +E++F+    
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRV 290
           +++   H+NI+RL G      R   F++ +    G L  +L +        + L     +
Sbjct: 62  IMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP----LIADCGLHKLLADDI 346
                +AKG  YL  +       +HR+++    L+  +  P     IAD G    +A DI
Sbjct: 120 FCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCK-GPGRVAKIADFG----MARDI 169

Query: 347 VFSVL--KTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
             +    K   AM    ++ PE    G FT ++D+++FGV++ +I +
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 33/291 (11%)

Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K        VA++ +   +   + ++ V  + ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G  C++  G  +++ ++A KG L +YL            D  +     L +   V
Sbjct: 80  IINLLG-ACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 138 SCAYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----LGGSPYPGIPVEELFKL 248

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 460
           +    +     +   +L  +   C H  P  RPT + ++E+L     V +T
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 39/217 (17%)

Query: 192 LGKGNFSSVY---KGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLR 239
           + KG +  V+   K +  D  + AI+ I          V    +E         +L+  +
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERD-------ILSQAQ 51

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
              +++L  +   +G+   +L+ ++ P G L+  L+        LD       I  I   
Sbjct: 52  SPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLA 105

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-------LLADDIVFSVLK 352
           + YLHS+      I+HR+L  + +LID   +  + D GL K       +  +D      +
Sbjct: 106 LEYLHSN-----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
                 Y+APE +     ++  D ++ G I+ + L G
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHEN 242
           + ++G+G +  V K   +  G +VAI+       +SE+ E VK   L     L  LRHEN
Sbjct: 6   LGVVGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L+     +GR   +L++++  +      L+  E S   L      S I  + + I Y
Sbjct: 62  IVNLKEAFRRKGR--LYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
            HS       I+HR++  E +L+ +     + D G  + L       +    A   Y AP
Sbjct: 116 CHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 363 E-YVTTGRFTERSDIFAFGVIILQILTG 389
           E  V    + +  D++A G I+ ++L G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 60/271 (22%), Positives = 124/271 (45%), Gaps = 27/271 (9%)

Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 243 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           + +  G   S  +G + ++I ++   G     L      +   D     +++  I KG+ 
Sbjct: 64  VTKYYG---SYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLD 115

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLHS +      +HR++    VL+ +Q +  +AD G+   L D    + +K +  +G   
Sbjct: 116 YLHSEKK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++APE +    +  ++DI++ G+  +++  G     S M                L G+F
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEF 225

Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           S+       +    C ++DP  RPT + +++
Sbjct: 226 SKP----FKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 48/217 (22%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F  +  LG+G++ SVYK   ++ G +VAI+ + V     +  E +K + +L       
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPY 59

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLS-------KYLDQEEGSSNVLDWSTRVSIIIG 295
           I++  G        + +++ ++   G +S       K L +EE +          +I+  
Sbjct: 60  IVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA----------AILYQ 107

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
             KG+ YLHS++      +HR++    +L++++    +AD G+   L D    ++ K + 
Sbjct: 108 TLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----TMAKRNT 158

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            +G   ++APE +    +  ++DI++ G+  +++  G
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 62/292 (21%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL-----YLLTSLRHENII 244
           L+G+G++  V K   ++ G +VAI+       +SE+ + VK +      +L  LRHEN++
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L      R +   +L+++F         LD  E   N LD S     +  I +GI + H
Sbjct: 64  NLIEVF--RRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVFSVLKTSAAMG 358
           S       I+HR++  E +L+ Q     + D G  + LA       D V       A   
Sbjct: 118 SHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-------ATRW 165

Query: 359 YLAPEY-VTTGRFTERSDIFAFGVIILQILTGSLVLTSS----------MRLAAESATFE 407
           Y APE  V   ++    DI+A G ++ ++LTG  +                L       +
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225

Query: 408 NFIDRN----------------LKGKFSESEAAKLGKMALVCTHEDPENRPT 443
               +N                L+ +F +     L      C   DP++RP+
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ-CLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 62/271 (22%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  VYKG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 243 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           I R  G   S  +G + ++I ++   G     L         L+ +   +I+  I KG+ 
Sbjct: 64  ITRYYG---SYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLHS        +HR++    VL+ +Q +  +AD G+   L D    + +K +  +G   
Sbjct: 116 YLHSERK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++APE +    +  ++DI++ G+  +++  G      +  L      F   I +N     
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLF--LIPKNSPPTL 221

Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
               +    +    C ++DP  RPT + +++
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 245
           LLG+G F  VY     D G  +A++ +       E  + V  L     LL +L+HE I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 304
             G  C R      +  ++ P G +   L      +  V    TR      I +G+ YLH
Sbjct: 69  YYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH 121

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S+      IVHR++    +L D   N  + D G  K L   I  S     +  G   +++
Sbjct: 122 SNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMS 175

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
           PE ++   +  ++D+++ G  ++++LT
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 191 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
           +LGKG +  VY    L     +AI+ I        ++ +V+ L+    L + L+H NI++
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 246 LRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKGI 300
             G   S      F I+ +  P G LS  L  + G    +   + + T+      I +G+
Sbjct: 70  YLG-SDS--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGL 121

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKT-SAAMG 358
            YLH ++     IVHR++  + VL++     + I+D G  K LA   +    +T +  + 
Sbjct: 122 KYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQ 174

Query: 359 YLAPEYVTTGR--FTERSDIFAFGVIILQILTG 389
           Y+APE +  G   +   +DI++ G  I+++ TG
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 62/274 (22%), Positives = 126/274 (45%), Gaps = 33/274 (12%)

Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           + +  G      +   ++I ++   G     L  E G    LD +   +I+  I KG+ Y
Sbjct: 64  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--EPGP---LDETQIATILREILKGLDY 116

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 117 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 167

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 415
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGE---PPHSELHPMKVLF--LIPKNNPPTLE 222

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           G +S+     L +    C +++P  RPT + +++
Sbjct: 223 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 29/269 (10%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR-LR 247
           +G+G FS VY+ T L D   VA++ + +      +A  + VK + LL  L H N+I+ L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            F       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  
Sbjct: 70  SFIED---NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 361
           V     +HR++    V I       + D GL +  +        KT+AA        Y++
Sbjct: 127 V-----MHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
           PE +    +  +SDI++ G ++ ++    S      M L +     E      L     E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT---E 231

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             + KL ++  +C + DP+ RP +  V +
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 192 LGKGNFSSVYKG-TLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           +G+G +  VYK      G +VAI+ I     +    K+   E      LL  L H NII+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNIIK 62

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L      R +G+ +L+++F     L K +         L  S   S +  + +G+ + HS
Sbjct: 63  LLDVF--RHKGDLYLVFEFM-DTDLYKLIK---DRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPE 363
                  I+HR+L  E +LI+ +    +AD GL +            T       Y APE
Sbjct: 117 H-----GILHRDLKPENLLINTEGVLKLADFGLARSFGSP---VRPYTHYVVTRWYRAPE 168

Query: 364 -YVTTGRFTERSDIFAFGVIILQILTGS 390
             +    ++   DI++ G I  ++L+  
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 56/278 (20%), Positives = 130/278 (46%), Gaps = 39/278 (14%)

Query: 186 FSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENI 243
           + +V  +G+G+F  ++   +  DG    I+ IN++    +E  E  K + +L++++H NI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 244 IRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAK 298
           ++ +  F      G  +++ D+   G L K ++ + G       +LDW       + I  
Sbjct: 62  VQYQESF---EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICL 112

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            + ++H  +     I+HR++  + + + +     + D G+ ++L      +V      +G
Sbjct: 113 ALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIG 163

Query: 359 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
              YL+PE      +  +SDI+A G ++ ++ T        ++ A E+   +N + + ++
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--------LKHAFEAGNMKNLVLKIIR 215

Query: 416 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           G +   S   +  L  +       +P +RP++ +++E+
Sbjct: 216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK      G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    S   +      S +  + +G+ + 
Sbjct: 62  VKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFC 116

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKT----SAAMG 358
           HS  V     +HR+L  + +LI+ +    +AD GL +       F V ++T       + 
Sbjct: 117 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165

Query: 359 YLAPEYVTTGRF-TERSDIFAFGVIILQILT 388
           Y APE +   ++ +   DI++ G I  +++T
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 57/266 (21%), Positives = 109/266 (40%), Gaps = 33/266 (12%)

Query: 192 LGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG GN  SV K   +  GT++A + +++ +  S   + ++ L ++   R   I+   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG-- 70

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                    +  +F   G L +   ++ G     +L       I + + +G+ YL+    
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILG-----KIAVAVVEGLTYLY---- 120

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
           N   I+HR++    +L++ +    + D G+   L + I  + + TS    Y++PE +  G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST---YMSPERIQGG 177

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-----------RNLKGK 417
           ++T +SD+++ G+ I+++  G      S             +D           R     
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237

Query: 418 FSESEAAKLGKMALVCTHEDPENRPT 443
           F E     L      C  +DP  RPT
Sbjct: 238 FPED----LRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 56/278 (20%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F+ +  +GKG+F  VYK    R   +VAI+ I++   + E  +  + +  L+  R   I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 245 RLRGFCCSRGRGECFLIYDFAPKG-KL---SKYLDQEEGS------SNVLDWSTRVSIII 294
           +  G          FL      KG KL    +Y     GS         LD +    I+ 
Sbjct: 63  KYYG---------SFL------KGSKLWIIMEYCGG--GSCLDLLKPGKLDETYIAFILR 105

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            +  G+ YLH     K   +HR++    +L+ ++ +  +AD G    ++  +  ++ K +
Sbjct: 106 EVLLGLEYLHEE--GK---IHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRN 156

Query: 355 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLAAESATFE-- 407
             +G   ++APE +    + E++DI++ G+  +++  G   L+    MR       F   
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIP 211

Query: 408 -NFIDRNLKGKFSESEAAKLGKMAL-VCTHEDPENRPT 443
            N        KFS     K  K  + +C ++DP+ RP+
Sbjct: 212 KNNPPSLEGNKFS-----KPFKDFVSLCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 39/220 (17%)

Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGL 232
           F  + +LG+G+F  V    YK T   G L AI+++          V S   E+  F    
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFE--- 54

Query: 233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
               S RH  ++ L  F C +       + ++A  G L  ++  +     V      V  
Sbjct: 55  -TANSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFY 106

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +  G+ YLH    NK  IV+R+L ++ +L+D +    IAD GL K   + + F   +
Sbjct: 107 AACVVLGLQYLHE---NK--IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGD-R 157

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           TS   G   +LAPE +T   +T   D +  GV+I ++L G
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 245
           LLG+G F  VY     D G  +A + +       E ++ V  L     LL +L+HE I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 246 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             G  C R R E  L    ++ P G +    DQ +    + +  TR      I +G+ YL
Sbjct: 69  YYG--CLRDRAEKTLTIFMEYMPGGSVK---DQLKAYGALTESVTR-KYTRQILEGMSYL 122

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS+      IVHR++    +L D   N  + D G  K L   I  S     +  G   ++
Sbjct: 123 HSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWM 176

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT 388
           +PE ++   +  ++D+++ G  ++++LT
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 61/303 (20%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGL---YLLTSLR 239
           F ++N +G+G +  VY+   RD   G +VA++ + +      +   +  L    LL +LR
Sbjct: 9   FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMD--NERDGIPISSLREITLLLNLR 64

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------SI 292
           H NI+ L+     +     FL+ +         Y +Q+  S  +LD             +
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVME---------YCEQDLAS--LLDNMPTPFSESQVKCL 113

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
           ++ + +G+ YLH +      I+HR+L V  +L+  +    IAD GL +         +  
Sbjct: 114 MLQLLRGLQYLHEN-----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-LPAKPMTP 167

Query: 353 TSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---------- 401
               + Y APE +     +T   D++A G I+ ++L    +L     +            
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227

Query: 402 -ESATFENFID--------------RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
              + +  F D               NLK KF     A L  +  +  + DP+ R T E 
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY-DPKKRATAEE 286

Query: 447 VIE 449
            +E
Sbjct: 287 ALE 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 42/281 (14%)

Query: 191 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSC-----KSEEAEFVKGLY----LLTSLRH 240
           L+GKG +  VY    +  G ++A++ + + +       S + + VK L      L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGK----LSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            NI++  GF  +      FL Y   P G     L  Y   EE                 +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEY--VPGGSIGSCLRTYGRFEE--------QLVRFFTEQV 117

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-- 354
            +G+ YLHS       I+HR+L  + +L+D      I+D G+ K  +DDI  +    S  
Sbjct: 118 LEGLAYLHSK-----GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ 171

Query: 355 AAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
            ++ ++APE + +    ++ + DI++ G ++L++  G    +      A +A F+    R
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKR 228

Query: 413 NLKGKFSESEAAKLGKMAL----VCTHEDPENRPTMEAVIE 449
           +         +  L  +AL     C   +P+NRPT   +++
Sbjct: 229 S-APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.7 bits (138), Expect = 5e-09
 Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 17/157 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHE 241
           + ++  LG+G +  VYK    + G +VA++ I +     EE   +  ++ + LL  L+H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI++L     +  +   +L++++     L KYLD+  G    L  +   SI+  + +G+ 
Sbjct: 59  NIVKLLDVIHTERK--LYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLA 112

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           Y HS   ++  I+HR+L  + +LI++     +AD GL
Sbjct: 113 YCHS---HR--ILHRDLKPQNILINRDGVLKLADFGL 144

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 38/271 (14%)

Query: 191 LLGKGNFSSVYKGTLRDG--TLVAIRSINVTS-----CKSEEAEFVKGL-----YLLTSL 238
            LG G F  VYK   ++    L+A++ INV +      K E  + +  +      +   L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 239 RHENIIRLRGFCCSRGRGECFLIYDF---APKGKLSKYLDQEEGS-SNVLDWSTRVSIII 294
           RH NI+R         R   +++ D    AP G+    L +++   +    W+    I +
Sbjct: 67  RHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFV 120

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            +   + YLH  +     IVHR+L+   +++ +     I D GL K    +      K +
Sbjct: 121 QMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-----SKLT 171

Query: 355 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 411
           + +G   Y  PE V    + E++D++AFG I+ Q+ T      S+  L+  +   E   +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231

Query: 412 RNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
              +G +SE     +  +   C   D E RP
Sbjct: 232 PLPEGMYSE----DVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 190 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 247
           N +G G F  VY    L  G L+A++ I +     +  + +   + +L  L+H N+++  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 248 GFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R   E   I+ ++   G L + L  E G   +LD        + + +G+ YLHS 
Sbjct: 66  GVEVHR---EKVYIFMEYCSGGTLEELL--EHG--RILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLAD--DIVFSVLKTSA--AMGYL 360
                 IVHR++    + +D   N +I   D G    L +    +   +++ A     Y+
Sbjct: 119 -----GIVHRDIKPANIFLD--HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-YM 170

Query: 361 APEYVTTGRFTER---SDIFAFGVIILQILTGS 390
           APE +T G+       +DI++ G ++L++ TG 
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 69/293 (23%), Positives = 131/293 (44%), Gaps = 37/293 (12%)

Query: 174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL 232
           ++L  +      F  V ++G G +  VYKG  ++ G L AI+ ++VT  + EE E    +
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEI 63

Query: 233 YLLTSL-RHENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
            +L     H NI    G F      G   + +L+ +F   G ++  +   +G++   DW 
Sbjct: 64  NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             +     I +G+ +LH+ +V     +HR++  + VL+ +     + D G+   L     
Sbjct: 124 AYIC--REILRGLAHLHAHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--- 173

Query: 348 FSVLKTSAAMG---YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSM 397
            +V + +  +G   ++APE +         +  RSDI++ G+  +++  G+  L     M
Sbjct: 174 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232

Query: 398 RLAAESATFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           R     A F   I RN   K  S+  + K       C  ++  +RP+ E +++
Sbjct: 233 R-----ALF--LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 239
           + +V  +G+G +  VYK      G +VA++ I + +    E E V     + + LL  L 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET----EDEGVPSTAIREISLLKELN 56

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI+RL     S  +   +L+++F     L KY+D        LD     S +  + +G
Sbjct: 57  HPNIVRLLDVVHSENK--LYLVFEFLDL-DLKKYMDSS--PLTGLDPPLIKSYLYQLLQG 111

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           I Y HS       ++HR+L  + +LID++    +AD GL
Sbjct: 112 IAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 65/281 (23%), Positives = 124/281 (44%), Gaps = 37/281 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENI 243
           F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + + +L     H NI
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65

Query: 244 IRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
               G    +       + +L+ +F   G ++  +   +G++   +W     I   I +G
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRG 123

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 358
           + +LH  +V     +HR++  + VL+ +     + D G+   L      +V + +  +G 
Sbjct: 124 LSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGT 174

Query: 359 --YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENF 409
             ++APE +         +  +SD+++ G+  +++  G+  L     MR     A F   
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--L 227

Query: 410 IDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           I RN   +  S+  + K       C  ++   RPT E +++
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 191 LLGKGNFSSVY---KGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRHENIIR 245
           +LG+G+F  V+   K T  D G L A++ +   + K  +    K    +L  + H  I++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 246 LR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 303
           L   F   +  G+ +LI DF   G L   L +E     V+     V   +  +A  + +L
Sbjct: 63  LHYAF---QTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHL 114

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLA 361
           HS       I++R+L  E +L+D++ +  + D GL K   D     +S   T   + Y+A
Sbjct: 115 HSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMA 166

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           PE V     T+ +D ++FGV++ ++LTGSL
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 46/213 (21%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 243
           +  +  +G+G+F  +Y    + D     I+ I++T    +E E  K  + LL  ++H NI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKG 299
           +    F   +  G  F++ ++   G L K ++++ G       +L W  ++S+      G
Sbjct: 62  VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA---DCGLHKLLADDIVFSVLKTSAA 356
           + ++H  +     I+HR++  + + + +  N ++A   D G+ + L D +  +   T   
Sbjct: 114 LKHIHDRK-----ILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELA--YTCVG 164

Query: 357 MGY-LAPEYVTTGRFTERSDIFAFGVIILQILT 388
             Y L+PE      +  ++DI++ G ++ ++ T
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 61/296 (20%), Positives = 122/296 (41%), Gaps = 58/296 (19%)

Query: 180 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 236
           E   + F+++  +G G+F +VY    +R   +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            ++H N I  +G  C       +L+ ++     L    D  E     L      +I  G 
Sbjct: 81  RIKHPNSIEYKG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAITHGA 134

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+ YLHS       ++HR++    +L+ +     +AD G   + +    F        
Sbjct: 135 LQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184

Query: 357 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-------ESAT- 405
             ++APE +     G++  + D+++ G+  +++      L +   ++A       ES T 
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244

Query: 406 --------FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 453
                   F NF+D                     C  + P++RPT E +++ + V
Sbjct: 245 QSNEWSDYFRNFVDS--------------------CLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 73/306 (23%), Positives = 119/306 (38%), Gaps = 69/306 (22%)

Query: 181 SATQCFSE---VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           SA +  SE   VN +G G   +VYK   R  G L A++ I      +   +  + + +L 
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS-KYLDQEEGSSNVLDWSTRVSIIIG 295
            + H N+++          GE  ++ +F   G L   ++  E+  ++V     R      
Sbjct: 128 DVNHPNVVKCHDM--FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV----AR-----Q 176

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKT 353
           I  GI YLH        IVHR++    +LI+   N  IAD G+ ++LA   D   S + T
Sbjct: 177 ILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT 231

Query: 354 SAAMGYLAPEYVTT----GRFTERS-DIFAFGVIILQILTG-------------SLVLTS 395
            A   Y++PE + T    G +   + DI++ GV IL+   G             SL+   
Sbjct: 232 IA---YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288

Query: 396 SMRLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
            M    E     S  F +FI                      C   +P  R +   +++ 
Sbjct: 289 CMSQPPEAPATASREFRHFISC--------------------CLQREPAKRWSAMQLLQH 328

Query: 451 LTVAAP 456
             +   
Sbjct: 329 PFILRA 334

Length = 353

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 53/235 (22%), Positives = 108/235 (45%), Gaps = 24/235 (10%)

Query: 168 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA 226
             NS  L LE +   T  +  +  +GKG +  VYK T  +DG+L A++ ++  S   EE 
Sbjct: 6   PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI 65

Query: 227 EFVKGLYLLTSL-RHENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSN 282
           E      +L SL  H N+++  G      +   G+ +L+ +    G +++ +        
Sbjct: 66  E--AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 342
            LD +    I+ G   G+ +LH++      I+HR++    +L+  +    + D G+   L
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 343 ADDIVFSVLKTSAAMG---YLAPEYVTTGR-----FTERSDIFAFGVIILQILTG 389
                 + L+ + ++G   ++APE +   +     +  R D+++ G+  +++  G
Sbjct: 179 TS----TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 245
           LLG+G F  VY     D G  +A++ +       E ++ V  L     LL +L HE I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 304
             G           +  +  P G +   L      + NV    TR      I +G+ YLH
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLH 123

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S+      IVHR++    +L D   N  + D G  K L   I  S     +  G   +++
Sbjct: 124 SN-----MIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMS 177

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
           PE ++   +  ++DI++ G  ++++LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +G+G +  VYK   +DG       L  I    I++++C+         + LL  L+H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE--------IALLRELKHPNV 60

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDW--STRVSIIIGIAKG 299
           I L+    S    + +L++D+A      + K+    + +   +    S   S++  I  G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I YLH++ V     +HR+L    +L+     ++    IAD G  +L       S LK  A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170

Query: 356 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 388
            +        Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 31/222 (13%)

Query: 186 FSEVNLLGKGNFSSVYKG---TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLL 235
           +     +G+G +  VYK      +DG   AI+       K ++ ++        + + LL
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGSSNVLDWSTRVSII 293
             L+HEN++ L            +L++D+A     ++ K+  Q +  S  +  S   S++
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS--IPPSMVKSLL 114

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIV-- 347
             I  G+ YLHS+      ++HR+L    +L+     ++    I D GL +L    +   
Sbjct: 115 WQILNGVHYLHSN-----WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 348 FSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 388
             +      + Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 24/159 (15%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLTSLR 239
              LG+G ++ VYK      G +VAI+ I +     E  E   G+         LL  L+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELK 60

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NII L      +      L+++F     L K +      S VL  +   S ++   +G
Sbjct: 61  HPNIIGLLDVFGHKSN--INLVFEFME-TDLEKVIKD---KSIVLTPADIKSYMLMTLRG 114

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           + YLHS+      I+HR+L    +LI       +AD GL
Sbjct: 115 LEYLHSN-----WILHRDLKPNNLLIASDGVLKLADFGL 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +G+G +  VYK   +DG       L  I    I++++C+         + LL  L+H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE--------IALLRELKHPNV 60

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKG 299
           I L+    S    + +L++D+A      + K+    + +   +     +  S++  I  G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I YLH++ V     +HR+L    +L+     ++    IAD G  +L       S LK  A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170

Query: 356 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 388
            +        Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 43/279 (15%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINV------TSCKSEEAEFVKGLYLLTSLRHENII 244
           LG+G F+ ++KG  R+ G    +    V       S ++    F +   +++ L H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-L 303
              G C      E  ++ ++   G L  YL + +   N+  W   V      AK + + L
Sbjct: 63  LNYGVCV--CGDESIMVQEYVKFGSLDTYLKKNKNLINIS-WKLEV------AKQLAWAL 113

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS---AAMGYL 360
           H  E     + H N+  + VL+ ++ +    +    KL    I  +VL        + ++
Sbjct: 114 HFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171

Query: 361 APEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
            PE +   +  +  +D ++FG  + +I +G         L+A        +D   K +F 
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA--------LDSQKKLQFY 218

Query: 420 ESE----AAKLGKMALV---CTHEDPENRPTMEAVIEEL 451
           E      A K  ++A +   C   +P+ RP+  A+I +L
Sbjct: 219 EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + + +++ LG+G +++VYKG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L     +       L++++  K  L +YLD      N ++       +  + +G+ Y
Sbjct: 66  IVTLHDIIHT--EKSLTLVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNY 119

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
            H  +V     +HR+L  + +LI+++    +AD GL +  A  I            +  P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRP 172

Query: 363 EYVTTGR--FTERSDIFAFGVIILQILTG 389
             +  G   ++ + D++  G I  ++ TG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 224 EEAEFVKGLYLLTSLRHENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 281
           + A F +   L   L H NI+ L   G       G  F ++++ P   L + L   +G  
Sbjct: 21  QRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFEYVPGRTLREVL-AADG-- 74

Query: 282 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 338
             L       +++ +   +   H+       IVHR+L  + +++     + +  + D G+
Sbjct: 75  -ALPAGETGRLMLQVLDALACAHNQ-----GIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

Query: 339 HKLLA---DDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 392
             LL    D  V ++ +T+  +G   Y APE +     T  SD++A+G+I L+ LTG  V
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

Query: 393 LT 394
           + 
Sbjct: 189 VQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLR 239
           F  + ++G+G +  V K   ++   +VAI+        SEE E VK      L +L +L+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLK 58

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
            ENI+ L+     R RG+ +L++++  K  L      EE  + V     R S I  + K 
Sbjct: 59  QENIVELKE--AFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKA 112

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           I + H ++     IVHR++  E +LI       + D G  + L++    +  +  A   Y
Sbjct: 113 IHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            +PE +    + +  D+++ G I+ ++  G
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 29/218 (13%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEA------EFVKGLY 233
           Q +  V  +G+G +  V+K   RD    G  VA++ + V +   EE         V  L 
Sbjct: 1   QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 56

Query: 234 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 289
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 112

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +  +  +
Sbjct: 113 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167

Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
            +  +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 168 SVVVT--LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  D  + V K SA
Sbjct: 183 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSA 236

Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +    L +S     +    E F  R 
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQ--INEEFCQRL 290

Query: 414 LKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             G   +  E+   ++ ++ L C   DP+ RPT  A++E L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 44/235 (18%)

Query: 190 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------------VKGLYLL 235
             LG+G +  V K      G +VAI+ + +    ++  +              ++ L ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 236 TSLRHENIIRLRGFCCSRGRGECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
             ++HENI+ L            F  L+ D      L K +D        L  S    I+
Sbjct: 75  NEIKHENIMGLVDVYVEGD----FINLVMDIM-ASDLKKVVD----RKIRLTESQVKCIL 125

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF---SV 350
           + I  G+  LH         +HR+LS   + I+ +    IAD GL +           S 
Sbjct: 126 LQILNGLNVLHKW-----YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 351 LKTSAAMGYLAPEYVT-----------TGRFTERSDIFAFGVIILQILTGSLVLT 394
            +T      +  + VT             ++    D+++ G I  ++LTG  +  
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235

Length = 335

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 15/194 (7%)

Query: 264 FAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 319
           F  +  LS   ++E         VL     +     +AKG+ +L S +      +HR+L+
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC-----IHRDLA 206

Query: 320 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYVTTGRFTERSDIF 377
              +L+ +     I D GL + +  D  + V K  A   + ++APE +    +T +SD++
Sbjct: 207 ARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVW 265

Query: 378 AFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED 437
           +FGV++ +I +        +++  E   F   +    + +  +    ++ +  L C H +
Sbjct: 266 SFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322

Query: 438 PENRPTMEAVIEEL 451
           P  RPT   ++E L
Sbjct: 323 PSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 192 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENIIRL 246
           LG+G F  VYK   ++ G +VA++ I +    +E+  F    ++ + +L  L+H N++ L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 247 ------RGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-----EGSSNVLDWSTRVSIIIG 295
                 R     R RG  +++         + Y+D +     E  S  L  S     ++ 
Sbjct: 73  IDMAVERPDKSKRKRGSVYMV---------TPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + +GI YLH +      I+HR++    +LID Q    IAD GL +           K   
Sbjct: 124 LLEGINYLHENH-----ILHRDIKAANILIDNQGILKIADFGLARPYDGPP--PNPKGGG 176

Query: 356 AMG------------YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             G            Y  PE +   R +T   DI+  G +  ++ T   +L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 18/196 (9%)

Query: 262 YDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 319
           Y  +   ++   L  D  EG +  LD    +S    +A+G+ +L S        VHR+L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLT-TLDL---LSFTYQVARGMEFLASKNC-----VHRDLA 264

Query: 320 VEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFA 378
              VL+ Q     I D GL + ++ D    S   T   + ++APE +    +T  SD+++
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324

Query: 379 FGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP 438
           +G+++ +I +        M +    +TF N I    +    +    ++  + + C + +P
Sbjct: 325 YGILLWEIFSLGGTPYPGMIV---DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381

Query: 439 ENRPT---MEAVIEEL 451
           E RP+   +  ++E L
Sbjct: 382 EKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 56/281 (19%), Positives = 119/281 (42%), Gaps = 57/281 (20%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  +  +G+G    VYK T R  G  VAI+ + +   +++E   +  + ++   +H NI+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKEL-IINEILIMKDCKHPNIV 78

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 303
                       E +++ ++   G L+  + Q     N      +++ +   + +G+ YL
Sbjct: 79  DYYD--SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN----EPQIAYVCREVLQGLEYL 132

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGYLA 361
           HS  V     +HR++  + +L+ +  +  +AD G    L        SV+ T   M   A
Sbjct: 133 HSQNV-----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM---A 184

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG-----------SLVLTSS-----MRLAAE-SA 404
           PE +    +  + DI++ G++ +++  G           +L L ++     ++   + S 
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244

Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 445
            F++F+++                    C  +DPE RP+ E
Sbjct: 245 EFKDFLNK--------------------CLVKDPEKRPSAE 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 21/153 (13%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHENIIR 245
           +G+G + +V+K   R+   +VA++ + +     ++ E V     + + LL  L+H+NI+R
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L  +       +  L++++  +  L KY D   G    +D     S +  + KG+ + HS
Sbjct: 64  L--YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHS 117

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
             V     +HR+L  + +LI++     +AD GL
Sbjct: 118 HNV-----LHRDLKPQNLLINKNGELKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 54/282 (19%)

Query: 191 LLGKGNFSSV----YKGT--------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL 238
           +LGKG+F  V     KGT        L+   ++    +  T  +            LT L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
                       C + +   F + ++   G L  ++ +    S   D          I  
Sbjct: 62  ----------HSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVL 107

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAA 356
           G+ +LH        I++R+L ++ VL+D + +  IAD G+ K  +L          TS  
Sbjct: 108 GLQFLHER-----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV------TTSTF 156

Query: 357 MG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
            G   Y+APE ++   +    D +A GV++ ++L G     S      E   F++ ++  
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ----SPFEGDDEDELFQSILEDE 212

Query: 414 LK-GKFSESEAAKLGKMALVCTHEDPENR----PTMEAVIEE 450
           ++  ++   EA  + K  L    ++PE R    PT E  I+ 
Sbjct: 213 VRYPRWLSKEAKSILKSFLT---KNPEKRLGCLPTGEQDIKG 251

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 34/261 (13%)

Query: 191 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           +LGKG+F  V+   L+      AI+++    V      E   V+   L  +  H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +C  + +   F + ++   G L  ++     S +  D          I  G+ +LHS 
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAAMG---YLA 361
                 IV+R+L ++ +L+D   +  IAD G+ K  +L D       KT    G   Y+A
Sbjct: 116 -----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD------AKTCTFCGTPDYIA 164

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-IDRNLKGKFSE 420
           PE +   ++    D ++FGV++ ++L G     S      E   F++  +D     ++  
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ----SPFHGHDEEELFQSIRMDNPCYPRWLT 220

Query: 421 SEAAKLGKMALVCTHEDPENR 441
            EA  +     V    +PE R
Sbjct: 221 REAKDILVKLFV---REPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 245
           LLG+G F  VY     D G  +A++ +       E ++ V  L     LL +LRH+ I++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 246 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGY 302
             G  C R   E  L    ++ P G +   L      + NV    TR      I +G+ Y
Sbjct: 69  YYG--CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSY 121

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS+      IVHR++    +L D   N  + D G  K +   I  S     +  G   +
Sbjct: 122 LHSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYW 175

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILT 388
           ++PE ++   +  ++D+++    ++++LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 43/275 (15%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           LG G F  VYK   ++ G   A + I + S   EE E F+  + +L+  +H NI+ L  +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGL--Y 68

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                  + +++ +F   G L   + + E     L       +   + + + +LHS +V 
Sbjct: 69  EAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHKV- 124

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 366
               +HR+L    +L+    +  +AD G+       +     K    +G   ++APE V 
Sbjct: 125 ----IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----QKRDTFIGTPYWMAPEVVA 176

Query: 367 TGRFTE-----RSDIFAFGVIILQILTGSL--VLTSSMR-----LAAESATFENFIDRNL 414
              F +     ++DI++ G+ ++++          + MR     L +E  T +       
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ------ 230

Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             K+S S    L      C  +DP++RPT   +++
Sbjct: 231 PSKWSSSFNDFLKS----CLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 239
           + +V  +G+G +  VYK   R     +A++ I +     +E E V     + + LL  ++
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQ 59

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIA 297
           H NI+RL+    S  R   +L++++     L K++D    SS     + R+  + +  I 
Sbjct: 60  HGNIVRLQDVVHSEKR--LYLVFEYLDL-DLKKHMD----SSPDFAKNPRLIKTYLYQIL 112

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDI-VFSVLKTSA 355
           +GI Y HS  V     +HR+L  + +LID++ N L +AD GL +  A  I V +      
Sbjct: 113 RGIAYCHSHRV-----LHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165

Query: 356 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 388
            + Y APE +   R ++   DI++ G I  +++ 
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           + ++  LG+G++++VYKG  + +G LVA++ I +   +      ++   LL  L+H NI+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L     +  +    L++++     L +Y+D+  G    L        +  + +G+ Y+H
Sbjct: 67  LLHDIIHT--KETLTLVFEYV-HTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLSYIH 120

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                +  I+HR+L  + +LI       +AD GL +  A  +            +  P  
Sbjct: 121 -----QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173

Query: 365 VTTGRFTERS---DIFAFGVIILQILTG 389
           V  G  TE S   D++  G I ++++ G
Sbjct: 174 VLLGS-TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
            I+ RG  C       +L+ ++     L    D  E     L      ++  G  +G+ Y
Sbjct: 77  TIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
           LHS       ++HR++    +L+ +     + D G   ++A    F          ++AP
Sbjct: 131 LHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAP 180

Query: 363 EYVTT---GRFTERSDIFAFGVIILQI 386
           E +     G++  + D+++ G+  +++
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 192 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRHEN-IIR 245
           +G+G +  VYK      G LVA++    T  + +E       ++ + LL  L     I+R
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 246 LRGFCC-----SRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKG 299
           L            G+   +L++++     L K++D    G    L   T  S +  + KG
Sbjct: 66  L--LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTS---- 354
           + + H     K  ++HR+L  + +L+D+Q   L IAD GL +       FS+   S    
Sbjct: 123 VAHCH-----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHE 171

Query: 355 -AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTG 389
              + Y APE +     ++   DI++ G I  ++   
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 191 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           +LGKG+F  V    L+  G   A++++    V      E   V+   L  +L  EN    
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL--ALAWENPFLT 59

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +C  + +   F + +F   G L  ++ Q++G  ++   +   + I+    G+ +LHS 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVC---GLQFLHSK 115

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 I++R+L ++ V++D+  +  IAD G+ K    + VF   + S   G   Y+APE
Sbjct: 116 -----GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPE 166

Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +   ++T   D ++FGV++ ++L G
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 16/209 (7%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + + ++  LG+G +++V+KG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L     +       L++++  K  L +Y+D      N++        +  I +G+ Y
Sbjct: 66  IVTLHDIVHT--DKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAY 119

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
            H  +V     +HR+L  + +LI+++    +AD GL +  A  +            +  P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRP 172

Query: 363 EYVTTG--RFTERSDIFAFGVIILQILTG 389
             V  G   ++ + D++  G I  ++ +G
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 187 SEVNL--LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRH 240
           S +NL  LG+G++++VYKG  R +G LVA++   V S K+EE      ++   LL  L+H
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKH 62

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIA 297
            NI+ L     ++        Y       L++Y+ Q  G     NV         +  + 
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEY---MHTDLAQYMIQHPGGLHPYNVR------LFMFQLL 113

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           +G+ Y+H        I+HR+L  + +LI       +AD GL +  A  I      +    
Sbjct: 114 RGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVT 166

Query: 358 GYLAPEYVTTG--RFTERSDIFAFGVIILQILTGS 390
            +  P  V  G   ++   DI+  G I +++L G 
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 34/154 (22%), Positives = 68/154 (44%), Gaps = 13/154 (8%)

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           LL ++ H ++IR++      G   C ++  +     L  YL +       L     + I 
Sbjct: 110 LLQNVNHPSVIRMKD-TLVSGAITCMVLPHY--SSDLYTYLTKRSRP---LPIDQALIIE 163

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             I +G+ YLH+       I+HR++  E + I+      I D G  +       F  L  
Sbjct: 164 KQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--LGL 216

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           +  +   APE +   ++  ++DI++ G+++ ++L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 48/287 (16%)

Query: 192 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +G G F  V    +   T VA   ++ +   +   E+ EF++       L+H NI++  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            C         L++++   G L  YL QE+    +S +L       +   IA G+ ++H 
Sbjct: 63  QCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH- 116

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEY 364
               K   +H +L++    +       + D G+      +D + +       + +LAPE 
Sbjct: 117 ----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 365 VT-------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
           V        T   T+ S+++A GV + ++             AA+   + +  DR +   
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFEN----------AAQP--YSHLSDREVLNH 220

Query: 418 FSESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 452
             + +  KL K  L   + +            PE R T E V   LT
Sbjct: 221 VIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 13/138 (9%)

Query: 260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 318
           LI D+   G+L  +L Q E           V I  G I   + +LH     K  I++R++
Sbjct: 82  LILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLH-----KLGIIYRDI 131

Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 376
            +E +L+D   + ++ D GL K   +D V         + Y+AP+ V  G     +  D 
Sbjct: 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191

Query: 377 FAFGVIILQILTGSLVLT 394
           ++ GV++ ++LTG+   T
Sbjct: 192 WSMGVLMYELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + + +++ LG+G +++V+KG  +    LVA++ I +   +      ++ + LL +L+H N
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 243 IIRLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           I+ L     +     C  L++++     L +YLD      N++        +  + +G+ 
Sbjct: 65  IVTLHDIIHTE---RCLTLVFEYL-DSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           Y H     K  I+HR+L  + +LI+++    +AD GL +  A  +            +  
Sbjct: 118 YCH-----KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYR 170

Query: 362 PEYVTTGRFTERS---DIFAFGVIILQILTG 389
           P  V  G  TE S   D++  G I+ ++ TG
Sbjct: 171 PPDVLLGS-TEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 45/215 (20%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRL 246
           LG G F SVY    ++ G LVAI+ +       EE     E VK L  L    H NI++L
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-VKSLRKLNE--HPNIVKL 63

Query: 247 RG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           +  F   R   E + ++++  +G L + +   +G       S   SII  I +G+ ++H 
Sbjct: 64  KEVF---RENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIH- 116

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
               K    HR+L  E +L+       IAD GL + +     ++             +YV
Sbjct: 117 ----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-------------DYV 159

Query: 366 TTG--RFTE---RS-------DIFAFGVIILQILT 388
           +T   R  E   RS       DI+A G I+ ++ T
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 41/245 (16%), Positives = 101/245 (41%), Gaps = 31/245 (12%)

Query: 212 AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR-GFCCSRGRGECFLIYDFAPKGKL 270
           A++ I +    S   +  K   LL  ++H NI+  +  F      G  +++ ++   G L
Sbjct: 29  AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF---EADGHLYIVMEYCDGGDL 85

Query: 271 SKYLDQEEG----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 326
            + +  + G       +L W  ++ +      G+ ++H   V     +HR++  + + + 
Sbjct: 86  MQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKRV-----LHRDIKSKNIFLT 134

Query: 327 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
           Q     + D G  +LL     ++         Y+ PE      +  +SDI++ G I+ ++
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYEL 193

Query: 387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH---EDPENRPT 443
            T        ++   ++ +++N I +  +G +    +    ++  +       +P +RP+
Sbjct: 194 CT--------LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245

Query: 444 MEAVI 448
              ++
Sbjct: 246 ATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 43/285 (15%)

Query: 192 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +G G F  V  G +  G     V ++ + V++   E+ +F++      SL+H N+++  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL-DWSTRVSIIIGIAKGIGYLHSSE 307
            C         L+ +F P G L  YL     +  +  D +T   +   IA G+ +LH   
Sbjct: 63  QCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYV- 365
             K   +H +L++   L+       I D GL H    +D   +  +    + ++APE V 
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 366 -TTGRF-----TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
              G       T+ S++++ GV I ++                S  + +  D  +     
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELG------------SQPYRHLSDEQVLTYTV 223

Query: 420 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 452
             +  KL K  L     D            PE RP+ E V   L+
Sbjct: 224 REQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)

Query: 192 LGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +GKG+F  V     + T R   L  IR  ++ S +SE    +    +L  +    I+ L+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 248 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 305
             F   +   + +L+  F   G+L  +L Q EG  +     +R       +   +  LH 
Sbjct: 60  FSF---QSPEKLYLVLAFINGGELFHHL-QREGRFD----LSRARFYTAELLCALENLHK 111

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSAAMG---YLA 361
             V     ++R+L  E +L+D Q +  + D GL KL + DD      KT+   G   YLA
Sbjct: 112 FNV-----IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----KTNTFCGTPEYLA 161

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +    +T+  D +  GV++ ++LTG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 31/152 (20%)

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           I + I K + YLHS    K +++HR++    VLI++     + D G+   L D    SV 
Sbjct: 108 IAVSIVKALEYLHS----KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD----SVA 159

Query: 352 KTSAA--MGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGS--------------- 390
           KT  A    Y+APE +        +  +SD+++ G+ ++++ TG                
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219

Query: 391 LVLTSSMRLAAE--SATFENFIDRNLKGKFSE 420
           +V   S +L AE  S  F++F+++ LK  + E
Sbjct: 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKE 251

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 39/158 (24%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  D  + V K  A
Sbjct: 182 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDA 235

Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEG 292

Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + +  E    ++  + L C H +PE+RPT   ++E L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRHENIIRLR 247
           +G+G    V+K   R+ G  VA++ + +   + E     + ++ +  L + +H  +++L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 248 G-FCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
             F      G  F L+ ++ P   LS+ L  EE     L  +   S +  + KG+ Y+H+
Sbjct: 66  DVFPH----GSGFVLVMEYMPSD-LSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
           +      I+HR+L    +LI       IAD GL +L +++         A   Y APE +
Sbjct: 118 N-----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 366 TTGR-FTERSDIFAFGVIILQILTGS 390
              R +    D++A G I  ++L GS
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 191 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFV-KGLYLLTSLRHENIIRL 246
           ++GKG+F  V     + DG+  A++ +   +   K E+   + +   LL +L+H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 247 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 304
              F  +    + + + D+   G+L  +L +E           R       +A  IGYLH
Sbjct: 62  HYSFQTAE---KLYFVLDYVNGGELFFHLQRERCFL-----EPRARFYAAEVASAIGYLH 113

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S       I++R+L  E +L+D Q + ++ D GL K    + V     TS   G   YLA
Sbjct: 114 SLN-----IIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLA 164

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +    +    D +  G ++ ++L G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 39/238 (16%)

Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK 222
           F RE +N     L E       ++ +  +G G + SV      R G  VAI+ +     +
Sbjct: 1   FYREEVNKTVWELPER------YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SR 50

Query: 223 SEEAE-FVKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDF---AP--KGKLSK 272
             ++E F K  Y    LL  ++HEN+I L     S   G+ F   DF    P  +  L K
Sbjct: 51  PFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF--QDFYLVMPYMQTDLQK 108

Query: 273 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 332
            +        V        ++  +  G+ Y+HS+      I+HR+L    + +++     
Sbjct: 109 IMGHPLSEDKVQ------YLVYQMLCGLKYIHSA-----GIIHRDLKPGNLAVNEDCELK 157

Query: 333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           I D GL +    ++   V+       Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 158 ILDFGLARHADAEMTGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 191 LLGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           ++GKG+F  V       DG   A++ +    V + K ++    +   LL +++H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 247 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 304
              F  +    + + + DF   G+L  +L +E           R       IA  +GYLH
Sbjct: 62  HYSFQTTE---KLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLH 113

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAP 362
           S       IV+R+L  E +L+D Q + ++ D GL K   + I  S   T+      YLAP
Sbjct: 114 SIN-----IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAP 165

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTG 389
           E +    +    D +  G ++ ++L G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 191 LLGKGNFSSVY----KGTLRDGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENII 244
           LLGKG F  V     K T   G   A++ +   V   K E A  +    +L + RH  + 
Sbjct: 2   LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGY 302
            L+    +  R  CF++ ++A  G+L  +L +E   S   +   R     G  I   +GY
Sbjct: 59  ALKYSFQTHDR-LCFVM-EYANGGELFFHLSRERVFS---EDRAR---FYGAEIVSALGY 110

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +     +V+R+L +E +++D+  +  I D GL K   + I           G   Y
Sbjct: 111 LHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGA-TMKTFCGTPEY 161

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.2 bits (113), Expect = 8e-06
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 235 LTSLRHENIIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           L S+RH  ++ L G F         +L+ ++ P G+L  +L +          +   +  
Sbjct: 55  LQSIRHPFLVNLYGSFQDDS---NLYLVMEYVPGGELFSHLRKSGRFPE--PVARFYAAQ 109

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
           + +A  + YLHS +     IV+R+L  E +L+D      I D G  K +         +T
Sbjct: 110 VVLA--LEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-------RT 155

Query: 354 SAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
               G   YLAPE + +  + +  D +A G++I ++L G
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 32/206 (15%)

Query: 194 KGNFSSVYKGTLR-DGTLVAIRSI---------NVTSCKSEEAEFVKGLYLLTSLRHENI 243
           KG F SVY    R  G   AI+ +          VT+ K+E A       ++       +
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERA------IMMIQGESPYV 59

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
            +L  +   + +   +L+ ++   G  +  +    G     DW+ +   I  +  G+  L
Sbjct: 60  AKL--YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP--EDWAKQY--IAEVVLGVEDL 113

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           H     +  I+HR++  E +LIDQ  +  + D GL +           K      YLAPE
Sbjct: 114 H-----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPE 163

Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +      + SD ++ G +I + L G
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 44/205 (21%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  +  +G G +  VYK   +  G LVAI+ I +     +     + + +L   RH NI+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIV 63

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGY 302
              G      R + +++ ++   G L        G  S   + +  R ++     KG+ Y
Sbjct: 64  AYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAY 116

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LH +       +HR++    +L+ +  +  +AD G    ++  +  ++ K  + +G   +
Sbjct: 117 LHETGK-----IHRDIKGANILLTEDGDVKLADFG----VSAQLTATIAKRKSFIGTPYW 167

Query: 360 LAPEYV---TTGRFTERSDIFAFGV 381
           +APE       G +  + DI+A G+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 21/191 (10%)

Query: 269 KLSKYLDQE------EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 322
           +   Y+DQ+      E     LD    +S    +AKG+ +L S        +HR+L+   
Sbjct: 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC-----IHRDLAARN 244

Query: 323 VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFG 380
           +L+       I D GL + + +D  + V+K +A +   ++APE +    +T  SD++++G
Sbjct: 245 ILLTHGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 303

Query: 381 VIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDP 438
           +++ +I   SL  +    +  +S  ++   +  R L  + + SE   + K    C   DP
Sbjct: 304 ILLWEIF--SLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK---SCWDADP 358

Query: 439 ENRPTMEAVIE 449
             RPT + +++
Sbjct: 359 LKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I  G+ +LH        IV+R+L  E VL+D   N  I+D GL   L        +K  A
Sbjct: 104 IICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRA 155

Query: 356 AM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
              GY+APE +    +    D FA G  + +++ G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 13/134 (9%)

Query: 260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 318
           LI D+   G+L  +L Q E  +      + V + I  I   + +LH     +  I++R++
Sbjct: 82  LILDYVNGGELFTHLYQREHFT-----ESEVRVYIAEIVLALDHLH-----QLGIIYRDI 131

Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 376
            +E +L+D + + ++ D GL K    +           + Y+APE +  G     +  D 
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 377 FAFGVIILQILTGS 390
           ++ GV+  ++LTG+
Sbjct: 192 WSLGVLTFELLTGA 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRH 240
           +  ++ +G G +  V        G  VAI+ +   S   + A   K  Y    LL  + H
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRPFQSAIHAKRTYRELRLLKHMDH 73

Query: 241 ENIIRLRG-FCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           EN+I L   F  +    +   +Y         L+  +  ++ S + + +     ++  I 
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-----LVYQIL 128

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           +G+ Y+HS+      I+HR+L    + +++     I D GL +   D++   V    A  
Sbjct: 129 RGLKYIHSA-----GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATR 179

Query: 358 GYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 389
            Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 41/205 (20%)

Query: 208 GTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 262
           G  VA++ +     N T  K    E V    LL  + H+NII L              + 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISL--------------LN 87

Query: 263 DFAPKGKLSK----YLDQEEGSSNV-------LDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            F P+  L +    YL  E   +N+       LD      ++  +  GI +LHS+     
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA----- 142

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
            I+HR+L    +++       I D GL +    +  F +        Y APE +    + 
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYK 200

Query: 372 ERSDIFAFGVIILQILTGSLVLTSS 396
           E  DI++ G I+ +++ GS++   +
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGT 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 354
           I  G+  LH        IV+R+L  E +L+D   +  I+D GL  ++   + +   + T 
Sbjct: 111 ITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT- 164

Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             +GY+APE V   R+T   D +  G +I +++ G     S  R   E    E  ++R +
Sbjct: 165 --VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK----SPFRQRKEKVKREE-VERRV 217

Query: 415 K-------GKFSESEAAKLGKMALVCTHEDPENR 441
           K        KFSE  A  + +  L    +DP  R
Sbjct: 218 KEDQEEYSEKFSE-AARSICRQLL---TKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 354
           I  G+  LH     +   V+R+L  E +L+D   +  I+D GL  K+   + +   + T 
Sbjct: 111 ILCGLEDLH-----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT- 164

Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             +GY+APE +   R+T   D +  G +I +++ G     S  R   E    E    R L
Sbjct: 165 --VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ----SPFRGRKEKVKREEVDRRVL 218

Query: 415 K------GKFSESEAAKLGKMALVCTHEDPENR 441
           +       KFSE EA  + KM L    +DP+ R
Sbjct: 219 ETEEVYSAKFSE-EAKSICKMLLT---KDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   L+  R  I++    +   + ++ L +L       I+
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 67  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 113 IKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167

Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/213 (21%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F  ++ LG GN   V K   +   L+  R  I++    +   + ++ L +L       I+
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 67  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 113 LRGLAYLRE----KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167

Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 183 TQCFSEVNLLGKGNFSSV--YKGTLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLR 239
           T  + ++  +G G F  V   +  L  G  VAI+ I    S         + L LL  LR
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           HENII L     S    + + + +      L + L         + +      +  I +G
Sbjct: 68  HENIISLSDIFISP-LEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQILRG 120

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + Y+HS+ V     VHR+L    +LI++  +  I D GL ++    +   V    +   Y
Sbjct: 121 LKYVHSAGV-----VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV----STRYY 171

Query: 360 LAPEYVTT-GRFTERSDIFAFGVIILQILTG 389
            APE + T  ++    DI++ G I  ++L G
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 28/136 (20%)

Query: 270 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 329
           LSK  +  E +S        +SI   I   I Y+HS       ++HR+L  + +L+    
Sbjct: 102 LSK--ELAEKTS----VGAFLSIFHKICATIEYVHSK-----GVLHRDLKPDNILLGLFG 150

Query: 330 NPLIADCGLHK--------LLADD-----IVFSVL----KTSAAMGYLAPEYVTTGRFTE 372
             +I D G           LL  D     I +S +    K      Y+APE +     +E
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210

Query: 373 RSDIFAFGVIILQILT 388
            +DI+A GVI+ Q+LT
Sbjct: 211 STDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 43/209 (20%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +V+    +  G  VAI+ IN+     +E   +  + ++  L++ NI+
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEILVMKELKNPNIV 79

Query: 245 RLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
               F  S   G E F++ ++   G L+  +     +   +D +   ++     + + +L
Sbjct: 80  ---NFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFL 131

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           H+++V     +HR++  + VL+    +  + D G        I     K S  +G   ++
Sbjct: 132 HANQV-----IHRDIKSDNVLLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 182

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 191 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH  +  L
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +    +  R  CF++ ++A  G+L  +L +E     V            I   + YLHS 
Sbjct: 61  KYAFQTHDR-LCFVM-EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR 114

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYV 365
           +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YLAPE +
Sbjct: 115 DV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 167

Query: 366 TTGRFTERSDIFAFGVIILQILTGSL 391
               +    D +  GV++ +++ G L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLR-- 239
           +  V  +G G + +VYK      G  VA++S+ V +  +E+      V+ + LL  L   
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQT--NEDGLPLSTVREVALLKRLEAF 59

Query: 240 -HENIIRLRGFCCS-RGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
            H NI+RL   C + R   E    L+++   +  L  YLD+        +  T   ++  
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQ 116

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
             +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  + +  + 
Sbjct: 117 FLRGLDFLHAN-----CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT- 170

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
            + Y APE +    +    D+++ G I  ++ 
Sbjct: 171 -LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I  GI +LHS +     IV+R++  E VL+D Q N  ++D GL   L D    ++ + + 
Sbjct: 104 ITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             GY+APE +    ++   D FA G  I +++ G
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 191 LLGKGNFSSVYKGTLRD---GTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LLGKG F  V    +R+   G   A++ +   V   K E A  +    +L + RH  +  
Sbjct: 2   LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L+    ++ R  CF++ ++   G+L  +L +E   S   +  TR      I   + YLHS
Sbjct: 60  LKYSFQTKDR-LCFVM-EYVNGGELFFHLSRERVFS---EDRTRF-YGAEIVSALDYLHS 113

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEY 364
            +     IV+R+L +E +++D+  +  I D GL K    D   + +KT      YLAPE 
Sbjct: 114 GK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEV 166

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSL 391
           +    +    D +  GV++ +++ G L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           IA G+ +LHS       I++R+L ++ V++D + +  IAD G+ K    + +F    T  
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRT 160

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 26/213 (12%)

Query: 192 LGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL- 246
           LG G F  V    +       A++ +    +     +E  F +   +L    H  I++L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKE-ILEECNHPFIVKLY 59

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           R F   + +   +++ ++   G+L   L ++ G     D  T    I  +     YLH+ 
Sbjct: 60  RTF---KDKKYIYMLMEYCLGGELWTIL-RDRGL---FDEYTARFYIACVVLAFEYLHNR 112

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 I++R+L  E +L+D      + D G  K      + S  KT    G   Y+APE
Sbjct: 113 G-----IIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPE 162

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 396
            +    +    D ++ G+++ ++LTG       
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 18/142 (12%)

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
           ++ +  IV+R+L  E +L+D + +  I+D GL   + +    +V      +GY+APE + 
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVIN 174

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-------KFS 419
             ++T   D +  G +I +++ G     S  R   E    E  +DR +K        KFS
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ----SPFRKRKERVKREE-VDRRVKEDQEEYSEKFS 229

Query: 420 ESEAAKLGKMALVCTHEDPENR 441
           E +A  + +M L    ++P+ R
Sbjct: 230 E-DAKSICRMLLT---KNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 6/109 (5%)

Query: 281 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
           S  L +   V     +A G+ +L S        VHR+L+   VLI +     I D GL +
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASKNC-----VHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 341 -LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            ++ D    S   T   + ++APE +    +T  SD+++FG+++ +I T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 62/280 (22%), Positives = 130/280 (46%), Gaps = 42/280 (15%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRS----INVT-----SCKSEEAEFVKGLYLLTSLRHEN 242
           LG+G F+++YKG LR  + + I      ++V      S   +   F +   L++ L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +++L G C    R E  ++ ++   G L  +L +E+ + ++  W  ++ +   +A  + Y
Sbjct: 63  LVKLYGVCV---RDENIMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALHY 116

Query: 303 LHSSEVNKPAIVH-----RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           L   E  K  +VH     +N+ V +  +++ + P I      KL    I  +VL     +
Sbjct: 117 L---EDKK--LVHGNVCGKNILVARYGLNEGYVPFI------KLSDPGIPITVLSREERV 165

Query: 358 G---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
               ++APE +  G+   T  +D ++FG  +L+I +      S++  + +   +++    
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---- 221

Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
             + +    + A+L  +   C   DP  RP+  A++ +L 
Sbjct: 222 --QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 12/97 (12%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           IA G+ +LHS       I++R+L ++ V++D + +  IAD G+ K    + ++  + T  
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKT 160

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 25/162 (15%)

Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENI 243
           +  +G+G F  V+K   +    +VA++ + +   ++E+  F    ++ + +L  L+HEN+
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLM---ENEKEGFPITALREIKILQLLKHENV 73

Query: 244 IRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV-LDWSTRVSIIIGI 296
           + L   C       +R +G  +L+++F     L+  L       NV    S    ++  +
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKML 128

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
             G+ Y+H    NK  I+HR++    +LI +     +AD GL
Sbjct: 129 LNGLYYIHR---NK--ILHRDMKAANILITKDGILKLADFGL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 26/205 (12%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  I++L G  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLG-- 76

Query: 251 CSRGRGECFLIYDFAPKGKL-SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                G+ +++ +F P G + +  L+ + G   + +   +V I   + + + YLHS +  
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQV-ICRQMLEALQYLHSMK-- 130

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 366
              I+HR+L    VL+    +  +AD G    ++   V ++ +  + +G   ++APE V 
Sbjct: 131 ---IIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 367 TGRFTE-----RSDIFAFGVIILQI 386
                +     ++DI++ G+ ++++
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 191 LLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +LGKG+F  V    L+  G L A++ +      + ++ E       + SL   +    + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +CC +     F + +F   G L  ++ +    S   D +        I   + +LH    
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYV 365
               I++R+L ++ VL+D + +  +AD G+ K    + +F+   TS   G   Y+APE +
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 366 TTGRFTERSDIFAFGVIILQILTG 389
               +    D +A GV++ ++L G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 16/133 (12%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           IA  +GYLHS       IV+R+L  E +L+D Q + ++ D GL K    + +     TS 
Sbjct: 105 IASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST 155

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
             G   YLAPE +    +    D +  G ++ ++L G     S  R  AE   ++N +++
Sbjct: 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAE--MYDNILNK 211

Query: 413 NLKGKFSESEAAK 425
            L+ K + + +A+
Sbjct: 212 PLQLKPNITNSAR 224

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG-F 249
           LGKGN+ SVYK   R  G  +A++ I +   +S+  + +  L +L       I+   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                 G  ++  ++   G L K L     ++  +       I   + KG+ +L   E N
Sbjct: 69  FI---EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEHN 123

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYVTTG 368
              I+HR++    VL++      + D G    ++ ++V S+ KT+     Y+APE + +G
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 369 ------RFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDRNLKGKFS 419
                  +T +SD+++ G+ IL++  G       T +   A  SA  +      L   +S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-LPSGYS 235

Query: 420 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             +A         C ++ P  RPT   ++E
Sbjct: 236 -DDAQDFVAK---CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 23/83 (27%), Positives = 46/83 (55%), Gaps = 2/83 (2%)

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
           ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V 
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVK 174

Query: 367 TGRFTERSDIFAFGVIILQILTG 389
             R+T   D +A G ++ +++ G
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGL--YLLTSLRHENIIRLR 247
           +GKG+F  V     + DG   A++ +   +  K +E + +      LL +++H  ++ L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 248 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 305
             F   +   + + + D+   G+L  +L +E           R       IA  +GYLHS
Sbjct: 63  YSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHS 114

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 362
                  I++R+L  E +L+D Q + ++ D GL K   + I  S   TS   G   YLAP
Sbjct: 115 LN-----IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSK-TTSTFCGTPEYLAP 165

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTG 389
           E +    +    D +  G ++ ++L G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 191 LLGKGNFSSVYKGTLRDGT-LVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           +LGKG+F  V    L+      AI+++    V      E   V+   L  +  H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             FC  + +   F + ++   G L  ++      S   D +        I  G+ +LH  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 I++R+L ++ VL+D+  +  IAD G+ K      +    K S   G   Y+APE
Sbjct: 116 -----GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN----MNGEGKASTFCGTPDYIAPE 166

Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +   ++ E  D ++FGV++ ++L G
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 186 FSEVNLLGKGNFSSV-YKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY----LLTSLR 239
           + ++  +G G + +V      R G  VAI+ +     +  ++E F K  Y    LL  ++
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMK 72

Query: 240 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
           HEN+I L          + F    L+  F     L K +  E+ S + + +     ++  
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQF-----LVYQ 126

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + KG+ Y+H++      I+HR+L    + +++     I D GL +    ++   V+    
Sbjct: 127 MLKGLKYIHAA-----GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV---- 177

Query: 356 AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
              Y APE +     +T+  DI++ G I+ ++LTG
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)

Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN----- 217
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 3   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 56

Query: 218 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-- 275
           +   K    E    L LL  ++HEN+I L                 F P   L ++ D  
Sbjct: 57  IIHAKRTYRE----LRLLKHMKHENVIGLLDV--------------FTPARSLEEFNDVY 98

Query: 276 -----QEEGSSNVLDWSTRVS-----IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 325
                     +N++            +I  I +G+ Y+HS++     I+HR+L    + +
Sbjct: 99  LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAV 153

Query: 326 DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIIL 384
           ++     I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ 
Sbjct: 154 NEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209

Query: 385 QILTG 389
           ++LTG
Sbjct: 210 ELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 50/273 (18%), Positives = 122/273 (44%), Gaps = 30/273 (10%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T++  G LVA++ +++   +  E  F + + ++   +HEN++ +  + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNE-VVIMRDYQHENVVEM--YN 84

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + K +  LH+     
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQ---- 135

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +  + +G   ++APE ++ 
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPELISR 190

Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   +  NL  K S S    
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH-KVSPSLKGF 249

Query: 426 LGKMALVCTHEDPENRPTMEAVIEE--LTVAAP 456
           L ++ +     DP  R T   +++   L  A P
Sbjct: 250 LDRLLV----RDPAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 191 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH  +  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGYLH 304
           +    +  R  CF++ ++A  G+L  +L +E        +S   +   G  I   + YLH
Sbjct: 61  KYSFQTHDR-LCFVM-EYANGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLH 112

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPE 363
           S +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      YLAPE
Sbjct: 113 SEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 166

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSL 391
            +    +    D +  GV++ +++ G L
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 9/88 (10%)

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     I++R+L  E +L+D + +  + D G  K + D   F++  T     YLA
Sbjct: 133 YLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPE---YLA 183

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +    +  D +  GV++ + + G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 24/167 (14%)

Query: 256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 315
           G+ +LI ++   G+L  +L++E     +    T    +  I+  + +LH     +  I++
Sbjct: 73  GKLYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH-----QQGIIY 123

Query: 316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTE 372
           R+L  E +L+D Q +  + D GL K    + +     T    G   Y+APE +      +
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 373 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
             D ++ G ++  +LTG+   T+  R        +  ID+ LKGK +
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLN 218

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 25/98 (25%), Positives = 52/98 (53%), Gaps = 7/98 (7%)

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           I I + +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S +
Sbjct: 104 ISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            T +   Y++PE +    +T +SDI++ G+ ++++  G
Sbjct: 160 GTRS---YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 192 LGKG--NFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS-LRHENIIRLR 247
           +G+G  N +SVY       GTLV +R  ++ +C  E  + ++   +L+   RH NI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS- 64

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +         ++I  F   G  +  L     EG S  L      +I+ G  +G+ YLH 
Sbjct: 65  -WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQ 119

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL------------HKLLADDIVFSVLKT 353
           +       +HRN+    +LI    + L++  GL             K++ D   FS    
Sbjct: 120 N-----GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS---- 168

Query: 354 SAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTG 389
           ++ + +L+PE +      +  +SDI++ G+   ++ TG
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 54/291 (18%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR----H 240
           F  V ++G+G +  VYK    + G LVAI+ +++   + EE +          LR    H
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-----YNILRKYSNH 62

Query: 241 ENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----- 291
            NI    G F      G   + +L+ +    G ++  +        +     R+      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIA 116

Query: 292 -IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
            I+    +G+ YLH ++V     +HR++  + +L+ +     + D G+   L      ++
Sbjct: 117 YILRETLRGLAYLHENKV-----IHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TL 167

Query: 351 LKTSAAMG---YLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLA 400
            + +  +G   ++APE +         +  RSD+++ G+  +++  G   L     MR  
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-- 225

Query: 401 AESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPTMEAVIE 449
              A F+  I RN        E  + K       C  ++ E RP ME ++E
Sbjct: 226 ---ALFK--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG GN  +VYK   L    ++A++ I +      + + +  L +L       II   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               R    +  +F   G L  Y    E   +VL       I + + KG+ YL S +   
Sbjct: 69  FVENR--ISICTEFMDGGSLDVYRKIPE---HVLG-----RIAVAVVKGLTYLWSLK--- 115

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 370
             I+HR++    +L++ +    + D G+   L + I  + + T+A   Y+APE ++  ++
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---YMAPERISGEQY 170

Query: 371 TERSDIFAFGVIILQILTGSL 391
              SD+++ G+  +++  G  
Sbjct: 171 GIHSDVWSLGISFMELALGRF 191

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           ++GKG++  V        G  VAI+ I +V    S+    ++ + LL  LRH +I+ ++ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 249 FCCSRGRGE---CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
                 R E    +++++      +   L Q   +++ L        +  + + + Y+H+
Sbjct: 67  IMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPE 363
           + V      HR+L  + +L +      I D GL ++  +D   ++  T   A   Y APE
Sbjct: 122 ANV-----FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 364 YVTT--GRFTERSDIFAFGVIILQILTG 389
              +   ++T   DI++ G I  ++LTG
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 12/133 (9%)

Query: 260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 318
           LI D+   G++  +L Q +  S        V    G I   + +LH     K  IV+R++
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEIILALEHLH-----KLGIVYRDI 131

Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIF 377
            +E +L+D + + ++ D GL K    +           + Y+APE +   G   +  D +
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191

Query: 378 AFGVIILQILTGS 390
           + G++I ++LTG+
Sbjct: 192 SLGILIFELLTGA 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 16/150 (10%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF--VKGLYLLTSLRHENIIRLRG 248
           LG+G++++VYKG  +  G LVA++ I +     E A F  ++   LL  L+H NI+ L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                 +    L++++     L +Y+D        L        +  + +G+ Y H    
Sbjct: 71  II--HTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
               ++HR+L  + +LI ++    +AD GL
Sbjct: 124 ----VLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 26/97 (26%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I+ G+ +LH     +  I++R+L ++ V++D + +  IAD G+ K    + +   + T  
Sbjct: 110 ISVGLFFLH-----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRT 160

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             G   Y+APE +    + +  D +A+GV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.5 bits (94), Expect = 0.002
 Identities = 55/265 (20%), Positives = 111/265 (41%), Gaps = 27/265 (10%)

Query: 180 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTS 237
           ES    +  +  +G G F  V+     R       ++I+    K  E+++ V  + ++  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           L+H+NI+R      ++   + +++ +F   G LS+ + +       ++    V I   + 
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 298 KGIGYLHSSE--VNKPAIVHRNLSVEKVL----------IDQQFNPL-------IADCGL 338
             + Y H+ +   N   ++HR+L  + +           I  Q N L       I D GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 339 HKLLA-DDIVFSVLKTSAAMGYLAPEYV--TTGRFTERSDIFAFGVIILQILTGSLVLTS 395
            K +  + +  S + T     Y +PE +   T  + ++SD++A G II ++ +G      
Sbjct: 189 SKNIGIESMAHSCVGTPY---YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 396 SMRLAAESATFENFIDRNLKGKFSE 420
           +   +   +  +   D  +KGK  E
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKE 270

Length = 1021

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 16/201 (7%)

Query: 192 LGKGNFSSVY----KGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRL 246
           LGKG+F +VY    K  + +  L  ++ I V     +E  +  +   LL+ L H  I++ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK- 66

Query: 247 RGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
             F  S    + F +I ++     L   L++ + +   L  +      I +  G+ Y+H 
Sbjct: 67  --FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                  I+HR+L  + + +       I D G+ +LL      +   T     Y++PE +
Sbjct: 125 RR-----ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPY-YMSPEAL 177

Query: 366 TTGRFTERSDIFAFGVIILQI 386
               +  +SDI++ G I+ ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV----KGLYLLTSLRHENIIR 245
           ++G+G F  VY     D G + A++ ++    K ++ E +    + +  L S      I 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
              +        CF I D    G L  +L Q    S          II+G+     ++H+
Sbjct: 61  CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE----HMHN 115

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 362
             V     V+R+L    +L+D+  +  I+D G    LA D  FS  K  A++   GY+AP
Sbjct: 116 RFV-----VYRDLKPANILLDEHGHVRISDLG----LACD--FSKKKPHASVGTHGYMAP 164

Query: 363 EYVTTGR-FTERSDIFAFGVIILQILTG 389
           E +  G  +   +D F+ G ++ ++L G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 24/231 (10%)

Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 223
           F R+ LN     + EV    Q  + V     G+  S Y   LR    V   S    S   
Sbjct: 1   FYRQELNK---TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH 57

Query: 224 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEG 279
               + + L LL  ++HEN+I L          E F    L+ +      L+  +  ++ 
Sbjct: 58  ARRTY-RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL 115

Query: 280 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 339
           S   + +     +I  + +G+ Y+HS+      I+HR+L    V +++     I D GL 
Sbjct: 116 SDEHVQF-----LIYQLLRGLKYIHSA-----GIIHRDLKPSNVAVNEDCELRILDFGLA 165

Query: 340 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           +   D++   V    A   Y APE +     + +  DI++ G I+ ++L G
Sbjct: 166 RQADDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 71/332 (21%), Positives = 128/332 (38%), Gaps = 88/332 (26%)

Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  ++   E    +  L +L+ L +H+NI+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 245 RLRGFC------------CSRG--------RGECFLIYDFAP------------------ 266
            L G C            C  G        + E FL +  A                   
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165

Query: 267 -----KGKLSK----YLDQEEGSSNV-----------------LDWSTRVSIIIGIAKGI 300
                 G  S+    Y++    SS+                  LD    +     +A+G+
Sbjct: 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--G 358
            +L S        +HR+++   VL+       I D GL + + +D  + V+K +A +   
Sbjct: 226 DFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VVKGNARLPVK 279

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--- 415
           ++APE +    +T +SD++++G+++ +I   SL  +    +   S  F   + R  +   
Sbjct: 280 WMAPESIFDCVYTVQSDVWSYGILLWEIF--SLGKSPYPGILVNS-KFYKMVKRGYQMSR 336

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
             F+  E   + KM   C + +P  RPT   +
Sbjct: 337 PDFAPPEIYSIMKM---CWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 12/95 (12%)

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-- 353
           I  G+ +LH        I++R+L  E VL+D   N  I+D GL   L D       KT  
Sbjct: 106 IISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKD----GQSKTKG 156

Query: 354 -SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
            +   G++APE +    +    D FA GV + +++
Sbjct: 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 28/247 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           + ++  LG G+   V+     D    VA++ I +T  +S +   ++ + ++  L H+NI+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK-HALREIKIIRRLDHDNIV 65

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKL-SKYLDQEEGSS---NVLDWSTRVS-----IIIG 295
           ++       G     L  D     +L S Y+ QE   +   NVL+            +  
Sbjct: 66  KVYEVLGPSGSD---LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ 122

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFS--VLK 352
           + +G+ Y+HS+ V     +HR+L    V I+ +   L I D GL +++         + +
Sbjct: 123 LLRGLKYIHSANV-----LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 353 TSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSS-----MRLAAESATF 406
                 Y +P  + +   +T+  D++A G I  ++LTG  +   +     M+L  ES   
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 407 ENFIDRN 413
               DRN
Sbjct: 238 VREEDRN 244

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	464
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
smart00090	237	RIO RIO-like kinase.	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1243	690	consensus Protein kinase [General function predict	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	98.99
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.93
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.86
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
PRK09902	216	hypothetical protein; Provisional	98.58
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.58
COG4248	637	Uncharacterized protein with protein kinase and he	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.39
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.31
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.12
PLN02876	822	acyl-CoA dehydrogenase	98.1
PF01636	239	APH: Phosphotransferase enzyme family This family	98.08
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.04
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.03
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.9
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.88
PRK10593	297	hypothetical protein; Provisional	97.74
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.67
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.63
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.43
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.4
PRK05231	319	homoserine kinase; Provisional	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.13
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.81
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.74
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.68
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.55
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.45
PLN02756	418	S-methyl-5-thioribose kinase	96.37
PLN02236	344	choline kinase	96.23
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.19
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.06
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.82
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.75
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.19
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.05
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.02
COG2334	331	Putative homoserine kinase type II (protein kinase	94.82
PRK06148	1013	hypothetical protein; Provisional	94.77
PRK11768	325	serine/threonine protein kinase; Provisional	94.74
KOG2270	520	consensus Serine/threonine protein kinase involved	93.91
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	93.88
PRK12396	409	5-methylribose kinase; Reviewed	93.44
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	92.94
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.67

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-58  Score=457.54  Aligned_cols=277  Identities=39%  Similarity=0.766  Sum_probs=237.6

Q ss_pred             cccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEE
Q 012392          172 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  251 (464)
Q Consensus       172 ~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~  251 (464)
                      ..|+++++..||++|+..++||+|+||.||+|.+.+|..||||++....... ..+|.+|+.++++++|||+|+|+|||.
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            4689999999999999999999999999999999999999999887655333 567999999999999999999999996


Q ss_pred             eCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCe
Q 012392          252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       252 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                      +.+. +.+||||||++|+|.++|+.....  +|+|.+|++||.++|+||+|||+..  .|+||||||||+|||||+++++
T Consensus       142 e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~--~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  142 EGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGC--PPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             cCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCC--CCCEecCCCCHHHeeECCCCCE
Confidence            5332 599999999999999999986543  6999999999999999999999864  6899999999999999999999


Q ss_pred             EEeeCCccccccC-CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchH-----------HH
Q 012392          332 LIADCGLHKLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM-----------RL  399 (464)
Q Consensus       332 kl~DfGl~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~-----------~~  399 (464)
                      ||+|||+++.... ........ .+|.+|+|||++..+..+.|+|||||||+|+||+||+.+.....           ..
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999976654 22211111 68999999999999999999999999999999999997765321           11


Q ss_pred             HHhhhhHHHhhhhhcC-CCCCH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          400 AAESATFENFIDRNLK-GKFSE-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ......+.+++|+.+. ..++. .+...+..++.+|++.+|.+||+|.||+++|..+.
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            2223467888998887 56664 68888999999999999999999999999996554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-54  Score=421.16  Aligned_cols=262  Identities=28%  Similarity=0.537  Sum_probs=227.8

Q ss_pred             cccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEE
Q 012392          172 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  251 (464)
Q Consensus       172 ~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~  251 (464)
                      +.+..+++.       ..+.||+|-||.||.|.++....||||.++...  -...+|.+|+.+|++|+|+|||+|+|+|.
T Consensus       201 wei~r~~l~-------l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  201 WEIPREELK-------LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             eeecHHHHH-------HHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            445555554       447899999999999999888899999998753  23467999999999999999999999995


Q ss_pred             eCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCe
Q 012392          252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       252 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                      .  ...++||||||++|+|.+||+...+  ..+...+.+.++.|||+||+||++++     +|||||.++||||+++..+
T Consensus       272 ~--~~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~-----~IHRDLAARNiLV~~~~~v  342 (468)
T KOG0197|consen  272 K--QEPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN-----YIHRDLAARNILVDEDLVV  342 (468)
T ss_pred             c--CCceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC-----ccchhhhhhheeeccCceE
Confidence            4  4479999999999999999997433  34889999999999999999999998     9999999999999999999


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHHHhh
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      ||+||||++...++.+.......-++.|+|||.+..++|+.|||||||||+||||+|- +.|+...     ....+.+.+
T Consensus       343 KIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev~~~l  417 (468)
T KOG0197|consen  343 KISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEVLELL  417 (468)
T ss_pred             EEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHHHHHH
Confidence            9999999997777777666666778899999999999999999999999999999984 5555432     244566778


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +++.+...|..|++.++++|..||+.+|++|||++.+...|+....
T Consensus       418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            8899999999999999999999999999999999999888876643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-53  Score=435.62  Aligned_cols=262  Identities=25%  Similarity=0.438  Sum_probs=224.5

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .+....+.||+|.||+||+|+..      +.+.||||.++.....+..++|.+|+++|+.++|||||+|+|.|  ...+.
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC--~~~~P  563 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC--REGDP  563 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE--ccCCe
Confidence            33455688999999999999864      35689999999888776889999999999999999999999999  55778


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGS----------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      .++|+|||..|||.+||+.....          ..+|+-.+.+.||.|||.||+||-+++     +|||||..+|+||.+
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-----FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-----FVHRDLATRNCLVGE  638 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-----ccccchhhhhceecc
Confidence            99999999999999999764321          234888999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhh
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  405 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~  405 (464)
                      +..+||+||||+|......++... .+..+++|||||.|..++||.+||||||||+|||++| |+.|+++..     +.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----n~E  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----NQE  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----hHH
Confidence            999999999999977665555544 5566789999999999999999999999999999997 778887643     223


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      +.+.+..+.-...++.++.+++.||..||+.+|.+||+++||-..|+.....
T Consensus       714 VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            3344444444788999999999999999999999999999999998876544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=410.22  Aligned_cols=253  Identities=28%  Similarity=0.519  Sum_probs=215.5

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC-eEEEEEecCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG-ECFLIYDFAPK  267 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~-~~~lv~E~~~~  267 (464)
                      +.||+|+||+||+|.++....||||.+...... ...++|.+|+.+|++++|||||+++|+|.+  .. .++||||||++
T Consensus        47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~--~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS--PPGSLCIVTEYMPG  124 (362)
T ss_pred             hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCceEEEEEeCCC
Confidence            569999999999999985555999999865422 225689999999999999999999999954  33 68999999999


Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCccccccCCc
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKLLADDI  346 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~~~~~~~  346 (464)
                      |+|.++|+..  ....++|..++.++.|||+||.|||+.+   + ||||||||+||||+.++ ++||+|||+++......
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~---~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG---P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---C-eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999875  2345999999999999999999999876   3 99999999999999997 99999999998766432


Q ss_pred             eeeeeccCCCCccCcccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          347 VFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                       .......||..|||||++.  ...|+.|+|||||||+||||+||+.||.....    ......++....++.++..++.
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcCCCCCCCccCCH
Confidence             2233367889999999999  56899999999999999999999999987543    2233445556677777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .+..++.+||+.||+.||++.+++..|+.+.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            9999999999999999999999999998653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-53  Score=422.92  Aligned_cols=260  Identities=23%  Similarity=0.466  Sum_probs=229.9

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++..+.++||.|.||+||+|+++    ....||||.++....++.+.+|+.|..+|.++.||||++|.|+.  ......+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCceeE
Confidence            34556689999999999999986    34689999999988888889999999999999999999999998  4567899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      ||+|||+||+|+.||+.+++.   +++.+++-++++||.||.||.+++     +|||||.++|||++.+..+|++||||+
T Consensus       707 IiTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~-----YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMN-----YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcC-----chhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999987753   999999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCc--eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |.+.++.  .+.......+++|+|||.+..+++|..||||||||+|||.++ |..||....     +..+...+....+.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----NQdVIkaIe~gyRL  853 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVIKAIEQGYRL  853 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----hHHHHHHHHhccCC
Confidence            9886653  344555556789999999999999999999999999999876 778886543     34455667778888


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..|.+|+..|.+||+.||++|-.+||.+.||+..|.++....
T Consensus       854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            889999999999999999999999999999999999875544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=379.84  Aligned_cols=261  Identities=20%  Similarity=0.383  Sum_probs=217.3

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEE
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  251 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~  251 (464)
                      .++..+++.       .+.||+|..|+|||++++ +++.+|+|.+.........++..+|++++.+.+||+||+++|.|.
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            355666654       488999999999999987 789999999977666677789999999999999999999999996


Q ss_pred             eCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCC
Q 012392          252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       252 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      .... +..|+||||++|||++++....    .+++...-+|+.+|++||.|||+ .+     ||||||||+|||+++.|+
T Consensus       148 ~~~~-~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~-----IIHRDIKPsNlLvNskGe  217 (364)
T KOG0581|consen  148 SNGE-EISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK-----IIHRDIKPSNLLVNSKGE  217 (364)
T ss_pred             eCCc-eEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC-----eeeccCCHHHeeeccCCC
Confidence            6443 6999999999999999997642    38899999999999999999995 55     999999999999999999


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH-HhhhhHHHh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENF  409 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~-~~~~~~~~~  409 (464)
                      +||||||.++.+.+.   ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....... .....+..+
T Consensus       218 VKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  218 VKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI  294 (364)
T ss_pred             EEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence            999999999988765   2234457888999999999999999999999999999999999987641111 111122233


Q ss_pred             hhhhcCCCCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          410 IDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       410 ~~~~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ++ ...+..+.. .++++..++..|+++||.+||++.|+++|-+-.
T Consensus       295 v~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  295 VD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             hc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence            32 233445554 889999999999999999999999999987654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=378.47  Aligned_cols=265  Identities=25%  Similarity=0.394  Sum_probs=219.0

Q ss_pred             HhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .+.+...+.++||+|-||+|.++....+..||||.++.+.++..+.+|.+|+++|.+++|||||+|+|+|..  .+.+++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicm  612 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCM  612 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHH
Confidence            345556677999999999999999988899999999999888888999999999999999999999999954  566899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+|||++|+|.+||.......  +.-...++|+.|||.||+||.+.+     +|||||.++|||++.++++||+|||+++
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n-----fVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN-----FVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc-----hhhccccccceeecCcccEEecCccccc
Confidence            999999999999998764322  344556789999999999999988     9999999999999999999999999999


Q ss_pred             cccCCceeeee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcchHHHHHhhhhHHHhhhhhcC--
Q 012392          341 LLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLK--  415 (464)
Q Consensus       341 ~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~--  415 (464)
                      .+....++... +...+++|||+|.+..++++.+||||+|||+|||+++  ...||....+.... .+...+.+..-+  
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en~~~~~~~~~~~~  764 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-ENAGEFFRDQGRQV  764 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-HhhhhhcCCCCcce
Confidence            77655544433 3445689999999999999999999999999999965  56777654432221 222233222111  


Q ss_pred             -CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          416 -GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       416 -~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                       ...+.-++.++++++.+||+.|.++||+++++...|+..+
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence             2346778999999999999999999999999999988654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=411.98  Aligned_cols=258  Identities=27%  Similarity=0.497  Sum_probs=217.2

Q ss_pred             CccccccccCCceEEEEEEECC--C----cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRD--G----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ....+.||+|.||.||.|...+  |    ..||||.++.....++..+|++|..+|++++|||||+++|+|.+  ....+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~  771 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPL  771 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcE
Confidence            3455789999999999999753  3    35999999988878888999999999999999999999999965  66789


Q ss_pred             EEEecCCCCCHHHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          260 LIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      |++|||++|||..||++.+..   ...|+..+.+.|+.|||+|+.||++++     +|||||.++||||++...+||+||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-----fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-----FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-----CcCcchhhhheeecccCcEEEccc
Confidence            999999999999999976321   345899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeecc-CCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCC-CCCcchHHHHHhhhhHHH-hhhhh
Q 012392          337 GLHKLLADDIVFSVLKT-SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFEN-FIDRN  413 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~-~~~~~  413 (464)
                      |+|+...+..++..... .-+++|||||++..+.|+.|+|||||||+|||++|.+ .||.+..     +..+.. +....
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-----n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-----NFEVLLDVLEGG  921 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-----hHHHHHHHHhCC
Confidence            99996655544444333 4567899999999999999999999999999999955 4554332     222222 33333


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                       +...+..|++.++++|..||+.+|++||++..+++.+....+
T Consensus       922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence             777889999999999999999999999999999997766543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=358.77  Aligned_cols=251  Identities=23%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .+|...+.||+|.|+.||+|+++ ++..||||.+.... .+.......+|+++|+.++|||||+|++++  ...+.+|+|
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~~~i~lV   87 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI--EDDDFIYLV   87 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecCCeEEEE
Confidence            34666678999999999999986 68999999997664 345556678999999999999999999988  457789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC------CCeEEee
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ------FNPLIAD  335 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~------~~~kl~D  335 (464)
                      ||||.+|||.+||+...    .++..+...++.|+|.||++||+++     ||||||||+||||+..      -.+||+|
T Consensus        88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~-----IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN-----IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            99999999999999765    3899999999999999999999998     9999999999999875      4589999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--h
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--N  413 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~  413 (464)
                      ||+++.+.....  ....-|++-|||||++..++|+.|+|+||.|++|||+++|+.||......     ++...+.+  .
T Consensus       159 FGfAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-----eL~~~~~k~~~  231 (429)
T KOG0595|consen  159 FGFARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-----ELLLYIKKGNE  231 (429)
T ss_pred             cchhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHHHhcccc
Confidence            999999875432  22344777899999999999999999999999999999999999754321     11112211  1


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .....+......+.++...-++.+|.+|-+..+...+.-
T Consensus       232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~  270 (429)
T KOG0595|consen  232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPF  270 (429)
T ss_pred             ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence            222233344445557777777788888887777765543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-48  Score=350.91  Aligned_cols=261  Identities=19%  Similarity=0.349  Sum_probs=214.1

Q ss_pred             CccccccccCCceEEEEEE-ECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |.+.++||+|.||+|||++ +.+|..||.|.++.+.. ....++.++|+.+|++|+|||||+++++-..++..-++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            5566899999999999997 56899999999886543 345577899999999999999999998544444445899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      ||..|||.+.+..-......+++.++++++.|++.||.++|+.- .+..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999877666777999999999999999999999843 12349999999999999999999999999999987


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC-HHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  422 (464)
                      .+..+. ....||+.||+||.+....|+.||||||+||++|||+.-..||.+..- ......+    ...--...+ ..+
T Consensus       180 s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-~~L~~KI----~qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  180 SKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-LSLCKKI----EQGDYPPLPDEHY  253 (375)
T ss_pred             chhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-HHHHHHH----HcCCCCCCcHHHh
Confidence            654432 345689999999999999999999999999999999999999987621 1111222    222112233 678


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +..+..|+..|+..||+.||+...+++.+..
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            9999999999999999999996666665544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=377.70  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=214.6

Q ss_pred             CccccccccCCceEEEEEEECC--C--cE-EEEEEecc--CCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRD--G--TL-VAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ....++||+|+||.||+|+++.  +  .. ||||..+.  ........+|++|..+|++++|||||+++|++..  ...+
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl  236 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPL  236 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCcc
Confidence            3445899999999999999753  2  23 89999885  2345566899999999999999999999999954  5679


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      +||||+|+||+|.+||.....   .++..+++.++.+.|.||+|||+++     ++||||.++|||++.++.+||+|||+
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~-----~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN-----CIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC-----CcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999987653   4899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++.... ..........+++|+|||.+..+.|+.++|||||||++||+++ |..||.+....    .....++....+..
T Consensus       309 s~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  309 SRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMP  383 (474)
T ss_pred             ccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCC
Confidence            886541 1111112246688999999999999999999999999999998 77788764322    11223335566777


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      .+...+..+..++..||..||++||+|.++.+.|+.+.....
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            777888999999999999999999999999999988765543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-46  Score=365.83  Aligned_cols=263  Identities=25%  Similarity=0.395  Sum_probs=208.4

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ++++...+.+.....||+|.||+||+|+|..  .||||.++.... ....+.|.+|+..+++-+|.||+-+.|||..  +
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~--p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN--P  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--C
Confidence            4444444445566889999999999999964  499999987653 3455789999999999999999999999943  3


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      + ..||+-+|++-+|+.+||..+   ..|+..+.++||.|||.||.|||.++     |||||||+.||+|.++++|||+|
T Consensus       461 ~-~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~-----IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  461 P-LAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN-----IIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             c-eeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh-----hhhhhccccceEEccCCcEEEec
Confidence            3 489999999999999999865   34999999999999999999999999     99999999999999999999999


Q ss_pred             CCccccccCC-ceeeeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          336 CGLHKLLADD-IVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       336 fGl~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |||+..-..- .........+.+.|||||++..   ..|+..+||||||+++|||+||..||....+.    ..+-.+-.
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIifmVGr  607 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIFMVGR  607 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEEEecc
Confidence            9998643211 0111122335577999999964   46899999999999999999999999844321    11211111


Q ss_pred             hhcCC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          412 RNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       412 ~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..+..   .....++.++.+|+..||..++++||.+.+|+..|+.+.+
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11111   2234678899999999999999999999999998877765

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-46  Score=368.66  Aligned_cols=252  Identities=20%  Similarity=0.388  Sum_probs=213.3

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..|...++||+|||+++|.++. ..|+.||+|++.....  ........+|+++.++|+|||||+++++|  ++.+.+||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence            4578889999999999999997 7899999999976432  23445688999999999999999999999  67889999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |.|+|++|+|..++..+    .++++.+...++.||+.||.|||+++     |+|||||-.|++|++++++||+|||||.
T Consensus        96 vLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~-----IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG-----IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC-----ceecccchhheeecCcCcEEecccceee
Confidence            99999999999999743    35999999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .+..+.. .....-||+.|+|||++.....+..+||||+||+||-|+.|++||....-    ...+..+..  ..-.+|.
T Consensus       167 ~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----kety~~Ik~--~~Y~~P~  239 (592)
T KOG0575|consen  167 QLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----KETYNKIKL--NEYSMPS  239 (592)
T ss_pred             eecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----HHHHHHHHh--cCccccc
Confidence            8764321 12233488999999999998999999999999999999999999976421    122222221  1233566


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+.+..+|+..+|+.||.+|||+++|+.+-..
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            778889999999999999999999999998766

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-47  Score=370.99  Aligned_cols=264  Identities=22%  Similarity=0.404  Sum_probs=229.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ++++.-..+....++||-|-||.||.|.|+. .-.||||.++.+.  .+..+|++|..+|+.++|||+|+|+|+|..  .
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~--E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--E  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--C
Confidence            5566666667788999999999999999974 4679999998764  456789999999999999999999999954  4


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...|||+|||.+|+|.+||+.....  .++--..+.++-||+.||+||..++     +|||||.++|+|+.++-.+|++|
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn-----FIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh-----hhhhhhhhhhccccccceEEeec
Confidence            5689999999999999999987643  3777778999999999999999888     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |||++++..+.+.......-++.|+|||.+....++.|+|||+|||+|||+.| |..||.+-.     ...+..++.+..
T Consensus       409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqVY~LLEkgy  483 (1157)
T KOG4278|consen  409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYGLLEKGY  483 (1157)
T ss_pred             cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHHHHHhccc
Confidence            99999998877666666666789999999999999999999999999999987 556665432     334556777888


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +...++.|++.+++||..||+.+|.+||+++|+-+.++.+-.
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            889999999999999999999999999999999998887643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-47  Score=369.10  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=217.7

Q ss_pred             ccccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEE
Q 012392          171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC  250 (464)
Q Consensus       171 ~~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~  250 (464)
                      .|.+.+++|.       +++-||.|+.|.||+|+++ ++.||||+.+.-.        ..+|+.|++|+||||+.|.|+|
T Consensus       118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeee
Confidence            3456777764       4588999999999999996 6789999765321        1478899999999999999999


Q ss_pred             EeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       251 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                        ....-++||||||..|-|...|+...    +++-...+.+..+||.||.|||.+.     |||||||+-||||+.+..
T Consensus       182 --tqsPcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK-----IIHRDLKSPNiLIs~~d~  250 (904)
T KOG4721|consen  182 --TQSPCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK-----IIHRDLKSPNILISYDDV  250 (904)
T ss_pred             --cCCceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh-----HhhhccCCCceEeeccce
Confidence              55678999999999999999998643    4777888999999999999999988     999999999999999999


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      +||+|||-++.+.+..  ......||+.|||||++.+...++|+||||||||||||+||..||.+...    ...+-.+-
T Consensus       251 VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG  324 (904)
T KOG4721|consen  251 VKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG  324 (904)
T ss_pred             EEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc
Confidence            9999999999876532  23345688999999999999999999999999999999999999976432    33344445


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ...+....+..+++.+.-|+++||+..|..||++++++.||+-+.|.+
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            566777889999999999999999999999999999999999887754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-46  Score=355.50  Aligned_cols=258  Identities=20%  Similarity=0.319  Sum_probs=205.4

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch------HHHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      ....|-..+.||+|+||.|-+|..+ +|+.||||.+.......      ......+|+++|++++|||||++++++  +.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ec
Confidence            3455677899999999999999854 89999999997643111      223357899999999999999999999  55


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNP  331 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~  331 (464)
                      ....|||+|||++|+|.+++....    .+.+..-.-++.|++.|+.|||+.|     |+||||||+|||++.+   ..+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~G-----I~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQG-----IIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcC-----cccccCCcceEEeccCCcceEE
Confidence            677899999999999999998654    3666667889999999999999999     9999999999999866   789


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCC---CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      ||+|||+|+..+...  -....-||+.|.|||++.+..+   ..+.|+||+||+||-+++|-+||.......   .-.++
T Consensus       319 KItDFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~eQ  393 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLKEQ  393 (475)
T ss_pred             Eecccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHHHH
Confidence            999999999876432  2223458899999999976543   347899999999999999999998654321   11222


Q ss_pred             hhhhhcC--CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          409 FIDRNLK--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       409 ~~~~~~~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      +....+.  +..-...+++..+++.+++..||++|||+.|+++|.|.-.
T Consensus       394 I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  394 ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            2222222  1233467889999999999999999999999999988653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-45  Score=364.59  Aligned_cols=264  Identities=23%  Similarity=0.411  Sum_probs=208.0

Q ss_pred             hcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  255 (464)
                      .++|...+.||+|+||.||+|..      .++..||||.++..........+.+|+.++.++ +||||++++|+|.. ..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence            45678889999999999999974      235689999997654444556799999999999 89999999998853 34


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCC-------------------------------------------------------
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGS-------------------------------------------------------  280 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------------------------  280 (464)
                      +..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4689999999999999999753210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee-eeeccCCC
Q 012392          281 ---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAA  356 (464)
Q Consensus       281 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~  356 (464)
                         ...+++.+++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++........ ......++
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence               134888899999999999999999988     999999999999999999999999999865432211 11122345


Q ss_pred             CccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhh
Q 012392          357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH  435 (464)
Q Consensus       357 ~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~  435 (464)
                      ..|+|||++.+..++.++|||||||+||||++ |..||......    ..+...+........+...+..+.+++.+||+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQRLKDGTRMRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            67999999998899999999999999999997 88888653211    11112222222223344566789999999999


Q ss_pred             cCCCCCCCHHHHHHHHhhhcC
Q 012392          436 EDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       436 ~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .||++|||+.|+++.|+.+..
T Consensus       316 ~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         316 GDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=350.09  Aligned_cols=258  Identities=28%  Similarity=0.447  Sum_probs=207.7

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +...+.||+|.||.||++... +|...|||......... .+.+.+|+.+|++++|||||+++|.........+++.|||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            455689999999999999976 48999999987764222 5568899999999999999999997433222368999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCcccccc
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLA  343 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~~~  343 (464)
                      +++|+|.+++....+   .|+...+..+.+||++||+|||+++     ||||||||+||||+. ++.+||+|||+++...
T Consensus        98 ~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g-----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG-----IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999987653   3999999999999999999999998     999999999999999 7999999999998766


Q ss_pred             C--CceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          344 D--DIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       344 ~--~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .  ..........||+.|||||++..+. ...++|||||||++.||+||+.||.....  . ...+..+......+.++.
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~-~~~~~~ig~~~~~P~ip~  246 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--E-AEALLLIGREDSLPEIPD  246 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--h-HHHHHHHhccCCCCCCCc
Confidence            3  1112233456888999999998643 33599999999999999999999875310  0 111112222223346777


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+.+..+++..|++.||++|||+++++++.....
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            78889999999999999999999999999877644

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.5e-44  Score=345.69  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEe--CCCCeEEEEEec
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCS--RGRGECFLIYDF  264 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~--~~~~~~~lv~E~  264 (464)
                      ...||+|++|.||+|.+ +|+.||||.++.....  .....|.+|+.+|++++||||++++|++.+  ......++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 6889999998764322  224678899999999999999999999865  444578999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      +++|+|.+++....    .++|...+.++.|++.||.|||+. +     ++||||||+|||+++++.+||+|||+++...
T Consensus       104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~-----~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN-----KPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC-----CCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999997542    488999999999999999999974 5     7899999999999999999999999998654


Q ss_pred             CCceeeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...    ....++..|+|||.+.+  ..++.++|||||||++|||+||+.||......    .....++....+...+..
T Consensus       175 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~  246 (283)
T PHA02988        175 SPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDLIINKNNSLKLPLD  246 (283)
T ss_pred             ccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCCc
Confidence            321    22346678999999976  68999999999999999999999999754321    112223233333344556


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ++..+.+++.+||+.||++|||++++++.|+....
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            77889999999999999999999999999987643

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=361.00  Aligned_cols=254  Identities=25%  Similarity=0.465  Sum_probs=223.1

Q ss_pred             ccccccccCCceEEEEEEECC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          187 SEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ...++||.|-||.||+|...+     .-.||||..+.+........|+.|..+|++++||||++|+|+|.+   ...|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wiv  468 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIV  468 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEE
Confidence            445789999999999998643     246999999987767777889999999999999999999999954   468999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||.++.|.|..||..+..   .|+..+...++.||+.+|+|||+..     +|||||.++|||+.+.--+||+||||+|.
T Consensus       469 mEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr-----fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR-----FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             EecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc-----hhhhhhhhhheeecCcceeeecccchhhh
Confidence            999999999999987543   4888999999999999999999988     99999999999999999999999999999


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      +.++.++......-++.|||||.+..++++..||||-|||.+||++. |..||.+..     +..+...+..+-+...++
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk-----NsDVI~~iEnGeRlP~P~  615 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK-----NSDVIGHIENGERLPCPP  615 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc-----ccceEEEecCCCCCCCCC
Confidence            99988888877778889999999999999999999999999999975 778887542     233334455667778899


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .|+..++.|+.+||..||.+||.+.++...|....+
T Consensus       616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            999999999999999999999999999988876543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=341.15  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=202.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..++||+|+||+||.++.+ +++.+|+|.+++...-  .+.+....|..+|.+++||+||+++-.+  ++...+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLyl  102 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLYL  102 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEEE
Confidence            45888999999999999999865 6899999999875422  2456678899999999999999997655  77889999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+.||.|..+|.+..    .+++.....++.+|+.||.|||+.+     ||||||||+|||||++|.++|+||||++
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g-----IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG-----IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHeeecCCCcEEEeccccch
Confidence            999999999999998654    3888889999999999999999999     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..-.... .+....||+.|||||++....|+..+|+||+||++|||++|.+||........    .+.+.... ....+.
T Consensus       174 ~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k-~~~~p~  247 (357)
T KOG0598|consen  174 EDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGK-LPLPPG  247 (357)
T ss_pred             hcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCc-CCCCCc
Confidence            5433221 12234688999999999999999999999999999999999999987643211    22222211 112233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRP----TMEAVIEE  450 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP----s~~evl~~  450 (464)
                      -.+.+..+++...++.||++|.    ++.+|-+|
T Consensus       248 ~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  248 YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            3567788899999999999995    45555433

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.5e-44  Score=340.92  Aligned_cols=256  Identities=19%  Similarity=0.377  Sum_probs=207.1

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++..........|.+|+..+.+++||||++++|++.  ..+..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCcE
Confidence            45778899999999999999863    457899999987654455567999999999999999999999984  466799


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..++|..++.++.|++.||+|||+.+     ++||||||+|||++.++.+|++|||.+
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~-----iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG-----YVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeeccccHhhEEEcCCCcEEECCCccc
Confidence            9999999999999997543   24899999999999999999999988     999999999999999999999999987


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ...............++..|+|||.+.+..++.++|||||||++||+++ |..||......     .....+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~~~~~~~~~  229 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKAVEDGFRLPA  229 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHCCCCCCC
Confidence            6543322222222334567999999999999999999999999999875 88888653221     11111222223334


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..++..+.+++..||+.+|++||+++++++.|..+
T Consensus       230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            556778899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=339.02  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=199.8

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--CCCCCceeeeeEEEeCC--CCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSRG--RGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~--l~H~niv~l~g~~~~~~--~~~~~lv~E~~  265 (464)
                      +++|+|+||.||||.+. ++.||||.+..    ...+.|+.|-.+.+.  ++|+||++++++-...+  ..+++||+||.
T Consensus       216 eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             HHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            67999999999999996 58999999874    456678888777664  58999999998642111  23799999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS----EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ++|||.+||..+     .++|....+|+..+++||+|||+.    +..||+|+|||||++||||.+|+++.|+|||||..
T Consensus       291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            999999999754     499999999999999999999974    23689999999999999999999999999999988


Q ss_pred             ccCCce-eeeeccCCCCccCcccccccCC-CC-----CcchhHHHHHHHHHHHhCCCCC------------cchHHHHH-
Q 012392          342 LADDIV-FSVLKTSAAMGYLAPEYVTTGR-FT-----ERSDIFAFGVIILQILTGSLVL------------TSSMRLAA-  401 (464)
Q Consensus       342 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~sDv~s~Gvll~el~tg~~p~------------~~~~~~~~-  401 (464)
                      +..... .......||.+|||||++.+.. +.     .+.||||+|.|||||++.....            ........ 
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            764432 3344577999999999997632 22     3689999999999999864322            11100000 


Q ss_pred             hhhhHHHhhhhhcCCCCCH-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          402 ESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ......-++.+..++.++.     ..+..+.+.+..||..||+.|.|+.-|-+.++.+....
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            0111223344455555544     35678899999999999999999999988887765544

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-44  Score=343.17  Aligned_cols=249  Identities=29%  Similarity=0.588  Sum_probs=197.1

Q ss_pred             ccccccCCceEEEEEEEC-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          189 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .+.||.|.||.||+|.+.     .+..|+||.++.........+|.+|+..+++++||||++++|+|.  ..+..++|+|
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccccc
Confidence            478999999999999987     357899999976554555788999999999999999999999996  3456899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.++|.....  ..+++.++..|+.||++||+|||+.+     ++|+||+++||++++++.+||+|||++....
T Consensus        82 ~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~-----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSNN-----IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             --TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHTT-----EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccc--cccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence            9999999999987622  34899999999999999999999988     9999999999999999999999999998763


Q ss_pred             CC-ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          344 DD-IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       344 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .. .............|+|||.+....++.++||||||+++|||+| |+.|+.....     ..+...+....+...+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~  229 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLKQGQRLPIPDN  229 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHHTTEETTSBTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccceeccc
Confidence            22 2222222335567999999998889999999999999999999 5677754321     112222233334445566


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ++..+.+++..||+.||++||+++++++.|
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            788899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.4e-43  Score=344.11  Aligned_cols=261  Identities=24%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEECC-----------------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceee
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL  246 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l  246 (464)
                      ++|...+.||+|+||.||+|.+++                 +..||+|.+..........+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778999999999999998642                 347999998865545556789999999999999999999


Q ss_pred             eeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 012392          247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP  311 (464)
Q Consensus       247 ~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  311 (464)
                      +|++..  .+..++||||+++|+|.+++.....               ....++|..+.+++.||+.||.|||+.+    
T Consensus        85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----  158 (304)
T cd05096          85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN----  158 (304)
T ss_pred             EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC----
Confidence            999844  5678999999999999999865321               1134788999999999999999999988    


Q ss_pred             CeeecCCCCCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhC-
Q 012392          312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-  389 (464)
Q Consensus       312 ~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg-  389 (464)
                       |+||||||+|||+++++.+||+|||+++......... .....++..|+|||++..+.++.++||||||+++|||+++ 
T Consensus       159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence             9999999999999999999999999998664432222 1222346779999999888999999999999999999874 


Q ss_pred             -CCCCcchHHHHHhhhhHHHhhhhh---cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          390 -SLVLTSSMRLAAESATFENFIDRN---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       390 -~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                       ..|+........ ...........   .....+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       238 ~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTDEQV-IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCHHHH-HHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             456654321111 11111111111   111223456678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-44  Score=357.51  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             hcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  255 (464)
                      .++|...+.||+|+||.||+|+.      .++..||||.++..........+.+|+.++..+ +||||++++|+|  ...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~--~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC--TVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee--ccC
Confidence            34577789999999999999974      245689999997654445556789999999999 899999999998  446


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCC-------------------------------------------------------
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGS-------------------------------------------------------  280 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------------------------  280 (464)
                      +..++||||+++|+|.+++......                                                       
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            7789999999999999999753210                                                       


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          281 ----------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       281 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                                      ...++|..++.++.||++||+|||+.+     |+||||||+|||+++++.+||+|||+++....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                            124789999999999999999999988     99999999999999999999999999986644


Q ss_pred             Cceeeee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          345 DIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       345 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ....... ...++..|+|||.+.+..++.++|||||||++|||++ |..|+......    ..+...+........+...
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~  342 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKMIKEGYRMLSPECA  342 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHHHHhCccCCCCCCC
Confidence            3221111 1223467999999999999999999999999999998 77777543211    1222233333333333445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.++.+++.+||+.||++||++.||++.|+..
T Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         343 PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            67899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-44  Score=346.16  Aligned_cols=261  Identities=20%  Similarity=0.344  Sum_probs=208.7

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..|+.+++||+|.||.||+|+. .+|+.||+|+++.+..+.+ ..-..+||.+|++|+||||++|.+...+.....+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3466678999999999999985 5899999999987763333 3445789999999999999999999877767789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +|||++ ||.-++....-   .++..++..++.|++.||+|+|+++     |+|||||.+|||||.+|.+||+|||||++
T Consensus       197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~g-----vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRG-----VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcC-----eeeccccccceEEcCCCCEEeccccceee
Confidence            999977 99988875432   3899999999999999999999999     99999999999999999999999999998


Q ss_pred             ccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--------  412 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  412 (464)
                      +..+..........|+-|.|||.+.+ ..|+...|+||.||||.||++|++.+.+..........++-.-.+        
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            87655444445567888999999986 479999999999999999999999988765543333222211100        


Q ss_pred             hcC------C--CCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 NLK------G--KFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 ~~~------~--~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+.      .  .+.       ...+....+|+..+|..||++|.|+.++++.=..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            011      0  011       1224556788999999999999999999976443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-43  Score=355.08  Aligned_cols=262  Identities=21%  Similarity=0.408  Sum_probs=208.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      ..++|...+.||+|+||.||+|+..      ++..||||.++..........+.+|+.+++.+ +|+||++++|+|  ..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--TH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe--cC
Confidence            3446788899999999999998742      34579999998655444456788999999999 899999999998  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC-------------------------------------------------------
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG-------------------------------------------------------  279 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  279 (464)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            6779999999999999999864321                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          280 -----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       280 -----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                                 ....+++..+++++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                       0124788899999999999999999988     999999999999999999999999999865433221


Q ss_pred             eee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHH
Q 012392          349 SVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  426 (464)
Q Consensus       349 ~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  426 (464)
                      ... ...++..|+|||++....++.++|||||||++|||++ |+.||.....    ...+...+........+...+.++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHHHHcccCccCCCCCCHHH
Confidence            111 1224467999999998899999999999999999997 9988865432    112223333333333334456789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          427 GKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+++.+||+.||++|||+.+|++.|+.+
T Consensus       345 ~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=335.86  Aligned_cols=260  Identities=20%  Similarity=0.318  Sum_probs=208.6

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ..|+..++||.|.-+.||+|+. ..+..||||++..+.+.....+..+|+..|+.++||||++++..|  ....++|+||
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF--vv~~~LWvVm  103 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF--VVDSELWVVM  103 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE--EecceeEEee
Confidence            4477789999999999999985 467999999999998888888899999999999999999997766  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      .||.+||+.+.+...-..  .+++..+..|++++++||.|||.+|     .||||||+.||||+++|.+||+|||.+..+
T Consensus       104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G-----~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG-----HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC-----ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999865432  3899999999999999999999999     899999999999999999999999987765


Q ss_pred             cCCceeee---eccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh----h
Q 012392          343 ADDIVFSV---LKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR----N  413 (464)
Q Consensus       343 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~  413 (464)
                      .+......   ....+++.|||||++..  ..|+.|+||||||++..||.+|..||..-........++..-...    .
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            44332111   33468899999999643  569999999999999999999999997543222111111111100    1


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      +...........+.+++..|++.||++|||+++++++-+
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence            111112234567899999999999999999999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-42  Score=387.65  Aligned_cols=251  Identities=32%  Similarity=0.554  Sum_probs=198.5

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ..|...++||+|+||.||+|+. .++..||||.++.....     ...|++.+++++|||||+++|+|..  ....++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence            4577788999999999999997 47899999998653311     1245788999999999999999944  56789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.++++.       ++|.++.+|+.|||+||+|||+..  .++|+||||||+||+++.++.+++. ||.....
T Consensus       763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC--SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCC--CCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999952       899999999999999999999652  4569999999999999999998886 6665433


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH----------HHhhhhHHHhhhh
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL----------AAESATFENFIDR  412 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~----------~~~~~~~~~~~~~  412 (464)
                      ..+     ....++..|+|||++.+..++.++|||||||++|||+||+.|+......          .........++++
T Consensus       833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence            221     1224567899999999999999999999999999999999997432110          0001122333444


Q ss_pred             hcCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          413 NLKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       413 ~~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+..  ..+..+..++.+++.+||+.||++||+|+||++.|+.+.+
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            4432  2345667788999999999999999999999999998755

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-43  Score=344.19  Aligned_cols=259  Identities=24%  Similarity=0.430  Sum_probs=209.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|+..+.||+|+||.||+|++. ++.    .||||.++........++|.+|+.+++.++||||++++|+|..   ...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence            45788899999999999999864 333    4899998765444556789999999999999999999999843   346


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEecCCCcEEEccccc
Confidence            79999999999999998643   23889999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++....... ........+..|+|||++....++.++|||||||++|||++ |..|+......     .+...+......
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERL  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHhCCCCC
Confidence            987653322 12222234567999999999999999999999999999998 88888653221     122333333333


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+..++..+.+++..||+.||++||++.+++..|..+....
T Consensus       231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            344456678999999999999999999999999998776544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=350.56  Aligned_cols=255  Identities=18%  Similarity=0.328  Sum_probs=213.6

Q ss_pred             hhcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ....|....+||+|..|.||.|+. .+++.||||++.... .....-.++|+.+|+..+|+|||+++..+..  .+++|+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence            445688889999999999999974 478899999998764 3334457899999999999999999998854  478999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||||++|+|.+.+...     .+++.++..|+++++.||+|||.++     |+|||||++|||++.++.+||+|||++.
T Consensus       348 VMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~g-----IiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARG-----IIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcc-----eeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999998653     3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .+..... ......||+.|||||++....|.+|.||||||++++||+.|.+||.........   +............++
T Consensus       418 qi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl---yLIa~ng~P~lk~~~  493 (550)
T KOG0578|consen  418 QISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPKLKNPE  493 (550)
T ss_pred             ccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH---HHHhhcCCCCcCCcc
Confidence            8765543 233456899999999999999999999999999999999999999864332111   111112223344567


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+..+.+++.+||+.|+++|+++.|+|+|-..
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            788899999999999999999999999998543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-44  Score=324.87  Aligned_cols=254  Identities=20%  Similarity=0.345  Sum_probs=197.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHH-HHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .|+.+.++|+|+||.|||++.+ +|+.||||.+..+...... +-.++|+.+|++++|+|+|.|+.+|  .....++||+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhLVF   80 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHLVF   80 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEEEe
Confidence            4666788999999999999987 6999999999766543333 4468999999999999999999998  6678899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |||+..-|.+ |....   ..++.....+++.|++.|+.|+|+++     +|||||||+||||+.++.+||||||+|+.+
T Consensus        81 E~~dhTvL~e-Le~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n-----~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   81 EYCDHTVLHE-LERYP---NGVPSELVKKYLYQLLKAIHFCHKNN-----CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eecchHHHHH-HHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC-----eecccCChhheEEecCCcEEeccchhhHhh
Confidence            9998744444 43322   33888889999999999999999998     999999999999999999999999999988


Q ss_pred             c-CCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh---hhH-------HHhh
Q 012392          343 A-DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES---ATF-------ENFI  410 (464)
Q Consensus       343 ~-~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~---~~~-------~~~~  410 (464)
                      . ....+.  .-.+|.-|.|||.+.+ -.|....||||.||++.||++|.+.|.+..+....-   ..+       .+++
T Consensus       152 ~~pgd~YT--DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SAPGDNYT--DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cCCcchhh--hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            6 332222  2346778999999987 689999999999999999999999887644322111   111       1111


Q ss_pred             hh-----hcC-----CCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          411 DR-----NLK-----GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       411 ~~-----~~~-----~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..     ++.     ...+     +..+..+.+++..|++.||++|++-+|++.+-
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence            00     000     0000     12345688999999999999999999999653

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.8e-43  Score=336.20  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=208.0

Q ss_pred             CCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      +|+..+.||+|+||.||+|....      ...||+|.++.........+|.+|+.++++++||||+++++++.  .....
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCce
Confidence            46777899999999999998642      25799999876554445567999999999999999999999984  45678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      +++|||+++|+|.+++......            ...+++.+++.++.|++.||+|||+.+     ++|+||||+||+++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nil~~  158 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVG  158 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccccceEEEc
Confidence            9999999999999999754211            135889999999999999999999988     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      +++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||+| |..|+......     
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----  233 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----  233 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            999999999999986533221 11222334677999999998899999999999999999998 98888653321     


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+...+........+..++..+.+++.+||+.||++||++.||+++|+.
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1222232333334556778899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=332.05  Aligned_cols=256  Identities=23%  Similarity=0.461  Sum_probs=208.7

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..+.||+|+||.||+|++.    +...||||.++.........+|.+|+.++++++||||+++++++.  ..+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceE
Confidence            46788899999999999999874    245899999876654555678999999999999999999999884  456789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....+   .+++..++.++.|++.||+|||+.+     |+|+||||+||++++++.+||+|||++
T Consensus        82 iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCCEEECccchh
Confidence            99999999999999976432   4899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccC-CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          340 KLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       340 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +.... ...........+..|+|||.+.+..++.++||||||+++|||++ |..|+......     .+...+.......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~  228 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIKAVEDGYRLP  228 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHHHHHcCCCCC
Confidence            87642 22222222334567999999998899999999999999999998 88888543221     1112222222223


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+++.+.+++.+||+.+|++||++.+|+++|..+
T Consensus       229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3445678899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.9e-43  Score=330.98  Aligned_cols=251  Identities=24%  Similarity=0.455  Sum_probs=203.0

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      .|+..+.||+|+||.||+++++++..+|+|.+....  ....+|.+|+.++++++||||+++++++  ......++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEE--ccCCCEEEEEEc
Confidence            467778999999999999999888899999886443  2346789999999999999999999998  446679999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.++++....   .++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          81 MENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS-----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999975432   3889999999999999999999988     99999999999999999999999999886644


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..........++..|+|||.+....++.++||||||+++|||++ |+.|+......    ..+..+.. ......+...+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~~-~~~~~~~~~~~  227 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMISR-GFRLYRPKLAS  227 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHC-CCCCCCCCCCC
Confidence            33222223334567999999988889999999999999999999 88888653321    11111111 11222233455


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+.+++.+||+.+|++||++.++++.|+
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            67899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=344.83  Aligned_cols=261  Identities=21%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|..+++||.|.||.||+|+- ..|..||||+++..-...++..-++|++.|++++ |||||+|...+.+.++ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence            35678889999999999999985 4789999999987765666666789999999998 9999999999855433 8999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||||+ .+|.+.+..+   ...++..++..|+.||+.||+|+|.+|     +.|||+||+|||+..+..+||+||||||
T Consensus        88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G-----fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG-----FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCChhheEecccceeEeccccccc
Confidence            999995 5999999876   346999999999999999999999999     9999999999999999999999999999


Q ss_pred             cccCCceeeeeccCCCCccCcccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------HHH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FEN  408 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------~~~  408 (464)
                      .......+..  -..|.-|.|||++. .+-|+.+.|+||+||+++|+.+-++.|.+........+.           +.+
T Consensus       159 ev~SkpPYTe--YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  159 EVRSKPPYTE--YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccCCCcch--hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            8866543332  23566799999985 678999999999999999999999888765332111100           000


Q ss_pred             --hhhhhcCCC-----------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          409 --FIDRNLKGK-----------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       409 --~~~~~~~~~-----------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                        .+...+.-.           .-...+.+..+++.+|++.||++|||+.|.+++.....
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence              000011000           01236788899999999999999999999999865443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.6e-43  Score=337.47  Aligned_cols=255  Identities=19%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |...+.||+|+||.||+|... +++.||||.+......  .....+.+|+.++++++|+||+++++.+  ...+..++|+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~--~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY--ETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE--ccCCeEEEEE
Confidence            667789999999999999864 7899999998754322  2334678999999999999999999988  4466899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++...
T Consensus        80 e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER-----IVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            99999999988865332  24899999999999999999999988     999999999999999999999999999865


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .....  .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+ ......++...
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~  228 (285)
T cd05631         153 PEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRV-KEDQEEYSEKF  228 (285)
T ss_pred             CCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHh-hcccccCCccC
Confidence            43221  12345788899999999999999999999999999999999999754321111 1111111 11122334456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      +..+.+++..||+.||++||+     +++++++.+.
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence            678999999999999999997     8999987553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-42  Score=340.93  Aligned_cols=260  Identities=18%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||+|+||.||+++.. ++..||+|.+...........|.+|+.++++++||||+++++++..  .+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEe
Confidence            56888899999999999999976 6889999998765434445679999999999999999999999844  56799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+.    |+||||||+|||+++++.+||+|||++...
T Consensus        83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          83 EHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC----EEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            9999999999997543    38899999999999999999997532    999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh------------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA------------------  404 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~------------------  404 (464)
                      ....   .....++..|+|||++.+..++.++|||||||++|||+||+.||...........                  
T Consensus       155 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             cccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            4321   1223467889999999988999999999999999999999999864321100000                  


Q ss_pred             --------------------hHHHhhh---hhcCCC-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          405 --------------------TFENFID---RNLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       405 --------------------~~~~~~~---~~~~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                                          ......+   ...... .....+.++.+++.+||+.||++|||+++++++.+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                0000000   000011 112345779999999999999999999999999875543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-42  Score=330.16  Aligned_cols=254  Identities=24%  Similarity=0.446  Sum_probs=206.2

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|+..++||+|+||.||+|...++..||+|.+....  .....|.+|+.++++++|+||+++++.+  ...+..++++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVV--TKEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCCcEEEEe
Confidence            4577889999999999999998888899999886543  2356789999999999999999999987  44667899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..+++.+++.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN-----YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEecCCCcEEECCCccceecC
Confidence            9999999999976432  34889999999999999999999988     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||++..+.++.++|||||||++|||+| |..||.......     ....+............
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  229 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQRGYRMPRMENC  229 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCC
Confidence            432222222334567999999988889999999999999999999 888886432211     11111222222233345


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-42  Score=333.58  Aligned_cols=263  Identities=26%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .|...+.||+|+||.||+|.+. +++    .|++|.+..........++..|+..+++++||||++++|++.  . ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~-~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--G-ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--C-CccE
Confidence            4667789999999999999874 344    478888765443344567888999999999999999999873  2 3467


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +++||+++|+|.+++....   ..++|..+..++.||+.||+|||+.+     ++||||||+|||+++++.+||+|||++
T Consensus        85 ~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEEcCCccc
Confidence            8999999999999997543   24899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          340 KLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       340 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +...... ........++..|+|||.+.++.++.++||||||+++||++| |..|+......     ...+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~  231 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLLEKGERLA  231 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCCcCC
Confidence            8654322 111222335567999999998899999999999999999998 88888654221     1223333322223


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccccccC
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLF  463 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~~  463 (464)
                      .+..+...+.+++.+||+.||++|||+.|+++.|..+......+|+
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~~  277 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLV  277 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcceec
Confidence            3334556788999999999999999999999999998888777664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=355.63  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=222.9

Q ss_pred             cccccccCCceEEEEEEEC-CC----cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ..++||.|+||+||+|.+- +|    .+||||.+......+...+|+.|+..|.+++|||+++|+|+|..  . .+.||+
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--s-~~qlvt  776 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML--S-TLQLVT  776 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--c-hHHHHH
Confidence            4588999999999999863 33    47999999877767777899999999999999999999999954  2 378999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      +||+.|+|.+|++..+.   .+.-+..+.+..|||+||.|||.++     +|||||.++||||.+-..+||+|||+++.+
T Consensus       777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr-----lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR-----LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc-----hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            99999999999997553   3788899999999999999999888     999999999999999999999999999988


Q ss_pred             cCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          343 ADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       343 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..+. .+......-.+.|||-|.+....|+.++|||||||++||++| |..|+.+-.     ...+.+++....+...++
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----~~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----AEEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----HHHhhHHHhccccCCCCC
Confidence            6543 333333444578999999999999999999999999999998 666776432     345667777778888899


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccccc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  462 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~  462 (464)
                      .++-.++.++.+||..|++.||+++++..+....+.....++
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl  965 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL  965 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence            999999999999999999999999999999998887766554

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-42  Score=329.84  Aligned_cols=256  Identities=23%  Similarity=0.446  Sum_probs=208.5

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .++|...+.||+|+||.||+|...+++.||||.++...  ....+|.+|+.++++++||||+++++++.  ..+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCT--LEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEe--cCCCeeeee
Confidence            45678889999999999999998878899999987543  23467899999999999999999999884  456789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++....  ...++|..+..++.|++.||.|||+.+     ++||||||+||++++++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            9999999999997644  234899999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .............+..|+|||++.+..++.++||||||+++|||+| |+.|+......     .....+........+..
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~  228 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQVDQGYRMPCPPG  228 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCc
Confidence            5432222222223457999999998899999999999999999999 88888653221     11112222223334455


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            678899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-42  Score=348.71  Aligned_cols=264  Identities=25%  Similarity=0.413  Sum_probs=209.4

Q ss_pred             hhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~  254 (464)
                      ..++|.+.++||+|+||.||+|+..      .+..||||.++........+.|.+|+.+++++. ||||++++|+|  ..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--TK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE--cc
Confidence            3456778899999999999999853      234799999976554455567999999999996 99999999998  45


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC-------------------------------------------------------
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG-------------------------------------------------------  279 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  279 (464)
                      .+..++||||+++|+|.++|+....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            6789999999999999999875321                                                       


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          280 -------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       280 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                                                           ....+++..++.++.||+.||+|||+.+     |+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dikp~N  267 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-----CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHh
Confidence                                                 0124788899999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+...... 
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence            99999999999999999865432211 1122334567999999998899999999999999999997 88887643211 


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                         ..+...+........+...+..+.+++.+||+.||++||++.+|.+.|+.+.+
T Consensus       347 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ---STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence               11112222222333445667789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-42  Score=329.10  Aligned_cols=254  Identities=22%  Similarity=0.422  Sum_probs=206.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .|...+.||+|+||.||+|... .++.||+|.+..+  .....+|.+|+.++++++||||+++++++.  ..+..++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEEEE
Confidence            4667789999999999999875 5889999998754  334567999999999999999999999984  4567899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999999975432  34899999999999999999999988     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ............+..|+|||++.+..++.++|||||||++|||+| |..|+......     .....+........+...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  230 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKGYRMERPEGC  230 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCCCCCCCCCC
Confidence            433222222233567999999998999999999999999999998 88887643221     111222223333445556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++.+||+.||++||++.++++.|+.+
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            78899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-42  Score=329.91  Aligned_cols=256  Identities=25%  Similarity=0.508  Sum_probs=211.1

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +..+|...+.||+|+||.||+|...++..+|+|.+.... .....++..|+.+++.++||||+++++++.  .....++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEE
Confidence            445678889999999999999999889999999987654 334567889999999999999999999884  45678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....+  ..+++..+..++.|++.||.|||+.+     ++|+||||+||++++++.+||+|||++..
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN-----SIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             EeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccCcceEEEcCCceEEEccccchhh
Confidence            999999999999986543  34899999999999999999999988     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... .....++..|+|||.+..+.++.++||||||+++|+|++ |..|+.....    ...+.. +....+...+.
T Consensus       154 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~  227 (261)
T cd05148         154 IKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQ-ITAGYRMPCPA  227 (261)
T ss_pred             cCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHH-HHhCCcCCCCC
Confidence            6543222 223345567999999988899999999999999999998 7888854321    111222 22333344455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+++.+.+++.+||+.||++|||+.++++.|+.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            677889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.7e-42  Score=326.60  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +|...+.||+|+||.||+|+..++..||||.+....  ....+|.+|+.++.+++||||+++++++.  .....++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEEEEEc
Confidence            466778999999999999998777789999987543  23457999999999999999999999984  45668999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++.....   .+++..++.++.||+.||+|||+.+     ++|+||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          81 MSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ-----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            999999999975432   4899999999999999999999988     99999999999999999999999999886654


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..........++..|+|||.+.+..++.++||||||+++|||+| |..|+......    .....+. .......+...+
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~~~~  227 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVS-QGLRLYRPHLAS  227 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHh-cCCCCCCCCCCC
Confidence            43322223345567999999988889999999999999999999 88887543221    1111111 122222334456


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+.+++.+||+.||++||++.++++.|+
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            78999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.3e-42  Score=330.59  Aligned_cols=259  Identities=22%  Similarity=0.388  Sum_probs=205.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      .+++|+..+.||+|+||.||+|...      .+..||||.+..........+|.+|+.+++.++||||+++++++  ...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--cCC
Confidence            4567888999999999999999753      35679999986544344556799999999999999999999998  446


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      ...++||||+++|+|.+++......      ...++|..++.++.|++.||+|||+.+     ++||||||+||++++++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCcchheEEEcCCC
Confidence            6789999999999999999753221      234688899999999999999999987     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHH
Q 012392          330 NPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  407 (464)
                      .+||+|||+++......... .....++..|+|||++.++.++.++|||||||++|||++ |..|+......    ....
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~  232 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLR  232 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence            99999999988654432221 112234567999999998889999999999999999999 67777543221    1111


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..... .....+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       233 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111 112234456678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-42  Score=341.67  Aligned_cols=263  Identities=23%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      .+|...+.||+|+||.||+|...      .++.||+|.++..........+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-GG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-CC
Confidence            45778899999999999999742      24789999987654344456788999999999 899999999988543 45


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCC--------------------------------------------------------
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGS--------------------------------------------------------  280 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  280 (464)
                      ..++++||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999998643210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCc
Q 012392          281 -SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMG  358 (464)
Q Consensus       281 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~  358 (464)
                       ...++|..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.+..... .......++..
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence             125899999999999999999999988     99999999999999999999999999987643221 11112234567


Q ss_pred             cCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcC
Q 012392          359 YLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED  437 (464)
Q Consensus       359 y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~d  437 (464)
                      |+|||++.+..++.++|||||||++|||++ |..|+......    ..+...+........+.....++.+++.+||+.+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence            999999999999999999999999999998 88888642110    1122222222233334455678999999999999


Q ss_pred             CCCCCCHHHHHHHHhhhcC
Q 012392          438 PENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       438 p~~RPs~~evl~~L~~~~~  456 (464)
                      |++||++.|++++|..+.+
T Consensus       317 p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         317 PEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             hhhCcCHHHHHHHHHHHHh
Confidence            9999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=339.40  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch--HHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  257 (464)
                      ..++|...+.||+|+|.+|++|+.. .++.+|||++.+...-.  ..+-...|-..|.+| .||.|++|+--|  ++...
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccc
Confidence            3456888899999999999999865 68999999987643222  123456788899999 799999996655  66778


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      +|.|+||+++|+|.++|+..+    .|+......++.+|+.||+|||++|     ||||||||+|||||+|+.+||+|||
T Consensus       149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G-----IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG-----IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeEcCCCcEEEeecc
Confidence            999999999999999998764    3888888999999999999999999     9999999999999999999999999


Q ss_pred             ccccccCCcee----------ee--eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh
Q 012392          338 LHKLLADDIVF----------SV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  405 (464)
Q Consensus       338 l~~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~  405 (464)
                      .++.+......          ..  ....||..|.+||++..+..+..+|+|+|||+||+|+.|.+||.....    ...
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli  295 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI  295 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH
Confidence            99987543211          11  224578889999999999999999999999999999999999987654    344


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ++.+++  +.-.+++..++.+.+|+.+.|..||.+|++.+||-+|.
T Consensus       296 FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            555554  33445666668889999999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.2e-43  Score=339.94  Aligned_cols=248  Identities=21%  Similarity=0.364  Sum_probs=210.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|.||.||||+.+ +.+.||+|.+.+.. .+.+.+...+|++++++++|||||.++.+|  +...+.|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence            45777889999999999999865 78999999987643 344567789999999999999999999988  778899999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+.+ +|..+|.+..    .+++..+..|+.+++.||.|||+++     |+|||+||+|||++.++++|++|||+++.
T Consensus        80 te~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r-----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR-----ILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             ehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCCcceeeecCCCceeechhhhhhh
Confidence            999965 9999998654    3999999999999999999999998     99999999999999999999999999998


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--CCCC
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKFS  419 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  419 (464)
                      .+.... ......||+-|||||+..++.|+..+|.||+||+|||+.+|++||....        +.+.+...+.  ...+
T Consensus       150 m~~~t~-vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~p  220 (808)
T KOG0597|consen  150 MSTNTS-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKPP  220 (808)
T ss_pred             cccCce-eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCCc
Confidence            765433 3345568999999999999999999999999999999999999997542        1222222222  2234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ...+..+..++...+..||.+|.+-.+++.|-.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence            577788999999999999999999999998753

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=325.61  Aligned_cols=251  Identities=24%  Similarity=0.446  Sum_probs=202.9

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +|+..+.||+|+||.||+|..+++..+|+|.+.....  ...+|.+|+.++++++||||+++++++  ...+..++|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCceEEEEec
Confidence            3667789999999999999988777899998865432  235688999999999999999999988  446678999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++++|.+++.....   .++|..++.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++...+
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG-----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999999975432   4899999999999999999999988     99999999999999999999999999986644


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...........+..|+|||.+.+..++.++||||||+++|||+| |..|+.......    .. ..+....+...+...+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~-~~~~~~~~~~~~~~~~  227 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VV-ESVSAGYRLYRPKLAP  227 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HH-HHHHcCCcCCCCCCCC
Confidence            32222222233457999999998899999999999999999999 778875432211    11 1122222333344567


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+.+++.+||+.+|++|||+.++++.|.
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            78999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=339.75  Aligned_cols=250  Identities=19%  Similarity=0.389  Sum_probs=212.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .|...++||+|.||.||||... .++.||+|.+..+..+.+..+..+|+.++++++++||.+++|.+..  ...+|++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHH
Confidence            3666688999999999999965 6889999999988877777889999999999999999999998854  567999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      ||.+|++.+.|....    .+++..+.-|++++..||.|||+.+     .+|||||+.|||+.++|.+||+|||++..+.
T Consensus        92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~-----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK-----KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc-----eecccccccceeEeccCcEEEEecceeeeee
Confidence            999999999997543    2577778889999999999999998     8999999999999999999999999998887


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...... ....||+-|||||++....|+.|+||||||++++||.+|.+|+.....+     .+.-.+.+...+......+
T Consensus       163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rvlflIpk~~PP~L~~~~S  236 (467)
T KOG0201|consen  163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RVLFLIPKSAPPRLDGDFS  236 (467)
T ss_pred             chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eEEEeccCCCCCccccccC
Confidence            655443 4567899999999999889999999999999999999999998754331     1112223333344444677


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..+.+++..|+..||+.||++.+++++=
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            7899999999999999999999999874

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.3e-42  Score=329.61  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=206.4

Q ss_pred             cCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||.||+|+..+      +..||||.++..........|.+|++++++++||||+++++++..  ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCC
Confidence            456777899999999999998643      478999998866544456789999999999999999999999844  567


Q ss_pred             EEEEEecCCCCCHHHHhhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEG----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      .++||||+++|+|.+++.....          ....+++..+..++.|++.||.|||+.+     ++||||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~  157 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGY  157 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eeccccccceEEEcC
Confidence            9999999999999999976421          2234889999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhh
Q 012392          328 QFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  405 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~  405 (464)
                      ++.+||+|||+++......... ......+..|+|||++.++.++.++|||||||++|||++ |..|+......    . 
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~-  232 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----E-  232 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----H-
Confidence            9999999999987653322111 122234567999999999999999999999999999999 99888643221    1 


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....+........+...+..+.+++.+||+.||++||++.||++.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            11112222222334456778999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=336.15  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+.++++++||||+++++++  .+....++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeEEEE
Confidence            5778899999999999999976 689999999865321  22345688999999999999999999887  456789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          80 MEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            99999999999997543    3889999999999999999999988     99999999999999999999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .....    ....++..|+|||.+.+..++.++|||||||++|||++|+.||......    .....+....  ...+..
T Consensus       151 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~--~~~~~~  220 (291)
T cd05612         151 LRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGK--LEFPRH  220 (291)
T ss_pred             ccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCC--cCCCcc
Confidence            64321    1234678899999999888999999999999999999999999754321    1122222211  223344


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      ....+.+++.+||+.||.+||+     +++++++.+.
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence            4667899999999999999995     9999988765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.6e-42  Score=329.87  Aligned_cols=260  Identities=23%  Similarity=0.425  Sum_probs=206.3

Q ss_pred             CccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      |...+.||+|+||+||++..     .++..||+|.++..........|.+|+.++++++||||+++++++........++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37778999999999988653     3578999999876543345567899999999999999999999886655567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++...     .+++.++..++.|++.||.|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccChheEEEcCCCcEEEeeccccc
Confidence            99999999999999642     3899999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH----------hhhhHHH
Q 012392          341 LLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFEN  408 (464)
Q Consensus       341 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~----------~~~~~~~  408 (464)
                      .........  .....++..|+|||.+....++.++||||||+++|||+||..|+........          ....+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            664432111  1112234569999999888899999999999999999999988754321100          0011222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .++.......+...+..+.+++..||+.||++|||++++++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22222233334556788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-41  Score=321.54  Aligned_cols=248  Identities=25%  Similarity=0.479  Sum_probs=201.4

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK  269 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gs  269 (464)
                      ++||+|+||.||+|...++..||+|.+...........|.+|+.++++++||||+++++++.  ..+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT--QRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe--cCCccEEEEECCCCCc
Confidence            36899999999999988899999999876554444567999999999999999999999984  4567899999999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceee
Q 012392          270 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS  349 (464)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  349 (464)
                      |.+++....   ..+++..++.++.|++.||.|||+.+     ++||||||+||++++++.+||+|||++..........
T Consensus        79 L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (250)
T cd05085          79 FLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS  150 (250)
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence            999987543   23889999999999999999999988     9999999999999999999999999987654332211


Q ss_pred             eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       350 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......+..|+|||++..+.++.++||||||+++||+++ |..||.......     ....+........+...+..+.+
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  225 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGYRMSCPQKCPDDVYK  225 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCCCHHHHH
Confidence            112233467999999998899999999999999999998 888886432211     11112222233344556788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          429 MALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       429 l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ++.+||+.+|++||++.+++++|.
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.7e-42  Score=331.83  Aligned_cols=262  Identities=23%  Similarity=0.425  Sum_probs=209.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+..........++.+|+.++.++ +|+||+++++++  ..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--TQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--cC
Confidence            3455778899999999999999864      23689999987655445556789999999999 799999999998  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      .+..+++|||+++|+|..++....            .....+++..++.++.|++.||+|||+.+     |+||||||+|
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~N  162 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-----CIHRDLAARN  162 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----ccccccceee
Confidence            667999999999999999997532            12345899999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      |++++++.+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..|+...... 
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence            999999999999999998765432211 122234567999999988899999999999999999998 88887643211 


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                          .....+........+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       242 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ----ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                111222222233344556778999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.3e-42  Score=308.01  Aligned_cols=261  Identities=21%  Similarity=0.323  Sum_probs=206.4

Q ss_pred             CCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...++||+|.||.||+|+. .+|+.||||+++....+.. ....++|++.|+.++|+||+.|++.+  .....+.||+
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lVf   80 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLVF   80 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEEE
Confidence            466778999999999999995 4799999999987754332 24678999999999999999999998  5567799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |||+. ||...+++..   ..|+-.++..++.++++||+|||++.     |+||||||.|+|+++++.+||+|||+++..
T Consensus        81 Efm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~-----IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW-----ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             Eeccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh-----hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99955 9999998644   45888999999999999999999998     999999999999999999999999999987


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-------  414 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------  414 (464)
                      ......... ...|.-|.|||.+.+ +.|+...||||.||++.||+-|.+.+.+..+.......+..+-.+..       
T Consensus       152 ~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  152 GSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             CCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            643322222 245677999999876 56999999999999999999999877765443322222211111100       


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          415 ---------------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       415 ---------------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                                     .......++....+++..+|..||.+|++++|++++-.....+
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                           0012223456679999999999999999999999987655433

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-41  Score=328.21  Aligned_cols=263  Identities=21%  Similarity=0.361  Sum_probs=212.2

Q ss_pred             hcCCccccccccCCceEEEEEEECC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .++|...++||+|+||.||+|...+     +..|++|.+...........+.+|+.++++++||||+++++++... ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence            4567788999999999999999765     6889999987655455567789999999999999999999987543 467


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      .++++||+++|+|.+++.......    ..+++.+++.++.|++.||+|||+.+     ++||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCHhhEEEcCCCcEEE
Confidence            899999999999999997643221    45899999999999999999999988     999999999999999999999


Q ss_pred             eeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhh
Q 012392          334 ADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      +|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+......     .+...+.
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----EMAAYLK  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----HHHHHHH
Confidence            999999865433221 1122334567999999988889999999999999999999 88888653221     1222222


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..........+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            223333344556789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-41  Score=327.61  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=204.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||++...     ++..||||.+.... ......|.+|+.++++++||||+++++++...+....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            45777899999999999999753     57899999987543 4445678999999999999999999998865555678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++....   ..++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR-----YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHhhEEECCCCeEEECCCcc
Confidence            99999999999999997542   24899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCceeeee--ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----------hhh
Q 012392          339 HKLLADDIVFSVL--KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------SAT  405 (464)
Q Consensus       339 ~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----------~~~  405 (464)
                      ++...........  ....+..|+|||++.+..++.++|||||||++|||++|..+..........           ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            9876443221111  112234599999998888999999999999999999987654332111000           001


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1122222222223344567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-41  Score=335.49  Aligned_cols=259  Identities=19%  Similarity=0.332  Sum_probs=203.3

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+...........+.+|+.++++++||||++++++|..  .+..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence            356888899999999999999976 6889999988765434445679999999999999999999999854  6789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.....++.|++.||.|||+.+    .|+||||||+|||+++++.+||+|||++..
T Consensus        82 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            99999999999997532    3888999999999999999999742    299999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh-----------------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------------  404 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~-----------------  404 (464)
                      .....   .....++..|+|||++.+..++.++|||||||++|||++|+.|+...........                 
T Consensus       154 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            53321   1123467789999999988899999999999999999999999864321100000                 


Q ss_pred             -------------------hHHHhhhhhcC---CCC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          405 -------------------TFENFIDRNLK---GKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       405 -------------------~~~~~~~~~~~---~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                         ......+....   ... ....+.++.+++.+||+.||++|||+.|++++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence                               00000000000   011 112346789999999999999999999999887654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=322.08  Aligned_cols=273  Identities=19%  Similarity=0.328  Sum_probs=229.3

Q ss_pred             cccCHHHHHHhhcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee
Q 012392          172 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  245 (464)
Q Consensus       172 ~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~  245 (464)
                      +.....++.....+++...++-+|.||+||+|.|++      .+.|-||.++....+-....|+.|-.++..+.|||+..
T Consensus       272 ~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  272 FNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            344556677777788888899999999999997653      45678898887776767778999999999999999999


Q ss_pred             eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCC
Q 012392          246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  321 (464)
Q Consensus       246 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~  321 (464)
                      +.|++.+. ....+++|.++.-|+|..||...++.    .+.++-.+.+.++.|++.||+|||..+     +||.||.++
T Consensus       352 V~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-----ViHkDiAaR  425 (563)
T KOG1024|consen  352 VLGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-----VIHKDIAAR  425 (563)
T ss_pred             eeEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-----cccchhhhh
Confidence            99999764 45688999999999999999854422    234777788999999999999999998     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccC-CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHH
Q 012392          322 KVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL  399 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~  399 (464)
                      |+++|+...+||+|-.++|.+-. +...-......+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-.  
T Consensus       426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--  503 (563)
T KOG1024|consen  426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--  503 (563)
T ss_pred             cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--
Confidence            99999999999999999997644 33333445556788999999999999999999999999999988 667775432  


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                         ..+.+..+..+.+...|-+|++++..+|.-||..+|++||+++|++.-|....
T Consensus       504 ---PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  504 ---PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ---HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence               23445666777888889999999999999999999999999999999887653

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-41  Score=321.74  Aligned_cols=248  Identities=25%  Similarity=0.465  Sum_probs=199.6

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      +.||+|+||.||+|+.. +++.||+|.+...........|.+|+.++++++||||++++++|  ......++|+||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCCeEEEEeeccCC
Confidence            36899999999999975 78999999886554344556799999999999999999999998  4466789999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++....   ..+++.+++.++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||+++........
T Consensus        79 ~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          79 DFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH-----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            9999997532   24889999999999999999999988     999999999999999999999999998765432211


Q ss_pred             eee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHH
Q 012392          349 SVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  426 (464)
Q Consensus       349 ~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  426 (464)
                      ... ....+..|+|||.+.++.++.++||||||+++|||++ |..|+.....     ......+........+...+..+
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  225 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQGVRLPCPELCPDAV  225 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCCCCCCcccCCHHH
Confidence            111 1112346999999998899999999999999999998 7777753221     11222222333334455567789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          427 GKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+++.+||+.||++|||+.++++.|+
T Consensus       226 ~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         226 YRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            99999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-41  Score=326.90  Aligned_cols=262  Identities=24%  Similarity=0.437  Sum_probs=210.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|++. ++.    .||+|.++.........++.+|+.++..++||||+++++++..   ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence            45777899999999999999854 444    4899998766555556789999999999999999999999843   346


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++++||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR-----LVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCCcEEECCCCc
Confidence            79999999999999997543   24899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++....... ........+..|+|||.+.+..++.++|||||||++|||+| |..|+.....     ..+...+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~  230 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEKGERL  230 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcC
Confidence            987643321 11122234567999999998899999999999999999998 7888754322     1122233333333


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccccc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF  461 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~  461 (464)
                      ..+...+..+.+++..||+.||++||++.++++.|..++.....+
T Consensus       231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05109         231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF  275 (279)
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence            334456778999999999999999999999999999887776554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-41  Score=327.12  Aligned_cols=258  Identities=21%  Similarity=0.435  Sum_probs=205.8

Q ss_pred             hcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      +++|...+.||+|+||.||+|.+.+      +..||+|.+..........+|.+|+.++++++|+||+++++++.+  ..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence            4568888999999999999998753      568999988765544555679999999999999999999998843  56


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC---C
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~  330 (464)
                      ..++||||+++|+|.+++.....   ....++|..++.++.||+.||+|||+.+     ++||||||+||++++++   .
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchheEEEeccCCCcc
Confidence            68999999999999999976432   1134899999999999999999999988     99999999999998754   5


Q ss_pred             eEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHH
Q 012392          331 PLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  408 (464)
                      +||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......     .+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~  232 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVME  232 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence            9999999998764322211 111222457999999998999999999999999999997 88888653221     1222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+........+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            23333333444556778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=326.58  Aligned_cols=265  Identities=24%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--CCCCCceeeeeEEEeCC--CCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSRG--RGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~--l~H~niv~l~g~~~~~~--~~~  257 (464)
                      ........+.||+|+||+||+|+++ |..||||.+..    .+++.+.+|.++...  |+|+||+.+++.-....  -.+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            3445667789999999999999997 78899999874    345667777777765  59999999988642221  126


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE---VNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      +|||+||.++|||++||...     .++-...++++..+|.||+|||..-   ..+|.|.|||||+.|||+..++++.|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            99999999999999999753     3888999999999999999999421   148999999999999999999999999


Q ss_pred             eCCccccccCC---ceeeeeccCCCCccCcccccccCC----C--CCcchhHHHHHHHHHHHhC----------CCCCcc
Q 012392          335 DCGLHKLLADD---IVFSVLKTSAAMGYLAPEYVTTGR----F--TERSDIFAFGVIILQILTG----------SLVLTS  395 (464)
Q Consensus       335 DfGl~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~sDv~s~Gvll~el~tg----------~~p~~~  395 (464)
                      |+|||......   .........||.+|||||++....    |  -..+||||||.++||+.-.          ..||+.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999766443   222334456899999999986432    2  1368999999999999652          356665


Q ss_pred             hHHHHHhhhhHHHh-hhhhcCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          396 SMRLAAESATFENF-IDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       396 ~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ............++ -.+.+++..     +.+....+.+||+.||..+|.-|.|+--+-+.|..+..
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            43322211222222 123344443     34678889999999999999999999999998887764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.5e-42  Score=342.33  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |...+.||+|+||.||+|+.. +++.||||.+...........|.+|+.+++.++|+||+++++++  ...+..++||||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~  153 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEF  153 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCeEEEEEec
Confidence            345588999999999999875 68999999987655444556789999999999999999999988  556789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|....        .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++....
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999986532        2566778899999999999999988     99999999999999999999999999986543


Q ss_pred             CceeeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ... ......++..|+|||++..     ...+.++|||||||++|||++|+.||.......  ...+...+........+
T Consensus       221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  297 (353)
T PLN00034        221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQPPEAP  297 (353)
T ss_pred             ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccCCCCCC
Confidence            211 1123357788999998743     223568999999999999999999986321100  00011111111222334


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+.++.+++.+||+.||++||++.|++++-+...
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            456678999999999999999999999999866543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-41  Score=343.76  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=206.5

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~  256 (464)
                      ++|...+.||+|+||.||+|+++      .+..||||.++........+.+.+|+.+|.++. ||||++++|+|  ...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~--~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC--TKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE--ccCC
Confidence            34566789999999999999864      246899999986543444557899999999997 99999999998  4456


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcC---------------------------------------------------------
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEG---------------------------------------------------------  279 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  279 (464)
                      ..++|+||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            79999999999999999975321                                                         


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          280 -------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       280 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                                                           ....++|..++.++.||+.||+|||+.+     ++||||||+|
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrdlkp~N  269 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-----CVHRDLAARN  269 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cCcccCCcce
Confidence                                                 1124788889999999999999999887     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.|+.....  
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--
Confidence            9999999999999999986532211 11122335677999999998889999999999999999998 7888754321  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                        .......+....+...+...+..+.+++..||+.+|++||++++|++.|+.+
T Consensus       348 --~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 --NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1112233333333344555678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-42  Score=340.63  Aligned_cols=249  Identities=18%  Similarity=0.282  Sum_probs=203.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+.++++++||||+++++++  ...+..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF--QDENRVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE--EcCCEEEE
Confidence            34777899999999999999976 68899999987532  122345688999999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        96 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            999999999999997543    3788888999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......    ....++..|+|||++.+..++.++|||||||++|||+||..||......    ...+.+....  ...+.
T Consensus       167 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~--~~~p~  236 (329)
T PTZ00263        167 KVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKILAGR--LKFPN  236 (329)
T ss_pred             EcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCC--cCCCC
Confidence            764432    1234778899999999988999999999999999999999999754321    1122222221  22333


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      ..+..+.+++..||+.||.+||+     +++++.|.+.
T Consensus       237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f  274 (329)
T PTZ00263        237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF  274 (329)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence            45667899999999999999986     7999977543

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-41  Score=323.32  Aligned_cols=261  Identities=20%  Similarity=0.321  Sum_probs=208.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.++...  .......|.+|+.+++.++||||+++++++..  .+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence            46788899999999999999865 78999999876422  23344578999999999999999999998854  567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+++|+|.+++.........++...+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            99999999999998754433445888999999999999999999988     9999999999999999999999999988


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  419 (464)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......   ..+...+.. .......
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (267)
T cd08228         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCDYPPLPT  230 (267)
T ss_pred             eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCCCCCCCh
Confidence            6643221 1112346678999999988889999999999999999999999986532211   111111211 1222223


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            456678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.7e-42  Score=330.43  Aligned_cols=256  Identities=20%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.+ +++.||||.++.... ......+.+|+.++++++||||+++++++  ...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE--ecCCEEEEE
Confidence            35888899999999999999986 678999999875432 22345688999999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|..+....    ..+++..+..++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||+++.
T Consensus        79 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          79 FEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             EecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999987776554321    24889999999999999999999988     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh-----------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----------  410 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-----------  410 (464)
                      .............++..|+|||++.+..++.++|||||||++|||++|+.||......... .......           
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL-FTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhCCCCHHHHHhh
Confidence            6433222222334677899999999888999999999999999999999998653221110 0000000           


Q ss_pred             --hhhc-----C---C------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          411 --DRNL-----K---G------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       411 --~~~~-----~---~------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                        ++..     .   .      ......+..+.+++.+||+.||++|||++|+++|-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence              0000     0   0      00112456799999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-41  Score=328.03  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=207.3

Q ss_pred             CccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      |...+.||+|+||.||+|+..      ....+|+|.+..........++.+|+.+++.++||||+++++.|.  ..+..+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCcE
Confidence            567789999999999999853      235799998876654455577999999999999999999999884  456789


Q ss_pred             EEEecCCCCCHHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCC
Q 012392          260 LIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  319 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk  319 (464)
                      +|+||+++|+|.+++.....                    ....+++.+++.++.|++.||+|||+.+     |+|||||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~dik  154 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDLA  154 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhh
Confidence            99999999999999865321                    1234889999999999999999999988     9999999


Q ss_pred             CCceEEcCCCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchH
Q 012392          320 VEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSM  397 (464)
Q Consensus       320 ~~Nill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~  397 (464)
                      |+|||+++++.+||+|||+++........ .......+..|+|||.+.+..++.++||||||+++|||+| |..|+....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999865332211 1122234567999999988889999999999999999999 888886432


Q ss_pred             HHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          398 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .     ..+.+.+........+...+..+.+++..||+.+|++||++.++++.|+.+..
T Consensus       235 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 P-----ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-----HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1     12223333333444455567789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=312.20  Aligned_cols=237  Identities=22%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+.++.||.|+||+|.+++.+ +|..+|+|+++....-  ...+...+|..+|+.+.||++++|.+.|  .+.+.++|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~lym  121 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNLYM  121 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeEEE
Confidence            34677799999999999999976 6899999999865321  2234567899999999999999999888  66788999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||.++|.|.++|+..+.    ++......+|.||+.||+|||+.+     |++|||||+|||||.+|.+||+|||+++
T Consensus       122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~-----iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD-----IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC-----eeeccCChHHeeeccCCcEEEEeccceE
Confidence            9999999999999987543    888999999999999999999998     9999999999999999999999999999


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .+...    +....||+.|+|||.+....++..+|.|||||++|||+.|.+||.....    ....+.++...+  .+|.
T Consensus       193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v--~fP~  262 (355)
T KOG0616|consen  193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKV--KFPS  262 (355)
T ss_pred             EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcc--cCCc
Confidence            88664    2334588899999999999999999999999999999999999987754    333444444322  3566


Q ss_pred             HHHHHHHHHHHHhhhcCCCCC
Q 012392          421 SEAAKLGKMALVCTHEDPENR  441 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~R  441 (464)
                      -.+..+.+|+...++.|-.+|
T Consensus       263 ~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  263 YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCHHHHHHHHHHHhhhhHhh
Confidence            666778888888888898888

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-41  Score=321.11  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=200.2

Q ss_pred             cccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||+|+||.||+|.++   ++..||+|.+..........+|.+|+.++++++||||+++++++  . ....++||||+++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~-~~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--E-AEALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--c-CCCeEEEEEeCCCC
Confidence            899999999999864   35679999987665444456799999999999999999999987  3 34678999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++....   ..+++.+++.++.|++.||+|||+.+     ++||||||+|||++.++.+||+|||+++........
T Consensus        80 ~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          80 PLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            9999997533   24899999999999999999999988     999999999999999999999999999865433211


Q ss_pred             e--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          349 S--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       349 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .  ......+..|+|||.+....++.++||||||+++||+++ |..|+......     .+...+........+..++++
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMSFIEQGKRLDCPAECPPE  226 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHCCCCCCCCCCCCHH
Confidence            1  111223467999999988889999999999999999996 88888654321     122333333344455566788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          426 LGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.+++..||+.||++||++.+|.+.|+..
T Consensus       227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         227 MYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            99999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.9e-42  Score=337.87  Aligned_cols=245  Identities=23%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.||+|+||.||+++.. +|+.||||.++...  .......+.+|+.++++++||||+++++++  ...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EcCCEEEEEEeCCC
Confidence            36899999999999865 78999999987542  123345688899999999999999999988  44678999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      +|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          79 GGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            999999997532    4889999999999999999999998     9999999999999999999999999987532211


Q ss_pred             eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHH
Q 012392          347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  426 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  426 (464)
                      . ......++..|+|||.+.+..++.++|||||||++|||+||+.||.......    ....+...  ...++...+..+
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~--~~~~p~~~~~~~  222 (323)
T cd05571         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILME--EIRFPRTLSPEA  222 (323)
T ss_pred             C-cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHHHHcC--CCCCCCCCCHHH
Confidence            1 1122347788999999998899999999999999999999999997543211    11111111  123344566789


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          427 GKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      .+++.+||+.||++||     ++.+++++-+
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence            9999999999999999     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-41  Score=327.12  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=207.2

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||.||++...      ++..+|+|.+.... ......|.+|+.++++++||||+++++++.  ..+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence            45778899999999999999852      34578999887543 444567999999999999999999999984  4567


Q ss_pred             EEEEEecCCCCCHHHHhhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEG---------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      .++|+||+++++|.+++.....         ....+++.+++.++.|++.||+|||+.+     ++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-----i~H~dlkp~Nili~~~  156 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN  156 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccC
Confidence            8999999999999999975431         2234899999999999999999999988     9999999999999999


Q ss_pred             CCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhH
Q 012392          329 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  406 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~  406 (464)
                      +.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |..|+.......    ..
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~  232 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VI  232 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH
Confidence            99999999999865432211 1122234567999999998889999999999999999999 788876432211    11


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+. .......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       233 ~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         233 ECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHH-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            1211 11111223345567999999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-41  Score=326.44  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             CCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .|+..+.||+|+||.||+|++     .++..||+|.+..........+|.+|+.++++++||||+++++++.  .....+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT--QEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCceE
Confidence            466778999999999999985     2567899999976554445567899999999999999999999884  456789


Q ss_pred             EEEecCCCCCHHHHhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          260 LIYDFAPKGKLSKYLDQEEG-------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      +||||+++|+|.+++.....             ....+++.+.+.++.|++.||+|||+.+     ++||||||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~nili~  158 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIG  158 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----eehhccccceEEEc
Confidence            99999999999999864321             1234889999999999999999999988     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      +++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+.....     .
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~  233 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----Q  233 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            999999999999986543221 11122223567999999988889999999999999999999 8878765321     1


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+.+.+........+...+..+.+++.+||+.||++||++.+|+++|..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1122222222223444566789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=336.21  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc----hHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~  255 (464)
                      ....|...+.||+|.||+|+.|+.. ++..||||.+......    .......+|+.++++++ ||||++++.++  ...
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~--~t~   92 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF--ATP   92 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE--ecC
Confidence            3456788899999999999999754 7899999977654111    22334557999999999 99999999998  446


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEe
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIA  334 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~  334 (464)
                      ...++||||+.+|+|.+++....    .+.+.....++.|++.|++|||+.+     |+||||||+|||++.+ +++||+
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g-----i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG-----IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEecCCCCCEEEe
Confidence            66999999999999999998732    3888899999999999999999998     9999999999999999 999999


Q ss_pred             eCCcccccc-CCceeeeeccCCCCccCcccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          335 DCGLHKLLA-DDIVFSVLKTSAAMGYLAPEYVTTGR-FT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       335 DfGl~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |||++.... .+.  ......|++.|+|||++.+.. |+ .++||||+||+||.|++|..||......    ..+..+..
T Consensus       164 DFG~s~~~~~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~ki~~  237 (370)
T KOG0583|consen  164 DFGLSAISPGEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRKIRK  237 (370)
T ss_pred             ccccccccCCCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHHHhc
Confidence            999998773 221  233455888899999999877 86 6799999999999999999999874321    11222211


Q ss_pred             hhcCCCCCHHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          412 RNLKGKFSESE-AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       412 ~~~~~~~~~~~-~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .  .-.++... +.++..++.+|+..||.+|+++.+|+++-|...
T Consensus       238 ~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 G--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1  12234444 888999999999999999999999998887765

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-41  Score=330.19  Aligned_cols=260  Identities=19%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++..........+.+|+.+++.++||||+++++++.  .....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe--cCCeEEEE
Confidence            356888899999999999999976 688999999876543333456788999999999999999999884  46689999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||++ ++|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        82 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY-----ILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             EECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECCCCccee
Confidence            99994 78988886543   23888899999999999999999988     99999999999999999999999999875


Q ss_pred             ccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--------  412 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  412 (464)
                      ...... ......++..|+|||.+.+ ..++.++|||||||++|||+||..||...................        
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         153 KSVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             ccCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence            432211 1122346778999998865 457889999999999999999999997532211111111000000        


Q ss_pred             ----------hcCCCCCH---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 ----------NLKGKFSE---------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ----------~~~~~~~~---------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ......+.         .....+.+++..|++.||++|||++|+++|-+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence                      00000000         1234678999999999999999999999886654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=329.51  Aligned_cols=263  Identities=19%  Similarity=0.299  Sum_probs=212.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-------------HHHHHHHHHHHHhcCCCCCceee
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-------------EEAEFVKGLYLLTSLRHENIIRL  246 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~f~~e~~~l~~l~H~niv~l  246 (464)
                      ..-+.|...+.||+|.||.|-+|+.. +++.||||.+.+.....             ..+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34467888899999999999999965 79999999987532111             12367889999999999999999


Q ss_pred             eeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       247 ~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      +.+..+.....+|||+|||..|.+...    ......|+..+..+++++++.||+|||.++     ||||||||+|+||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-----iiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG-----IIHRDIKPSNLLLS  244 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEEc
Confidence            999877777789999999998886532    112222899999999999999999999999     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCC----ceeeeeccCCCCccCcccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcchHH
Q 012392          327 QQFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMR  398 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvll~el~tg~~p~~~~~~  398 (464)
                      +++++||+|||.+......    .......+.||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+...
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            9999999999998865221    112233477999999999987743    24578999999999999999999987653


Q ss_pred             HHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                          ...+..++...+.-....+..+.+.+|++++|.+||+.|.+..+|..|+|....
T Consensus       325 ----~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 ----LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                233455555555444445678899999999999999999999999999986644

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.3e-41  Score=321.82  Aligned_cols=256  Identities=23%  Similarity=0.455  Sum_probs=206.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CC---cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..+.||+|+||.||+|+.. ++   ..+|+|.++........++|.+|+.++++++||||+++.+++  ...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV--TKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--ccCCCcE
Confidence            46777899999999999999975 33   379999987654445567799999999999999999999998  4456789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++++|.+++....   ..+++.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          83 IITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN-----YVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEEcCCCcEEECCCccc
Confidence            9999999999999997543   24899999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ..........  ......+..|+|||++..+.++.++|||||||++|||++ |..|+......     .+...+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~~~~~~  229 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAINDGFRL  229 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhcCCCC
Confidence            8664322111  111223456999999988889999999999999999998 89888643221     122222222233


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            33445677899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-41  Score=326.12  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             CccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      |...+.||+|+||.||+|+..      ++..||||.++..........|.+|+.++++++||||+++++++  ......+
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~~~~~~   84 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV--TKEQPLS   84 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--cCCCceE
Confidence            455688999999999999863      25789999998654333446788999999999999999999998  4456789


Q ss_pred             EEEecCCCCCHHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +++||+++++|.+++....            .....+++..+..++.|++.||+|||+.+     |+||||||+||++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-----i~H~dlkp~Nil~~~  159 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFD  159 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhheEecC
Confidence            9999999999999986321            11234888999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhh
Q 012392          328 QFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  405 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~  405 (464)
                      ++.+||+|||+++......... .....++..|+|||.+..+.++.++||||||+++|||+| |..|+.....    ...
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~  235 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDV  235 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence            9999999999988654332211 122234567999999988889999999999999999998 6667654321    111


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ... +........+..++..+.+++..||+.+|++||++++|++.|+.
T Consensus       236 ~~~-i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEM-IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            222 22222233455677889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=337.91  Aligned_cols=254  Identities=16%  Similarity=0.252  Sum_probs=203.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||+|+||.||+|+.. +++.||||.++....  ......+.+|+.++..++||||+++++++  ...+..++|
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~--~~~~~~~lv   79 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF--QDDEYLYLA   79 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE--EcCCEEEEE
Confidence            5788899999999999999976 588999999875421  22345688999999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          80 MEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            99999999999997532    3889999999999999999999988     99999999999999999999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC--
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--  419 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  419 (464)
                      ...    ......++..|+|||++.+..++.++|||||||++|||++|..||......... ..+.............  
T Consensus       151 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         151 IVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-ENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             ccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HHHHhccccccCCCCCcc
Confidence            543    122345778899999999889999999999999999999999999754321111 0111100000011111  


Q ss_pred             -HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 -ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 -~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ...+.++.+++..||+.+|++||++++++++.+..
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence             23467889999999999999999999999886543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=351.44  Aligned_cols=265  Identities=15%  Similarity=0.241  Sum_probs=210.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      .+.....++|...+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+..+..++|+||+++.+.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            444455678999999999999999999864 789999999876532 334467889999999999999999987664322


Q ss_pred             C------CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          255 R------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       255 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      .      ..+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+     |+||||||+|||++++
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-----IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-----MIHRDIKSANILLCSN  179 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEeCC
Confidence            2      1368999999999999999865544456899999999999999999999988     9999999999999999


Q ss_pred             CCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH
Q 012392          329 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~  407 (464)
                      +.+||+|||+++........ ......+|..|+|||++.+..++.++|||||||++|||++|+.||......    ..+.
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~  255 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMH  255 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHH
Confidence            99999999999865432111 112234778899999999999999999999999999999999999754221    1111


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .... ......+...+..+.+++..||+.||++||++.+++++.
T Consensus       256 ~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        256 KTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             HHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            1111 112234455677899999999999999999999998763

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-41  Score=326.91  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||+|+||+||++... +++.||||.+......  .....+..|+.++++++|+||+++.+++  ......++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE--cCCCeEEEEEeCCCCC
Confidence            699999999999865 7889999998754322  2235678899999999999999999887  4467799999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++.........+++..+..++.||+.||+|||+.+     |+||||||+||++++++.+||+|||++........ 
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            999988654333345899999999999999999999988     99999999999999999999999999876543221 


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||...................  ....+...+..+.+
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  230 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKS  230 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHH
Confidence            1122346788999999999999999999999999999999999986532211111111111111  11234456778999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          429 MALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       429 l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ++..||+.||++||     ++++++++.+
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            99999999999999     8899998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-41  Score=325.91  Aligned_cols=262  Identities=23%  Similarity=0.387  Sum_probs=207.7

Q ss_pred             CCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      +|...+.||+|+||.||+|+..      ++..+++|.+.... ......|.+|+.++++++||||+++++++.  .....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCce
Confidence            4667789999999999999753      34578999886543 344567899999999999999999999984  46678


Q ss_pred             EEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      ++||||+++++|.+++.....            ....++|..++.++.||+.||+|||+++     |+||||||+||+++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nil~~  157 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVG  157 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEc
Confidence            999999999999999975421            1234899999999999999999999988     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      .++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |..|+.......    
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  233 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----  233 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            9999999999999765432211 1122334567999999998899999999999999999999 888875432211    


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                       ..+.+........+...+..+.+++.+||+.||++||++++|++.|..+....+
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~  287 (291)
T cd05094         234 -VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP  287 (291)
T ss_pred             -HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence             111122222222334456789999999999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3e-41  Score=321.57  Aligned_cols=254  Identities=25%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+.|...++||+|+||.||+|...+++.||+|.+.....  ...+|.+|+.++++++|+||+++++++.   ....++|+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEE
Confidence            456778899999999999999988899999999875442  3457899999999999999999998862   34689999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....+  ..+++.++..++.|++.||+|||+.+     ++||||||+||++++++.++|+|||++...
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN-----YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999999999876443  34899999999999999999999988     999999999999999999999999999766


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ............++..|+|||++....++.++||||||+++||+++ |+.|+......     .....+........+..
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQNLERGYRMPRPDN  227 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHcCCCCCCCCC
Confidence            5322222222334567999999988889999999999999999999 88888643321     11112222233334445


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+..+.+++.+||+.+|++||++++++..|+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            56789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.6e-41  Score=321.12  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=200.2

Q ss_pred             ccccccccCCceEEEEEEECC-Cc--EEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CCeE
Q 012392          187 SEVNLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGEC  258 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~  258 (464)
                      ...+.||+|+||.||+|++.+ +.  .||+|.++... .......|.+|+.+++.++||||++++++|....    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            455789999999999999764 32  68999887643 2334567899999999999999999999874321    2246


Q ss_pred             EEEEecCCCCCHHHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          259 FLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ++++||+++|+|.+++....  .....+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhheEEcCCCCEEECCC
Confidence            89999999999999985432  12245899999999999999999999987     999999999999999999999999


Q ss_pred             CccccccCCceeee-eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          337 GLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       337 Gl~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |+++.......... .....+..|+|||++....++.++||||||+++|||++ |..|+......     .+...+....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~~~  231 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EIYDYLRQGN  231 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHcCC
Confidence            99987644322111 11224567999999998899999999999999999999 67777543211     1112222222


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2223345667799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.9e-41  Score=320.77  Aligned_cols=253  Identities=25%  Similarity=0.475  Sum_probs=204.9

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|...++..||+|.+.....  ...+|.+|+.++++++|+|++++++++  . ....++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~~~~~lv~e   80 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVV--S-EEPIYIVTE   80 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEE--C-CCCcEEEEE
Confidence            35677789999999999999988888899999876432  345799999999999999999999987  3 245789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++.....  ..+++.++..++.|++.||+|||+.+     |+||||||+||++++++.++|+|||++....
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN-----YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999976432  34899999999999999999999988     9999999999999999999999999998664


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||++....++.++||||||+++|||++ |..|+......     .....+........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVERGYRMPCPQDC  228 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcC
Confidence            432222222334567999999988889999999999999999999 77787543211     112222223333445566


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            7789999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.8e-41  Score=321.30  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             ccccCCceEEEEEEECC---CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          191 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      .||+|+||.||+|.+.+   +..+|+|.++..........|.+|+.++++++||||++++|++  ......++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC--TEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCCcEEEEECCCC
Confidence            58999999999998653   4579999987665444556799999999999999999999988  445678999999999


Q ss_pred             CCHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          268 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       268 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      |+|.+++...... ....++..+..++.|++.||+|||+.+     ++||||||+||++++++++||+|||+++......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999764322 224678888899999999999999988     9999999999999999999999999987554332


Q ss_pred             eee-eeccCCCCccCcccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          347 VFS-VLKTSAAMGYLAPEYVTTG-------RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       347 ~~~-~~~~~~~~~y~aPE~~~~~-------~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ... .....++..|+|||++...       .++.++||||||+++|||++ |..||..................+.....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            211 1122345679999998532       35789999999999999996 99888643321111111111111111112


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ......+.+.+++..|| .+|++|||+++|++.|+
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22234567889999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.6e-41  Score=326.13  Aligned_cols=261  Identities=21%  Similarity=0.392  Sum_probs=204.9

Q ss_pred             hhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ...+|++.+.||+|+||.||+|..+      .+..||+|.++..........|.+|+.+++.++||||+++++++.  ..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence            4567888999999999999999754      245899998875543444567889999999999999999999884  45


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      ...++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+.+     |+||||||+||++++++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dikp~nili~~~~  156 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCCChheEEEcCCC
Confidence            678999999999999999975321      1234678888999999999999999988     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHH
Q 012392          330 NPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  407 (464)
                      .+||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..|+......     .+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~  231 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVL  231 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence            99999999988654322211 111223567999999998899999999999999999998 67677543211     111


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+........+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            22111111223344567899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=349.75  Aligned_cols=252  Identities=17%  Similarity=0.257  Sum_probs=202.8

Q ss_pred             CccccccccCCceEEEEEEEC-C-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-D-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|+||.||+|... + +..||+|.+.... ......+.+|+.+++.++||||+++++++..  .+..+||||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E  145 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME  145 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence            777899999999999999854 3 6788989775443 3344567889999999999999999999844  678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.++|........++++..+..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-----MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999999998764433446889999999999999999999988     9999999999999999999999999998765


Q ss_pred             CCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......+|..|+|||++.+..++.++|||||||++|||+||+.||......    ..+....... ....+...
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~~~~~-~~~~~~~~  295 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQQVLYGK-YDPFPCPV  295 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCC-CCCCCccC
Confidence            43211 122334788899999999999999999999999999999999998654321    1112222111 11233455


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +..+.+++..||+.||++||++.+++++
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            6789999999999999999999999864

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.7e-41  Score=326.83  Aligned_cols=259  Identities=22%  Similarity=0.407  Sum_probs=203.9

Q ss_pred             cCCccccccccCCceEEEEEEECC-C--cEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD-G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..+.||+|+||.||+|...+ +  ..+++|.++........+.|.+|+.++.++ +||||+++++++  ...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCCcce
Confidence            467788999999999999998753 3  347888887544344556799999999999 799999999988  4456789


Q ss_pred             EEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +|+||+++|+|.+++.....            ....+++..+..++.|++.||+|||+.+     |+||||||+|||+++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~  154 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-----FIHRDLAARNVLVGE  154 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCcCCcceEEECC
Confidence            99999999999999975321            1134889999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  406 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~  406 (464)
                      ++.+||+|||++......  ........+..|+|||++....++.++|||||||++|||+| |..||.......     +
T Consensus       155 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~  227 (297)
T cd05089         155 NLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----L  227 (297)
T ss_pred             CCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence            999999999998643221  11111222456999999988889999999999999999998 888886543211     1


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+........+...+..+.+++.+||+.+|.+||+++++++.|..+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11122222333344566789999999999999999999999999886644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-41  Score=326.82  Aligned_cols=257  Identities=19%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             CCccccccccCCceEEEEEEEC--CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcC---CCCCceeeeeEEEe---CCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCS---RGR  255 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~---~~~  255 (464)
                      +|...+.||+|+||.||+|+..  +++.||||.++..... .....+.+|+.+++.+   +||||++++++|..   ...
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5788899999999999999863  4688999998754322 2234566777776655   69999999998842   123


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++|+||++ ++|.+++.....  ..+++.++..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~-----iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEcCCCCEEEcc
Confidence            46899999995 699999975432  34899999999999999999999988     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh-----
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----  410 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-----  410 (464)
                      ||+++......  ......++..|+|||.+....++.++|||||||++|||++|+.||.................     
T Consensus       154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            99998654331  12233467889999999888899999999999999999999999875432211111110000     


Q ss_pred             ---------hhhcC--CC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          411 ---------DRNLK--GK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       411 ---------~~~~~--~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                               .....  ..     .....+..+.+++.+|++.||++|||+.|++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence                     00000  00     0112345678999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7e-41  Score=318.56  Aligned_cols=246  Identities=22%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             ccccCCceEEEEEEEC---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          191 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      .||+|+||.||+|.++   ++..||+|.++.... .....+|.+|+.+++.++||||++++|++  . ....++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--E-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--c-CCCcEEEEecCC
Confidence            5899999999999753   578899999875432 23456799999999999999999999987  3 245789999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      +|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++......
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          79 LGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            999999996532    3889999999999999999999988     9999999999999999999999999998764432


Q ss_pred             eee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          347 VFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       347 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...  ......+..|+|||.+....++.++|||||||++|||+| |..||......     .+...+........+...+
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~i~~~~~~~~~~~~~  224 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVTQMIESGERMECPQRCP  224 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHCCCCCCCCCCCC
Confidence            211  112223467999999988889999999999999999998 88888654221     2223333333344555677


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .++.+++.+||+.||++||++++|.+.|++
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-41  Score=335.20  Aligned_cols=263  Identities=24%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             cCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      ++|...+.||+|+||.||+|..      .+++.||||.++..........+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-CC
Confidence            4678889999999999999974      356889999997655444556788999999999 689999999988543 34


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCC--------------------------------------------------------
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGS--------------------------------------------------------  280 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  280 (464)
                      ..++|+||+++|+|.++++.....                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            678999999999999999753210                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeec
Q 012392          281 -------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLK  352 (464)
Q Consensus       281 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~  352 (464)
                             ...++|..+..++.||++||+|||+.+     |+||||||+|||+++++++||+|||++........ .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                   123788899999999999999999988     99999999999999999999999999886533211 11112


Q ss_pred             cCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHH
Q 012392          353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL  431 (464)
Q Consensus       353 ~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  431 (464)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..|+......    ..+...+........+...+..+.+++.
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTRMRAPDYTTPEMYQTML  316 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            234567999999988899999999999999999997 77787543211    1111222222222233334567899999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          432 VCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       432 ~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .||+.||++||++.+|+++|+.+.+
T Consensus       317 ~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-41  Score=320.56  Aligned_cols=256  Identities=22%  Similarity=0.448  Sum_probs=205.0

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .+|...+.||+|+||.||+|+..    .+..+|+|.++..........|.+|+.++++++||||+++++++.  ..+..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccE
Confidence            45777899999999999999864    234799999876544445568999999999999999999999984  456789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..+++.+++.++.|++.||+|||+.+     ++||||||+|||+++++.++|+|||++
T Consensus        82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            9999999999999997643   24899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCceeee--eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +..........  .....+..|+|||++.+..++.++||||||+++||+++ |..|+......    ..... +....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~-~~~~~~~  228 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKA-IEEGYRL  228 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHH-HhCCCcC
Confidence            87654322111  11223457999999998899999999999999999886 99888643221    11111 1122222


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+...+..+.+++.+||+.+|++||+|.++++.|..+
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            33345567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.4e-41  Score=328.86  Aligned_cols=262  Identities=23%  Similarity=0.412  Sum_probs=204.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc--EEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..+.||+|+||.||+|+++ ++.  .+|+|.++.........+|.+|+.++.++ +||||+++++++  ...+..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCCCce
Confidence            35677789999999999999975 443  46888776544444556789999999999 899999999998  4466799


Q ss_pred             EEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +|+||+++|+|.++++....            ....+++.+++.++.|++.||+|||+.+     ++||||||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dlkp~Nili~~  159 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  159 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEecC
Confidence            99999999999999975431            1134889999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  406 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~  406 (464)
                      ++.+||+|||+++.....  ........+..|+|||++....++.++|||||||++|||+| |..|+......     ..
T Consensus       160 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~  232 (303)
T cd05088         160 NYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL  232 (303)
T ss_pred             CCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HH
Confidence            999999999998643211  11111223457999999988889999999999999999998 88888643221     11


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      ...+........+...+..+.+++.+||+.+|++||++.+++++|..+...-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         233 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            11122222222333455678999999999999999999999999887654443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=342.30  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=208.1

Q ss_pred             cccccccCCceEEEEEEEC--CC--cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          188 EVNLLGKGNFSSVYKGTLR--DG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ..++||+|.||.|++|.|.  +|  ..||||.++.+.......+|++|+.+|-+|+|||+++|+|+...   ....+|+|
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~E  190 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFE  190 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhh
Confidence            4478999999999999986  33  46899999987655567899999999999999999999998743   46789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      .++.|||.+.|+...  ...|-......++.|||.||.||.+++     +|||||.++|+||-....+||+||||.+-+.
T Consensus       191 LaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLeskr-----lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESKR-----LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhhh-----hhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999832  234777888999999999999999988     9999999999999999999999999999875


Q ss_pred             CCc-eeee-eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCC-CCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          344 DDI-VFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       344 ~~~-~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ... +|.. .....+..|.|||.+..+.|+.+||||+|||++|||+|++ .||.+...     ..+.+.+|.+-+...+.
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~qIL~~iD~~erLpRPk  338 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----IQILKNIDAGERLPRPK  338 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----HHHHHhccccccCCCCC
Confidence            432 2322 2223446799999999999999999999999999999854 56654321     22334455666777888


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .|++.++++|+.||..+|++|||+..|.+++
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            9999999999999999999999999998543

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.8e-41  Score=319.74  Aligned_cols=254  Identities=25%  Similarity=0.455  Sum_probs=204.1

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|+..+...||+|.++....  ...+|.+|+.++++++||||+++++++  . ....++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV--S-EEPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEE--C-CCCcEEEEE
Confidence            45788899999999999999987777899999875432  235789999999999999999999976  2 245789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          81 YMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             cCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999999975432  34789999999999999999999988     9999999999999999999999999998664


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||+..+..++.++||||||+++|||+| |..|+.......    .... +........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~~~  228 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ-VERGYRMPCPPEC  228 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHH-HhcCCCCCCcccc
Confidence            432222223335567999999988899999999999999999999 677775432211    1111 1112222334566


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++.+||+.||++||++.++++.|+..
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            78899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-41  Score=326.75  Aligned_cols=257  Identities=18%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|...+.||+|+||.||+|+.. ++..||+|.++..........+.+|+.++++++||||+++++++  ......++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII--HTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE--cCCCeEEEEE
Confidence            35788899999999999999875 68899999987654333445678999999999999999999988  4456789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ |+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          83 EYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK-----ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             eCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            9996 59999987543   24788999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------HH---
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FE---  407 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------~~---  407 (464)
                      ..... ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||............           +.   
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         154 SVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             cCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            32211 1122345778999998865 56899999999999999999999998654321111000           00   


Q ss_pred             ------HhhhhhcCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          408 ------NFIDRNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       408 ------~~~~~~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                            ....+.....    .....+.+..+++.+|++.||.+|||++|+++|-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence                  0000000000    00123456789999999999999999999998743

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-41  Score=328.61  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             cCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      .+|...+.||+|+||.||+++..        +...+|+|.++.........++..|+.++..+ +||||++++++|.  .
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--Q   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--c
Confidence            45788899999999999999753        23579999998654444556788999999999 7999999999984  4


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      .+..++|+||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.+     ++||||||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  170 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  170 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHHh
Confidence            5678999999999999999976432            1134899999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      |++++++.+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..|+.....  
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence            99999999999999998765432111 1112223457999999988889999999999999999998 7777754321  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                         ..+...+........+...+..+.+++..||+.+|++||++.+|++.|..+.+.
T Consensus       249 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 ---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ---HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence               112222222233334455677899999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-41  Score=323.37  Aligned_cols=263  Identities=26%  Similarity=0.446  Sum_probs=205.4

Q ss_pred             cCCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ..|...+.||+|+||.||+++.     .++..||+|.++..........|.+|+.++++++||||+++.+++...+....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467789999999999999984     25788999998765444455679999999999999999999999865545678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++++|.+++....   ..++|.++..++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccchheEEEcCCCCEEECCCcc
Confidence            99999999999999996532   24899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCcee-e-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH-------hh---hhH
Q 012392          339 HKLLADDIVF-S-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-------ES---ATF  406 (464)
Q Consensus       339 ~~~~~~~~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~-------~~---~~~  406 (464)
                      ++........ . .....++..|+|||++.+..++.++||||||+++|||+|++.|.........       ..   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            9866432211 1 1122345569999999888899999999999999999998765432211000       00   011


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+........+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111122223445677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=350.72  Aligned_cols=263  Identities=20%  Similarity=0.311  Sum_probs=213.9

Q ss_pred             hhcCCccccccccCCceEEEEEEECCC-cEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeee-EEEeC---C-
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRG-FCCSR---G-  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g-~~~~~---~-  254 (464)
                      ...+.++.+.|.+|||+.||.|+...+ ..||+|++-.. .+...+...+|+++|++|+ |+|||.+++ .....   . 
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            334566779999999999999998766 99999998776 3666778899999999997 999999998 32211   1 


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ..+++|+||||++|+|-+++..+....  |++.++++|+.|+++|+++||..   +|||||||||.+||||+.++..|||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~---~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL---KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC---CCccchhhhhhhheEEcCCCCEEeC
Confidence            247999999999999999999776544  99999999999999999999974   5999999999999999999999999


Q ss_pred             eCCccccccCCc--------eeeeeccCCCCccCccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          335 DCGLHKLLADDI--------VFSVLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       335 DfGl~~~~~~~~--------~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      |||.+.......        .........|+.|.|||++   .+...++|+|||+|||+||-|+....||......    
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence            999986432111        1111233467889999998   3567899999999999999999999999865332    


Q ss_pred             hhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                          .++.....-...+.+.+.+.+|+..||++||++||++-||+.++..++...
T Consensus       265 ----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 ----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                222333333334688999999999999999999999999999998876543

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=323.80  Aligned_cols=258  Identities=22%  Similarity=0.418  Sum_probs=206.3

Q ss_pred             hcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|...+.||+|+||.||+|...+      +..||+|.+...........|.+|+.+++.++||||+++++++.  ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CCC
Confidence            3467788999999999999998642      36899999876554455567999999999999999999999984  457


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      ..++||||+++|+|.+++......      ...++|..++.++.|++.||.|||+.+     ++||||||+||++++++.
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~di~p~nill~~~~~  157 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-----FVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccChheEEEcCCCC
Confidence            789999999999999999754321      234789999999999999999999988     999999999999999999


Q ss_pred             eEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHH
Q 012392          331 PLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  408 (464)
                      +||+|||+++........ ......++..|+|||.+..+.++.++|||||||++||++| |..|+......    ... .
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~-~  232 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVL-K  232 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHH-H
Confidence            999999998865433221 1122234678999999988889999999999999999998 88887543221    111 1


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+........+...+..+.+++..||+.+|++|||+.++++.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            22222223344556788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.5e-42  Score=338.21  Aligned_cols=248  Identities=19%  Similarity=0.257  Sum_probs=202.1

Q ss_pred             CCccccccccCCceEEEEEEECC--CcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +|...+.||+|+||.||+|+.++  +..||+|.+....  .......+.+|+.+++.++||||+++++++.  ..+..++
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~l  108 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLYL  108 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEEE
Confidence            47788999999999999998653  3689999986432  1233456889999999999999999999984  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN-----IVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            999999999999997543    3889999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......    ....+|..|+|||++.+..++.++|||||||++|||++|..||.......    ....+....  ..++.
T Consensus       180 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~i~~~~--~~~p~  249 (340)
T PTZ00426        180 VVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILEGI--IYFPK  249 (340)
T ss_pred             ecCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHHHHhcCC--CCCCC
Confidence            654321    22347788999999998889999999999999999999999997643321    112222211  12344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      ..+..+.+++.+|++.||++|+     ++++++++.+.
T Consensus       250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence            4556788999999999999995     89999988654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=332.31  Aligned_cols=243  Identities=21%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||+|+||.||+|+.. +++.||+|.++...  .......+.+|+.++.+++||||+++++++  ...+..++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF--QSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE--ecCCeEEEEEcCCCCC
Confidence            699999999999975 68899999987532  233445688999999999999999999988  4467899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          79 ELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN-----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            9999997532    3889999999999999999999988     99999999999999999999999999885432211 


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......++..|+|||.+.+..++.++|||||||++|||+||+.||......    ..+..+...  ....+...+..+.+
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----~~~~~~~~~--~~~~~~~~~~~~~~  222 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----EMYRKILQE--PLRFPDGFDRDAKD  222 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----HHHHHHHcC--CCCCCCcCCHHHHH
Confidence            112234778899999999989999999999999999999999999754221    112222221  12334556678999


Q ss_pred             HHHHhhhcCCCCCC---CHHHHHHHHh
Q 012392          429 MALVCTHEDPENRP---TMEAVIEELT  452 (464)
Q Consensus       429 l~~~C~~~dp~~RP---s~~evl~~L~  452 (464)
                      ++..||+.||++||   ++.+++.+.+
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence            99999999999997   5788887644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.8e-41  Score=333.90  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.||+|+||.||+++.. +|..||+|.++...  .+.....+.+|+.++++++||||+++++++  ...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCEEEEEEeCCC
Confidence            36899999999999865 78999999987542  123445678899999999999999999988  44678999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      +|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          79 GGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            999999886532    4889999999999999999999988     9999999999999999999999999987532211


Q ss_pred             eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHH
Q 012392          347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  426 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  426 (464)
                      . ......++..|+|||++.++.++.++|||||||++|||++|+.||......    .....+....  ...+...+..+
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~~--~~~p~~~~~~~  222 (323)
T cd05595         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEE--IRFPRTLSPEA  222 (323)
T ss_pred             C-ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCC--CCCCCCCCHHH
Confidence            1 112234778899999999889999999999999999999999999654321    1111222111  12344556788


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          427 GKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      .+++..||+.||++||     ++.+++++-+.
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~  254 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  254 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence            9999999999999998     89999887543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=319.22  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=204.1

Q ss_pred             CccccccccCCceEEEEEEECC----CcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----C
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  256 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  256 (464)
                      |...+.||+|+||.||+|.+..    +..||||.++.... ......|.+|+..++.++||||+++++++.....    .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4566889999999999998752    36799999876432 3345679999999999999999999998754322    2


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ..++|+||+++|+|..++.....  ....+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-----FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchheEEECCCCeEEEC
Confidence            37899999999999999865432  2235899999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhh
Q 012392          335 DCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       335 DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |||+++.......+ .......+..|+|||++....++.++||||||+++|||++ |..|+......     .+.+.+..
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~~~~~  230 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYDYLRH  230 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc
Confidence            99999866433221 1112234567999999988889999999999999999999 77777543211     11122222


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            223334556678899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=325.71  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|+..++||+|+||.||++... +++.||||.+......  .....+.+|+.++++++||||+++++.+  ...+..++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee--cCCCeEEEE
Confidence            3677899999999999999865 6899999998754322  2234578899999999999999999988  445689999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+     |+||||||+||++++++.++|+|||+++.
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          79 LTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             EeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999999886532  234899999999999999999999988     99999999999999999999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ......  .....++..|+|||++.+..++.++|||||||++|||++|..||........ ...+...+.. ....++..
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~~~~~  227 (285)
T cd05605         152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVERRVKE-DQEEYSEK  227 (285)
T ss_pred             cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHHHhhh-cccccCcc
Confidence            543221  1223467889999999988899999999999999999999999975432111 1112222221 22234455


Q ss_pred             HHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~  454 (464)
                      .+..+.+++..||+.||++||     ++.+++++.+..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            677899999999999999999     899998875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-41  Score=326.19  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=205.9

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      ++|...+.||+|+||.||++...      .+..||||.++..........|.+|+.+++++ +||||+++++++.  ..+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--IGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--cCC
Confidence            45788899999999999999742      34579999987654344456789999999999 7999999999884  456


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+++|+|.++++....  ..+++.++..++.|++.||+|||+.+     |+|+||||+|||++.++.+||+||
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhccceEEEcCCCeEEECCC
Confidence            78999999999999999975432  23899999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          337 GLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       337 Gl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |+++........ ......++..|+|||.+....++.++|||||||++|||+| |..|+......    ..+...+....
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~~~~~~~~~~~  261 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----SKFYKLIKEGY  261 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----HHHHHHHHcCC
Confidence            999865433211 1112234567999999998889999999999999999998 88887643211    11222222222


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....+...+..+.+++.+||+.+|++||++.|+++.|..+
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2223334567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7e-41  Score=326.67  Aligned_cols=261  Identities=24%  Similarity=0.419  Sum_probs=206.3

Q ss_pred             cCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      .+|...+.||+|+||.||+|+..        ++..||+|.+..........++.+|+.+++.+ +||||+++++++.  .
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~   92 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--Q   92 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--c
Confidence            44667789999999999999742        34579999987554344557799999999999 8999999999884  4


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      ....++||||+++|+|.+++......            ...++|.+++.++.||+.||.|||+.+     ++||||||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  167 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-----CIHRDLAARN  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-----eeecccccce
Confidence            56789999999999999999764321            234889999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      |++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....  
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--  245 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  245 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence            999999999999999998664322211 122234567999999988889999999999999999998 6666653221  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                         ..+...+........+..++..+.+++.+||+.+|++||++.++++.|..+..
T Consensus       246 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 ---EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ---HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence               11112222222333445667889999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-40  Score=317.56  Aligned_cols=253  Identities=25%  Similarity=0.474  Sum_probs=203.5

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .+|...+.||+|+||.||+|...++..||+|.+....  .....|.+|+.++++++|||++++++++  . .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVV--S-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEE--c-CCCcEEEEE
Confidence            3466778899999999999998777789999876543  2345788999999999999999999887  3 245789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..++|..+..++.|++.||+|||+.+     ++|+||||+||++++++.++|+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          81 FMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN-----YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             cCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999999999976432  34889999999999999999999988     9999999999999999999999999998664


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||++.+..++.++||||||+++|||+| |..|+.......    .... +........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~~~  228 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQ-VERGYRMPCPQGC  228 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-HHcCCCCCCCccc
Confidence            332212222334567999999988889999999999999999999 888886543211    1111 2222223344556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +..+.+++.+||+.||++||++++|++.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            7889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-41  Score=319.09  Aligned_cols=256  Identities=27%  Similarity=0.499  Sum_probs=207.7

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..++|...+.||+|+||.||+|...++..||||.+....  ....++.+|+.++++++|+||+++++++  ......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVC--SEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeee--ecCCceEEE
Confidence            345688889999999999999998888899999987543  2346789999999999999999999987  445678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++....+  ..+++..+..++.|++.||.|||+++     ++|+||||+||++++++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN-----YIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             EeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcchheEEEcCCCCEEECcccccee
Confidence            999999999999976432  34899999999999999999999988     99999999999999999999999999886


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..............+..|+|||.+.+..++.++||||||+++||++| |+.|+......    ..+.. +........+.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~  227 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQ-VERGYRMPRPP  227 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH-HHcCCCCCCCC
Confidence            65332222222334567999999998889999999999999999999 88888643221    11112 22222333344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            456789999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-42  Score=301.63  Aligned_cols=254  Identities=23%  Similarity=0.366  Sum_probs=211.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|++.+.||+|.||.||.|+.+ ++-.||+|++.++...  ...+++.+|+++-+.|+||||++++|++.+  ....||
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyL   99 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYL   99 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeEE
Confidence            34677899999999999999975 6789999998764321  224678899999999999999999999954  567999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ++||.+.|+|...|+....  ..++......++.|+|.||.|+|..+     ++||||||+|+|++..+..||+|||.+.
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~-----VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR-----VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC-----cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999985433  23777778889999999999999887     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......   ....-||+.|.+||...+..++...|+|++||+.||++.|.+||.+...    ...+.++..  .+-.++.
T Consensus       173 ~~p~~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k--~~~~~p~  243 (281)
T KOG0580|consen  173 HAPSNK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRK--VDLKFPS  243 (281)
T ss_pred             ecCCCC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHH--ccccCCc
Confidence            654322   1223478889999999999999999999999999999999999987642    223333332  3344567


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+....+++.+|+..+|.+|.+..|++++.+-.+
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            77888999999999999999999999999987543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=356.91  Aligned_cols=265  Identities=26%  Similarity=0.425  Sum_probs=221.3

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC----C----CcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeE
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR----D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGF  249 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~  249 (464)
                      ++...++....+.||+|.||.|++|...    .    ...||||.++......+.+.+..|+++|+.+ +|+||+.++|.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3334444455568999999999999853    1    4579999999887777788999999999999 59999999999


Q ss_pred             EEeCCCCeEEEEEecCCCCCHHHHhhhhc---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecC
Q 012392          250 CCSRGRGECFLIYDFAPKGKLSKYLDQEE---GS-------S--NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN  317 (464)
Q Consensus       250 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~d  317 (464)
                      |..  .+..++|+||++.|+|..||+..+   ..       .  ..|+..+.++++.|||.||+||++..     +||||
T Consensus       371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-----~vHRD  443 (609)
T KOG0200|consen  371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-----CVHRD  443 (609)
T ss_pred             ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-----ccchh
Confidence            944  778999999999999999998766   00       1  13889999999999999999999987     99999


Q ss_pred             CCCCceEEcCCCCeEEeeCCccccccCCceeeeeccC--CCCccCcccccccCCCCCcchhHHHHHHHHHHHhC-CCCCc
Q 012392          318 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLT  394 (464)
Q Consensus       318 lk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg-~~p~~  394 (464)
                      |.++|||+.++..+||+|||+++......++......  .+.+|||||.+....|+.|||||||||+||||+|. ..||.
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999999999977666555544333  45679999999999999999999999999999985 55665


Q ss_pred             chHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          395 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      + ...   ...+.+.+..+.+...|..+..+++++|..||+.+|++||++.++++.+...
T Consensus       524 ~-~~~---~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  524 G-IPP---TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             C-CCc---HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            4 110   1222346777788888999999999999999999999999999999988874

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-40  Score=317.32  Aligned_cols=252  Identities=25%  Similarity=0.463  Sum_probs=195.4

Q ss_pred             cccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|.+.    +...||+|.+...........|.+|+.+++.++||||+++++++... .+..++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence            46899999999999863    24579999886544344556789999999999999999999987533 44578999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++.....   .+++..++.++.|+++||+|||+.+     ++||||||+|||+++++.+||+|||+++.....
T Consensus        80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          80 KHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            99999999975432   3678888999999999999999988     999999999999999999999999999865432


Q ss_pred             ceeee---eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IVFSV---LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .....   ....++..|+|||++....++.++||||||+++|||++|+.|+.......    .....+........+...
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  227 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLLQGRRLLQPEYC  227 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcCCCCCCCCcC
Confidence            21111   12234567999999988889999999999999999999655443221111    111112121222223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++..||+.+|++||++.++++.|+.+
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            67899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-40  Score=316.25  Aligned_cols=261  Identities=20%  Similarity=0.332  Sum_probs=209.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...  .......+.+|++++++++|+||+++++++.  ..+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEEE
Confidence            46888899999999999999986 78999999886422  2233567899999999999999999999884  3567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++.........+++..+..++.+++.||.|||+.+     |+||||+|+||++++++.++|+|||+++
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-----IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecCCcChhhEEECCCCcEEEeccceee
Confidence            99999999999999764433445899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+........   .+.+.+........+.
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  230 (267)
T cd08224         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEKCDYPPLPA  230 (267)
T ss_pred             eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---HHHhhhhcCCCCCCCh
Confidence            6543221 11123456779999999888899999999999999999999999864321100   1111111111222222


Q ss_pred             -HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 -SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 -~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                       ..+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             56678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-41  Score=334.76  Aligned_cols=255  Identities=18%  Similarity=0.255  Sum_probs=199.2

Q ss_pred             CCccccccccCCceEEEEEEE----CCCcEEEEEEeccCC---CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      +|...+.||+|+||.||+++.    .++..||+|.+....   .......+..|+.++..+ +||||+++++++  ...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence            367789999999999999875    357899999986432   122234678899999999 599999999887  4567


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHeEECCCCCEEEeeC
Confidence            8999999999999999997542    3889999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      |+++..............+|..|+|||.+.+. .++.++|||||||++|||+||+.||...............+..  ..
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~  227 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CD  227 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CC
Confidence            99986533222222234578889999998765 4788999999999999999999998642211111111111111  12


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ...+...+..+.+++.+||+.||++||     ++++++++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            233445567789999999999999999     8889998755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.7e-41  Score=321.72  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=192.9

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||+|+||.||+++.. +|+.||+|.+.....  ......+..|++++++++||||+++++++  ......++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE--ecCCeEEEEEecCCCC
Confidence            699999999999865 689999999864321  22334566799999999999999999888  4467899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+||++++++.++|+|||++........ 
T Consensus        79 ~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-  150 (277)
T cd05607          79 DLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-  150 (277)
T ss_pred             CHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-
Confidence            99998865432  34889999999999999999999988     99999999999999999999999999886654321 


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.|+...................... ......+.++.+
T Consensus       151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  228 (277)
T cd05607         151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKD  228 (277)
T ss_pred             -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHH
Confidence             223457788999999998889999999999999999999999986532211111111111111111 111245677899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 012392          429 MALVCTHEDPENRPTMEAVIE  449 (464)
Q Consensus       429 l~~~C~~~dp~~RPs~~evl~  449 (464)
                      ++..||+.||++||+++|+++
T Consensus       229 li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHhccCHhhCCCCccchh
Confidence            999999999999999965543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-41  Score=333.48  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.||+|+||.||+++.. +++.||||.+....  .......+.+|+.+++.++||||+++++++  ...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCEEEEEEeCCC
Confidence            36899999999999865 68999999987542  223446788999999999999999999888  45678999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      +|+|..++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++......
T Consensus        79 ~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          79 GGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            999999986532    4899999999999999999999988     9999999999999999999999999987542211


Q ss_pred             eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHH
Q 012392          347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  426 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  426 (464)
                      . ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    ....+..  .....+...+..+
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~--~~~~~p~~~~~~~  222 (328)
T cd05593         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILM--EDIKFPRTLSADA  222 (328)
T ss_pred             c-ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHhcc--CCccCCCCCCHHH
Confidence            1 1122347788999999998899999999999999999999999996543211    1111111  1122344556788


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          427 GKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      .+++.+||+.||++||     ++.+++++.+.
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            9999999999999997     89999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-40  Score=323.81  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-----------------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-----------------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  245 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~  245 (464)
                      .++|+..+.||+|+||.||++...                 ++..||+|.+..........+|.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356888899999999999998532                 244799999876544455678999999999999999999


Q ss_pred             eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC
Q 012392          246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  318 (464)
Q Consensus       246 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl  318 (464)
                      +++++..  .+..++||||+++|+|.+++......       ...+++.++..++.|++.||+|||+.+     ++||||
T Consensus        84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl  156 (296)
T cd05095          84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-----FVHRDL  156 (296)
T ss_pred             EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccC
Confidence            9999843  56789999999999999999764321       124788899999999999999999988     999999


Q ss_pred             CCCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcc
Q 012392          319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTS  395 (464)
Q Consensus       319 k~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t--g~~p~~~  395 (464)
                      ||+|||+++++.++|+|||+++......... ......+..|++||....+.++.++|||||||++|||+|  |..|+..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999999998654332211 112223567999999888889999999999999999998  6667753


Q ss_pred             hHHHHHhhhhHHHhhhhh---cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          396 SMRLAAESATFENFIDRN---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....... ..........   .....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDEQVI-ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChHHHH-HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2211111 1111111111   111223345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.1e-41  Score=319.84  Aligned_cols=255  Identities=24%  Similarity=0.475  Sum_probs=203.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CC---cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +|...+.||+|+||.||+|++. ++   ..||||.+..........+|..|+.++++++||||+++++++  ......++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE--CCCCceEE
Confidence            4667789999999999999975 23   369999987654444567899999999999999999999988  45667899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++.+++.++.|++.||+|||+.+     ++|+||||+||+++.++.+||+|||+++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g-----~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          83 ITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             EEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccChheEEEcCCCcEEECCCcccc
Confidence            999999999999997643   24899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeee----eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          341 LLADDIVFSV----LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       341 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ..........    .....+..|+|||++....++.++|||||||++||+++ |..|+......     .....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~~~~  229 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQDYR  229 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCCc
Confidence            6543221111    11112346999999998999999999999999999987 88888643221     11112222222


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..++..+.+++..||+.+|++||++.+|+..|+.+
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            233445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-41  Score=324.32  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=201.7

Q ss_pred             hcCCccccccccCCceEEEEEEECC---------------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeee
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD---------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR  247 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~  247 (464)
                      .++|...+.||+|+||.||+++..+               ...||||.++..........|.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4568888999999999999987642               2358999987654444556799999999999999999999


Q ss_pred             eEEEeCCCCeEEEEEecCCCCCHHHHhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCC
Q 012392          248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  319 (464)
Q Consensus       248 g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk  319 (464)
                      +++  ...+..++||||+++++|.+++.....        ....++|..++.++.|++.||+|||+.+     ++|||||
T Consensus        84 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlk  156 (295)
T cd05097          84 GVC--VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLA  156 (295)
T ss_pred             EEE--cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-----eeccccC
Confidence            998  446778999999999999999965321        1123789999999999999999999988     9999999


Q ss_pred             CCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcch
Q 012392          320 VEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSS  396 (464)
Q Consensus       320 ~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t--g~~p~~~~  396 (464)
                      |+||++++++.+||+|||+++......... .....++..|+|||++..+.++.++|||||||++|||++  +..|+...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999997654332211 112233567999999988899999999999999999998  45566532


Q ss_pred             HHHHHhhhhHHHhhhh---hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          397 MRLAAESATFENFIDR---NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..... .....+....   ......+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQV-IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHHH-HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            21111 0111111111   1111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-40  Score=318.74  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=191.4

Q ss_pred             ccccCCceEEEEEEECC---CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          191 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      .||+|+||.||+|...+   ...+|+|.+...........|.+|+..++.++||||++++|.+  ......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~--~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC--IESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCceEEEEEeCCC
Confidence            58999999999997543   3578999877655445556789999999999999999999988  446779999999999


Q ss_pred             CCHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          268 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       268 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      |+|.+++...... ....++.....++.||+.||+|||+.+     |+||||||+|||+++++++||+|||+++......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-----EecccccHhheEecCCCcEEEeccccccccccch
Confidence            9999999765432 223567888999999999999999988     9999999999999999999999999987543322


Q ss_pred             ee-eeeccCCCCccCccccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          347 VF-SVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       347 ~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      .. ......++..|+|||++..       ..++.++|||||||++|||++ |..|+..................+.....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            11 1122234567999998743       356789999999999999999 66777543221111111111100111122


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+...+..+.+++..|| .||++||++++|++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            33456677888999999 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.2e-41  Score=323.16  Aligned_cols=259  Identities=21%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|+..+.||+|+||.||++...      ++..||+|.+..........+|.+|+.++++++||||+++++++.  ...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCC
Confidence            456888899999999999999863      467899999876554445577999999999999999999999884  456


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEG------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  318 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl  318 (464)
                      ..++|+||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.+     ++||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dl  156 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-----FVHRDL  156 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----eecccc
Confidence            78999999999999999975321                  1124788999999999999999999988     999999


Q ss_pred             CCCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcch
Q 012392          319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSS  396 (464)
Q Consensus       319 k~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~  396 (464)
                      ||+||++++++.++|+|||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..|+...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987653322111 112223567999999998899999999999999999998 77777543


Q ss_pred             HHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...    ..... +........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       237 ~~~----~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHE----EVIYY-VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHH----HHHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            221    11111 11111112234556789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-40  Score=314.94  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|+.. ++..|++|.+.... ......++.+|+.++++++||||+++++++.  ..+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEE
Confidence            3667789999999999999975 68999999987543 2345567999999999999999999999884  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++.....  ..+++..+..++.|++.||.|||+.+     ++|+||||+||++++++.+||+|||+++..
T Consensus        79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~-----i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          79 EYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             EeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEeCCCCEEEcccccceec
Confidence            99999999999986532  34899999999999999999999988     999999999999999999999999998866


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ....... ....++..|+|||++.+..++.++|+||||+++|||+||+.|+.......    ...... .......+...
T Consensus       152 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~~  225 (256)
T cd08529         152 SDNTNFA-NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----LILKII-RGVFPPVSQMY  225 (256)
T ss_pred             cCccchh-hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-cCCCCCCcccc
Confidence            4432211 12235677999999999889999999999999999999999987543211    111111 12222334456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +..+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            7789999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-40  Score=326.51  Aligned_cols=260  Identities=24%  Similarity=0.420  Sum_probs=205.5

Q ss_pred             cCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      .+|...+.||+|+||.||+++..        ....||+|.++.........++.+|+.+++++ +||||++++++|.  .
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--Q   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--c
Confidence            45677899999999999999742        24579999987654445566789999999999 6999999999984  4


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      .+..++|+||+++|+|.+++.....            ....++|.+++.++.|++.||.|||+.+     ++||||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  164 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-----CIHRDLAARN  164 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccee
Confidence            5678999999999999999976421            1234899999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..|+.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--  242 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--  242 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999998664322111 112223356999999988889999999999999999999 7777754321  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                         ..+...+........+...+..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       243 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         243 ---EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence               1111222222222334556678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-41  Score=339.71  Aligned_cols=256  Identities=14%  Similarity=0.256  Sum_probs=203.7

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ..++|...+.||+|+||.||+++.. ++..||+|.+....  .......+.+|+.+++.++||||+++++++  ...+..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~--~~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCEE
Confidence            4456888999999999999999875 68899999986432  122334577899999999999999999887  456789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++...     .++...+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999998643     2777888899999999999999988     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +...............++..|+|||.+...    .++.++|||||||++|||++|+.||......    ..+..+.....
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~  264 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIMDHKN  264 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCC
Confidence            986643322222234578889999998643    4788999999999999999999999764321    22233332221


Q ss_pred             CCCCCH--HHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhh
Q 012392          415 KGKFSE--SEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV  453 (464)
Q Consensus       415 ~~~~~~--~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~  453 (464)
                      ....+.  ..+..+.+++..|++.+|++  |+++.+++++.+.
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            122222  35678899999999999987  9999999988653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.2e-40  Score=317.22  Aligned_cols=254  Identities=19%  Similarity=0.311  Sum_probs=189.0

Q ss_pred             ccccCCceEEEEEEECCC---cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          191 LLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      .||+|+||.||+|+..++   ..+++|.+...........|.+|+.+++.++||||+++++.|.  .....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCC
Confidence            589999999999986433   3567777765544445678999999999999999999999984  45678999999999


Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc-
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-  346 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~-  346 (464)
                      |+|.++++........+++..+..++.||+.||+|||+.+     ++||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9999999865433344677788899999999999999988     9999999999999999999999999986432211 


Q ss_pred             eeeeeccCCCCccCccccccc-------CCCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          347 VFSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ........++..|+|||++..       ..++.++|||||||++|||+++ ..|+............+........+...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence            111122345678999998743       2457899999999999999975 55664322111111111110011112223


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .....+.+.+++..|| .+|++||++++|++.|.
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3345677889999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-40  Score=318.15  Aligned_cols=261  Identities=20%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             CCccccccccCCceEEEEEEE-CCCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||+|+||.||+|+. .++..||||.+....  ......+|.+|+.+++.++||||+++++++..  .+..+++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v   80 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIV   80 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEEE
Confidence            567778999999999999996 478999999876532  22344678999999999999999999998854  5678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++.........+++..+..++.||+.||.|||+.+     ++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~  155 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence            9999999999999754434456899999999999999999999988     99999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|..|+........  .....+............
T Consensus       156 ~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         156 FSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             cccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhhhhhcCCCCCCCccc
Confidence            5432211 1223466789999999888899999999999999999999999864321111  111111111111122234


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .+..+.+++.+||+.||++||||.+|++.++.+.
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            6778999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=317.87  Aligned_cols=251  Identities=23%  Similarity=0.440  Sum_probs=196.7

Q ss_pred             cccccCCceEEEEEEECC-Cc--EEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|++.+ +.  .+|+|.++..........|.+|+.++.++ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeC
Confidence            368999999999999753 43  57889887544344556789999999999 7999999999984  456789999999


Q ss_pred             CCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          266 PKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       266 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      ++|+|.+++.....            ....+++.++..++.|++.||+|||+.+     ++||||||+||++++++.+||
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccccceEEEcCCCeEEE
Confidence            99999999975431            1234889999999999999999999988     999999999999999999999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      +|||++.......  .......+..|+|||++....++.++|||||||++|||+| |..||......     ...+.+..
T Consensus       154 ~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~  226 (270)
T cd05047         154 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQ  226 (270)
T ss_pred             CCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhC
Confidence            9999986332110  1111223456999999988889999999999999999997 88888543211     11111222


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+...+..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            222223344567799999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-41  Score=312.40  Aligned_cols=261  Identities=18%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |..++.|++|.||.||+|+.+ +++.||+|+++.+..+.. ...-++|+.+|.+++|||||.+..+......+..|||||
T Consensus        78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            556789999999999999975 789999999986542222 235689999999999999999998887677778999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      ||+. ||...+....   +++...+...++.|+++|++|||.+.     |+|||||++|+|++..|.+||+||||||.++
T Consensus       158 ~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w-----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  158 YVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW-----ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce-----eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9976 9999998765   35888999999999999999999999     9999999999999999999999999999887


Q ss_pred             CCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh----------
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR----------  412 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------  412 (464)
                      .... .......|.-|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+..........+...-.+          
T Consensus       229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            5421 2233445778999999876 468999999999999999999999887654433322222111100          


Q ss_pred             ---------------hcCCCCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          413 ---------------NLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       413 ---------------~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                                     .++..+... .++.-.+++...+..||.+|.|++|.+++=+....
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                           011111111 34667889999999999999999999998776553

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-40  Score=330.20  Aligned_cols=259  Identities=20%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC---CeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~  259 (464)
                      +|...+.||+|+||.||+|+.. ++..||||.+.... .......+.+|+.++++++||||+++++++.....   ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677899999999999999965 68999999987432 12334578899999999999999999998754322   3589


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+. ++|.+++....    .+++..+..++.||++||.|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 79999986532    3899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCce--eeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh------------
Q 012392          340 KLLADDIV--FSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------  403 (464)
Q Consensus       340 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~------------  403 (464)
                      +.......  .......++..|+|||++..  ..++.++|||||||++|||+||+.||..........            
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            86432211  11123357788999999865  678999999999999999999999986432111000            


Q ss_pred             -------hhHHHhhhh---hcCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          404 -------ATFENFIDR---NLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       404 -------~~~~~~~~~---~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                             ......+..   .......   ...+..+.+++.+||+.||++|||++|++++-+.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence                   000001100   0000000   1234567899999999999999999999998654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-40  Score=320.56  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=208.7

Q ss_pred             CCccccccccCCceEEEEEEEC-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .|...+.||+|+||.||+|++.     ++..||||.+..........+|.+|+.++++++||||+++++++........+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566688999999999999864     36789999988654333456899999999999999999999988655566789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++++|.+++....   ..+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++
T Consensus        85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR-----YIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccccc
Confidence            9999999999999997643   24899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCcee-e-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH----------hhhhHH
Q 012392          340 KLLADDIVF-S-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFE  407 (464)
Q Consensus       340 ~~~~~~~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~----------~~~~~~  407 (464)
                      ......... . ......+..|+|||.+....++.++||||||+++|||+||..|+........          ....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876532211 1 1112334569999999888899999999999999999999988754321110          011222


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.+........+..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            22333333333445567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-40  Score=322.38  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCceEEEEEEECC-----------------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  245 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~  245 (464)
                      .++|...+.||+|+||.||+|+..+                 +..||+|.+..........+|.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3567888999999999999998642                 24689999887655556678999999999999999999


Q ss_pred             eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC
Q 012392          246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  318 (464)
Q Consensus       246 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl  318 (464)
                      +++++.  ..+..++|+||+++++|.+++......       ...+++..++.++.|++.||+|||+.+     |+||||
T Consensus        84 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl  156 (296)
T cd05051          84 LLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDL  156 (296)
T ss_pred             EEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccc
Confidence            999984  356789999999999999999764421       125899999999999999999999988     999999


Q ss_pred             CCCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcc
Q 012392          319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTS  395 (464)
Q Consensus       319 k~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t--g~~p~~~  395 (464)
                      ||+||++++++.++|+|||+++......... .....++..|+|||++..+.++.++|||||||++|||++  +..|+..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999988654332211 122334567999999988889999999999999999998  5566643


Q ss_pred             hHHHHHhhhhHHHhh---hhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          396 SMRLAAESATFENFI---DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       396 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....... .......   ........+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQVI-ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHHHH-HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2211110 1111110   001111122344578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=338.04  Aligned_cols=254  Identities=20%  Similarity=0.300  Sum_probs=205.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.++...  .......+.+|+.++..++||||+++++++  ...+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF--QDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe--ecCCeEEE
Confidence            35788899999999999999976 78999999987542  123445788999999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        79 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g-----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG-----FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            99999999999999764    24889999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCc----------------------------eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 012392          341 LLADDI----------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV  392 (464)
Q Consensus       341 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p  392 (464)
                      ......                            ........+|..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            664332                            0112233477889999999999999999999999999999999999


Q ss_pred             CcchHHHHHhhhhHHHhhh--hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhh
Q 012392          393 LTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELTV  453 (464)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~~  453 (464)
                      |.......    ....+..  ...........+..+.+++..|++ ||++||+ +++++++.+.
T Consensus       230 f~~~~~~~----~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         230 FYSDTLQE----TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             CCCCCHHH----HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            97654221    1222222  111111122247789999999997 9999999 9999988653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=318.59  Aligned_cols=263  Identities=25%  Similarity=0.449  Sum_probs=211.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .+|...+.||+|+||.||+|... +|.    .||+|.+..........++.+|+.++++++||||++++++|..   ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence            34677789999999999999865 332    6899988766544555789999999999999999999999843   568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++.....   .+++..++.++.||+.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EEecccCcceEEEcCCCeEEECCCcc
Confidence            999999999999999976432   3899999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++....... ........+..|+|||.+....++.++|+||||+++||++| |+.|+.....     ..+...+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~  230 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLEKGERL  230 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhCCCCC
Confidence            987643221 11112223457999999988889999999999999999999 9988865422     1122222222223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccccc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  462 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~  462 (464)
                      ..+..++..+.+++..||..||.+||++.++++.|..+....+.++
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~  276 (279)
T cd05057         231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL  276 (279)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceE
Confidence            3344456778999999999999999999999999999877666554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=313.86  Aligned_cols=249  Identities=23%  Similarity=0.460  Sum_probs=204.6

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||.|+||.||+|... |+.||||.++....  ..+++.+|+.++++++|+||+++++++.  .....++|||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e   80 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVL--QGNPLYIVTE   80 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEc--CCCCeEEEEE
Confidence            35677789999999999999875 78899999976542  4567999999999999999999999984  3667899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++.....  ..++|..+..++.|++.||.|||+.+     ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999999976542  24899999999999999999999988     9999999999999999999999999998764


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ....    ....+..|+|||++..+.++.++||||||+++||+++ |..|+......     .+...+........+...
T Consensus       154 ~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         154 QGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             cccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHhcCCCCCCccCC
Confidence            3221    2234567999999988889999999999999999997 88887644221     111222222233334455


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ++.+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            6889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-40  Score=314.67  Aligned_cols=248  Identities=23%  Similarity=0.436  Sum_probs=201.4

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +|...+.||+|+||.||++... |..||+|.++...   ..+.|.+|+.++++++|+|++++++++.. ..+..++|+||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEEC
Confidence            4677789999999999999875 7789999886532   34578999999999999999999997643 34568999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++.....  ..+++..++.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999976432  34889999999999999999999988     99999999999999999999999999875533


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..    .....+..|+|||++....++.++||||||+++|||++ |+.|+.....     ..+...+........+...+
T Consensus       155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05082         155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAPDGCP  225 (256)
T ss_pred             cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCCCCCCCCC
Confidence            21    11223457999999988889999999999999999998 8888754321     11112222223333445667


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-41  Score=334.18  Aligned_cols=255  Identities=20%  Similarity=0.281  Sum_probs=203.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||||.++....  ......+.+|+.+++.++||||+++++++  ......++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~--~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF--QDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeEEE
Confidence            35788899999999999999875 789999999875432  22345688899999999999999999887  44677999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++..+..++.||+.||.|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        79 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~-----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG-----YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             EECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEcccCchHheEECCCCCEEeccCCCCe
Confidence            999999999999997642   24899999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh-
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-  413 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  413 (464)
                      ..............++..|+|||++.      ...++.++|||||||++|||++|+.||......    ..+..+.... 
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~  226 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNIMNFQR  226 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHHHcCCC
Confidence            76544332233345788899999986      456789999999999999999999999754321    1122222211 


Q ss_pred             -cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          414 -LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       414 -~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       .........+..+.+++..|++ +|++||++++++++-+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~  266 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF  266 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence             1111122356778899999998 99999999999987553

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-40  Score=315.15  Aligned_cols=251  Identities=23%  Similarity=0.470  Sum_probs=201.6

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      .|+..+.||+|+||.||+|.+.++..+|+|.+.....  ...+|.+|+.++++++|||++++++++  ......++|+||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVC--TERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEE--ccCCceEEEEEc
Confidence            4667789999999999999987788999998875432  245789999999999999999999988  446678999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          81 MEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999999997543   24889999999999999999999988     99999999999999999999999999876543


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...........+.+|+|||++.++.++.++||||||+++|||++ |..|+.......     ..+.+....+...+...+
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~  227 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETINAGFRLYKPRLAS  227 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHhCCCCCCCCCCCC
Confidence            32222222334567999999998889999999999999999998 888876432111     111111112222233456


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+.+++.+||+.+|++||++.+++++|.
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            78999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-40  Score=315.69  Aligned_cols=254  Identities=23%  Similarity=0.443  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ...|...+.||+|+||.||++...++..+|+|.+...  ......|.+|+.++++++|+||+++.+++..   ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEE
Confidence            3567788999999999999999888888999988753  2334678999999999999999999998743   5679999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+     ++|+||||+||+++.++.+||+|||++...
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            99999999999976432  34889999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ............++..|+|||++..+.++.++|+|||||++||++| |..|+......     .....+........+..
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALERGYRMPRPEN  227 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHhCCCCCCCccc
Confidence            4332212222234467999999998889999999999999999999 88888643221     11122222222233345


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            56789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-40  Score=319.26  Aligned_cols=257  Identities=22%  Similarity=0.377  Sum_probs=201.5

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC----
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG----  254 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~----  254 (464)
                      .+++.|+..+.||+|+||.||+|... +++.||+|.+....  ....++..|+.++.++ +||||+++++++....    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45667888899999999999999875 68899999987543  3345688899999998 6999999999986532    


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ....++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+|+||||+||++++++.+||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHEEECCCCCEEEc
Confidence            2468999999999999999976432  34889999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  409 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  409 (464)
                      |||++........ ......++..|+|||++.     ...++.++|||||||++|||++|+.|+.........    ...
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~~~  228 (272)
T cd06637         154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLI  228 (272)
T ss_pred             cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----HHH
Confidence            9999876533211 112234667899999986     335788999999999999999999998643221111    111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .............+..+.+++.+||+.||.+|||+.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  270 (272)
T cd06637         229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP  270 (272)
T ss_pred             hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence            111111122234556899999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=313.21  Aligned_cols=248  Identities=25%  Similarity=0.456  Sum_probs=200.1

Q ss_pred             cccccCCceEEEEEEEC--C--CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR--D--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||.||+|++.  +  +..||+|.+..........++.+|+.+++++.||||+++++++  . ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC--K-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--c-CCceEEEEEeC
Confidence            46899999999999853  2  2689999988765444567899999999999999999999987  3 34579999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          78 PLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999997643    4899999999999999999999988     999999999999999999999999999866433


Q ss_pred             ceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ....  .....++..|+|||.+....++.++||||||+++|||++ |..|+.....     ..+...+........+...
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~  223 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLESGERLPRPEEC  223 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHcCCcCCCCCCC
Confidence            2111  111223457999999998899999999999999999998 8888864322     1122222222233344556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++.+||+.+|++||++.++++.|+..
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            67899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-40  Score=318.96  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=199.7

Q ss_pred             CCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...++||+|+||.||+|+. .+++.||+|.+..........+|.+|+.++++++||||+++++++..  .+..++|+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEe
Confidence            467778999999999999986 47889999998765434455679999999999999999999999854  567899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|..+.        .+++..+..++.|++.||.|||+.+     |+|+||||+|||++.++.+||+|||++....
T Consensus        80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            99999997653        2678888999999999999999988     9999999999999999999999999997654


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH---hhhhHHHhhhhhcCCCCCH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  420 (464)
                      ...   .....++..|+|||++.+..++.++||||||+++|||++|+.||........   .........+.........
T Consensus       147 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (279)
T cd06619         147 NSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG  223 (279)
T ss_pred             ccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence            321   1223467789999999988999999999999999999999999864221100   0011111111111111122


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+..+.+++.+||+.||++||++++++++.+..
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence            3456789999999999999999999999886643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-40  Score=333.56  Aligned_cols=253  Identities=19%  Similarity=0.244  Sum_probs=196.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..+|...+.||+|+||.||++... +++.||+|...       ...+.+|+.++++++||||+++++++..  ....++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEE
Confidence            467999999999999999999865 68899999643       2346789999999999999999998844  5678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +|++ .++|..++....    .+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus       162 ~e~~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        162 LPRY-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             EecC-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            9999 579999886542    3889999999999999999999988     99999999999999999999999999975


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH-------HH-------------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-------AA-------------  401 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~-------~~-------------  401 (464)
                      .............+|..|+|||++.+..++.++|||||||++|||+||..|+......       ..             
T Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            4322111222345788999999999889999999999999999999999876432100       00             


Q ss_pred             -----hhhhHHHhh----hhhcC--CCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          402 -----ESATFENFI----DRNLK--GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       402 -----~~~~~~~~~----~~~~~--~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                           ....+....    .....  ...+     ...+..+.+++.+||+.||++|||++|++++-+..
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                 000000000    00000  0000     12356788999999999999999999999987754

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6e-41  Score=335.88  Aligned_cols=261  Identities=14%  Similarity=0.252  Sum_probs=204.9

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      ++....++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++  ..
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~  114 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF--QD  114 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--Ec
Confidence            34445578999999999999999999976 68899999986422  122334578899999999999999999988  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ....++||||+++|+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~-----IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG-----LIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEE
Confidence            67899999999999999999643     2788889999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      |||++...............+|..|+|||++...    .++.++|||||||++|||++|+.||......    ..+..+.
T Consensus       185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~~~~i~  260 (370)
T cd05621         185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GTYSKIM  260 (370)
T ss_pred             ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HHHHHHH
Confidence            9999987643322222334578899999998653    3788999999999999999999999754321    2233333


Q ss_pred             hhhcCCCCCH--HHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhhh
Q 012392          411 DRNLKGKFSE--SEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTVA  454 (464)
Q Consensus       411 ~~~~~~~~~~--~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~~  454 (464)
                      +.......+.  ..+..+.+++..|+..++.+  |+++.|+++|.+..
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            3222222222  34667888899999755543  89999999986643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=313.88  Aligned_cols=254  Identities=20%  Similarity=0.308  Sum_probs=204.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||++... +++.||+|.+......    .....+.+|+.++++++||||+++++++  ......
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~   79 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL--RDDETL   79 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ccCCeE
Confidence            46788899999999999999864 6899999988654321    1235688899999999999999999998  445689


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.+     |+||||+|+||++++++.++|+|||+
T Consensus        80 ~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          80 SIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999999987532    3788889999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCceeee--eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++..........  ....++..|+|||.+.+..++.++||||||+++|||++|+.|+......    .............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~  226 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQPTNP  226 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhccCCCC
Confidence            876533211111  1233556799999999888999999999999999999999998653221    1112222222333


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+......+.+++..||+.+|++|||+.+++++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            455566778999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-41  Score=328.73  Aligned_cols=245  Identities=20%  Similarity=0.312  Sum_probs=197.0

Q ss_pred             cccccCCceEEEEEEE----CCCcEEEEEEeccCC---CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          190 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.||+|+||.||+++.    .+++.||||.++...   .......+.+|+.+|+.++||||+++++++.  ..+..++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEE
Confidence            6799999999999985    357899999987532   1223346788999999999999999999884  466899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....    .+.+..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        80 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          80 EYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             eCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999997532    3778888899999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++|+.||......    ..+..+...  ....+...
T Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~~~--~~~~~~~~  223 (323)
T cd05584         151 IHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTIDKILKG--KLNLPPYL  223 (323)
T ss_pred             ccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHHcC--CCCCCCCC
Confidence            32211 112234778899999999888999999999999999999999999754322    112222222  12234455


Q ss_pred             HHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          423 AAKLGKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      +..+.+++.+||+.||++||     ++.+++++.+
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence            67889999999999999999     8999988754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-40  Score=318.78  Aligned_cols=256  Identities=24%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .+|...+.||+|+||.||++...      ++..+|+|.+.... ......|.+|+.++++++|+||+++++++..  ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCc
Confidence            34666789999999999999742      45689999887543 4455689999999999999999999998843  566


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGS-----------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      .++|+||+++|+|.+++......           ...+++..++.++.|++.||+|||+.+     ++||||||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~nil~~  156 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVG  156 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccccHhhEEEc
Confidence            89999999999999999754311           134889999999999999999999988     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      +++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+.......    
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  232 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----  232 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----
Confidence            99999999999987654322211 112234567999999998899999999999999999998 888875432211    


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .... +........+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 AIEC-ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHH-HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111 1222222334456678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=301.55  Aligned_cols=266  Identities=21%  Similarity=0.343  Sum_probs=213.0

Q ss_pred             hhcCCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC---CCCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~---~~~~  257 (464)
                      ..++|.+.+.||+|||..||+++ +.++..+|+|++.... .++....++|++.-++++|||++++++++...   ...+
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34678899999999999999998 6688999999998765 55667789999999999999999999876433   2346


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .||++.|...|+|.+.+.........+++.+.+.|+.+|++||++||+..   |+++||||||.|||+++.+.++|.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~---~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE---PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC---CcccccCCCcceeEecCCCceEEEecc
Confidence            99999999999999999887665567999999999999999999999876   789999999999999999999999999


Q ss_pred             ccccccCCce--------eeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          338 LHKLLADDIV--------FSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       338 l~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      .+....-...        ........|+.|.|||.+.   +...++++|||||||+||+|+.|..||......   ...+
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---GgSl  251 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---GGSL  251 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---CCeE
Confidence            9876532211        1122344677899999984   445789999999999999999999999643210   0000


Q ss_pred             -HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 -ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 -~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       -.+....+........++.+.+++.+|++.||.+||++.+++..++.+
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             001111112222334788999999999999999999999999998865

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-40  Score=335.43  Aligned_cols=254  Identities=18%  Similarity=0.259  Sum_probs=197.0

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .|..++.||+|+||+||+|+.. +++.||||.+....  .......+.+|+.++.+++||||+++++++  .+.+..++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~--~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF--QDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE--ecCCEEEEE
Confidence            5778899999999999999865 68899999987543  123345788999999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          80 MDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG-----FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999997543    3888888999999999999999988     99999999999999999999999999764


Q ss_pred             ccCCc---ee-------------------------------------------eeeccCCCCccCcccccccCCCCCcch
Q 012392          342 LADDI---VF-------------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSD  375 (464)
Q Consensus       342 ~~~~~---~~-------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sD  375 (464)
                      .....   ..                                           ......+|..|+|||.+.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            31100   00                                           001234778899999999888999999


Q ss_pred             hHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--hcCCCCCHHHHHHHHHHHHH--hhhcCCCCCCCHHHHHHHH
Q 012392          376 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       376 v~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~--C~~~dp~~RPs~~evl~~L  451 (464)
                      ||||||++|||+||..||........    ...++..  ..........+.++.+++.+  |+..++..||++.++++|.
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp  306 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTET----QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP  306 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHH----HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence            99999999999999999975432111    1111111  11111111244566777766  6667777799999999886


Q ss_pred             hh
Q 012392          452 TV  453 (464)
Q Consensus       452 ~~  453 (464)
                      +.
T Consensus       307 ~f  308 (381)
T cd05626         307 FF  308 (381)
T ss_pred             cc
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-40  Score=315.80  Aligned_cols=257  Identities=23%  Similarity=0.426  Sum_probs=205.6

Q ss_pred             cCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .+|...+.||+|+||.||+|...+    ...||||...........+.|.+|+.++++++||||+++++++.  . ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--E-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--C-CCcE
Confidence            346677899999999999998643    24699998876554445568999999999999999999999873  2 4578


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     ++|+||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR-----FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccChheEEEecCCCeEEccCcee
Confidence            9999999999999997543   24899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      +...............+..|+|||.+....++.++||||||+++||+++ |..||.......    .. ..+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~-~~~~~~~~~~~  229 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VI-GRIENGERLPM  229 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----HH-HHHHcCCcCCC
Confidence            8765443222223334457999999988889999999999999999986 998886543211    11 11111222233


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus       230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            45567789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-40  Score=326.74  Aligned_cols=261  Identities=23%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             cCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      .+|.+.+.||+|+||.||+++..        .+..||+|.++.........++.+|+.+++++ +||||++++++|.  .
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--Q   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--c
Confidence            35778899999999999999742        12379999887654444567899999999999 7999999999984  4


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      .+..++++||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.+     |+||||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  164 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-----CIHRDLAARN  164 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccce
Confidence            5678999999999999999975321            1234889999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999998654322111 112223456999999999899999999999999999998 7777754321  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                         ..+...+........+...+..+.+++.+||+.+|++||++.++++.|+....
T Consensus       243 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 ---EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence               11112222222333444566789999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.6e-40  Score=321.02  Aligned_cols=256  Identities=20%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...+.||+|+||.||++... ++..+|+|.+..........++.+|++++.+++||||+++++.+.  ..+..++|+|
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEee
Confidence            5788899999999999999865 678899998876543344567889999999999999999999984  4678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |+++++|.+++...    ..+++..+..++.|+++||.|||+. +     ++|+||||+|||+++++.+||+|||++...
T Consensus        80 y~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          80 HMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            99999999999754    2388999999999999999999974 5     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH----------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------------  406 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~----------------  406 (464)
                      ....   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..+                
T Consensus       151 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccc
Confidence            3321   11234567899999998888999999999999999999999998543211100 000                


Q ss_pred             -------------HHhhhhhc---CCCCC-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          407 -------------ENFIDRNL---KGKFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       407 -------------~~~~~~~~---~~~~~-~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                                   .+..+...   ....+ ...+..+.+++.+||+.||++||++.+|+++.+...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                         00000000   00111 124567899999999999999999999999987544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4e-41  Score=331.66  Aligned_cols=246  Identities=22%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.||+|+||.||+++.. ++..||+|.++...  .......+..|+.++..++||||+++++++  ...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~--~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE--EcCCEEEEEEeCCC
Confidence            36899999999999864 78999999987542  123345678899999999999999999888  44678999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      +|+|..++....    .+++..+..++.||+.||+|||+ .+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~-----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          79 GGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            999999986532    48999999999999999999997 56     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||..||.......    ....+...  ....+...+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i~~~--~~~~p~~~~~~  222 (325)
T cd05594         150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILME--EIRFPRTLSPE  222 (325)
T ss_pred             Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----HHHHHhcC--CCCCCCCCCHH
Confidence            11 1122347788999999998899999999999999999999999996543211    11111111  12234445677


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          426 LGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      +.+++.+||+.||++|+     ++.+++++.+.
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  255 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF  255 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence            89999999999999996     99999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.4e-40  Score=312.08  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             cccccCCceEEEEEEECC--C--cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRD--G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|.+.+  +  ..||||.+.........++|.+|+.++++++||||+++++++.  . ...++|+||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL--T-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc--C-CeEEEEEEec
Confidence            368999999999998753  3  3699999987654355678999999999999999999999884  3 6789999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++.....  ..++|.....++.|++.||+|||+.+     ++|+||||+||+++.++.+||+|||+++.....
T Consensus        78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcccEEEecCCEEEecccccccccccc
Confidence            99999999986542  35899999999999999999999988     999999999999999999999999999876442


Q ss_pred             ce-e-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IV-F-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~-~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .. + ......++..|+|||++.+..++.++||||||+++|||+| |..|+.......    ..............+...
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~  226 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKIDKEGERLERPEAC  226 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHhcCCcCCCCccC
Confidence            11 1 1112335567999999998899999999999999999999 999885432211    111111111222234455


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      +..+.+++.+||+.+|++||++.++++.|.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=334.89  Aligned_cols=254  Identities=17%  Similarity=0.263  Sum_probs=200.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+.++..++||||+++++++  ...+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF--QDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCeEEE
Confidence            36888899999999999999975 68999999987532  122335678899999999999999999988  45778999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        79 v~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG-----YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             EECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEeecccce
Confidence            999999999999997543    3899999999999999999999998     9999999999999999999999999987


Q ss_pred             cccCCcee-------------------------------------eeeccCCCCccCcccccccCCCCCcchhHHHHHHH
Q 012392          341 LLADDIVF-------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVII  383 (464)
Q Consensus       341 ~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll  383 (464)
                      .+......                                     ......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            54321100                                     00112478899999999988999999999999999


Q ss_pred             HHHHhCCCCCcchHHHHHhhhhHHHhhhhh--cCCCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHHhh
Q 012392          384 LQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTV  453 (464)
Q Consensus       384 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~L~~  453 (464)
                      |||++|..||.......    ....+....  +........++.+.+++..|+. +|.+|++   +.+++++.+.
T Consensus       230 ~el~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~  299 (364)
T cd05599         230 YEMLVGYPPFCSDNPQE----TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF  299 (364)
T ss_pred             HHhhcCCCCCCCCCHHH----HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence            99999999997543211    111221111  1111112345678889999986 9999997   9999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-40  Score=322.04  Aligned_cols=258  Identities=25%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.+..........+|.+|+.++++++||||++++|+|..   ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence            45677789999999999999864 443    5799988765544445578999999999999999999999843   246


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++++||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC-----eeccccccceeeecCCCceEEccccc
Confidence            78999999999999987543   23889999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++....... ........+..|+|||++.+..++.++||||||+++|||++ |+.|+.....     ......+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~  230 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REIPDLLEKGERL  230 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCCCCC
Confidence            986643221 11122234567999999998899999999999999999997 8888864321     1122233332222


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+..++..+.+++..||..+|++||+++++++.|..+...
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            33344567889999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.3e-40  Score=316.06  Aligned_cols=259  Identities=24%  Similarity=0.461  Sum_probs=204.9

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .+|.....||+|+||.||+|+.+      +...|++|.+..........+|.+|+.++++++|+||+++++++  .....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC--REAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE--CCCCc
Confidence            45778899999999999999864      34679999886544333456799999999999999999999988  44567


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSS-----NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      .++||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-----cccCcCccceEEEeCCCcEE
Confidence            899999999999999997644221     25899999999999999999999988     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |+|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......    ..+.....
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQA  233 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHHHc
Confidence            99999987554332222223334567999999988888999999999999999999 66777532211    11112221


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .......+...+..+.+++.+||+.||++||++.++++.|++
T Consensus       234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            222233344566789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-40  Score=318.18  Aligned_cols=261  Identities=19%  Similarity=0.319  Sum_probs=206.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||+|+||+||++... +++.||+|.+...........|.+|+++++.++||||+++++++.  ..+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEEEEEE
Confidence            34667789999999999999865 688999998876554455678999999999999999999999984  457899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||+++++|.+++....    .+++..+..++.+++.||.|||+. +     ++||||||+||++++++.++|+|||++..
T Consensus        83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          83 EFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             ecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC-----eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            9999999999986532    489999999999999999999974 4     99999999999999999999999999875


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH---Hhh----hhHHHhhhhhc
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA---AES----ATFENFIDRNL  414 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~---~~~----~~~~~~~~~~~  414 (464)
                      .....   .....++..|+|||++.+..++.++|||||||++|||+||+.||.......   ...    ..+...+....
T Consensus       154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd06620         154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP  230 (284)
T ss_pred             hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence            43221   112346778999999988899999999999999999999999987543210   000    11122221111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ........+..+.+++.+||+.||++||++.|++++++......
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            11111235678999999999999999999999999876654433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-40  Score=317.43  Aligned_cols=261  Identities=19%  Similarity=0.316  Sum_probs=207.0

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...+.||.|++|.||++... +++.+|+|.+..........++.+|++++++++||||+++++++.....+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777899999999999999975 688999999886554455677999999999999999999999987666667899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++.........+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999988754333445889999999999999999999988     9999999999999999999999999987554


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh----hcCCCCC
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR----NLKGKFS  419 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  419 (464)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++|..|+................+..    .+.....
T Consensus       157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            3211   12235667999999998899999999999999999999999986542100000011111111    1111111


Q ss_pred             --HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          420 --ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       420 --~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ...++.+.+++.+||+.+|++|||+.|++++-+.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence              2346789999999999999999999999997664

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-40  Score=315.28  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=199.0

Q ss_pred             cccccCCceEEEEEEECC-------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          190 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.||+|+||.||+|+..+       +..||||.+..........+|.+|+.+++.++||||+++++++.  .....++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEE
Confidence            368999999999998642       25799998865543345668999999999999999999999984  456789999


Q ss_pred             ecCCCCCHHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-----CeEEe
Q 012392          263 DFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-----NPLIA  334 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-----~~kl~  334 (464)
                      ||+++|+|.+++.....   ....++|.+++.++.|++.||+|||+.+     ++|+||||+||+++.+.     .++|+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChheEEEecCCCCCCcceEEC
Confidence            99999999999975432   1234889999999999999999999988     99999999999999887     89999


Q ss_pred             eCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhh
Q 012392          335 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       335 DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |||+++......... ......+..|+|||++.++.++.++|||||||++|||+| |..|+......     .....+..
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~  228 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----EVLQHVTA  228 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----HHHHHHhc
Confidence            999987654322111 112234567999999999999999999999999999998 88887643221     11122222


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2223344556788999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.7e-40  Score=318.07  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++  ...+..++|+||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~   83 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY--LKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc--ccCCceEEEEEc
Confidence            556678999999999999865 67899999987655445556789999999999999999999988  446779999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++++|.+++..     ..+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC-----eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            999999999863     23889999999999999999999988     99999999999999999999999999876643


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      ... ......++..|+|||++.+..++.++|||||||++|||+||+.|+......     .....+............+.
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  227 (277)
T cd06642         154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLIPKNSPPTLEGQYSK  227 (277)
T ss_pred             cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhhhcCCCCCCCcccCH
Confidence            221 111123567799999999888999999999999999999999998643211     11111222222333445667


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+.+++.+||+.+|++||++.+++++.+.
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFI  256 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence            89999999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-40  Score=330.94  Aligned_cols=254  Identities=19%  Similarity=0.294  Sum_probs=194.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||+||+++.. +++.||||.++....  ......+..|+.++.+++||||+++++.+  .+....++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~--~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF--QDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCeEEE
Confidence            36788899999999999999865 688999999875321  22234678899999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g-----ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG-----FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            999999999999997542    4899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCcee----------------------------------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHH
Q 012392          341 LLADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI  386 (464)
Q Consensus       341 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el  386 (464)
                      ........                                  ......||..|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            54321000                                  00123578889999999998999999999999999999


Q ss_pred             HhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC--HHHHHHHHHHHHH--hhhcCCCCCCCHHHHHHHHh
Q 012392          387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--ESEAAKLGKMALV--CTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       387 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~--C~~~dp~~RPs~~evl~~L~  452 (464)
                      ++|+.||.......    .+..+........++  ...++.+.+++.+  |...++..||+++||+++-+
T Consensus       230 l~G~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~  295 (363)
T cd05628         230 LIGYPPFCSETPQE----TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF  295 (363)
T ss_pred             HhCCCCCCCCCHHH----HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence            99999997543211    122222111111111  1233455666655  33344456799999998844

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-40  Score=327.16  Aligned_cols=248  Identities=22%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHH---HhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYL---LTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~---l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      |...+.||+|+||.||+|... +++.||||.++...  .......+..|+.+   ++.++||||+++++++  ...+..+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~--~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE--EcCCEEE
Confidence            556789999999999999875 68999999987532  12223445566554   4567899999999988  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|..++..     ..+++..+..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            99999999999988854     23899999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......    ....+...  ....+
T Consensus       149 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~~i~~~--~~~~p  221 (324)
T cd05589         149 KEGMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFDSIVND--EVRYP  221 (324)
T ss_pred             ccCCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhC--CCCCC
Confidence            75322111 1122346788999999999899999999999999999999999997543211    11122211  12234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ...+..+.+++.+||+.||++||     ++.+++++.+
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence            45567789999999999999999     6888887653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-40  Score=309.32  Aligned_cols=248  Identities=25%  Similarity=0.470  Sum_probs=200.6

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK  269 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gs  269 (464)
                      ++||.|+||.||++...+++.||+|.+...........|.+|+.++++++|+||+++++++.  .....++|+||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence            36899999999999987799999999876554445567999999999999999999999884  4567899999999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceee
Q 012392          270 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS  349 (464)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~  349 (464)
                      |.+++....   ..+++..++.++.+++.||+|||+++     ++||||||+||+++.++.+||+|||+++.........
T Consensus        79 l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          79 LLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            999997543   24789999999999999999999988     9999999999999999999999999988654322111


Q ss_pred             e-eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHH
Q 012392          350 V-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG  427 (464)
Q Consensus       350 ~-~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  427 (464)
                      . .....+..|+|||.+.++.++.++|+|||||++|||+| |..|+......     .....+........+...+..+.
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTRERIESGYRMPAPQLCPEEIY  225 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHHHHHhcCCCCCCCccCCHHHH
Confidence            1 11223456999999988899999999999999999999 67777544321     11122222223334455677899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          428 KMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       428 ~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      +++.+||+.+|++||++.|+++.|.
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHHHhh
Confidence            9999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-40  Score=310.69  Aligned_cols=251  Identities=29%  Similarity=0.530  Sum_probs=204.6

Q ss_pred             cccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|...+    +..||+|.+...........+.+|+..+..++|+||+++++++.  .....++|+||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEEEec
Confidence            468999999999999763    78999999987654444678999999999999999999999884  467899999999


Q ss_pred             CCCCHHHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          266 PKGKLSKYLDQEEGS-----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ++++|.+++......     ...+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||.+.
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-----cccCccCcceEEECCCCcEEEccccccc
Confidence            999999999875211     245899999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          341 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       341 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ....... .......++..|+|||.+....++.++||||||+++|||++ |..|+......     .+.+.+........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~  228 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLRKGYRLPK  228 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCC
Confidence            7654321 12223445678999999988889999999999999999999 57777654211     11122222223344


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      +...+..+.+++.+||+.||++|||+.|++++|+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            5556788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-41  Score=318.84  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC---eEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---ECFLI  261 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~---~~~lv  261 (464)
                      |...+++|+|+||.||+|.+. ++..||||+...+..     ---+|+.+|+.++|||||+|+-++......   ...+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            556689999999999999976 568999998765431     112689999999999999999888765555   45689


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGl~~  340 (464)
                      ||||+. +|.++++.-......++...+.-+..||.+||+|||+.+     |+||||||+|+|+|.+ +.+||||||.|+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-----IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-----ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-----cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            999977 999999864333444777778889999999999999988     9999999999999966 999999999999


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH------------
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE------------  407 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~------------  407 (464)
                      .+.........  ..+.-|.|||.+.+ ..|+.+.||||.||++.||+-|++.|.+..........++            
T Consensus       175 ~L~~~epniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEPNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCCceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            87544322111  13445999999976 5799999999999999999999998876432211111110            


Q ss_pred             -----------HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          408 -----------NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       408 -----------~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                                 ++.............+.+..+++.++++.+|.+|.++.|++.+-
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence                       00000000012334567889999999999999999999999764

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-40  Score=332.96  Aligned_cols=261  Identities=19%  Similarity=0.262  Sum_probs=198.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC---CeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~  259 (464)
                      +|+..+.||+|+||.||+++.. +++.||||.+.... ......++.+|+.+++.++||||+++++++.....   ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3677899999999999999964 78999999886432 12334578899999999999999999998843221   2689


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+. ++|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHHEEECCCCCEEeccccce
Confidence            9999995 6888888543    24899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh--------------
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA--------------  404 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~--------------  404 (464)
                      +..............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........              
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            86543322222233456789999998764 478999999999999999999999865422111000              


Q ss_pred             ----hHHHhhhh-hcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          405 ----TFENFIDR-NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       405 ----~~~~~~~~-~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                          .....+.. ....       ......++++.+++.+||+.||++|||+.|++++.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                00000100 0000       011223567889999999999999999999999876443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-40  Score=324.97  Aligned_cols=243  Identities=19%  Similarity=0.302  Sum_probs=191.2

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +++.||||.++...  .......+..|..++... +||||+++++++  ......++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcCC
Confidence            36899999999999975 57899999987532  122334556677776654 899999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          79 NGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG-----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            9999999987532    3888999999999999999999988     999999999999999999999999999754322


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      . .......++..|+|||++.+..++.++|||||||++|||++|+.||......    ..+..+..  .....+...+..
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~--~~~~~~~~~~~~  222 (316)
T cd05592         150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSILN--DRPHFPRWISKE  222 (316)
T ss_pred             C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHc--CCCCCCCCCCHH
Confidence            1 1122334778899999999889999999999999999999999999754321    11111111  122344456677


Q ss_pred             HHHHHHHhhhcCCCCCCCHH-HHHHH
Q 012392          426 LGKMALVCTHEDPENRPTME-AVIEE  450 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~-evl~~  450 (464)
                      +.+++..||+.||++||++. +++++
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcC
Confidence            89999999999999999875 56554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=323.89  Aligned_cols=256  Identities=20%  Similarity=0.291  Sum_probs=207.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ..++|+.++.||+|+||.||+|+.+ +|..+|+|.+++...  ..+......|-.+|....+|+||+|+-.|  ++...+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L  216 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL  216 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence            3456888999999999999999966 699999999987542  23345678899999999999999997666  778899


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ||||||.+|||+..+|...+    .|+......++.+++.|++-||..|     +|||||||+|+|||..|++||+||||
T Consensus       217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g-----yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG-----YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC-----cccccCChhheeecCCCCEeeccccc
Confidence            99999999999999998654    4888889999999999999999999     99999999999999999999999999


Q ss_pred             cccccC----C-------------------ce-----ee------------------eeccCCCCccCcccccccCCCCC
Q 012392          339 HKLLAD----D-------------------IV-----FS------------------VLKTSAAMGYLAPEYVTTGRFTE  372 (464)
Q Consensus       339 ~~~~~~----~-------------------~~-----~~------------------~~~~~~~~~y~aPE~~~~~~~~~  372 (464)
                      +.-+..    +                   ..     ..                  ...+.||+.|||||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            853311    0                   00     00                  01256888999999999999999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh--cCCCCCHHHHHHHHHHHHHhhhcCCCCCC---CHHHH
Q 012392          373 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAV  447 (464)
Q Consensus       373 ~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~ev  447 (464)
                      ..|+||+|||+|||+.|-+||.+.....    ++..++.-.  +.........++..+++.+|+. ||++|.   .++||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~----T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQE----TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            9999999999999999999998765432    233333222  3333334556889999999998 999996   58888


Q ss_pred             HHHHhh
Q 012392          448 IEELTV  453 (464)
Q Consensus       448 l~~L~~  453 (464)
                      -+|.+.
T Consensus       443 K~HPfF  448 (550)
T KOG0605|consen  443 KKHPFF  448 (550)
T ss_pred             hcCCcc
Confidence            877653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-40  Score=339.24  Aligned_cols=259  Identities=19%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC------C
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------G  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~------~  254 (464)
                      ...+|...+.||+|+||.||+|+.. +++.||||.+....     ....+|+.+|+.++||||+++++++...      .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4567999999999999999999875 68899999885432     1234699999999999999999876432      1


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEE
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLI  333 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl  333 (464)
                      ....++||||++ ++|.+++.........+++..+..++.||+.||+|||+.+     |+||||||+|||++.++ .+||
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-----IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCcCHHHEEEcCCCCceee
Confidence            224679999996 5788877654333345899999999999999999999988     99999999999999664 7999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh---
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF---  409 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~---  409 (464)
                      +|||+++......  ......++..|+|||++.+ ..++.++|||||||++|||+||.+||.+..............   
T Consensus       213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999998664322  1122346778999999865 468999999999999999999999997543211111110000   


Q ss_pred             -------hhh-------------hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          410 -------IDR-------------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       410 -------~~~-------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                             ..+             .+...++...+.++.+++.+||+.||.+|||+.|+++|.+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence                   000             00011122345678999999999999999999999988764

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.3e-40  Score=311.38  Aligned_cols=251  Identities=16%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...+.||+|+||.||+++.. ++..||+|.++........+.+.+|+.++++++|+||+++++.+  ...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE--EECCEEEEEEe
Confidence            3667789999999999999865 68899999987654445566788999999999999999999988  44678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..+++...+.++.|++.||.|||+.+     |+|+||||+||++++++.++|+|||+++...
T Consensus        79 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          79 YCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             eCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            9999999999875432  34788999999999999999999988     9999999999999999999999999987664


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..... .....++..|+|||++.+..++.++||||||+++|+|++|..||.......    ..... ........+...+
T Consensus       152 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~~~~~  225 (255)
T cd08219         152 SPGAY-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----LILKV-CQGSYKPLPSHYS  225 (255)
T ss_pred             ccccc-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----HHHHH-hcCCCCCCCcccC
Confidence            32211 112346677999999988889999999999999999999999987543211    11111 1112222344566


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ..+.+++.+||+.||++||++.+++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            779999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.4e-40  Score=315.40  Aligned_cols=251  Identities=18%  Similarity=0.323  Sum_probs=197.6

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..  .+..++|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence            3577889999999999999996 478899999987543 2334567889999999999999999999844  56899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.++++...    .+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG-----KMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEECcCccceee
Confidence            9999999999987532    4889999999999999999999988     999999999999999999999999999865


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--  417 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  417 (464)
                      ..... ......++..|+|||.+.   ...++.++|||||||++|||++|+.|+........    ............  
T Consensus       157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  231 (267)
T cd06646         157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLMSKSNFQPPKL  231 (267)
T ss_pred             ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----heeeecCCCCCCCC
Confidence            43211 112234567899999884   34578899999999999999999998854321100    001111111111  


Q ss_pred             -CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          418 -FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       418 -~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                       .....+..+.+++.+||+.||++||++++++++|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             1123457899999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-40  Score=326.02  Aligned_cols=245  Identities=17%  Similarity=0.274  Sum_probs=195.8

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||.||+|+.. +++.||||.++....  ......+..|..++..+ +||||+++++++  ...+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~--~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF--QTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCeEEEEEeCC
Confidence            36899999999999876 578999999875421  23345677888888866 799999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          79 NGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            9999999987543    3889999999999999999999988     999999999999999999999999998754222


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||......    ..+..+...  ....+...+.+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i~~~--~~~~p~~~~~~  222 (321)
T cd05591         150 GV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFESILHD--DVLYPVWLSKE  222 (321)
T ss_pred             Cc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHHHHcC--CCCCCCCCCHH
Confidence            11 112234678899999999889999999999999999999999999754321    112222211  11233345677


Q ss_pred             HHHHHHHhhhcCCCCCC-------CHHHHHHHHh
Q 012392          426 LGKMALVCTHEDPENRP-------TMEAVIEELT  452 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RP-------s~~evl~~L~  452 (464)
                      +.+++..||+.||++||       ++++++++.+
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence            89999999999999999       8999997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-39  Score=310.46  Aligned_cols=255  Identities=20%  Similarity=0.378  Sum_probs=208.8

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||.|+||.||++... ++..||+|.+..... ......+..|+.++++++||||+++++++........+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3677789999999999999864 688999999875432 33446788999999999999999999988665566789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH-----SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      ||+++++|.+++.........+++..++.++.|++.||+|||     +.+     ++|+||+|+||++++++.+||+|||
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-----i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-----VLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-----ceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999765433456999999999999999999999     655     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++......... .....++..|+|||.+....++.++||||||+++|+|++|..|+.....     ..+.+.+.......
T Consensus       156 ~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~  229 (265)
T cd08217         156 LAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKIKEGKFRR  229 (265)
T ss_pred             ccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHHHHHhcCCCCC
Confidence            99876543221 1223467789999999988899999999999999999999999875431     12222233333334


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      .+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            555677889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-40  Score=332.25  Aligned_cols=262  Identities=13%  Similarity=0.246  Sum_probs=204.8

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      +.++....++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++.+  
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--  112 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  112 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            3445556688999999999999999999976 68899999986422  122334578899999999999999999988  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ......++||||+++|+|.+++...     .++...+..++.||+.||+|||+.+     |+||||||+|||++.++.+|
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHEEECCCCCEE
Confidence            4467899999999999999998643     2788888899999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      |+|||+++..............+|..|+|||++...    .++.++|||||||++|||++|..||......    ..+..
T Consensus       183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~  258 (371)
T cd05622         183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSK  258 (371)
T ss_pred             EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence            999999987654322222334578899999998653    3788999999999999999999999764321    12223


Q ss_pred             hhhhhcCCCC--CHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhh
Q 012392          409 FIDRNLKGKF--SESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV  453 (464)
Q Consensus       409 ~~~~~~~~~~--~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~  453 (464)
                      +.........  ....+..+.+++..|+..++.+  |+++++++++.+.
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            3222111112  2345677889999999844433  7899999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.5e-40  Score=314.34  Aligned_cols=256  Identities=20%  Similarity=0.358  Sum_probs=209.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .|+..+.||.|+||.||+|... ++..||||.+...........|.+|+.++++++||||+++++++..  .+..++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEe
Confidence            4667788999999999999975 5889999998765545556789999999999999999999999844  678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++...     .+++.....++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~-----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            99999999998642     3888899999999999999999988     9999999999999999999999999997664


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..... .....++..|+|||++.+..++.++|||||||++|||+||..|+......     .....+............+
T Consensus       153 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~  226 (277)
T cd06640         153 DTQIK-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLIPKNNPPTLTGEFS  226 (277)
T ss_pred             CCccc-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhhhcCCCCCCchhhh
Confidence            33211 11223566799999998888999999999999999999999998643221     1111222223344556678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+.+++..||+.+|++||++.+++++.+......
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            88999999999999999999999999876554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-40  Score=325.45  Aligned_cols=245  Identities=19%  Similarity=0.283  Sum_probs=195.3

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +++.||||.++...  .......+..|..++..+ +||||+++++++  ...+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~--~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE--EcCCEEEEEEcCC
Confidence            36899999999999975 68899999987532  123345677888888876 699999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~-----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          79 NGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            9999999987543    3889999999999999999999988     999999999999999999999999998754221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||.+.+..++.++|||||||++|||++|+.||......    ..+..+...  ....+...+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~--~~~~~~~~~~~  222 (320)
T cd05590         150 GK-TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILND--EVVYPTWLSQD  222 (320)
T ss_pred             CC-cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcC--CCCCCCCCCHH
Confidence            11 122334788899999999889999999999999999999999999754321    112222211  11233445678


Q ss_pred             HHHHHHHhhhcCCCCCCCH------HHHHHHHh
Q 012392          426 LGKMALVCTHEDPENRPTM------EAVIEELT  452 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~------~evl~~L~  452 (464)
                      +.+++..|++.||++||++      ++++++-+
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence            8999999999999999998      77877644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.3e-40  Score=326.81  Aligned_cols=249  Identities=16%  Similarity=0.246  Sum_probs=194.5

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+++.. +++.||+|.++...  .......+..|+.++.++ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence            36899999999999975 67899999987542  123345577888888777 7999999999884  467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          79 NGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            9999999886532    3899999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH----HHhhh-hHHHhhhhhcCCCCCH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL----AAESA-TFENFIDRNLKGKFSE  420 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~  420 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||......    ..... ....+..  .....+.
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~  226 (329)
T cd05618         150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR  226 (329)
T ss_pred             CC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--CCCCCCC
Confidence            11 112234678899999999999999999999999999999999998521100    00001 1111111  1223455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCC------HHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPT------MEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs------~~evl~~L~  452 (464)
                      ..+..+.+++.+||+.||++||+      +.++++|-+
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  264 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence            56778899999999999999998      578887643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.8e-40  Score=324.55  Aligned_cols=249  Identities=19%  Similarity=0.265  Sum_probs=197.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCC-CceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~l  260 (464)
                      +|...+.||+|+||.||+|+.. +++.||||.+....  .......+..|..++..++|+ +|+++++++  ...+..++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--EcCCEEEE
Confidence            4677899999999999999876 57899999987532  123345688899999999765 578888877  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            999999999999997542    3889999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||++.+..++.++|||||||++|||+||+.||......    ..+..+..  .....+.
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~--~~~~~~~  222 (324)
T cd05587         150 ENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIME--HNVSYPK  222 (324)
T ss_pred             ecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHc--CCCCCCC
Confidence            4321111 122334778899999999999999999999999999999999999754321    11122221  1223344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEEL  451 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~L  451 (464)
                      ..+..+.+++.+||+.||++|++.     ++++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         223 SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            556788999999999999999976     6777653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=334.37  Aligned_cols=254  Identities=19%  Similarity=0.241  Sum_probs=197.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||||.+....  .......+.+|+.++++++||||+++++++  .+....++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF--QDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCeeEE
Confidence            35788899999999999999865 78999999986532  122345688899999999999999999988  45678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG-----FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999997532    3888888999999999999999998     9999999999999999999999999986


Q ss_pred             cccCCce-------------e---------------------------------eeeccCCCCccCcccccccCCCCCcc
Q 012392          341 LLADDIV-------------F---------------------------------SVLKTSAAMGYLAPEYVTTGRFTERS  374 (464)
Q Consensus       341 ~~~~~~~-------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~s  374 (464)
                      .......             .                                 ......+|..|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            4321000             0                                 00013478889999999988999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC--HHHHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 012392          375 DIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENR---PTMEAVIE  449 (464)
Q Consensus       375 Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~R---Ps~~evl~  449 (464)
                      |||||||++|||+||..||.......    .+..+.........+  ...+.++.+++..|+. +|.+|   +++.|+++
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHE----TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHH----HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            99999999999999999996543211    111221111111111  1345678899999997 66665   69999999


Q ss_pred             HHhh
Q 012392          450 ELTV  453 (464)
Q Consensus       450 ~L~~  453 (464)
                      +.+.
T Consensus       305 hp~~  308 (377)
T cd05629         305 HPFF  308 (377)
T ss_pred             CCCc
Confidence            8654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.5e-40  Score=315.82  Aligned_cols=253  Identities=19%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|+.++++++|+||+++.+.+  ...+..++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY--ETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE--ecCCEEEEEE
Confidence            566788999999999999875 6889999998754322  2234578899999999999999999887  4466799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          80 TIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN-----TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            99999999998875432  24899999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .....  .....++..|+|||++.+..++.++|+|||||++|||++|..||............... +.. ....++...
T Consensus       153 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~  228 (285)
T cd05632         153 PEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-VLE-TEEVYSAKF  228 (285)
T ss_pred             CCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hhc-cccccCccC
Confidence            43221  12234678899999999889999999999999999999999999754322111111111 111 112234445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPT-----MEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L  451 (464)
                      +..+.+++..||+.||++||+     +.+++++-
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP  262 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence            667899999999999999999     77888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-41  Score=326.23  Aligned_cols=253  Identities=19%  Similarity=0.367  Sum_probs=212.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe-EEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE-CFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~-~~l  260 (464)
                      .+|..++++|+|+||.++..+.+ ++..+++|.+.... ....++...+|+.++++++|||||.+.+.+.+  .+. .+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~--~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE--DGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc--CCceEEE
Confidence            45777899999999999998865 67899999988655 33444578899999999999999999998843  444 999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||+|++||+|.+.+....+  ..++...+..++.|++.|+.|||+++     |+|||||+.||+++.+..+||.|||+++
T Consensus        82 vm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~-----iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR-----VLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             EEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh-----hhcccchhhhhhccccCceeecchhhhh
Confidence            9999999999999987653  34889999999999999999999887     9999999999999999999999999999


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .+..+.. ......||+.||.||.+.+.+|+.|+|+|||||++|||++-+++|.........     .-+-+..-...+.
T Consensus       155 ~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li-----~ki~~~~~~Plp~  228 (426)
T KOG0589|consen  155 ILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI-----LKINRGLYSPLPS  228 (426)
T ss_pred             hcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH-----HHHhhccCCCCCc
Confidence            8876541 223356889999999999999999999999999999999999999765432221     1122223345677


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+..++..++..|++.+|+.||++.+++.+.
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            8889999999999999999999999999873

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.5e-40  Score=312.93  Aligned_cols=258  Identities=25%  Similarity=0.348  Sum_probs=202.2

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++.+++++.....||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.  ..+.
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~   79 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDS--ENGF   79 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeec--cCCE
Confidence            3455666777789999999999999865 67889999887654 344567899999999999999999999984  4678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEe
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVL--DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIA  334 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~  334 (464)
                      .++|+||+++++|.+++.....   .+  ++..+..++.||+.||+|||+.+     |+||||||+||+++. ++.+||+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCeEEEe
Confidence            9999999999999999976432   24  78888999999999999999988     999999999999986 6799999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |||++........ ......++..|+|||++....  ++.++||||||+++|||++|+.|+.........  .. .....
T Consensus       152 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~-~~~~~  227 (268)
T cd06624         152 DFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MF-KVGMF  227 (268)
T ss_pred             cchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hh-hhhhh
Confidence            9999876532211 111234667899999986543  788999999999999999999998643211110  01 11011


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ......+....+.+.+++.+||+.+|++|||+.|++++-
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            122334555677899999999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-40  Score=327.18  Aligned_cols=250  Identities=16%  Similarity=0.264  Sum_probs=195.9

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||.||+++.. +++.||||.++....  ......+..|..++.++ +||||+++++++  ...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~--~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF--QTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE--EcCCEEEEEEeCC
Confidence            36899999999999875 688999999975431  22345678899999988 699999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          79 SGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            9999999886532    3899999999999999999999988     999999999999999999999999998743211


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH-----HhhhhHHHhhhhhcCCCCCH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||.......     ........+...  ....+.
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~  226 (329)
T cd05588         150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPR  226 (329)
T ss_pred             CC-ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCC
Confidence            11 1122346788999999999999999999999999999999999985321100     000111112211  122344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCC------HHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPT------MEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs------~~evl~~L~~  453 (464)
                      ..+..+.+++.+||+.||++||+      +++++++-+.
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence            55677899999999999999987      7899877544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=330.79  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=209.4

Q ss_pred             ccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          187 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ...+.||.|+-|.|-+|++. +|+.+|||.+....  .........+|+-+|+-+.|||+++|++.+  +.+.++|+|.|
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lylvlE   92 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYLVLE   92 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEEEEE
Confidence            34578999999999999975 89999999997652  223345677899999999999999999988  66789999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|.|+++|...+    +|+..+..+++.||+.|+.|+|..+     |+||||||+|+|||...++||+|||+|....
T Consensus        93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~-----icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN-----ICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999998654    3889999999999999999999998     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--CCH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSE  420 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  420 (464)
                      .+....  ..-|.+.|.+||++.+..|. .++||||.|||||-|+||+.||.++        ++..++.+..++.  ++.
T Consensus       164 ~gklLe--TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~MPs  233 (786)
T KOG0588|consen  164 PGKLLE--TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEMPS  233 (786)
T ss_pred             CCcccc--ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccCCC
Confidence            543222  23467889999999999985 6899999999999999999999854        2333344444443  456


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+.+..+|+.+|+..||+.|.|++||++|.+...
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            77888999999999999999999999999987653

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-39  Score=310.86  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             CCccccccccCCceEEEEEEECC--CcEEEEEEeccCC---------CchHHHHHHHHHHHHhc-CCCCCceeeeeEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTS---------CKSEEAEFVKGLYLLTS-LRHENIIRLRGFCCS  252 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~f~~e~~~l~~-l~H~niv~l~g~~~~  252 (464)
                      +|+..+.||+|+||.||+|....  +..+|+|.+....         ......++..|+.++.+ ++||||+++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            36777899999999999999764  6889999876432         12233567889988875 7999999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCCe
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                      ...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+     ++|+||+|+||++++++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-----i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-----IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-----eeecCCCHHHEEECCCCcE
Confidence            44678999999999999999986543333458999999999999999999996 45     9999999999999999999


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      ||+|||++.......  ......++..|+|||.+.++.++.++||||||+++|||++|+.|+.......    .......
T Consensus       154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~  227 (269)
T cd08528         154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVE  227 (269)
T ss_pred             EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhh
Confidence            999999998765432  2223446778999999998889999999999999999999999986543211    1112222


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ...........+..+.+++.+||+.||++||++.|+..++.
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            22221112245678999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.6e-40  Score=323.87  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+++.. +++.||||.++...  .......+..|..++..+ +||||+++++++  ...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~--~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF--QTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcCC
Confidence            36899999999999876 57899999987542  122345677888888888 699999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          79 NGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            9999999987542    3899999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    ....+...  ....+...+..
T Consensus       150 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~~~~i~~~--~~~~~~~~~~~  222 (318)
T cd05570         150 GV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----LFQSILED--EVRYPRWLSKE  222 (318)
T ss_pred             CC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----HHHHHHcC--CCCCCCcCCHH
Confidence            11 1112246778999999999999999999999999999999999997543211    11122111  12234455678


Q ss_pred             HHHHHHHhhhcCCCCCCCH-----HHHHHHHh
Q 012392          426 LGKMALVCTHEDPENRPTM-----EAVIEELT  452 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~-----~evl~~L~  452 (464)
                      +.+++.+||+.||++||++     .+++++-+
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~  254 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF  254 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence            9999999999999999999     99987643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-39  Score=317.16  Aligned_cols=255  Identities=16%  Similarity=0.304  Sum_probs=203.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|...+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++.+..  ....++||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEee
Confidence            46778889999999999999864 6889999998765433 34568899999999999999999998844  56899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++...     .+++.++..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++...
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g-----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             cccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            999999999998642     3789999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.........   .............+...
T Consensus       167 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~  242 (296)
T cd06654         167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTPELQNPEKL  242 (296)
T ss_pred             ccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH---HHHhcCCCCCCCCcccc
Confidence            43211 111234667899999998888999999999999999999999998654321110   11111111111223445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+.+++.+||..||++||++.+++++-+...
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            677899999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.4e-40  Score=322.28  Aligned_cols=243  Identities=19%  Similarity=0.300  Sum_probs=191.7

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhc-CCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTS-LRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~-l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +++.||||.++....  ......+..|..++.. ++||||+++++++.  ..+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence            36899999999999976 578999999875421  2233456677778776 48999999999884  467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+++.++..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          79 NGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG-----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            9999999997532    3889999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    .+.. +.. .....+......
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~-i~~-~~~~~~~~~~~~  222 (316)
T cd05619         150 DA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQS-IRM-DNPCYPRWLTRE  222 (316)
T ss_pred             CC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHh-CCCCCCccCCHH
Confidence            11 1223347788999999998899999999999999999999999997543211    1111 111 112233445677


Q ss_pred             HHHHHHHhhhcCCCCCCCHH-HHHHH
Q 012392          426 LGKMALVCTHEDPENRPTME-AVIEE  450 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~-evl~~  450 (464)
                      +.+++.+||+.||++||++. ++.++
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHHcC
Confidence            89999999999999999997 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.5e-40  Score=317.02  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |+..+.||+|+||.||++... +++.||||.+......  .....+.+|+.++++++|+||+.+++.+.  ..+..++||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe--cCCEEEEEE
Confidence            566788999999999999875 6889999998654322  22345788999999999999999999884  456899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.++|+|||++...
T Consensus        80 e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER-----IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            99999999999865432  24889999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .....  .....++..|+|||++.+..++.++|||||||++|||++|..||........ .......... .....+...
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~-~~~~~~~~~  228 (285)
T cd05630         153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE-VQEEYSEKF  228 (285)
T ss_pred             CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhh-hhhhcCccC
Confidence            43221  1223567889999999988999999999999999999999999975322111 0111111111 112233445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~~  454 (464)
                      ...+.+++..||+.||++|||     ++|++++.+..
T Consensus       229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            667899999999999999999     89999876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-39  Score=310.33  Aligned_cols=239  Identities=20%  Similarity=0.415  Sum_probs=186.3

Q ss_pred             cccccCCceEEEEEEECC-------------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRD-------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      +.||+|+||.||+|++.+             ...||+|.+.... ......|.+|+.+++.++||||+++++++.  ...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCV--RDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCC
Confidence            358999999999998642             2358999876543 334457889999999999999999999984  456


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC------
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN------  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~------  330 (464)
                      ..++||||+++|+|..++....   ..+++..++.++.||++||+|||+.+     |+||||||+|||++.++.      
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD-----LVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC-----eECCCCCcccEEEecCCccCCCCc
Confidence            7899999999999999987533   34899999999999999999999988     999999999999987664      


Q ss_pred             -eEEeeCCccccccCCceeeeeccCCCCccCcccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCcchHHHHHhhhhHH
Q 012392          331 -PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQIL-TGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       331 -~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvll~el~-tg~~p~~~~~~~~~~~~~~~  407 (464)
                       +|++|||++......     ....++..|+|||.+. ...++.++|||||||++|||+ +|..|+......     ...
T Consensus       150 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~  219 (262)
T cd05077         150 FIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----EKE  219 (262)
T ss_pred             eeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----HHH
Confidence             899999998755322     1223567799999886 466899999999999999997 577776543211     111


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+......  ......+.+.+++.+||+.||++||++.+|++++
T Consensus       220 ~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11111111  1222356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.4e-40  Score=317.22  Aligned_cols=267  Identities=15%  Similarity=0.312  Sum_probs=207.1

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEE
Q 012392          174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  251 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~  251 (464)
                      +.++.+..+.++|...+.||+|+||.||++... +++.+|+|.+....  ....++.+|+.+++++ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            345666778889999999999999999999875 67899999876432  2335678899999999 6999999999875


Q ss_pred             eC---CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          252 SR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       252 ~~---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      ..   ..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+     |+||||||+||+++++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~  160 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-----TIHRDVKGNNILLTTE  160 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCHHhEEECCC
Confidence            32   235689999999999999998754333345889999999999999999999988     9999999999999999


Q ss_pred             CCeEEeeCCccccccCCceeeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          329 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      +.+||+|||+++....... ......++..|+|||++..     ..++.++|||||||++|||++|+.|+.......   
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---  236 (286)
T ss_pred             CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---
Confidence            9999999999876543221 1122346788999998753     457889999999999999999999986543211   


Q ss_pred             hhHHHhhhhh-cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          404 ATFENFIDRN-LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       404 ~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                       .+....... .....+......+.+++.+||+.||++|||+.|++++++
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         237 -ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             -HHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence             111111100 011112234567999999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.7e-40  Score=326.58  Aligned_cols=257  Identities=19%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----C
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  256 (464)
                      .++|...+.||+|+||.||+++.. +|..||||.+.... .......+.+|+.+++.++||||+++++++.....    .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            467889999999999999999875 68899999986542 22344678899999999999999999998743221    3


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||++ ++|.+.+..      .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEecC
Confidence            5799999996 467776642      2788889999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh------------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA------------  404 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~------------  404 (464)
                      |+++......  ......++..|+|||.+.+..++.++|||||||++|||+||+.||...........            
T Consensus       168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            9997653321  11233467889999999999999999999999999999999999975422111000            


Q ss_pred             ------hHHHhhhhhc--CC----------------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 ------TFENFIDRNL--KG----------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 ------~~~~~~~~~~--~~----------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                            ..........  ..                .........+.+++.+||+.||++|||+.|++++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                  0011111000  00                0011124568899999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=313.21  Aligned_cols=254  Identities=20%  Similarity=0.380  Sum_probs=206.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...+.||.|+||.||+|+.. +++.||+|.+...........+.+|+.++++++|+||+++++++..  ....++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEE
Confidence            5777789999999999999976 6889999998765544555678899999999999999999998854  567999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.++|+|||+++...
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG-----KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            99999999999753     4899999999999999999999988     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH-H
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES-E  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  422 (464)
                      .... ......++..|+|||++.+..++.++||||||+++|||+||..|+.......     ....+........... .
T Consensus       150 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~  223 (274)
T cd06609         150 STMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIPKNNPPSLEGNKF  223 (274)
T ss_pred             cccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHhhhcCCCCCccccc
Confidence            4321 1122345667999999998889999999999999999999999986533211     1111112222222222 5


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..+.+++.+||+.||++||++++++++-+....
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            6779999999999999999999999988665443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-39  Score=309.69  Aligned_cols=254  Identities=20%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC----chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .+|...+.||+|+||.||+|... ++..||+|.+.....    ......+.+|+.++++++||||+++++++........
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46788899999999999999864 688999998864321    1233568889999999999999999998765445678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCCC
Confidence            89999999999999997532    3889999999999999999999887     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++.......  .......++..|+|||++.+..++.++|||||||++|||++|+.||......    .............
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~~~~~~~~  228 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKIATQPTNP  228 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHHhcCCCCC
Confidence            876532111  1111233667899999999888999999999999999999999998754221    1111221112223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..+....+.+.+++ .||..+|++||+++||+++-
T Consensus       229 ~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         229 QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence            34445556677777 78889999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.5e-41  Score=328.31  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=195.5

Q ss_pred             cccccCCceEEEEEEE----CCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          190 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +.||+|+||.||+++.    .+|+.||+|.+...... .....+..|+.++++++||||+++++++  ...+..++||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF--QTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE--EcCCEEEEEEcC
Confidence            5799999999999875    36789999998754321 2334577899999999999999999988  446789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++....
T Consensus        80 ~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          80 LRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            99999999996532    4899999999999999999999988     99999999999999999999999999876543


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      ... ......++..|+|||.+....++.++|||||||++|||+||+.||......    .....+...  ....+...+.
T Consensus       151 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i~~~--~~~~p~~~~~  223 (318)
T cd05582         151 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMILKA--KLGMPQFLSP  223 (318)
T ss_pred             CCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHHHcC--CCCCCCCCCH
Confidence            211 122345778899999998888999999999999999999999999754321    111222211  1223445567


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 012392          425 KLGKMALVCTHEDPENRPT-----MEAVIEEL  451 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs-----~~evl~~L  451 (464)
                      .+.+++..||+.||++||+     +++++++.
T Consensus       224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~  255 (318)
T cd05582         224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHP  255 (318)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCC
Confidence            8899999999999999999     56666553

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-40  Score=314.45  Aligned_cols=239  Identities=21%  Similarity=0.423  Sum_probs=185.8

Q ss_pred             ccccCCceEEEEEEECC-------------------------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee
Q 012392          191 LLGKGNFSSVYKGTLRD-------------------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  245 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~  245 (464)
                      .||+|+||.||+|.+..                         ...||+|.+.... .....+|.+|+.++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999998521                         1358999886543 233457889999999999999999


Q ss_pred             eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE
Q 012392          246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  325 (464)
Q Consensus       246 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill  325 (464)
                      ++|+|..  ....++||||+++|+|..++....   ..+++..++.++.||++||+|||+.+     |+||||||+|||+
T Consensus        81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~Nill  150 (274)
T cd05076          81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN-----LVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEEe--CCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC-----ccCCCCCcccEEE
Confidence            9999854  567899999999999999987533   24889999999999999999999988     9999999999999


Q ss_pred             cCCC-------CeEEeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCcch
Q 012392          326 DQQF-------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQIL-TGSLVLTSS  396 (464)
Q Consensus       326 ~~~~-------~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~-tg~~p~~~~  396 (464)
                      +..+       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..|+...
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            8643       3799999987644221     11235567999998865 56899999999999999995 688887643


Q ss_pred             HHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....     .........  ..+......+.+++.+||+.+|++||++.+|+++|+
T Consensus       226 ~~~~-----~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSE-----KERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHH-----HHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            2211     111222111  122233457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.9e-40  Score=320.45  Aligned_cols=261  Identities=17%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. ++..||+|.++..........+.+|+.++++++||||+++++++.  ..+..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH--TDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe--eCCeEEEEE
Confidence            45778899999999999999875 678999999876543444456889999999999999999999984  456799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ ++|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          84 EYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             eCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECccccceec
Confidence            9996 48988886543   24788999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------HHHh-
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FENF-  409 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------~~~~-  409 (464)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||............           +..+ 
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         155 SVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            33211 1122345678999998865 46889999999999999999999998654221110000           0000 


Q ss_pred             -----hhhhcCCC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          410 -----IDRNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       410 -----~~~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                           .+......       .....+..+.+++.+|++.||++|||+.|++++.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence                 00000000       011235578899999999999999999999998776643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.5e-40  Score=323.30  Aligned_cols=248  Identities=20%  Similarity=0.292  Sum_probs=196.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +|...+.||+|+||.||+|+.. +++.||||.+.....  ......+..|..++..+ +|++|+++++++  ...+..++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF--QTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE--ecCCEEEE
Confidence            4677899999999999999876 578999999875431  22334567788888777 589999998887  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            999999999999987543    3889999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||++.+..++.++|||||||++|||+||+.||......    .....+...  ...++.
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~--~~~~p~  222 (323)
T cd05616         150 ENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEH--NVAYPK  222 (323)
T ss_pred             ecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHhC--CCCCCC
Confidence            5432111 112334778899999999999999999999999999999999999754321    112222221  223444


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE  450 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~  450 (464)
                      ..+.++.+++.+|++.||++|++.     .++.++
T Consensus       223 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         223 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            566788999999999999999984     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.6e-40  Score=322.19  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=192.5

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +|..||||.++....  ......+..|..++... +||||+++++++  ...+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF--QTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE--EeCCEEEEEECCC
Confidence            46899999999999976 688999999875421  22334566777777754 899999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          79 NGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            9999999987532    3889999999999999999999988     999999999999999999999999998743211


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||......    ..++.+..  .....+.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~--~~~~~~~~~~~~  222 (316)
T cd05620         150 DN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRV--DTPHYPRWITKE  222 (316)
T ss_pred             CC-ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh--CCCCCCCCCCHH
Confidence            11 122334778899999999999999999999999999999999999754321    11111111  112233445677


Q ss_pred             HHHHHHHhhhcCCCCCCCHH-HHHHHHh
Q 012392          426 LGKMALVCTHEDPENRPTME-AVIEELT  452 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~-evl~~L~  452 (464)
                      +.+++..||+.||++||++. ++++|.+
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~~h~~  250 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIRGHPF  250 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence            89999999999999999984 6665543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.8e-40  Score=311.60  Aligned_cols=255  Identities=19%  Similarity=0.375  Sum_probs=205.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|+..+.||+|+||.||++... +++.||+|.+..........++.+|++++++++||||+++++++..  .+..++|+|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEE
Confidence            4667789999999999999976 6899999998876545566789999999999999999999998844  578999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |+++++|.+++....   ..+++..+..++.|++.||+|||+ .+     ++|+||||+||++++++.++|+|||.+...
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~-----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK-----IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC-----eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            999999999997643   348889999999999999999999 77     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-hhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-SATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  421 (464)
                      .......   ..++..|+|||++.+..++.++||||||+++|+|++|+.|+......... .......... .....+..
T Consensus       152 ~~~~~~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (265)
T cd06605         152 VNSLAKT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG  227 (265)
T ss_pred             HHHHhhc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCCChh
Confidence            4322111   44667799999998889999999999999999999999998654211000 1111222221 11222222


Q ss_pred             -HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          422 -EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       422 -~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       .+..+.+++..||..||++|||+.+++.+-+.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence             67789999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=349.12  Aligned_cols=263  Identities=16%  Similarity=0.302  Sum_probs=203.9

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..++|.+.+.||+|+||.||+++.. .+..||+|.+..... ......|..|+.++++++|||||++++++........|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4457888999999999999999975 577899999875432 33456789999999999999999999988766667899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--CCCCeeecCCCCCceEEcCC---------
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--NKPAIVHRNLSVEKVLIDQQ---------  328 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~~~ivH~dlk~~Nill~~~---------  328 (464)
                      |||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+.  ...+||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999997644333459999999999999999999998531  11349999999999999643         


Q ss_pred             --------CCeEEeeCCccccccCCceeeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHH
Q 012392          329 --------FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMR  398 (464)
Q Consensus       329 --------~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~  398 (464)
                              ..+||+|||++........  .....+|+.|+|||++..  ..++.++|||||||+||||+||..||.....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                    3489999999986643321  123357888999999854  4588999999999999999999999964322


Q ss_pred             HHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ...    +...+..... ......+..+.+|+..||+.+|++||++.|++++-
T Consensus       249 ~~q----li~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        249 FSQ----LISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             HHH----HHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            111    1111111111 11123457799999999999999999999999653

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-39  Score=306.38  Aligned_cols=251  Identities=29%  Similarity=0.539  Sum_probs=202.3

Q ss_pred             ccccccccCCceEEEEEEECC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          187 SEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ...+.||.|+||.||+++..+     +..||+|.+...........+..|+.++.+++|+||+++++++..  .+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEE
Confidence            456789999999999999763     488999999766544456789999999999999999999999843  5779999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++......  .+++..+..++.|++.||+|||+.+     ++|+||||+||++++++.++|+|||+++.
T Consensus        80 ~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~-----~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             EeccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC-----eeecccccceEEEccCCeEEEcccCCcee
Confidence            9999999999999764321  2899999999999999999999988     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .............++..|+|||.+.+..++.++||||+|++++||++ |..|+.....     ..+.+.+........+.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~  227 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEYLKKGYRLPKPE  227 (258)
T ss_pred             cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCCCCCC
Confidence            65543222222335678999999988889999999999999999998 6677654211     11111122222233344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..+..+.+++.+||+.||++|||+.|+++.|
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            4677899999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-39  Score=324.79  Aligned_cols=258  Identities=18%  Similarity=0.295  Sum_probs=198.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----C
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~  255 (464)
                      ..++|...+.||+|+||.||++... .++.||||.+.... .......+.+|+.+++.++||||+++++++....    .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4467889999999999999999865 68899999987543 2233467889999999999999999999875322    2


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++||||++ ++|.+++..      .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEECCCCCEEEee
Confidence            35799999995 577777642      2788899999999999999999988     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh-----------
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------  404 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~-----------  404 (464)
                      ||+++.......  .....++..|+|||.+.+..++.++|||||||++|||++|+.||...........           
T Consensus       163 fg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         163 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             CcccccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999986543321  1223467889999999988999999999999999999999999865322111100           


Q ss_pred             -------hHHHhhhhhcC------------------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 -------TFENFIDRNLK------------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 -------~~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                             ....+++....                  ..........+.+++.+|++.||++|||+.|++++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                   01111110000                  00011224578899999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.5e-40  Score=330.75  Aligned_cols=252  Identities=17%  Similarity=0.266  Sum_probs=193.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .|..++.||+|+||.||+|+.. +++.||||.+.....  ......+.+|+.++++++||||+++++.+.  +.+..++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEE
Confidence            5788899999999999999865 688999999875321  223456888999999999999999999884  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999997532    3788888999999999999999988     99999999999999999999999999753


Q ss_pred             ccCCc---e-------------------------------------------eeeeccCCCCccCcccccccCCCCCcch
Q 012392          342 LADDI---V-------------------------------------------FSVLKTSAAMGYLAPEYVTTGRFTERSD  375 (464)
Q Consensus       342 ~~~~~---~-------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sD  375 (464)
                      .....   .                                           .......+|..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            21000   0                                           0001124678899999999989999999


Q ss_pred             hHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh--hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 012392          376 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEE  450 (464)
Q Consensus       376 v~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~  450 (464)
                      ||||||++|||++|..||........    ...+..  ...........+.+..+++.+++ .+|++|++   +.++++|
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLET----QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHHH----HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            99999999999999999975432111    111111  11111111233455666666654 49999987   9998877


Q ss_pred             Hh
Q 012392          451 LT  452 (464)
Q Consensus       451 L~  452 (464)
                      -+
T Consensus       306 p~  307 (382)
T cd05625         306 PF  307 (382)
T ss_pred             CC
Confidence            44

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-39  Score=320.18  Aligned_cols=256  Identities=16%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             ccccccC--CceEEEEEEEC-CCcEEEEEEeccCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          189 VNLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       189 ~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      .++||+|  +|++||+++.+ +|+.||||.++....... ...+.+|+.+++.++||||+++++++..  .+..++|+||
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~   80 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSF   80 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEec
Confidence            4679999  68899999875 789999999976543333 3456679999999999999999999844  5789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.++++||+.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          81 MAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             cCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            999999999965432  23899999999999999999999988     99999999999999999999999986543321


Q ss_pred             Cce-ee-----eeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH----HHhhhh
Q 012392          345 DIV-FS-----VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----ENFIDR  412 (464)
Q Consensus       345 ~~~-~~-----~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~----~~~~~~  412 (464)
                      ... ..     .....++..|+|||++..  ..++.++|||||||++|||++|+.||.............    ....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            110 00     011234556999999875  458899999999999999999999986432111000000    000000


Q ss_pred             -------------------h-----------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 -------------------N-----------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 -------------------~-----------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                         .                 ............+.+++.+||+.||++|||++|++++.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                               0                 0000112335678999999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-39  Score=312.46  Aligned_cols=253  Identities=18%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |+..+.||+|+||.||+|... ++..+++|.+.... ......|.+|+.+++.++||||+++++++..  .+..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEe
Confidence            456688999999999999976 57788999886543 3455678999999999999999999998844  5679999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|..++....   ..+++..+..++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          84 CAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEccCCCEEEccccccccccc
Confidence            99999999886532   34899999999999999999999988     99999999999999999999999999876533


Q ss_pred             CceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh-cCCCC
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKF  418 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  418 (464)
                      ... ......++..|+|||++.     ...++.++|||||||++|||++|+.|+.......    ......... .....
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  230 (282)
T cd06643         156 TIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTLAQ  230 (282)
T ss_pred             ccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----HHHHHhhcCCCCCCC
Confidence            211 112234677899999984     3457889999999999999999999986533211    111111110 11122


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +...+..+.+++..||+.||++||++.+++++.+..
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            334567899999999999999999999999876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4e-39  Score=305.97  Aligned_cols=252  Identities=20%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||.|+||.||.++.. ++..+++|.+.... ......++.+|+.++++++|+||+++++++.+  .+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence            4778899999999999998854 68899999887543 23445678999999999999999999999844  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....  ...+++.++..++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            9999999999997643  234899999999999999999999988     999999999999999999999999998866


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......    .....+..... .......
T Consensus       152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~  225 (256)
T cd08221         152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLVVKIVQGNY-TPVVSVY  225 (256)
T ss_pred             ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCC-CCCcccc
Confidence            44321 122334677899999998888899999999999999999999998653221    11112222111 2223445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      +..+.+++.+||+.+|++||++.++++++
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            67899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-39  Score=307.13  Aligned_cols=250  Identities=20%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             cCCccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||+|+||.||+|+..+ +..|++|.+....   ...+|.+|+.++++++||||+++++++..  ....++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEE
Confidence            567888999999999999999874 7899999987543   25689999999999999999999999844  57799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus        78 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          78 EYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             ecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEECCCCcEEEcccccchhc
Confidence            9999999999996533   34899999999999999999999988     999999999999999999999999998876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  421 (464)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.......    ........ ......+..
T Consensus       150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~  224 (256)
T cd06612         150 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFMIPNKPPPTLSDPEK  224 (256)
T ss_pred             ccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhhhccCCCCCCCchhh
Confidence            54321 1112235678999999988899999999999999999999999986532211    11111000 011112334


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ....+.+++.+||+.||++|||+.||+++-
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~  254 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHP  254 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence            557899999999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.5e-40  Score=323.26  Aligned_cols=244  Identities=20%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHH-HHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||+||+|+.. +|+.||||.+....  ......++..|.. +++.++||||+++++.+  ...+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~--~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE--EeCCEEEEEEcCC
Confidence            36899999999999975 78999999987532  1222344555554 56789999999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g-----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            9999999997532    4888999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|..||......    .....+....  ...+...+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~--~~~~~~~~~~  222 (323)
T cd05575         150 SK-TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----EMYDNILNKP--LRLKPNISVS  222 (323)
T ss_pred             CC-ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCC--CCCCCCCCHH
Confidence            11 122234678899999999989999999999999999999999999754221    1112222211  1223344677


Q ss_pred             HHHHHHHhhhcCCCCCCCH----HHHHHHH
Q 012392          426 LGKMALVCTHEDPENRPTM----EAVIEEL  451 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~----~evl~~L  451 (464)
                      +.+++.+|++.||++||++    .+++++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence            8999999999999999987    4666554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-40  Score=312.51  Aligned_cols=241  Identities=19%  Similarity=0.418  Sum_probs=188.0

Q ss_pred             cccccCCceEEEEEEECC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          190 NLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +.||+|+||.||+|....        ...||+|.+.... .....+|.+|+.+++.++||||+++++++..  ....++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEE
Confidence            368999999999998642        2348888876443 3445678899999999999999999999854  4568999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC--------eEE
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--------PLI  333 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~--------~kl  333 (464)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+.+     |+||||||+||+++.++.        +++
T Consensus        78 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             EecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEecccccccCCCceEEe
Confidence            999999999999976432   4889999999999999999999988     999999999999987765        599


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      +|||++......     ....++..|+|||++.+ ..++.++||||||+++|||++|..++........    .......
T Consensus       150 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~  220 (258)
T cd05078         150 SDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQFYED  220 (258)
T ss_pred             cccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHHHHHc
Confidence            999998654322     11235677999999976 4578999999999999999999644432221111    1111111


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                        ....+.....++.+++.+||+.||++|||++++++.|.
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              22334445567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-39  Score=313.96  Aligned_cols=267  Identities=21%  Similarity=0.356  Sum_probs=207.9

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEE
Q 012392          174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  251 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~  251 (464)
                      +..+++..++++|...+.||+|+||.||++... +++.+|+|.+....  ....++.+|+.++.++ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            455677778899999999999999999999874 68899999986532  2345677899999999 7999999999886


Q ss_pred             eCC---CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          252 SRG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       252 ~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      ..+   .+..++|+||+++|+|.++++........+++..+..++.|++.||+|||+.+     ++||||||+||+++++
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~nili~~~  164 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTE  164 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCC
Confidence            432   24689999999999999998754333345899999999999999999999987     9999999999999999


Q ss_pred             CCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          329 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      +.+||+|||++......... .....++..|+|||++...     .++.++|||||||++|||++|+.|+.......   
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---  240 (291)
T ss_pred             CCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---
Confidence            99999999998865432211 1123456779999998543     36889999999999999999999986543211   


Q ss_pred             hhHHHhhhhhc-CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          404 ATFENFIDRNL-KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       404 ~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                       .+........ ....+......+.+++.+||+.+|++||++.+++++-+
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         241 -TLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             -HHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence             1111111101 11123344567999999999999999999999998743

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.1e-39  Score=312.44  Aligned_cols=258  Identities=18%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHH-HhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|+..+.||+|+||.||+++.. +|..||+|+++.........++..|+.. ++.++||||+++++++.  ..+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEE
Confidence            35788899999999999999975 6899999998765444445566677765 56678999999999984  45679999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||++ |+|.+++.........+++..++.++.||+.||+|||++ +     ++||||||+||++++++.+||+|||+++
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-----i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-----VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99995 799988876433335689999999999999999999986 6     9999999999999999999999999988


Q ss_pred             cccCCceeeeeccCCCCccCccccccc----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      .......  .....++..|+|||.+..    ..++.++|+||||+++|||++|+.|+.......   ..+..........
T Consensus       153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~  227 (283)
T cd06617         153 YLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVVEEPSPQ  227 (283)
T ss_pred             ccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHHhcCCCC
Confidence            6543211  112345677999998864    446889999999999999999999986432111   1122222211111


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+..+.+++..||+.+|++||++.+++++-+..
T Consensus       228 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence            11223567899999999999999999999999865544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=322.19  Aligned_cols=256  Identities=18%  Similarity=0.264  Sum_probs=196.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||||.+....  .......|.+|+.++..++|+||+++++++  ...+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF--QDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE--ecCCeEEE
Confidence            35788899999999999999975 68899999986422  122345688899999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        79 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG-----YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            999999999999997532   23888999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ..............++..|+|||++..     +.++.++|||||||++|||++|+.||.......    ....+......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----~~~~i~~~~~~  226 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKEH  226 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCc
Confidence            654432222222347888999999863     457889999999999999999999997543211    11122111111


Q ss_pred             CCC---CHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHhh
Q 012392          416 GKF---SESEAAKLGKMALVCTHE--DPENRPTMEAVIEELTV  453 (464)
Q Consensus       416 ~~~---~~~~~~~l~~l~~~C~~~--dp~~RPs~~evl~~L~~  453 (464)
                      ...   ....++.+.+++.+|+..  ++..||++++++++.+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence            111   122456778888876654  44448899999998653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-39  Score=307.56  Aligned_cols=247  Identities=21%  Similarity=0.455  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +.|...+.||+|+||.||++.. ++..||+|.++...   ....|.+|+.++++++|||++++++++..   +..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence            3467789999999999999975 57789999886532   34578899999999999999999998743   34789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||++....
T Consensus        79 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          79 LMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK-----LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999999976432  34889999999999999999999988     9999999999999999999999999987543


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...    .....+..|+|||++.++.++.++||||||+++|||++ |..|+......     .....+........+...
T Consensus       152 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         152 MGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             ccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhCCCCCCCCCcC
Confidence            221    12223456999999988899999999999999999998 88887643221     112222222333334456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +..+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            6789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-39  Score=311.96  Aligned_cols=256  Identities=21%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|+..+.||+|+||.||+++.. ++..||+|.+...........+.+|+.++.+++||||+++++.+.  ..+..++|+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEEEEEe
Confidence            4667789999999999999976 789999999876543444567999999999999999999999884  4678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |+++++|.+++.... ....+++..+..++.|++.||.|||+. +     |+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC-----EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999987542 123589999999999999999999964 5     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCC------CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      .....   ....++..|+|||.+.+..      ++.++|+|||||++|||++|+.||....... ....+..... ....
T Consensus       154 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~-~~~~  228 (286)
T cd06622         154 VASLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLSAIVD-GDPP  228 (286)
T ss_pred             cCCcc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHHHHhh-cCCC
Confidence            43211   1223566799999985543      4789999999999999999999986432211 1111222222 1223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+...+..+.+++.+||+.+|++||++.+++.+.+.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence            3455577889999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-40  Score=331.15  Aligned_cols=253  Identities=17%  Similarity=0.249  Sum_probs=196.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .|...+.||+|+||.||+++.. +++.||||.+.....  ......+.+|+.++.+++||||+++++.+  ...+..++|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF--QDKDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCEEEEE
Confidence            5888899999999999999865 689999999864321  12335678899999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .++......++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++..
T Consensus        80 ~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999999997532    3788888899999999999999988     99999999999999999999999999753


Q ss_pred             ccCC---c---------------------------------------eeeeeccCCCCccCcccccccCCCCCcchhHHH
Q 012392          342 LADD---I---------------------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAF  379 (464)
Q Consensus       342 ~~~~---~---------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~  379 (464)
                      +...   .                                       ........+|..|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            2100   0                                       000012247788999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh--hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCC---CHHHHHHHHhh
Q 012392          380 GVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIEELTV  453 (464)
Q Consensus       380 Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~evl~~L~~  453 (464)
                      ||++|||++|+.||........    ...+..  ...........+..+.+++.+|+ .+|++|+   ++.+++++.+.
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~  304 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAET----QLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF  304 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHH----HHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence            9999999999999976432211    111111  11111111234556777777765 4999999   99999988553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-40  Score=311.23  Aligned_cols=250  Identities=23%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchH--HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..+|++.+.||+|.||+|-+|.. ..|+.||||.++++..+.+  .-...+|+++|+.|+||||+.++.+|  +..+.+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv  129 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV  129 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence            34567778999999999999985 5899999999988764443  33567899999999999999999998  6678899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||||..+|.|.+|+..+..    |+..+...+++||++|+.|+|.++     ++|||||-+|||||.|+++||+||||+
T Consensus       130 ivMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknr-----VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNR-----VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhcc-----ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999987653    999999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      .++.+.....  ..-|.+-|.+||.+.+..|. +..|-||+||+||-|+.|..||.+...        ..++.+.-++.+
T Consensus       201 Nly~~~kfLq--TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaY  270 (668)
T KOG0611|consen  201 NLYADKKFLQ--TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAY  270 (668)
T ss_pred             hhhccccHHH--HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcccc
Confidence            8887654322  22356679999999988884 689999999999999999999986532        222333333333


Q ss_pred             -CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          419 -SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       419 -~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       .+..+....-|+.+++..+|++|.|+.+|..|-|.
T Consensus       271 rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  271 REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence             23345567789999999999999999999988663

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-39  Score=319.64  Aligned_cols=247  Identities=19%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      |...+.||+|+||.||+|+.. +++.||||.+....  .......+..|..++..+. |++|+++.+++  ...+..++|
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv   79 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF--QTVDRLYFV   79 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE--ecCCEEEEE
Confidence            667789999999999999865 68899999987532  1223456778888988885 57788888877  445679999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          80 MEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeccccccc
Confidence            99999999999986532    3899999999999999999999988     99999999999999999999999999875


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...... ......++..|+|||++.+..++.++|||||||++|||+||+.||......    .....+...  ....+..
T Consensus       151 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~--~~~~p~~  223 (323)
T cd05615         151 HMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIMEH--NVSYPKS  223 (323)
T ss_pred             cCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC--CCCCCcc
Confidence            432211 112234778899999999888999999999999999999999999754321    122222221  1233445


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTM-----EAVIEE  450 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~  450 (464)
                      .+..+.+++.+||+.||.+|++.     +++.++
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            56788999999999999999974     566555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.8e-40  Score=322.79  Aligned_cols=244  Identities=21%  Similarity=0.340  Sum_probs=190.1

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHH-HHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||.||+|+.. +++.||+|.+.....  .....++.+|.. +++.++||||+++++++  ...+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEcCC
Confidence            36899999999999975 688999999865321  222345555654 67889999999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .++...+..++.||+.||+|||+.+     |+||||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          79 NGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            9999999886532    3788888899999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      . .......++..|+|||.+.+..++.++|||||||++|||++|..||.......    ....+...  ....+......
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~--~~~~~~~~~~~  222 (321)
T cd05603         150 E-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHK--PLQLPGGKTVA  222 (321)
T ss_pred             C-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcC--CCCCCCCCCHH
Confidence            1 11223346788999999998889999999999999999999999997543211    11222221  12234455678


Q ss_pred             HHHHHHHhhhcCCCCCCCH----HHHHHHH
Q 012392          426 LGKMALVCTHEDPENRPTM----EAVIEEL  451 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~----~evl~~L  451 (464)
                      +.+++.+|++.||++||++    .+++++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~  252 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHV  252 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence            8999999999999999875    4665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=305.90  Aligned_cols=260  Identities=22%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCC-ceeeeeEEEeCCC----Ce
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGR----GE  257 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~n-iv~l~g~~~~~~~----~~  257 (464)
                      .|..+++||+|+||+||+|+.. +|+.||+|.++..... ......++|+.++++++|+| ||+|++++.....    ..
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            3555678999999999999965 7899999999876532 22345689999999999999 9999999865331    26


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++|+||++ -+|..|+.........++-..+..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-----IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-----ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCcceEEECCCCcEeeeccc
Confidence            889999995 5999999876532234777889999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--  414 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  414 (464)
                      +|+...-... .......|.-|.|||++.+. .|+...||||+||++.||++++..|.+..........++-.-.+..  
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9996542211 12234466779999999876 7999999999999999999999888765543222222211111100  


Q ss_pred             ----------CCCC-----CH-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          415 ----------KGKF-----SE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       415 ----------~~~~-----~~-------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                                ...+     +.       .......+++..|++.+|.+|.|++.++.|-
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence                      0000     11       1113678999999999999999999999883

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-39  Score=309.37  Aligned_cols=254  Identities=27%  Similarity=0.485  Sum_probs=199.1

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHH-HHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |+..+.||+|+||+||+++.. +++.||+|.+......... ....+|+.++++++||||+++++++..  ....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence            456789999999999999976 5678999999876533332 234569999999999999999999854  678899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++...    ..+++..+..++.|+++||+|||+.+     |+|+||||+||++++++.++|+|||.+....
T Consensus        79 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~-----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   79 YCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG-----IVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT-----EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             cccccccccccccc----cccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence            99999999999833    23899999999999999999999998     9999999999999999999999999987542


Q ss_pred             CCceeeeeccCCCCccCcccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC--CCCH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSE  420 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  420 (464)
                      .. ........++..|+|||.+. ...++.++||||+|+++|+|++|..|+...... ................  ....
T Consensus       150 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  150 EN-NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             ST-TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHHHHHTTSHT
T ss_pred             cc-ccccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhcccccccccccccc
Confidence            11 11333445677899999998 788999999999999999999999998865110 1111111111111110  1111


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .....+.+++..||+.||++||++.+++++-+
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence            12378999999999999999999999998654

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.9e-39  Score=307.76  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=199.8

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCC-----chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      |...+.||+|+||.||+|...+++.+|||.++....     ......+.+|+.++++++|+||+++++++.  ..+..++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l   79 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTISI   79 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeEEE
Confidence            567789999999999999988899999998875421     122346888999999999999999999984  4578999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+|+||+|+||++++++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHhEEECCCCeEEeccchhhH
Confidence            999999999999996532    3788999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCc-----eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hc
Q 012392          341 LLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NL  414 (464)
Q Consensus       341 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~  414 (464)
                      ......     ........++..|+|||++.+..++.++||||||+++|||++|..|+........    ....... ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~  226 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MFYIGAHRGL  226 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----HHHhhhccCC
Confidence            643210     1111223466789999999988899999999999999999999999865322111    1111111 11


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            223344566788999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.7e-39  Score=311.76  Aligned_cols=264  Identities=22%  Similarity=0.366  Sum_probs=205.3

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEE
Q 012392          174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  251 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~  251 (464)
                      .++.++..+.+.|+..+.||+|+||.||+|+.. +++.||+|.+....  ....++..|+.++.++ +||||+++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            345666667788999999999999999999974 68899999886542  3345688899999998 6999999999875


Q ss_pred             eC----CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          252 SR----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       252 ~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      ..    .....+++|||+++|+|.+++.....  ..+++..+..++.||+.||.|||+.+     |+|+||||+||++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dl~~~nili~~  156 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK-----VIHRDIKGQNVLLTE  156 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECC
Confidence            32    23578999999999999999976432  34788889999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE  402 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~  402 (464)
                      ++.++|+|||++........ ......++..|+|||.+.     ...++.++|||||||++|||++|+.|+......   
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---  232 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---  232 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---
Confidence            99999999999875532111 111233567799999885     345788999999999999999999998653221   


Q ss_pred             hhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          403 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                       ...................+..+.+++..||+.||.+||++.|++++-
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~  280 (282)
T cd06636         233 -RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP  280 (282)
T ss_pred             -hhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence             111111111111112234567899999999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.4e-39  Score=305.56  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=201.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|... ++..||||.+....    .......+.+|+.++++++||||+++++++.+......
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46788899999999999999875 68999999876432    11234568889999999999999999998754444568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++++|.+++....    .+++...+.++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM-----IVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEecCCCCEEECcCcc
Confidence            89999999999999987532    3788889999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++.......  .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......    ............
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~  228 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTNP  228 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HHHHHhcCCCCC
Confidence            876532111  11122346678999999988889999999999999999999999986542211    112222222233


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+......+.+++.+||. +|++||++++|+++.+
T Consensus       229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence            4455667788899999985 9999999999997643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=325.37  Aligned_cols=255  Identities=22%  Similarity=0.389  Sum_probs=211.9

Q ss_pred             CccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHH--HHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |..++.||+|+||.||.|+. ++...||||.+........+  ++.++|+.+|.+++|||++.+.|.|..  ....||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVM  105 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVM  105 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHHH
Confidence            66778899999999999985 47889999999876533333  579999999999999999999998744  45789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||| -||-.+.|....   .+|..-++..|..+.+.||+|||+.+     .||||||+-||||++.+.+||+|||.+...
T Consensus       106 EYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~-----~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----RIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh-----HHhhhccccceEecCCCeeeeccccchhhc
Confidence            999 778888887643   35888899999999999999999998     899999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ...     ....||+.|||||++.   .+.|+-|+||||+||+..||...++|+.+...+..    +..+....-+....
T Consensus       177 ~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----LYHIAQNesPtLqs  247 (948)
T KOG0577|consen  177 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPTLQS  247 (948)
T ss_pred             Cch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----HHHHHhcCCCCCCC
Confidence            543     3456899999999984   57899999999999999999999999876443222    22332222222335


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT  460 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~  460 (464)
                      .+.++.+.+++..|++.-|.+|||.+++++|-....+...+
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            67788999999999999999999999999998877766655

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=311.10  Aligned_cols=256  Identities=18%  Similarity=0.328  Sum_probs=203.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+++.. ++..||+|.+.... ......|..|++++++++||||+++++++.  .....++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEE
Confidence            345778899999999999999975 68899999987553 445567999999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++....   ..+++..+..++.|++.||.|||+.+     |+|+||||+||+++.++.++|+|||++..
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          81 IEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK-----VIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             eeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEECCCCCEEEccCccchh
Confidence            99999999999987643   24899999999999999999999988     99999999999999999999999999875


Q ss_pred             ccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-C
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-K  415 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  415 (464)
                      ...... ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+......    .....+..... .
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~  227 (280)
T cd06611         153 NKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSEPPT  227 (280)
T ss_pred             hccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCCCCC
Confidence            533211 111234667899999874     344678999999999999999999998654221    11111111111 1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+...+..+.+++..||+.+|++||++.+++++-+..
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence            112344567899999999999999999999999986644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.8e-39  Score=312.59  Aligned_cols=256  Identities=21%  Similarity=0.373  Sum_probs=193.3

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcC---CCCCceeeeeEEEeC---CCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL---RHENIIRLRGFCCSR---GRG  256 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~---~~~  256 (464)
                      +|...+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+.+++.+   +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4677889999999999999876 68899999987543221 223455677666655   799999999987432   134


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||++ ++|.+++.....  ..+++..+..++.|++.||.|||+.+     |+||||||+|||+++++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECcc
Confidence            5899999996 599999875432  34899999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh-----
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-----  411 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-----  411 (464)
                      |+++......  ......++..|+|||++.+..++.++|||||||++|||++|+.||............. ..+.     
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~  229 (288)
T cd07863         153 GLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLPPED  229 (288)
T ss_pred             CccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH-HHhCCCChh
Confidence            9998664322  1122346778999999998889999999999999999999999886543211111111 1000     


Q ss_pred             ---h-------hcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 ---R-------NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ---~-------~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                         .       ....       ......++.+.+++.+|++.||++|||+.|++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence               0       0000       00123456788999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.2e-39  Score=344.60  Aligned_cols=262  Identities=21%  Similarity=0.265  Sum_probs=201.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...++||+|+||.||+|+.. +++.||||.++....  +....+|.+|+.++++++||||+++++++.  ..+..++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEE
Confidence            46888899999999999999975 689999999875432  233467999999999999999999999884  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          261 IYDFAPKGKLSKYLDQEEG-------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      ||||+++|+|.+++.....       ....+++..++.++.||++||+|||+.+     |+||||||+|||++.++.+||
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-----IIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchheEEEcCCCCEEE
Confidence            9999999999999875311       1233677888999999999999999988     999999999999999999999


Q ss_pred             eeCCccccccCCce-----------------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcch
Q 012392          334 ADCGLHKLLADDIV-----------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS  396 (464)
Q Consensus       334 ~DfGl~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~  396 (464)
                      +|||+++.......                 .......+|..|+|||.+.+..++.++|||||||++|||+||+.|+...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            99999986521100                 0001124788899999999999999999999999999999999998653


Q ss_pred             HHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhc
Q 012392          397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAA  455 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~  455 (464)
                      .....   .....+............+..+.+++.+|++.||++|| +++++++.|+...
T Consensus       235 ~~~ki---~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        235 KGRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             chhhh---hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            21100   01111110000011124456789999999999999995 6677777776653

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-39  Score=321.82  Aligned_cols=255  Identities=18%  Similarity=0.259  Sum_probs=199.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....  .......|.+|..++..++|+||+++++++  ...+..++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~--~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF--QDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEEE
Confidence            36788899999999999999976 67899999986422  122334578899999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCchHHEEEcCCCCEEEEecccee
Confidence            999999999999997633   23888999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ..............++..|+|||++..     +.++.++|||||||+||||++|+.||......    ..+..+.....+
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~~~~~~  226 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHEER  226 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HHHHHHHcCCCc
Confidence            665433322233457889999999865     56788999999999999999999999754321    112222222111


Q ss_pred             CCCC---HHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHh
Q 012392          416 GKFS---ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELT  452 (464)
Q Consensus       416 ~~~~---~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~  452 (464)
                      ...+   ...++.+.+++.+|+..++++  |+++++++++.+
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence            1111   234577889999988865544  578999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-39  Score=306.90  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=204.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||.|+||+||+|... ++..+|+|.+...........+.+|++.++.++|+||+++++.+.  .....++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEE
Confidence            35788899999999999999864 678999999876554446678999999999999999999999884  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++..... ...+++.....++.|++.||+|||+.+     ++||||+|+||++++++.++|+|||++...
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~-----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG-----QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            99999999999976432 134899999999999999999999988     999999999999999999999999998766


Q ss_pred             cCCcee---eeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh---hcC
Q 012392          343 ADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---NLK  415 (464)
Q Consensus       343 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~  415 (464)
                      ......   ......++..|+|||++... .++.++|||||||++|||++|+.|+......    ..+.+....   .+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~  228 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLTLQNDPPSLE  228 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHHhcCCCCCcC
Confidence            443211   11122356789999998776 7899999999999999999999998653221    111121111   111


Q ss_pred             CCC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          416 GKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       416 ~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ... ....+..+.+++..||+.||++||++.+++++-
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p  265 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK  265 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence            111 124567889999999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.3e-39  Score=323.01  Aligned_cols=257  Identities=17%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  256 (464)
                      .++|...+.||+|+||.||++... .++.||||.+.... .......+.+|+.+++.++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888999999999999999865 68899999987542 2334467889999999999999999999874321    23


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||++ ++|.+++..      .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEECCCCcEEEEeC
Confidence            5799999995 578877742      2788899999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH---------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------  407 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~---------  407 (464)
                      |+++.......  .....++..|+|||++.+..++.++|||||||++|||++|+.||............+.         
T Consensus       171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CCccccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99986543321  1223467889999999999999999999999999999999999865432111111100         


Q ss_pred             ---------Hhhhhhc--CC----------------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          408 ---------NFIDRNL--KG----------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       408 ---------~~~~~~~--~~----------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                               .......  ..                .........+.+++.+|++.||++|||+.|++++.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                     0000000  00                0011123568899999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.5e-39  Score=303.73  Aligned_cols=253  Identities=21%  Similarity=0.388  Sum_probs=202.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+++.. +++.||+|.+..... ......+.+|+.++++++|+|++++++.+.. .....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence            3677899999999999999865 578999999875432 3344568899999999999999999987632 344688999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++.....  ..+++.++..++.|++.||+|||+.+     ++||||||+||+++.++.++|+|||++...
T Consensus        80 e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~-----i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             cccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            99999999999976432  34899999999999999999999988     999999999999999999999999998766


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.......    ....... ......+...
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~  226 (257)
T cd08223         153 ENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----LVYRIIE-GKLPPMPKDY  226 (257)
T ss_pred             cccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHh-cCCCCCcccc
Confidence            43221 1122345678999999999899999999999999999999999986432111    1111111 1122334556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      +..+.+++.+||+.||++||++.+++++.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  255 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILRQP  255 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            67899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8e-39  Score=306.82  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=200.1

Q ss_pred             CccccccccCCceEEEEEEEC----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC----
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG----  256 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~----  256 (464)
                      |...+.||+|+||.||+|.+.    .++.||||.+..... .....++.+|+.++++++||||+++++++......    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455688999999999999864    368899999875432 33456788999999999999999999987543221    


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ..++++||+++|+|.+++.....  ....+++....+++.|++.||+|||+.+     |+||||||+||++++++.+||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-----FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccchhhEEEcCCCCEEEC
Confidence            24788999999999998854321  1224788999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhh
Q 012392          335 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       335 DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |||+++......... .....++..|++||.+....++.++||||||+++|||++ |..|+......     .....+..
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~  230 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIK  230 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHHc
Confidence            999998664332211 112233457999999988889999999999999999999 77777543221     11111111


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111222334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.9e-39  Score=304.79  Aligned_cols=252  Identities=19%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+++.. +++.||+|.+.... ......++.+|+.++++++||||+++++++  ...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEEEE
Confidence            4778899999999999999865 68899999987543 233446789999999999999999999988  5567899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++.....  ..+++.+++.++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          79 DYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            99999999999975432  24789999999999999999999988     999999999999999999999999999765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||++.++.++.++|||||||+++||+||+.|+......    ......... .....+...
T Consensus       152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~  225 (256)
T cd08218         152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NLVLKIIRG-SYPPVSSHY  225 (256)
T ss_pred             Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HHHHHHhcC-CCCCCcccC
Confidence            43221 111223567799999999888999999999999999999999998643221    111122211 122234456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      +..+.+++.+||+.+|++||++.+|+++-
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~  254 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKN  254 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence            77899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-39  Score=320.30  Aligned_cols=254  Identities=18%  Similarity=0.265  Sum_probs=196.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||+|+||.||+++.. +++.||+|.+....  .......|.+|+.++..++|+||+++++.+  ...+..++|
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv   79 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF--QDENNLYLV   79 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCEEEEE
Confidence            5788899999999999999976 57889999986422  122234578899999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++..
T Consensus        80 ~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~-----iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEeecchhee
Confidence            99999999999997633   23889999999999999999999988     99999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      .............+|..|+|||++.     .+.++.++|||||||++|||++|+.||......    .....+.....+.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~  227 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHKERF  227 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----HHHHHHhCCCccc
Confidence            5433222222345788999999986     346889999999999999999999999754321    1122222221111


Q ss_pred             CCC---HHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHHHh
Q 012392          417 KFS---ESEAAKLGKMALVCTHEDPE--NRPTMEAVIEELT  452 (464)
Q Consensus       417 ~~~---~~~~~~l~~l~~~C~~~dp~--~RPs~~evl~~L~  452 (464)
                      ..+   ...+..+.+++.+|+..+++  .|+++++++++-+
T Consensus       228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence            121   23466788888887755444  4789999998854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-39  Score=320.14  Aligned_cols=248  Identities=15%  Similarity=0.258  Sum_probs=194.1

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+++.. +++.||||.++....  ......+.+|+.++.++ +||||+++++++  ...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF--QTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE--EeCCEEEEEEeCC
Confidence            36999999999999975 678999999976432  22345678899999888 699999999987  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          79 NGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG-----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            9999999886532    3899999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH---HHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL---AAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||......   .........+...  ....+...
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~  226 (327)
T cd05617         150 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFL  226 (327)
T ss_pred             CC-ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCC
Confidence            11 112334778899999999999999999999999999999999999532110   0001111111111  12244455


Q ss_pred             HHHHHHHHHHhhhcCCCCCCC------HHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPT------MEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs------~~evl~~L  451 (464)
                      +..+.+++.+||+.||++|++      +++++++-
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            677899999999999999998      56887664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.6e-39  Score=307.68  Aligned_cols=252  Identities=21%  Similarity=0.381  Sum_probs=204.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      -|+..+.||+|+||.||+|... ++..||||.+...........|.+|+.++++++||||+++++++.  .....++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEE
Confidence            3667789999999999999864 688999999876544455567899999999999999999999984  4667999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          83 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC-----eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            99999999998642     3889999999999999999999988     9999999999999999999999999987654


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||++|..|+......     .....+............+
T Consensus       153 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~  226 (277)
T cd06641         153 DTQIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKNNPPTLEGNYS  226 (277)
T ss_pred             cchhh-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcCCCCCCCcccC
Confidence            32211 11223566799999998888999999999999999999999998643221     1111122222223344566


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+.+++.+||+.+|++||++.+++++-+..
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            7899999999999999999999999975543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.4e-39  Score=311.77  Aligned_cols=253  Identities=16%  Similarity=0.315  Sum_probs=204.2

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.  .....++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEE
Confidence            4588889999999999999986 478999999987544 333467889999999999999999999984  466899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|..++...     .+++.++..++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||++...
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~-----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ-----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999999998642     3899999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  421 (464)
                      ...... .....++..|+|||.+.+..++.++|||||||++|||++|+.||........    ....... ......+..
T Consensus       166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~  240 (296)
T cd06655         166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEK  240 (296)
T ss_pred             cccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCcccCCccc
Confidence            433211 1223466789999999988899999999999999999999999875432111    1111111 111122344


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+.+++.+||+.||++||++.+++++-+..
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            566789999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=306.18  Aligned_cols=238  Identities=22%  Similarity=0.461  Sum_probs=187.1

Q ss_pred             cccccCCceEEEEEEECCCc-----------EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          190 NLLGKGNFSSVYKGTLRDGT-----------LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      +.||+|+||.||+|.+.+..           .|++|.+.....  ....|.+|+.++++++||||++++|++..   ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR---DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence            36899999999999986432           578887765432  25789999999999999999999999854   457


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-------Ce
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-------NP  331 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-------~~  331 (464)
                      ++|+||+++|+|.+++.....   .+++..++.++.||+.||+|||+.+     |+||||||+|||++.++       .+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK-----LVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC-----eecccCccceEEEecCccccCCceeE
Confidence            899999999999999986432   4899999999999999999999988     99999999999999888       79


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccC--CCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHHH
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~  408 (464)
                      ||+|||++......     ....++..|+|||++...  .++.++||||||+++|||++| ..|+..... ..    ...
T Consensus       148 kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~----~~~  217 (259)
T cd05037         148 KLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SE----KER  217 (259)
T ss_pred             EeCCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hh----HHH
Confidence            99999998865431     112344569999998776  789999999999999999995 555543321 11    111


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....  ....+......+.+++.+||..+|++||++.++++.|+
T Consensus       218 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FYQD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHhc--CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111  11111122278899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-39  Score=313.96  Aligned_cols=254  Identities=15%  Similarity=0.302  Sum_probs=203.9

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.  .....++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEe
Confidence            35688889999999999999996 478999999987654 233456889999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++...     .+++..+..++.|++.||.|||+.+     ++||||||+|||++.++.++|+|||++..
T Consensus        95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~-----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          95 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             ecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEECcCccceE
Confidence            9999999999998642     3789999999999999999999988     99999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh-hhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-RNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  420 (464)
                      ....... .....++..|+|||.+.+..++.++|||||||++|++++|..||........    ...... .......+.
T Consensus       165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~  239 (297)
T cd06656         165 ITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPE  239 (297)
T ss_pred             ccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----eeeeccCCCCCCCCcc
Confidence            5433211 1122456779999999988899999999999999999999999965322111    001111 111111234


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+..+.+++.+||+.||++||++.+++++-+..
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            4567789999999999999999999999976654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.9e-39  Score=309.64  Aligned_cols=254  Identities=20%  Similarity=0.324  Sum_probs=200.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++.+..  .+..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEE
Confidence            45777899999999999999976 58899999987653 4455678999999999999999999998844  56799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|..++....   ..+++..+..++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||++...
T Consensus        89 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          89 EFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK-----IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             ecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC-----eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999886543   23899999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-CC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KG  416 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  416 (464)
                      ..... ......++..|+|||++.     ...++.++|||||||++|||++|..|+......    .....+..... ..
T Consensus       161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~  235 (292)
T cd06644         161 VKTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPPTL  235 (292)
T ss_pred             ccccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHhcCCCccC
Confidence            32211 111233567799999984     345688999999999999999999998653221    11111111111 11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+...+..+.+++.+||+.||++||++.+++++.+.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            1233455678999999999999999999999987553

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-39  Score=307.80  Aligned_cols=252  Identities=20%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc---------hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK---------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      +|...+.||.|+||.||+|... +++.||+|.++.....         ...+.+.+|+.++++++||||+++++++  ..
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE--TT   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe--cc
Confidence            3556789999999999999864 6889999987642110         1123577899999999999999999988  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      .+..++|+||+++|+|.+++...    ..+++..+..++.||+.||.|||+.+     ++||||+|+||++++++.++|+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC-----eeecCCChhhEEEcCCCeEEEe
Confidence            67899999999999999999764    24889999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCce-eeeeccCCCCccCcccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          335 DCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       335 DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |||+++....... .......++..|+|||.+....  ++.++||||||+++||+++|..|+.......    ...+...
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~  226 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMFKLGN  226 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHHHhhc
Confidence            9999876543211 1112234667899999987654  7899999999999999999999986432211    1111111


Q ss_pred             hhcCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 RNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ~~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ......    .....+..+.+++..||+.||++||++.+|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence            111111    2223467899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-39  Score=320.48  Aligned_cols=239  Identities=21%  Similarity=0.323  Sum_probs=186.8

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHH-HHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~-~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +++.||+|.+.....  .....++..|. .+++.++||||+++++++  ...+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~--~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE--EcCCeEEEEEeCC
Confidence            36899999999999976 678899999875321  12233445554 456788999999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+.......++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g-----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          79 NGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            9999999997532    3777888889999999999999998     999999999999999999999999998754221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|..||.......    .+..+...  ........+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~--~~~~~~~~~~~  222 (325)
T cd05602         150 NG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNK--PLQLKPNITNS  222 (325)
T ss_pred             CC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHHHhC--CcCCCCCCCHH
Confidence            11 1223347788999999999999999999999999999999999997543211    12222221  11233445677


Q ss_pred             HHHHHHHhhhcCCCCCCCHHH
Q 012392          426 LGKMALVCTHEDPENRPTMEA  446 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~e  446 (464)
                      +.+++..|++.||.+||++.+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCC
Confidence            899999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.7e-39  Score=303.51  Aligned_cols=250  Identities=23%  Similarity=0.373  Sum_probs=201.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC----chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      +|...+.||+|+||.||+|... ++..|++|.+.....    +...+.+..|+.++++++|+||+++++++  ......+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~   78 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE--REEDNLY   78 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE--ecCCeEE
Confidence            3566789999999999999976 789999998865431    23446788999999999999999999988  4456799


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.+||+|||++
T Consensus        79 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN-----TVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccc
Confidence            9999999999999997532    3889999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      .......  ......++..|++||.+.... ++.++|+||||+++|+|++|+.|+.......    ..............
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~  223 (258)
T cd06632         150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFKIGRSKELPPI  223 (258)
T ss_pred             eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----HHHHHHhcccCCCc
Confidence            7654332  112234667799999987766 8999999999999999999999986543211    11111111112234


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      +......+.+++.+||+.+|++||++.+++++-
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  256 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP  256 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence            445667889999999999999999999999753

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.3e-39  Score=313.86  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=188.5

Q ss_pred             ccccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          189 VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .++||+|+||.||+|+..   +++.||+|.+....   ....+.+|+.++++++||||+++++++........++|+||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            367999999999999865   46789999987543   224577899999999999999999988666666789999999


Q ss_pred             CCCCHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE----cCCCCeEEeeC
Q 012392          266 PKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADC  336 (464)
Q Consensus       266 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df  336 (464)
                      . ++|.+++.....     ....+++..+..++.||+.||+|||+.+     |+||||||+|||+    +.++.+||+||
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            5 589888764321     1234888999999999999999999988     9999999999999    46678999999


Q ss_pred             CccccccCCce--eeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH---------hh-
Q 012392          337 GLHKLLADDIV--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---------ES-  403 (464)
Q Consensus       337 Gl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~---------~~-  403 (464)
                      |+++.......  .......+|..|+|||++.+ ..++.++||||+||++|||++|+.||........         .. 
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99987643221  11223456788999999876 4589999999999999999999999853211000         00 


Q ss_pred             ----------hhHHHh---------hhhhcCCCC------------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          404 ----------ATFENF---------IDRNLKGKF------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       404 ----------~~~~~~---------~~~~~~~~~------------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                                ..+...         .........            .......+.+++.+|++.||++|||++|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                      000000         000000000            001124578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-39  Score=308.39  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++||||+++++.+..  .+..++|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEE
Confidence            34666788999999999999865 68899999987654 3334568889999999999999999998844  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++....    .+++.++..++.|++.||.|||+.+     ++|+||||+||+++.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          86 EFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG-----KMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999999986532    3889999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC-C
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK-F  418 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  418 (464)
                      ..... ......++..|+|||++.   .+.++.++|||||||++|||++|..|+........    ............ .
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~  231 (267)
T cd06645         157 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLMTKSNFQPPKL  231 (267)
T ss_pred             cCccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----HHhhhccCCCCCcc
Confidence            43211 122334677899999974   45688999999999999999999999864321111    111111111111 0


Q ss_pred             --CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          419 --SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       419 --~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                        ....+..+.+++.+||+.||++||++++++++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              11244678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.8e-39  Score=305.17  Aligned_cols=249  Identities=22%  Similarity=0.416  Sum_probs=198.9

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch--------HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      |.....||+|+||.||+|... +++.||+|.+.......        ....+.+|+.++++++||||+++++++..  ..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   79 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD   79 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence            556688999999999999864 67899999886543211        12467889999999999999999998844  56


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+++++|.+++...    ..+++..+..++.|++.||+|||+.+     ++||||+|+||++++++.+||+||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~-----ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG-----IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC-----cccccCCHHHEEEcCCCCEEeccc
Confidence            789999999999999999753    23888999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceee-----eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          337 GLHKLLADDIVFS-----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       337 Gl~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |+++.........     .....++..|+|||.+.+..++.++||||||+++|||++|..||......    ........
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~  226 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIGE  226 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHhc
Confidence            9988664321100     11123567799999999888999999999999999999999999754221    11111111


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                       ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 -NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             22233445567789999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.9e-39  Score=309.69  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=195.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|+.. ++..||||.++.... ......+.+|+.++++++||||+++++++.  ..+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEE
Confidence            3677789999999999999975 689999999875432 223356888999999999999999999984  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ ++|.+++..... ...+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR-----VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            9996 699999865432 234899999999999999999999988     999999999999999999999999998755


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH-------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-------------  408 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-------------  408 (464)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.|+............+..             
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         152 GIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             CCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            33211 1112235677999998865 45788999999999999999999998653221111000000             


Q ss_pred             -------hhhhhcCC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          409 -------FIDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       409 -------~~~~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                             ........   ......+.++.+++.+||+.||++|||+.+|+++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~  283 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP  283 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence                   00000000   00112356778999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.4e-39  Score=313.58  Aligned_cols=259  Identities=19%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.++++++||||+++++++.  ..+..++|+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEE
Confidence            35778899999999999999875 688999999876543444456788999999999999999999984  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ ++|.+++....   ..+++..+..++.||+.||+|||+.+     |+|+||||+||++++++.+||+|||++...
T Consensus        84 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          84 EYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             eccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            9996 69999987543   24889999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh-----------hhHHHhh
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-----------ATFENFI  410 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~-----------~~~~~~~  410 (464)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||..........           ..+....
T Consensus       155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         155 SIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            32211 1112235677999998865 457889999999999999999999986543211100           0001110


Q ss_pred             hh------hcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          411 DR------NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       411 ~~------~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..      ....       ......+..+.+++.+|++.||.+|||++|++++-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            00      0000       00112355788999999999999999999999876653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-39  Score=320.49  Aligned_cols=243  Identities=21%  Similarity=0.318  Sum_probs=189.7

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHH-HHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +|+.||||.+....  ......++..|.. +++.++||||+++++.+  ...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~--~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE--ecCCEEEEEEcCC
Confidence            36899999999999865 78999999986532  1223345566655 56789999999999888  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g-----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN-----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            9999999886532    4889999999999999999999988     999999999999999999999999998753221


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|..||......    ..+..+....  .......+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~~~~~~--~~~~~~~~~~  222 (325)
T cd05604         150 SD-TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNILHKP--LVLRPGASLT  222 (325)
T ss_pred             CC-CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHHHHHcCC--ccCCCCCCHH
Confidence            11 112334678899999999999999999999999999999999999754321    1122222211  1122345567


Q ss_pred             HHHHHHHhhhcCCCCCCCHH----HHHHH
Q 012392          426 LGKMALVCTHEDPENRPTME----AVIEE  450 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~----evl~~  450 (464)
                      +.+++..|++.||.+||+++    +++++
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            88999999999999999875    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=308.35  Aligned_cols=250  Identities=20%  Similarity=0.350  Sum_probs=209.9

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |+++.+||+|+||.||+|.++ .|+.||||....+   ...++.++|+.+|.+.+.|++|+++|.+.  ....+||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhh
Confidence            667789999999999999876 7999999998764   46788999999999999999999999874  35679999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      |..|+..+.++.+.   .+|+..++..++.+.++||+|||...     -+|||||+-||||+.+|.+||+|||.+..+++
T Consensus       110 CGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~-----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  110 CGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK-----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             cCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH-----HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            99999999998754   45999999999999999999999887     79999999999999999999999999988765


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      .- .......||+-|||||++..-.|+.++||||+|++..||..|++||..-.....   .+.--..+...-..++..++
T Consensus       182 TM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  182 TM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             hH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCChHhhhh
Confidence            32 233455688899999999999999999999999999999999999975432111   11000011111223567789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ++.+++..|+-..|++|-|+.++++|-.
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence            9999999999999999999999998854

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=302.91  Aligned_cols=252  Identities=20%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++..  ....+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence            356788899999999999999875 57889999987654 3355678999999999999999999998844  6679999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++....   ..+++..+..++.|++.||+|||+.+     |+|+||+|+||++++++.+||+|||++..
T Consensus        79 ~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          79 MEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG-----KIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             EeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCChhhEEECCCCCEEECccccchh
Confidence            99999999999987642   24889999999999999999999988     99999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccC---CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC---
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK---  415 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  415 (464)
                      ...... ......++..|+|||.+...   .++.++||||||+++|||+||+.|+........    ..........   
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~~~~~~~~~~~~~  225 (262)
T cd06613         151 LTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----LFLISKSNFPPPK  225 (262)
T ss_pred             hhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCcc
Confidence            543211 11123456679999998776   789999999999999999999999865332111    1111111111   


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      .......+..+.+++.+||+.+|++|||+.+|+.+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11233456789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-38  Score=302.08  Aligned_cols=250  Identities=22%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||++... +++.+|||.+.... .......+.+|+.++++++||||+++++.+.  ..+..++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence            4677899999999999999864 68899999987543 2334567889999999999999999999873  467799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGl~~~  341 (464)
                      ||+++++|.+++.....  ..+++..+..++.+++.||+|||+.+     ++|+||+|+||+++++ ..+||+|||++..
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             ecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            99999999999976432  34899999999999999999999988     9999999999999855 5689999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ......  .....++..|+|||.+....++.++||||||+++|+|++|+.|+.......    ....... ......+..
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~  224 (256)
T cd08220         152 LSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKIMS-GTFAPISDR  224 (256)
T ss_pred             cCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHHHHHh-cCCCCCCCC
Confidence            654321  112335678999999998889999999999999999999999986542211    1111111 112233445


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      .+..+.+++..||+.||++|||+.|++++
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            67789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-39  Score=306.04  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC----
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG----  254 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~----  254 (464)
                      .++++|...+.||+|+||.||+|... +++.+++|.+....  ....+|.+|+.+++++ +|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            45678999999999999999999975 67899999987653  2346789999999999 6999999999986533    


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ....++||||+++++|.+++.........+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.+||+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-----VIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEEccCCeEEEC
Confidence            34589999999999999998764423345899999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  409 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  409 (464)
                      |||++........ ......++..|+|||++..     ..++.++||||||+++|||++|..|+......    ....++
T Consensus       156 d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~  230 (275)
T cd06608         156 DFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RALFKI  230 (275)
T ss_pred             CCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHHHHh
Confidence            9999876543211 1122336678999998753     34678999999999999999999998643221    111122


Q ss_pred             hhhhc-CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          410 IDRNL-KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       410 ~~~~~-~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..... ....+...+..+.+++.+||+.||++|||+.+++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~  273 (275)
T cd06608         231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP  273 (275)
T ss_pred             hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence            11111 1112233567899999999999999999999999764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-39  Score=324.63  Aligned_cols=253  Identities=19%  Similarity=0.291  Sum_probs=196.5

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|+..+.||+|+||.||+++.. +++.||||.++...  .......+..|+.++.+++||||+++++.+  ...+..++|
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~~~~lv   79 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF--QDKRNLYLI   79 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEEEE
Confidence            5778899999999999999875 68999999987432  122345678899999999999999999988  456789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g-----ivHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          80 MEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG-----FIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            99999999999997543    3889999999999999999999988     99999999999999999999999999875


Q ss_pred             ccCCcee----------------------------------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHH
Q 012392          342 LADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL  387 (464)
Q Consensus       342 ~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~  387 (464)
                      .......                                  ......+|..|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221000                                  001234778899999999999999999999999999999


Q ss_pred             hCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC--HHHHHHHHHHHHHhhhcCCCCCC---CHHHHHHHHhh
Q 012392          388 TGSLVLTSSMRLAAESATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRP---TMEAVIEELTV  453 (464)
Q Consensus       388 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RP---s~~evl~~L~~  453 (464)
                      ||..||.......    .+..+........++  ...+.++.+++.+++ .||.+|+   +++++++|-+.
T Consensus       231 tG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  296 (360)
T cd05627         231 IGYPPFCSETPQE----TYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF  296 (360)
T ss_pred             cCCCCCCCCCHHH----HHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCC
Confidence            9999997543221    112222111111111  123556777777765 4999998   47899888653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-39  Score=330.58  Aligned_cols=253  Identities=18%  Similarity=0.214  Sum_probs=193.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ...|.+.+.||+|+||.||+|+.. .++.||||....       ..+.+|+.+|++++|+|||++++++..  .+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence            346888999999999999999976 578899995322       246689999999999999999998854  5678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||++ .++|.+++....   ..++|..++.|+.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus       239 ~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        239 LPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG-----IIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             EEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            9999 579999986533   24999999999999999999999988     99999999999999999999999999986


Q ss_pred             ccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH---HhhhhHHHhhhhh----
Q 012392          342 LADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA---AESATFENFIDRN----  413 (464)
Q Consensus       342 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~----  413 (464)
                      ....... ......+|..|+|||++.+..++.++|||||||+||||++|..++.......   .....+.+++...    
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            5432111 1123357889999999999999999999999999999999876553221100   0000011111100    


Q ss_pred             ----------------------cCCCCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          414 ----------------------LKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       414 ----------------------~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                            ......       ......+.+|+.+||+.||.+|||+.|++++-+.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence                                  000000       0122467889999999999999999999998654

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=312.56  Aligned_cols=257  Identities=20%  Similarity=0.302  Sum_probs=205.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||+|+||.||+|... ++..||+|.+......  .....+..|+++++.++||||+++++.+  ......++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF--QTETYLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee--ecCCEEEEE
Confidence            5778899999999999999976 5899999998765433  2445788999999999999999999988  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+.+++|.+++.....  ..+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          80 MDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            999999999999875432  34899999999999999999999988     99999999999999999999999999875


Q ss_pred             ccCCcee----------------------------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 012392          342 LADDIVF----------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL  393 (464)
Q Consensus       342 ~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~  393 (464)
                      .......                            ......++..|+|||++.+..++.++||||||+++|+|++|..|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4321100                            001123567799999999888999999999999999999999998


Q ss_pred             cchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHHHHhhh
Q 012392          394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT----MEAVIEELTVA  454 (464)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs----~~evl~~L~~~  454 (464)
                      ......    ..+..+.............+..+.+++.+||+.||++||+    +++++++-+..
T Consensus       233 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         233 KGSNRD----ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             CCCchH----HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            654321    2233333322222222236788999999999999999999    88888875543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-38  Score=309.34  Aligned_cols=254  Identities=20%  Similarity=0.373  Sum_probs=200.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..|...+.||+|+||.||+|+.. +++.||+|.+.....  .....++.+|+.+++.++||||+++.++|..  .+..++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence            44777889999999999999875 689999998864432  2334578899999999999999999999854  567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||++ |+|.+++....   ..+++..+..++.|++.||.|||+.+     |+||||+|+||++++++.+||+|||++.
T Consensus        93 v~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~-----i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          93 VMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE-----RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             EHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEECCCCCEEEeecCcce
Confidence            999996 68888776432   24899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ......     ...++..|+|||++.   .+.++.++||||||+++|||+||..|+........    ............
T Consensus       164 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~  234 (307)
T cd06607         164 LVSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNDSPTL  234 (307)
T ss_pred             ecCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----HHHHhcCCCCCC
Confidence            654321     223566799999874   45688999999999999999999999865432111    111111111111


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .....+..+.+++.+||+.||++||++.+++.+.+.....
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            2334667899999999999999999999999987755433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.7e-39  Score=310.52  Aligned_cols=255  Identities=20%  Similarity=0.385  Sum_probs=195.4

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|+||.||+++.. +++.||+|.+...........+.+|+.++.++. |+||+++++++..  .+..++++|
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e   83 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICME   83 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEe
Confidence            445578999999999999875 689999999876554455667899999999996 9999999998843  567899999


Q ss_pred             cCCCCCHHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          264 FAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       264 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |+. ++|.++.... ......+++..+..++.+++.||+|||+. +     ++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            985 4665543221 11123489999999999999999999975 5     99999999999999999999999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccC---CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh---hhcC
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---RNLK  415 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~  415 (464)
                      ......  .....++..|+|||.+...   .++.++|||||||++|||++|+.||.......   ....+...   +.+.
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~  232 (288)
T cd06616         158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF---DQLTQVVKGDPPILS  232 (288)
T ss_pred             hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH---HHHhhhcCCCCCcCC
Confidence            543221  1223466789999998765   68999999999999999999999986543111   11111111   1112


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .......+..+.+++.+||+.||++|||+.+|+++-+.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            22223466789999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=324.06  Aligned_cols=243  Identities=19%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~  258 (464)
                      -++|...++||+|.||+|+++.++ +++.+|||.++++..  ..+....+.|-.++... +||.+++|+..+  +.+.++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l  444 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHL  444 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeE
Confidence            356889999999999999999986 688999999987652  22334566677777666 599999997766  778999


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |.||||..+||+..+.+.     ..++......++..|+.||.|||+++     |||||||-+|||||.+|.+||+|||+
T Consensus       445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~-----IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG-----IIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC-----ceeeecchhheEEcccCcEEeccccc
Confidence            999999999995444332     34999999999999999999999999     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++..-.... .+...-||+.|||||++.+..|+..+|+|||||+||||+.|..||.+...    ...+..++.  ....+
T Consensus       515 cKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----ee~FdsI~~--d~~~y  587 (694)
T KOG0694|consen  515 CKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----EEVFDSIVN--DEVRY  587 (694)
T ss_pred             ccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhc--CCCCC
Confidence            985431111 22334588899999999999999999999999999999999999986543    222333322  12346


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCH
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTM  444 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~  444 (464)
                      |...+.+...|+.+.+..+|++|.-+
T Consensus       588 P~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  588 PRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCcccHHHHHHHHHHhccCcccccCC
Confidence            77888899999999999999999765

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.6e-39  Score=314.91  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=188.5

Q ss_pred             cccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      .+||+|+||.||+|+..   ++..||+|.+....   ....+.+|+.++++++||||+++++++........++|+||++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            57999999999999975   35789999886543   2245778999999999999999999887666678899999995


Q ss_pred             CCCHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE----cCCCCeEEeeCC
Q 012392          267 KGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCG  337 (464)
Q Consensus       267 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG  337 (464)
                       ++|.+++.....     ....+++..+..++.||+.||.|||+.+     |+||||||+|||+    ++++.+||+|||
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence             588888753221     1234888999999999999999999988     9999999999999    567899999999


Q ss_pred             ccccccCCce--eeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----h------
Q 012392          338 LHKLLADDIV--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----S------  403 (464)
Q Consensus       338 l~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----~------  403 (464)
                      +++.......  .......++..|+|||++.+ ..++.++|||||||++|||+||+.||.........     .      
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9986643221  11122346778999999876 45789999999999999999999998642211000     0      


Q ss_pred             ---------hhHHHh---------hhhhcCCCC------------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          404 ---------ATFENF---------IDRNLKGKF------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       404 ---------~~~~~~---------~~~~~~~~~------------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                               ..+...         .........            .......+.+++.+|++.||.+|||++|++++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                     000000         000000000            0112345788999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-39  Score=293.30  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=206.5

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc----h---HHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----S---EEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~---~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      ..+.|...+.||.|..+.|-++..+ .|..+|+|.+......    .   ...+-.+|+.+|+++ .||||+.+.+++  
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--   92 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--   92 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--
Confidence            3455777789999999999888765 6888999998754311    1   123456799999999 599999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      +.+...++|+|.|+.|.|.+||...-    .++.....+|++|+.+|++|||.++     ||||||||+|||+|++.++|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~-----IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN-----IVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh-----hhhcccChhheeeccccceE
Confidence            66788999999999999999997543    3888899999999999999999988     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      |+|||++..+....  .....-||++|+|||.+..      ..|+...|.||.||+||-|+.|.+||....+...    +
T Consensus       164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM----L  237 (411)
T KOG0599|consen  164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM----L  237 (411)
T ss_pred             EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH----H
Confidence            99999999876543  2334568999999999853      3478899999999999999999999976544332    2


Q ss_pred             HHhhhhhcCCC--CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          407 ENFIDRNLKGK--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       407 ~~~~~~~~~~~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..++.....-.  .-.+.++...+|+.+|++.||.+|.|++|+++|.+.
T Consensus       238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            22222222222  224667889999999999999999999999998765

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=327.37  Aligned_cols=262  Identities=17%  Similarity=0.238  Sum_probs=195.2

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC------CCCceeeeeE
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR------HENIIRLRGF  249 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~------H~niv~l~g~  249 (464)
                      +++...+++|.+.++||+|+||+||+|... .++.||||.++...  ....++..|+.++..++      |.++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            445556788999999999999999999875 67899999986432  22344556777776665      4568889888


Q ss_pred             EEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCC
Q 012392          250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       250 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      +.. .....++|||++ +++|.+++....    .+++..+..|+.||+.||+|||+ .+     ||||||||+|||++.+
T Consensus       200 ~~~-~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g-----IiHrDlKP~NILl~~~  268 (467)
T PTZ00284        200 FQN-ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH-----LMHTDLKPENILMETS  268 (467)
T ss_pred             EEc-CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEEecC
Confidence            753 345789999998 789999987542    48999999999999999999997 46     9999999999999876


Q ss_pred             C----------------CeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 012392          329 F----------------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV  392 (464)
Q Consensus       329 ~----------------~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p  392 (464)
                      +                .+||+|||++......    .....+|..|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            5                4999999987643221    1234577889999999999999999999999999999999999


Q ss_pred             CcchHHHHHhhhh----------H---------HHhhhhh--cCCCC---------------CHHHHHHHHHHHHHhhhc
Q 012392          393 LTSSMRLAAESAT----------F---------ENFIDRN--LKGKF---------------SESEAAKLGKMALVCTHE  436 (464)
Q Consensus       393 ~~~~~~~~~~~~~----------~---------~~~~~~~--~~~~~---------------~~~~~~~l~~l~~~C~~~  436 (464)
                      |............          +         ..+.+..  +....               .......+.+|+..||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            9653321100000          0         0000000  00000               001235678999999999


Q ss_pred             CCCCCCCHHHHHHHHhhhc
Q 012392          437 DPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       437 dp~~RPs~~evl~~L~~~~  455 (464)
                      ||++|||++|+++|-+...
T Consensus       425 dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        425 DRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             ChhhCCCHHHHhcCccccc
Confidence            9999999999999876543

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-38  Score=302.26  Aligned_cols=251  Identities=22%  Similarity=0.398  Sum_probs=200.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|... +++.||+|.++..... ....++..|+.++++++|+||+++++++  ...+..++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE--VHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE--ecCCEEEEEE
Confidence            4677789999999999999865 6889999998765532 3557789999999999999999999987  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus        79 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          79 EYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             ecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccccccccc
Confidence            9999999999997532    3788899999999999999999988     999999999999999999999999998876


Q ss_pred             cCCceeee---eccCCCCccCcccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          343 ADDIVFSV---LKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       343 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ........   ....++..|+|||++....   ++.++||||||+++||+++|..||.........   ... +......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~-~~~~~~~  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFH-VGAGHKP  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHH-HhcCCCC
Confidence            44322111   1234567899999998766   889999999999999999999998643211111   001 1111122


Q ss_pred             CCCHH--HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          417 KFSES--EAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       417 ~~~~~--~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ..+..  ....+.+++.+||+.+|++||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            22222  36778899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=305.40  Aligned_cols=253  Identities=21%  Similarity=0.417  Sum_probs=202.0

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .|+..+.||+|+||.||+|... ++..||+|.++.........++.+|+.++++++   |||++++++++.  .....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEE
Confidence            4677789999999999999964 789999999876554555567889999999996   999999999884  4567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++...     .+++...+.++.|++.||.|||+.+     |+|+||+|+||++++++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG-----VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            99999999999998642     4899999999999999999999988     9999999999999999999999999988


Q ss_pred             cccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ....... ......++..|+|||.+.++ .++.++|||||||++|+|++|..|+........    . ..+........+
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~-~~~~~~~~~~~~  223 (277)
T cd06917         150 LLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----M-MLIPKSKPPRLE  223 (277)
T ss_pred             ecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----h-hccccCCCCCCC
Confidence            6654321 11223466789999998654 468899999999999999999999865422111    1 111111111111


Q ss_pred             H-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 E-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~-~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      . ..+..+.+++.+||+.||++||++.+++++-+...
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         224 DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            1 25678999999999999999999999998766543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=308.29  Aligned_cols=256  Identities=19%  Similarity=0.374  Sum_probs=194.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.+ +++.||||.+...........+.+|+.++++++|+||+++++++  ......++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII--HTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE--ecCCeEEEEE
Confidence            45778899999999999999976 68999999987544333334577899999999999999999998  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ ++|.+++.....   .+++.....++.|+++||.|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          83 EYLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             ecCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            9997 599999875432   4889999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh---------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---------  412 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------  412 (464)
                      ..... ......++..|+|||++.+ ..++.++||||||+++|||++|..||................+..         
T Consensus       154 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         154 SVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            32111 1112234667999998865 457899999999999999999999986432111100000000000         


Q ss_pred             ---------hcCC--------CC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          413 ---------NLKG--------KF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       413 ---------~~~~--------~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                               ....        .. .......+.+++..|++.+|++|||+.+++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence                     0000        00 001125678999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.5e-39  Score=310.32  Aligned_cols=251  Identities=15%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             ccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          187 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .....||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+||+++++.+.  ..+..++||||+
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~~  101 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFL  101 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeCC
Confidence            33467999999999999865 68899999986543 334556889999999999999999999884  467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++++|.+++...     .+++.++..++.||+.||+|||+.+     |+||||||+||++++++.++|+|||++......
T Consensus       102 ~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658         102 EGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG-----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999988532     3889999999999999999999988     999999999999999999999999998755332


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      .. ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ...+.........  .....+..
T Consensus       172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~  247 (292)
T cd06658         172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRDNLPPRVK--DSHKVSSV  247 (292)
T ss_pred             cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCccc--cccccCHH
Confidence            11 11123356789999999888899999999999999999999999875432111 1111111111111  12234567


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          426 LGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.+++..||+.||++|||+++++++-+..
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence            88999999999999999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-38  Score=301.54  Aligned_cols=254  Identities=20%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|...+.||+|++|.||+|+.. ++..|+||.+..........+|.+|+..+.+++|+||+++++++  ......++|+|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF--YKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--ccCCeEEEEEE
Confidence            5778899999999999999976 58999999988765434567899999999999999999999998  44678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |+++++|.+++...    ..+++..++.++.|+++||+|||+ .+     ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~-----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH-----IIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC-----CccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999999754    348999999999999999999999 88     999999999999999999999999998866


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH-
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES-  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  421 (464)
                      ....... ....++..|+|||.+....++.++||||||+++|||+||..|+...... ........+.. ......+.. 
T Consensus       151 ~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~  227 (264)
T cd06623         151 ENTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICD-GPPPSLPAEE  227 (264)
T ss_pred             ccCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhc-CCCCCCCccc
Confidence            4332111 1223566799999999888999999999999999999999998654310 01111222221 222223334 


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+..+.+++..||+.+|++||++.+++++-+
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence            6788999999999999999999999998744

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.3e-39  Score=310.64  Aligned_cols=256  Identities=18%  Similarity=0.309  Sum_probs=194.3

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|+.. +|..||+|.++..... .....+.+|+.++++++||||+++++++  .+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL--HSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh--ccCCceEEEE
Confidence            3677789999999999999975 6899999998754322 2234678899999999999999999988  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ ++|.+++....   ..+++..+..++.||++||.|||+.+     |+||||||+||+++.++.+||+|||+++..
T Consensus        79 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          79 EYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            9996 58888886532   24899999999999999999999988     999999999999999999999999998865


Q ss_pred             cCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH-------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-------------  408 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-------------  408 (464)
                      ..... ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+............+..             
T Consensus       150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            43211 11223456779999998664 4789999999999999999999886432211110000000             


Q ss_pred             --hhhhhcCCC---------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          409 --FIDRNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       409 --~~~~~~~~~---------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                        ..+......         .....+..+.+++.+||+.||++|||+++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence              000000000         01124567889999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-38  Score=307.02  Aligned_cols=255  Identities=18%  Similarity=0.300  Sum_probs=195.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++.  .....++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v~   79 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLVF   79 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEEE
Confidence            5778899999999999999976 689999998865432 223356789999999999999999999984  466789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|..++...    ..+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++...
T Consensus        80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          80 EYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             eccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCChhhEEEcCCCcEEECccccceec
Confidence            999998888876542    23899999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh---hHHHh-------hh
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENF-------ID  411 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~---~~~~~-------~~  411 (464)
                      ..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...........   .....       .+
T Consensus       151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         151 TGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             CCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence            44321 1112235567999999865 4578999999999999999999999864322111000   00000       00


Q ss_pred             ----------hhcCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 ----------RNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ----------~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                                +......     ....+..+.+++.+||+.||++||++.|++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence                      0000000     012356788999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-38  Score=315.96  Aligned_cols=252  Identities=17%  Similarity=0.262  Sum_probs=191.4

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...+|...+.||+|+||.||+|+.. ++..||+|.....       ....|+.++++++||||+++++++..  ....++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence            3457999999999999999999976 5678999975432       23468999999999999999999854  567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+ .|+|.+++....   ..++|..+..|+.||+.||.|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       135 v~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        135 VLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             EEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEecCcccc
Confidence            99999 579999987533   34899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHH------HHHhhhhHHHhhhhhc
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR------LAAESATFENFIDRNL  414 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~------~~~~~~~~~~~~~~~~  414 (464)
                      ......  ......+|..|+|||++.+..++.++|||||||++|||+++..++.....      .......+...+....
T Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~  283 (357)
T PHA03209        206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK  283 (357)
T ss_pred             ccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            543221  11234477889999999999999999999999999999997665422100      0000011111111000


Q ss_pred             --CCCCC------------------------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          415 --KGKFS------------------------------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       415 --~~~~~------------------------------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ...++                              ...+..+.+++..||+.||++|||+.|+++|-+.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence              00000                              0123345679999999999999999999988653

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-38  Score=319.87  Aligned_cols=254  Identities=16%  Similarity=0.250  Sum_probs=196.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..+|...+.||+|+||.||++...   .+..||||.+...      ..+.+|+.++++++||||+++++++.  .....+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYR--WKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEe--eCCEEE
Confidence            457999999999999999999754   3578999987643      23457999999999999999999884  456799


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+. ++|.+++...    ..+++.+++.++.||+.||.|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       163 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG-----IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             EEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            9999994 7999998432    34899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh--------
Q 012392          340 KLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI--------  410 (464)
Q Consensus       340 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~--------  410 (464)
                      +....... .......+|..|+|||++....++.++|||||||++|||++|+.||....... ....+..++        
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCcc
Confidence            76543321 11223457889999999999999999999999999999999999986431100 000000000        


Q ss_pred             -----------------hhhcCCCCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          411 -----------------DRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       411 -----------------~~~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                                       ....+....       ......+.+++.+||+.||++|||+.|++.+-+...
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                             000011110       122456788999999999999999999999876653

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-38  Score=305.84  Aligned_cols=258  Identities=20%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++++|...+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++|+||+++.+++.  .....++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEE
Confidence            4567888999999999999999865 688999999876543333456788999999999999999999984  4567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+. ++|.+++....   ..+++..+..++.|++.||+|||+.+     |+|+||||+||+++.++.+||+|||+++
T Consensus        81 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             EEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEEcCCCcEEEecccccc
Confidence            999995 78888775432   23788888999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH-----------
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-----------  408 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-----------  408 (464)
                      ....... ......++..|+|||.+.+. .++.++|||||||++|||+||..||...............           
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         152 AKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             ccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence            5432211 11222356789999998754 5788999999999999999999998653321110000000           


Q ss_pred             -------hhhhhcCCCCC---------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          409 -------FIDRNLKGKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       409 -------~~~~~~~~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                             ..........+         ......+.+++.+|++.||.+|||+.|++.+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~  289 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP  289 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence                   00000000000         01245788999999999999999999998763

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.1e-39  Score=309.76  Aligned_cols=255  Identities=22%  Similarity=0.362  Sum_probs=196.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.++||||+++++++  ...+..++|+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc--ccCCeEEEEE
Confidence            5778899999999999999986 5899999987654322 2345688999999999999999999998  4567899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|..+....    ..++|..+..++.||+.||+|||+.+     ++|+||+|+||++++++.++|+|||++...
T Consensus        80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          80 EFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             ecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            999999998876543    23899999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH----------HHhhh
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------ENFID  411 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~----------~~~~~  411 (464)
                      ..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+.............          ....+
T Consensus       151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         151 AAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             cCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence            43221 1112235677999999865 457889999999999999999998886432211000000          00000


Q ss_pred             ------hhcCCC---------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 ------RNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ------~~~~~~---------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                            ......         .....+..+.+++.+||+.+|++||++.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  284 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE  284 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence                  000000         0123456799999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=301.60  Aligned_cols=254  Identities=20%  Similarity=0.252  Sum_probs=208.6

Q ss_pred             CccccccccCCceEEEEEEECC-CcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |..++.||.|.-|+||++++++ +..+|+|++.+....  ....+...|-+||+.++||.++.|++.+  +.....++||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~m  156 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVM  156 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEE
Confidence            4556889999999999999874 589999999865422  2234567799999999999999999998  6678899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |||+||+|...++...+  ..++...+..++.+|+.||+|||-.|     ||+|||||+||||.++|++.|+||.|+...
T Consensus       157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG-----ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG-----IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc-----eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999886554  44999999999999999999999999     999999999999999999999999997654


Q ss_pred             cCCce------------------------------e-e------------------------eeccCCCCccCccccccc
Q 012392          343 ADDIV------------------------------F-S------------------------VLKTSAAMGYLAPEYVTT  367 (464)
Q Consensus       343 ~~~~~------------------------------~-~------------------------~~~~~~~~~y~aPE~~~~  367 (464)
                      .....                              . .                        ...-.||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            21000                              0 0                        001134556999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC----
Q 012392          368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT----  443 (464)
Q Consensus       368 ~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs----  443 (464)
                      ...+..+|+|+|||+||||+.|..||.+...    ..++.+++.+.+.-.-....+....+|+...|.+||.+|.-    
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG  385 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG  385 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence            9999999999999999999999999987653    45566776665554444466788999999999999999998    


Q ss_pred             HHHHHHHHh
Q 012392          444 MEAVIEELT  452 (464)
Q Consensus       444 ~~evl~~L~  452 (464)
                      +.||-+|-.
T Consensus       386 A~eIK~HpF  394 (459)
T KOG0610|consen  386 AAEIKRHPF  394 (459)
T ss_pred             hHHhhcCcc
Confidence            888887754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-38  Score=309.48  Aligned_cols=252  Identities=15%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             cccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      ....||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++++.  ..+..++|+||++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv~e~~~  101 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQ  101 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEEEecCC
Confidence            3457999999999999865 68999999987544 233456889999999999999999999884  3677999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      +++|..++..     ..+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++.......
T Consensus       102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            9999998754     23889999999999999999999988     9999999999999999999999999987554322


Q ss_pred             eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--CCCCCHHHHH
Q 012392          347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGKFSESEAA  424 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  424 (464)
                      . ......++..|+|||++.+..++.++|||||||++|||++|+.|+........    ... +....  ........+.
T Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~  245 (297)
T cd06659         172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKR-LRDSPPPKLKNAHKISP  245 (297)
T ss_pred             c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HhccCCCCccccCCCCH
Confidence            1 11223466789999999888899999999999999999999999864332111    111 11111  1111223456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      .+.+++..||+.+|++||++.+++++-+.....+
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            7899999999999999999999999876665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=302.90  Aligned_cols=259  Identities=22%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEecc-CCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe---CCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS---RGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~---~~~~~~  258 (464)
                      ..|...+.||+|+||.|+.+..+ +|..||||.+.. -......++-.+|+++|+.++|+||+.+...+..   ..-+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            44555688999999999999875 789999998872 2224455678899999999999999999988743   223569


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |+|+|+| ..||.+.++...    .|+......++.|+++||.|+||-+     |+||||||.|+|++.+...||+|||+
T Consensus       102 YiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn-----ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN-----VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc-----ccccccchhheeeccCCCEEeccccc
Confidence            9999999 669999997543    3888888999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCc-eeeeeccCCCCccCcccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh-------------
Q 012392          339 HKLLADDI-VFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-------------  403 (464)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~-------------  403 (464)
                      |+...... ....+.-..|.-|.|||.+. ...|+...||||.||++.||++|++.|.+........             
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            99875321 11123334667799999985 4679999999999999999999999887643221110             


Q ss_pred             ------hhHHHhhhhhcC-CCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          404 ------ATFENFIDRNLK-GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       404 ------~~~~~~~~~~~~-~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                            ......+..... ...     -........+|+.+++..||.+|+|++|.++|.-
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence                  111112211110 011     1244567889999999999999999999998854

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-38  Score=306.07  Aligned_cols=257  Identities=20%  Similarity=0.293  Sum_probs=199.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|+.. +|+.||||.+..... ......+.+|+.++++++||||+++++++.  .....++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeEEEe
Confidence            3677789999999999999975 789999999876542 233467899999999999999999999984  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+ +++|.+++....   ..+++.++..++.||+.||+|||+.+     ++|+||||+||++++++.++|+|||++...
T Consensus        79 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          79 EYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG-----IMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             ccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            999 999999987543   34899999999999999999999988     999999999999999999999999998876


Q ss_pred             cCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh-----------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----------  410 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-----------  410 (464)
                      ............++..|+|||.+.+. .++.++||||+|+++|||+||..++................-           
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            54321112233467789999998654 468899999999999999999777754332111111000000           


Q ss_pred             ---------hhhcCC----CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          411 ---------DRNLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       411 ---------~~~~~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                               ......    .........+.+++.+|++.||++||++++++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence                     000000    001133578899999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-38  Score=308.68  Aligned_cols=254  Identities=18%  Similarity=0.264  Sum_probs=197.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||++... .++.||+|.+.....  ......+.+|+.+++.++||||+++++.+  ...+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ecCCEEEE
Confidence            35788899999999999999975 578999999875432  22345788999999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.+     ++||||||+||++++++.+||+|||+++
T Consensus        79 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          79 VMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999999996542    3889999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCce--------------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          341 LLADDIV--------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       341 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      .......              .......++..|+|||++....++.++|+||||+++|||++|..|+.+....    ..+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~  225 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELF  225 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH
Confidence            4211100              0001123566799999998888999999999999999999999998754221    111


Q ss_pred             HHhhhhhcC-CCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHHh
Q 012392          407 ENFIDRNLK-GKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELT  452 (464)
Q Consensus       407 ~~~~~~~~~-~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~L~  452 (464)
                      ......... .......+..+.+++.+||+.||++||+   +.+++++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            121111111 1111245677899999999999999998   566665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=294.58  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=206.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +.|+..+.||+|.|+.||++... .|+.+|+|.++... .....++..+|+.+-..++||||++|...+  .+.+..+||
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ylv   88 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLV   88 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEEE
Confidence            34566688999999999998754 78899999876532 233456788899999999999999999877  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEeeCCc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfGl  338 (464)
                      +|+|.+|+|..-+-.+.    .+++...-..++||+++|.|+|.++     |||||+||+|+||-+   .--+||+|||+
T Consensus        89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~-----IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNG-----IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeeeeccCCCceeecccce
Confidence            99999999987776542    3677788899999999999999998     999999999999954   34589999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--C
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--G  416 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  416 (464)
                      +..+.+..  ......||++|||||++...+|+..+|||+.||+||-|+.|.+||.+...    ...+++++.....  +
T Consensus       160 Ai~l~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  160 AIEVNDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPS  233 (355)
T ss_pred             EEEeCCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCC
Confidence            99887433  34566789999999999999999999999999999999999999987432    2334444433322  2


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..-....++..+|+.+|+..||.+|.|+.|.++|.|-
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence            2334566788999999999999999999999988764

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=316.60  Aligned_cols=258  Identities=19%  Similarity=0.279  Sum_probs=196.7

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----  254 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----  254 (464)
                      ...++|...+.||+|+||.||+|... ++..||||.+..... ......+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34567899999999999999999864 688999999875421 123356788999999999999999998764321    


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ....++++|++ +++|.+++..     ..+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG-----IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChhhEEECCCCCEEEc
Confidence            23578999998 8899988753     23899999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh--------
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--------  405 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~--------  405 (464)
                      |||+++......    ....++..|+|||++.+ ..++.++|||||||++|||++|..||............        
T Consensus       161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998654421    22346778999999876 56889999999999999999999998643211100000        


Q ss_pred             -----------HHHhhhhhcCCCCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 -----------FENFIDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 -----------~~~~~~~~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                 ...... .+.....       ......+.+++.+|++.||++|||+.|++++-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         237 PEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             HHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                       000000 0000000       01234578999999999999999999999986544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=322.79  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEecc---CCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINV---TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .+||+|+|-+||||... +|..||.-.++.   .......+.|..|+.+|+.|+||||++++.++.+..+...-+|+|.|
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            67999999999999875 688888544332   23344457899999999999999999999998887777889999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEeeCCccccccC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKLLAD  344 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGl~~~~~~  344 (464)
                      ..|+|..|+...+.    ++...+.++++||++||.|||++.   |||||||||..||+|+.+ |.+||+|+|||.....
T Consensus       126 TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~---PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD---PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC---CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999987543    788899999999999999999975   999999999999999855 8999999999998765


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      ....   ...||+.|||||+.. ..|++..||||||+.++||+|+.-||..-...   ...++.++....+..+..-...
T Consensus       199 s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  199 SHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---AQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             cccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---HHHHHHHHcCCCHHHhhccCCH
Confidence            4322   257899999999887 78999999999999999999999999754322   2233343333222222223356


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ++.+++..|+.. .++|||+.|+|++-..
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff  299 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFF  299 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence            799999999998 8899999999987543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=312.51  Aligned_cols=256  Identities=20%  Similarity=0.328  Sum_probs=214.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch--HHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~  258 (464)
                      ...|...+.||+|.||.||+++.+ +|+.+|+|.+.......  ....+.+|+.+|+++. |||||.+.+.+  +....+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~~~  111 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPDSV  111 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCCeE
Confidence            345777789999999999999977 49999999998654322  3357889999999998 99999999998  557789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC----CCeEEe
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIA  334 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~  334 (464)
                      ++|||++.+|.|.+.+...    . ++......++.||+.++.|||+.+     |+||||||+|+|+...    +.+|++
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~g-----vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSLG-----VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCHHHeeeccccCCCCcEEEe
Confidence            9999999999999999875    2 899999999999999999999988     9999999999999643    479999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |||++......  .......||+.|+|||++....|+..+||||.||++|.|++|..||.......    ....+.....
T Consensus       182 DFGla~~~~~~--~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~----~~~~i~~~~~  255 (382)
T KOG0032|consen  182 DFGLAKFIKPG--ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE----IFLAILRGDF  255 (382)
T ss_pred             eCCCceEccCC--ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH----HHHHHHcCCC
Confidence            99999987762  24455678999999999999999999999999999999999999998764322    2223333322


Q ss_pred             --CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          415 --KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       415 --~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                        ....-...++.+.+++..++..||.+|+|+.++++|.|....
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence              223345668889999999999999999999999999875543

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-37  Score=305.80  Aligned_cols=255  Identities=19%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |...+.||+|+||.||+++.. ++..||+|.+.....  .....++.+|+.++++++|||++++++++..  ....++||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  104 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVM  104 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEE
Confidence            566788999999999999965 688999999875432  2234578899999999999999999999844  56789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ |+|.+++....   ..++|.++..++.|++.||.|||+.+     |+||||+|+||+++.++.+||+|||++...
T Consensus       105 e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         105 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             eCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            9996 58888876432   34899999999999999999999988     999999999999999999999999998754


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ...     ....++..|+|||++.   .+.++.++|||||||++|||++|+.|+......    .....+..........
T Consensus       176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  246 (317)
T cd06635         176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPTLQS  246 (317)
T ss_pred             CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhccCCCCCC
Confidence            432     1234567799999973   456889999999999999999999998653211    1122222222222223


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT  460 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~  460 (464)
                      ...+..+.+++.+||+.+|++||++.+++++++.......+
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            45567899999999999999999999999998876655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-38  Score=304.36  Aligned_cols=251  Identities=16%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .|...+.||+|++|.||++... +++.|++|.+.... ......+.+|+.+++.++||||+++++++.  ..+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEe
Confidence            3555689999999999999864 78899999886543 334456889999999999999999999884  4677999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++++|.+++...     .+++..+..++.|++.||+|||+.+     |+||||+|+||++++++.++|+|||++....
T Consensus        97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648          97 FLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG-----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            99999999998752     3889999999999999999999988     9999999999999999999999999887554


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--CCHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSES  421 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  421 (464)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+........    ...+. ......  ....
T Consensus       167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~  240 (285)
T cd06648         167 KEVPR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIR-DNLPPKLKNLHK  240 (285)
T ss_pred             cCCcc-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHH-hcCCCCCccccc
Confidence            32211 1223466789999999888899999999999999999999999865332111    11111 111111  1222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+.+++.+||+.+|++||++.+++++-+..
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  273 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA  273 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence            557899999999999999999999999875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-38  Score=299.89  Aligned_cols=252  Identities=18%  Similarity=0.370  Sum_probs=201.1

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||+|... +|..||+|.+..... ......+.+|+.++++++|+||+++++.+  ......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF--QENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee--ccCCeEEEEE
Confidence            4677889999999999999976 688999999875432 23345688999999999999999999988  4567899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~~  341 (464)
                      ||+++++|.+++.....  ..+++..+..++.|++.||.|||+.+     ++|+||||+||++++++ .+||+|||.+..
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          79 EYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEcCCCCeEEecccccchh
Confidence            99999999999976432  34899999999999999999999988     99999999999999885 469999999876


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...... ......++..|+|||++....++.++||||||+++|||++|..|+......    .......... .......
T Consensus       152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~~~~~  225 (257)
T cd08225         152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKICQGY-FAPISPN  225 (257)
T ss_pred             ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhccc-CCCCCCC
Confidence            644321 111234667799999998888999999999999999999999998643221    1112222211 1122334


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+..+.+++.+||+.+|++|||+.+++++.
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            556799999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-39  Score=317.48  Aligned_cols=245  Identities=20%  Similarity=0.262  Sum_probs=188.2

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC---CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ||+|+||+||+|+.. +++.||||.+.....  ......+..|..++...   +||||+++++.+  ......++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEcCC
Confidence            699999999999875 689999999864321  12233456677777655   699999999887  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          79 SGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD-----IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            9999999987532    3889999999999999999999988     999999999999999999999999998754221


Q ss_pred             ceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      .. ......++..|+|||.+.+. .++.++|||||||++|||+||+.||.......    .+..+....... .....+.
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~-~~~~~~~  223 (330)
T cd05586         150 NK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRF-PKNVLSD  223 (330)
T ss_pred             CC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCC-CCccCCH
Confidence            11 11223477889999998754 47899999999999999999999987543211    111111111111 1123456


Q ss_pred             HHHHHHHHhhhcCCCCCC----CHHHHHHHHhh
Q 012392          425 KLGKMALVCTHEDPENRP----TMEAVIEELTV  453 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RP----s~~evl~~L~~  453 (464)
                      .+.+++.+||+.||++||    ++.+++++.+.
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~  256 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF  256 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence            788999999999999998    68888876553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-38  Score=299.96  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             CCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+......     .....+.+|+.++++++|+||+++++++  ...+..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~   78 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--CEDSHF   78 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--ccCCeE
Confidence            366778999999999999986 47899999998753311     1245788999999999999999999998  456789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCC
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCG  337 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG  337 (464)
                      ++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++ .+||+|||
T Consensus        79 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~-----i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ-----IIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEcccc
Confidence            99999999999999997532    4889999999999999999999998     99999999999998775 59999999


Q ss_pred             ccccccCCceee---eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          338 LHKLLADDIVFS---VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       338 l~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      ++..........   .....++..|+|||.+.+..++.++||||+|+++|||++|..|+........ ............
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~  228 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATT  228 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCC
Confidence            987665431110   1112356789999999888899999999999999999999999864321111 111111111122


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ....+......+.+++.+||+.+|++||++.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence            3345556778899999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.9e-38  Score=304.81  Aligned_cols=256  Identities=20%  Similarity=0.369  Sum_probs=194.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+|+.. +++.||||.++.... ......+.+|+.++++++||||+++++++  ......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc--ccCCcEEEEe
Confidence            4778899999999999999875 688999998875432 22235688999999999999999999998  4467799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||+++..
T Consensus        79 e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          79 EFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             eccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            9995 689999876432  34899999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------------  409 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~------------  409 (464)
                      ..... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+................            
T Consensus       151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            43211 111223466799999886544 5889999999999999999999986543211110000000            


Q ss_pred             -----hhhhcCC--C----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          410 -----IDRNLKG--K----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       410 -----~~~~~~~--~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                           .......  .    ........+.+++.+||+.||++||++++++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  282 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP  282 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence                 0000000  0    0112345678999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-38  Score=304.55  Aligned_cols=248  Identities=20%  Similarity=0.314  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||++... +++.||+|.+.....  ......+.+|++++++++||||+++++++.  ..+..++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEE
Confidence            35778899999999999999875 689999999865321  233456889999999999999999999884  4677999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.+||+|||+++
T Consensus        79 v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          79 VMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            999999999999997642    4889999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .....    .....++..|+|||.+.+...+.++||||||+++|||++|..|+......    .........  ....+.
T Consensus       150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~--~~~~~~  219 (290)
T cd05580         150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKILEG--KVRFPS  219 (290)
T ss_pred             ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcC--CccCCc
Confidence            76543    12234667899999998888899999999999999999999998654321    111222211  223344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ..+..+.+++.+||+.||.+|+     +++|++++.+
T Consensus       220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence            4567899999999999999999     8888887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.9e-38  Score=301.93  Aligned_cols=258  Identities=18%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..++.|...+.||+|+||.||+|... ++..|++|.+.....  ....+.+|++++++++|+|++++++.+..  ....+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEE
Confidence            34566777889999999999999986 688999999876542  45678899999999999999999998854  57899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++++|.+++....   ..+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g-----i~H~dl~p~ni~i~~~~~~~l~d~~~~  163 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFA  163 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCChhhEEEcCCCCEEECccchh
Confidence            9999999999999998653   24999999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC-CC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  418 (464)
                      ........ ......++..|++||.+.+..++.++|||||||++|||++|..|+.......    ............ ..
T Consensus       164 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  238 (286)
T cd06614         164 AQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFLITTKGIPPLKN  238 (286)
T ss_pred             hhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCcc
Confidence            75543211 1112235567999999988889999999999999999999999986533211    111111111111 11


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ....+..+.+++.+||+.+|.+||++.+++++.+...
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            2235678999999999999999999999998776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-38  Score=297.69  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+++.. ++..+|+|.+.... ......++.+|+.++++++|+||+++++++..  ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence            3677889999999999999865 78899999987643 23345678899999999999999999998843  57899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++.........+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            999999999999775433456899999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ....   .....++..|++||.+.+..++.++|+||||+++|||++|+.|+......     .+...+........+...
T Consensus       154 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  225 (256)
T cd08530         154 KKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKVQRGKYPPIPPIY  225 (256)
T ss_pred             ccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCCCCCchhh
Confidence            5441   11234567899999999888999999999999999999999998654321     111222222333344567


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      +..+.+++.+||+.+|++||++.+++++.
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence            78899999999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.8e-38  Score=299.10  Aligned_cols=247  Identities=18%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||.|+||.||+++.. +++.||+|.+.....  ......+.+|+.++++++||||+++++++.  .....++|+||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence            689999999999976 588999999875432  234467899999999999999999999884  456789999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 ~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~-----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          79 ELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG-----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             cHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            9999997542    3888999999999999999999988     9999999999999999999999999998765432  


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......++..|++||.+....++.++|+||||+++|||++|..|+......  .......+.........+...+..+.+
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKD  225 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHH
Confidence            111224567799999998888999999999999999999999999754310  111222233222334445555788999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          429 MALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       429 l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      ++..||+.+|++||+     ++|++++-+.
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            999999999999999     8999887654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4e-38  Score=305.69  Aligned_cols=253  Identities=16%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|...+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++.  ..+..++|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYL--VGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheee--eCCcEEEEE
Confidence            56778899999999999999864 67899999986543 334467889999999999999999999984  356799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||+.+     ++|+||||+||+++.++.+||+|||++...
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g-----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            999999999999643     3789999999999999999999988     999999999999999999999999998755


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh-hhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  421 (464)
                      ..... ......++..|+|||.+....++.++||||||+++||+++|..||........    +.... ........+..
T Consensus       166 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~  240 (293)
T cd06647         166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEK  240 (293)
T ss_pred             ccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----eeehhcCCCCCCCCccc
Confidence            43221 11122466779999999888899999999999999999999999965422110    00010 11111112234


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+.+++..||+.+|++||++.+++.+-+..
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            456789999999999999999999999885543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=304.88  Aligned_cols=255  Identities=20%  Similarity=0.364  Sum_probs=197.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|+||.||+|... +++.||||.++.... ......+.+|+.++++++|+||+++++++..  .+..++|+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence            5788899999999999999976 578999998875432 2334678899999999999999999999854  66799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++++.+..++...    ..+++..+..++.||+.||+|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus        80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          80 EYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             ecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            999987776665432    23889999999999999999999988     999999999999999999999999998876


Q ss_pred             cCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh-----------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----------  410 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-----------  410 (464)
                      ............++..|+|||++... .++.++||||||+++|||++|..|+......... .......           
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhc
Confidence            54321111123355679999999887 7899999999999999999999888643221100 0000000           


Q ss_pred             --hhhcC--------------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          411 --DRNLK--------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       411 --~~~~~--------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                        +....              ..++...+.++.+++.+||+.+|++||++++++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  286 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP  286 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence              00000              011122367899999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6e-38  Score=304.89  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      +|...+.||+|+||.||+|... +++.||||.++.....    .....+..|++++++++|+||+++++++..  .+..+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~   78 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN   78 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence            3667789999999999999975 6899999999765422    123457789999999999999999999844  67899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+ +|+|.+++....   ..+++..+..++.||++||.|||+.+     |+|+||||+||+++.++.+||+|||++
T Consensus        79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCChhhEEEcCCCCEEEccceee
Confidence            999999 999999997543   24899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh---------
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF---------  409 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~---------  409 (464)
                      +....... ......++..|+|||.+.+ ..++.++|||||||++|||++|..++................         
T Consensus       150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            86643211 1112234567999998854 457899999999999999999977665432211111111000         


Q ss_pred             --------hhhhcCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          410 --------IDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       410 --------~~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                              .........     ....+..+.+++.+||+.||++|||+.|++++-+.....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                    000000000     123357789999999999999999999999986554433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=296.68  Aligned_cols=254  Identities=19%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .+|...+.||+|+||.||+|+.. ++..||+|.+....    .......|.+|+.++++++|+||+++++++........
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            45778899999999999999865 68999999875421    12334578899999999999999999998865545678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++++|.+++....    .+++.....++.|++.||.|||+.+     ++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcccc
Confidence            89999999999999987532    3788899999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++.......  .......++..|+|||++.+..++.++|||||||++|||++|+.||......    ....+........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~  228 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKIATQPTKP  228 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHHHHcCCCCC
Confidence            986532110  0111233667899999998888999999999999999999999998754221    1122222222334


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..+....+.+.+++..||+ +|..||++.+++.+.
T Consensus       229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            4566777889999999999 579999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=320.19  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=203.1

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      -+||+|.||+||-|+.. +...+|||.+.... .+..+-...|+.+-++++|.|||+++|.|  ..++..-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCC
Confidence            37999999999999976 46679999987654 34455678899999999999999999988  5577888999999999


Q ss_pred             CHHHHhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCccccccCC
Q 012392          269 KLSKYLDQEEGSSNVL--DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~~~~~~  345 (464)
                      ||.+.|+..-+   ++  .+.++-.+-.||++||.|||++.     |||||||-.|||++ -.|.+||+|||-++.+..-
T Consensus       658 SLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~-----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  658 SLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK-----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             cHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc-----eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            99999987654   35  67888889999999999999998     99999999999997 4689999999999877542


Q ss_pred             ceeeeeccCCCCccCcccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ... +....||..|||||++..+  .|...+|||||||++.||.||++||..........   .++---...+.+|++.+
T Consensus       730 nP~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmyKvHP~iPeels  805 (1226)
T KOG4279|consen  730 NPC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMYKVHPPIPEELS  805 (1226)
T ss_pred             Ccc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhcceecCCCCcHHHH
Confidence            221 2234588999999999765  48889999999999999999999997543322221   11111224567889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+...++++|+.+||.+||++.++++..
T Consensus       806 aeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  806 AEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             HHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            9999999999999999999999999764

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-38  Score=300.56  Aligned_cols=250  Identities=21%  Similarity=0.295  Sum_probs=203.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +|...+.||.|+||.||+|+.. ++..||+|.+.....  ....+.+.+|+.++++++||||+++++.+  ......++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence            4777899999999999999976 688999999875432  23456789999999999999999999987  556789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+++++|.+++...    ..+++..+..++.|+++||.|||+.+     ++|+||+|+||++++++.++|+|||++..
T Consensus        79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG-----IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            9999999999999754    24889999999999999999999988     99999999999999999999999999886


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .....  ......++..|+|||.+....++.++|+||||+++|+|++|..|+......  ....+...... .....+..
T Consensus       150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~~~~  224 (258)
T cd05578         150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET-ADVLYPAT  224 (258)
T ss_pred             cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-ccccCccc
Confidence            64432  122334667799999998888999999999999999999999998754321  01111111111 23344555


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCH--HHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTM--EAVIEE  450 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~--~evl~~  450 (464)
                      .+..+.+++.+||+.||.+||++  +|++++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            67889999999999999999999  777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.1e-38  Score=303.71  Aligned_cols=257  Identities=18%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.++.+++||||+++++++........++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            35777889999999999999976 6889999998754322 223457789999999999999999999865544789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||++ ++|.+++....   ..+++..+..++.||+.||+|||+.+     ++|+||||+||++++++.+||+|||+++.
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCcEEEeecCceee
Confidence            99996 59999987543   24899999999999999999999988     99999999999999999999999999886


Q ss_pred             ccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH-----------h
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-----------F  409 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-----------~  409 (464)
                      ...... ......++..|+|||.+.+. .++.++|+||||+++|||++|..|+...............           .
T Consensus       156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            654311 11123356779999998654 4688999999999999999999988653221111100000           0


Q ss_pred             --------------hhhhcCCCCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          410 --------------IDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       410 --------------~~~~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                                    ....+...++.. ..+.+.+++..||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                          000001111111 36678899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-37  Score=299.92  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=193.4

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|+||.||+|+.. +++.||+|.++............+|+..+.++. |+|++++++++.....+..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999865 688999999876432333345567899999985 999999999986544478999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |++ |+|.+++....   ..++|.++..++.|++.||+|||+.+     ++||||+|+||+++. +.+||+|||+++...
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            996 68888886533   34899999999999999999999988     999999999999999 999999999998664


Q ss_pred             CCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh----------hHHHhhhh
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------TFENFIDR  412 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~----------~~~~~~~~  412 (464)
                      .....  ....++..|+|||++.. +.++.++|||||||++|||++|..|+...........          .+......
T Consensus       151 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         151 SKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             cCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            33221  12235677999997644 5578899999999999999999999865322110000          00000000


Q ss_pred             hc--CCCC-----------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          413 NL--KGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       413 ~~--~~~~-----------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..  ....           ....+..+.+++.+||+.+|++||++++++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~  280 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP  280 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence            00  0000           123468899999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=300.02  Aligned_cols=256  Identities=23%  Similarity=0.403  Sum_probs=196.3

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.++++++|+|++++++++.....+..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999976 58899999998653 2233456889999999999999999999985543368999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |++ ++|.+++....   ..+++..+..++.||++||+|||+.+     ++|+||+|+||++++++.+||+|||++....
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~-----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            997 49999886542   34899999999999999999999988     9999999999999999999999999998665


Q ss_pred             CCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh-----------
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-----------  411 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------  411 (464)
                      ...........++..|+|||.+.+ ..++.++||||||+++|||+||+.|+........... +.....           
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELCGSPTDENWPGVS  230 (287)
T ss_pred             CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchhhccccc
Confidence            432111222334567999998764 4578999999999999999999999865432111110 000000           


Q ss_pred             -----hhcC----------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 -----RNLK----------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 -----~~~~----------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                           ....          ......++..+.+++.+||+.+|++||++++++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence                 0000          000111266789999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-37  Score=302.10  Aligned_cols=255  Identities=17%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             cCCccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|...+ ++.||||.++.........++..|+.++.+.. ||||+++++++.  .....++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEEE
Confidence            346677899999999999999874 89999999976544445566778888777775 999999999984  46679999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||++ ++|.+++....   ..+++..+..++.||+.||+|||+. +     |+||||+|+||++++++.+||+|||++.
T Consensus        93 ~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~-----i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             eeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC-----EecCCCcHHHEEEcCCCCEEECccccch
Confidence            99984 57877775533   2589999999999999999999974 5     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ........  ....++..|+|||++....    ++.++||||||+++|||++|+.|+......   ...+..........
T Consensus       164 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~  238 (296)
T cd06618         164 RLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPS  238 (296)
T ss_pred             hccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCC
Confidence            65432211  1233567799999987543    788999999999999999999998653211   11122222221111


Q ss_pred             -CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 -~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ......+.++.+++.+||+.||++||++.+++++.+..
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence             11123567899999999999999999999999887643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-37  Score=299.47  Aligned_cols=248  Identities=19%  Similarity=0.272  Sum_probs=190.5

Q ss_pred             ccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHH---hcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          191 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLL---TSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l---~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +||+|+||.||++... +++.||||.+......  .....+.+|..++   ...+||||+.+++++.  ..+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence            4899999999999875 6899999988654321  2223344554433   3447999999998884  35678999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.++|+|||++.....
T Consensus        79 ~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          79 MNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            99999999987532    4899999999999999999999988     99999999999999999999999999875543


Q ss_pred             CceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ..   .....++..|+|||.+.. ..++.++|||||||++|||++|..||.......  ...+... ........+...+
T Consensus       150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~~  223 (279)
T cd05633         150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRM-TLTVNVELPDSFS  223 (279)
T ss_pred             cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHH-hhcCCcCCccccC
Confidence            21   122346788999999864 557899999999999999999999986432110  0111111 1112233445567


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhhc
Q 012392          424 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVAA  455 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~~  455 (464)
                      ..+.+++..||+.||++||     ++++++++.+...
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            7899999999999999999     6999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-37  Score=299.37  Aligned_cols=248  Identities=20%  Similarity=0.280  Sum_probs=195.2

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||+|+||+||++... +|+.||+|.+.....  ......|..|++++++++||||+++++.+  ...+..++|+||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE--ecCCeEEEEEecCCCC
Confidence            689999999999865 689999999865321  22345678899999999999999999988  4467899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++.....  ..+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.+||+|||++.......  
T Consensus        79 ~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  149 (277)
T cd05577          79 DLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--  149 (277)
T ss_pred             cHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence            99999976542  34899999999999999999999988     9999999999999999999999999987654321  


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......++..|+|||++.++.++.++|||||||++|+|++|+.||......... ..+..... ......+...+..+.+
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  227 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELKRRTL-EMAVEYPDKFSPEAKD  227 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHHhccc-cccccCCccCCHHHHH
Confidence            112233566799999998888999999999999999999999998654321111 11111111 1122233445778999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          429 MALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       429 l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ++.+||+.||++||     ++.+++++.+
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhChh
Confidence            99999999999999     7777887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-37  Score=299.88  Aligned_cols=256  Identities=22%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +|+..+.||.|++|.||+|+.. +|..||||.++..........+.+|+.++++++||||+++++++..  .+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence            4778899999999999999986 6889999998865434344567889999999999999999999844  567899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |++ |+|.+++..... ...+++..+..++.|+++||+|||+.+     ++||||||+||++++++.++|+|||+++...
T Consensus        79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          79 YMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR-----VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             cCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            997 589998875432 235899999999999999999999988     9999999999999999999999999987654


Q ss_pred             CCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH-----------HHhhh
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-----------ENFID  411 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~-----------~~~~~  411 (464)
                      .... ......++..|++||.+.+ ..++.++|||||||++|||++|+.|+.............           ..+..
T Consensus       152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            3211 1112335677999998865 457889999999999999999999986543211111100           00000


Q ss_pred             -hhcCCC-----------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          412 -RNLKGK-----------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       412 -~~~~~~-----------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                       +.....           .....+..+.+++..|++.||++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             000000           011235678899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-37  Score=301.40  Aligned_cols=260  Identities=19%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCC---CeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR---GEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~---~~~  258 (464)
                      +|+..+.||+|+||.||+|+.. +++.||||.++..... .....+.+|+.++++++ ||||+++++++.....   ...
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5788899999999999999975 6899999987654322 22356888999999995 6999999998754322   137


Q ss_pred             EEEEecCCCCCHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeC
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADC  336 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df  336 (464)
                      ++||||+++ +|.+++...... ...+++..+..++.||+.||.|||+.+     |+||||||+||+++. ++.+||+||
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEecCCCeEEEeec
Confidence            999999975 899998754332 345899999999999999999999988     999999999999998 899999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh--
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--  413 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  413 (464)
                      |+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..|+..................+.  
T Consensus       156 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         156 GLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             ccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99876533211 1112234567999998865 4578999999999999999999998865432211111000000000  


Q ss_pred             -------------cCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          414 -------------LKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       414 -------------~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                                   ...       ......+..+.+++..||+.||++||++.|++.+-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~  292 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP  292 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence                         000       00123456789999999999999999999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.3e-37  Score=290.06  Aligned_cols=247  Identities=23%  Similarity=0.430  Sum_probs=200.7

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |...+.||+|++|.||++... ++..+++|.+..... ....++.+|+.++++++|+|++++++++..  ....++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEec
Confidence            566789999999999999986 688999999876543 355689999999999999999999998843  5778999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++++|.+++....   ..+++..+..++.|++.||.|||+.+     ++|+||+|+||++++++.++|+|||.+.....
T Consensus        79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC-----EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            99999999987643   34899999999999999999999988     99999999999999999999999999887654


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH--HH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SE  422 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  422 (464)
                      ...  .....++..|+|||++....++.++||||||+++|+|++|+.|+........    ...... ........  ..
T Consensus       151 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~  223 (253)
T cd05122         151 TKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA----LFKIAT-NGPPGLRNPEKW  223 (253)
T ss_pred             ccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH----HHHHHh-cCCCCcCccccc
Confidence            321  1223456779999999888899999999999999999999999865421111    111111 11111111  22


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +..+.+++.+||+.||++|||+.+++++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            6779999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-37  Score=302.93  Aligned_cols=261  Identities=22%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++++++|+||+++++++.....+..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            46788899999999999999975 68999999987543222 22356789999999999999999999865555678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||++ ++|.+++....   ..+++.++..++.||+.||+|||+.+     ++||||||+||++++++.+||+|||++..
T Consensus        87 ~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          87 MEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccceeee
Confidence            99996 58998887532   34899999999999999999999988     99999999999999999999999999986


Q ss_pred             ccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh----------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----------  410 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~----------  410 (464)
                      ...... .......+..|+|||.+.+ ..++.++|||||||++|||++|..|+........... +....          
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~  235 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL-IIQLLGTPNESIWPG  235 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCChhhchh
Confidence            643211 1112234567999999865 4578999999999999999999999865432211110 00000          


Q ss_pred             --hhh------cCCC-C------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          411 --DRN------LKGK-F------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       411 --~~~------~~~~-~------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                        ...      .... .      ....+..+.+++..|++.||++|||+.+++++.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence              000      0000 0      0113567789999999999999999999999887653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.5e-37  Score=291.09  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=206.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|++|.||+|... ++..|++|.+..... ......+.+|+..+++++||||+++++.+........++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999986 789999999876542 23456789999999999999999999988543226799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999997643    4899999999999999999999988     999999999999999999999999998876


Q ss_pred             cCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...... ......++..|+|||.+....++.++||||||+++|+|++|..|+......   ................+..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  228 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPPEIPEH  228 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCCcCCCcc
Confidence            543210 112234567799999998888999999999999999999999998654311   1111122222233345556


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+..+.+++.+|++.||++||++.+++++-
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence            678999999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=299.42  Aligned_cols=255  Identities=22%  Similarity=0.376  Sum_probs=194.5

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |+..+.||.|++|.||+|... +|..||+|.+...... .....+.+|+.++++++|||++++++++.  ..+..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence            456788999999999999875 7999999998754322 22356889999999999999999999984  4678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+ +++|.+++.....  ..+++..++.++.|+++||+|||+.+     ++||||+|+||++++++.++|+|||+++...
T Consensus        79 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          79 FL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             cc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            99 4799999875432  34899999999999999999999987     9999999999999999999999999997653


Q ss_pred             CCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH---------------
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------------  407 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~---------------  407 (464)
                      .... ......++..|+|||++.+. .++.++||||||+++|||+||+.||..............               
T Consensus       151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            3211 11122346779999988654 578899999999999999999999864432111100000               


Q ss_pred             --HhhhhhcCC------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          408 --NFIDRNLKG------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       408 --~~~~~~~~~------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                        +........      ......+..+.+++.+||+.||++||+++|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  281 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP  281 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence              000000000      01122346788999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.3e-37  Score=291.35  Aligned_cols=253  Identities=19%  Similarity=0.386  Sum_probs=205.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|...+.||+|+||.||++... ++..||+|.+..... .....++.+|++++++++|||++++++.+..  ....++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence            4677789999999999999976 688999999876542 2455678899999999999999999998743  57899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++.........+++..+..++.+++.||.|||+.+     ++|+||+|+||++++++.++|+|||++...
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHHeEEcCCCcEEECCccceeec
Confidence            999999999999875422345999999999999999999999988     999999999999999999999999998866


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||.+....++.++||||+|+++|+|++|..|+......    ........ ......+...
T Consensus       154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~~  227 (258)
T cd08215         154 SSTVD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELALKILK-GQYPPIPSQY  227 (258)
T ss_pred             ccCcc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHHHHhc-CCCCCCCCCC
Confidence            44321 112224566799999998888999999999999999999999998654311    11111121 1223344456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +..+.+++.+||+.+|++||++.+++++
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            7789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=308.98  Aligned_cols=259  Identities=20%  Similarity=0.323  Sum_probs=196.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC---CCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~  258 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+...........+.+|+.++++++||||+++++++....   ....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            457888999999999999999864 789999999875443444567889999999999999999999874332   2357


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||++ ++|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEECcccc
Confidence            99999996 5888887542     3899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCceee--eeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh-----------h
Q 012392          339 HKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-----------A  404 (464)
Q Consensus       339 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~-----------~  404 (464)
                      +..........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........           .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            87654321111  112245678999998754 568899999999999999999999986432111000           0


Q ss_pred             hHHHhhhh-------hcCC--CCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          405 TFENFIDR-------NLKG--KFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       405 ~~~~~~~~-------~~~~--~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .+......       ....  ..+     ...+..+.+++.+||+.||++|||+.+++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            00000000       0000  000     123567889999999999999999999998844

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=303.15  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=195.0

Q ss_pred             CCccccccccCCceEEEEEEEC---CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .|...+.||+|+||.||+|...   ++..||+|.+....  .......+.+|+.++++++||||+++++++........+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677789999999999999975   47899999987632  122235677899999999999999999999665447899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC----CCCeEEe
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSS-NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNPLIA  334 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~----~~~~kl~  334 (464)
                      +||||+++ +|.+++....... ..++...+..++.||+.||.|||+.+     |+||||||+||+++.    ++.+||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-----VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99999964 7777775433222 25888999999999999999999988     999999999999999    9999999


Q ss_pred             eCCccccccCCce--eeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHH-----HhhhhH
Q 012392          335 DCGLHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATF  406 (464)
Q Consensus       335 DfGl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~-----~~~~~~  406 (464)
                      |||+++.......  .......++..|+|||++.+. .++.++|||||||++|||++|..|+.......     .....+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999886643221  112223456779999988664 57899999999999999999999886432211     000000


Q ss_pred             HHhh------------------------hhhcCCCCC---------H--HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          407 ENFI------------------------DRNLKGKFS---------E--SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       407 ~~~~------------------------~~~~~~~~~---------~--~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..++                        +......++         .  .....+.+++.+|++.||++|||+.|++++-
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            0000                        000001111         0  2345688999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.4e-37  Score=303.29  Aligned_cols=255  Identities=20%  Similarity=0.348  Sum_probs=191.8

Q ss_pred             cccccC--CceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ..||+|  +||+||+++.. +|+.||||.+...... ...+.+.+|+.+++.++||||+++++++.  ..+..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe--cCCceEEEEecc
Confidence            356666  89999999875 7899999998765422 23456888999999999999999999984  456789999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      .+|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.++++||+........
T Consensus        82 ~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          82 AYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG-----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             cCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            99999999976432  24889999999999999999999988     999999999999999999999999865432111


Q ss_pred             c-e----e-eeeccCCCCccCcccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH----------
Q 012392          346 I-V----F-SVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------  407 (464)
Q Consensus       346 ~-~----~-~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~----------  407 (464)
                      . .    . ......++..|+|||++.+.  .++.++|||||||++|||++|+.|+............+.          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            0 0    0 00111234569999998763  478999999999999999999999865432111100000          


Q ss_pred             -------------------------------HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          408 -------------------------------NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       408 -------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                                     ......+...........+.+++.+||+.||++|||+.|++++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                                           0000011111233466789999999999999999999999988664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.7e-37  Score=305.87  Aligned_cols=259  Identities=20%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|... ++..||||.+.... .......+.+|+.+++++ +||||+++++++........+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456778899999999999999976 68899999885432 223345677899999999 999999999988655555789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||++ ++|..++...     .++|..+..++.||+.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccch
Confidence            9999996 6999988643     4889999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCcee----eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh---------
Q 012392          340 KLLADDIVF----SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---------  405 (464)
Q Consensus       340 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~---------  405 (464)
                      +........    ......++..|+|||.+.. ..++.++||||||+++|||+||+.|+............         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            865432211    1112235677999998764 45788999999999999999999988643221110000         


Q ss_pred             ----------HHHhhhhhcCC------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          406 ----------FENFIDRNLKG------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       406 ----------~~~~~~~~~~~------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                                ...+++.....      ......+..+.+++.+||+.||++|||+.+++++-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~  297 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY  297 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence                      00011100000      001124567899999999999999999999998743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.2e-37  Score=301.51  Aligned_cols=253  Identities=20%  Similarity=0.376  Sum_probs=199.0

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |+..+.||+|+||.||+|+.. ++..||+|.+....  ......++.+|+.+++.++|+|++++++++..  ....++|+
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   94 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVM   94 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEEEE
Confidence            566688999999999999975 67899999886432  22334578899999999999999999998844  56789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+. |+|.+++....   ..+++.++..++.|++.||.|||+.+     ++||||+|+||+++.++.+||+|||++...
T Consensus        95 e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          95 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHhEEECCCCcEEECCcccceee
Confidence            9996 68888876432   24889999999999999999999988     999999999999999999999999998765


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ....     ...++..|+|||.+.   .+.++.++|||||||++|||++|..|+.......    ...............
T Consensus       166 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  236 (308)
T cd06634         166 APAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPALQS  236 (308)
T ss_pred             cCcc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----HHHHHhhcCCCCcCc
Confidence            4321     223567899999974   3567889999999999999999999886432111    111111111112223


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ...+..+.+++.+||+.+|++||++.+++++.+......
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            356678999999999999999999999999877665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.2e-37  Score=306.55  Aligned_cols=258  Identities=19%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----C
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~  255 (464)
                      ..++|+..+.||+|+||.||+|+.. +++.||||.+.... ......++.+|+.++++++||||+++++++....    .
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3467889999999999999999865 78999999986432 2233456788999999999999999999874322    1


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++|+||+. ++|.+++...      +++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEcc
Confidence            35799999995 5888887531      788889999999999999999988     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh----------
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------  405 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~----------  405 (464)
                      ||+++.......  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||............          
T Consensus       162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999987644321  12234567899999999989999999999999999999999988643211110000          


Q ss_pred             --------HHHhhhhhcC-------------------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          406 --------FENFIDRNLK-------------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       406 --------~~~~~~~~~~-------------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                              .....+....                   .......+..+.+++.+||+.||++|||+.|++++-+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                    0000000000                   00011345678899999999999999999999988654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-37  Score=300.47  Aligned_cols=260  Identities=18%  Similarity=0.331  Sum_probs=196.4

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC-----
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG-----  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~-----  254 (464)
                      ..++|+..+.||+|+||.||+|... +++.||||.++.... ......+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567888899999999999999986 688999999875432 223356778999999999999999999885432     


Q ss_pred             ---CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCe
Q 012392          255 ---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       255 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                         ....++|+||+++ +|..++....   ..+++..+..++.||+.||+|||+.+     |+|+||||+||++++++.+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN-----FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCcE
Confidence               2378999999975 7877776432   24899999999999999999999988     9999999999999999999


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      ||+|||++................+..|+|||.+.+ ..++.++|||||||++|||++|+.|+........ ...+....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~  234 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLC  234 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence            999999998664432111112234567999998864 4578899999999999999999988865322111 11111110


Q ss_pred             hhhcCC-------------------------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          411 DRNLKG-------------------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       411 ~~~~~~-------------------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ......                         ......+..+.+++..||+.||++||++.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  300 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP  300 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            000000                         00112356789999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.7e-37  Score=298.20  Aligned_cols=254  Identities=19%  Similarity=0.291  Sum_probs=196.9

Q ss_pred             CCccccccccCCceEEEEEEE----CCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      +|+..+.||+|+||.||+++.    .+|..||+|.++....   ......+.+|+.++.++ +|+||+++++.+  ....
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCC
Confidence            366778999999999999986    3688999999875321   22335678899999999 599999999877  4466


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.+     ++||||+|+|||+++++.+||+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEECCCCCEEEeeC
Confidence            7899999999999999997542    3888999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |+++..............++..|+|||.+...  .++.++||||||+++|+|++|..|+..................  .
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence            99986644322222233467789999998753  4678999999999999999999998642211111111111111  1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEEL  451 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L  451 (464)
                      ....+......+.+++.+||+.||++||     ++.+++.+-
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~  269 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP  269 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence            1223445667889999999999999997     788888763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.8e-37  Score=296.54  Aligned_cols=246  Identities=17%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ..||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+||+++++++.  ..+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEecCCCC
Confidence            57999999999999875 78999999886543 334567889999999999999999999884  467899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++...     .+++.....++.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++........ 
T Consensus       103 ~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g-----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         103 ALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            999987532     3789999999999999999999988     99999999999999999999999999875543221 


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--CCHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSESEAAKL  426 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  426 (464)
                      ......++..|+|||++....++.++||||||+++|||++|..|+........    . ..+.......  .....+..+
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~l  246 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----M-KMIRDNLPPKLKNLHKVSPSL  246 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHhhCCcccCCcccCCHHH
Confidence            11223456789999999888899999999999999999999999865322111    1 1111111111  122345678


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          427 GKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       427 ~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+++.+||+.||.+||++.+++++-+..
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~  274 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLA  274 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHh
Confidence            8999999999999999999999875533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.7e-37  Score=296.58  Aligned_cols=260  Identities=20%  Similarity=0.330  Sum_probs=194.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|++|.||+|+.. +++.||+|.+..... ......+.+|+.++++++||||+++++++.  .....++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence            45788899999999999999975 788999998865432 223356889999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~  340 (464)
                      |||++ ++|.+++.....  ..+++.....++.||+.||+|||+.+     ++|+||+|+||++++ ++.+||+|||++.
T Consensus        80 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             Eeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCcceEEEECCCCEEEEccccccc
Confidence            99995 688888865332  23678888899999999999999988     999999999999985 5679999999997


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh--------
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--------  411 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~--------  411 (464)
                      ....... ......++..|+|||++.+ ..++.++|||||||++|+|+||..|+............+...-.        
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        152 AFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             ccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            6533211 1112234677999998865 45789999999999999999999998654321111111000000        


Q ss_pred             ---------h--hcCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          412 ---------R--NLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       412 ---------~--~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                               .  .....    .....+..+.+++.+|++.+|++||++.+++++-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                     0  00000    0112356688999999999999999999999875543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=295.48  Aligned_cols=259  Identities=15%  Similarity=0.149  Sum_probs=184.9

Q ss_pred             cCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchH----------HHHHHHHHHHHhcCCCCCceeeeeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSE----------EAEFVKGLYLLTSLRHENIIRLRGF  249 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~----------~~~f~~e~~~l~~l~H~niv~l~g~  249 (464)
                      ++|...++||+|+||.||+|...+    +..+|+|..........          ......+...+..+.|+|++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            468888999999999999999764    45667775433221110          0122334455667789999999986


Q ss_pred             EEeCCC--CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          250 CCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       250 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +.....  ...++++|++ ..++.+.+....    ..++..+..++.|++.||+|||+.+     |+||||||+|||++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDiKp~Nill~~  161 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDG  161 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcC
Confidence            543322  1356788877 346766665321    2567888999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCce------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH
Q 012392          328 QFNPLIADCGLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA  401 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~  401 (464)
                      ++.++|+|||+++.......      .......+|..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999986532210      011123478889999999999999999999999999999999999965421111


Q ss_pred             hh-hhHHHhhhhhcCCC-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          402 ES-ATFENFIDRNLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       402 ~~-~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .. ....+++.+...+. ....++..+.+++..||+.+|++||++.++++.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            00 01111222211111 12344678999999999999999999999998763

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-36  Score=290.92  Aligned_cols=252  Identities=19%  Similarity=0.246  Sum_probs=192.8

Q ss_pred             HHHHHhhcCCcccccc--ccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          177 EEVESATQCFSEVNLL--GKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~l--g~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      .++....++|...+.+  |+|+||.||+++.. ++..+|+|.+........      |+.....+ +||||+++++.+..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEec
Confidence            3444445566676666  99999999999865 688899998865421111      22222212 79999999998844


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-Ce
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NP  331 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~  331 (464)
                        .+..++||||+++|+|.+++....    .++|.++..++.|+++||.|||+.+     ++||||||+||+++.++ .+
T Consensus        81 --~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~  149 (267)
T PHA03390         81 --LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN-----IIHNDIKLENVLYDRAKDRI  149 (267)
T ss_pred             --CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEeCCCCeE
Confidence              568999999999999999997543    4899999999999999999999988     99999999999999998 99


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      +|+|||+++......     ...++..|+|||++.+..++.++||||||+++|||++|+.|+............+.....
T Consensus       150 ~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  224 (267)
T PHA03390        150 YLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ  224 (267)
T ss_pred             EEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc
Confidence            999999987654322     224677899999999888999999999999999999999998743221111111211111


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHh
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELT  452 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~  452 (464)
                      .  ........+..+.+++..||+.||.+||+ +++++++-+
T Consensus       225 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        225 K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            1  11233356778999999999999999996 699997643

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-36  Score=298.01  Aligned_cols=254  Identities=15%  Similarity=0.250  Sum_probs=189.4

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccC-CCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVT-SCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      +.+|.|+++.||++.. +++.||||.++.. ........+.+|+.++++++|+||+++++++.  .....+++|||+++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCC
Confidence            3345555555555544 6899999998765 23445567999999999999999999999884  467799999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-  347 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-  347 (464)
                      +|.+++.....  ..+++.....++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||.+........ 
T Consensus        85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~-----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999986432  23888899999999999999999988     99999999999999999999999998865432111 


Q ss_pred             -----eeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh----hh-----
Q 012392          348 -----FSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF----ID-----  411 (464)
Q Consensus       348 -----~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~----~~-----  411 (464)
                           .......++..|+|||++..  ..++.++|||||||++|||++|..||................    ++     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                 01112234567999999865  358899999999999999999999997532211100000000    00     


Q ss_pred             -------------------hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          412 -------------------RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       412 -------------------~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                         ..............+.+++.+||+.||++|||+++++++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence                               000011123345678899999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.1e-37  Score=296.93  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             CccccccccCCceEEEEEEEC----CCcEEEEEEeccCCC---chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  257 (464)
                      |...+.||+|+||.||+++..    ++..||||.++....   ......+.+|+.++.++ +||||+++++.+  .....
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDTK   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCCE
Confidence            667789999999999999752    578899999874321   12335688999999999 599999999887  44667


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++||||+++|+|.+++....    .+++..+..++.|+++||.|||+.+     ++||||+|+||+++.++.++|+|||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG-----IIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEEECc
Confidence            899999999999999987532    3889999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      +++..............++..|+|||.+.+..  .+.++||||||+++|||++|..|+..................  ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~  228 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SK  228 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cC
Confidence            98765433221222234667899999987655  788999999999999999999998532211111111111111  11


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ...+......+.+++.+||+.||++|||+.++.+.|
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         229 PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            233444567789999999999999999976665444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.1e-37  Score=292.19  Aligned_cols=245  Identities=21%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||.|+||.||+++.. +|+.||+|.+.....  ......+.+|+.++++++||||+++++.+  ......++|+||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe--ecCcEEEEEEecCCCC
Confidence            689999999999987 489999999875432  23445788999999999999999999987  4467899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-  347 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-  347 (464)
                      +|.+++....    .+++..+..++.||+.||+|||+.+     ++|+||+|+||++++++.++|+|||++........ 
T Consensus        79 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          79 DLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            9999997543    4899999999999999999999988     99999999999999999999999999875433211 


Q ss_pred             ------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          348 ------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       348 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                            .......++..|+|||......++.++||||||+++|||++|..|+......    ..................
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~  225 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNILNGKIEWPEDVE  225 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCcCCCcccc
Confidence                  0112233556799999998888999999999999999999999998654321    112222211111111111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCH---HHHHHHH
Q 012392          422 EAAKLGKMALVCTHEDPENRPTM---EAVIEEL  451 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~---~evl~~L  451 (464)
                      .+..+.+++.+||+.+|++|||+   .+++++-
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence            26789999999999999999999   6666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=286.35  Aligned_cols=249  Identities=23%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +|+..+.||+|++|.||+++.. +++.||+|.+...... .....+.+|++++++++|||++++++++..  .+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence            3667789999999999999875 6789999998765422 345678999999999999999999998844  57899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.+     |+||||+|+||+++.++.++|+|||++...
T Consensus        79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEECCCCCEEEeccccceec
Confidence            999999999998754    34899999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...... .....++..|+|||......++.++||||+|+++|+|++|..|+........    ..... .......+...
T Consensus       150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~  223 (254)
T cd06627         150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV-QDDHPPLPEGI  223 (254)
T ss_pred             CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh-ccCCCCCCCCC
Confidence            543221 1223456779999999887789999999999999999999999865332111    11111 11223344456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +..+.+++.+||+.+|++||++.+++.+
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            7789999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.3e-37  Score=290.82  Aligned_cols=253  Identities=18%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccC---C-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVT---S-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      +|...+.||+|+||.||+++.. .+..+++|.++..   . ......++..|+.++++++||||+++++++.  .....+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   78 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC   78 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence            3677789999999999999865 3444555554431   1 1233446778999999999999999999883  456789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++++|.+++.........+++..++.++.|++.||.|||+.+     ++|+||+|+||+++++ .+||+|||++
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~~l~~~nili~~~-~~~l~d~g~~  152 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-----ILHRDLKAKNIFLKNN-LLKIGDFGVS  152 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCChhheEeecC-CEeecccCce
Confidence            999999999999999764434456999999999999999999999988     9999999999999864 6999999998


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....... ......++..|+|||.+....++.++|+||||+++|+|++|..|+......    ....... .......+
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~  226 (260)
T cd08222         153 RLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRIV-EGPTPSLP  226 (260)
T ss_pred             eecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH-cCCCCCCc
Confidence            76543221 112234567799999998888899999999999999999999998643221    1111111 12223345


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ...+..+.+++.+||+.||++||++.+++++-
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  258 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP  258 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence            56778899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=290.00  Aligned_cols=244  Identities=20%  Similarity=0.276  Sum_probs=188.5

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHH-hcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLL-TSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l-~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|+.. +++.||||.++....  ......+..|..++ ...+|+|++++++++  ...+..++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF--QSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE--EcCCeEEEEEecc
Confidence            46899999999999875 688999999865431  12223445555444 455899999999988  4467899999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++++|.+++....    .+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.+||+|||+++.....
T Consensus        80 ~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  150 (260)
T cd05611          80 NGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN  150 (260)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence            9999999997542    3888999999999999999999988     999999999999999999999999998754331


Q ss_pred             ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--CCCCCHHHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGKFSESEA  423 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  423 (464)
                           ....++..|+|||.+.+..++.++||||||+++|||+||..|+.......    .+........  ........+
T Consensus       151 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  221 (260)
T cd05611         151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCS  221 (260)
T ss_pred             -----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcccCCCCcccccCC
Confidence                 12235677999999988888999999999999999999999986543211    1111111111  112223457


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH---HHHHHHHhh
Q 012392          424 AKLGKMALVCTHEDPENRPTM---EAVIEELTV  453 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~---~evl~~L~~  453 (464)
                      ..+.+++.+||+.||++||++   +|++.+.+.
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            889999999999999999965   566666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-37  Score=320.70  Aligned_cols=266  Identities=16%  Similarity=0.223  Sum_probs=188.5

Q ss_pred             hhcCCccccccccCCceEEEEEEECC--CcEEEEEEec--------------c--CCCchHHHHHHHHHHHHhcCCCCCc
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSIN--------------V--TSCKSEEAEFVKGLYLLTSLRHENI  243 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~--------------~--~~~~~~~~~f~~e~~~l~~l~H~ni  243 (464)
                      ..++|...+.||+|+||+||++.++.  +..+++|.+.              .  .........|.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45689999999999999999987642  2222222110              0  0112234568899999999999999


Q ss_pred             eeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       244 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      +++++++..  .+..++|+|++ .++|..++...... ...........|+.||+.||+|||+.+     ||||||||+|
T Consensus       226 v~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-----IiHrDLKP~N  297 (501)
T PHA03210        226 LKIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-----LIHRDIKLEN  297 (501)
T ss_pred             CcEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHH
Confidence            999999844  56789999999 56888887643211 112335567789999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHH--HH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR--LA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~--~~  400 (464)
                      ||++.++.+||+|||+++..............++..|+|||++.+..++.++|||||||++|||++|+.++.....  ..
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999987654332222234578889999999999999999999999999999999865432110  00


Q ss_pred             Hhhh------------------hHHHhhhhhcCC----CCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          401 AESA------------------TFENFIDRNLKG----KFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       401 ~~~~------------------~~~~~~~~~~~~----~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ....                  .+..+++...-.    ..+     ......+.+++.+|++.||.+|||+.|++++.+.
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            0000                  000111000000    000     0123456778999999999999999999998765


Q ss_pred             hc
Q 012392          454 AA  455 (464)
Q Consensus       454 ~~  455 (464)
                      ..
T Consensus       458 ~~  459 (501)
T PHA03210        458 SA  459 (501)
T ss_pred             hc
Confidence            43

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=299.15  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=204.3

Q ss_pred             HHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          180 ESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       180 ~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      ....+.|+..++||+|+||.||-++.+ +|..+|.|.+.+...+  ..+...+.|-.+|.+++.+.||.|--.+  +..+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd  258 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKD  258 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCC
Confidence            344567899999999999999999876 7999999988755433  2344577899999999999999985444  6788


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      .+++|+..|.+|||.-+|.+...  ..+++...+.++.+|+.||++||..+     ||+|||||+|||||++|+++|+|.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~-----iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR-----IVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc-----eeeccCChhheeeccCCCeEeecc
Confidence            89999999999999999987653  45999999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--  414 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  414 (464)
                      |||..+.....  .....||.||||||++.++.|+...|+||+||+||||+.|..||........    .+++-...+  
T Consensus       332 GLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----~eEvdrr~~~~  405 (591)
T KOG0986|consen  332 GLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----REEVDRRTLED  405 (591)
T ss_pred             ceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----HHHHHHHHhcc
Confidence            99998766542  2334789999999999999999999999999999999999999965332111    112211122  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPT  443 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs  443 (464)
                      ...+++..+++..+|...-++.||++|.-
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            23456677788889999999999999864

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.4e-36  Score=296.04  Aligned_cols=249  Identities=19%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |...+.||+|+||.||+|+.. ++..||+|.+.....  ......+.+|+.+++.++|||++++++++.+  ....++||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence            555678999999999999864 688999999875432  2333568899999999999999999999844  56789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+. |+|.+++....   ..+++.++..++.||+.||.|||+.+     ++|+||+|+||++++++.+||+|||++...
T Consensus       101 e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         101 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            9995 68888876532   34899999999999999999999988     999999999999999999999999998654


Q ss_pred             cCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ...     ....++..|+|||++.   .+.++.++|||||||++|||++|..|+.........    .............
T Consensus       172 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~  242 (313)
T cd06633         172 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDSPTLQS  242 (313)
T ss_pred             CCC-----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCCCCCCc
Confidence            321     1234567799999984   456888999999999999999999998654321111    1111111122222


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++.+||+.+|.+||++.+++++-+..
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            34456789999999999999999999999875543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-37  Score=293.97  Aligned_cols=254  Identities=22%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|+||.||+|+.. +++.||||.+.............+|+..+.+++ ||||+++++++.  ..+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEEe
Confidence            456688999999999999986 578999999876543333445667999999999 999999999884  4678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+ +|+|.+++.....  ..+++..+..++.|++.+|.|||+.+     ++|+||+|+||++++++.++|+|||++....
T Consensus        79 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          79 YM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG-----FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             cC-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            99 8899999876542  34899999999999999999999988     9999999999999999999999999998664


Q ss_pred             CCceeeeeccCCCCccCcccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------H-----
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------F-----  406 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------~-----  406 (464)
                      .....  ....++..|+|||.+. ...++.++|+||||+++|||++|+.|+............           +     
T Consensus       151 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         151 SRPPY--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCCCc--CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            43211  1233566799999875 455789999999999999999999888543211110000           0     


Q ss_pred             -HHhhhhhcCCCC-------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          407 -ENFIDRNLKGKF-------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       407 -~~~~~~~~~~~~-------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                       ...+........       .......+.+++.+||+.||++||+++|++.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~  281 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP  281 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence             000000000000       011246789999999999999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=280.59  Aligned_cols=249  Identities=18%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             cccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .+..||+|..|.||+++.+ .|...|||.+.....+.+.+..+..+.++..-+ .|.||+.+|+|..  +..++|.||.|
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMelM  173 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICMELM  173 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHHHH
Confidence            3467999999999999976 689999999998887777788888898887765 8999999999965  45688999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                       ...++..|....   .++++..+-++...+.+||.||-+++.    |+|||+||+|||+|+.|++||+|||.+-.+.++
T Consensus       174 -s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~----viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  174 -STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             -HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcc----eeecccCccceEEccCCCEEeecccccceeecc
Confidence             446777776543   347888888999999999999997653    999999999999999999999999999877654


Q ss_pred             ceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC--H
Q 012392          346 IVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--E  420 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  420 (464)
                      ..  ..+..|-..|||||.+.   ..+|+.++|||||||.|+||.||..||......   -..+..+++ ...+..+  .
T Consensus       246 kA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkvln-~ePP~L~~~~  319 (391)
T KOG0983|consen  246 KA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKVLN-EEPPLLPGHM  319 (391)
T ss_pred             cc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHHHh-cCCCCCCccc
Confidence            32  23344667799999985   457899999999999999999999999864321   111222222 1112111  2


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ..+..+.+++..|++.|+.+||...++++|-.
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F  351 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF  351 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence            25678999999999999999999999998753

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=292.85  Aligned_cols=254  Identities=22%  Similarity=0.370  Sum_probs=196.9

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |...+.||+|++|.||+|... +++.+++|.+...... .....+.+|+.++++++|+||+++++++.  .....++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence            456688999999999999875 7889999998765422 33467888999999999999999999884  4578999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++ +|.+++....   ..+++..+..++.|++.||.|||+.+     |+|+||||+||++++++.+||+|||.+....
T Consensus        79 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          79 FMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             ccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            9964 9999887643   34899999999999999999999988     9999999999999999999999999988765


Q ss_pred             CCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh----------
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR----------  412 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------  412 (464)
                      .... ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||.................++          
T Consensus       150 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         150 SPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             CCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            4321 11122355679999998776 78999999999999999999998886533211111100000000          


Q ss_pred             -------hcC-------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          413 -------NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       413 -------~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                             ...       .......+.++.+++..||+.||.+||++.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence                   000       001123567899999999999999999999999764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-36  Score=296.57  Aligned_cols=259  Identities=17%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC------C
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~------~  255 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+.++++++||||++++++|....      .
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            45788899999999999999975 689999998865432 222345678999999999999999999885432      2


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++||||+. ++|.+++....   ..+++.++..++.||+.||+|||+.+     ++|+||||+||+++.++.+||+|
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK-----ILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEECCCCcEEECc
Confidence            35699999995 58888886532   24899999999999999999999988     99999999999999999999999


Q ss_pred             CCccccccCCcee---eeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          336 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       336 fGl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      ||++.........   ......++..|+|||.+.+. .++.++||||||+++|||+||..|+........ ...+..+..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~~~  241 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQLCG  241 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhC
Confidence            9999765432211   11122345679999988654 468899999999999999999988865432111 001111000


Q ss_pred             h------------------hcCCCC---------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          412 R------------------NLKGKF---------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       412 ~------------------~~~~~~---------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .                  ......         .......+.+++.+||+.||++|||+++++++-+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            0                  000000         0012345678999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=291.51  Aligned_cols=255  Identities=20%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcC---CCCCceeeeeEEEeCCC---Ce
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGR---GE  257 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~~~---~~  257 (464)
                      |+..+.||+|+||.||+|+.+ ++..||+|.++..... .....+.+|+.++.++   +|||++++++++.....   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            556789999999999999987 4899999998754322 2234566777776655   69999999999854322   13


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .+++|||+. ++|.+++.....  ..+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.+||+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~-----i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhEEEccCCCEEEeccC
Confidence            899999996 589999876433  24899999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh------
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------  411 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~------  411 (464)
                      ++........  .....++..|+|||++.+..++.++||||||+++|||++|..|+..................      
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         153 LARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             cceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence            9887643321  11223567799999999888999999999999999999998887643321111111110000      


Q ss_pred             --------hhcCCC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          412 --------RNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       412 --------~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                              ......       ........+.+++.+||+.||++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                    000000       011335677899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.8e-37  Score=293.32  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=203.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||.||+|+.. ++..||+|.+.....  ......+..|..++.+++ ||||+++++++  ...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceEE
Confidence            35778889999999999999976 789999999875321  233467888999999998 99999999987  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++++|.+++....    .+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++
T Consensus        79 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEecCCccc
Confidence            9999999999999997643    4999999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCce-------------------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH
Q 012392          340 KLLADDIV-------------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA  400 (464)
Q Consensus       340 ~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~  400 (464)
                      ........                   .......++..|+|||......++.++||||||++++++++|..|+...... 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence            86543221                   1111223467799999998888999999999999999999999998754321 


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCH----HHHHHHH
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTM----EAVIEEL  451 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~----~evl~~L  451 (464)
                         ..+.....  .....+...++.+.+++.+||+.||++||++    ++++++.
T Consensus       229 ---~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         229 ---LTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             ---HHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence               12222221  2233445557789999999999999999999    8888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.9e-37  Score=306.79  Aligned_cols=254  Identities=19%  Similarity=0.299  Sum_probs=198.5

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-C-----CCceeeeeEEEeCCCCe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-H-----ENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~  257 (464)
                      +|.+.++||+|.||.|-+|... +++.||||.++..  +....+-..|+.+|..|+ |     -|+|++++++..  +++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccc
Confidence            6888999999999999999865 6999999999864  445566778999999996 4     499999999954  788


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC--CCeEEee
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIAD  335 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~--~~~kl~D  335 (464)
                      .|||+|.+ .-+|.++|..+.-  ..|+...+..|+.||+.||.+||+.+     |||+||||+||||.+-  ..+||+|
T Consensus       263 lciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~-----IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG-----IIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCChhheeeccCCcCceeEEe
Confidence            99999999 5599999987654  34999999999999999999999998     9999999999999643  4799999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-------------
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-------------  402 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-------------  402 (464)
                      ||.+.......+ ...   -+.-|.|||++.+..|+.+.||||||||+.||+||.+.|.+.......             
T Consensus       335 FGSSc~~~q~vy-tYi---QSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  335 FGSSCFESQRVY-TYI---QSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             cccccccCCcce-eee---eccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            999998766543 111   224499999999999999999999999999999997777553211000             


Q ss_pred             ----hhhHHHhhhh-----------------------------hcCCCC-----------CHHHHHHHHHHHHHhhhcCC
Q 012392          403 ----SATFENFIDR-----------------------------NLKGKF-----------SESEAAKLGKMALVCTHEDP  438 (464)
Q Consensus       403 ----~~~~~~~~~~-----------------------------~~~~~~-----------~~~~~~~l~~l~~~C~~~dp  438 (464)
                          ......+++.                             ......           ....-..+.+++.+|+..||
T Consensus       411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP  490 (586)
T KOG0667|consen  411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP  490 (586)
T ss_pred             HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence                0000000000                             000001           11234568999999999999


Q ss_pred             CCCCCHHHHHHHHhhh
Q 012392          439 ENRPTMEAVIEELTVA  454 (464)
Q Consensus       439 ~~RPs~~evl~~L~~~  454 (464)
                      .+|+|..|+++|-+.-
T Consensus       491 ~~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  491 AERITPAQALNHPFLT  506 (586)
T ss_pred             hhcCCHHHHhcCcccc
Confidence            9999999999987654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.3e-36  Score=291.14  Aligned_cols=247  Identities=19%  Similarity=0.277  Sum_probs=189.4

Q ss_pred             ccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHH---HHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          191 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGL---YLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~---~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      +||+|+||.||+++.. +++.||+|.+......  .....+..|.   .+++...||||+++++++  ...+..++|+||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCEEEEEEec
Confidence            4799999999999864 6889999988754322  1122244443   344556899999999887  446789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++|+|.+++...    ..+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|||++.....
T Consensus        79 ~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          79 MNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            9999999988643    24899999999999999999999988     99999999999999999999999999875543


Q ss_pred             CceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...   ....++..|+|||.+.++ .++.++|||||||++|||++|+.||.........  ...... .......+...+
T Consensus       150 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~-~~~~~~~~~~~s  223 (278)
T cd05606         150 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT-LTMAVELPDSFS  223 (278)
T ss_pred             cCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHh-hccCCCCCCcCC
Confidence            211   123467889999998754 5899999999999999999999998754211111  111111 111223334456


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhh
Q 012392          424 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  454 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~  454 (464)
                      ..+.+++.+|++.+|++||     ++.+++++.+..
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            7899999999999999999     999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=295.94  Aligned_cols=251  Identities=20%  Similarity=0.334  Sum_probs=208.5

Q ss_pred             CccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |+..+.||+|.|..|-+|++ -.|..||||++.+.... -....+.+|+..|+-++|||||+|+.+.  .....+|||+|
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLE   97 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILE   97 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEE
Confidence            55557899999999999984 48999999999865422 2335688999999999999999999987  55677999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~~  342 (464)
                      .-.+|+|++|+...+.   .+.+.-..+++.||+.|+.|+|..+     +|||||||+||.+-+ -|-+||+|||++..+
T Consensus        98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH-----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH-----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh-----hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999987653   3888888999999999999999988     999999999998764 588999999999766


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ....  .....-|.+.|-|||.+.+..|. +..||||+||+||.|++|+.||....    +...+..++|..  -..+..
T Consensus       170 ~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----DSETLTmImDCK--YtvPsh  241 (864)
T KOG4717|consen  170 QPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----DSETLTMIMDCK--YTVPSH  241 (864)
T ss_pred             CCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----chhhhhhhhccc--ccCchh
Confidence            5443  22223356779999999999986 57899999999999999999997543    345566666643  346778


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+.+..+|+..|+..||.+|.+.++|+..-|..
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            889999999999999999999999999876543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-36  Score=301.70  Aligned_cols=260  Identities=17%  Similarity=0.293  Sum_probs=196.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC---Ce
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~  257 (464)
                      .++|...+.||+|+||.||+|+.. ++..||||.+.... .......+.+|+.+++.++|+||+++++++.....   ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            356888899999999999999865 68999999987532 22234567789999999999999999998753321   35


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++|+||+. ++|.+++...    ..+++..+..++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcCc
Confidence            799999995 7999988643    23899999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh--------------
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE--------------  402 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~--------------  402 (464)
                      +++....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........              
T Consensus       154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         154 LARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED  232 (337)
T ss_pred             cccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            9986643211 1112235677999998864 46889999999999999999999988643211000              


Q ss_pred             -----hhhHHHhhhhhcCCC------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          403 -----SATFENFIDRNLKGK------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       403 -----~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                           .......+.......      .....+..+.+++.+||+.||++|||+++++++-+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence                 000111111000000      012345678999999999999999999999998543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=308.94  Aligned_cols=252  Identities=17%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             ccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          187 SEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .++..||.|+||.||+|..++ +...|-|++.... ..+..+|+-|+++|+.+.||+||+|++.|+.  .+.+||+.|||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwiliEFC  111 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWILIEFC  111 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEEEeec
Confidence            345779999999999998774 4455678776544 4556789999999999999999999997754  46699999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      .||-++..+-.-+   .+|+..++.-+++|++.||.|||+.+     |||||||+-|||++-+|.++|+|||.+......
T Consensus       112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~-----iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN-----IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc-----hhhhhccccceEEEecCcEeeecccccccchhH
Confidence            9999999876543   35999999999999999999999998     999999999999999999999999997654322


Q ss_pred             ceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh-cCCCCC
Q 012392          346 IVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFS  419 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  419 (464)
                      . .......||+.|||||+..     ...|+.++||||||++|.||..+.+|-.....+    ..+..+.... .....+
T Consensus       184 ~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  184 R-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             H-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHhhcCCCcccCc
Confidence            1 1223456899999999874     467999999999999999999999887643221    1111111111 112235


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++..|+..||+.||++.++++|.+..
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            56778899999999999999999999999987765

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-36  Score=299.81  Aligned_cols=261  Identities=19%  Similarity=0.314  Sum_probs=198.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--CCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~  259 (464)
                      .+|+..+.||+|+||.||+|+.. ++..||+|.+..... ......+.+|+.++++++||||+++++++...  .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            56888899999999999999865 689999999875432 23345677899999999999999999876432  234689


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+. |+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEecccccc
Confidence            9999995 69999986432    3899999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCcee---eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-------------
Q 012392          340 KLLADDIVF---SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-------------  402 (464)
Q Consensus       340 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-------------  402 (464)
                      .........   ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........             
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            765332111   1112245677999999865 46889999999999999999999998643211000             


Q ss_pred             ------hhhHHHhhhhh-cCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          403 ------SATFENFIDRN-LKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       403 ------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                            ...+....+.. .....     ....+..+.+++..||+.||++||++.+++.+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                  00011111100 00011     123467899999999999999999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=300.94  Aligned_cols=252  Identities=20%  Similarity=0.333  Sum_probs=191.2

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----C
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  256 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+.... .......+.+|+.++++++||||+++++++.....    .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            367888999999999999999864 68999999986532 12233568899999999999999999998753321    3


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+. .+|..++.      ..+++..+..++.|++.||+|||+.+     ++||||||+||+++.++.+||+||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeC
Confidence            5699999996 47777652      13889999999999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH---------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~---------  406 (464)
                      |+++......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+         
T Consensus       162 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         162 GLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             CCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9987653321    12234567999999876 468899999999999999999999987542211100000         


Q ss_pred             ----------HHhhhhh---cCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          407 ----------ENFIDRN---LKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       407 ----------~~~~~~~---~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                                .......   .+...   .......+.+++.+||+.||++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      0000000   00000   01234568899999999999999999999977

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=309.39  Aligned_cols=199  Identities=25%  Similarity=0.415  Sum_probs=172.2

Q ss_pred             ccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CCeEEEEEe
Q 012392          189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGECFLIYD  263 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~~lv~E  263 (464)
                      .+.||+|+||.||+|+.+ .|+.||||.++............+|+++|++++|+|||++++.=....    .....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            367999999999999955 799999999998776777778899999999999999999988632222    235789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc--CCC--CeEEeeCCcc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQF--NPLIADCGLH  339 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~--~~~--~~kl~DfGl~  339 (464)
                      ||.+|||...|+..+.. ..|+..+.+.++.+++.||.|||+++     |+||||||.||++-  +++  .-||+|||.|
T Consensus        98 yC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn~-----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLRENG-----IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999987644 45999999999999999999999988     99999999999994  333  3699999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                      +.+.++.  ......||..|++||.... +.|+...|.|||||++||.+||..||..
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9988765  3445678999999999984 7889999999999999999999999854

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-36  Score=298.92  Aligned_cols=259  Identities=21%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC---CCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~~  259 (464)
                      +|...+.||.|+||.||+|+.. ++..||||.+..... ....+.+.+|+.+++.++|+||+++++++....   ....+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677889999999999999976 589999999875432 334467899999999999999999999884432   13689


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||++ ++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.++|+|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g-----i~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999997 58999886532    4899999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCce--eeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------
Q 012392          340 KLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------  405 (464)
Q Consensus       340 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------  405 (464)
                      ........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............           
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence            87654321  111223356679999999877 7899999999999999999999998654321110000           


Q ss_pred             --------HHHhhhh-hcCCC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          406 --------FENFIDR-NLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       406 --------~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                              ....+.. .....     .....+..+.+++.+||+.+|++||++++++++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence                    0000000 00000     011235678999999999999999999999998554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-36  Score=297.89  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeC
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR  253 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~  253 (464)
                      ..++...+++|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4566778899999999999999999999864 788999999875321 22345688899999999999999999987432


Q ss_pred             C----CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          254 G----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       254 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      .    ....++++|++ +++|.+++...     .+++..+..++.|+++||+|||+.+     |+||||||+||++++++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEcCCC
Confidence            1    23467888887 88999887532     3899999999999999999999988     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh---
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---  405 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~---  405 (464)
                      .+||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+............   
T Consensus       158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999998865332    122345677999998865 56788999999999999999999988643221100000   


Q ss_pred             ----------------HHHhh---hhhcCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 ----------------FENFI---DRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 ----------------~~~~~---~~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                      ....+   ........   .......+.+++..|++.||.+||++.+++.+-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence                            00000   00000000   012345688999999999999999999999887643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=290.33  Aligned_cols=255  Identities=21%  Similarity=0.377  Sum_probs=195.9

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      |+..+.||+|+||.||+|+.. +++.||+|.+.... .......+..|+.++++++|+||+++++++.  .....++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEec
Confidence            455678999999999999976 58999999987653 1223456788999999999999999999984  4578999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |++ ++|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||+|+||++++++.+||+|||+++...
T Consensus        79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            997 59999998643   24899999999999999999999988     9999999999999999999999999988664


Q ss_pred             CCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-----------HHHhh-
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FENFI-  410 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-----------~~~~~-  410 (464)
                      .... .......+..|+|||.+... .++.++||||||+++|||++|+.|+............           +.... 
T Consensus       150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            3221 11122345669999998766 7899999999999999999999888654322111000           00000 


Q ss_pred             ----hhhcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          411 ----DRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       411 ----~~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                          +.....       .........+.+++..||+.||++||++++++.+-+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence                000000       000122567999999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-36  Score=296.87  Aligned_cols=257  Identities=19%  Similarity=0.329  Sum_probs=205.4

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccC-CCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVT-SCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..|++.++||+||..+||++...+.+.+|+|++... ...+...-|..|+.+|.+|+ |.+||+|++|-  -..+.+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE--v~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE--VTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee--ccCceEEEE
Confidence            347778999999999999999888888888876543 33455678999999999995 99999999986  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||- ..||..+|.+....  ..+| .+..+..|++.++.++|..+     |||.||||.|.|+-.+ .+||+|||.|..
T Consensus       439 mE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g-----IVHSDLKPANFLlVkG-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG-----IVHSDLKPANFLLVKG-RLKLIDFGIANA  508 (677)
T ss_pred             eecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc-----eeecCCCcccEEEEee-eEEeeeechhcc
Confidence            9987 66999999876543  2445 77889999999999999998     9999999999999764 799999999987


Q ss_pred             ccCCce-eeeeccCCCCccCcccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh
Q 012392          342 LADDIV-FSVLKTSAAMGYLAPEYVTTGR-----------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  409 (464)
Q Consensus       342 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-----------~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  409 (464)
                      ...+.. .......||+.||+||.+....           .+.+|||||+||+||+|+.|+.||..-.   .....+..+
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAI  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhh
Confidence            765432 2233456899999999985332           4678999999999999999999996432   223456666


Q ss_pred             hhhhcCCCCCHHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          410 IDRNLKGKFSESE-AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       410 ~~~~~~~~~~~~~-~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .++...-.++... ..++.++|+.||+.||.+||+..++|++-...-
T Consensus       586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            6665544444322 233999999999999999999999998865443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.1e-37  Score=322.23  Aligned_cols=254  Identities=22%  Similarity=0.391  Sum_probs=192.3

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--------
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--------  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--------  253 (464)
                      .++|+++++||+||||.||+++.+ ||+.||||++.............+|+.++++|+|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            355777889999999999999977 99999999998876445556788899999999999999998322110        


Q ss_pred             --------------------------------------------------------------------------------
Q 012392          254 --------------------------------------------------------------------------------  253 (464)
Q Consensus       254 --------------------------------------------------------------------------------  253 (464)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -----------------------------CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 012392          254 -----------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH  304 (464)
Q Consensus       254 -----------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  304 (464)
                                                   ....+||=||||+.-.|.++++.+....   .-...++++++|++||+|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence                                         0012588899999988888877543211   24556789999999999999


Q ss_pred             cCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc---CC--------------ceeeeeccCCCCccCccccccc
Q 012392          305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA---DD--------------IVFSVLKTSAAMGYLAPEYVTT  367 (464)
Q Consensus       305 ~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~---~~--------------~~~~~~~~~~~~~y~aPE~~~~  367 (464)
                      +.+     ||||||||.||+||++..+||.|||++....   ..              .........||.-|+|||.+.+
T Consensus       715 ~~g-----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  715 DQG-----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             hCc-----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            998     9999999999999999999999999998721   00              0111223456777999999965


Q ss_pred             C---CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--CCHHHHHHHHHHHHHhhhcCCCCCC
Q 012392          368 G---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSESEAAKLGKMALVCTHEDPENRP  442 (464)
Q Consensus       368 ~---~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~C~~~dp~~RP  442 (464)
                      .   .|+.|+|+||+||||+||+.   ||...+.....   +..+-+..++..  +..+....-..++.++++.||.+||
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i---L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP  863 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI---LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP  863 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH---HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC
Confidence            4   49999999999999999987   46655543332   222222222222  2344555667899999999999999


Q ss_pred             CHHHHHHH
Q 012392          443 TMEAVIEE  450 (464)
Q Consensus       443 s~~evl~~  450 (464)
                      |+.|+|+.
T Consensus       864 tA~eLL~s  871 (1351)
T KOG1035|consen  864 TATELLNS  871 (1351)
T ss_pred             CHHHHhhc
Confidence            99999863

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.5e-36  Score=294.90  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      +...+++|+..+.||.|+||.||++... ++..||||.+.... .......+.+|+.++++++||||+++.+++... ..
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~   83 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE   83 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence            3456788999999999999999999865 78999999876432 223346688899999999999999999987542 44


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+ +++|.+++...     .+++.....++.|+++||+|||+.+     |+||||+|+||++++++.+||+||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~-----iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEeECCCCCEEeCcc
Confidence            688999999 67999888642     3788888899999999999999988     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh------------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------  403 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~------------  403 (464)
                      |++.......    ....++..|+|||.+.+ ..++.++||||||+++|||+||+.|+..........            
T Consensus       153 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         153 GLARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             ccccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9987543321    12234567999998865 568999999999999999999999886432210000            


Q ss_pred             -------hhHHHhhhh-hcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          404 -------ATFENFIDR-NLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       404 -------~~~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                             .....+... ......+     ...+..+.+++.+||+.+|++||++.+++.+-+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence                   000000000 0011111     1235789999999999999999999999987443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-36  Score=291.72  Aligned_cols=260  Identities=22%  Similarity=0.317  Sum_probs=193.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC-----
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-----  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-----  255 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+....... ....+.+|++++++++||||+++++++.....     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            357888899999999999999975 68899999886543222 23457789999999999999999998754322     


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          256 -GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       256 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                       ...++|+||+. ++|...+....   ..+++..+..++.|+++||+|||+.+     |+|+||||+||++++++.+||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH-----ILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEC
Confidence             25799999995 47887776432   24899999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCceeee----------eccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          335 DCGLHKLLADDIVFSV----------LKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      |||+++..........          ....++..|+|||.+.+. .++.++|||||||++|||++|+.|+..........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999986543221111          112235669999987654 57899999999999999999999886543221111


Q ss_pred             hhHHHh-----------------hhhhcCCCCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          404 ATFENF-----------------IDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       404 ~~~~~~-----------------~~~~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ..+...                 .........+       ......+.+++.+|++.||++|||+.+++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~  309 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP  309 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence            100000                 0000000000       11235688999999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.3e-36  Score=294.61  Aligned_cols=253  Identities=20%  Similarity=0.293  Sum_probs=191.7

Q ss_pred             ccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchH-------------HHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE-------------EAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      .+.||.|+||.||+|... +++.||||.++.......             ...+.+|++++++++||||+++++++.  .
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~   91 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV--E   91 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe--c
Confidence            367999999999999865 689999998865432210             124778999999999999999999984  4


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ....++||||++ |+|.+++...    ..+++.....++.|++.||+|||+.+     |+|+||+|+||+++.++.+||+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~-----i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY-----FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHeEECCCCCEEEC
Confidence            567899999996 6999998643    23888999999999999999999988     9999999999999999999999


Q ss_pred             eCCccccccCCce-------------eeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHH
Q 012392          335 DCGLHKLLADDIV-------------FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLA  400 (464)
Q Consensus       335 DfGl~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~  400 (464)
                      |||+++.......             .......++..|+|||.+.+. .++.++|||||||++|||+||..|+.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999876541110             011112345679999998764 46889999999999999999999987543221


Q ss_pred             HhhhhHHHhhhhhcC----------------CC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          401 AESATFENFIDRNLK----------------GK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~----------------~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...... ........                ..       .....+..+.+++..||+.||++||+++|++.+.+..
T Consensus       242 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        242 QLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             HHHHHH-HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            111110 00000000                00       0112356788999999999999999999999887643

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-36  Score=296.26  Aligned_cols=260  Identities=20%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC-
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-  255 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-  255 (464)
                      +....++|...+.||+|+||.||++... ++..||||.+..... ......+.+|+.++++++||||+++++++..... 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3345678999999999999999999864 789999999864322 2234568899999999999999999998743322 


Q ss_pred             ---CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          256 ---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       256 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                         ...++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g-----i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG-----IIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEE
Confidence               2468999999 7799988853     23899999999999999999999988     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh------
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT------  405 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~------  405 (464)
                      |+|||++.......    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............      
T Consensus       159 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07880         159 ILDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT  234 (343)
T ss_pred             EeecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999998654321    22345677999999875 45889999999999999999999998654221110000      


Q ss_pred             ----H---------HHhhhhh--cC-C---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          406 ----F---------ENFIDRN--LK-G---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       406 ----~---------~~~~~~~--~~-~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                          +         .......  .. .   .........+.+++.+|++.||++|||+.+++++-+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence                0         0000000  00 0   0011234568899999999999999999999976543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=280.70  Aligned_cols=263  Identities=18%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             cccccCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHh-cCCCCCceeee
Q 012392          170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLT-SLRHENIIRLR  247 (464)
Q Consensus       170 ~~~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~-~l~H~niv~l~  247 (464)
                      ..+.|+.+.++.       ...||.|.||+|+|-.++ .|+..|||+++......+.++++.|.+... .-+.||||+++
T Consensus        57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            334566555543       367999999999998876 799999999998877777788999988654 44799999999


Q ss_pred             eEEEeCCCCeEEEEEecCCCCCHHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       248 g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      |.+..  .+.+||.||.| .-||..+-..- ......+++.-.-+|..-++.||.||-...    .|||||+||+|||||
T Consensus       130 Ga~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l----kiIHRDvKPSNILld  202 (361)
T KOG1006|consen  130 GALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL----KIIHRDVKPSNILLD  202 (361)
T ss_pred             hhhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh----hhhhccCChhheEEe
Confidence            99854  56799999999 44776654321 111223788878888889999999998654    399999999999999


Q ss_pred             CCCCeEEeeCCccccccCCceeeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~  404 (464)
                      ..|.+||+|||.+-.+.++...  ....|-..|||||.+..  ..|..+|||||+|++|+|+.||+.|+..+.....   
T Consensus       203 r~G~vKLCDFGIcGqLv~SiAk--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe---  277 (361)
T KOG1006|consen  203 RHGDVKLCDFGICGQLVDSIAK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE---  277 (361)
T ss_pred             cCCCEeeecccchHhHHHHHHh--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---
Confidence            9999999999999877654322  22335566999999953  3489999999999999999999999987764322   


Q ss_pred             hHHHhhhhhcC----CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          405 TFENFIDRNLK----GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       405 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .+.+++....+    .......+..+..++..|+..|-+.||+..++.+.-
T Consensus       278 ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  278 QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence            22222222111    111234677899999999999999999999998653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=280.81  Aligned_cols=241  Identities=23%  Similarity=0.342  Sum_probs=195.5

Q ss_pred             cccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      ||.|+||.||++... +++.||+|.+......  .....+..|+.++++++||||+++++.+  ......++||||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCCC
Confidence            689999999999976 5889999998764322  2345788999999999999999999887  4567899999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      +|.+++....    .+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~-----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          79 ELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            9999997543    3899999999999999999999988     99999999999999999999999999876543211 


Q ss_pred             eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      ......++..|++||.+.+...+.++|+||||+++||+++|..|+.....    .........  .....+...+..+.+
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~--~~~~~~~~~~~~l~~  222 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK--DPLRFPEFLSPEARD  222 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc--CCCCCCCCCCHHHHH
Confidence            12233456779999999888889999999999999999999999865432    111222222  223344455788999


Q ss_pred             HHHHhhhcCCCCCCCH---HHHHHH
Q 012392          429 MALVCTHEDPENRPTM---EAVIEE  450 (464)
Q Consensus       429 l~~~C~~~dp~~RPs~---~evl~~  450 (464)
                      ++.+||..||++||++   .+++++
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhC
Confidence            9999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-35  Score=295.05  Aligned_cols=258  Identities=18%  Similarity=0.316  Sum_probs=192.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC--------
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG--------  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~--------  254 (464)
                      .+|...+.||.|+||.||+|+.. ++..||+|.+..... .....+.+|+.++++++||||+++++++....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            56888899999999999999875 688999999876543 34466889999999999999999998663322        


Q ss_pred             ----CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCC
Q 012392          255 ----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQF  329 (464)
Q Consensus       255 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~  329 (464)
                          ....++|+||++ ++|.+++...     .+++.....++.||++||.|||+.+     |+||||||+||+++ ++.
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCc
Confidence                135789999996 5999888532     3889999999999999999999988     99999999999997 556


Q ss_pred             CeEEeeCCccccccCCceee--eeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          330 NPLIADCGLHKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      .+||+|||+++.........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||............+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            78999999987653321111  111235667999998754 567889999999999999999999996432211110000


Q ss_pred             H------------------Hhhh-hhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          407 E------------------NFID-RNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       407 ~------------------~~~~-~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .                  .... .......+     .....++.+++..||+.||++|||+.+++++-+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence            0                  0000 00000001     1234678899999999999999999999987544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.2e-35  Score=290.49  Aligned_cols=259  Identities=21%  Similarity=0.261  Sum_probs=192.9

Q ss_pred             CCccccccccCCceEEEEEEEC-C--CcEEEEEEeccCCC-chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeC--CCCe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-D--GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR--GRGE  257 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~  257 (464)
                      +|...+.||+|+||.||+++.. .  +..||||.+..... ....+.+.+|+.++.++ +||||+++++++...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3677789999999999999975 3  77899999875321 22345688899999999 599999999875322  2245


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++++||+. ++|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+||++++++.+||+|||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHeEEcCCCCEEeCcCC
Confidence            788999985 6999998643    24899999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCcee---eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh---------
Q 012392          338 LHKLLADDIVF---SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---------  404 (464)
Q Consensus       338 l~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~---------  404 (464)
                      +++........   ......++..|+|||++.+ ..++.++|+|||||++|+|++|..|+...........         
T Consensus       151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (332)
T cd07857         151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD  230 (332)
T ss_pred             CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence            99865432111   1112346778999998765 4688999999999999999999998864321110000         


Q ss_pred             --hHHHhhhh-------hc----CCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 --TFENFIDR-------NL----KGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 --~~~~~~~~-------~~----~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        .+..+..+       ..    ...   ........+.+++.+|++.||++|||+.+++++-+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence              00000000       00    000   011235678999999999999999999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-35  Score=293.39  Aligned_cols=257  Identities=20%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----  255 (464)
                      ..++|...+.||+|+||.||+|+.. ++..||||.+..... ......+.+|+.++++++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567888999999999999999976 678999998865321 2234567789999999999999999987643221    


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEcc
Confidence            2489999999 6799999864     23899999999999999999999988     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH--------
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------  406 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~--------  406 (464)
                      ||++......    .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.............        
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9999865432    112235667999999865 367889999999999999999999986543211100000        


Q ss_pred             -----------HHhhhhhcCC---CC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          407 -----------ENFIDRNLKG---KF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       407 -----------~~~~~~~~~~---~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                 ..++......   ..   ....+..+.+++.+||+.||++|||+.+|+++-+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence                       0000000000   00   01235678999999999999999999999987543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-35  Score=294.05  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...|.+...||+|.|+.|.+|+.. .+..||||.+.+... ....+.+.+|+++|+.++|||||+++.+.  .....+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecceeEE
Confidence            456788899999999999999865 689999999987642 33345688999999999999999999987  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+.+|.+++||.....    +...+...++.|+.++++|||+++     |||||||++||||+.++++||+|||++.
T Consensus       133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~-----ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN-----IVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc-----eeccccchhhcccccccceeeeccccce
Confidence            9999999999999987653    445777889999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC--
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--  417 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  417 (464)
                      .+.....  .....+++.|.|||+..+..| .++.|+||+|++||-|+.|..||.+..-        ...-++.+.+.  
T Consensus       204 ~~~~~~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~r  273 (596)
T KOG0586|consen  204 FFDYGLM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYR  273 (596)
T ss_pred             eeccccc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeec
Confidence            8764322  223346677999999988776 5789999999999999999999986532        22222333332  


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ++.....+..+++.+.+-.+|.+|++++++.++-|
T Consensus       274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            23334455677888888899999999999998755

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-35  Score=275.96  Aligned_cols=225  Identities=16%  Similarity=0.188  Sum_probs=178.0

Q ss_pred             CCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHH
Q 012392          195 GNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY  273 (464)
Q Consensus       195 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~  273 (464)
                      |.||.||+++.. +++.||+|.+....      .+.+|...+....||||+++++++.  .....++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHH
Confidence            899999999875 78899999987542      2334555555667999999999884  46789999999999999999


Q ss_pred             hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeecc
Q 012392          274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT  353 (464)
Q Consensus       274 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~  353 (464)
                      +....    .+++..+..++.|+++||+|||+.+     |+||||||+||++++++.++++|||++.......    ...
T Consensus        76 l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~  142 (237)
T cd05576          76 ISKFL----NIPEECVKRWAAEMVVALDALHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGE  142 (237)
T ss_pred             HHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccC
Confidence            97543    3899999999999999999999988     9999999999999999999999999876554321    122


Q ss_pred             CCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHh
Q 012392          354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVC  433 (464)
Q Consensus       354 ~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C  433 (464)
                      .++..|+|||.+....++.++||||+|+++|||++|..++......      .    ........+...+..+.+++.+|
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~li~~~  212 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------I----NTHTTLNIPEWVSEEARSLLQQL  212 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------c----ccccccCCcccCCHHHHHHHHHH
Confidence            3445699999998888999999999999999999998776432110      0    00111123334567789999999


Q ss_pred             hhcCCCCCCCH-----HHHHHH
Q 012392          434 THEDPENRPTM-----EAVIEE  450 (464)
Q Consensus       434 ~~~dp~~RPs~-----~evl~~  450 (464)
                      ++.||++||++     +++++|
T Consensus       213 l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         213 LQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             ccCCHHHhcCCCccchHHHHcC
Confidence            99999999996     666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=322.26  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=205.8

Q ss_pred             HHhhcCCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          180 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       180 ~~~~~~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ...+.++.....||.|.||.||-|. ..+|...|+|-++..... .......+|+.++..++|||+|+++|+=  ..+..
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE--vHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE--VHREK 1308 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee--ecHHH
Confidence            3445566777899999999999988 457999999988765433 2234577899999999999999999975  44677


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .+|-||||++|+|.+.+...+.    +++....-+-.|++.|++|||+.+     ||||||||.||+|+.+|.+|+.|||
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~g-----IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHG-----IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcC-----ceecCCCccceeeecCCcEEeeccc
Confidence            8999999999999999976432    556666678899999999999999     9999999999999999999999999


Q ss_pred             ccccccCCc---eeeeeccCCCCccCcccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          338 LHKLLADDI---VFSVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       338 l~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      .|.......   ........||+-|||||++.+..   -..+.||||+|||+.||+||+.||..-..    +-.+.-.+.
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIMy~V~ 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIMYHVA 1455 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHHhHHh
Confidence            998775442   11123456888899999997543   35679999999999999999999964322    111222233


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      -+..+++|+..+.+-.+++..|+..||.+|.++.|++++-
T Consensus      1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            4556778888889999999999999999999999998764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.1e-36  Score=272.45  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             cCCccccccccCCceEEEEEEEC---C--CcEEEEEEeccCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR---D--GTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ..|+.+..||+|.||.||+|.-.   +  ...+|||.++.+..... -....+|+.+++.++|||++.|..++.+. ...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~  102 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK  102 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence            45788899999999999999643   2  23799999886532222 24577899999999999999999988654 567


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC----CCeE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPL  332 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~----~~~k  332 (464)
                      +++++||.+. ||.+.++-.... ...++-....+|+.||+.|+.|||++.     |+||||||.|||+..+    |.+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-----vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-----VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-----eeeccCCcceEEEeccCCccCeeE
Confidence            9999999976 899988754322 245888889999999999999999999     9999999999999877    9999


Q ss_pred             EeeCCccccccCCc--eeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh------
Q 012392          333 IADCGLHKLLADDI--VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------  403 (464)
Q Consensus       333 l~DfGl~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~------  403 (464)
                      |+|||++|.+.+..  .++.....-|+-|.|||.+.+ ..||...||||.||++.||+|-.+.|..........      
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999876532  234445556788999999986 569999999999999999999876664321110000      


Q ss_pred             --------------hh---------HHHhhhhhcCCCCCHH-----------HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 012392          404 --------------AT---------FENFIDRNLKGKFSES-----------EAAKLGKMALVCTHEDPENRPTMEAVIE  449 (464)
Q Consensus       404 --------------~~---------~~~~~~~~~~~~~~~~-----------~~~~l~~l~~~C~~~dp~~RPs~~evl~  449 (464)
                                    ..         ....+.......+...           -+....+|+..++..||-+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence                          00         0000000000000000           1123678889999999999999999999


Q ss_pred             HHhhh
Q 012392          450 ELTVA  454 (464)
Q Consensus       450 ~L~~~  454 (464)
                      +.-..
T Consensus       337 h~yF~  341 (438)
T KOG0666|consen  337 HPYFT  341 (438)
T ss_pred             ccccc
Confidence            86544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=295.47  Aligned_cols=266  Identities=18%  Similarity=0.293  Sum_probs=186.8

Q ss_pred             hhcCCccccccccCCceEEEEEEE-----------------CCCcEEEEEEeccCCCchHHHHH--------------HH
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL-----------------RDGTLVAIRSINVTSCKSEEAEF--------------VK  230 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~f--------------~~  230 (464)
                      ..++|.+.++||+|+||.||+|.+                 .+++.||||++.... .....+|              ..
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence            356799999999999999999964                 235689999987543 2222333              34


Q ss_pred             HHHHHhcCCCCCc-----eeeeeEEEeC------CCCeEEEEEecCCCCCHHHHhhhhcCC-------------------
Q 012392          231 GLYLLTSLRHENI-----IRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEGS-------------------  280 (464)
Q Consensus       231 e~~~l~~l~H~ni-----v~l~g~~~~~------~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------  280 (464)
                      |+.++.+++|.|+     ++++|+|...      ..+..++||||+++|+|.++|+...+.                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6677777776654     6788887432      234689999999999999999753210                   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCcc
Q 012392          281 -SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY  359 (464)
Q Consensus       281 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y  359 (464)
                       ...++|..+..++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||+++...............++.|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG-----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence             123578889999999999999999988     99999999999999999999999999976543322222223346789


Q ss_pred             CcccccccCCC----------------------CCcchhHHHHHHHHHHHhCCC-CCcchHHHHHh-------hhhHHHh
Q 012392          360 LAPEYVTTGRF----------------------TERSDIFAFGVIILQILTGSL-VLTSSMRLAAE-------SATFENF  409 (464)
Q Consensus       360 ~aPE~~~~~~~----------------------~~~sDv~s~Gvll~el~tg~~-p~~~~~~~~~~-------~~~~~~~  409 (464)
                      +|||.+.....                      ..+.||||+||+++||++|.. |+........+       ...+...
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~  456 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY  456 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence            99998754321                      234799999999999999976 44321111000       1111111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHHHhh
Q 012392          410 IDRNLKGKFSESEAAKLGKMALVCTHEDP---ENRPTMEAVIEELTV  453 (464)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp---~~RPs~~evl~~L~~  453 (464)
                      ......-.......+...+++..++..+|   .+|+|++|+++|.+.
T Consensus       457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence            11111111223446778889999998766   689999999998765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.2e-34  Score=308.23  Aligned_cols=146  Identities=23%  Similarity=0.338  Sum_probs=127.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|.+.+.||+|+||.||+|... +++.||||.++...  .......+..|+.++..++||||+++++++.  .....++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~l   81 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYL   81 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEE
Confidence            46788899999999999999976 68999999987533  1233467888999999999999999998874  4568999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....    .+++..++.|+.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG-----IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999997532    3788899999999999999999987     9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=271.57  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+.+++||+|.||+|.+++-+ .++.+|+|.++++.  .+.+...-+.|-.+|...+||.+..|.-.+  +..+.+|.
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlCF  245 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLCF  245 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEEE
Confidence            45788899999999999999865 79999999998754  233445567788999999999999887655  66788999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||..+|.|.-+|...+    .++......+-..|+.||.|||+++     ||+||||-+|.|||.+|.+||+||||++
T Consensus       246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~-----ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN-----IVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC-----eeeeechhhhheeccCCceEeeecccch
Confidence            999999999999997654    3777777889999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .--... ......-||+.|+|||++....|....|+|.+||++|||++|+.||++....    ..++-++...  ..++.
T Consensus       317 E~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl~ed--~kFPr  389 (516)
T KOG0690|consen  317 EEIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELILMED--LKFPR  389 (516)
T ss_pred             hccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----HHHHHHHhhh--ccCCc
Confidence            532111 1223345788999999999999999999999999999999999999875432    2222222222  23566


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEEL  451 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L  451 (464)
                      ..+.+...|+...+..||.+|.     .+.||.++-
T Consensus       390 ~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~  425 (516)
T KOG0690|consen  390 TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR  425 (516)
T ss_pred             cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence            6667778888888999999995     467777653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=294.23  Aligned_cols=265  Identities=22%  Similarity=0.379  Sum_probs=212.2

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          175 NLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       175 ~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      .++.+...+.-|.+.+.||.|.+|.||+++. ++++.+|||.+......  ..+...|..+++.. .|||++.++|++..
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3445555666788889999999999999985 47899999988765433  33455778888877 69999999998865


Q ss_pred             CC---CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          253 RG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       253 ~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      ..   .+++|||||||.+||..+.+.+..+  ..+.|..+.-|++.++.||.|||.+.     ++|||||-.|||+++++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g--~rl~E~~IaYI~re~lrgl~HLH~nk-----viHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG--NRLKEEWIAYILREILRGLAHLHNNK-----VIHRDIKGQNVLLTENA  160 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcc--cchhhHHHHHHHHHHHHHHHHHhhcc-----eeeecccCceEEEeccC
Confidence            43   3589999999999999999987663  34999999999999999999999887     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  404 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~  404 (464)
                      .+||.|||++..++.... ......||+.|||||++...     .|+.++|+||+|++..||-.|.+|+.........  
T Consensus       161 ~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL--  237 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL--  237 (953)
T ss_pred             cEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--
Confidence            999999999988764322 22334578899999999643     4677899999999999999999999765543221  


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                       +...-.+......+..-.+++.+++..|+..|-++||++.+++++-.
T Consensus       238 -F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF  284 (953)
T KOG0587|consen  238 -FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF  284 (953)
T ss_pred             -ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence             11111122233346778899999999999999999999999998743

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=304.93  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=213.3

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-C-chHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-C-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      ..++.....+|.++++||+|+||.|..++.+ .++.||.|++++-. . .....-|..|-.+|.--+.+=|+.|+-.|  
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--  144 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--  144 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--
Confidence            3455556677899999999999999999976 68899999987522 1 22345688899999998999999997666  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ++..++|+|||||+||||-..+....    .++......++..|+.||.-||+.|     +|||||||.|||||.+|++|
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg-----yVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG-----YVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc-----ceeccCCcceeEecccCcEe
Confidence            77889999999999999999997654    3888888999999999999999999     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccc----c-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT----T-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~  407 (464)
                      |+|||.+-.+..+.........||+.|++||++.    + +.|....|+||+||++|||+.|..||+....    ..++.
T Consensus       216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----veTY~  291 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----VETYG  291 (1317)
T ss_pred             eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----HHHHH
Confidence            9999999877766666666778999999999984    2 6789999999999999999999999987543    33444


Q ss_pred             HhhhhhcCCCCC--HHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHHhh
Q 012392          408 NFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTV  453 (464)
Q Consensus       408 ~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~L~~  453 (464)
                      .+++..-...+|  ...+++..+|+..-+. +|+.|..   ++++-.|...
T Consensus       292 KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  292 KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence            555543333344  3456777788776433 7888887   9999877653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-33  Score=264.06  Aligned_cols=238  Identities=24%  Similarity=0.375  Sum_probs=191.5

Q ss_pred             CceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHh
Q 012392          196 NFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL  274 (464)
Q Consensus       196 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l  274 (464)
                      +||.||+|+.. +++.+|+|.+...........|.+|+..+++++|+||+++++++..  ....++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence            58999999987 4899999998765533325789999999999999999999999844  56789999999999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccC
Q 012392          275 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS  354 (464)
Q Consensus       275 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  354 (464)
                      .....    +++..+..++.+++.+|.|||+.+     ++|+||+|+||++++++.++|+|||.+.......  ......
T Consensus        79 ~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  147 (244)
T smart00220       79 KKRGR----LSEDEARFYARQILSALEYLHSNG-----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV  147 (244)
T ss_pred             HhccC----CCHHHHHHHHHHHHHHHHHHHHcC-----eecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence            75432    889999999999999999999987     9999999999999999999999999998765432  122334


Q ss_pred             CCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH--HHHHHHHHHHH
Q 012392          355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES--EAAKLGKMALV  432 (464)
Q Consensus       355 ~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~  432 (464)
                      ++..|++||.+....++.++||||||+++|+|++|..|+......    ....+.............  .+..+.+++.+
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  223 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKPKPPFPPPEWKISPEAKDLIRK  223 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCccccccCCHHHHHHHHH
Confidence            566799999998888999999999999999999999998652111    111111111111111111  56789999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 012392          433 CTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       433 C~~~dp~~RPs~~evl~~  450 (464)
                      ||..+|++||++.+++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      224 LLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HccCCchhccCHHHHhhC
Confidence            999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=287.36  Aligned_cols=243  Identities=19%  Similarity=0.276  Sum_probs=200.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +..|.....+|.|+|+.|-++... +++..+||.+....     .+-.+|+.++... +||||+++.+.+  .+..+.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeeccee--cCCceeee
Confidence            566777788999999999998865 67889999987652     2233566566555 699999999998  66788999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE-cCCCCeEEeeCCcc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI-DQQFNPLIADCGLH  339 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfGl~  339 (464)
                      |||++.+|-|.+.+....     .....+..|+.+|+.++.|||+++     +|||||||+|||+ ++.++++|+|||.+
T Consensus       394 v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g-----vvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG-----VVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             eehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC-----eeecCCChhheeecCCCCcEEEEEechh
Confidence            999999988888776543     222677889999999999999998     9999999999999 68999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....+    .....-|..|.|||++....|++.+|+||||++||+|++|..|+......       .++......+.+.
T Consensus       464 ~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s  532 (612)
T KOG0603|consen  464 SELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS  532 (612)
T ss_pred             hhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc
Confidence            987665    12223466799999999999999999999999999999999999765432       2333344456666


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...++...+|+.+|++.||.+||+|.++..+-+.
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            7888999999999999999999999999998776

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.8e-34  Score=297.04  Aligned_cols=264  Identities=16%  Similarity=0.177  Sum_probs=171.7

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-C----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEE----e
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC----S  252 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~----~  252 (464)
                      ..++|...+.||+|+||.||+|++. +    +..||||++....   ....+..+  .+....+.+++.++..+.    .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            3456888899999999999999976 4    6899999876432   11111111  122222333333222111    1


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeec
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSS----------------NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  316 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~  316 (464)
                      ....+.++|+||+++++|.+++.......                .......+..++.||+.||+|||+.+     |+||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-----IiHR  279 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IVHR  279 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-----EEeC
Confidence            34567999999999999999987532100                00112345679999999999999988     9999


Q ss_pred             CCCCCceEEcC-CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC----------------------CCCCc
Q 012392          317 NLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----------------------RFTER  373 (464)
Q Consensus       317 dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~  373 (464)
                      ||||+|||+++ ++.+||+|||+++.+.....+......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 58999999999986543322222334467789999965321                      23456


Q ss_pred             chhHHHHHHHHHHHhCCCCCcchHHHHHh--------hhhHHHhhhhhcCCCC------CHHHHHHHHHHHHHhhhcCCC
Q 012392          374 SDIFAFGVIILQILTGSLVLTSSMRLAAE--------SATFENFIDRNLKGKF------SESEAAKLGKMALVCTHEDPE  439 (464)
Q Consensus       374 sDv~s~Gvll~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~C~~~dp~  439 (464)
                      +|||||||+||||+++..+..........        ...+...+........      .........+|+.+|++.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            79999999999999987665432211100        0011111111100000      001122345899999999999


Q ss_pred             CCCCHHHHHHHHhhhc
Q 012392          440 NRPTMEAVIEELTVAA  455 (464)
Q Consensus       440 ~RPs~~evl~~L~~~~  455 (464)
                      +|||++|+++|-+...
T Consensus       440 kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        440 QRISAKAALAHPYFDR  455 (566)
T ss_pred             cCCCHHHHhCCcCcCC
Confidence            9999999999977544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=241.70  Aligned_cols=256  Identities=19%  Similarity=0.346  Sum_probs=189.2

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .|...++||+|.||+|++|+.+ .++.||+|+.+.+.... .....++|+.+++.++|.|||++++..  .....+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl--hsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeH
Confidence            3555688999999999999965 68899999988665333 335688999999999999999999987  3456788999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |||. -+|..|.....+   .++.....+++.|+++||.|+|+++     +.||||||+|.|++.+|+.||+|||+++-+
T Consensus        81 e~cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshn-----vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN-----VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             HHhh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh-----hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            9994 489999876543   4888999999999999999999998     899999999999999999999999999987


Q ss_pred             cCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCC-CcchHHHHHhhhhHHHhhhhh-------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLV-LTSSMRLAAESATFENFIDRN-------  413 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~-------  413 (464)
                      +...... .....|.-|.+|.++.+. -|+...|+||-||++.|+...+.| |.+..-.....+.+...-.+.       
T Consensus       152 gipvrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  152 GIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             CCceEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            6543221 223456789999999775 488999999999999999765444 444322111112221111100       


Q ss_pred             --cC-----CCCC---------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          414 --LK-----GKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       414 --~~-----~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                        +.     +.++         +.....=++++...+.-+|.+|.++++.+++.-
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence              00     0111         111122345555555569999999999998754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=260.14  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=192.3

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe--CCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS--RGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~--~~~~~~~lv~E~~  265 (464)
                      ++||-|-.|.|-.+..+ .|+.+|+|.+....      ...+|+++--.. .|||||.+++++..  .....+++|||+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            67999999999998865 78999999987532      233667665444 59999999998732  2334688999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCCeEEeeCCccccc
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLL  342 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGl~~~~  342 (464)
                      ++|.|++.+.++..  ..+++.+.-.|+.||+.|+.|||+.+     |.||||||+|+|..   .|..+||+|||+++.-
T Consensus       142 eGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n-----IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  142 EGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN-----IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             cchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc-----hhhccCChhheeeecCCCCcceEeccccccccc
Confidence            99999999987654  45999999999999999999999998     99999999999996   4567999999999875


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC---
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS---  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  419 (464)
                      ....  .....--|+.|.|||++-..+|+...|+||+||++|-|++|-+||++........+.-..+....  -.++   
T Consensus       215 ~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq--y~FP~pE  290 (400)
T KOG0604|consen  215 QEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ--YEFPEPE  290 (400)
T ss_pred             CCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC--ccCCChh
Confidence            4322  22233456789999999999999999999999999999999999987543221111111111111  1123   


Q ss_pred             -HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 -ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 -~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ...++...++++..+..+|.+|.|+.+++.+-|..
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence             24467778889999999999999999999987754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=272.04  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             CCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHH------HHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          185 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~------~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      +|-.+++||+|||+.||+|. +...+.||||.-..+..-.++      +...+|..+-+.|.||.||++++|+... ...
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-tds  542 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TDS  542 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-ccc
Confidence            45566899999999999998 457889999987654322211      2356788999999999999999998643 456


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEe
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIA  334 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~  334 (464)
                      .|-|+|||++.+|+-||.+..    .++..+..+|+.||+.||.||.+.   +|||||-||||.||||-+   .|.+||+
T Consensus       543 FCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi---kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI---KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc---CCCeeeeccCCccEEEecCcccceeEee
Confidence            889999999999999998654    488999999999999999999976   499999999999999954   4789999


Q ss_pred             eCCccccccCCceee------eeccCCCCccCcccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH--h
Q 012392          335 DCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--E  402 (464)
Q Consensus       335 DfGl~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~--~  402 (464)
                      ||||++.+.++.+..      +....||..|++||.+.-+    +.+.|+||||.||++|..+.|+.||........  .
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999999887654322      2334577789999988544    578999999999999999999999976432111  0


Q ss_pred             hhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          403 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ..++...  ....-...+..+.+...++.+|+++--++|....++..+
T Consensus       696 eNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  696 ENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            1111110  011111123445677889999999999999998887754

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-33  Score=254.39  Aligned_cols=259  Identities=20%  Similarity=0.350  Sum_probs=197.9

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeC
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  253 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~  253 (464)
                      ++++-..|.     +.||+|+|+.|--+. +.+|..+|||.+.+.. ...+....+|++++.+.+ |+||+.|+.|+  +
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefF--E  146 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFF--E  146 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHh--c
Confidence            555555544     789999999999886 6789999999998763 445667889999999995 99999999999  5


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC---C
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N  330 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~  330 (464)
                      +....|||||-|.+|+|.++++++..    +++.+...+..+||.||.|||.++     |.||||||+|||..+-.   -
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~kg-----IAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTKG-----IAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhcC-----cccccCCccceeecCCCCcCc
Confidence            56778999999999999999987643    888999999999999999999998     99999999999996543   4


Q ss_pred             eEEeeCCccccccCCceee------eeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH
Q 012392          331 PLIADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRL  399 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~------~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~  399 (464)
                      +||+||.|.....-....+      .....|...|||||+..     ...|+.+.|.||+||+||-|++|-+||.+....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            8999999876432211111      11223445699999863     345788999999999999999999999753221


Q ss_pred             -----------HHhhhhHHHhhhhhcCCCCCH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          400 -----------AAESATFENFIDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       400 -----------~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                 .-.+..++.+-+...  .+|+    ..+.+..+++...+..|+.+|.++.+++.+.+.
T Consensus       298 dCGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~  364 (463)
T KOG0607|consen  298 DCGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV  364 (463)
T ss_pred             cCCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence                       111222333222211  2333    345667788888888999999999999987654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=289.82  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=185.8

Q ss_pred             CCccccccccCCceE-EEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSS-VYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .|...+++|.|+-|+ ||+|.. +|+.||||++-.+.    ..-..+|+..|..- +|||||++  ||.+.+++..||..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEE--EeeccCCceEEEEe
Confidence            355557789998875 899998 48899999885432    22345799998877 59999999  56778889999999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---C--CCeEEeeCC
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---Q--FNPLIADCG  337 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~--~~~kl~DfG  337 (464)
                      |.| ..+|.+++...........-...+.++.|+++||+|||+.+     ||||||||+||||+.   +  ..++|+|||
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-----iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-----IVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-----cccccCCCceEEEEccCCCcceeEEecccc
Confidence            999 66999999874111100111345778999999999999988     999999999999976   3  568999999


Q ss_pred             ccccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          338 LHKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       338 l~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +++.+..+..  .......||-||+|||.+....-+..+|++|+||++|+.++| ..||.........  .+... ....
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~-~~L~  733 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGN-YTLV  733 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCc-ccee
Confidence            9998865432  224456788999999999998888899999999999999997 6788765432111  11000 0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ......++  +..+|+.++++.||..||++.+|+.|
T Consensus       734 ~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            01111112  78899999999999999999999965

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-34  Score=256.65  Aligned_cols=265  Identities=20%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeC------CCCe
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------GRGE  257 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~------~~~~  257 (464)
                      |....+||+|.||+|++|+.+ .|+.||+|..--+..+ ......++|+.+|..++|+|++.++..|...      .+..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            444578999999999999975 5788998865443322 2234678999999999999999999988422      2235


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++|+++|+. ||.-.|.+..   ..++..++.+++.++.+||.|+|.+.     |+|||+||.|+|++.++.+||+|||
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k-----ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK-----ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh-----HHhhcccHhhEEEcCCceEEeeccc
Confidence            8999999966 9999987643   23888999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceee---eeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----------
Q 012392          338 LHKLLADDIVFS---VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------  402 (464)
Q Consensus       338 l~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----------  402 (464)
                      +++.+.......   ......|.-|.+||.+.+ ..|+++.|||.-||++.||+|+.+.+.+.......           
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            998664322111   112224677999999876 56899999999999999999998877654322110           


Q ss_pred             --------hhhHHHhh--hhhcCCCCC--HH------HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          403 --------SATFENFI--DRNLKGKFS--ES------EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       403 --------~~~~~~~~--~~~~~~~~~--~~------~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                              +..+.+.+  .+...+.+.  .+      -.+...+++...+..||.+|+++.+++.+-+.-.-+++
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                    00011111  000011110  01      12356788999999999999999999998776665555

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-32  Score=237.84  Aligned_cols=202  Identities=19%  Similarity=0.353  Sum_probs=166.6

Q ss_pred             cccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ....||+|+||.|-+-++. +|+..|||+++..-..++.+..+.|+.+..+. ..|.+|.++|...  .....||.||.|
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwIcME~M  127 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWICMELM  127 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEEeHHHh
Confidence            3467999999999888764 79999999998877677777888999876655 7999999999773  356799999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                       ..||..|-.+--.....+++..+-+|+..|.+||.|||++-    .++|||+||+|||++.+|++|+||||.+-.+.++
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL----~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL----SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh----hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence             55998887654333445888889999999999999999864    3999999999999999999999999999887664


Q ss_pred             ceeeeeccCCCCccCccccccc----CCCCCcchhHHHHHHHHHHHhCCCCCcchHH
Q 012392          346 IVFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSMR  398 (464)
Q Consensus       346 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~  398 (464)
                      ....  -..|-..|||||.+..    ..|+.||||||+|+.+.||.+++.||.++..
T Consensus       203 iAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  203 IAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            3221  1224456999999842    3689999999999999999999999987754

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=270.69  Aligned_cols=248  Identities=20%  Similarity=0.320  Sum_probs=194.0

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      ++||+|-||+||-|+.+ +|+.||||.+.+... ...+....+|+.+|.+++||.||.|.-.|  +..+..|+|||-+ +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKL-H  646 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhh-c
Confidence            78999999999999876 799999999976543 33446788999999999999999997776  7788899999999 5


Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCeEEeeCCccccccC
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCGLHKLLAD  344 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfGl~~~~~~  344 (464)
                      ||..+.+-..+..  .|+...-..++.||+.||.|||.++     |||.||||+||||.+.   -.+||+|||+++..+.
T Consensus       647 GDMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn-----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  647 GDMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN-----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             chHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc-----eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            5665555443332  3888888889999999999999998     9999999999999754   4699999999999876


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      ....  ....||+.|+|||++.+..|+..-|+||.||++|--++|..||....+......+. .++-+   ...-.+...
T Consensus       720 ksFR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-aFMyP---p~PW~eis~  793 (888)
T KOG4236|consen  720 KSFR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-AFMYP---PNPWSEISP  793 (888)
T ss_pred             hhhh--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-ccccC---CCchhhcCH
Confidence            5432  23568899999999999999999999999999999999999997543221111110 11111   111124455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...+++...++..-++|-|...-+.+.|.
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence            67788888888899999999888876553

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=258.66  Aligned_cols=241  Identities=20%  Similarity=0.305  Sum_probs=189.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHH--HHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .+|..+.+||+|+||+|.+|..+ ..+.+|||.++++..-+..  .--+.|-.+|+-- +-|.+++|...+  +..+.+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLy  426 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLY  426 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhee
Confidence            45778899999999999999765 5678999999875422211  1122345555555 467888887766  6678899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      .||||+.+|+|--++++-..    +.+...+.+|.+||-||-|||+++     |++||||-.|||||.+|.+||+|||++
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg-----IiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC-----eeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999987553    667778999999999999999999     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +.---+.. .+...-||+.|+|||.+..+.|...+|+|||||+||||+.|.+||.+...    ...+..+.+.  .-.++
T Consensus       498 KEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~elF~aI~eh--nvsyP  570 (683)
T KOG0696|consen  498 KENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQAIMEH--NVSYP  570 (683)
T ss_pred             cccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHc--cCcCc
Confidence            85322111 12233478899999999999999999999999999999999999987643    2233444433  33467


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCC
Q 012392          420 ESEAAKLGKMALVCTHEDPENRP  442 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RP  442 (464)
                      ...+.+...++..-+...|.+|.
T Consensus       571 KslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  571 KSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ccccHHHHHHHHHHhhcCCcccc
Confidence            77778888888888888998884

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=257.87  Aligned_cols=257  Identities=18%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CC-----CceeeeeEEEeCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HE-----NIIRLRGFCCSRGR  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~-----niv~l~g~~~~~~~  255 (464)
                      +++|.++..+|+|.||.|-.+..+ .+..||||.++.-  .......+-|+.+|.++. +.     -+|.+.+|+  +-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hcc
Confidence            678999999999999999999865 4789999998753  233345667999999994 22     356777777  557


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--------
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--------  327 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--------  327 (464)
                      +..+||+|.+ +-|+.+||..+.-  .+++...+..|+.|++++++|||+.+     ++|-||||+|||+.+        
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k-----l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK-----LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc-----eeecCCChheEEEeccceEEEec
Confidence            8899999998 7799999986543  45888899999999999999999998     999999999999842        


Q ss_pred             ------------CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          328 ------------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       328 ------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                                  +..+||+|||.+..-....    .....|..|.|||++.+-.++..+||||+||+|.|+.||...|..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                        3458999999998654432    223356679999999999999999999999999999999887764


Q ss_pred             hHHHH---Hhh------------hh-HHHhhh-hhcC-----------------------CCCCHHHHHHHHHHHHHhhh
Q 012392          396 SMRLA---AES------------AT-FENFID-RNLK-----------------------GKFSESEAAKLGKMALVCTH  435 (464)
Q Consensus       396 ~~~~~---~~~------------~~-~~~~~~-~~~~-----------------------~~~~~~~~~~l~~l~~~C~~  435 (464)
                      .....   .-+            +. .+.... ..+.                       ......+..++.+|+..++.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            32100   000            00 000000 0010                       01123456779999999999


Q ss_pred             cCCCCCCCHHHHHHHHhhhc
Q 012392          436 EDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       436 ~dp~~RPs~~evl~~L~~~~  455 (464)
                      .||.+|+|+.|+++|-....
T Consensus       392 fDP~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFAR  411 (415)
T ss_pred             cCccccccHHHHhcCHHhhc
Confidence            99999999999999876544

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=266.38  Aligned_cols=253  Identities=17%  Similarity=0.254  Sum_probs=205.7

Q ss_pred             CCccccccccCCceEEEEEEECCCc-EEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGT-LVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++..+..||-|+||+|=+.+..... .+|+|.+++...  .........|-.+|.+.+.|.||+|+.-+  .+...+|++
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYmL  498 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYML  498 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhhh
Confidence            4455677999999999998876443 488888876432  22334577899999999999999999877  667889999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||-|-+|.|...|+.+..    ++..+...++..+++|++|||+++     ||+|||||+|.+|+.+|-+||.|||+++.
T Consensus       499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~-----iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG-----IIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC-----ceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999987643    777888889999999999999999     99999999999999999999999999998


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      +....  .+-..-||+.|.|||.+.+...+..+|.||+|+++|||+||.+||.+...+..-+..+    ...-...+|..
T Consensus       570 i~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL----kGid~i~~Pr~  643 (732)
T KOG0614|consen  570 IGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL----KGIDKIEFPRR  643 (732)
T ss_pred             hccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----hhhhhhhcccc
Confidence            86543  2223457889999999999999999999999999999999999998876544333222    22223445666


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~~  454 (464)
                      ......++++.....+|.+|.-     +.+|-+|-|..
T Consensus       644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            6777788888877889999976     78888887754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.7e-30  Score=234.93  Aligned_cols=212  Identities=32%  Similarity=0.565  Sum_probs=181.2

Q ss_pred             cccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCH
Q 012392          192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL  270 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL  270 (464)
                      ||+|.+|.||+++..+ ++.+++|.+...........+.+|+..++.++|++++++++++.  .....++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCCCcH
Confidence            6899999999999864 89999999886653323567999999999999999999999884  35778999999999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCccccccCCceee
Q 012392          271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFS  349 (464)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~~~~~~~~~  349 (464)
                      .+++....   ..+++..+..++.+++++|.|||+.+     ++|+||+|.||+++. +..++|+|||.+........ .
T Consensus        79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~  149 (215)
T cd00180          79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG-----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L  149 (215)
T ss_pred             HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence            99997642   24889999999999999999999988     999999999999999 89999999999986654321 1


Q ss_pred             eeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHH
Q 012392          350 VLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  428 (464)
Q Consensus       350 ~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  428 (464)
                      .........|++||..... .++.++|+|++|+++++|                                     ..+.+
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~  192 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKD  192 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHH
Confidence            1223345679999998877 788999999999999998                                     56889


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 012392          429 MALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       429 l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ++..|++.||++||++.++++++
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.7e-31  Score=234.90  Aligned_cols=252  Identities=17%  Similarity=0.281  Sum_probs=194.0

Q ss_pred             cCCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .+|++.+++|+|.|++|+.|. ..+.+.++||.++.-    ..+...+|+++|..++ ||||++|++...+..+....||
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            457788999999999999998 457889999999843    3456789999999997 9999999999877777778999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~  340 (464)
                      +||+++.+....-.       .|+..++..++.++++||.|+||+|     |.|||+||.|+++|. .-..+|+|+|||.
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G-----ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC-----cccccCCcceeeechhhceeeeeecchHh
Confidence            99999988877653       2777888999999999999999999     999999999999984 5679999999999


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----------------
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------------  402 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----------------  402 (464)
                      +......+...-  ++.-|..||.+.. +.|...-|+|||||+|..|+..+.||..+......                 
T Consensus       182 FYHp~~eYnVRV--ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYNVRV--ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceeeeee--ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            887765444322  3345788999864 56888999999999999999999988542211000                 


Q ss_pred             -------hhhHHHhhhhhcCCCC--------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          403 -------SATFENFIDRNLKGKF--------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       403 -------~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                             ...+..++....+...        ..-...+..+++...+..|-.+|+|++|.+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                   0011111111111000        00123667888889999999999999999987543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.9e-31  Score=260.09  Aligned_cols=243  Identities=19%  Similarity=0.347  Sum_probs=188.8

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .-|..++.||-|+||+|.+++. +....+|.|.+++.+  ..........|-.||..-..+=||+|+-.|  ++.+.+|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence            3367778999999999999874 456789999987643  122234567799999999999999996555  77889999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++||+-.+|.+.+    .+.+.-...++.++..|+++.|..|     +|||||||.|||||.+|.+||+||||+.
T Consensus       707 VMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG-----FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc-----ceecccCccceEEccCCceeeeeccccc
Confidence            999999999999998754    3777778889999999999999988     9999999999999999999999999985


Q ss_pred             cc---cCCceee--------------------------------------eeccCCCCccCcccccccCCCCCcchhHHH
Q 012392          341 LL---ADDIVFS--------------------------------------VLKTSAAMGYLAPEYVTTGRFTERSDIFAF  379 (464)
Q Consensus       341 ~~---~~~~~~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~  379 (464)
                      -+   ++..++.                                      .....||..|+|||++....|+...|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            33   2222111                                      112357778999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCcchHHH--HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 012392          380 GVIILQILTGSLVLTSSMRL--AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP  442 (464)
Q Consensus       380 Gvll~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP  442 (464)
                      ||+||||+.|+.||......  .....+|+.+++-...+..+.++.+.+.+|   |.  +++.|.
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL---c~--sad~RL  917 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL---CC--SADSRL  917 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH---hc--Chhhhh
Confidence            99999999999999754322  223355677666555566666665555554   33  455553

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=239.29  Aligned_cols=247  Identities=16%  Similarity=0.263  Sum_probs=190.5

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  257 (464)
                      ..++|..+.+||+|+|.+|..+++. ..+.+|+|.++++..  .........|-.+..+- +||.+|.|...+  +....
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesr  325 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESR  325 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccce
Confidence            3467889999999999999999975 678899999876432  22223445566676666 699999998766  56678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      ++.|.||+++|+|--++++.+    .|+......+..+|..||.|||+++     |++||||-.|||+|..+.+||+|+|
T Consensus       326 lffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg-----iiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC-----eeeeeccccceEEccCCceeecccc
Confidence            999999999999988876543    3888888999999999999999999     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH----HhhhhHHHhhhhh
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA----AESATFENFIDRN  413 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~  413 (464)
                      +++.--.... .+...-||+.|+|||.+.+..|....|+|++||+++||+.|+.||.-.....    .+.-.+.-++.+.
T Consensus       397 mcke~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq  475 (593)
T KOG0695|consen  397 MCKEGLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ  475 (593)
T ss_pred             hhhcCCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence            9985432211 2223457889999999999999999999999999999999999996432111    1111122222222


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRP  442 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RP  442 (464)
                        -.++...+.+...+++.-++.||.+|.
T Consensus       476 --iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 --IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --ccccceeehhhHHHHHHhhcCCcHHhc
Confidence              224555566677788888999999885

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-31  Score=240.64  Aligned_cols=252  Identities=19%  Similarity=0.343  Sum_probs=186.1

Q ss_pred             cccccCCceEEEEEEE-CCCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC-----CeEEEEE
Q 012392          190 NLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-----GECFLIY  262 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-----~~~~lv~  262 (464)
                      +-||-|+||.||..+. ++|+.||.|++..-- .-..-+.+.+|+++|..++|.|++..+++.  +..     .++|+|+
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL--QPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL--QPANPSFFQELYVLT  136 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc--CCCCchHHHHHHHHH
Confidence            6799999999999886 489999999875321 112335788999999999999999998875  322     2578899


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |.| ..||...+-..    ..|+-..+.-+++||++||.|||+-+     |.||||||-|.|+++|...||+|||+++..
T Consensus       137 ELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~-----ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  137 ELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN-----ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc-----hhhccCCCccEEeccCceEEeccccccccc
Confidence            999 55888887643    34777778889999999999999988     999999999999999999999999999976


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-------------------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-------------------  402 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-------------------  402 (464)
                      ..+..........|-.|.|||.+.+ +.|+...||||.||++.||+..+..|.........                   
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            5544333333445567999999976 56999999999999999999988776532211110                   


Q ss_pred             hhhHHHhhhhhcCCC-C--------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          403 SATFENFIDRNLKGK-F--------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       403 ~~~~~~~~~~~~~~~-~--------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ++.-..++....+.. .        +.....+...+...++..||+.|.+..+.+.++..
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            001111122212111 0        11223345566777889999999999999877643

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-28  Score=228.17  Aligned_cols=200  Identities=28%  Similarity=0.481  Sum_probs=167.7

Q ss_pred             CccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |...+.||.|++|.||++...+ ++.+|+|.+...........+.+|++.+.+++|+|++++++++.  .....++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEEEec
Confidence            4556789999999999999875 88999999986543325678899999999999999999999884  35678999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +++++|.+++.....   .+++.....++.+++.++.|||+.+     ++|+||++.||+++.++.++|+|||++.....
T Consensus        79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG-----IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            999999999975432   1789999999999999999999987     99999999999999999999999999887654


Q ss_pred             CceeeeeccCCCCccCccccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          345 DIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                      ..........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            320011122345679999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=234.01  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=185.6

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CCeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~  258 (464)
                      +|..+..+|.|.- .|..+... .++.||+|.+.... .....+...+|+.++..++|+||++++.++.-..    -.+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555567788776 55555433 57899999765432 1222345678999999999999999999873221    1358


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |+||||| ..+|.+.+...      ++-.++..|..|++.|+.|||+.+     |+||||||+||++..+..+||.|||+
T Consensus        97 y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~-----IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   97 YLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSAG-----IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc-----eeecccCcccceecchhheeeccchh
Confidence            9999999 66999988722      667788899999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh-------------
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-------------  405 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~-------------  405 (464)
                      ++....+  .....-..+.-|.|||++.+..+.+.+||||.||++.||++|+..|.+........+.             
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9865543  2233334556699999999888999999999999999999999877653322111100             


Q ss_pred             -----HHHhhh-----------hhcCCC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          406 -----FENFID-----------RNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       406 -----~~~~~~-----------~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                           ...++.           ...++.       .+........+++.+++-.||++|.+++++|+|.
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                 000000           000000       0112345678999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=249.52  Aligned_cols=198  Identities=21%  Similarity=0.295  Sum_probs=166.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHH-----HHHHHHHHHhcCC---CCCceeeeeEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEA-----EFVKGLYLLTSLR---HENIIRLRGFCCS  252 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~-----~f~~e~~~l~~l~---H~niv~l~g~~~~  252 (464)
                      ..|...+.+|.|+||.|+.|.++ +...|+||.+.++..-  .+.+     ..-.|+.+|..++   |+||++++.||  
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence            45888899999999999999986 5667999998765421  1111     2345899999997   99999999999  


Q ss_pred             CCCCeEEEEEecC-CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCe
Q 012392          253 RGRGECFLIYDFA-PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       253 ~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                      ++.+.+||+||-- ++-+|.+|+....    .+++.+..-|+.||+.|+++||+.+     |||||||-+||.++.+|-+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~-----ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG-----IVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC-----ceecccccccEEEecCCeE
Confidence            6688899999975 5779999997543    3889999999999999999999999     9999999999999999999


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCC-cchhHHHHHHHHHHHhCCCCCcc
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTE-RSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                      ||+|||.+........   ....||++|.|||++.+.+|-- .-|||++|++||-++....||++
T Consensus       710 klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999987655432   2335889999999999988854 47999999999999998888863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=257.51  Aligned_cols=254  Identities=18%  Similarity=0.283  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..+|.....+|.|.||.|||++.. .++..|||.++... .....-..+|+-+++..+|||||.++|-+..  ....|+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEEE
Confidence            345677789999999999999964 78999999998765 2233445679999999999999999998844  5678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||||.+|+|++.-+..    .+|+.-++....+...+||+|||+.+     -+|||||-.|||+++.+.+|++|||.+..
T Consensus        91 MEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~g-----k~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQG-----KIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             EEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCC-----cccccccccceeecccCceeecccCchhh
Confidence            9999999999987643    35888888899999999999999998     79999999999999999999999999887


Q ss_pred             ccCCceeeeeccCCCCccCccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++.... ......||+.|||||+.   ..+.|++++|||+.|+...|+-.-.+|.............-+...++ ....-
T Consensus       162 itati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-p~lkD  239 (829)
T KOG0576|consen  162 ITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-PTLKD  239 (829)
T ss_pred             hhhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-CcccC
Confidence            654322 22345688999999987   35679999999999999999987777765544322221111111111 11112


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ...-.+.+-++++.|+..+|.+||+++.++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            23456678899999999999999999988865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=230.99  Aligned_cols=133  Identities=21%  Similarity=0.318  Sum_probs=110.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-----C---CCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----H---ENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-----H---~niv~l~g~~~~~~  254 (464)
                      .+|...++||-|.|++||++... +.+.||+|+.+..  +......+.||++|++++     |   .+||+|+++|...+
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            57888899999999999999865 5688999987643  444556788999999983     2   47999999886544


Q ss_pred             C--CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE
Q 012392          255 R--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  325 (464)
Q Consensus       255 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill  325 (464)
                      .  .+++||+|+. +-+|..++....-  ..++...+.+|++||+.||.|||....    |||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecg----IIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECG----IIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcC----ccccCCCcceeee
Confidence            3  3799999999 8899999987543  238889999999999999999998753    9999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=222.32  Aligned_cols=248  Identities=19%  Similarity=0.339  Sum_probs=181.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      +.|.+.+.||+|.||.+-+++++ ..+.+++|.+...  ....++|.+|..---.| .|.||+.-+.... +..+.++.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEe
Confidence            44778899999999999999987 5678999987654  34567899998765555 5999998776432 556788899


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc--CCCCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfGl~  339 (464)
                      +||++.|||.+-+...     .+.+....+++.|+++||.|+|+++     +||||||.+||||-  +...+||+|||+.
T Consensus       101 qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn-----lVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN-----LVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             eccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc-----hhhcccccceEEEecCCccEEEeeecccc
Confidence            9999999999988653     2677778899999999999999998     99999999999993  3457999999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccccc---C--CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTT---G--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +..+...    ....-+..|.+||....   +  ...+.+|+|.||++++.++||+.||....-....-.++.++..+ .
T Consensus       171 ~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r-k  245 (378)
T KOG1345|consen  171 RKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR-K  245 (378)
T ss_pred             cccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc-c
Confidence            8665422    12223345999998643   2  24678999999999999999999997432222222233333322 1


Q ss_pred             CCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 012392          415 KGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIE  449 (464)
Q Consensus       415 ~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~  449 (464)
                      ....|   ...++.+.++..+-+..++.+|=...++-+
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            11222   234556777777888889998844444433

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-29  Score=224.38  Aligned_cols=247  Identities=21%  Similarity=0.395  Sum_probs=192.3

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      .+|.+...|+.|+|+++ |..+++|.++..... .-.++|..|.-.|+-+.||||+.++|.|  ..+....++..||+.|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeeccch
Confidence            56778889999999997 445666777665432 2236799999999999999999999999  5567789999999999


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCcee
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  348 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~  348 (464)
                      ||...|+...  .-..+-.+.++++.+||+||+|||+..   |-|.---|.++.|++|++.+++|+- +-.++     .+
T Consensus       273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsle---p~ipr~~lns~hvmidedltarism-ad~kf-----sf  341 (448)
T KOG0195|consen  273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE---PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SF  341 (448)
T ss_pred             HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc---hhhhhhhcccceEEecchhhhheec-cccee-----ee
Confidence            9999998643  335777889999999999999999986   4455557999999999999999862 11111     11


Q ss_pred             eeeccCCCCccCcccccccCCC---CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHH
Q 012392          349 SVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  425 (464)
Q Consensus       349 ~~~~~~~~~~y~aPE~~~~~~~---~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (464)
                      ......-.+.||+||.++...-   -...|+|||.++||||.|...||.........    ..+.-.+++..+++..+..
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----mkialeglrv~ippgis~h  417 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----MKIALEGLRVHIPPGISRH  417 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----hhhhhccccccCCCCccHH
Confidence            1111122356999999976543   24689999999999999999999765432221    2333456777888899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          426 LGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       426 l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +.+++.-|+++||.+||.+..|+-.|+.+
T Consensus       418 m~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  418 MNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            99999999999999999999999888765

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.4e-27  Score=212.24  Aligned_cols=167  Identities=16%  Similarity=0.203  Sum_probs=127.7

Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  347 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  347 (464)
                      |+|.+++....   ..++|.+++.|+.||++||.|||+.+           ||+|||++.++.+|+  ||+++...... 
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~-----------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA-----------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----------CcccEeEcCccceee--ccceEeecccc-
Confidence            78999997543   24999999999999999999999753           999999999999999  99988654321 


Q ss_pred             eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC--CCCHHHHH-
Q 012392          348 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSESEAA-  424 (464)
Q Consensus       348 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-  424 (464)
                           ..++..|||||++.+..++.++|||||||++|||+||+.|+............+..........  .......+ 
T Consensus        64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA  138 (176)
T ss_pred             -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence                 2467889999999999999999999999999999999999865432211111111111111110  11222333 


Q ss_pred             -HHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          425 -KLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       425 -~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                       .+.+++.+||+.||++||++.|++++++...+
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence             69999999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=4.1e-28  Score=235.52  Aligned_cols=259  Identities=17%  Similarity=0.241  Sum_probs=196.2

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC------CCCceeeeeEEEeC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR------HENIIRLRGFCCSR  253 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~------H~niv~l~g~~~~~  253 (464)
                      ....+|.+....|+|-|++|.+|... .|+.||||.|..+  +...+.=++|+++|++|+      --|.++|+-.|  .
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--~  504 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--K  504 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh--h
Confidence            34567888888999999999999865 5789999999865  344456678999999994      35889998877  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL  332 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~k  332 (464)
                      ..+++|||+|-+ ..+|.+.|..-+.. -.|....+..++.|+..||..|-.-+     |+|.||||.|||++++ ..+|
T Consensus       505 hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~-----vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  505 HKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG-----VLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             hcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC-----eeecccCccceEeccCcceee
Confidence            578999999987 66999999876543 34888889999999999999999877     9999999999999976 4579


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh------hhh-
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE------SAT-  405 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~------~~~-  405 (464)
                      |||||.|...........   ....-|.|||.+.+-.|+...|+||.||+||||.||+..|.+.......      .+. 
T Consensus       578 LCDfGSA~~~~eneitPY---LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENEITPY---LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCccccccccccccHH---HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            999999987765432111   1112399999999999999999999999999999999988753221110      000 


Q ss_pred             ---------H-HHhhhhhc--------------------------------CC--CCCH---HHHHHHHHHHHHhhhcCC
Q 012392          406 ---------F-ENFIDRNL--------------------------------KG--KFSE---SEAAKLGKMALVCTHEDP  438 (464)
Q Consensus       406 ---------~-~~~~~~~~--------------------------------~~--~~~~---~~~~~l~~l~~~C~~~dp  438 (464)
                               + .+.+|..+                                ..  .++.   .....+.+|+..|+..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence                     0 00001000                                00  1122   234567889999999999


Q ss_pred             CCCCCHHHHHHHHhh
Q 012392          439 ENRPTMEAVIEELTV  453 (464)
Q Consensus       439 ~~RPs~~evl~~L~~  453 (464)
                      ++|.|..|.|+|...
T Consensus       735 ~KRit~nqAL~HpFi  749 (752)
T KOG0670|consen  735 EKRITVNQALKHPFI  749 (752)
T ss_pred             hhcCCHHHHhcCCcc
Confidence            999999999988643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.4e-28  Score=266.36  Aligned_cols=202  Identities=16%  Similarity=0.187  Sum_probs=141.4

Q ss_pred             cCCC-CCceeeeeEEEeC-----CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012392          237 SLRH-ENIIRLRGFCCSR-----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  310 (464)
Q Consensus       237 ~l~H-~niv~l~g~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  310 (464)
                      .++| +||++++++|...     .....+.++||+ .++|.++|....   ..+++.+++.++.||++||+|||+++   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            3445 5788888876211     112456778888 669999997532   34899999999999999999999988   


Q ss_pred             CCeeecCCCCCceEEcC-------------------CCCeEEeeCCccccccCCce---------------eeeeccCCC
Q 012392          311 PAIVHRNLSVEKVLIDQ-------------------QFNPLIADCGLHKLLADDIV---------------FSVLKTSAA  356 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~-------------------~~~~kl~DfGl~~~~~~~~~---------------~~~~~~~~~  356 (464)
                        |+||||||+||||+.                   ++.+|++|||+++.......               .......+|
T Consensus       101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence              999999999999954                   45566777777654211000               000112356


Q ss_pred             CccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhc
Q 012392          357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHE  436 (464)
Q Consensus       357 ~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~  436 (464)
                      ..|||||++.+..++.++|||||||+||||++|..|+......      +.......+.... ........+++.+||+.
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~  251 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT------MSSLRHRVLPPQI-LLNWPKEASFCLWLLHP  251 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH------HHHHHHhhcChhh-hhcCHHHHHHHHHhCCC
Confidence            7799999999999999999999999999999988776432211      1111111111111 11234456888999999


Q ss_pred             CCCCCCCHHHHHHHHhhh
Q 012392          437 DPENRPTMEAVIEELTVA  454 (464)
Q Consensus       437 dp~~RPs~~evl~~L~~~  454 (464)
                      ||.+||+|.|++++.+..
T Consensus       252 ~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        252 EPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             ChhhCcChHHHhhchhhh
Confidence            999999999999876643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=6.7e-27  Score=223.05  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=193.2

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeC
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  253 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~  253 (464)
                      +....+.|..+++||.|.|+.||++.+.    ..+.||+|.+......   .....|+++|..+. +.||+++.+.+  .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~--r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCF--R  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhh--c
Confidence            3345567889999999999999999864    4678999999876533   35778999999995 99999999877  6


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL  332 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~k  332 (464)
                      .++...+|+||++..+..+++..       ++..++..+++.+..||.|+|.+|     ||||||||.|+|.+.. ..-.
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G-----IvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG-----IVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC-----ccccCCCccccccccccCCce
Confidence            67889999999999999999864       778889999999999999999999     9999999999999855 5578


Q ss_pred             EeeCCcccccc-----------------C--Cc---------------e---------eeeeccCCCCccCccccccc-C
Q 012392          333 IADCGLHKLLA-----------------D--DI---------------V---------FSVLKTSAAMGYLAPEYVTT-G  368 (464)
Q Consensus       333 l~DfGl~~~~~-----------------~--~~---------------~---------~~~~~~~~~~~y~aPE~~~~-~  368 (464)
                      |.||||+....                 .  ..               +         .......||.||.|||++.. .
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999987210                 0  00               0         00112357889999999864 5


Q ss_pred             CCCCcchhHHHHHHHHHHHhCCCCCcchHHHH------------------H-hhh------------------hHHHh-h
Q 012392          369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLA------------------A-ESA------------------TFENF-I  410 (464)
Q Consensus       369 ~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~------------------~-~~~------------------~~~~~-~  410 (464)
                      ..++++||||-||+++-+++++.||.......                  . ..+                  .++.+ +
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            67899999999999999999999885321100                  0 000                  00000 0


Q ss_pred             hhhcCCC--------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          411 DRNLKGK--------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       411 ~~~~~~~--------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .......        ..+..+..+++++.+|+..||.+|.|+++.|+|..
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF  383 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF  383 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence            0000000        01122347889999999999999999999998753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1e-24  Score=214.41  Aligned_cols=165  Identities=16%  Similarity=0.153  Sum_probs=126.1

Q ss_pred             hhcCCccccccccCCceEEEEEEEC--CCcEEEEEEeccCC----CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ...+|...+.||+|+||+||+|+.+  +++.||||.+....    .......|.+|+.+|++++|+|++..+..+     
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence            4456888899999999999999875  57888999875331    122345689999999999999998533221     


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC-CCCceEEcCCCCeEEe
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIA  334 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl-k~~Nill~~~~~~kl~  334 (464)
                      +..++||||+++++|... ..       ..   ...++.++++||.|||+.+     |+|||| ||+|||++.++.+||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~g-----IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRAG-----ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHCC-----CeeCCCCCcceEEEcCCCCEEEE
Confidence            347999999999999732 11       11   1467889999999999988     999999 9999999999999999


Q ss_pred             eCCccccccCCcee-------eeeccCCCCccCccccccc
Q 012392          335 DCGLHKLLADDIVF-------SVLKTSAAMGYLAPEYVTT  367 (464)
Q Consensus       335 DfGl~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~  367 (464)
                      |||+++........       ......++..|+|||++.-
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999876543211       1123345667999999854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=6.4e-23  Score=201.52  Aligned_cols=261  Identities=17%  Similarity=0.183  Sum_probs=191.4

Q ss_pred             CCccccccccCCceEEEEEEECCC--cEEEEEEeccCCCchHHHHHHHHHHHHhcCCC----CCceeeeeEEEeCCCCeE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH----ENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H----~niv~l~g~~~~~~~~~~  258 (464)
                      .|...+.||+|+||.||++...+.  ..+|+|........... .+..|..++..+.+    +++..+++... ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence            688889999999999999997643  57899987654322222 56678888888863    57888877652 235578


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-----CCeEE
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLI  333 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-----~~~kl  333 (464)
                      ++||+.. +.+|.++.....  ...++..+.+.|+.|++.+|++||+.|     ++||||||.|+++...     ..+.|
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G-----~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG-----FIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC-----cccCCcCHHHeeecCCCCcccceEEE
Confidence            9999988 889999876544  345999999999999999999999999     9999999999999855     46899


Q ss_pred             eeCCccc--cccCCce-----e-e-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh
Q 012392          334 ADCGLHK--LLADDIV-----F-S-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  404 (464)
Q Consensus       334 ~DfGl~~--~~~~~~~-----~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~  404 (464)
                      .|||+++  .......     . . .....||.+|.++....+...+.+.|+||++.++.|++.|..||........ ..
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~  247 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS  247 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH
Confidence            9999998  3321110     0 1 1234488999999999999999999999999999999999999865332111 11


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+................+..+.+++..+-..+..++|....+...|+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            1211111111111223344566667666667899999999999988766543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.3e-22  Score=197.34  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=194.4

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCCch--HHHHHHHHHHHHhcCCCC-CceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~f~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....|.+|+.+++.+.|+ |++++.+++  ......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEEEEE
Confidence            456678999999999999986  789999988765444  367899999999999988 799999988  3345579999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~~  341 (464)
                      +|+.+++|.+++...... ..+.......++.|++.++.|+|+.+     ++|||+||+||+++... .++++|||+++.
T Consensus        78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~-----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            999999999777654321 24788899999999999999999988     99999999999999988 799999999985


Q ss_pred             ccCCcee-----eeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          342 LADDIVF-----SVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       342 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      .......     ......++..|++||.+..   ..++...|+||+|++++++++|..|+........ .......+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~  230 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA-TSQTLKIILEL  230 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc-HHHHHHHHHhc
Confidence            5443221     2234557788999999987   5788899999999999999999998654432000 01111111111


Q ss_pred             cCC----CCCH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          414 LKG----KFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       414 ~~~----~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ...    ....    .....+.+++..|+..+|..|.++.+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111    1111    123578899999999999999999887765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1e-22  Score=203.89  Aligned_cols=214  Identities=25%  Similarity=0.383  Sum_probs=159.5

Q ss_pred             HhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCee
Q 012392          235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV  314 (464)
Q Consensus       235 l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~iv  314 (464)
                      |+.+.|.|+.+++|.+..  ....++|.+||..|+|.+.+....   ..++|.....++++|++||+|||..-    -..
T Consensus         1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~----i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP----IGY   71 (484)
T ss_pred             CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc----cee
Confidence            467889999999999965  477999999999999999998743   34999999999999999999999643    349


Q ss_pred             ecCCCCCceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccC---C----CCCcchhHHHHHHHHHH
Q 012392          315 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTG---R----FTERSDIFAFGVIILQI  386 (464)
Q Consensus       315 H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~---~----~~~~sDv~s~Gvll~el  386 (464)
                      |+.|+++|+++|..+.+||+|||+........... ........-|.|||.+...   .    .+.+.||||||++++|+
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999999999999999988764311101 1111122359999998653   1    46789999999999999


Q ss_pred             HhCCCCCcchHHHHHhhhhHHHhhh---hhcCCCCC-H-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          387 LTGSLVLTSSMRLAAESATFENFID---RNLKGKFS-E-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       387 ~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ++.+.||............+..+.+   ...++... . ...+.+..++..||.++|++||++++|-..+..+...
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999998753322111111111111   11222221 1 3345789999999999999999999999888776554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=7e-23  Score=214.20  Aligned_cols=252  Identities=19%  Similarity=0.270  Sum_probs=180.6

Q ss_pred             cccccccCCceEEEEEEEC-CCcEEEEEEec----cCCCchH-HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSIN----VTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ...++|.|.+|.|+..... .....+.|...    ....... ...+..|+.+-..++|||++..+..+.+  .....-+
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~~  399 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQS  399 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchhh
Confidence            4578999999977776543 33334444332    1111111 1226668888889999999887766532  3334445


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||++. ||..++....    .++..++-.++.|+..|+.|||+.+     |.|||+|++|++++.++.+||+|||.+..
T Consensus       400 mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G-----iahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG-----LAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             hhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC-----ceeccCccccEEEecCCceEEeecCccee
Confidence            999999 9999997542    3777888999999999999999999     99999999999999999999999999876


Q ss_pred             ccCCce---eeeeccCCCCccCcccccccCCCCCc-chhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-h---
Q 012392          342 LADDIV---FSVLKTSAAMGYLAPEYVTTGRFTER-SDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-N---  413 (464)
Q Consensus       342 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~---  413 (464)
                      ......   .......+...|+|||.+....|.+. .||||.||++..|++|+.||.........   +...... .   
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~---~~~~~~~~~~~~  546 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS---FKTNNYSDQRNI  546 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc---hhhhcccccccc
Confidence            543221   23334456667999999999999875 79999999999999999988644321110   0000000 0   


Q ss_pred             cCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 LKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+  ......+..-..++.++++.||.+|.|+++|++.-|..
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            000  11234566778899999999999999999999876654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=9.6e-22  Score=177.84  Aligned_cols=139  Identities=17%  Similarity=0.136  Sum_probs=106.9

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCch-H-------HHH-----------------HHHHHHHHhcCCCCCce
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-E-------EAE-----------------FVKGLYLLTSLRHENII  244 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------f~~e~~~l~~l~H~niv  244 (464)
                      ..||+|+||.||+|...+|+.||||.++...... .       ...                 ...|+..+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            6799999999999998889999999997642110 0       011                 23489999999887764


Q ss_pred             eeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCeeecCCCCCce
Q 012392          245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAIVHRNLSVEKV  323 (464)
Q Consensus       245 ~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~ivH~dlk~~Ni  323 (464)
                      ....+.  .  ...+|||||+++++|.......    ..+++.+...++.|++.+|.|| |+.+     |+||||||+||
T Consensus        83 ~p~~~~--~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g-----iiHrDlkP~NI  149 (190)
T cd05147          83 CPEPIL--L--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR-----LVHADLSEYNL  149 (190)
T ss_pred             CCcEEE--e--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHE
Confidence            433222  1  1238999999988776553221    2488899999999999999999 6777     99999999999


Q ss_pred             EEcCCCCeEEeeCCccccc
Q 012392          324 LIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       324 ll~~~~~~kl~DfGl~~~~  342 (464)
                      |+++ +.++|+|||++...
T Consensus       150 li~~-~~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-GKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-CcEEEEEccccccC
Confidence            9984 78999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=7.7e-22  Score=180.90  Aligned_cols=174  Identities=11%  Similarity=0.095  Sum_probs=133.8

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchH--HHH------HHHHHHHHhcCCCCCceeeeeEEEeC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE--EAE------FVKGLYLLTSLRHENIIRLRGFCCSR  253 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~------f~~e~~~l~~l~H~niv~l~g~~~~~  253 (464)
                      ..++|...++||.|+||.||+... ++..+|||.+.......+  ...      |.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999765 577899999975442221  122      57899999999999999998876533


Q ss_pred             C------CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          254 G------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       254 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      .      .+..+|||||+++.+|.++..        ++.    ....+++.+|..+|..+     ++|||++|.||+++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g-----i~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG-----MVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-----CccCCCChHHEEEeC
Confidence            2      235789999999999988742        222    34669999999999998     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL  387 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~  387 (464)
                      ++ ++|+|||.......+...             ..+.....+..++|+||||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88 999999988755322111             11334455677999999999877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=4.8e-21  Score=170.44  Aligned_cols=254  Identities=16%  Similarity=0.230  Sum_probs=189.7

Q ss_pred             hcCCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC-CCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...|..++.||+|+||.+|.|. ..+|..||||.-....   ...+...|..+...++| ..|..+..|.  .+...-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence            3568889999999999999997 5689999999765433   23356778888888875 4555555555  34556689


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG  337 (464)
                      |||.. +.||.+.+.-+..   .++..+.+-++-|++.-++|+|.++     +|||||||+|.|..-+   ..+-|+|||
T Consensus        89 VMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~-----fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN-----FIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             eeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc-----cccccCCccceeeccccccceEEEEecc
Confidence            99998 8899999876553   3899999999999999999999998     9999999999999744   457799999


Q ss_pred             ccccccCCc------eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          338 LHKLLADDI------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       338 l~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |++.+.+..      +.......||.+|.+-....+-..+.+.|+-|+|.+|.+..-|..||.+-.. .......+.+..
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka-~tk~QKyEkI~E  238 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA-ATKKQKYEKISE  238 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch-hhHHHHHHHHHH
Confidence            998764322      1222344578888887777766778899999999999999999999986432 223344444444


Q ss_pred             hhcCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          412 RNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       412 ~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ........   ...+.++...+..|-..--++-|...-+-+..
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            43332221   23467788888889888888888876655443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.4e-20  Score=171.37  Aligned_cols=253  Identities=18%  Similarity=0.204  Sum_probs=186.9

Q ss_pred             CCccccccccCCceEEEEEE-ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .|.+.++||+|.||.++.|+ +-+++.||||.-...   ++..++..|....+.|. -+.|...+-|-  +...+-.||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhh
Confidence            47888999999999999998 458999999975443   23334555666666664 67887775443  4445567899


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-----CCeEEeeCC
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLIADCG  337 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-----~~~kl~DfG  337 (464)
                      |.. +-||.++..-+..   .++..+...+|.|+..-++|+|++.     +|+|||||+|.||..-     ..+.+.|||
T Consensus       104 dLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~-----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD-----LIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc-----eeecccCccceeecCCCCCCCceEEEEecc
Confidence            998 8899999877653   3899999999999999999999998     9999999999999743     347899999


Q ss_pred             ccccccCCc------eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          338 LHKLLADDI------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       338 l~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      +++.+.+..      +.......||.+||+-....+.+.+.+.|.=|+|-++.+.+-|..||.+... .......+.+-+
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-~tnK~kYeKIGe  253 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-DTNKEKYEKIGE  253 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-cchHHHHHHhcc
Confidence            999875432      2223345789999999999999999999999999999999999999976432 122233444433


Q ss_pred             hhcCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          412 RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       412 ~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .......   .+..++++..-+...-+.+-++-|..+-+-..+.
T Consensus       254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            3222221   1234566666666666678888888766554443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.1e-20  Score=171.45  Aligned_cols=141  Identities=17%  Similarity=0.151  Sum_probs=110.0

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCch------------------------H-HHHHHHHHHHHhcCCCCCc
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS------------------------E-EAEFVKGLYLLTSLRHENI  243 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~-~~~f~~e~~~l~~l~H~ni  243 (464)
                      ...||+|+||.||+|+..+|+.||||.++......                        . ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36799999999999998789999999987653110                        0 1123578999999999988


Q ss_pred             eeeeeEEEeCCCCeEEEEEecCCCCCHHHH-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCC
Q 012392          244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE  321 (464)
Q Consensus       244 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~  321 (464)
                      .....+...    ..++||||++++++... +..     ..++..+...++.|++.+|.|||+ .+     |+||||||+
T Consensus        82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g-----ivHrDlkP~  147 (190)
T cd05145          82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG-----LVHGDLSEY  147 (190)
T ss_pred             CCceEEEec----CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCChh
Confidence            554444321    24899999988865443 332     136778889999999999999999 88     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccC
Q 012392          322 KVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      |||++ ++.++|+|||++.....
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCC
Confidence            99999 78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-21  Score=204.44  Aligned_cols=246  Identities=20%  Similarity=0.267  Sum_probs=174.4

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHH--HhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYL--LTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~--l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++...+.||+++|=+|.+|+.++|. |+||++-.....-....|.++++-  ...++|||.+.+.-+-  ......|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~--~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL--VTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH--HhhHHHHHHH
Confidence            3555688999999999999999887 889988654433333444443332  5556899999987654  3345567888


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc-
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~-  341 (464)
                      +|.. -+|.+.|..+.    -|...+..-|+.|++.||.-+|..+     |+|||||.+||||++-.-+.|+||..-+. 
T Consensus       101 qyvk-hnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g-----VcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG-----VCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHh-hhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC-----ccccccccceEEEeeechhhhhcccccCCc
Confidence            8884 48998886433    3777888899999999999999998     99999999999999998899999987543 


Q ss_pred             -ccCCc----eeeeeccCCCCccCcccccccC-----------CCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhh
Q 012392          342 -LADDI----VFSVLKTSAAMGYLAPEYVTTG-----------RFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESA  404 (464)
Q Consensus       342 -~~~~~----~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~  404 (464)
                       +..+.    .+-......-.+|+|||.+...           ..+++.||||.||++.||++- +++|.-+.......+
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~  250 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG  250 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence             22221    1112222233579999987431           156789999999999999774 555643322111111


Q ss_pred             ---hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          405 ---TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       405 ---~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                         ..+..+. .       -+...+++++..|++.||++|.++++.|+.-
T Consensus       251 ~~~~~e~~Le-~-------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  251 NADDPEQLLE-K-------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             CccCHHHHHH-h-------CcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence               1111111 1       1122588999999999999999999999863

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.9e-20  Score=165.03  Aligned_cols=186  Identities=13%  Similarity=0.055  Sum_probs=134.8

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCch---HHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEe
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS---EEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +...|++|+||+||.+.- ++..++.+.+.....-.   ....|.+|+++|+++. |+++++++++      +..+++||
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme   78 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS   78 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence            457899999999997765 67788888776543211   1125789999999995 5889999885      23589999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC-CCCceEEcCCCCeEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl-k~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |+.+.+|.+.+..           ....++.|++.+|.++|+.+     |+|||| ||+|||+++++.++|+|||++...
T Consensus        79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G-----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG-----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc-----CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            9999998754321           01357789999999999998     999999 799999999999999999999855


Q ss_pred             cCCce-----e-e------eeccCCCCccCccccccc-CCCC-CcchhHHHHHHHHHHHhCCCCCcch
Q 012392          343 ADDIV-----F-S------VLKTSAAMGYLAPEYVTT-GRFT-ERSDIFAFGVIILQILTGSLVLTSS  396 (464)
Q Consensus       343 ~~~~~-----~-~------~~~~~~~~~y~aPE~~~~-~~~~-~~sDv~s~Gvll~el~tg~~p~~~~  396 (464)
                      .....     . .      ......+..|++|+-..- ...+ ...+.++-|.-+|.++|++.+..+.
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            43221     0 0      001113345666654321 1223 4578899999999999999877543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.4e-21  Score=193.05  Aligned_cols=226  Identities=22%  Similarity=0.344  Sum_probs=177.2

Q ss_pred             ccccCCceEEEEEE----ECCCcEEEEEEeccCCCchHH-HHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEec
Q 012392          191 LLGKGNFSSVYKGT----LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~~~-~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      .+|+|.||.|++++    .+.|..+|.|.++........ .....|..++..++ ||.+|++.-.+  +.....+++.+|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence            37899999998765    235778899887754422211 13455778888887 99999997655  667789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      ..+|+|...+....    .++......+...+|-+++++|+.+     |+|||+|++||+++.+|.+++.|||+++..-.
T Consensus        79 ~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~-----iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG-----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             cccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH-----HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            99999999887543    2666677788889999999999998     99999999999999999999999999997654


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      ....     -||..|||||.+.  .....+|.||||++++||+||..||...        ....+.  .....++.....
T Consensus       150 ~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------~~~~Il--~~~~~~p~~l~~  212 (612)
T KOG0603|consen  150 EKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------TMKRIL--KAELEMPRELSA  212 (612)
T ss_pred             hhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------HHHHHh--hhccCCchhhhH
Confidence            3322     4677899999987  4567899999999999999999999761        111211  123456777788


Q ss_pred             HHHHHHHHhhhcCCCCCCCH
Q 012392          425 KLGKMALVCTHEDPENRPTM  444 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~  444 (464)
                      ...+++...+..+|..|.-.
T Consensus       213 ~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhcc
Confidence            88888888888899888654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=8.8e-20  Score=172.96  Aligned_cols=195  Identities=17%  Similarity=0.271  Sum_probs=139.7

Q ss_pred             CCCCceeeeeEEEeC-------------------------CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHH
Q 012392          239 RHENIIRLRGFCCSR-------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII  293 (464)
Q Consensus       239 ~H~niv~l~g~~~~~-------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  293 (464)
                      +|||||++.++|+++                         .+..+|+||.-.+. +|.+||..+.     .+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence            699999999887542                         12357889887744 9999997543     4555667799


Q ss_pred             HHHHHHHHHHhcCCCCCCCeeecCCCCCceEE--cCCC--CeEEeeCCccccccCC---cee--eeeccCCCCccCcccc
Q 012392          294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQF--NPLIADCGLHKLLADD---IVF--SVLKTSAAMGYLAPEY  364 (464)
Q Consensus       294 ~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill--~~~~--~~kl~DfGl~~~~~~~---~~~--~~~~~~~~~~y~aPE~  364 (464)
                      .|+++|..|||.++     |.|||+|++|||+  |+|.  ...|+|||.+---...   ..+  ......|...-||||.
T Consensus       348 aQlLEav~hL~~hg-----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG-----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHcc-----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            99999999999998     9999999999999  3443  3578999976422111   111  1122234556899998


Q ss_pred             cccCC--C----CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCC
Q 012392          365 VTTGR--F----TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP  438 (464)
Q Consensus       365 ~~~~~--~----~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp  438 (464)
                      .....  .    -.|+|.|+.|.+.||+++...||+.......+...+.+--    -+..++.++..+.+++...++.||
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q----LPalp~~vpp~~rqlV~~lL~r~p  498 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ----LPALPSRVPPVARQLVFDLLKRDP  498 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh----CCCCcccCChHHHHHHHHHhcCCc
Confidence            75422  1    3589999999999999999999998554444444433322    233455666778889999999999


Q ss_pred             CCCCCHHHHH
Q 012392          439 ENRPTMEAVI  448 (464)
Q Consensus       439 ~~RPs~~evl  448 (464)
                      ++|++..-..
T Consensus       499 skRvsp~iAA  508 (598)
T KOG4158|consen  499 SKRVSPNIAA  508 (598)
T ss_pred             cccCCccHHH
Confidence            9999865443

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=2.6e-19  Score=163.60  Aligned_cols=138  Identities=22%  Similarity=0.328  Sum_probs=104.4

Q ss_pred             ccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-----CCCCceeeeeEEEeCCC-CeEE-
Q 012392          187 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-----RHENIIRLRGFCCSRGR-GECF-  259 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-----~H~niv~l~g~~~~~~~-~~~~-  259 (464)
                      +..+.||+|+||.||. .-.++.. +||++.... .....++.+|+.+++.+     .||||++++|++..... +..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999996 2234444 799887643 23456789999999999     57999999999854321 2333 


Q ss_pred             EEEec--CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCCCeeecCCCCCceEEcC----CCCeE
Q 012392          260 LIYDF--APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI-GYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNPL  332 (464)
Q Consensus       260 lv~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~~ivH~dlk~~Nill~~----~~~~k  332 (464)
                      +|+||  +++|+|.+++.+..     +++.  ..++.+++.++ +|||+++     |+||||||+|||++.    ++.++
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~-----IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR-----IVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEeccCCCCCcEE
Confidence            78999  55799999996521     4544  35678888888 9999998     999999999999974    34799


Q ss_pred             EeeCCcc
Q 012392          333 IADCGLH  339 (464)
Q Consensus       333 l~DfGl~  339 (464)
                      |+||+.+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=2.9e-19  Score=168.80  Aligned_cols=234  Identities=19%  Similarity=0.286  Sum_probs=149.7

Q ss_pred             ccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCC-----------CCceeeeeEEE-
Q 012392          187 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRH-----------ENIIRLRGFCC-  251 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H-----------~niv~l~g~~~-  251 (464)
                      ...+.||.|+++.||.++.. +++.+|||......  ......++.+|......+.+           .-++.+ +... 
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i   93 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRI   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEE
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEE
Confidence            34578999999999999986 58999999875443  22334566666655555332           111111 1110 


Q ss_pred             -------eCCC--C-----eEEEEEecCCCCCHHHHhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCee
Q 012392          252 -------SRGR--G-----ECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV  314 (464)
Q Consensus       252 -------~~~~--~-----~~~lv~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~iv  314 (464)
                             ....  .     ..+++|+-+ .+||.+++..   .......+....++.+..|+++.+++||+.+     +|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-----lV  167 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-----LV  167 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-----eE
Confidence                   0000  1     246788877 6799888643   2222223556677888899999999999999     99


Q ss_pred             ecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC--------CCCCcchhHHHHHHHHHH
Q 012392          315 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--------RFTERSDIFAFGVIILQI  386 (464)
Q Consensus       315 H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~sDv~s~Gvll~el  386 (464)
                      |+||+|+|++++++|.+.|+||+.....+.....    ...+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999877655432111    2344679999976432        478899999999999999


Q ss_pred             HhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCC
Q 012392          387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR  441 (464)
Q Consensus       387 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~R  441 (464)
                      .++..|+...........         .-.... +.++.+..|+...++.||++|
T Consensus       244 WC~~lPf~~~~~~~~~~~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999975432211111         111233 778889999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=6e-18  Score=155.97  Aligned_cols=135  Identities=14%  Similarity=0.284  Sum_probs=110.6

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCch-------HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.||+|++|.||+|+. +|..|+||.........       ....+.+|+.++..++|+|+.....++..  ....++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEE
Confidence            5789999999999987 57789999765432111       12357889999999999998876666533  34578999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||+++++|.+++...       .+ .+..++.+++.+|.+||+.+     ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~-----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG-----IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC-----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998642       22 78899999999999999988     99999999999999 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=6.4e-18  Score=154.30  Aligned_cols=146  Identities=18%  Similarity=0.129  Sum_probs=111.9

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCc---------------------hHHHHHHHHHHHH
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---------------------SEEAEFVKGLYLL  235 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~f~~e~~~l  235 (464)
                      .++...-..|...+.||+|+||.||++...+|+.||||+++.....                     .....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444444447778999999999999999888999999987643200                     0112356788899


Q ss_pred             hcCCCCC--ceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 012392          236 TSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI  313 (464)
Q Consensus       236 ~~l~H~n--iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~i  313 (464)
                      ..+.|++  +...++.      ...++||||+++++|......          .....++.+++.++.++|+.+     |
T Consensus        88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g-----i  146 (198)
T cd05144          88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG-----I  146 (198)
T ss_pred             HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC-----C
Confidence            9998874  4444432      235899999999999765431          124568899999999999988     9


Q ss_pred             eecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          314 VHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       314 vH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      +||||||+||++++++.++|+|||.+....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2.8e-18  Score=183.40  Aligned_cols=195  Identities=19%  Similarity=0.272  Sum_probs=150.5

Q ss_pred             HHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCC
Q 012392          180 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRG  256 (464)
Q Consensus       180 ~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~  256 (464)
                      +..-..|.+.+.||+|+||+||+|...+|+.||+|.-+....    -+|.--.+++.+|+   -+-|..+...+.  -.+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~--~~~  767 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHV--FQN  767 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHc--cCC
Confidence            334455788899999999999999998899999998765432    24444455666666   122333322222  244


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-------CCC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-------QQF  329 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-------~~~  329 (464)
                      ..+||+||.+.|+|.+++..    ...++|.-.+.++.|+++-+++||..+     |||+||||+|.||.       ++.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~-----IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG-----IIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc-----eecccCCcceeEeecccCCCCccc
Confidence            56899999999999999983    345899999999999999999999998     99999999999994       345


Q ss_pred             CeEEeeCCccccc---cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 012392          330 NPLIADCGLHKLL---ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL  391 (464)
Q Consensus       330 ~~kl~DfGl~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~  391 (464)
                      .++|+|||-+-.+   .+..  .......|-++-.+|...++.++...|-|.++.+++-|+-|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~--~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGT--KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCc--EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            6899999998644   2322  2223345667889999999999999999999999999999863

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=6.1e-18  Score=177.34  Aligned_cols=141  Identities=16%  Similarity=0.217  Sum_probs=110.5

Q ss_pred             HhhcCCccccccccCCceEEEEEEECCCcEEEEEE-eccC-CCc-----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVT-SCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR  253 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~-~~~-----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~  253 (464)
                      .....|...+.||+|+||.||+|.+.+.. +++|. .... ..+     .....+.+|+.++.+++|+|++....++.. 
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-  407 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-  407 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-
Confidence            33445566789999999999999886544 33333 2211 111     123468899999999999999987776643 


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                       ....++||||+++++|.+++.            ....++.+++.+|.|||+.+     ++||||||+|||+ +++.++|
T Consensus       408 -~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g-----iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        408 -PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG-----IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             -CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC-----CccCCCChHHEEE-ECCcEEE
Confidence             345689999999999999885            24678999999999999988     9999999999999 6779999


Q ss_pred             eeCCccccc
Q 012392          334 ADCGLHKLL  342 (464)
Q Consensus       334 ~DfGl~~~~  342 (464)
                      +|||+++..
T Consensus       469 iDFGla~~~  477 (535)
T PRK09605        469 IDFGLGKYS  477 (535)
T ss_pred             EeCcccccC
Confidence            999998753

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=8.7e-18  Score=157.17  Aligned_cols=144  Identities=15%  Similarity=0.097  Sum_probs=109.5

Q ss_pred             CCccccccccCCceEEEEEE--ECCCcEEEEEEeccCCCc-------------------h----HHHHHHHHHHHHhcCC
Q 012392          185 CFSEVNLLGKGNFSSVYKGT--LRDGTLVAIRSINVTSCK-------------------S----EEAEFVKGLYLLTSLR  239 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~-------------------~----~~~~f~~e~~~l~~l~  239 (464)
                      .|...+.||+|+||.||+|.  ..+|+.||||.++.....                   .    ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36778999999999999998  568999999998754210                   0    1123567999999997


Q ss_pred             CC--CceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecC
Q 012392          240 HE--NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN  317 (464)
Q Consensus       240 H~--niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~d  317 (464)
                      +.  .+.+++++      ...++||||+++++|..+....    ..+...+...++.||+.+|.|||+.+.    |+|||
T Consensus       109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g~----iiH~D  174 (237)
T smart00090      109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEGE----LVHGD  174 (237)
T ss_pred             hcCCCCCeeeEe------cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcCC----EEeCC
Confidence            53  34444442      1247999999998887664322    124555678899999999999998762    89999


Q ss_pred             CCCCceEEcCCCCeEEeeCCcccccc
Q 012392          318 LSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       318 lk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |||+||+++ +++++|+|||.+....
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 8899999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=9.9e-18  Score=153.08  Aligned_cols=131  Identities=18%  Similarity=0.288  Sum_probs=103.8

Q ss_pred             ccccCCceEEEEEEECCCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      .||+|+||.||+|.+ ++..|++|........       ....++.+|+.++..++|+++.....++..  ....++|||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEE
Confidence            489999999999986 5778999986543211       112457789999999998876544444433  344689999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |+++++|.+++....     .      .++.+++.+|.+||+.+     ++|+|++|.||+++ ++.+++.|||+++.
T Consensus        78 ~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g-----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG-----IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC-----eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999875421     1      78999999999999988     99999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=4.1e-18  Score=167.97  Aligned_cols=176  Identities=20%  Similarity=0.347  Sum_probs=131.8

Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..+|.|++|...+|.+||..+... ...+|...+.++.|++.|++|   ++     .+|+|+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k~-----~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---KG-----LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---cc-----chhhhccccccccccchhhhhhhh
Confidence            478999999999999999865533 347888999999999999999   66     899999999999999999999999


Q ss_pred             CccccccCCc-----eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          337 GLHKLLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       337 Gl~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |+........     ........+|..||+||.+.++.|+.|+||||+|++|+||++-   |....   ...+.+.++-+
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~---er~~t~~d~r~  474 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQF---ERIATLTDIRD  474 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHH---HHHHhhhhhhc
Confidence            9987665443     2334455688899999999999999999999999999999882   11111   12223333333


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI  448 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl  448 (464)
                      ..+...+-.+. ..-+.++.++++..|.+||++.++.
T Consensus       475 g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  475 GIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             CCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence            22221211122 2335788899999999999655543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=4.7e-17  Score=171.16  Aligned_cols=206  Identities=22%  Similarity=0.348  Sum_probs=142.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .+|..++++..|+||.||..+++ ..+.+|.|.-+.+.             ++     +||..+.        +..++| 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------------il-----Rnilt~a--------~npfvv-  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------------IL-----RNILTFA--------GNPFVV-  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccch-------------hh-----hcccccc--------CCccee-
Confidence            45778899999999999999876 35667774322111             11     1233321        123344 


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                           ||-...+.....    ++-        +++.+++|||+.+     |+|||+||+|.+|..-|.+|++|||+++..
T Consensus       136 -----gDc~tllk~~g~----lPv--------dmvla~Eylh~yg-----ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP----LPV--------DMVLAVEYLHSYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             -----chhhhhcccCCC----Ccc--------hhhHHhHhhccCC-----eecCCCCCCcceeeecccccccchhhhhhh
Confidence                 555555543221    221        2378999999988     999999999999999999999999998754


Q ss_pred             cCCc--------------eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          343 ADDI--------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       343 ~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      ....              -+......+|+.|+|||++..+.|...+|+|++|+++||.+.|..||.+....    ..+..
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe----elfg~  269 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQ  269 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH----HHHhh
Confidence            2111              01122346788999999999999999999999999999999999999876432    11222


Q ss_pred             hhhhhc-CCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 012392          409 FIDRNL-KGKFSESEAAKLGKMALVCTHEDPENRP  442 (464)
Q Consensus       409 ~~~~~~-~~~~~~~~~~~l~~l~~~C~~~dp~~RP  442 (464)
                      ++.... ...-.+....+.++++.+.++.+|.+|-
T Consensus       270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            222211 1222445567788999999999999993

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=5.1e-16  Score=140.26  Aligned_cols=137  Identities=18%  Similarity=0.189  Sum_probs=96.9

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCchH-HHHH----------------------HHHHHHHhcCCCCC--c
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEF----------------------VKGLYLLTSLRHEN--I  243 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~f----------------------~~e~~~l~~l~H~n--i  243 (464)
                      .+.||+|+||.||+|...+++.||||.++....... ...+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            367999999999999988899999998875431111 1111                      24555566654432  4


Q ss_pred             eeeeeEEEeCCCCeEEEEEecCCCCCHHHH-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCC
Q 012392          244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE  321 (464)
Q Consensus       244 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~  321 (464)
                      .+.++.      ...++||||++++++... +....     .. .....++.+++.++.++|+ .+     |+|+||||+
T Consensus        82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~-----ivH~Dl~p~  144 (187)
T cd05119          82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG-----LVHGDLSEY  144 (187)
T ss_pred             CceEec------CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC-----cCcCCCChh
Confidence            444432      135899999998554321 11110     11 4567899999999999998 76     999999999


Q ss_pred             ceEEcCCCCeEEeeCCcccccc
Q 012392          322 KVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      ||+++ ++.++|+|||.+....
T Consensus       145 Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         145 NILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hEEEE-CCcEEEEECccccccc
Confidence            99999 8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.5e-15  Score=131.27  Aligned_cols=135  Identities=16%  Similarity=0.153  Sum_probs=110.7

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC--CCceeeeeEEEeCCCCeEEEEEecC
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.+.||+|.++.||+++..+ ..++||.......   ...+.+|+.++..++|  .++++++++.  ...+..++++||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEEec
Confidence            34679999999999999854 7899998865432   4578899999999976  5899988876  4446789999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +++++..+           +......++.+++++|++||...  ...++|+|++|+||++++++.+++.|||.+..
T Consensus        76 ~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~--~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLP--LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCC--ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            88777644           44566778999999999999753  24599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=3.5e-15  Score=139.83  Aligned_cols=138  Identities=15%  Similarity=0.136  Sum_probs=105.4

Q ss_pred             ccccc-cCCceEEEEEEECCCcEEEEEEeccCC------------CchHHHHHHHHHHHHhcCCCCCc--eeeeeEEEeC
Q 012392          189 VNLLG-KGNFSSVYKGTLRDGTLVAIRSINVTS------------CKSEEAEFVKGLYLLTSLRHENI--IRLRGFCCSR  253 (464)
Q Consensus       189 ~~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~f~~e~~~l~~l~H~ni--v~l~g~~~~~  253 (464)
                      ...|| .|+.|+||+.... +..++||.+....            .......+.+|+.++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999885 6678888875321            01223467889999999998875  6777765332


Q ss_pred             CCC--eEEEEEecCCC-CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          254 GRG--ECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       254 ~~~--~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      ...  ..++|+||+++ .+|.+++...     .++..    .+.+|+.+|.+||+.+     |+||||||.|||++.++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G-----I~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG-----VYHADLNAHNILLDPDGK  180 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC-----CCCCCCCchhEEEcCCCC
Confidence            221  23599999997 6999988542     24432    3678999999999998     999999999999999889


Q ss_pred             eEEeeCCcccc
Q 012392          331 PLIADCGLHKL  341 (464)
Q Consensus       331 ~kl~DfGl~~~  341 (464)
                      ++|+|||.++.
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=1.8e-15  Score=140.82  Aligned_cols=206  Identities=21%  Similarity=0.284  Sum_probs=143.2

Q ss_pred             HHhcCCCCCceeeeeEEEeC---CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012392          234 LLTSLRHENIIRLRGFCCSR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  310 (464)
Q Consensus       234 ~l~~l~H~niv~l~g~~~~~---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  310 (464)
                      -|-++.|.|||+++.|+.+.   +..+..+++|||.-|+|.+||+........+......+++-||..||.|||+   +.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs---~~  196 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS---CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc---cC
Confidence            35556799999999887432   2335778999999999999999866555556666778899999999999997   46


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccccCC----ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHH
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI  386 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el  386 (464)
                      |+|+|+++..+.|++..++-+|+.- +........    .........+-.+|.+||+-.....+..+|||+||...+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            9999999999999999998888752 211111110    01111122345689999998877888899999999999999


Q ss_pred             HhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       387 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      .-+......+.........+...+-.        .+...-++++..|++..|..||+|++++.|.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheee--------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            88765433221111111111111110        0111224567789999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=3.8e-16  Score=163.71  Aligned_cols=255  Identities=18%  Similarity=0.253  Sum_probs=181.7

Q ss_pred             CccccccccCCceEEEEEEEC--CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      |...+.||+|.|+.|-.....  ....+|+|.+.... ..........|..+-..+. |+|++++++..  ......+++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~~   99 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLLS   99 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccccc
Confidence            445567999999999887754  34456776655442 1111122334666666676 99999999976  557788999


Q ss_pred             EecCCCCCHHHHh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCc
Q 012392          262 YDFAPKGKLSKYL-DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl  338 (464)
                      .||..+|++...+ +...   ...+....-.++.|+..++.|+| ..+     +.|||+||+|.+++.++ ..+++|||+
T Consensus       100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~-----~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG-----VTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc-----cccCCCCCccchhccCCCcccCCCchh
Confidence            9999999999988 3321   12444556678999999999999 766     99999999999999999 999999999


Q ss_pred             cccccC--CceeeeeccCC-CCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          339 HKLLAD--DIVFSVLKTSA-AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       339 ~~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +..+..  ..........+ +..|+|||...+. -.....|+||.|+++.-+++|..|+.........   ...+.....
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~~  248 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---YSSWKSNKG  248 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---ceeeccccc
Confidence            987655  33333344455 7889999998874 4466789999999999999999998765432211   111221111


Q ss_pred             C--CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          415 K--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       415 ~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .  ............++...++..+|+.|.+.+++...-+.
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~  289 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWL  289 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhccccccccccccc
Confidence            1  11223344556777788888999999999988765443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=9.2e-14  Score=141.39  Aligned_cols=143  Identities=17%  Similarity=0.228  Sum_probs=102.7

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchH---------------------------------------HHHHHH
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE---------------------------------------EAEFVK  230 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~f~~  230 (464)
                      +-||.|++|.||+|++++|+.||||..+....+.-                                       +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999999999999999865421110                                       113555


Q ss_pred             HHHHHhcC----CCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 012392          231 GLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK-GIGYLHS  305 (464)
Q Consensus       231 e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~  305 (464)
                      |...+.++    +|.+-+.+-..+++. ....+|||||+++++|.++.......   .+   +..++..++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHHHHHHh
Confidence            66555555    233334443444322 33468999999999999887542211   22   3456666666 4688898


Q ss_pred             CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       306 ~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      .+     ++|+|++|.||++++++.+++.|||++..+..
T Consensus       276 ~g-----~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG-----FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC-----ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            87     99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=8.8e-14  Score=140.01  Aligned_cols=248  Identities=21%  Similarity=0.268  Sum_probs=173.7

Q ss_pred             CCcccccccc--CCceEEEEEEE---CCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCe
Q 012392          185 CFSEVNLLGK--GNFSSVYKGTL---RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       185 ~f~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~  257 (464)
                      .|...+.+|.  |.+|.||.++.   .++..+|+|.-+.... ......=++|.....+++ |+|.++....+  .+.+.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~  192 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGI  192 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCCc
Confidence            3555678899  99999999987   3788899997332211 111222345566666664 99999977766  55778


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK----GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL  332 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~k  332 (464)
                      .++-+|++ +.+|.++.+....   .++....+.+..+...    ||.++|+.+     ++|-|+||.||++.++ ..++
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~-----~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN-----IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc-----ccccccchhheecccccceee
Confidence            89999988 5799998876432   2555556667777777    999999987     9999999999999999 8899


Q ss_pred             EeeCCccccccCCceee----eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          333 IADCGLHKLLADDIVFS----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      ++|||+.....+.....    .....+...|++||.+. +-++..+|+|++|.+..|..++..+.....     ...|.+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~  337 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQ  337 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccc
Confidence            99999998776543211    11223445699999754 567889999999999999999876554321     011111


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE  449 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~  449 (464)
                      .-...++..+.......+...+..+++++|-.|++.+.+..
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11111223333344455666888899999999999887764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=8.6e-13  Score=135.99  Aligned_cols=148  Identities=11%  Similarity=0.144  Sum_probs=95.9

Q ss_pred             hcCCccccccccCCceEEEEEEECC-CcEEEEEEeccCCCch--------------------------------------
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKS--------------------------------------  223 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------------  223 (464)
                      ...|+. +-||+|++|.||+|++++ |+.||||+.+....+.                                      
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999987 9999999997542100                                      


Q ss_pred             -HHHHHHHHHHHHhcCC----CCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHh--hhhcCCCCCCCHHHHHHHHHHH
Q 012392          224 -EEAEFVKGLYLLTSLR----HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGI  296 (464)
Q Consensus       224 -~~~~f~~e~~~l~~l~----H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i  296 (464)
                       .+-+|.+|...+.+++    +.+.+.+-.++++- ....+|||||++|+.+.++-  .........+.......++.|+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence             0113455555555542    44444443444322 24568999999999998753  2211000112222222333333


Q ss_pred             HHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeEEeeCCccccccC
Q 012392          297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLIADCGLHKLLAD  344 (464)
Q Consensus       297 a~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfGl~~~~~~  344 (464)
                             +..+     ++|+|+||.||+++.++    .+++.|||+...+..
T Consensus       277 -------f~~G-----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FRDG-----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HhCC-----eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3455     99999999999999988    999999999887754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=3.9e-12  Score=112.74  Aligned_cols=131  Identities=18%  Similarity=0.077  Sum_probs=96.4

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCce-eeeeEEEeCCCCeEEEEEecCCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII-RLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv-~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      +.|+.|.++.||+++.. +..|++|.......  ....+.+|..++..+.+.+++ +++.+.  .  ...++||||+++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence            56788999999999875 77899998754421  223467888888888655544 555443  2  2347999999998


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ++...    .     ..   ...++.+++++|+.||+.+.....++|+|++|.||+++ ++.+++.||+.+.
T Consensus        77 ~l~~~----~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE----D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc----c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87643    0     11   13456789999999998763344579999999999999 6689999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.4e-12  Score=131.43  Aligned_cols=248  Identities=20%  Similarity=0.209  Sum_probs=174.1

Q ss_pred             hhcCCccccccccCCceEEEEEEEC--CCcEEEEEEeccCCCchHHHHH-HHHHHHHhcC-CCCCceeeeeEEEeCCCCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAEF-VKGLYLLTSL-RHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~f-~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  257 (464)
                      .+..|..+..||.|.|+.|++...+  ++..+++|.+.........+.| +.|+.+...+ .|.+++++...+.  ....
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--cccc
Confidence            4456888999999999999988754  6788999987765533333222 4566666666 4888888665442  2345


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEeeC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADC  336 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df  336 (464)
                      .++=-||++++++...+.-    ...++...++.+..|++.++.++|+..     ++|+|+||+||++..+ +..++.||
T Consensus       341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~-----~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL-----FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh-----hhcccccccceeeccchhhhhcccc
Confidence            6688899999999877732    233777788999999999999999887     9999999999999886 88899999


Q ss_pred             CccccccCCceeeeeccCCCCccC--cccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYL--APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |.+..+.-.   ..... ...+++  +++......+..+.|++|||.-+.|.+++...........       .+... .
T Consensus       412 ~~~t~~~~~---~~~~~-~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~-~  479 (524)
T KOG0601|consen  412 GCWTRLAFS---SGVFH-HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG-D  479 (524)
T ss_pred             cccccccee---ccccc-ccccccccchhhccccccccccccccccccccccccCcccCcccccce-------eeecc-c
Confidence            988643211   11111 122334  5555667778899999999999999999976544332111       11111 1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      -.. .......+..+.......++..||.+.++..+...
T Consensus       480 ~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  480 TPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            111 12222677778888889999999999988766543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.27  E-value=1.2e-10  Score=118.87  Aligned_cols=167  Identities=16%  Similarity=0.191  Sum_probs=119.9

Q ss_pred             ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCC
Q 012392          205 LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL  284 (464)
Q Consensus       205 ~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l  284 (464)
                      ..++.+|.|...+.... .......+.++.|+.++||||++++...  +..+..|||+|-+.  -|..++...       
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~--Pl~~~lk~l-------  101 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVR--PLETVLKEL-------  101 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeeccc--cHHHHHHHh-------
Confidence            34788899888876553 3334466788899999999999999876  44567999999873  466677542       


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccc
Q 012392          285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY  364 (464)
Q Consensus       285 ~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~  364 (464)
                      .-....-.+.||+.||.|||..+.    ++|++|.-..|++++.|.-||.+|-+......... .......-..|..|+.
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~----lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCN----LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEE  176 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCC----eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhh
Confidence            233445578899999999996653    99999999999999999999999988754432110 0000001123667765


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHhCC
Q 012392          365 VTTGRFTERSDIFAFGVIILQILTGS  390 (464)
Q Consensus       365 ~~~~~~~~~sDv~s~Gvll~el~tg~  390 (464)
                      +....  -..|.|-||+++||++.|.
T Consensus       177 ~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  177 IDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCccc--cchhhhhHHHHHHHHhCcc
Confidence            43222  3469999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=7.7e-11  Score=109.06  Aligned_cols=147  Identities=18%  Similarity=0.232  Sum_probs=109.7

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC--CCceeeeeEEEeCC-CCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRG-RGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~-~~~~~lv~E~~~  266 (464)
                      +.|+.|.++.||+++..+|..+++|............++.+|.++++.+++  .++.+++.+..... .+..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999877788999987654322234567889999999875  44677777652211 124689999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------------
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--------------------------------------  308 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--------------------------------------  308 (464)
                      +.++.+.+..     ..++...+..++.+++++|.+||+...                                      
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776532     126777788889999999999986321                                      


Q ss_pred             -------------CCCCeeecCCCCCceEEcC--CCCeEEeeCCcccc
Q 012392          309 -------------NKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHKL  341 (464)
Q Consensus       309 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~DfGl~~~  341 (464)
                                   ....++|+|+.+.||+++.  +..+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         1356799999999999998  56688999987763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=6.5e-10  Score=100.05  Aligned_cols=136  Identities=15%  Similarity=0.084  Sum_probs=96.5

Q ss_pred             cccccCCceEEEEEEECC-------CcEEEEEEeccCCC---------------------chHHHHHH----HHHHHHhc
Q 012392          190 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSC---------------------KSEEAEFV----KGLYLLTS  237 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~f~----~e~~~l~~  237 (464)
                      ..||.|.-+.||.|.-.+       +..+|||..+....                     ....+.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998553       47899998764320                     01122233    78889988


Q ss_pred             CC--CCCceeeeeEEEeCCCCeEEEEEecCCCCCHHH-HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCe
Q 012392          238 LR--HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAI  313 (464)
Q Consensus       238 l~--H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~i  313 (464)
                      +.  .-++...+++      ..-+|||||+.++.+.. .|.+.     .++..+...+..+++.+|.+| |..+     |
T Consensus        83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g-----l  146 (197)
T cd05146          83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN-----L  146 (197)
T ss_pred             HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC-----e
Confidence            85  3466666653      22479999997654422 22211     144455667889999999999 7777     9


Q ss_pred             eecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          314 VHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       314 vH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+||++.|||+++ +.+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            99999999999974 67999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.09  E-value=2.8e-09  Score=105.70  Aligned_cols=217  Identities=17%  Similarity=0.269  Sum_probs=146.3

Q ss_pred             eEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe--CCCCeEEEEEecCCC-CCHHHH
Q 012392          198 SSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS--RGRGECFLIYDFAPK-GKLSKY  273 (464)
Q Consensus       198 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~--~~~~~~~lv~E~~~~-gsL~~~  273 (464)
                      .+.||+... ||..|+.|++....... ...-..-++..+++.|+|+|++..++..  -....+++||+|.++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            568898754 89999999994332111 1112244678899999999999887641  123468999999986 778776


Q ss_pred             hhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          274 LDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       274 l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      --....           .....++..++.++.|+..||.++|+.|     +.-+-|.+++||++.+..++|+..|....+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-----LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-----LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-----ceeecccHhHeEeeCcceEEEecccceeee
Confidence            533211           1123677889999999999999999998     788999999999999999999998887655


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..+.             .  |.+..   -.+-|.=.||.+++-|.||..--....  ......++         .+....
T Consensus       444 ~~d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d--~~~~s~~~---------~I~~~y  494 (655)
T KOG3741|consen  444 QEDP-------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTD--STQSSHLT---------RITTTY  494 (655)
T ss_pred             cCCC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccccccccc--chHHHHHH---------Hhhhhh
Confidence            4332             0  11222   246799999999999999964311100  00001111         122345


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      +.++++++..-...++++ -+..+++.+
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            556667776666667765 566666654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.99  E-value=1.1e-08  Score=88.94  Aligned_cols=144  Identities=17%  Similarity=0.249  Sum_probs=97.8

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...++-+|+-+.|+++.+. |+...||.-......       -..+.-.+|..++.+++--.|.--.=++++...  -.|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeE
Confidence            3467889999999999885 777777743222111       122456778888888753222221123333333  368


Q ss_pred             EEecCCC-CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC---CeEEeeC
Q 012392          261 IYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADC  336 (464)
Q Consensus       261 v~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df  336 (464)
                      +|||+++ -++.+|+.......  ..-.....++..|-+.+.-||.++     |+|+||..+||+|..++   .+.+.||
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~nd-----iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDND-----IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCC-----eecccccccceEEecCCCcCceEEEee
Confidence            8999965 48888887643221  222223678889999999999988     99999999999997654   4579999


Q ss_pred             Ccccc
Q 012392          337 GLHKL  341 (464)
Q Consensus       337 Gl~~~  341 (464)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=2.1e-08  Score=95.22  Aligned_cols=143  Identities=13%  Similarity=0.076  Sum_probs=97.7

Q ss_pred             ccccCCceEEEEEEECCCcEEEEEEeccCCCchHH----------HHHHHHHHHHhcCCCC--CceeeeeEEEeCC---C
Q 012392          191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE----------AEFVKGLYLLTSLRHE--NIIRLRGFCCSRG---R  255 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~f~~e~~~l~~l~H~--niv~l~g~~~~~~---~  255 (464)
                      .+-.-....|.+..+ +|+.|.||+..........          ..+.+|...+.++..-  ..+..+++.....   .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344334445777766 5778999976433211111          1367888888777422  2334444442211   2


Q ss_pred             CeEEEEEecCCCC-CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-------
Q 012392          256 GECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-------  327 (464)
Q Consensus       256 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-------  327 (464)
                      ...++|+|++++- +|.+++.....  ...+...+..++.+++..+.-||..|     |+|+|++++|||++.       
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G-----i~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG-----INHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc-----CccCCCChhhEEEeccccCCCC
Confidence            3578999999875 89999854221  22455667789999999999999999     999999999999985       


Q ss_pred             CCCeEEeeCCcccc
Q 012392          328 QFNPLIADCGLHKL  341 (464)
Q Consensus       328 ~~~~kl~DfGl~~~  341 (464)
                      +..+.|+||+.++.
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            47789999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.93  E-value=3.2e-10  Score=120.46  Aligned_cols=245  Identities=19%  Similarity=0.198  Sum_probs=158.6

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      |.+.+-+-+|.++.+..+.-. .|...++|.......  ....+....+-.++-..+||-+++..--+  ......+||+
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~  883 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVG  883 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcchhh
Confidence            444456677888888776543 344444444332210  00011111222222223456555443221  2345688999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      +|..+++|..-|+....    .+..-....+..+...++|||+..     +.|+|++|.|.+...++..+++|||.....
T Consensus       884 ~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~-----r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSL-----RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             HHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccch-----hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999987542    332223456667888999999876     899999999999999999999999843321


Q ss_pred             cC------C---------------c---------eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 012392          343 AD------D---------------I---------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV  392 (464)
Q Consensus       343 ~~------~---------------~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p  392 (464)
                      ..      .               .         ........+|..|.+||.+.+......+|+|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10      0               0         0011233467789999999999999999999999999999999999


Q ss_pred             CcchHHHHHhhhhHHHhhhhhcCCC-CCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 012392          393 LTSSMRLAAESATFENFIDRNLKGK-FSESEAAKLGKMALVCTHEDPENRPTME  445 (464)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~  445 (464)
                      +.....    ...++.+......+. .+........+++..-+..+|.+|-.|.
T Consensus      1035 ~na~tp----q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETP----QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcch----hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            976543    233344333333222 3445567778888888888999997765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=1.9e-08  Score=87.90  Aligned_cols=130  Identities=15%  Similarity=0.283  Sum_probs=92.9

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCc--h-----HHHHHHHHHHHHhcCCC--CCceeeeeEEEeCCCCeEEE
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK--S-----EEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-----~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..+++|+-..+|.+.+. |..+.+|.-......  .     ....-.+|..++.+++-  -|...++.+    +.+...|
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----D~~~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----DPDNGLI   76 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCEE
Confidence            35789999999999775 334666643222111  1     11235578888888753  233334332    2455789


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      +|||.++-.|.+++...           +..++..+-.-+.-||..+     |||+||.++||+++.+. +.++||||+.
T Consensus        77 ~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g-----ivHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          77 VMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG-----IVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             EEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC-----eecCCCccceEEEeCCc-EEEEECCccc
Confidence            99999999999898653           2457777888888999988     99999999999998775 9999999987


Q ss_pred             c
Q 012392          341 L  341 (464)
Q Consensus       341 ~  341 (464)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=3.1e-08  Score=88.83  Aligned_cols=126  Identities=21%  Similarity=0.226  Sum_probs=81.0

Q ss_pred             EEEEEEECCCcEEEEEEeccCCCc------------h-------------HHHHHHHHHHHHhcCCCC--CceeeeeEEE
Q 012392          199 SVYKGTLRDGTLVAIRSINVTSCK------------S-------------EEAEFVKGLYLLTSLRHE--NIIRLRGFCC  251 (464)
Q Consensus       199 ~Vy~~~~~~~~~vavK~~~~~~~~------------~-------------~~~~f~~e~~~l~~l~H~--niv~l~g~~~  251 (464)
                      .||.|...+|..+|||..+.....            .             ......+|...|.++..-  ++.+.+.+- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999989999999987653210            0             012456799999999755  567776542 


Q ss_pred             eCCCCeEEEEEecCC--CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          252 SRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-LHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       252 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                         .  -.|||||++  +..+...... .     ++......++.+++..+.. +|..+     |+|+||.+.|||++++
T Consensus        80 ---~--~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~~~g-----ivHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   80 ---R--NVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLHKAG-----IVHGDLSEYNILVDDG  143 (188)
T ss_dssp             ---T--TEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHHCTT-----EEESS-STTSEEEETT
T ss_pred             ---C--CEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHHhcC-----ceecCCChhhEEeecc
Confidence               2  269999998  5444433221 1     1123345677778776665 46777     9999999999999988


Q ss_pred             CCeEEeeCCccccc
Q 012392          329 FNPLIADCGLHKLL  342 (464)
Q Consensus       329 ~~~kl~DfGl~~~~  342 (464)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             9999999987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=1.4e-09  Score=111.49  Aligned_cols=160  Identities=23%  Similarity=0.336  Sum_probs=108.3

Q ss_pred             HHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc--eeeeecc------CCCCccCcccccc
Q 012392          295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKT------SAAMGYLAPEYVT  366 (464)
Q Consensus       295 ~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~--~~~~~~~------~~~~~y~aPE~~~  366 (464)
                      +++.||.|+|..    +.+||++|.|++|.++.++..||+.|+.+.......  .+.....      .....|.|||++.
T Consensus       107 ~v~dgl~flh~s----Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  107 NVADGLAFLHRS----AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             cccchhhhhccC----cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            455999999954    559999999999999999999999999876543311  1111111      1124599999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHhCCCC-CcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 012392          367 TGRFTERSDIFAFGVIILQILTGSLV-LTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME  445 (464)
Q Consensus       367 ~~~~~~~sDv~s~Gvll~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~  445 (464)
                      ....+.++|+||+||++|.+..|+.+ +......  ....+....+..-...++...+.++.+-+.+.+..++.-||++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCc--chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            88889999999999999999855443 3221110  01111111122222234456677888888888999999999988


Q ss_pred             HHHHHHhhhcCcccc
Q 012392          446 AVIEELTVAAPVMAT  460 (464)
Q Consensus       446 evl~~L~~~~~~~~~  460 (464)
                      ++........+...+
T Consensus       261 ~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  261 LLLSIPFFSDPGLKA  275 (700)
T ss_pred             hhhcccccCCchhhh
Confidence            887666555554443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=6.2e-07  Score=82.21  Aligned_cols=108  Identities=23%  Similarity=0.235  Sum_probs=80.7

Q ss_pred             HHHHHHHHHHhcCC--CCCceeeeeEEEeCCC--CeEEEEEecCCC-CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 012392          226 AEFVKGLYLLTSLR--HENIIRLRGFCCSRGR--GECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI  300 (464)
Q Consensus       226 ~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~--~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL  300 (464)
                      ..+.+|...+..+.  .=...+.+++......  ...++|+|++++ -+|.+++.....    ++......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            34667777666663  2234455565533221  245899999987 489999976332    44556788999999999


Q ss_pred             HHHhcCCCCCCCeeecCCCCCceEEcCCC---CeEEeeCCccccc
Q 012392          301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADCGLHKLL  342 (464)
Q Consensus       301 ~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfGl~~~~  342 (464)
                      +-||..+     |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       132 ~~lH~~g-----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG-----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc-----CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999     99999999999999887   7899999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=2e-06  Score=77.88  Aligned_cols=140  Identities=11%  Similarity=0.109  Sum_probs=100.7

Q ss_pred             ccCCceEEEEEEECCCcEEEEEEeccCCC-----chHHHHHHHHHHHHhcCCC--CCceeeeeEEE---eCCCCeEEEEE
Q 012392          193 GKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRH--ENIIRLRGFCC---SRGRGECFLIY  262 (464)
Q Consensus       193 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~---~~~~~~~~lv~  262 (464)
                      |+||-+-|++-.+. |..+-+|+-..-..     +-.+..|.+|...|.++..  -++.+.+ ++.   .......+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            56888889987764 44688887541110     2345689999999988852  2344444 331   11123478999


Q ss_pred             ecCC-CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC--eEEeeCCcc
Q 012392          263 DFAP-KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLIADCGLH  339 (464)
Q Consensus       263 E~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfGl~  339 (464)
                      |-++ .-||.+++.+..-  ...+...+..++.+++..+.-||..+     +.|+|+.+.||+++.++.  ++++||.-+
T Consensus       105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G-----v~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN-----RQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            9775 3699999865322  23566778899999999999999998     999999999999986666  999999876


Q ss_pred             cc
Q 012392          340 KL  341 (464)
Q Consensus       340 ~~  341 (464)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            64

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.58  E-value=4.2e-07  Score=84.20  Aligned_cols=134  Identities=17%  Similarity=0.153  Sum_probs=91.1

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCCc-----------------h----HHHHHHHHHHHHhcCCCC--C
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------S----EEAEFVKGLYLLTSLRHE--N  242 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~----~~~~f~~e~~~l~~l~H~--n  242 (464)
                      ..+.+.||-|.-+.||.|...+|..+|||.-+.....                 +    ......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3455889999999999999999999999976543211                 0    112356788999998644  6


Q ss_pred             ceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       243 iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      +.+-+++      +.-.+||||+++--|...--      ..-....   ++..|++-+.-+-..|     |||+|+..-|
T Consensus       173 VP~P~~~------nRHaVvMe~ieG~eL~~~r~------~~en~~~---il~~il~~~~~~~~~G-----iVHGDlSefN  232 (304)
T COG0478         173 VPKPIAW------NRHAVVMEYIEGVELYRLRL------DVENPDE---ILDKILEEVRKAYRRG-----IVHGDLSEFN  232 (304)
T ss_pred             CCCcccc------ccceeeeehcccceeecccC------cccCHHH---HHHHHHHHHHHHHHcC-----ccccCCchhe
Confidence            7777654      23479999998855543210      0112222   3333333333333445     9999999999


Q ss_pred             eEEcCCCCeEEeeCCcc
Q 012392          323 VLIDQQFNPLIADCGLH  339 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~  339 (464)
                      |++++++.+.++||--+
T Consensus       233 IlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         233 ILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             EEEecCCCEEEEeCccc
Confidence            99999999999999543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.54  E-value=9.7e-07  Score=86.00  Aligned_cols=253  Identities=17%  Similarity=0.223  Sum_probs=149.5

Q ss_pred             cccccCCceEEEE-EEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeE----EEeCCCCe-EEEEE
Q 012392          190 NLLGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGF----CCSRGRGE-CFLIY  262 (464)
Q Consensus       190 ~~lg~G~fg~Vy~-~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~----~~~~~~~~-~~lv~  262 (464)
                      .-||+|+-+.+|- +...|  .|| |+..... .....+   -+..|... .||-+-.=+.|    .+....+. .-++|
T Consensus        17 r~LgqGgea~ly~l~e~~d--~VA-KIYh~Pp-pa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          17 RPLGQGGEADLYTLGEVRD--QVA-KIYHAPP-PAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             ccccCCccceeeecchhhc--hhh-eeecCCC-chHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            5689999999994 33322  344 4443322 111121   23334443 46644331111    00111222 44566


Q ss_pred             ecCCCC-CHHHHhhh--hcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          263 DFAPKG-KLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       263 E~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      ..+++. -...++.-  +++.....+|...+..++.+|.+.+-||..|     .+-+|+.++|+|++++..+.|.|-..-
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-----h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-----HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-----CcccccCccceeeecCceEEEEcccce
Confidence            655442 23333322  1223345789999999999999999999998     688999999999999999999986543


Q ss_pred             ccccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHH------
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFE------  407 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~------  407 (464)
                      ....++..+  ....+...|++||.-.     +-..+...|-|.+||++++++.| +.||.+-..........+      
T Consensus       165 qi~~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QINANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeccCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            333222211  1233556699999754     23456789999999999999877 778764221111111111      


Q ss_pred             ---Hhhh--hhcCC---CCC-HHHHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHhhhcC
Q 012392          408 ---NFID--RNLKG---KFS-ESEAAKLGKMALVCTHED--PENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       408 ---~~~~--~~~~~---~~~-~~~~~~l~~l~~~C~~~d--p~~RPs~~evl~~L~~~~~  456 (464)
                         ..-+  +.++.   ..+ .-.+..+..+..+|+...  +.-|||++.-+..|..++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence               1111  11111   111 234567888889999753  5679999998887766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=2e-06  Score=88.56  Aligned_cols=144  Identities=11%  Similarity=0.125  Sum_probs=94.0

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCch---------------------------------------HHHHHHH
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS---------------------------------------EEAEFVK  230 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~f~~  230 (464)
                      +-|+.++-|.||+|++++|+.||||+.+.+-.+.                                       .+-+|.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5688999999999999999999999987643111                                       0113445


Q ss_pred             HHHHHhcC----CCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 012392          231 GLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS  306 (464)
Q Consensus       231 e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  306 (464)
                      |...+.++    +...-+++=..+++- .+...|+|||++|-.+.+...-...   .++-..+.....++.--.-+-  .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f~~q~~~--d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAFLRQLLR--D  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHHHHHHHh--c
Confidence            55555554    222223333344432 3456899999999888888533221   145333333222222222232  3


Q ss_pred             CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccC
Q 012392          307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       307 ~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~  344 (464)
                      +     +.|.|..|-||+++.++++.+.|||+...+..
T Consensus       285 g-----ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G-----FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C-----ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4     89999999999999999999999999877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.31  E-value=8.9e-08  Score=97.52  Aligned_cols=189  Identities=17%  Similarity=0.125  Sum_probs=131.9

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC-ceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~~~lv~  262 (464)
                      .-+...+-+++++++++||.+-...+...++.+...      ....-++++|.+++||| .++.++-+  +.....++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~  313 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPM  313 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhh
Confidence            334444567899999999988654444445554432      23345789999999999 66666655  5566789999


Q ss_pred             ecCCCC-CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          263 DFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +|+..| +-..-...   ....+...+...+.+.-+++++|||+.-     =+|+|    ||+..+ ...|..||+....
T Consensus       314 ~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~-----~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  314 RICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY-----KVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc-----ccCcc----cccccc-cccccccccCCcc
Confidence            999877 22111111   1112344445566777788999999863     38999    777776 5889999999887


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                      +....  ......++..|+|||+...+.+..+.|+|+.|+-..++--|-+|...
T Consensus       381 L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  381 LTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            76532  23344567789999999999999999999999877777777666543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.31  E-value=1.2e-05  Score=74.64  Aligned_cols=139  Identities=9%  Similarity=0.125  Sum_probs=81.0

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC--ceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      ..||.|..+.||+.   .+..+++|......   ......+|.++++.+..-.  +.+.++++  ...+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence            56899999999984   24456788766433   2234567888888875333  35556665  334557789999988


Q ss_pred             CC-HHHHh---------------------hhhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhcCCCCCCCe
Q 012392          268 GK-LSKYL---------------------DQEEGSSNVLDWSTRVS-III----------GIAK-GIGYLHSSEVNKPAI  313 (464)
Q Consensus       268 gs-L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~~~~~~~i  313 (464)
                      .+ +...+                     |......  .....+.. +-.          .+.. ...+|.+. ...+.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~-~~~~~~  155 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV-PDTSTC  155 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC-CCCCce
Confidence            63 22111                     1110001  11111000 000          0111 12333322 234568


Q ss_pred             eecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          314 VHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       314 vH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      +|+|+.|.||++++++ +.+.||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=9.3e-06  Score=83.51  Aligned_cols=141  Identities=11%  Similarity=0.145  Sum_probs=92.5

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCch------------------------------------HHHHHHHHHH
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS------------------------------------EEAEFVKGLY  233 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~f~~e~~  233 (464)
                      +-||.-+.|.||+|++++|+.||||+-+..-.+.                                    .+-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5689999999999999999999999865432111                                    0114666655


Q ss_pred             HHhcC----CCCC------ceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012392          234 LLTSL----RHEN------IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL  303 (464)
Q Consensus       234 ~l~~l----~H~n------iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL  303 (464)
                      -..++    .|-+      |.+++   ++- .....|+||||+|..+.+.-.-...   .++-..+..-+.++..-+-+-
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy---~~~-st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVY---WDL-STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeeh---hhc-CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHHh
Confidence            44433    4555      44443   222 3457899999999776655322221   155454444444443333333


Q ss_pred             hcCCCCCCCeeecCCCCCceEEcC----CCCeEEeeCCccccccC
Q 012392          304 HSSEVNKPAIVHRNLSVEKVLIDQ----QFNPLIADCGLHKLLAD  344 (464)
Q Consensus       304 H~~~~~~~~ivH~dlk~~Nill~~----~~~~kl~DfGl~~~~~~  344 (464)
                      |  |     ++|.|=.|-||+++.    ++.+.+.|||+......
T Consensus       320 ~--G-----ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 T--G-----FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             c--C-----CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3  3     899999999999994    67899999999876654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=8.1e-06  Score=73.46  Aligned_cols=103  Identities=16%  Similarity=0.162  Sum_probs=78.3

Q ss_pred             HHHHHHhcCCC-CCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 012392          230 KGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV  308 (464)
Q Consensus       230 ~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  308 (464)
                      .|.-+|..+++ +++.+++|+|  .    .++|.||...+++...-..-. .--.-+|..|.+||.++++.+++|++.- 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~-   79 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGP-   79 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCC-
Confidence            47778888876 6999999999  2    267899998776642100000 0012689999999999999999999753 


Q ss_pred             CCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       309 ~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                       ...+.-.|++++|+-+++++++|+.|......
T Consensus        80 -~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   80 -LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             -CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence             22377799999999999999999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.12  E-value=5.3e-05  Score=68.97  Aligned_cols=140  Identities=14%  Similarity=0.141  Sum_probs=88.1

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHH---------HHHHHHhcCC---CCCceeeeeE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV---------KGLYLLTSLR---HENIIRLRGF  249 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~---------~e~~~l~~l~---H~niv~l~g~  249 (464)
                      ..++|...+++-......|.+-.. +|..+.+|..+... ...++.|.         +.+..+.+++   --..+.++..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            456677777777766666665555 57788999876544 22222222         2333333332   2222222211


Q ss_pred             EEe---CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          250 CCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       250 ~~~---~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      ...   .-....++||||++|-.|.++..        ++.    .++..++.+|.-||..|     ++|+|..|.|++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G-----~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG-----FYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC-----CccCCCCcCcEEEE
Confidence            110   11234678999999988876542        221    24566778899999999     99999999999999


Q ss_pred             CCCCeEEeeCCcccc
Q 012392          327 QQFNPLIADCGLHKL  341 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~  341 (464)
                      ++ .+++.||+..+.
T Consensus       170 ~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  170 NN-GIRIIDTQGKRM  183 (229)
T ss_pred             CC-cEEEEECccccc
Confidence            66 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=4e-05  Score=84.81  Aligned_cols=154  Identities=14%  Similarity=0.216  Sum_probs=91.7

Q ss_pred             ccccccCCceEEEEEEECCC---cEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCc--eeeeeEEEeCC-CCeEEEE
Q 012392          189 VNLLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI--IRLRGFCCSRG-RGECFLI  261 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~ni--v~l~g~~~~~~-~~~~~lv  261 (464)
                      ++.++.|.+..+|+....++   ..+++|+............+.+|..+|+.+. |.++  .+++++|.+.. .+..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788899999999877654   3677777654332223346789999999995 6665  77888773321 1457899


Q ss_pred             EecCCCCCHHH--------------------H---hhhhcCC-------CCCCCH--------HHHHHH---------HH
Q 012392          262 YDFAPKGKLSK--------------------Y---LDQEEGS-------SNVLDW--------STRVSI---------II  294 (464)
Q Consensus       262 ~E~~~~gsL~~--------------------~---l~~~~~~-------~~~l~~--------~~~~~i---------~~  294 (464)
                      |||+++..+.+                    .   ||.-...       ..+..+        ...+.-         .-
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998754321                    1   1111100       001111        111000         11


Q ss_pred             HHHHHHHHHhcCCCC------CCCeeecCCCCCceEEcCC-CC-eEEeeCCccccc
Q 012392          295 GIAKGIGYLHSSEVN------KPAIVHRNLSVEKVLIDQQ-FN-PLIADCGLHKLL  342 (464)
Q Consensus       295 ~ia~gL~yLH~~~~~------~~~ivH~dlk~~Nill~~~-~~-~kl~DfGl~~~~  342 (464)
                      .+...+.+|..+-..      ++.+||+|+++.|||++.+ .. +-|.||.++..-
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            233445677543211      2459999999999999853 33 568999887643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.08  E-value=4.3e-05  Score=70.84  Aligned_cols=147  Identities=18%  Similarity=0.160  Sum_probs=83.6

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCC--CceeeeeEEEeCC-CCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE--NIIRLRGFCCSRG-RGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~--niv~l~g~~~~~~-~~~~~lv~E~~~  266 (464)
                      +.|+.|..+.||+....+ ..+++|.....   .......+|..++..+...  .+.+++.++.... ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568899999999999877 58999986543   3445677888888777422  3566766443222 234789999999


Q ss_pred             CCCHHH----------------Hh---hhhcCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 012392          267 KGKLSK----------------YL---DQEEGSSNVLDWST---------RVSI------------IIGIAK-GIGYLHS  305 (464)
Q Consensus       267 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~  305 (464)
                      +..+..                .+   +........+.+..         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   11111111111111         0000            112222 2333332


Q ss_pred             CC--CCCCCeeecCCCCCceEEc-CCCCeEEeeCCccc
Q 012392          306 SE--VNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHK  340 (464)
Q Consensus       306 ~~--~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~  340 (464)
                      .-  .....++|+|+.+.|||++ +++.+-|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            10  1245699999999999999 66666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.04  E-value=1.7e-05  Score=86.31  Aligned_cols=205  Identities=20%  Similarity=0.180  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHhcCCCCCceeeeeEEEeCCCC--eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012392          226 AEFVKGLYLLTSLRHENIIRLRGFCCSRGRG--ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL  303 (464)
Q Consensus       226 ~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL  303 (464)
                      ..-..|++.+.++.|+|++++++|-.+....  ...+..|++..-++...+..-    ...+..+.+.+..+..+||+|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHH
Confidence            3444577888899999999998886543221  123455788888888877643    2377788888999999999999


Q ss_pred             hcCCCCCCCeeecCCCCC---ceEEcCCCCeEEe--eCCccccccCCceeeeeccCCCCccCcccccccCCCCC--cchh
Q 012392          304 HSSEVNKPAIVHRNLSVE---KVLIDQQFNPLIA--DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTE--RSDI  376 (464)
Q Consensus       304 H~~~~~~~~ivH~dlk~~---Nill~~~~~~kl~--DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~sDv  376 (464)
                      |+..     ..|.-|..+   +.-.+..+...++  ||+.++.+.+.....  ....+..|.++|......+..  ..|+
T Consensus       303 h~~~-----l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  303 HSLS-----LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHhc-----cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHH
Confidence            9875     555555544   4455566667766  998887765533211  112234488888877665544  4799


Q ss_pred             HHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          377 FAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       377 ~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      |.+|.++..+..|........       ....+++        ......+.+....|+..++++|+++.+++.+.....+
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~-------~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSA-------VPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             HHHHHHHhhhhhcCccccccc-------chhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            999999999988865443211       1111111        1111157778889999999999999999988765444

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=0.0001  Score=69.38  Aligned_cols=142  Identities=11%  Similarity=0.109  Sum_probs=80.8

Q ss_pred             cccCCc-eEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEecCCCCC
Q 012392          192 LGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAPKGK  269 (464)
Q Consensus       192 lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E~~~~gs  269 (464)
                      |-.|.. ..||+.... +..+.||......    ..+..+|+.++..+. +--+.+++++..  ..+..++|||++++.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEEEeeCCcc
Confidence            344554 679998764 4678888765432    234557787777773 344557777653  2345789999999887


Q ss_pred             HHHHh-------------------hhhcCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHhcC--
Q 012392          270 LSKYL-------------------DQEEGSSNVLD--WSTRVSIII--------------------GIAKGIGYLHSS--  306 (464)
Q Consensus       270 L~~~l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~~--  306 (464)
                      |....                   +........+.  +..++.-..                    .+...+..|-..  
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            76432                   11110000111  001110000                    011111222110  


Q ss_pred             CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       307 ~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ....+.++|+|+.|.|||++++..+.|.||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            1134669999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.03  E-value=0.00014  Score=67.00  Aligned_cols=152  Identities=18%  Similarity=0.195  Sum_probs=97.1

Q ss_pred             cCHHHHHHhhcCCccccccc---cCCceEEEEEEECCCcEEEEEEeccCCCchHH-----------------------HH
Q 012392          174 LNLEEVESATQCFSEVNLLG---KGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE-----------------------AE  227 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg---~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~  227 (464)
                      .+++.+....++..+....|   +|.-..||+|.-.++..||||..+........                       ..
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            45556666666655555544   67777899999888999999998754321110                       11


Q ss_pred             HHHHHHHHhcCC--CCCceeeeeEEEeCCCCeEEEEEecCCCC-CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 012392          228 FVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH  304 (464)
Q Consensus       228 f~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  304 (464)
                      -.+|..-|.++.  +-.+.+-+++.    .  -.|||||+... .-.-.|..     -.+...+...+..++++.|.-|-
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~--nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----N--NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----C--CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHH
Confidence            235666676663  44455555543    1  26899999543 11111111     11222245566777777777776


Q ss_pred             c-CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          305 S-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       305 ~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      . -+     +||+||+.-|||+. ++++.++|+|-+...
T Consensus       184 ~~a~-----LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         184 KEAG-----LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HhcC-----cccccchhhheEEE-CCeEEEEECcccccc
Confidence            5 34     99999999999999 779999999977644

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.90  E-value=9.4e-05  Score=64.53  Aligned_cols=127  Identities=24%  Similarity=0.261  Sum_probs=85.9

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee-eeeEEEeCCCCeEEEEEecCC
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR-LRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~-l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      ..+.|++|.+|.||+|.+. |..+|+|.-+.+   +....+..|.++|..+.-.++.. ++.|-      +-++.|||..
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhhc
Confidence            3478999999999999997 457888876543   34567889999999887666653 44332      2356799998


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCC--CceEEcCCCCeEEeeCCcccc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV--EKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~--~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +-.|.+.-...       +-..    +..+++.---|-..+     |-|+.|.-  .||++.++ .+-|+||..|+.
T Consensus        96 G~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~G-----I~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG-------DRKH----LLRVLEKAYKLDRLG-----IEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc-------cHHH----HHHHHHHHHHHHHhc-----cchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            88888765421       2222    233444422233334     88888864  56666655 899999988773

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.88  E-value=0.0003  Score=63.65  Aligned_cols=130  Identities=20%  Similarity=0.265  Sum_probs=85.2

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCC---------------CchHHHHHHHHHHHHhcCC------CCCceee
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS---------------CKSEEAEFVKGLYLLTSLR------HENIIRL  246 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~f~~e~~~l~~l~------H~niv~l  246 (464)
                      ....||+|+.-.||.  +.+.....||+.....               ......++.+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999999984  4455667888877654               0112345556665544444      8999999


Q ss_pred             eeEEEeCCCCeEEEEEecCCC------CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCC
Q 012392          247 RGFCCSRGRGECFLIYDFAPK------GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV  320 (464)
Q Consensus       247 ~g~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~  320 (464)
                      +|+.  +++.-.-+|+|.+.+      -+|.+++...     .++. ...+.+.+..   .||-+.+     |+.+|++|
T Consensus        83 ~G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f~---~~l~~~~-----Iv~~dl~~  146 (199)
T PF10707_consen   83 YGFV--ETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEFK---RYLLDHH-----IVIRDLNP  146 (199)
T ss_pred             eEEE--ecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHHH---HHHHHcC-----CeecCCCc
Confidence            9987  445557788887743      3678888532     2554 4444444444   4555555     99999999


Q ss_pred             CceEEcCCC----CeEEee
Q 012392          321 EKVLIDQQF----NPLIAD  335 (464)
Q Consensus       321 ~Nill~~~~----~~kl~D  335 (464)
                      .||++..+.    .+.|.|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            999996432    456665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.74  E-value=0.00069  Score=65.73  Aligned_cols=79  Identities=10%  Similarity=0.076  Sum_probs=55.5

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC---CCceeeeeEEEeC-CCCeEEEEEe
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH---ENIIRLRGFCCSR-GRGECFLIYD  263 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H---~niv~l~g~~~~~-~~~~~~lv~E  263 (464)
                      ..+.||.|..+.||+....+++ +.+|..+..   .....|..|...|+.+.-   -.+.+++++|... ..+..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3467999999999998776664 666764321   122467889988888842   3677888877432 2345799999


Q ss_pred             cCCCCCH
Q 012392          264 FAPKGKL  270 (464)
Q Consensus       264 ~~~~gsL  270 (464)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9988754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.67  E-value=0.00084  Score=60.46  Aligned_cols=128  Identities=18%  Similarity=0.263  Sum_probs=90.0

Q ss_pred             cCCccccccccCCc-eEEEEEEECCCcEEEEEEecc---CCC-------c----------hHHHHHHHHHHHHhcCC---
Q 012392          184 QCFSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINV---TSC-------K----------SEEAEFVKGLYLLTSLR---  239 (464)
Q Consensus       184 ~~f~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~-------~----------~~~~~f~~e~~~l~~l~---  239 (464)
                      ..++.++.||.|.- |.||++++. |..+|+|.++.   ...       .          ....-|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56777899999999 999999995 77999999321   110       0          11235888888887774   


Q ss_pred             CCCc--eeeeeEEEeCC----------------CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 012392          240 HENI--IRLRGFCCSRG----------------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG  301 (464)
Q Consensus       240 H~ni--v~l~g~~~~~~----------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~  301 (464)
                      +.++  |+.+||..-..                .....||.||.+...             .+.    .+-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            5566  89999874331                112467888775533             122    233556777788


Q ss_pred             HHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       302 yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      .+|..+     |+=+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~g-----I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG-----IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC-----eeeccCcccccc-----CCEEEecccC
Confidence            999988     999999999975     4589999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.63  E-value=0.00047  Score=64.47  Aligned_cols=31  Identities=19%  Similarity=0.291  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      .+.++|+|+.+.|||++++...-|.||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            3458999999999999977656799999765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.49  E-value=0.0011  Score=61.74  Aligned_cols=142  Identities=15%  Similarity=0.127  Sum_probs=79.2

Q ss_pred             cccccCCceEEEEEEECC--CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC-CCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.|..|-...+|+....+  +..|++|...... . ...+-.+|+.++..+.. .-..++++.+  . .   .+||||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-E-LIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-c-ceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEEEeeC
Confidence            456677788999988764  6788889765432 1 11223367777777743 3344554433  2 2   37999998


Q ss_pred             CCCHHHH-----------------hhhhcCCC-------CCCC-HHHHHHHH-------------------------HHH
Q 012392          267 KGKLSKY-----------------LDQEEGSS-------NVLD-WSTRVSII-------------------------IGI  296 (464)
Q Consensus       267 ~gsL~~~-----------------l~~~~~~~-------~~l~-~~~~~~i~-------------------------~~i  296 (464)
                      +-++...                 +|......       .... |..+..+.                         .+.
T Consensus        76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  155 (235)
T cd05157          76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE  155 (235)
T ss_pred             CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence            8665321                 11111100       0111 22211111                         111


Q ss_pred             HHHH-HHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCccc
Q 012392          297 AKGI-GYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK  340 (464)
Q Consensus       297 a~gL-~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~  340 (464)
                      +..| +.+-... ....++|+|+.+.|||+++ +..+.|.||..+.
T Consensus       156 ~~~l~~~l~~~~-~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         156 ISWLKELLSALN-SPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHHHhcccC-CCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1111 1222221 2356999999999999998 5789999997765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.0022  Score=64.34  Aligned_cols=76  Identities=11%  Similarity=0.067  Sum_probs=51.6

Q ss_pred             cccccCCceEEEEEEECCC-cEEEEEEeccC-----C-CchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEE
Q 012392          190 NLLGKGNFSSVYKGTLRDG-TLVAIRSINVT-----S-CKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~-~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~  259 (464)
                      +.||.|.+..||+....+| +.|.||.-...     . ..-....+..|.+.|..+.   -.++.+++.+.    ....+
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCCE
Confidence            5689999999999998877 48999974311     0 1112345566777777652   34677787653    24468


Q ss_pred             EEEecCCCCC
Q 012392          260 LIYDFAPKGK  269 (464)
Q Consensus       260 lv~E~~~~gs  269 (464)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.43  E-value=0.002  Score=61.00  Aligned_cols=140  Identities=11%  Similarity=0.072  Sum_probs=76.6

Q ss_pred             cccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCc-eeeeeEEEeCCCCeEEEEEecCCCCCH
Q 012392          192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECFLIYDFAPKGKL  270 (464)
Q Consensus       192 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~lv~E~~~~gsL  270 (464)
                      +..|-...+|+... ++..+++|...... .....+..+|..+++.+....+ .++++.+  .    -++|+||+++..+
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~-~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVC-KALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccc-ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence            45577788998874 56678888754332 1111234667788887753323 3444443  2    2689999988665


Q ss_pred             HHH-----------------hhhhcCCCCCCCHHHHH-HHHHH---------HHHHHHHHhcC---CCCCCCeeecCCCC
Q 012392          271 SKY-----------------LDQEEGSSNVLDWSTRV-SIIIG---------IAKGIGYLHSS---EVNKPAIVHRNLSV  320 (464)
Q Consensus       271 ~~~-----------------l~~~~~~~~~l~~~~~~-~i~~~---------ia~gL~yLH~~---~~~~~~ivH~dlk~  320 (464)
                      ...                 ||........++...++ .+..+         +..-+..+-..   ...++.++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321                 12211111122322111 11111         11112222111   01234689999999


Q ss_pred             CceEEcCCCCeEEeeCCccc
Q 012392          321 EKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       321 ~Nill~~~~~~kl~DfGl~~  340 (464)
                      .||++++++ +.|.||..+.
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC-CEEEeccccC
Confidence            999999876 7899998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.40  E-value=2.3e-05  Score=87.32  Aligned_cols=166  Identities=16%  Similarity=0.029  Sum_probs=117.0

Q ss_pred             HHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012392          228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE  307 (464)
Q Consensus       228 f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  307 (464)
                      .+.|...++...|+++.....=.......+-+.+++|+..|++.+.|...-.....++..-......+......-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34455556667899998775544344455678999999999999999875544444554433333333366666666654


Q ss_pred             CCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHH
Q 012392          308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL  387 (464)
Q Consensus       308 ~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~  387 (464)
                      .....-+|++||+-|.+|..+..+|+.++|+.+........- ....+++-|+.|+....-.++.++|+|..|+.+|+..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~-Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF-GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhh-hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            344557999999999999999999999999999443322111 1122344578888777777888899999999999998


Q ss_pred             hCCCCCc
Q 012392          388 TGSLVLT  394 (464)
Q Consensus       388 tg~~p~~  394 (464)
                      -|..++.
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8876664

>PRK05231 homoserine kinase; Provisional

Probab=97.27  E-value=0.011  Score=57.92  Aligned_cols=30  Identities=17%  Similarity=0.173  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ..++|+|+.+.||+++.+...-|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            459999999999999977556899998765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0021  Score=62.50  Aligned_cols=143  Identities=19%  Similarity=0.201  Sum_probs=80.5

Q ss_pred             cccccCCceEEEEEEECC-------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC-ceeeeeEEEeCCCCeEEEE
Q 012392          190 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~~~lv  261 (464)
                      +.|..|-...+|+....+       +..+++|......  ....+..+|..++..+.... ..++++++  .+    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEe--CC----Cch
Confidence            345556667899988765       4788899865432  12234456777777764222 33555554  22    358


Q ss_pred             EecCCCCCHHHH-----------------hhhhcCC--C---CCC--CHHHHHH--------------------------
Q 012392          262 YDFAPKGKLSKY-----------------LDQEEGS--S---NVL--DWSTRVS--------------------------  291 (464)
Q Consensus       262 ~E~~~~gsL~~~-----------------l~~~~~~--~---~~l--~~~~~~~--------------------------  291 (464)
                      +||++|..+...                 +|.....  .   ...  -|..+..                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            999988766431                 1111111  0   001  1111100                          


Q ss_pred             HHHHHHHHHHHHhcCC----CCCCCeeecCCCCCceEEcCC----CCeEEeeCCccc
Q 012392          292 IIIGIAKGIGYLHSSE----VNKPAIVHRNLSVEKVLIDQQ----FNPLIADCGLHK  340 (464)
Q Consensus       292 i~~~ia~gL~yLH~~~----~~~~~ivH~dlk~~Nill~~~----~~~kl~DfGl~~  340 (464)
                      +...+..-+.+|-...    .....++|+|+.+.|||++++    ..+.++||..+.
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1122223334443211    135679999999999999985    789999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.13  E-value=0.01  Score=57.84  Aligned_cols=148  Identities=16%  Similarity=0.074  Sum_probs=79.6

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC--CCceeeeeE----EEeCCCCeEEEEE
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGF----CCSRGRGECFLIY  262 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~----~~~~~~~~~~lv~  262 (464)
                      ++.++.|.-..+|+....+| .+++|.......   ..+...|+.++..|..  -++.+++..    ......+..++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45566776678999876555 466787654221   1233345555555532  123444331    1112235678999


Q ss_pred             ecCCCCCHH-----------HH---hhhhcCC-----C---CCCCHHHHH------------HHHHHHHHHHHHHhcCC-
Q 012392          263 DFAPKGKLS-----------KY---LDQEEGS-----S---NVLDWSTRV------------SIIIGIAKGIGYLHSSE-  307 (464)
Q Consensus       263 E~~~~gsL~-----------~~---l~~~~~~-----~---~~l~~~~~~------------~i~~~ia~gL~yLH~~~-  307 (464)
                      ||++|..+.           ..   +|.....     .   ..-.|....            .....+...++++.... 
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875432           11   1211000     0   011232211            11122344555554310 


Q ss_pred             -CCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          308 -VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       308 -~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                       .....++|+|+.+.||+++++....|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             123569999999999999998777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.81  E-value=0.046  Score=52.81  Aligned_cols=147  Identities=16%  Similarity=0.100  Sum_probs=82.2

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCC--CceeeeeEE----EeCCCCeEEEEE
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE--NIIRLRGFC----CSRGRGECFLIY  262 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~--niv~l~g~~----~~~~~~~~~lv~  262 (464)
                      .+.|..|....+|+....++ .+++|.....    ...+...|+.++..+.+.  .+.+.+...    .....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            45666777788999876544 6888877541    123445566666666432  244443311    111234568999


Q ss_pred             ecCCCCCHHH-----------H---hhhhc-C------CCCCCCHHHHH----------HHHHHHHHHHHHHhcC--CCC
Q 012392          263 DFAPKGKLSK-----------Y---LDQEE-G------SSNVLDWSTRV----------SIIIGIAKGIGYLHSS--EVN  309 (464)
Q Consensus       263 E~~~~gsL~~-----------~---l~~~~-~------~~~~l~~~~~~----------~i~~~ia~gL~yLH~~--~~~  309 (464)
                      +|++|..+..           .   +|... .      ......|....          .....+...+.++...  ...
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998866432           0   11110 0      01112343221          0112233445555431  111


Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ...++|+|+.|.|||++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            2358999999999999998777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.74  E-value=0.02  Score=55.65  Aligned_cols=143  Identities=14%  Similarity=0.197  Sum_probs=79.3

Q ss_pred             EEEEEEECCCcEEEEEEecc-CCCchHHHHHHHHHHHHhcCCC--CCceeeeeEEEeCCCCeEEEEEecCCCCCHHH---
Q 012392          199 SVYKGTLRDGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSK---  272 (464)
Q Consensus       199 ~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~---  272 (464)
                      .+|..... ++.++++ ... ...........+|..+|+.+.-  --..+.++.|.+...+..|.||+|.++..+.+   
T Consensus        40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            34444333 6777887 331 2223334455677788877742  23445667774433246799999998732221   


Q ss_pred             ---------------Hhhh---hc-------------CCCCCCCHHHHHHHHH--------HHHHHHHHHhcCC---CCC
Q 012392          273 ---------------YLDQ---EE-------------GSSNVLDWSTRVSIII--------GIAKGIGYLHSSE---VNK  310 (464)
Q Consensus       273 ---------------~l~~---~~-------------~~~~~l~~~~~~~i~~--------~ia~gL~yLH~~~---~~~  310 (464)
                                     +|..   -.             ...+.-.|...+..+.        ....-..||+++.   ..+
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence                           2111   00             0001111222221000        1122245555432   145


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      +.++|+|+.+.|++++.+..+-+.||+++..-.
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            679999999999999999889999999987543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.68  E-value=0.011  Score=56.95  Aligned_cols=143  Identities=19%  Similarity=0.305  Sum_probs=70.8

Q ss_pred             ccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEEEEEe
Q 012392          187 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ...+.++-|....+|+.. .++..+.||.-..    .....|..|..-|+.|.   --.+.+.+++...  .+..+||+|
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEEE
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEEE
Confidence            344668888889999877 5678899998762    22345777877777773   3456678777643  344589999


Q ss_pred             cCCCCC--------HHH---Hhhh-hcCC-----------------CCCCCHHH-----HHHHHH--------------H
Q 012392          264 FAPKGK--------LSK---YLDQ-EEGS-----------------SNVLDWST-----RVSIII--------------G  295 (464)
Q Consensus       264 ~~~~gs--------L~~---~l~~-~~~~-----------------~~~l~~~~-----~~~i~~--------------~  295 (464)
                      |++.+.        |..   .||. ....                 ...-+|.+     |+.-..              .
T Consensus        93 ~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~  172 (288)
T PF03881_consen   93 FLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELER  172 (288)
T ss_dssp             --------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHH
T ss_pred             eecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHH
Confidence            998761        111   1233 1100                 00123432     111111              1


Q ss_pred             HHHHH-HHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          296 IAKGI-GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       296 ia~gL-~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      +.+.+ ..|+... .+|.++|+||.+-|++.+.++.+.|.|-.
T Consensus       173 l~~~~~~~l~~~~-~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  173 LVERLPSLLPGRE-PKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHHHHCCTTS-----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHHHHhcCCC-CCceeeEcCccccceeecCCCCceeeccc
Confidence            12222 2234333 57899999999999999999889998865

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.55  E-value=0.0061  Score=61.78  Aligned_cols=50  Identities=16%  Similarity=0.287  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhh
Q 012392          226 AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE  277 (464)
Q Consensus       226 ~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~  277 (464)
                      .+.+-....++.+.|+|+..++.+. ........+|+|++ +.||.+++..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhh-ccchHHHHHhc
Confidence            3456667789999999999998875 23334578899999 77999998754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.50  E-value=0.037  Score=53.04  Aligned_cols=32  Identities=25%  Similarity=0.356  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCceEEcCCCC-eEEeeCCcccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFN-PLIADCGLHKL  341 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~-~kl~DfGl~~~  341 (464)
                      .+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            456899999999999997555 45999988753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.45  E-value=0.0045  Score=59.33  Aligned_cols=132  Identities=14%  Similarity=0.133  Sum_probs=89.2

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCC-------ch----------H----HHHHHHHHHHHhcCC-CC-C
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-------KS----------E----EAEFVKGLYLLTSLR-HE-N  242 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~----------~----~~~f~~e~~~l~~l~-H~-n  242 (464)
                      ++..+.||-|.-+.||.+...+|++.++|.-+....       +.          +    +-...+|...|+.|. |. -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            566789999999999999999999999886543221       00          1    123457888888884 32 2


Q ss_pred             ceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       243 iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      +.+.+++      +.-++|||++.+-.|.+.-+-       .+..++..-+.+   -+.-|-..|     +||+|..-=|
T Consensus       174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~---~Iv~la~~G-----lIHgDFNEFN  232 (465)
T KOG2268|consen  174 VPKPIDH------NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMG---LIVRLANHG-----LIHGDFNEFN  232 (465)
T ss_pred             CCCcccc------cceeeHHHhhcccceeeeeec-------CChHHHHHHHHH---HHHHHHHcC-----ceecccchhe
Confidence            3344443      345799999988777654322       222333332322   234444556     9999999999


Q ss_pred             eEEcCCCCeEEeeCCc
Q 012392          323 VLIDQQFNPLIADCGL  338 (464)
Q Consensus       323 ill~~~~~~kl~DfGl  338 (464)
                      |+++++..++++||--
T Consensus       233 imv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             eEEecCCCEEEeechH
Confidence            9999999999999953

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.37  E-value=0.096  Score=52.69  Aligned_cols=81  Identities=15%  Similarity=0.074  Sum_probs=49.2

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCC---c---hHHHHHHHHHHHHhcC---CCCCceeeeeEEEeCCCCeEE
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC---K---SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~---~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .+.||.|....||+.... +..|+||+-.....   .   -....-..|...|..+   ...++.+++.++  +  ...+
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~v  111 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMAL  111 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCCE
Confidence            367899999999998764 45688997541110   0   0111222335555544   235788888887  3  3457


Q ss_pred             EEEecCCC--CCHHHHh
Q 012392          260 LIYDFAPK--GKLSKYL  274 (464)
Q Consensus       260 lv~E~~~~--gsL~~~l  274 (464)
                      ++|||++.  ..+.+-+
T Consensus       112 lvME~L~~~~~ilr~~L  128 (418)
T PLN02756        112 IGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEeecCCcceehhhhh
Confidence            89999976  3444433

>PLN02236 choline kinase

Probab=96.23  E-value=0.043  Score=54.46  Aligned_cols=142  Identities=17%  Similarity=0.176  Sum_probs=77.9

Q ss_pred             ccccCCceEEEEEEECC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCce-eeeeEEEeCCCCeEEEEEec
Q 012392          191 LLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII-RLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv-~l~g~~~~~~~~~~~lv~E~  264 (464)
                      .|-.|-.-.+|+..+.+     +..|++|...... . ..-+-.+|..++..+..-++. ++++.+  . .+   .|+||
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~--~-~g---~v~ef  114 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRF--P-NG---RVEEF  114 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEE--C-Cc---eEEEe
Confidence            44446677899987542     3678898765432 1 112235677777777533333 455554  2 22   57999


Q ss_pred             CCCCCHHHH-----------------hhhhcC--CCCCCCHHHHHHHHHHH-----------------HHHHHH----Hh
Q 012392          265 APKGKLSKY-----------------LDQEEG--SSNVLDWSTRVSIIIGI-----------------AKGIGY----LH  304 (464)
Q Consensus       265 ~~~gsL~~~-----------------l~~~~~--~~~~l~~~~~~~i~~~i-----------------a~gL~y----LH  304 (464)
                      +++.+|..-                 +|....  ......|.+...+..++                 ...+..    +.
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987665421                 122111  11112233332222111                 111112    22


Q ss_pred             cCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCcccc
Q 012392          305 SSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKL  341 (464)
Q Consensus       305 ~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~  341 (464)
                      ... ....++|+|+++.|||+++ +..+.++||..+..
T Consensus       195 ~~~-~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDD-QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccC-CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            212 2446899999999999986 46899999987653

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.19  E-value=0.07  Score=48.94  Aligned_cols=139  Identities=17%  Similarity=0.280  Sum_probs=80.5

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      +.+.-|.--.-|.... +...+-||+-.    ......|..|+.-|..+.   --++.+++.+-  ......|+|+||.+
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~   94 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLP   94 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeecc
Confidence            4454455445554433 35678888643    334567888877666653   34566665444  56788999999999


Q ss_pred             CCCHHH-----------HhhhhcCC--------------CCC----CCHHH-----HHHHHHH--------------HHH
Q 012392          267 KGKLSK-----------YLDQEEGS--------------SNV----LDWST-----RVSIIIG--------------IAK  298 (464)
Q Consensus       267 ~gsL~~-----------~l~~~~~~--------------~~~----l~~~~-----~~~i~~~--------------ia~  298 (464)
                      .|.+..           .||.-...              ..+    -+|.+     |+-...|              ++.
T Consensus        95 ~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~  174 (286)
T COG3001          95 TGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVE  174 (286)
T ss_pred             CCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHH
Confidence            876651           12221100              011    12221     2222222              233


Q ss_pred             HHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       299 gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      .+.-+=..+..+|..+|+||...|+....++ +.+-|-
T Consensus       175 ~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP  211 (286)
T COG3001         175 KIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP  211 (286)
T ss_pred             HHHHHHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence            3444433334679999999999999999998 666653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.06  E-value=0.096  Score=51.75  Aligned_cols=80  Identities=14%  Similarity=0.034  Sum_probs=47.8

Q ss_pred             ccccCCceEEEEEEECCC-cEEEEEEecc------CCCchHHHHHHHHHHHHhcCC--CC-CceeeeeEEEeCCCCeEEE
Q 012392          191 LLGKGNFSSVYKGTLRDG-TLVAIRSINV------TSCKSEEAEFVKGLYLLTSLR--HE-NIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~~-~~vavK~~~~------~~~~~~~~~f~~e~~~l~~l~--H~-niv~l~g~~~~~~~~~~~l  260 (464)
                      .||.|....||++...+| +.|+||.-..      ...+-....-.-|...|....  -| .+.+++.|-    .....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence            479999999999998754 5799996421      111222223335566665542  23 466665542    344578


Q ss_pred             EEecCCC-CCHHHHh
Q 012392          261 IYDFAPK-GKLSKYL  274 (464)
Q Consensus       261 v~E~~~~-gsL~~~l  274 (464)
                      |||+++. ..|.+.|
T Consensus        78 vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        78 VMEDLSHHKIARKGL   92 (370)
T ss_pred             hHhhCccchHHHHHH
Confidence            9999954 3444444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.82  E-value=0.0035  Score=40.08  Aligned_cols=29  Identities=34%  Similarity=0.588  Sum_probs=15.8

Q ss_pred             ceeeehhHHHHHHHHHHHHHHHHHHhhhc
Q 012392           82 QIAVLAAVTSVTVILAGTGILIFFRYRRH  110 (464)
Q Consensus        82 ~~~ii~~~~~~~~~~~~~~~~~~~~~rr~  110 (464)
                      ..+.+++++.++++++++++++|++|||+
T Consensus        11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen   11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             EEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            34444444555555565556666556654

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.75  E-value=0.18  Score=49.01  Aligned_cols=30  Identities=10%  Similarity=0.244  Sum_probs=25.4

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ...++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            355899999999999998 568899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.19  E-value=0.19  Score=49.49  Aligned_cols=142  Identities=14%  Similarity=0.166  Sum_probs=77.0

Q ss_pred             ccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCc-eeeeeEEEeCCCCeEEEEEecC
Q 012392          191 LLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      .|..|-...+|+....+    +..|++|...... . ..-+-.+|..+++.+..-++ .++++++  . .+   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~IdR~~E~~il~~l~~~gl~P~~l~~~--~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVIDRERELQAIKYLSAAGFGAKLLGVF--G-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEechHHHHHHHHHHHhcCCCCceeEEe--C-Cc---Eeehhh
Confidence            44446667789887543    2378888765432 1 12233467777777754444 3555554  2 22   589999


Q ss_pred             CCCCHHH-----------------HhhhhcCC--CCCCCHHHHHHHHHHH-------------------------HHHH-
Q 012392          266 PKGKLSK-----------------YLDQEEGS--SNVLDWSTRVSIIIGI-------------------------AKGI-  300 (464)
Q Consensus       266 ~~gsL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~~i-------------------------a~gL-  300 (464)
                      ++-.|..                 .+|.....  ...--|..+.++..++                         +..+ 
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            7665421                 01221111  1111233322222111                         1111 


Q ss_pred             HHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCcccc
Q 012392          301 GYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKL  341 (464)
Q Consensus       301 ~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~  341 (464)
                      .++.+.+ ...-+.|.|+.+.|||+++ ++.++++||..+..
T Consensus       173 ~~~~~~~-~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLK-APVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCC-CCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            2222222 3345899999999999975 57899999987753

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.05  E-value=0.11  Score=47.53  Aligned_cols=137  Identities=15%  Similarity=0.191  Sum_probs=83.8

Q ss_pred             EEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHH
Q 012392          211 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV  290 (464)
Q Consensus       211 vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  290 (464)
                      ..+|+++...+.-...-|..+..++++++  .|++|..    .....+-++.|+|-.-.             ...   .-
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~-------------i~~---~N  145 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK-------------INF---SN  145 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc-------------cch---hH
Confidence            34555554433323345677888888875  4677753    33445678899883311             011   11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCC
Q 012392          291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF  370 (464)
Q Consensus       291 ~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  370 (464)
                      .|..+ .+.|.-.|+.+   +..+|+|-.|+||+-|..|.+||.|-+.--  ...           .-|.--|   ....
T Consensus       146 ~i~ag-i~~L~~fH~~~---~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~-----------V~~vN~~---Y~~l  205 (308)
T PF07387_consen  146 FITAG-IKDLMDFHSEN---QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQ-----------VNMVNIE---YESL  205 (308)
T ss_pred             HHHHh-HHHHHHhhccC---CCeecCCCChhheeecCCCCEEecChhhhh--hhe-----------eeEEeee---cccc
Confidence            22222 36677788643   569999999999999999999999987432  111           1133312   1234


Q ss_pred             CCcchhHHHHHHHHHHHhC
Q 012392          371 TERSDIFAFGVIILQILTG  389 (464)
Q Consensus       371 ~~~sDv~s~Gvll~el~tg  389 (464)
                      |+++.+-+|=.-+++++..
T Consensus       206 T~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  206 TQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             ChHHHHHHHHHHHHHHHHH
Confidence            7788888887777777654

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.02  E-value=0.26  Score=48.07  Aligned_cols=31  Identities=19%  Similarity=0.293  Sum_probs=27.3

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      +..++|+|+.+.|||+++++.+-++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3459999999999999999899999997765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.82  E-value=0.62  Score=45.77  Aligned_cols=141  Identities=18%  Similarity=0.214  Sum_probs=79.4

Q ss_pred             CceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCC---ceeeeeEEEeCCCC--eEEEEEecCCC
Q 012392          196 NFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HEN---IIRLRGFCCSRGRG--ECFLIYDFAPK  267 (464)
Q Consensus       196 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~n---iv~l~g~~~~~~~~--~~~lv~E~~~~  267 (464)
                      .-..||+....+|.. ++|...... .  ..+...|+.+|..+.   .+=   +..+=|-....-..  ..+-|++|++|
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~~-~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPGW-T--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCCC-C--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            445699998887776 888877652 2  223444555555542   211   33333322222233  67889999998


Q ss_pred             CCHHH------------H---hhh--------hcCCCCCCCHHH-------------HHHHHHHHHHHHHHHhcCCC---
Q 012392          268 GKLSK------------Y---LDQ--------EEGSSNVLDWST-------------RVSIIIGIAKGIGYLHSSEV---  308 (464)
Q Consensus       268 gsL~~------------~---l~~--------~~~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~~---  308 (464)
                      ..+..            +   ||.        +........|..             ......++...+..+.+.-.   
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            87772            1   111        011111234431             11233444455555543210   


Q ss_pred             C--CCCeeecCCCCCceEEcCCCC-eEEeeCCccc
Q 012392          309 N--KPAIVHRNLSVEKVLIDQQFN-PLIADCGLHK  340 (464)
Q Consensus       309 ~--~~~ivH~dlk~~Nill~~~~~-~kl~DfGl~~  340 (464)
                      .  ...+||+|+.+.||+++.+.. +.+.||+-+.
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            0  122899999999999999875 8899998765

>PRK06148 hypothetical protein; Provisional

Probab=94.77  E-value=0.79  Score=52.20  Aligned_cols=144  Identities=17%  Similarity=0.213  Sum_probs=76.4

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-------CCCCceeee-eEE---Ee--CCCC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-------RHENIIRLR-GFC---CS--RGRG  256 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-------~H~niv~l~-g~~---~~--~~~~  256 (464)
                      +.|+ |..-.+|+....+|..+++|..+... ....  ...|..+|..|       .-|.+++-. |-.   ..  ....
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~--~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVE--SDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhH--HHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            4454 45678899888888889999987543 2222  22233343322       233444322 111   11  1111


Q ss_pred             eEEEEEecCCCCCHHHHh-----------------hh------hcCCCCCCCHHH-----------------HHHHHHHH
Q 012392          257 ECFLIYDFAPKGKLSKYL-----------------DQ------EEGSSNVLDWST-----------------RVSIIIGI  296 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l-----------------~~------~~~~~~~l~~~~-----------------~~~i~~~i  296 (464)
                      ..+.+++|.++..|.+..                 +.      .......+.|..                 ...++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            467789999987776511                 10      000111233421                 11222233


Q ss_pred             HHHHH-----HHhcCCCCCCCeeecCCCCCceEEcCCC--CeE-EeeCCccc
Q 012392          297 AKGIG-----YLHSSEVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHK  340 (464)
Q Consensus       297 a~gL~-----yLH~~~~~~~~ivH~dlk~~Nill~~~~--~~k-l~DfGl~~  340 (464)
                      .....     .|.+.   ...+||+|+.+.|||++.+.  .+. |.|||-+.
T Consensus       187 ~~~~~~~v~p~l~~L---p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        187 LARFERNVAPRLAAL---PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHHhcC---CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            32221     12221   23499999999999999875  454 99999765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.74  E-value=1.1  Score=44.00  Aligned_cols=94  Identities=14%  Similarity=0.108  Sum_probs=50.8

Q ss_pred             ccCHHHHHHhhcCCccc-----cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC--CCcee
Q 012392          173 RLNLEEVESATQCFSEV-----NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIR  245 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~-----~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H--~niv~  245 (464)
                      .++.+.+..+...+...     ..| .+.-..||+....++..+++|..+...  ....+...|+..+..+.-  =.++.
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            45566666655554321     122 234567999988888889999875432  122344456666555521  11222


Q ss_pred             ---eeeEEEeCCCCeEEEEEecCCCCC
Q 012392          246 ---LRGFCCSRGRGECFLIYDFAPKGK  269 (464)
Q Consensus       246 ---l~g~~~~~~~~~~~lv~E~~~~gs  269 (464)
                         .-|-......+..+.|+++++|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence               122111112356788999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=93.91  E-value=0.35  Score=47.60  Aligned_cols=139  Identities=19%  Similarity=0.198  Sum_probs=87.2

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCC--------------------CchHH-----HHHHHHHHHHhcCCCCCce
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTS--------------------CKSEE-----AEFVKGLYLLTSLRHENII  244 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------------------~~~~~-----~~f~~e~~~l~~l~H~niv  244 (464)
                      ..|..|.-..||.+.-.+|..+|||..+.+.                    ++...     -...+|+.-|.+++.-.|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4677888899999999999999999875321                    11101     1234577777777544332


Q ss_pred             eeeeEEEeCCCCeEEEEEecCCCCC-HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCce
Q 012392          245 RLRGFCCSRGRGECFLIYDFAPKGK-LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV  323 (464)
Q Consensus       245 ~l~g~~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Ni  323 (464)
                      .---+..   . .-.|||+|+.... -.-.|..     -.++...+..+-.+++.-|.-|-...    .+||.||.--|+
T Consensus       230 ~PePIlL---k-~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c----~LVHADLSEfN~  296 (520)
T KOG2270|consen  230 CPEPILL---K-NHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC----RLVHADLSEFNL  296 (520)
T ss_pred             CCCceee---e-cceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh----ceeccchhhhhh
Confidence            1111110   1 1358999994211 1111211     12555566777778888787776543    399999999999


Q ss_pred             EEcCCCCeEEeeCCccccc
Q 012392          324 LIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       324 ll~~~~~~kl~DfGl~~~~  342 (464)
                      |+.++ .+.|+|-+-+...
T Consensus       297 LyhdG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  297 LYHDG-KLYIIDVSQSVEH  314 (520)
T ss_pred             eEECC-EEEEEEccccccC
Confidence            98764 7888998766543

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=93.88  E-value=0.03  Score=46.28  Aligned_cols=45  Identities=24%  Similarity=0.351  Sum_probs=34.9

Q ss_pred             cccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC
Q 012392          190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL  238 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l  238 (464)
                      +-|+.|+.|.||+|++++|+.||||..+...    ...+..++.+|..+
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i----~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGI----EEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHH----HHHHHHHHHHHHHH
Confidence            5699999999999999999999999887543    34455566665543

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.44  E-value=0.52  Score=47.26  Aligned_cols=82  Identities=12%  Similarity=0.070  Sum_probs=49.2

Q ss_pred             ccccccCCceEEEEEEECC-CcEEEEEEec----cC-CCchHHHHHHHHHHHHhcCC--CC-CceeeeeEEEeCCCCeEE
Q 012392          189 VNLLGKGNFSSVYKGTLRD-GTLVAIRSIN----VT-SCKSEEAEFVKGLYLLTSLR--HE-NIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~----~~-~~~~~~~~f~~e~~~l~~l~--H~-niv~l~g~~~~~~~~~~~  259 (464)
                      .+.||.|.-..||++...+ +..|+||.-.    .. ..+-...+-.-|.+.|+...  -| .+.+++.+-    .....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhh
Confidence            3578999999999999753 5679998632    11 11222233445566666552  23 466676542    34467


Q ss_pred             EEEecCCC-CCHHHHh
Q 012392          260 LIYDFAPK-GKLSKYL  274 (464)
Q Consensus       260 lv~E~~~~-gsL~~~l  274 (464)
                      +|||+++. ..|.+.|
T Consensus       110 ~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        110 CVMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHHhCcccHHHHHHH
Confidence            89999954 3344443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=92.94  E-value=0.025  Score=57.32  Aligned_cols=74  Identities=18%  Similarity=0.304  Sum_probs=60.8

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      +..-.++|.....+|.|+||+|+.+... ++..+|||+|............++|...+.++.|++++++...+..
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence            3444567888999999999999999876 4558999999887766666778899999999999999998766543

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.67  E-value=0.56  Score=46.82  Aligned_cols=61  Identities=11%  Similarity=0.067  Sum_probs=41.4

Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      ..|+-+|+++-++..++....     .+..-+.+++.--+.|+.-+--..    .++|.|+.|.||++--
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vD----NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVD----NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhh----cceecccCCCcEEEEe
Confidence            457778999999999997543     333445556655556654333221    2899999999999953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	464
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-05
3soa_A	444	Full-Length Human Camkii Length = 444		6e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/298 (31%), Positives = 162/298 (54%), Gaps = 18/298 (6%)
Query: 168 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 226
           HL    R +L E++ A+  FS  N+LG+G F  VYKG L DGTLVA++ +     +  E 
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL 80
Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
             R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL KL+    
Sbjct: 139 PKRQRIALGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 393
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 93/298 (31%), Positives = 160/298 (53%), Gaps = 18/298 (6%)
Query: 168 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 226
           HL    R +L E++ A+  F   N+LG+G F  VYKG L DG LVA++ +     +  E 
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL 72
Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
             R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL KL+    
Sbjct: 131 PKRQRIALGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 393
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 148/298 (49%), Gaps = 24/298 (8%)
Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
           S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E    +
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
               L+  RH +++ L GFC  R   E  LIY +   G L ++L   +  +  + W  R+
Sbjct: 86  IE-TLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIV 347
            I IG A+G+ YLH+      AI+HR++    +L+D+ F P I D G+ K    L    +
Sbjct: 143 EICIGAARGLHYLHTR-----AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 348 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM--------RL 399
             V+K    +GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+          
Sbjct: 198 XXVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 400 AAES---ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
           A ES      E  +D NL  K       K G  A+ C     E+RP+M  V+ +L  A
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 145/296 (48%), Gaps = 20/296 (6%)
Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
           S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E    +
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
               L+  RH +++ L GFC  R   E  LIY +   G L ++L   +  +  + W  R+
Sbjct: 86  IE-TLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
            I IG A+G+ YLH+      AI+HR++    +L+D+ F P I D G+ K   + D    
Sbjct: 143 EICIGAARGLHYLHTR-----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM--------RLAA 401
                  +GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+          A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 402 ES---ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
           ES      E  +D NL  K       K G  A+ C     E+RP+M  V+ +L  A
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 149/301 (49%), Gaps = 36/301 (11%)
Query: 178 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 229
           E+++ T  F E       N +G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
           + + ++   +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 79  QEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSCLDGTPP-LSWHMR 135
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDI 346
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL +     A  +
Sbjct: 136 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTSS 396
           + S +  + A  Y+APE +  G  T +SDI++FGV++L+I+TG           L+L   
Sbjct: 191 MXSRIVGTTA--YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV---IEELTV 453
             +  E  T E++ID+ +    S S  A +  +A  C HE    RP ++ V   ++E+T 
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
Query: 454 A 454
           +
Sbjct: 307 S 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 38/302 (12%)
Query: 178 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 229
           E+++ T  F E       N +G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 72
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
           + + ++   +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 73  QEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSCLDGTPP-LSWHMR 129
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL----HKLLADD 345
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL     K     
Sbjct: 130 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTS 395
           +   ++ T+A   Y+APE +  G  T +SDI++FGV++L+I+TG           L+L  
Sbjct: 185 MXXRIVGTTA---YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 240
Query: 396 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV---IEELT 452
              +  E  T E++ID+ +    S S  A +  +A  C HE    RP ++ V   ++E+T
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
Query: 453 VA 454
            +
Sbjct: 300 AS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 38/302 (12%)
Query: 178 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 229
           E+++ T  F E       N +G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
           + + ++   +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 79  QEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSCLDGTPP-LSWHMR 135
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL----HKLLADD 345
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL     K     
Sbjct: 136 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 346 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTS 395
           +   ++ T+A   Y+APE +  G  T +SDI++FGV++L+I+TG           L+L  
Sbjct: 191 MXXRIVGTTA---YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 396 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV---IEELT 452
              +  E  T E++ID+ +    S S  A +  +A  C HE    RP ++ V   ++E+T
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 453 VA 454
            +
Sbjct: 306 AS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 137/291 (47%), Gaps = 33/291 (11%)
Query: 178 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 229
           E+++ T  F E       N  G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 69
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
           + + +    +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 70  QEIKVXAKCQHENLVELLGFS-SDGDDLC-LVYVYXPNGSLLDRLSCLDGTPP-LSWHXR 126
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL +  A +    
Sbjct: 127 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQ 179
Query: 350 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTSS 396
            +  S  +G   Y APE +  G  T +SDI++FGV++L+I+TG           L+L   
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
             +  E  T E++ID+      S S  A    +A  C HE    RP ++ V
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDADSTSVEAXYS-VASQCLHEKKNKRPDIKKV 288

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 149/310 (48%), Gaps = 43/310 (13%)
Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 217
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 218 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 270
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 328
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 329 FNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVII 383
             P+   +AD GL    +   V SV        ++APE +      +TE++D ++F +I+
Sbjct: 163 NAPVCAKVADFGL----SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 384 LQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
             ILTG          +     F N I +  L+    E    +L  +  +C   DP+ RP
Sbjct: 219 YTILTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275
Query: 443 TMEAVIEELT 452
               +++EL+
Sbjct: 276 HFSYIVKELS 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 134
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HRNL+   +L++ +    I D GL K+L  D  +  +K    + + + APE 
Sbjct: 135 RY-----IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D  F  +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI +F P G L +YL + +     +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 136
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 6   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 122
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 123 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 174
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 175 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 230
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 231 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 289 SRISA---IFSTFI 299

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 24  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 81
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 82  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 140
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 141 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 192
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 193 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 248
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 249 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 306
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 307 SRISA---IFSTFI 317

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 25  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 82
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 83  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 141
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 142 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 193
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 194 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 249
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 250 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 307
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 308 SRISA---IFSTFI 318

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 59  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 117
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 118 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 169
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 225
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 226 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 284 SRISA---IFSTFI 294

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 29/286 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 26  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 84  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 139
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 358
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 140 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +      + 
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITVYLLQGRRL 248
Query: 419 SESEAA--KLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 462
            + E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 249 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 5   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 121
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 122 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 173
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 174 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 229
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 230 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 288 SRISA---IFSTFI 298

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 4   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 61
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 62  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 120
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 121 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 172
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 173 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 228
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 229 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 287 SRISA---IFSTFI 297

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 6   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 122
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 123 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 174
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 175 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 230
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 231 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 289 SRISA---IFSTFI 299

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 146/307 (47%), Gaps = 37/307 (12%)
Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 217
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 218 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 270
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 328
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 329 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQI 386
             P+ A      L +   V SV        ++APE +      +TE++D ++F +I+  I
Sbjct: 163 NAPVCAKVADFSL-SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
Query: 387 LTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 445
           LTG          +     F N I +  L+    E    +L  +  +C   DP+ RP   
Sbjct: 222 LTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 446 AVIEELT 452
            +++EL+
Sbjct: 279 YIVKELS 285

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 149/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 119
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 120 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 171
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D   +SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 172 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 227
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 228 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 286 SRISA---IFSTFI 296

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 148/310 (47%), Gaps = 43/310 (13%)
Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 217
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 218 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 270
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 328
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 329 FNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVII 383
             P+   +AD G     +   V SV        ++APE +      +TE++D ++F +I+
Sbjct: 163 NAPVCAKVADFGT----SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 384 LQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
             ILTG          +     F N I +  L+    E    +L  +  +C   DP+ RP
Sbjct: 219 YTILTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275
Query: 443 TMEAVIEELT 452
               +++EL+
Sbjct: 276 HFSYIVKELS 285

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL   +  +  +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 185 CFSEVNLLGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
           C +   ++G G F  VYKG L+  +      VAI+++     + +  +F+    ++    
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NIIRL G           +I ++   G L K+L +++G  +VL     V ++ GIA G
Sbjct: 105 HHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAG 159
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAM 357
           + YL +        VHR+L+   +L++      ++D GL ++L DD    ++       +
Sbjct: 160 MKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            + APE ++  +FT  SD+++FG+++ +++T
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 165 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 5   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 121
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL S +      VHR+L+    ++D++F   +
Sbjct: 122 IRNETHNPTVKD---LIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKV 173
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 174 ADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 229
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 230 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 288 SRISA---IFSTFI 298

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 138
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 139 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 139
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 140 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 137
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 138 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 151
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 152 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 140
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 141 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 132
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 133 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 151
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 152 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 136
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 192 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 131
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 132 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 365 VTTGRFTERSDIFAFGVIILQILT 388
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L+   +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 73  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 122
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 238
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 239 QCWRKDPEERPTFE 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 75  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 124
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 240
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 241 QCWRKDPEERPTFE 254

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 120/266 (45%), Gaps = 16/266 (6%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
           E   +    +  LG G F  V+ GT    T VAI+++   +   E   F++   ++  L+
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES--FLEEAQIMKKLK 62
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H+ +++L            +++ ++  KG L  +L   EG +  L     V +   +A G
Sbjct: 63  HDKLVQLYAVVSEE---PIYIVTEYMNKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAG 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + Y     + +   +HR+L    +L+       IAD GL +L+ D+   +       + +
Sbjct: 118 MAY-----IERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
            APE    GRFT +SD+++FG+++ +++T   V    M         E  ++R  +    
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ-VERGYRMPCP 228
Query: 420 ESEAAKLGKMALVCTHEDPENRPTME 445
           +     L ++ + C  +DPE RPT E
Sbjct: 229 QDCPISLHELMIHCWKKDPEERPTFE 254

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVCEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 251 EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 300
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 416
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 417 QCWRKDPEERPTFE 430

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 333 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 382
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 499 QCWRKEPEERPTFE 512

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVMEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  +RHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 150/319 (47%), Gaps = 39/319 (12%)
Query: 163 GFSREHLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTL 210
           G +  H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKK 117
Query: 211 V--AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 268
           +  A++S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHG 176
Query: 269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 328
            L  ++  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++
Sbjct: 177 DLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEK 228
Query: 329 FNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQ 385
           F   +AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ +
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 386 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPT 443
           +      +T       +  TF+  +      +  + E     L ++ L C H   E RP+
Sbjct: 289 L------MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 342
Query: 444 MEAVIEELTVAAPVMATFL 462
              ++  ++    + +TF+
Sbjct: 343 FSELVSRISA---IFSTFI 358

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 432 VCTHEDPENRPTME 445
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 150/319 (47%), Gaps = 39/319 (12%)
Query: 163 GFSREHLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTL 210
           G +  H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  
Sbjct: 1   GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKK 58
Query: 211 V--AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 268
           +  A++S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G
Sbjct: 59  IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHG 117
Query: 269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 328
            L  ++  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++
Sbjct: 118 DLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEK 169
Query: 329 FNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQ 385
           F   +AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ +
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 386 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPT 443
           +      +T       +  TF+  +      +  + E     L ++ L C H   E RP+
Sbjct: 230 L------MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 283
Query: 444 MEAVIEELTVAAPVMATFL 462
              ++  ++    + +TF+
Sbjct: 284 FSELVSRISA---IFSTFI 299

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 6   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 122
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++F   +
Sbjct: 123 IRNETHNPTVKD---LIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKV 174
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 175 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 230
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 231 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 289 SRISA---IFSTFI 299

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 11  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 68
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 69  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 127
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++F   +
Sbjct: 128 IRNETHNPTVKD---LIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKV 179
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 180 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 235
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 236 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 293
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 294 SRISA---IFSTFI 304

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 7   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 123
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++F   +
Sbjct: 124 IRNETHNPTVKD---LIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKV 175
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 176 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 231
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 232 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 290 SRISA---IFSTFI 300

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 4   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 61
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 62  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 120
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++F   +
Sbjct: 121 IRNETHNPTVKD---LIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKV 172
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 173 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 228
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 229 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 287 SRISA---IFSTFI 297

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVGEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 148/314 (47%), Gaps = 39/314 (12%)
Query: 168 HLNSFRLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTL--RDGTLV--AI 213
           H++   LN E V++              F+EV  +G+G+F  VY GTL   DG  +  A+
Sbjct: 7   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G C  R  G   ++  +   G L  +
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNF 123
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ +L S +      VHR+L+    ++D++F   +
Sbjct: 124 IRNETHNPTVKDL---IGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKV 175
Query: 334 ADCGLHKLLADDIVFSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A   + ++A E + T +FT +SD+++FGV++ ++    
Sbjct: 176 ADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL---- 231
Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVI 448
             +T       +  TF+  +      +  + E     L ++ L C H   E RP+   ++
Sbjct: 232 --MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289
Query: 449 EELTVAAPVMATFL 462
             ++    + +TF+
Sbjct: 290 SRISA---IFSTFI 300

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH NI+   G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                    ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ YLH+     
Sbjct: 104 TQPP--NLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHN---RN 157
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
           P IVHRNL    +L+D+++   + D GL +L A     + L + +A G   ++APE +  
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGTPEWMAPEVLRD 213
Query: 368 GRFTERSDIFAFGVIILQILT 388
               E+SD+++FGVI+ ++ T
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 77  EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 126
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 242
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 243 QCWRKEPEERPTFE 256

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 80
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 81  ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 132
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G FT
Sbjct: 133 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 246
Query: 432 VCTHEDPENRPTMEAV 447
            C    PE RPT E +
Sbjct: 247 RCWKNRPEERPTFEYI 262

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 81  EE---PIYIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQIASGMAY-----VERM 130
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 246
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 247 QCWRKEPEERPTFE 260

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 81  EE---PIYIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQIASGMAY-----VERM 130
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 246
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 247 QCWRKEPEERPTFE 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 253
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 254 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G FT
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 419
Query: 432 VCTHEDPENRPTMEAV 447
            C    PE RPT E +
Sbjct: 420 RCWKNRPEERPTFEYI 435

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 285
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 286 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 334
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HRNL+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 449
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 450 ELMRACWQWNPSDRPSFAEI 469

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 192 LGKGNFSSV----YKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G+F  V    Y     + G  VA++S+   S  +  A+  K + +L +L HENI++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C   G     LI +F P G L +YL +   + N ++   ++   + I KG+ YL S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
           +      VHR+L+   VL++ +    I D GL K +  D     +K    + + + APE 
Sbjct: 146 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
           +   +F   SD+++FGV + ++LT     +S M L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 192 LGKGNFSSV----YKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G+F  V    Y     + G  VA++S+   S  +  A+  K + +L +L HENI++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C   G     LI +F P G L +YL +   + N ++   ++   + I KG+ YL S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 364
           +      VHR+L+   VL++ +    I D GL K +  D     +K    + + + APE 
Sbjct: 134 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
           +   +F   SD+++FGV + ++LT     +S M L
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 223

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 16/254 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                   ++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 74  EE---PIXIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 123
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 239
Query: 432 VCTHEDPENRPTME 445
            C  ++PE RPT E
Sbjct: 240 QCWRKEPEERPTFE 253

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 127/280 (45%), Gaps = 19/280 (6%)
Query: 178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
           E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+  
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQ 60
Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           L+H+ ++RL            ++I ++   G L  +L    G    L  +  + +   IA
Sbjct: 61  LQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIA 115
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           +G+ ++          +HRNL    +L+    +  IAD GL +L+ D+   +       +
Sbjct: 116 EGMAFIEERNY-----IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 170
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
            + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  +  
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMV 226
Query: 418 FSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
             ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 227 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 69
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 70  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 125 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 235
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 71
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 72  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 126
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 127 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 182 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 237
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 238 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 73
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 74  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 128
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 129 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 184 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 239
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 240 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH NI+   G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                    ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ YLH+     
Sbjct: 104 TQPP--NLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHN---RN 157
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-YLAPEYVTTGR 369
           P IVHR+L    +L+D+++   + D GL +L A   + S  K +A    ++APE +    
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVLRDEP 215
Query: 370 FTERSDIFAFGVIILQILT 388
             E+SD+++FGVI+ ++ T
Sbjct: 216 SNEKSDVYSFGVILWELAT 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 324
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 325 TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 373
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HRNL+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 374 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 488
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 72
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 73  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 127
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 128 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 183 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 238
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 239 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 279

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 135/282 (47%), Gaps = 26/282 (9%)
Query: 189 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 73
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 130
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 361
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 131 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS----------LVLTSSMRLAAESATFENFID 411
           PE ++   F+ +SD+++FGV++ ++ T            L +  S R     +     ++
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 453
              +     +  A++ ++  +C    P++RP+  A+  +L +
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 287

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 69
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 70  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 125 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 235
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 65
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 66  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 120
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 121 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 176 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 231
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 232 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 64
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 65  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 119
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 120 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 175 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 230
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 231 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 68
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 69  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 123
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 124 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 179 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 234
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 235 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 275

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
              V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+    ++ S+ H
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            +++RL G C S       L+    P G L +Y+ + +   GS  +L+W       + IA
Sbjct: 100 PHLVRLLGVCLS---PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIA 150
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  ++       
Sbjct: 151 KGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +   +FT +SD++++GV I +++T
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 58
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            L+H+ ++RL            ++I ++   G L  +L    G    L  +  + +   I
Sbjct: 59  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQI 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 114 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 169 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 224
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 225 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 132
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 70
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ RG     GR E  L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 127
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 361
            S        VHR+L+   +L++ + +  IAD GL KLL  D    V++    + + + A
Sbjct: 128 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
              V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+    ++ S+ H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            +++RL G C S       L+    P G L +Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHLVRLLGVCLS---PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  ++       
Sbjct: 128 KGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +   +FT +SD++++GV I +++T
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 86
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 361
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 144 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 74
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 131
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 361
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 132 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT 388
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G F  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 80  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE--- 129
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 243
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 82
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 83  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 132 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 246
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 247 ELMRACWQWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 80  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 128
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 129 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 243
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 91
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 92  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 140
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 141 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 255
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 256 ELMRACWQWNPSDRPSFAEI 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 428 KMALVCTHEDPENRPTMEAV 447
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               +   +++ +    G    +L  E     V    T + ++   A G+ YL S     
Sbjct: 182 TQ--KQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESK---- 232
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR 369
              +HR+L+    L+ ++    I+D G+ +  AD +   S       + + APE +  GR
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKM 429
           ++  SD+++FG+++ +  +    L +S      +     F+++  +    E     + ++
Sbjct: 292 YSSESDVWSFGILLWETFS----LGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 430 ALVCTHEDPENRPTMEAVIEEL 451
              C   +P  RP+   + +EL
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               +   +++ +    G    +L  E     V    T + ++   A G+ YL S     
Sbjct: 182 TQ--KQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESK---- 232
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR 369
              +HR+L+    L+ ++    I+D G+ +  AD +   S       + + APE +  GR
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKM 429
           ++  SD+++FG+++ +  +    L +S      +     F+++  +    E     + ++
Sbjct: 292 YSSESDVWSFGILLWETFS----LGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 430 ALVCTHEDPENRPTMEAVIEEL 451
              C   +P  RP+   + +EL
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 161 GTGFSREHLNSFRLNLEEV----ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI 216
           G  F+RE + + R+++E++    +S   C+  + + G+ +              VAI+++
Sbjct: 39  GRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP------------VAIKAL 85
Query: 217 NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 276
                + +  +F+    ++    H NIIRL G   +RGR    ++ ++   G L  +L  
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGR-LAMIVTEYMENGSLDTFLRT 143
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 336
            +G   ++     V ++ G+  G+ YL     +    VHR+L+   VL+D      ++D 
Sbjct: 144 HDGQFTIMQL---VGMLRGVGAGMRYL-----SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 337 GLHKLLAD--DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 394
           GL ++L D  D  ++       + + APE +    F+  SD+++FGV++ ++        
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV-------- 247
Query: 395 SSMRLAAESATFENFIDRNLKGKFSESE--AAKLG------KMALVCTHEDPENRPTMEA 446
               LA     + N  +R++     E     A +G      ++ L C H+D   RP    
Sbjct: 248 ----LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 447 VIEEL 451
           ++  L
Sbjct: 304 IVSVL 308

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 128/270 (47%), Gaps = 20/270 (7%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 17  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 72
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +         ++I +F  KG L  +L  +EG   +L     +     IA+G+ Y     +
Sbjct: 73  YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAY-----I 125
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
            +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE +  G
Sbjct: 126 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 369 RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            FT +S++++FG+++ +I+T G +           SA  + +  R  + +    E   + 
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY--RMPRMENCPDELYDIM 243
Query: 428 KMALVCTHEDPENRPT---MEAVIEELTVA 454
           KM   C  E  E RPT   +++V+++   A
Sbjct: 244 KM---CWKEKAEERPTFDYLQSVLDDFYTA 270

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 128/270 (47%), Gaps = 20/270 (7%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 73
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +         ++I ++  KG L  +L  +EG   +L     +     IA+G+ Y     +
Sbjct: 74  YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAY-----I 126
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
            +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE +  G
Sbjct: 127 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 186
Query: 369 RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
            FT +SD+++FG+++ +I+T G +           +A  + +  R  + +    E   + 
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY--RMPRVENCPDELYDIM 244
Query: 428 KMALVCTHEDPENRPT---MEAVIEELTVA 454
           KM   C  E  E RPT   +++V+++   A
Sbjct: 245 KM---CWKEKAEERPTFDYLQSVLDDFYTA 271

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 132/288 (45%), Gaps = 30/288 (10%)
Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK--SEEAEFVKG-L 232
           L E++ A     E+  +G G F  VY+     G  VA+++      +  S+  E V+   
Sbjct: 1   LLEIDFAELTLEEI--IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            L   L+H NII LRG C         L+ +FA  G L++ L  +    ++L     V+ 
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNW 110
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF------NPL--IADCGLHKLLAD 344
            + IA+G+ YLH   +    I+HR+L    +LI Q+       N +  I D GL +    
Sbjct: 111 AVQIARGMNYLHDEAIV--PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
               S    + A  ++APE +    F++ SD++++GV++ ++LTG +       LA    
Sbjct: 169 TTKMS---AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
              N +   +     E  A    K+   C + DP +RP+   ++++LT
Sbjct: 226 VAMNKLALPIPSTCPEPFA----KLMEDCWNPDPHSRPSFTNILDQLT 269

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 115/256 (44%), Gaps = 26/256 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 247
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 248 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 299
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L    +L+       IAD GL ++ A             + + APE +  G FT
Sbjct: 300 --IHRDLRAANILVSASLVCKIADFGLARVGA----------KFPIKWTAPEAINFGSFT 347
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 403
Query: 432 VCTHEDPENRPTMEAV 447
            C    PE RPT E +
Sbjct: 404 RCWKNRPEERPTFEYI 419

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 161 GTGFSREHLNSFRLNLEEV----ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI 216
           G  F+RE + + R+++E++    +S   C+  + + G+ +              VAI+++
Sbjct: 39  GRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP------------VAIKAL 85
Query: 217 NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 276
                + +  +F+    ++    H NIIRL G   +RGR    ++ ++   G L  +L  
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGR-LAMIVTEYMENGSLDTFLRT 143
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 336
            +G   ++     V ++ G+  G+ YL     +    VHR+L+   VL+D      ++D 
Sbjct: 144 HDGQFTIMQL---VGMLRGVGAGMRYL-----SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 337 GLHKLLADDIVFSVLKTSAAMG--YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 394
           GL ++L DD   +   T   +   + APE +    F+  SD+++FGV++ ++        
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV-------- 247
Query: 395 SSMRLAAESATFENFIDRNLKGKFSESE--AAKLG------KMALVCTHEDPENRPTMEA 446
               LA     + N  +R++     E     A +G      ++ L C H+D   RP    
Sbjct: 248 ----LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 447 VIEEL 451
           ++  L
Sbjct: 304 IVSVL 308

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 123/256 (48%), Gaps = 22/256 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 97
Query: 251 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                   +++ ++ P G L  YL   ++EE ++ VL     + +   I+  + YL    
Sbjct: 98  TLEP--PFYIVTEYMPYGNLLDYLRECNREEVTAVVL-----LYMATQISSAMEYL---- 146
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 147 -EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 205
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 427
             F+ +SD++AFGV++ +I T  +     + L    +   + +++  + +  E    K+ 
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYDLLEKGYRMEQPEGCPPKVY 261
Query: 428 KMALVCTHEDPENRPT 443
           ++   C    P +RP+
Sbjct: 262 ELMRACWKWSPADRPS 277

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 69
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 70  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
              +++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 123 ---SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 180 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 233 VYQIMNH---CWKERPEDRPAFSRLLRQLAAIA 262

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   S    E +F++   ++  L H  +++L G
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 90  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 142
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 143 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 200 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 252
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 253 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 282

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 72
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 73  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 125
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 126 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 183 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 236 VYQIMNH---CWRERPEDRPAFSRLLRQLAEIA 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 19/278 (6%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
           E   +    V  LG G    V+ G     T VA++S+   S   +   F+    L+  L+
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQ 66
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H+ ++RL            ++I ++   G L  +L    G    ++    + +   IA+G
Sbjct: 67  HQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEG 121
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + ++          +HR+L    +L+    +  IAD GL +L+ D    +       + +
Sbjct: 122 MAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
            APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  +    
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMVRP 232
Query: 420 ESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 454
           ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 69
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 70  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 123 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 180 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 233 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 67
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 68  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 120
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 178 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 231 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 260

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 185 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 34  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 93
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            N+I L G           +I +F   G L  +L Q +G   V+     V ++ GIA G+
Sbjct: 94  PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGM 148
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI----VFSVLKTSAA 356
            YL  +++N    VHR+L+   +L++      ++D GL + L DD       S L     
Sbjct: 149 KYL--ADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +   +FT  SD++++G+++ ++++        M     +    N I+++ + 
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAIEQDYRL 259
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                  + L ++ L C  +D  +RP    ++  L
Sbjct: 260 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL----VAIRSIN-VTSCKSEEAEFVKGLYLLTSLRHENII 244
            ++GKG+F  VY G   D        AI+S++ +T  +  EA   +GL L+  L H N++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL-LMRGLNHPNVL 85
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L G       G   ++  +   G L +++   + +  V D    +S  + +A+G+ YL 
Sbjct: 86  ALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLA 141
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLA 361
             +      VHR+L+    ++D+ F   +AD GL + + D   +SV +   A   + + A
Sbjct: 142 EQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
            E + T RFT +SD+++FGV++ ++LT        +    +     +F+ +  +    E 
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHFLAQGRRLPQPEY 252
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               L ++   C   DP  RPT   ++ E+
Sbjct: 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 99  LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 153
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 154 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 262
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 263 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 109 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 163
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 164 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 272
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 273 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           E    C     ++G G F  V  G L+        VAI+++ V   + +  +F+    ++
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
               H N++ L G   +RG+    ++ +F   G L  +L + +G   V+     V ++ G
Sbjct: 99  GQFDHPNVVHLEG-VVTRGK-PVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRG 153
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKT 353
           IA G+ YL          VHR+L+   +L++      ++D GL +++ DD   V++    
Sbjct: 154 IAAGMRYLADM-----GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGG 208
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + + APE +   +FT  SD++++G+++ ++++
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 82  LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 137 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIR-SINVTSCKSEEAEF---VKGLYLLTSLRH 240
             ++ +LG G F +V+KG  + +G  + I   I V   KS    F      +  + SL H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIIIGIA 297
            +I+RL G C         L+  + P G L  ++ Q  G+     +L+W  +      IA
Sbjct: 75  AHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 125
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVLKTS 354
           KG+ YL         +VHRNL+   VL+       +AD G+  LL  D   +++S  KT 
Sbjct: 126 KGMYYLEEH-----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             + ++A E +  G++T +SD++++GV + +++T      + +RLA      E       
Sbjct: 181 --IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------- 231
Query: 415 KG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 455
           KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIR-SINVTSCKSEEAEF---VKGLYLLTSLRH 240
             ++ +LG G F +V+KG  + +G  + I   I V   KS    F      +  + SL H
Sbjct: 33  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIIIGIA 297
            +I+RL G C         L+  + P G L  ++ Q  G+     +L+W  +      IA
Sbjct: 93  AHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 143
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVLKTS 354
           KG+ YL         +VHRNL+   VL+       +AD G+  LL  D   +++S  KT 
Sbjct: 144 KGMYYLEEH-----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             + ++A E +  G++T +SD++++GV + +++T      + +RLA      E       
Sbjct: 199 --IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------- 249
Query: 415 KG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 455
           KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 250 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 293

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 78  PHVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 129 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 185 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 8   CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 67
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            N+I L G           +I +F   G L  +L Q +G   V+     V ++ GIA G+
Sbjct: 68  PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGM 122
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI----VFSVLKTSAA 356
            YL  +++N    VHR L+   +L++      ++D GL + L DD       S L     
Sbjct: 123 KYL--ADMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           + + APE +   +FT  SD++++G+++ ++++        M     +    N I+++ + 
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAIEQDYRL 233
Query: 417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                  + L ++ L C  +D  +RP    ++  L
Sbjct: 234 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 70
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C  +      L+ +F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 71  VCLEQA--PICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 123
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 124 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 422
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 181 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             ++      C  E PE+RP    ++ +L   A
Sbjct: 234 VYQIMNH---CWRERPEDRPAFSRLLRQLAEIA 263

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 298
           HE+II+ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 128
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 356
           G+ YLHS        +HRNL+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 129 GMAYLHSQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 90  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 140
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 200 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 255
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 81  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 131
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 132 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 191 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 246
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 247 SCWHEKADERPTFKILL 263

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 81  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 132 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 35/223 (15%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV--KGLYLLTSLRHENIIRL 246
           + L+G+G + +VYKG+L D   VA++  +  + ++    F+  K +Y +  + H+NI R 
Sbjct: 18  LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARF 72
Query: 247 ---RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
                   + GR E  L+ ++ P G L KYL     S +  DW +   +   + +G+ YL
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 304 HSS----EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTSAAMG 358
           H+     +  KPAI HR+L+   VL+      +I+D GL  +L  + +V    + +AA+ 
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 359 ------YLAPEYVTTGRFTERS--------DIFAFGVIILQIL 387
                 Y+APE V  G    R         D++A G+I  +I 
Sbjct: 188 EVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 75  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 125
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 185 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 240
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 77  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 80  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 78  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 129 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 74  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 124
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 125 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 184 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 239
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 240 SCWHEKADERPTFKILL 256

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 298
           HE+II+ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 128
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 356
           G+ YLH+        +HRNL+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 129 GMAYLHAQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 87  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 137
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 138 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 90  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 140
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 200 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 255
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 83  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 134 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 79  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 70  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 120
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 180 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 235
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 236 SCWHEKADERPTFKILL 252

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 102 PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 152
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 153 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 190 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 82  LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 363
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 137 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 421
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             A L ++ L C  +D  NRP  E ++  L
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 127/281 (45%), Gaps = 23/281 (8%)
Query: 190 NLLGKGNFSSVYKGTLR--DGT--LVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENII 244
            +LG+G F SV +G L+  DGT   VA++++ +  S + E  EF+     +    H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 245 RLRGFCC---SRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 299
           RL G C    S+G  +  +I  F   G L  YL   + E     +   T +  ++ IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 358
           + YL +        +HR+L+    ++       +AD GL  K+ + D           + 
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++A E +    +T +SD++AFGV + +I T  +          ++    +++    + K 
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP----GVQNHEMYDYLLHGHRLKQ 270
Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAV---IEELTVAAP 456
            E    +L ++   C   DP +RPT   +   +E+L  + P
Sbjct: 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 71  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 121
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 122 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 75  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 125
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S   +   + +  PE +   +F+
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 431
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 185 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 240
Query: 432 VCTHEDPENRPTMEAVI 448
            C HE  + RPT + ++
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ L+G G F  V+K   R DG    I+ +   + K+E     + +  L  L H NI+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-----REVKALAKLDHVNIV 67
Query: 245 RLRGFC--------------CSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
              G C               SR + +C F+  +F  KG L +++++  G    LD    
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           + +   I KG+ Y+HS +     +++R+L    + +       I D GL   L +D    
Sbjct: 125 LELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GK 177
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
             ++   + Y++PE +++  + +  D++A G+I+ ++L    V  ++      S  F + 
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFET---SKFFTDL 231
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 453
            D  +   F + E   L K+      + PE+RP    ++  LTV
Sbjct: 232 RDGIISDIFDKKEKTLLQKLL----SKKPEDRPNTSEILRTLTV 271

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI  +   +      E +   Y++ S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 111 PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 161
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 162 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ L+G G F  V+K   R DG    IR +   + K+E     + +  L  L H NI+
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-----REVKALAKLDHVNIV 68
Query: 245 RLRGFC---------------------------CSRGRGEC-FLIYDFAPKGKLSKYLDQ 276
              G C                            SR + +C F+  +F  KG L +++++
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 336
             G    LD    + +   I KG+ Y+HS +     ++HR+L    + +       I D 
Sbjct: 128 RRGEK--LDKVLALELFEQITKGVDYIHSKK-----LIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 396
           GL   L +D      ++   + Y++PE +++  + +  D++A G+I+ ++L    V  ++
Sbjct: 181 GLVTSLKND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTA 235
Query: 397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 453
                 S  F +  D  +   F + E   L K+      + PE+RP    ++  LTV
Sbjct: 236 FET---SKFFTDLRDGIISDIFDKKEKTLLQKLL----SKKPEDRPNTSEILRTLTV 285

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGL 232
           +E+E++  C +   ++G G F  V  G L+        VAI+++ V   + +  +F+   
Sbjct: 17  KEIEAS--CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            ++    H NII L G           ++ ++   G L  +L + +G   V+     V +
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDTFLKKNDGQFTVIQ---LVGM 129
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSV 350
           + GI+ G+ YL          VHR+L+   +LI+      ++D GL ++L DD    ++ 
Sbjct: 130 LRGISAGMKYLSDM-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 351 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
                 + + APE +   +FT  SD++++G+++ ++++
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 22/269 (8%)
Query: 191 LLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           ++G G F  V +G L+      + VAI+++     + +  EF+    ++    H NIIRL
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G   +       ++ +F   G L  +L   +G   V+     V ++ GIA G+ YL   
Sbjct: 81  EGVVTNSM--PVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYLAEM 135
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL----ADDIVFSVLKTSAAMGYLAP 362
                + VHR+L+   +L++      ++D GL + L    +D    S L     + + AP
Sbjct: 136 -----SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E +   +FT  SD +++G+++ ++++        M     +    N I+++ +       
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM----SNQDVINAIEQDYRLPPPPDC 246
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              L ++ L C  +D   RP    V+  L
Sbjct: 247 PTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
            ++G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H NI++L G 
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLH 304
           C +       L+ ++A  G L   L   E      +++ + W  + S      +G+ YLH
Sbjct: 71  CLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLH 120
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           S +    A++HR+L    +L+      L I D G     A DI   +     +  ++APE
Sbjct: 121 SMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPE 174
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 423
                 ++E+ D+F++G+I+ +++T          +   +      +    +    ++  
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEELT 452
             +  +   C  +DP  RP+ME +++ +T
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 74  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           +G+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 125 EGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 81  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 132 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 84  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENIIR 245
           +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I++
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL S
Sbjct: 90  LIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES 143
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
             +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE +
Sbjct: 144 --IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 198
Query: 366 TTGRFTERSDIFAFGVIILQILT 388
              RFT  SD++ F V + +IL+
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILS 221

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
            ++G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H NI++L G 
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLH 304
           C +       L+ ++A  G L   L   E      +++ + W  + S      +G+ YLH
Sbjct: 70  CLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLH 119
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           S +    A++HR+L    +L+      L I D G     A DI   +     +  ++APE
Sbjct: 120 SMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPE 173
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 423
                 ++E+ D+F++G+I+ +++T          +   +      +    +    ++  
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDE---IGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEELT 452
             +  +   C  +DP  RP+ME +++ +T
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENIIR 245
           +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I++
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL S
Sbjct: 74  LIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES 127
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
             +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE +
Sbjct: 128 --IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 182
Query: 366 TTGRFTERSDIFAFGVIILQILT 388
              RFT  SD++ F V + +IL+
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILS 205

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 22/269 (8%)
Query: 191 LLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           ++G G F  V +G L+      + VAI+++     + +  EF+    ++    H NIIRL
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G   +       ++ +F   G L  +L   +G   V+     V ++ GIA G+ YL   
Sbjct: 83  EGVVTNSM--PVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM 137
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL----ADDIVFSVLKTSAAMGYLAP 362
                + VHR+L+   +L++      ++D GL + L    +D    S L     + + AP
Sbjct: 138 -----SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E +   +FT  SD +++G+++ ++++        M     +    N I+++ +       
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM----SNQDVINAIEQDYRLPPPPDC 248
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              L ++ L C  +D   RP    V+  L
Sbjct: 249 PTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENIIR 245
           +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL S
Sbjct: 78  LIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES 131
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
             +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE +
Sbjct: 132 --IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186
Query: 366 TTGRFTERSDIFAFGVIILQILT 388
              RFT  SD++ F V + +IL+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 297
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
             +V +LG G F +VYKG  + DG      VAI+ +   +      E +   Y++  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIA 297
             + RL G C +       L+    P G L  ++ +  G   S ++L+W  +      IA
Sbjct: 79  PYVSRLLGICLT---STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IA 129
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 356
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  +        
Sbjct: 130 KGMSYLEDVR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + ++A E +   RFT +SD++++GV + +++T
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 71  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
                + +   IA G+ YL     N    VHRNL+    ++   F   I D G+ + +  
Sbjct: 129 TLQEMIQMAAEIADGMAYL-----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 183
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 184 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 236
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 237 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 191 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +LGKG F    K T R+   V +    +   +  +  F+K + ++  L H N+++  G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               R     I ++   G L   +   +       WS RVS    IA G+ YLHS     
Sbjct: 77  YKDKRLN--FITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-----VFSVLKTSAAMGY------ 359
             I+HR+L+    L+ +  N ++AD GL +L+ D+      + S+ K      Y      
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 360 --LAPEYVTTGRFTERSDIFAFGVIILQIL----TGSLVLTSSMRLAAESATFENFIDRN 413
             +APE +    + E+ D+F+FG+++ +I+         L  +M           F+DR 
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---LNVRGFLDRY 243
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPT 443
                  S       + + C   DPE RP+
Sbjct: 244 CPPNCPPS----FFPITVRCCDLDPEKRPS 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
                + +   IA G+ YL     N    VHRNL+    ++   F   I D G+ + +  
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
             ++  LG+G+F  V    Y  T  DGT  +VA++++   +     + + + + +L +L 
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 298
           HE+II+ +G C   G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 145
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 356
           G+ YLH+        +HR+L+   VL+D      I D GL K + +      ++    + 
Sbjct: 146 GMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 25/305 (8%)
Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR--DGTLV--AIR 214
           L+  G S E     +  LE+V    Q F+   +LGKG F SV +  L+  DG+ V  A++
Sbjct: 2   LDSLGISDE----LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK 57
Query: 215 SINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCC-SRGRGEC---FLIYDFAPKGK 269
            +      S +  EF++    +    H ++ +L G    SR +G      +I  F   G 
Sbjct: 58  MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 270 LSKYLDQEEGSSNV--LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 327
           L  +L       N   L   T V  ++ IA G+ YL S        +HR+L+    ++ +
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAE 172
Query: 328 QFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
                +AD GL  K+ + D       +   + +LA E +    +T  SD++AFGV + +I
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
           +T      + +    E+A   N++    + K       ++  +   C   DP+ RP+   
Sbjct: 233 MTRGQTPYAGI----ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288
Query: 447 VIEEL 451
           +  EL
Sbjct: 289 LRMEL 293

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 66
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 67  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 125 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 345 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 232
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 233 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 72  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 345 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 345 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 63  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 345 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 192 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C +       L+ + A  G L K+L    G    +  S    ++  ++ G+ YL     
Sbjct: 404 VCQAEA---LMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYVT 366
                VHRNL+   VL+  +    I+D GL K L  D  +   +++    + + APE + 
Sbjct: 457 ----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 367 TGRFTERSDIFAFGVIILQILT 388
             +F+ RSD++++GV + + L+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 78  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 72  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 65  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 71  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + +  
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 345 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 404 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 127/292 (43%), Gaps = 38/292 (13%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 284
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ +    
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 345 DIVFSVLKTSAAMG-----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
           DI  +        G     ++APE +  G FT  SD+++FGV++ +I       TS    
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQ 231
Query: 400 AAESATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
             +  + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 232 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 69  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 100 EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 71  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 211 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK- 269
           VAI+ IN+  C++   E +K +  ++   H NI+    +     + E +L+      G  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSV 100
Query: 270 ---LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 326
              +   + + E  S VLD ST  +I+  + +G+ YLH     K   +HR++    +L+ 
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-----KNGQIHRDVKAGNILLG 155
Query: 327 QQFNPLIADCGLHKLLAD--DIVFSVLKTS--AAMGYLAPEYVTTGR-FTERSDIFAFGV 381
           +  +  IAD G+   LA   DI  + ++ +      ++APE +   R +  ++DI++FG+
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
Query: 382 IILQILTGSLVLTSSMRLAAESATFEN--------FIDRNLKGKFSESEAAKLGKMALVC 433
             +++ TG+        +     T +N          D+ +  K+ +S      KM  +C
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLC 271
Query: 434 THEDPENRPT 443
             +DPE RPT
Sbjct: 272 LQKDPEKRPT 281

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 211 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK- 269
           VAI+ IN+  C++   E +K +  ++   H NI+    +     + E +L+      G  
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSV 95
Query: 270 ---LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 326
              +   + + E  S VLD ST  +I+  + +G+ YLH     K   +HR++    +L+ 
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-----KNGQIHRDVKAGNILLG 150
Query: 327 QQFNPLIADCGLHKLLAD--DIVFSVLKTS--AAMGYLAPEYVTTGR-FTERSDIFAFGV 381
           +  +  IAD G+   LA   DI  + ++ +      ++APE +   R +  ++DI++FG+
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 210
Query: 382 IILQILTGSLVLTSSMRLAAESATFEN--------FIDRNLKGKFSESEAAKLGKMALVC 433
             +++ TG+        +     T +N          D+ +  K+ +S      KM  +C
Sbjct: 211 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLC 266
Query: 434 THEDPENRPT 443
             +DPE RPT
Sbjct: 267 LQKDPEKRPT 276

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D   +
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IIHLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 124
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 119
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 90  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 148 SCTYQLARGMEYLASQKC-----IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 258
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 259 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 116/260 (44%), Gaps = 22/260 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  +    VA++ I   S    E EF +    +  L H  +++  G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                  +++ ++   G L  YL         L+ S  + +   + +G+ +L S +    
Sbjct: 74  KEY--PIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---- 124
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L+D+     ++D G+ + + DD   S + T   + + APE     +++
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 372 ERSDIFAFGVIILQILT-GSLV--LTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
            +SD++AFG+++ ++ + G +   L ++  +  + +        +L        +  + +
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA-------SDTIYQ 236
Query: 429 MALVCTHEDPENRPTMEAVI 448
           +   C HE PE RPT + ++
Sbjct: 237 IMYSCWHELPEKRPTFQQLL 256

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IITLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAK 298
           HE+I++ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICE 123
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 356
           G+ YLH+        +HR L+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 124 GMAYLHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 192 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  VY+G  RD       T VA++++N ++   E  EF+    ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----LDWSTRVSIIIGIAKG 299
           L G   S+G+    ++ +    G L  YL   + E  +N           + +   IA G
Sbjct: 84  LLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 358
           + YL     N    VHR+L+    ++   F   I D G+ + +   D      K    + 
Sbjct: 142 MAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++APE +  G FT  SD+++FGV++ +I       TS      +  + E  +   + G +
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGLSNEQVLKFVMDGGY 249
Query: 419 SESE---AAKLGKMALVCTHEDPENRPTMEAVI 448
            +       ++  +  +C   +P+ RPT   ++
Sbjct: 250 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 144
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAK 298
           HE+I++ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICE 122
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 356
           G+ YLH+        +HR L+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 123 GMAYLHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 92  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 150 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 260
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 261 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 157
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 118
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 95  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 153 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 263
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 264 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 149 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 207 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 317
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 236 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 85  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGML 137
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 351
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 138 RGIGSGMKYLSDM-----SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 193 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 251 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 121
Query: 306 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 359
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 360 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 386
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 65  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+     + + F   I D G+ + +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 293
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 88  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A+G+ YL   +      +HRNL+   +L+ + +   IAD GL +    ++       
Sbjct: 146 ADVARGMDYLSQKQ-----FIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 198
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------SNVLDWSTRVSIIIGI 296
            L G C   G G   +I +F   G LS YL  +            + L     +     +
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA- 355
           AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A 
Sbjct: 154 AKGMEFLASRKX-----IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY-VRKGDAR 207
Query: 356 -AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +    
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FXRRLKEGT 264
Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   +   ++N +    
Sbjct: 78  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 236 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 64  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGML 116
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 351
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 117 RGIGSGMKYLSDM-----SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 172 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 236 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 70  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGML 122
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 351
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 123 RGIGSGMKYLSDM-----SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 178 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 193 GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 252
            +G F  V+K  L +   VA++   +   +S + E+   +Y L  ++HENI++   F  +
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQ---FIGA 86
Query: 253 RGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-- 305
             RG     + +LI  F  KG LS +L      +NV+ W+    I   +A+G+ YLH   
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 306 ---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
               + +KPAI HR++  + VL+       IAD GL   L  +   S   T   +G   Y
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--ALKFEAGKSAGDTHGQVGTRRY 199
Query: 360 LAPEYVTTGRFTERS-----DIFAFGVIILQI 386
           +APE +      +R      D++A G+++ ++
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 192 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            C +       L+ + A  G L K+L    +E   SNV +   +VS+      G+ YL  
Sbjct: 78  VCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM------GMKYLEE 128
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPE 363
                   VHR+L+   VL+  +    I+D GL K L  D  +   +++    + + APE
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F+ RSD++++GV + + L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 288
              ++      +++RL G   S+G+    +I +   +G L  YL   +   ++N +    
Sbjct: 68  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 289 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 343
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I  +A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G C   G    ++I  +A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 33/282 (11%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRV 290
           II L G C   G    ++I ++A KG L +YL   E                 L     V
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 349
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   D    
Sbjct: 154 SCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFKL 264
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/284 (19%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 186 FSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENI 243
           +  +  +G+G+F  ++   +  DG    I+ IN++   S+E  E  + + +L +++H NI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKG 299
           ++ R        G  +++ D+   G L K ++ ++G       +LDW  ++ + +     
Sbjct: 86  VQYRE--SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL----- 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 358
                   V+   I+HR++  + + + +     + D G+ ++L   +  +     A +G 
Sbjct: 139 ------KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RACIGT 188
Query: 359 --YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
             YL+PE      +  +SDI+A G ++ ++ T        ++ A E+ + +N + + + G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCT--------LKHAFEAGSMKNLVLKIISG 240
Query: 417 KF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 457
            F   S   +  L  +       +P +RP++ +++E+  +A  +
Sbjct: 241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------SNVLDWSTRVSIIIGI 296
            L G C   G G   +I +F   G LS YL  +            + L     +     +
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA- 355
           AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A 
Sbjct: 154 AKGMEFLASRKX-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDAR 207
Query: 356 -AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
             + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +    
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 264
Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 437 GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 489
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 490 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 597
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 598 PREMYDLMNLCWTYDVENRPGFAAV 622

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 137 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 193
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 194 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 300
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 438 GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 490
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 491 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 598
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 599 PREMYDLMNLCWTYDVENRPGFAAV 623

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 85  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 141
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 142 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 248
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 249 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 81  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL- 137
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 138 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 244
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 88  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 144
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 145 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 251
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 252 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 293
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 81  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 139 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 191
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 192 LGKGNFSSVYKG------TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   +  + + +F +   LLT+L+HE+I++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 81
Query: 246 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYLD------------QEEGSSNVLDWSTRVSI 292
             G C   G G+   +++++   G L+K+L             Q   +   L  S  + I
Sbjct: 82  FYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL- 351
              IA G+ YL S        VHR+L+    L+       I D G+ + +     + V  
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            T   + ++ PE +   +FT  SD+++FGVI+ +I T
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL- 152
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 245
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 293
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 91  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 149 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL- 152
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 73  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 125
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 126 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 233
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 234 PREMYDLMNLCWTYDVENRPGFAAV 258

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 79  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 239
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 240 PREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 89  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 145
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 146 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 252
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 253 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 95  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 255
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 256 PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 95  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 255
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 256 PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 192 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 285
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 152
Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 344
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 93  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 145
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 146 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 253
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 254 PREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 207
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 75  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 127
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 128 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 235
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAV 260

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 29/279 (10%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL----------DQEEGSSNVLDWSTRVSIII 294
            L G C   G G   +I +F   G LS YL            E+   + L     +    
Sbjct: 97  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K  
Sbjct: 156 QVAKGMEFLASRKX-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGD 209
Query: 355 A--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
           A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKE 266
Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 107
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 294
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 108 FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 353
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 166 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+  F  VYKG L           VAI+++   +      EF     L   L+H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 293
           L G           +I+ +   G L ++L            D +    + L+    V ++
Sbjct: 94  LLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             IA G+ YL S  V     VH++L+   VL+  + N  I+D GL + +     + +L  
Sbjct: 152 AQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 354 SA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           S   + ++APE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 97  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 156 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 209
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 266
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 267 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 85  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 137
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 138 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 245
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 175 NLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEF 228
            L+E+  +   F E   LG+  F  VYKG L           VAI+++   +      EF
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 229 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQ 276
                L   L+H N++ L G           +I+ +   G L ++L            D 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 336
           +    + L+    V ++  IA G+ YL S  V     VH++L+   VL+  + N  I+D 
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDL 172
Query: 337 GLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           GL + +     + +L  S   + ++APE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 132 NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 191 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 244
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 301
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 198
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 78
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 294
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 79  FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 353
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 137 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 37/280 (13%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHEN 242
           F  V  LGKG F +VY    +    + A++ +  +  + E  E +  + + + + LRH N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+R+  +   R R   +L+ +FAP+G+L K L Q+ G     D     + +  +A  + Y
Sbjct: 76  ILRMYNYFHDRKR--IYLMLEFAPRGELYKEL-QKHGR---FDEQRSATFMEELADALHY 129
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-------A 355
            H  +V     +HR++  E +L+  +    IAD G          +SV   S        
Sbjct: 130 CHERKV-----IHRDIKPENLLMGYKGELKIADFG----------WSVHAPSLRRRXMCG 174
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + YL PE +      E+ D++  GV+  + L G     S     + + T    ++ +LK
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS----PSHTETHRRIVNVDLK 230
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
                S+ +K     L+  H  P  R  ++ V+E   V A
Sbjct: 231 FPPFLSDGSKDLISKLLRYH--PPQRLPLKGVMEHPWVKA 268

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 198
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 84
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 294
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 85  FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 353
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 143 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP+G++ K L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLXGTLDYLP 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 30/280 (10%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSII 293
            L G C   G G   +I +F   G LS YL             E+   + L     +   
Sbjct: 96  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K 
Sbjct: 155 FQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKG 208
Query: 354 SA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 411
            A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   + 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLK 265
Query: 412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP+G++ K L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 207
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 198
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 46/295 (15%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 97
Query: 251 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHI 152
Query: 306 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
                  KPAI HR+L  + +L+ +     IAD GL  + +       +  +  +G   Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 360 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 406
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 272
Query: 407 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 273 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 46/295 (15%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 68
Query: 251 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 306 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
                  KPAI HR+L  + +L+ +     IAD GL  + +       +  +  +G   Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 360 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 406
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 407 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 46/295 (15%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 250
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 68
Query: 251 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 306 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
                  KPAI HR+L  + +L+ +     IAD GL  + +       +  +  +G   Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 360 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 406
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 407 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 198
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 192 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 244
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 292
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-XVRK 207
Query: 353 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 411 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 28/265 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 79  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 365
                 VHR+L+   VL+  Q    I+D GL K L  D      +T     + + APE +
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 424
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 239
Query: 425 --KLGKMALVCTHEDPENRPTMEAV 447
             ++  +  +C   D ENRP   AV
Sbjct: 240 PREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 37/274 (13%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +  +  + E  E +  + + + + LRH NI+R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +   R R   +L+ +FAP+G+L K L Q+ G     D     + +  +A  + Y H  +V
Sbjct: 83  YFHDRKR--IYLMLEFAPRGELYKEL-QKHGR---FDEQRSATFMEELADALHYCHERKV 136
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-------AAMGYLA 361
                +HR++  E +L+  +    IAD G          +SV   S         + YL 
Sbjct: 137 -----IHRDIKPENLLMGYKGELKIADFG----------WSVHAPSLRRRXMCGTLDYLP 181
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D++  GV+  + L G     S     + + T    ++ +LK     S
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS----PSHTETHRRIVNVDLKFPPFLS 237
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
           + +K     L+  H  P  R  ++ V+E   V A
Sbjct: 238 DGSKDLISKLLRYH--PPQRLPLKGVMEHPWVKA 269

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 48/290 (16%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHENIIRL 246
           V  +GKG +  V+ G  R G  VA++    T    EEA + +   +Y    +RHENI+  
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENIL-- 94
Query: 247 RGFCCSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
            GF  +  +G     + +LI D+   G L  YL      S  LD  + + +      G+ 
Sbjct: 95  -GFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 302 YLHS---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
           +LH+   S   KPAI HR+L  + +L+ +     IAD GL      D     +  +  +G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 359 ---YLAPEY----VTTGRFTE--RSDIFAFGVIILQI----LTGSLVLTSSM---RLAAE 402
              Y+ PE     +    F     +D+++FG+I+ ++    ++G +V    +    L   
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 403 SATFENFID----RNLKGKF-----SESEAAKLGKMALVCTHEDPENRPT 443
             ++E+  +    + L+  F     S+    ++GK+   C   +P +R T
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 80  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 134 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 278

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 126/285 (44%), Gaps = 33/285 (11%)
Query: 170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV 229
           + + LN++E++        +  +GKG F  V  G  R G  VA++ I   +       F+
Sbjct: 186 SGWALNMKELKL-------LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FL 234
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
               ++T LRH N+++L G      +G  +++ ++  KG L  YL +  G S VL     
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCL 291
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           +   + + + + YL  +       VHR+L+   VL+ +     ++D GL K  +      
Sbjct: 292 LKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
            L       + APE +   +F+ +SD+++FG+++ +I        S  R+       ++ 
Sbjct: 347 KLPVK----WTAPEALREKKFSTKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDV 395
Query: 410 IDRNLKG-KFSESEAAKLGKMALV--CTHEDPENRPTMEAVIEEL 451
           + R  KG K    +        ++  C H D   RPT   + E+L
Sbjct: 396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 119/276 (43%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    ++   + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS +V
Sbjct: 76  YFHDSTR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKKV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T+++   R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQDTYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 24/274 (8%)
Query: 192 LGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G     +     VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 86  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 139
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L  +    V++        + APE
Sbjct: 140 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+          +D  LVA++++   S  +   +F +   LLT+L+HE+I++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---------EEGSSNVLDWSTRVSIIIGI 296
             G C         +++++   G L+K+L           E      L  S  + I   I
Sbjct: 80  FYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSA 355
           A G+ YL S        VHR+L+    L+ +     I D G+ + +     + V   T  
Sbjct: 138 AAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
            + ++ PE +   +FT  SD+++ GV++ +I T
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHE 241
           F ++N L K N +    ++KG  + G  + ++ + V    + ++ +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   + +A+G+ 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMA 125
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGY 359
           +LH+ E   P I    L+   V+ID+     I+          D+ FS        A  +
Sbjct: 126 FLHTLE---PLIPRHALNSRSVMIDEDMTARISMA--------DVKFSFQSPGRMYAPAW 174
Query: 360 LAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDR 412
           +APE +      T R +  +D+++F V++ +++T  +     S+M +  + A        
Sbjct: 175 VAPEALQKKPEDTNRRS--ADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------E 226
Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            L+       +  + K+  +C +EDP  RP  + ++  L
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 24/274 (8%)
Query: 192 LGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G     +     VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 86  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 139
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 140 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 24/274 (8%)
Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L  +    V++        + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 192 LGKGNFSSVYKGTLRDGT-LVAIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    +VA++ +  +  + E  E +  + + +   L H NI+RL  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +   R R   +LI ++AP+G+L K L +    S   D     +I+  +A  + Y H  +V
Sbjct: 91  YFYDRRR--IYLILEYAPRGELYKELQK----SCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                +HR++  E +L+  +    IAD G   + A  +    +     + YL PE +   
Sbjct: 145 -----IHRDIKPENLLLGLKGELKIADFGW-SVHAPSLRRKTM--CGTLDYLPPEMIEGR 196
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
              E+ D++  GV+  ++L G+    S    A+ + T+   +  +LK
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFES----ASHNETYRRIVKVDLK 239

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 102 YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCG--LHKLLA--DDIVFSVLKTSAAMGYLAPEY 364
                +HR++  E +L+       IAD G  +H   +  DD+          + YL PE 
Sbjct: 156 -----IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-------GTLDYLPPEM 203
Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  +  
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 425 KLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
             G   L+      +P  RP +  V+E   + A
Sbjct: 256 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE----- 422
            RFT  SD++ FGV + +IL   +              F+   + ++ G+    E     
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIENGERLPMP 234
Query: 423 ---AAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                 L  +   C   DP  RP    +  +L+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 267

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 106 GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 159
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 160 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE----- 422
            RFT  SD++ FGV + +IL   +              F+   + ++ G+    E     
Sbjct: 215 RRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIENGERLPMP 262
Query: 423 ---AAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                 L  +   C   DP  RP    +  +L+
Sbjct: 263 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 295

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 27/269 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                +HR++  E +L+       IAD G     A     + L  S  + YL PE +   
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFGW-SCHAPSSRRTTL--SGTLDYLPPEMIEGR 182
Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
              E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  +    G 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 429 MALVCT--HEDPENRPTMEAVIEELTVAA 455
             L+      +P  RP +  V+E   + A
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 83  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 136
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 137 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE----- 422
            RFT  SD++ FGV + +IL   +              F+   + ++ G+    E     
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIENGERLPMP 239
Query: 423 ---AAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                 L  +   C   DP  RP    +  +L+
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL-----YL 234
            + + +  + L+G+G++  V K   +D G +VAI+       +S++ + VK +      L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKL 77
Query: 235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           L  LRHEN++ L   C  + R   +L+++F         LD  E   N LD+      + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKR--WYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131
Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVF 348
            I  GIG+ HS       I+HR++  E +L+ Q     + D G  + LA      DD V 
Sbjct: 132 QIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV- 185
Query: 349 SVLKTSAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTGS 390
                 A   Y APE  V   ++ +  D++A G ++ ++  G 
Sbjct: 186 ------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 458 GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 511
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 512 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 102 YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 156 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 200
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 252
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 80  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 133
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 134 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 81  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 134
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 135 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE----- 422
            RFT  SD++ FGV + +IL   +              F+   + ++ G+    E     
Sbjct: 190 RRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIENGERLPMP 237
Query: 423 ---AAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                 L  +   C   DP  RP    +  +L+
Sbjct: 238 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 270

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE----- 422
            RFT  SD++ FGV + +IL   +              F+   + ++ G+    E     
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIENGERLPMP 234
Query: 423 ---AAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                 L  +   C   DP  RP    +  +L+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 75  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 128
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 129 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTELCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 107/214 (50%), Gaps = 15/214 (7%)
Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
           S++  F ++  LG G +++VYKG  +  G  VA++ + + S +   +  ++ + L+  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTRVSIIIGIA 297
           HENI+RL     +  +    L+++F     L KY+D      +   L+ +        + 
Sbjct: 62  HENIVRLYDVIHTENK--LTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAA 356
           +G+ + H ++     I+HR+L  + +LI+++    + D GL +     +  FS       
Sbjct: 119 QGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS--SEVVT 171
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTG 389
           + Y AP+ +   R ++   DI++ G I+ +++TG
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 458 GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 511
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 512 -----FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRDTLCGTLDYLP 175
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 175
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 93  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 146
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 147 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 191
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 243
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 244 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           + +  +G F  V+K  L +   VA++   +   +S ++E  + ++    ++HEN+++   
Sbjct: 20  LEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQ--- 73
Query: 249 FCCSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           F  +  RG     E +LI  F  KG L+ YL       N++ W+    +   +++G+ YL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYL 128
Query: 304 HSS------EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK----T 353
           H        E +KP+I HR+   + VL+      ++AD GL       + F   K    T
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL------AVRFEPGKPPGDT 182
Query: 354 SAAMG---YLAPEYVTTGRFTERS-----DIFAFGVIILQILT 388
              +G   Y+APE +      +R      D++A G+++ ++++
Sbjct: 183 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 78  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 132 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 176
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 228
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCG--LHKLLA--DDIVFSVLKTSAAMGYLAPEY 364
                +HR++  E +L+       IAD G  +H   +  DD+          + YL PE 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-------GTLDYLPPEM 180
Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  +  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 425 KLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
             G   L+      +P  RP +  V+E   + A
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 26/263 (9%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 85  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 137
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L+   VL+ +     ++D GL K  +       L       + APE +   +F+
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFS 192
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKMA 430
            +SD+++FG+++ +I        S  R+       ++ + R  KG K    +        
Sbjct: 193 TKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 431 LV--CTHEDPENRPTMEAVIEEL 451
           ++  C H D   RP+   + E+L
Sbjct: 246 VMKNCWHLDAAMRPSFLQLREQL 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 75  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 128
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 129 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 173
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 225
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 226 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 133
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 178
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 230
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 231 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTXLCGTLDYLP 174
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 26/263 (9%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 70  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 122
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L+   VL+ +     ++D GL K  +       L       + APE +   +F+
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFS 177
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKMA 430
            +SD+++FG+++ +I        S  R+       ++ + R  KG K    +        
Sbjct: 178 TKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 230
Query: 431 LV--CTHEDPENRPTMEAVIEEL 451
           ++  C H D   RP+   + E+L
Sbjct: 231 VMKNCWHLDAAMRPSFLQLREQL 253

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/305 (21%), Positives = 129/305 (42%), Gaps = 43/305 (14%)
Query: 179 VESATQCFSEVNL-----LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAE 227
           +E     F   NL     LG+G F  V K T      R G T VA++ +   +  SE  +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----------- 276
            +    +L  + H ++I+L G C     G   LI ++A  G L  +L +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 277 ---------EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 327
                    +      L     +S    I++G+ YL        ++VHR+L+   +L+ +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-----SLVHRDLAARNILVAE 185
Query: 328 QFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
                I+D GL + +  +D      +    + ++A E +    +T +SD+++FGV++ +I
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
           +T    L  +           N +    + +  ++ + ++ ++ L C  ++P+ RP    
Sbjct: 246 VT----LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 447 VIEEL 451
           + ++L
Sbjct: 302 ISKDL 306

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 76  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 128
Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L+   VL+ +     ++D GL K  +       L       + APE +    F+
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREAAFS 183
Query: 372 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKMA 430
            +SD+++FG+++ +I        S  R+       ++ + R  KG K    +        
Sbjct: 184 TKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 236
Query: 431 LV--CTHEDPENRPTMEAVIEEL 451
           ++  C H D   RP+   + E+L
Sbjct: 237 VMKNCWHLDAAMRPSFLQLREQL 259

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/305 (21%), Positives = 129/305 (42%), Gaps = 43/305 (14%)
Query: 179 VESATQCFSEVNL-----LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAE 227
           +E     F   NL     LG+G F  V K T      R G T VA++ +   +  SE  +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----------- 276
            +    +L  + H ++I+L G C     G   LI ++A  G L  +L +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 277 ---------EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 327
                    +      L     +S    I++G+ YL   +     +VHR+L+   +L+ +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAE 185
Query: 328 QFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
                I+D GL + +  +D      +    + ++A E +    +T +SD+++FGV++ +I
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
           +T    L  +           N +    + +  ++ + ++ ++ L C  ++P+ RP    
Sbjct: 246 VT----LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 447 VIEEL 451
           + ++L
Sbjct: 302 ISKDL 306

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/305 (21%), Positives = 129/305 (42%), Gaps = 43/305 (14%)
Query: 179 VESATQCFSEVNL-----LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAE 227
           +E     F   NL     LG+G F  V K T      R G T VA++ +   +  SE  +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----------- 276
            +    +L  + H ++I+L G C     G   LI ++A  G L  +L +           
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 277 ---------EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 327
                    +      L     +S    I++G+ YL   +     +VHR+L+   +L+ +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAE 185
Query: 328 QFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 386
                I+D GL + +  +D      +    + ++A E +    +T +SD+++FGV++ +I
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 387 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 446
           +T    L  +           N +    + +  ++ + ++ ++ L C  ++P+ RP    
Sbjct: 246 VT----LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 447 VIEEL 451
           + ++L
Sbjct: 302 ISKDL 306

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 192 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 131
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D       K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 368 GRFTERSDIFAFGVIILQIL 387
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 73  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 126
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 127 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 171
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 223
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 224 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 40/263 (15%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    R    + A++ +  T  +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYCHSKRV 133
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSNGELKIADFG----------WSVHAPSSRRDTLCGTLDYLP 178
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------RLAAESATFENFID---R 412
           PE +      E+ D+++ GV+  + L G     +        R++    TF +F+    R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 413 NLKGKFSESEAAKLGKMALVCTH 435
           +L  +  +  A++   +A V  H
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEH 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 40/263 (15%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    R    + A++ +  T  +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYCHSKRV 133
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSNGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 178
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------RLAAESATFENFID---R 412
           PE +      E+ D+++ GV+  + L G     +        R++    TF +F+    R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 413 NLKGKFSESEAAKLGKMALVCTH 435
           +L  +  +  A++   +A V  H
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEH 261

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRLRG 248
           +G+G FS VY+   L DG  VA++ + +      +A  + +K + LL  L H N+I+   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-- 97
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  V
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLAP 362
                +HR++    V I       + D GL +  +        KT+AA        Y++P
Sbjct: 158 -----MHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMSP 205
Query: 363 EYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           E +    +  +SDI++ G ++ ++    S      M L +     E      L    S+ 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDH 262
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIE 449
            + +L ++  +C + DPE RP +  V +
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 24/265 (9%)
Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 80  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 134 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 423 AAKLGKMALVCTHEDPENRPTMEAV 447
              +  + + C    PE+RPT  A+
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 189 VNLLGKGNFSSVYKG------TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           V  +G+G F  V++            T+VA++ +   +    +A+F +   L+    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTR--------- 289
           I++L G C + G+  C L++++   G L+++L         S +  D STR         
Sbjct: 112 IVKLLGVC-AVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 290 -------VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-L 341
                  + I   +A G+ YL   +      VHR+L+    L+ +     IAD GL + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 401
            + D   +    +  + ++ PE +   R+T  SD++A+GV++ +I +  L     M   A
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---A 281
Query: 402 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
                    D N+     E+   +L  +  +C  + P +RP+
Sbjct: 282 HEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPS 322

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 78  T---KPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 127
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 366
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 128 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 184
Query: 367 --TGRFTERSDIFAFGVIILQILTGSL 391
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQL 211

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 24/265 (9%)
Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 363
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 422
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 423 AAKLGKMALVCTHEDPENRPTMEAV 447
              +  + + C    PE+RPT  A+
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 191 LLGKGNFSSVYKGTL----RDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENI 243
           +LG G F  V   T     + G    VA++ +   +  SE    +  L ++T L  HENI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-------------------QEEGSSNVL 284
           + L G C   G    +LI+++   G L  YL                    +EE   NVL
Sbjct: 112 VNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
            +   +     +AKG+ +L        + VHR+L+   VL+       I D GL + +  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK-----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 345 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           D  + V   +   + ++APE +  G +T +SD++++G+++ +I +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 78  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IA+ G          +SV   S+        + YL 
Sbjct: 132 -----IHRDIKPENLLLGSAGELKIANFG----------WSVHAPSSRRTTLCGTLDYLP 176
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 228
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 90  T---KPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 139
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 366
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 196
Query: 367 --TGRFTERSDIFAFGVIILQILTGSL 391
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 248
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 361
                +HR++  E +L+       IA+ G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIANFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 422 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 455
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/282 (20%), Positives = 120/282 (42%), Gaps = 30/282 (10%)
Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 238
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+     A +G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KAFVG 178
Query: 359 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
              Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L 
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELA 225
Query: 416 GKFSESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 449
           GK  E +        + +L ++     +    +RP++E ++E
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
            +    +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 90  TA---PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 139
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 366
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 196
Query: 367 --TGRFTERSDIFAFGVIILQILTGSL 391
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/280 (20%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 238
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+  KT     
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180
Query: 359 -YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
            Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L GK
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELAGK 227
Query: 418 FSESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 449
             E +        + +L ++     +    +RP++E ++E
Sbjct: 228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 134/286 (46%), Gaps = 56/286 (19%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------DQEEGSS----NVLDWSTRVSI 292
            L G  C+ G G   +I ++   G L  +L        D+E+G      ++L +S++V  
Sbjct: 106 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 161
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
               A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++K
Sbjct: 162 ----AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVK 211
Query: 353 TSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAES 403
            +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  + 
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 404 ATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
                  F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 272 YQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 305

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 17/230 (7%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK 222
            +RE+  S     ++ E   + F     LG G FS V     +  G L A++ I   + K
Sbjct: 2   MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALK 61
Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 282
            +E+     + +L  ++HENI+ L     S      +L+      G+L   +  E+G   
Sbjct: 62  GKESSIENEIAVLRKIKHENIVALEDIYESPNH--LYLVMQLVSGGELFDRI-VEKGFYT 118
Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLH 339
             D ST   +I  +   + YLH     +  IVHR+L  E +L    D++   +I+D GL 
Sbjct: 119 EKDAST---LIRQVLDAVYYLH-----RMGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           K+     V S        GY+APE +    +++  D ++ GVI   +L G
Sbjct: 171 KMEGKGDVMST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 247
           V  +GKG +  V++G L  G  VA++   + S + E++ F +  +Y    LRH+NI+   
Sbjct: 13  VECVGKGRYGEVWRG-LWHGESVAVK---IFSSRDEQSWFRETEIYNTVLLRHDNIL--- 65
Query: 248 GFCCS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           GF  S         + +LI  +   G L  +L ++      L+    + + +  A G+ +
Sbjct: 66  GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ-----TLEPHLALRLAVSAACGLAH 120
Query: 303 LHSS---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 358
           LH        KPAI HR+     VL+       IAD GL  + +    +  +  +  +G 
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 359 --YLAPEYVTTGRFTE------RSDIFAFGVIILQILTGSLV 392
             Y+APE +     T+       +DI+AFG+++ +I   ++V
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIV 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 134/286 (46%), Gaps = 56/286 (19%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------DQEEGSS----NVLDWSTRVSI 292
            L G  C+ G G   +I ++   G L  +L        D+E+G      ++L +S++V  
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 169
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
               A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++K
Sbjct: 170 ----AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVK 219
Query: 353 TSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAES 403
            +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  + 
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 404 ATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
                  F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 280 YQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 313

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 76  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 125
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 126 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 182
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQL 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 79  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 128
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 185
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 79  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 128
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 185
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 101 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 150
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 151 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 207
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQL 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 102 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 151
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 208
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 245 RLRG-------------FCCS-------RGRGECFLIYDFAPKGKLSKYLDQEEGSS--- 281
            L G             +CC        R + E  L    AP G+  + LD+E+G     
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAP-GQDPEGLDKEDGRPLEL 157
Query: 282 -NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
            ++L +S++V      A+G+ +L S        +HR+++   VL+       I D GL +
Sbjct: 158 RDLLHFSSQV------AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 341 LLADDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
            + +D  + ++K +A +   ++APE +    +T +SD++++G+++ +I +  L     + 
Sbjct: 207 DIMNDSNY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
           +   ++ F   +    +          +  +   C   +P +RPT + +
Sbjct: 266 V---NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 125/281 (44%), Gaps = 28/281 (9%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTS 237
           + Q F  +  LG G+F  V+    R +G   A++ +    V   K  E    + L +L+ 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSI 62
Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           + H  IIR+ G    +   + F+I D+   G+L   L + +   N +       + + + 
Sbjct: 63  VTHPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
               YLHS +     I++R+L  E +L+D+  +  I D G  K + D + + +  T    
Sbjct: 121 ----YLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYXLCGTP--- 167
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTG------SLVLTSSMRLAAESATFENFID 411
            Y+APE V+T  + +  D ++FG++I ++L G      S  + +  ++      F  F +
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 227
Query: 412 RNLKGKFSESEAAKLGKMA--LVCTHEDPENRPTMEAVIEE 450
            ++K   S      L +    L    ED +N P  + V+ E
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHE 241
           F ++N L K N +    ++KG  + G  + ++ + V    + ++ +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   +  A+G  
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWXPYGSLYNVL--HEGTNFVVDQSQAVKFALDXARGXA 125
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGY 359
           +LH+ E   P I    L+   V ID+     I+          D+ FS        A  +
Sbjct: 126 FLHTLE---PLIPRHALNSRSVXIDEDXTARISXA--------DVKFSFQSPGRXYAPAW 174
Query: 360 LAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDR 412
           +APE +      T R +  +D ++F V++ +++T  +     S+  +  + A        
Sbjct: 175 VAPEALQKKPEDTNRRS--ADXWSFAVLLWELVTREVPFADLSNXEIGXKVAL------E 226
Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 448
            L+       +  + K+  +C +EDP  RP  + ++
Sbjct: 227 GLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIV 262

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
            +    +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  TA---PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRL 246
           + LG G F  V  G     G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
                +    + F++ ++   G+L  Y+      +  LD      +   I  G+ Y H  
Sbjct: 82  YQVISTPS--DIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH-- 133
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 365
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+ S  +  Y APE V
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCGSPNYAAPE-V 186
Query: 366 TTGRFT--ERSDIFAFGVIILQILTGSL 391
            +GR       DI++ GVI+  +L G+L
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTL 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/279 (19%), Positives = 118/279 (42%), Gaps = 24/279 (8%)
Query: 181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 238
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+  +      
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK-EFVGTPY 181
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L GK 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELAGKI 228
Query: 419 SESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 449
            E +        + +L ++     +    +RP++E ++E
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 94  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 143
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 144 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 200
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQL 227

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 250
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 102 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 151
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 208
Query: 368 ---GRFTERSDIFAFGVIILQILTGSL 391
                ++ +SD++AFG+++ +++TG L
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 236
           +   + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            LRH N I+ RG  C       +L+ ++     L    D  E     L      ++  G 
Sbjct: 110 KLRHPNTIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+ YLHS       ++HR++    +L+ +     + D G   ++A    F        
Sbjct: 164 LQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGT 213
Query: 357 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
             ++APE +     G++  + D+++ G+  +++      L +   ++A     +N     
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             G +SE            C  + P++RPT E +++
Sbjct: 274 QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 305

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 352
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 353 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 409
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 163 GFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC 221
           GF+ +H    R++ EE+      F++++ +GKG+F  VYKG       +VAI+ I++   
Sbjct: 7   GFANQH---SRVDPEEL------FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEA 57
Query: 222 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 281
           + E  +  + + +L+      I R  G      +   ++I ++   G     L       
Sbjct: 58  EDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTK--LWIIMEYLGGGSALDLL-----KP 110
Query: 282 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 341
             L+ +   +I+  I KG+ YLHS        +HR++    VL+ +Q +  +AD G+   
Sbjct: 111 GPLEETYIATILREILKGLDYLHSERK-----IHRDIKAANVLLSEQGDVKLADFGVAGQ 165
Query: 342 LADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
           L D    + +K +  +G   ++APE +    +  ++DI++ G+  +++  G      +  
Sbjct: 166 LTD----TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSD 218
Query: 399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           L      F   I +N         +    +    C ++DP  RPT + +++
Sbjct: 219 LHPMRVLF--LIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 236
           +   + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            LRH N I+ RG  C       +L+ ++     L    D  E     L      ++  G 
Sbjct: 71  KLRHPNTIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+ YLHS       ++HR++    +L+ +     + D G   ++A    F        
Sbjct: 125 LQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGT 174
Query: 357 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
             ++APE +     G++  + D+++ G+  +++      L +   ++A     +N     
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             G +SE            C  + P++RPT E +++
Sbjct: 235 QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 266

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 186 FSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 240
           F  + +LG+G+F  V+   K T  D G L A++ +   + K  +    K    +L  + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 299
             +++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A G
Sbjct: 90  PFVVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALG 142
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + +LHS       I++R+L  E +L+D++ +  + D GL K  A D           + Y
Sbjct: 143 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYSFCGTVEY 196
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
           +APE V     +  +D +++GV++ ++LTGSL      R
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR 235

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 352
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 353 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 409
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 352
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 353 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 409
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 352
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 353 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 409
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 454
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 29/285 (10%)
Query: 189 VNLLGKGNFSSV-YKGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRL 246
           +  LG+G FS V     L DG   A++ I     +  EEA+    ++ L    H NI+RL
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL--FNHPNILRL 91
Query: 247 RGFCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             +C  R RG   E +L+  F  +G L   +++ +   N L     + +++GI +G+  +
Sbjct: 92  VAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----VLKTSAA--- 356
           H+         HR+L    +L+  +  P++ D G        +  S     L+  AA   
Sbjct: 151 HAK-----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 357 -MGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-TFENFID 411
            + Y APE  +        ER+D+++ G ++  ++ G        +     A   +N + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
                + S +    L  M  V    DP  RP +  ++ +L    P
Sbjct: 266 IPQSPRHSSALWQLLNSMMTV----DPHQRPHIPLLLSQLEALQP 306

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 189 VNLLGKGNFSSVYKGTLRDGTL----VAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           V+ LG G  S+VY   L + T+    VAI++I +   + EE    F + ++  + L H+N
Sbjct: 16  VDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 243 IIRLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           I+ +          +C+ L+ ++     LS+Y++    S   L   T ++    I  GI 
Sbjct: 73  IVSM---IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIK 125
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           + H        IVHR++  + +LID      I D G+ K L++    S+ +T+  +G   
Sbjct: 126 HAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---TSLTQTNHVLGTVQ 177
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           Y +PE        E +DI++ G+++ ++L G
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 44/282 (15%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L G  C+ G G   +I ++   G L  +L ++   S VL+     +I    A     LH
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTASTRDLLH 168
Query: 305 -SSEVNK-------PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            SS+V +          +HR+++   VL+       I D GL + + +D  + ++K +A 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVKGNAR 227
Query: 357 M--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAESATFE 407
           +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  +     
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 408 N--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
              F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 288 QPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 317

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/274 (21%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 192 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           LG+G F+ ++KG  R+         T V ++ ++       E+ F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEAASMMSKLSHKHL 74
Query: 244 IRLRGFC-CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +   G C C     E  L+ +F   G L  YL + +   N+L W   V+  +  A     
Sbjct: 75  VLNYGVCVCG---DENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEVAKQLAAA----- 125
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGY 359
           +H  E N   ++H N+  + +L+ ++ +    +    KL    I  +VL        + +
Sbjct: 126 MHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 360 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           + PE +   +     +D ++FG  + +I +G     S++    +   +E+      + + 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQL 237
Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
              +AA+L  +   C   +P++RP+  A+I +L 
Sbjct: 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/274 (21%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 192 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           LG+G F+ ++KG  R+         T V ++ ++       E+ F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEAASMMSKLSHKHL 74
Query: 244 IRLRGFC-CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +   G C C     E  L+ +F   G L  YL + +   N+L W   V+  +  A     
Sbjct: 75  VLNYGVCFCG---DENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEVAKQLAWA----- 125
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGY 359
           +H  E N   ++H N+  + +L+ ++ +    +    KL    I  +VL        + +
Sbjct: 126 MHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 360 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           + PE +   +     +D ++FG  + +I +G     S++    +   +E+      + + 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQL 237
Query: 419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
              +AA+L  +   C   +P++RP+  A+I +L 
Sbjct: 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA+R I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 367
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 368 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 421
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 187 SEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHEN 242
           SEV L   +G G+F +VYKG       VA++ + V     E+ + F   + +L   RH N
Sbjct: 36  SEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+   G+     +    ++  +     L K+L  +E    +      + I    A+G+ Y
Sbjct: 94  ILLFMGYMT---KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDY 147
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMGYLA 361
           LH+       I+HR++    + + +     I D GL  + +       V + + ++ ++A
Sbjct: 148 LHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 362 PEYVT---TGRFTERSDIFAFGVIILQILTGSL 391
           PE +       F+ +SD++++G+++ +++TG L
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 118/269 (43%), Gaps = 36/269 (13%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA+R I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAPEYVTT 367
              IVHR+L  E +L+D   N  IAD G     +++  F   + +   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDEFCGSPPYAAPELFQG 186
Query: 368 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 421
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/283 (21%), Positives = 128/283 (45%), Gaps = 44/283 (15%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------------DQEEGSSNVLDW 286
            L G  C+ G G   +I ++   G L  +L                  +++  S ++L +
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
           S++V      A+G+ +L S        +HR+++   VL+       I D GL + + +D 
Sbjct: 172 SSQV------AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 347 VFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
            + ++K +A +   ++APE +    +T +SD++++G+++ +I +  L     + +   ++
Sbjct: 221 NY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---NS 276
Query: 405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
            F   +    +          +  +   C   +P +RPT + +
Sbjct: 277 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 82  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 134
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 135 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNXFVGTPFW 185
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 415
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 240
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           G +S+     L +    C +++P  RPT + +++
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 67  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 119
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 120 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 170
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 415
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 225
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           G +S+     L +    C +++P  RPT + +++
Sbjct: 226 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 100/216 (46%), Gaps = 16/216 (7%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + + +++ LG+G +++VYKG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L     +       L++++  K  L +YLD      N+++       +  + +G+ Y
Sbjct: 62  IVTLHDIIHT--EKSLTLVFEYLDKD-LKQYLDD---CGNIINMHNVKLFLFQLLRGLAY 115
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
            H  +V     +HR+L  + +LI+++    +AD GL +  A  I            +  P
Sbjct: 116 CHRQKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRP 168
Query: 363 EYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSS 396
             +  G   ++ + D++  G I  ++ TG  +   S
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 290
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 114 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 172 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNY-V 225
Query: 351 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M + ++   F  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FYK 282
Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 87  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 139
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 140 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 190
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 415
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 245
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           G +S+     L +    C +++P  RPT + +++
Sbjct: 246 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 275

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 38/270 (14%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 366
              IVHR+L  E +L+D   N  IAD G     +++  F   K  A  G   Y APE   
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGN-KLDAFCGAPPYAAPELFQ 185
Query: 367 TGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----E 420
             ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMS 237
Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           ++   L K  L+    +P  R T+E ++++
Sbjct: 238 TDCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 290
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 91  NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 149 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 202
Query: 351 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
           +K +A +   ++APE +    +T  SD++++G+ + ++ +   + +S        + F  
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---LGSSPYPGMPVDSKFYK 259
Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 67  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 119
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 120 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNXFVGTPFW 170
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 415
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 225
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           G +S+     L +    C +++P  RPT + +++
Sbjct: 226 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 132/287 (45%), Gaps = 54/287 (18%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLD-----------WSTR--VS 291
            L G  C+ G G   +I ++   G L  +L ++   S VL+            STR  + 
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTLSTRDLLH 168
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
               +A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++
Sbjct: 169 FSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IV 222
Query: 352 KTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAE 402
           K +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 403 SATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
                   F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 283 GYQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 317

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 290
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 107 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 165 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 218
Query: 351 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M + ++   F  
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FYK 275
Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 290
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 114 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 172 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 225
Query: 351 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
           +K +A +   ++APE +    +T  SD++++G+ + ++ +   + +S        + F  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---LGSSPYPGMPVDSKFYK 282
Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 169 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSE 224
           LN  R +L+ ++   + F    +LGKG+F  V+    +      AI+++    V      
Sbjct: 4   LNKERPSLQ-IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 62
Query: 225 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 284
           E   V+   L  +  H  +  +  FC  + +   F + ++   G L  ++     S +  
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKF 116
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LL 342
           D S        I  G+ +LHS       IV+R+L ++ +L+D+  +  IAD G+ K  +L
Sbjct: 117 DLSRATFYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 171
Query: 343 ADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            D       KT+   G   Y+APE +   ++    D ++FGV++ ++L G     S    
Sbjct: 172 GD------AKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SPFHG 221
Query: 400 AAESATFENF-IDRNLKGKFSESEAAKLGKMALVCTHEDPENR 441
             E   F +  +D     ++ E EA  L     V    +PE R
Sbjct: 222 QDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV---REPEKR 261

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 192 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 290
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 109 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 167 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 220
Query: 351 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
           +K +A +   ++APE +    +T  SD++++G+ + ++ +   + +S        + F  
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---LGSSPYPGMPVDSKFYK 277
Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIRL 246
           + LG G F  V  G  +  G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
                +    + F++ ++   G+L  Y+ +      V +   R  +   I   + Y H  
Sbjct: 77  YQVISTPT--DFFMVMEYVSGGELFDYICKH---GRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 365
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS  +  Y APE V
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPE-V 181
Query: 366 TTGRFT--ERSDIFAFGVIILQILTGSL 391
            +GR       DI++ GVI+  +L G+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 367
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 368 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 421
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 367
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 368 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 421
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 169 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSE 224
           LN  R +L+ ++   + F    +LGKG+F  V+    +      AI+++    V      
Sbjct: 3   LNKERPSLQ-IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61
Query: 225 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 284
           E   V+   L  +  H  +  +  FC  + +   F + ++   G L  ++     S +  
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKF 115
Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LL 342
           D S        I  G+ +LHS       IV+R+L ++ +L+D+  +  IAD G+ K  +L
Sbjct: 116 DLSRATFYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 343 ADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            D       KT+   G   Y+APE +   ++    D ++FGV++ ++L G     S    
Sbjct: 171 GD------AKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SPFHG 220
Query: 400 AAESATFENF-IDRNLKGKFSESEAAKLGKMALVCTHEDPENR 441
             E   F +  +D     ++ E EA  L     V    +PE R
Sbjct: 221 QDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV---REPEKR 260

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 126/291 (43%), Gaps = 33/291 (11%)
Query: 174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL 232
           ++L  +      F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEI 71
Query: 233 YLLTSL-RHENIIRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
            +L     H NI    G    +       + +L+ +F   G ++  +   +G++   +W 
Sbjct: 72  NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
               I   I +G+ +LH  +V     +HR++  + VL+ +     + D G+   L     
Sbjct: 132 --AYICREILRGLSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--- 181
Query: 348 FSVLKTSAAMG---YLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            +V + +  +G   ++APE +         +  +SD+++ G+  +++  G+  L     +
Sbjct: 182 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---M 237
Query: 400 AAESATFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
               A F   I RN   +  S+  + K       C  ++   RP  E +++
Sbjct: 238 HPMRALF--LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 240
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 299
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 86  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAM 357
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D     +S   T   +
Sbjct: 139 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---V 190
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
            Y+APE V     T+ +D ++FGV++ ++LTG+L      R
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/279 (21%), Positives = 126/279 (45%), Gaps = 33/279 (11%)
Query: 179 VESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
           +    + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+ 
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
                + +  G      +   ++I ++   G     L      +   D     +++  I 
Sbjct: 78  CDSSYVTKYYGSYLKGSK--LWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEIL 130
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           KG+ YLHS +      +HR++    VL+ +Q +  +AD G+   L D    + +K +  +
Sbjct: 131 KGLDYLHSEKK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFV 181
Query: 358 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN- 413
           G   ++APE +    +  ++DI++ G+  +++  G      +  +      F   I +N 
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLF--LIPKNN 236
Query: 414 ---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
              L G F++S      +    C ++DP  RPT + +++
Sbjct: 237 PPTLVGDFTKS----FKEFIDACLNKDPSFRPTAKELLK 271

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 118/269 (43%), Gaps = 36/269 (13%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 72
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL     +   +      +    I   + Y H     
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYL----VAHGWMKEKEARAKFRQIVSAVQYCHQK--- 125
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 367
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 126 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 368 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 421
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 231
Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           +   L K  L+    +P  R T+E ++++
Sbjct: 232 DCENLLKKFLIL---NPSKRGTLEQIMKD 257

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +G+G+F +VYKG L   T V +    +      KSE   F +    L  L+H NI+R   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 249 FCCS--RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
              S  +G+    L+ +    G L  YL +      V       S    I KG+ +LH+ 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLRSWCRQILKGLQFLHT- 147
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
               P I+HR+L  + + I      + I D GL  L       +V+ T     + APE  
Sbjct: 148 --RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE---FXAPEXY 202
Query: 366 TTGRFTERSDIFAFGVIILQILT 388
              ++ E  D++AFG   L+  T
Sbjct: 203 EE-KYDESVDVYAFGXCXLEXAT 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 186 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 240
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S   +   R      I   +
Sbjct: 64  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMS---EQEAR-RFFQQIISAV 116
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 359
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 117 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 168
Query: 360 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GK 417
            APE ++   +     D+++ GVI+  +L   L         +    F+N  +      K
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGVYTLPK 224
Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           F    AA L K  L+    +P NR ++  ++++
Sbjct: 225 FLSPGAAGLIKRMLIV---NPLNRISIHEIMQD 254

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 186 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 240
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S   +   R      I   +
Sbjct: 68  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMS---EQEAR-RFFQQIISAV 120
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 359
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 121 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 172
Query: 360 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GK 417
            APE ++   +     D+++ GVI+  +L   L         +    F+N  +      K
Sbjct: 173 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGVYTLPK 228
Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           F    AA L K  L+    +P NR ++  ++++
Sbjct: 229 FLSPGAAGLIKRMLIV---NPLNRISIHEIMQD 258

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 240
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 299
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 86  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAM 357
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D     +S   T   +
Sbjct: 139 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---V 190
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
            Y+APE V     T+ +D ++FGV++ ++LTG+L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 186 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 240
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S   +   R      I   +
Sbjct: 73  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMS---EQEAR-RFFQQIISAV 125
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 359
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 126 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 177
Query: 360 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GK 417
            APE ++   +     D+++ GVI+  +L   L         +    F+N  +      K
Sbjct: 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGVYTLPK 233
Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           F    AA L K  L+    +P NR ++  ++++
Sbjct: 234 FLSPGAAGLIKRMLIV---NPLNRISIHEIMQD 263

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 34/273 (12%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VAI+ I+ T       +   + + ++  L H NI++L  F
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 77
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +LI ++A  G++  YL     +   +      S    I   + Y H     
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQKR-- 131
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYVTTG 368
              IVHR+L  E +L+D   N  IAD G         V   L T   +  Y APE     
Sbjct: 132 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDTFCGSPPYAAPELFQGK 185
Query: 369 RFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ESE 422
           ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       ++
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMSTD 237
Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
              L K  LV    +P  R T+E ++++  + A
Sbjct: 238 CENLLKRFLVL---NPIKRGTLEQIMKDRWINA 267

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 240
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 299
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 87  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 139
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAM 357
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D     +S   T   +
Sbjct: 140 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---V 191
Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
            Y+APE V     T+ +D ++FGV++ ++LTG+L
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 225

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 242
           F   NLLGKG+F+ VY+  ++  G  VAI+ I+  +  K+   + V+  + +   L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L  +         +L+ +    G++++YL   +        +     +  I  G+ Y
Sbjct: 73  ILELYNYF--EDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLY 127
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LHS       I+HR+L++  +L+ +  N  IAD G    LA  +     K     G   Y
Sbjct: 128 LHSH-----GILHRDLTLSNLLLTRNMNIKIADFG----LATQLKMPHEKHYTLCGTPNY 178
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           ++PE  T       SD+++ G +   +L G
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 234
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 235 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSV 350
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  + +F V
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV 171
Query: 351 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           + T   + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT---LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VAI+ I+ T       +   + + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +LI ++A  G++  YL    G     +  ++   I+     + Y H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVS---AVQYCHQKR-- 134
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR 369
              IVHR+L  E +L+D   N  IAD G        +   +     A  Y APE     +
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKK 189
Query: 370 FT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ESEA 423
           +     D+++ GVI+  +++GSL          +    +   +R L+GK+       ++ 
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 424 AKLGKMALVCTHEDPENRPTMEAVIEELTVAA 455
             L K  LV    +P  R T+E ++++  + A
Sbjct: 242 ENLLKRFLVL---NPIKRGTLEQIMKDRWINA 270

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 19/262 (7%)
Query: 192 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G F  V+    R   L   I++IN    +    +    + +L SL H NII++  F 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI--FE 87
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                   +++ +    G+L + +   +     L       ++  +   + Y HS  V  
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV-- 145
Query: 311 PAIVHRNLSVEKVLIDQQ--FNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
              VH++L  E +L       +P+ I D GL +L   D   S      A+ Y+APE V  
Sbjct: 146 ---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTAL-YMAPE-VFK 199
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLT-SSMRLAAESATFENFIDRNLKGKFSESEAAKL 426
              T + DI++ GV++  +LTG L  T +S+    + AT++   +  ++ +    +A  L
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVECRPLTPQAVDL 258
Query: 427 GKMALVCTHEDPENRPTMEAVI 448
            K  L    +DPE RP+   V+
Sbjct: 259 LKQMLT---KDPERRPSAAQVL 277

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 186 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 240
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S   +   R      I   +
Sbjct: 74  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMS---EQEAR-RFFQQIISAV 126
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 359
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 127 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 178
Query: 360 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GK 417
            APE ++   +     D+++ GVI+  +L   L         +    F+N  +      K
Sbjct: 179 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGVYTLPK 234
Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           F    AA L K  L+    +P NR ++  ++++
Sbjct: 235 FLSPGAAGLIKRMLIV---NPLNRISIHEIMQD 264

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 248
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 367
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGS 175
Query: 368 GRFTERSDIFAFGVIILQILTGS 390
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 248
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 367
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGS 175
Query: 368 GRFTERSDIFAFGVIILQILTGS 390
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGA 198

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 38/270 (14%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + +   L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL--F 79
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 366
              IVHR+L  E +L+D   N  IAD G     +++  F   K  A  G   Y APE   
Sbjct: 133 --FIVHRDLKAENLLLDADXNIKIADFG----FSNEFTFGN-KLDAFCGAPPYAAPELFQ 185
Query: 367 TGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----E 420
             ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYXS 237
Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
           ++   L K  L+    +P  R T+E + ++
Sbjct: 238 TDCENLLKKFLIL---NPSKRGTLEQIXKD 264

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 248
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 367
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGS 175
Query: 368 GRFTERSDIFAFGVIILQILTGS 390
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 234
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 235 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  + +
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
             +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIRL 246
           + LG G F  V  G  +  G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
                +    + F++ ++   G+L  Y+ +      V +   R  +   I   + Y H  
Sbjct: 77  YQVISTPT--DFFMVMEYVSGGELFDYICKH---GRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 365
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+ S  +  Y APE V
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRDSCGSPNYAAPE-V 181
Query: 366 TTGRFT--ERSDIFAFGVIILQILTGSL 391
            +GR       DI++ GVI+  +L G+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 179 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 230
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 76  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 129
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 341
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 130 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 185 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 50/288 (17%)
Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVV 65
Query: 245 R-----------LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           R           ++     + +   F+  ++   G L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW---RLF 122
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 343
             I + + Y+HS       I+HR+L    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 344 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 395
            ++  S    ++A+G   Y+A E +  TG + E+ D+++ G+I  +++    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 396 SMRLAAESATF-ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
             +L + S  F  +F D  +K +          K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRP 276

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++ L H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 247
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 248 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G           L  ++   G L KYL+Q E    + +   R +++  I+  + YLH +
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 141
Query: 307 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
                 I+HR+L  E +++    Q+    I D G  K L    + +  +    + YLAPE
Sbjct: 142 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFVGTLQYLAPE 194
Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +   ++T   D ++FG +  + +TG
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 247
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 248 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G           L  ++   G L KYL+Q E    + +   R +++  I+  + YLH +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 307 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
                 I+HR+L  E +++    Q+    I D G  K L    + +  +    + YLAPE
Sbjct: 141 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFVGTLQYLAPE 193
Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +   ++T   D ++FG +  + +TG
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++ L H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 234
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 235 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +    +
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV 171
Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
             +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 179 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 230
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 98
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 99  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 152
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 341
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 153 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 207
Query: 342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 208 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 179 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 230
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 99
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 100 EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 153
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 341
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 154 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 208
Query: 342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 209 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 170
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEF-------VKG 231
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V +               V  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 232 LYLLTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
           L  L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAET 121
Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 348
              ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  
Sbjct: 122 IKDLMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 349 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           + +  +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 177 TPVVVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 33/277 (11%)
Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRG 248
            L+GKG F  VY G  R    VAIR I++     ++ + F + +      RHEN++   G
Sbjct: 39  ELIGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C S        I     KG+    + ++  +  VLD +    I   I KG+GYLH+   
Sbjct: 97  ACMSPPH---LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK----LLADDIVFSVLKTSAAMGYLAPEY 364
               I+H++L  + V  D     +I D GL      L A      +   +  + +LAPE 
Sbjct: 150 ---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 365 VTTGR---------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
           +             F++ SD+FA G I  ++        +     AE+  ++  +   +K
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---PAEAIIWQ--MGTGMK 260
Query: 416 GKFSESEAAK-LGKMALVCTHEDPENRPTMEAVIEEL 451
              S+    K +  + L C   + E RPT   +++ L
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENII 244
           + ++  +G+G +  VYK     G +VA++ I + +  +   +  ++ + LL  L H NI+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 245 RLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
            L     S     C  L+++F  K  L K LD  E  + + D   ++  +  + +G+ + 
Sbjct: 83  SLIDVIHSE---RCLTLVFEFMEKD-LKKVLD--ENKTGLQDSQIKI-YLYQLLRGVAHC 135
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           H        I+HR+L  + +LI+      +AD GL +      V S       + Y AP+
Sbjct: 136 HQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPD 189
Query: 364 YVT-TGRFTERSDIFAFGVIILQILTGS 390
            +  + +++   DI++ G I  +++TG 
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 35/235 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLR-HEN 242
           +  V  LGKG +  V+K    R G +VA++ I      S +A+   + + +LT L  HEN
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L     +    + +L++D+  +  L   +      +N+L+   +  ++  + K I Y
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-----RANILEPVHKQYVVYQLIKVIKY 124
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH------KLLADDIVFSVLKTS-- 354
           LHS       ++HR++    +L++ + +  +AD GL       + + ++I  S+ + +  
Sbjct: 125 LHSG-----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 355 ------------AAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSS 396
                       A   Y APE +  + ++T+  D+++ G I+ +IL G  +   S
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 179 VESATQCFSE----VNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVK 230
           V+ +T  FS+      +LGKG+F  V     K T ++  +  I    V   K+++   ++
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLR 81
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 82  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 135
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 341
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 136 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 190
Query: 342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 191 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 170
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F     L K++D    +   L      S +  + +G+ + 
Sbjct: 72  VKLLDVIHTENK--LYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 127 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENII 244
           + ++  +G+G +  VYK     G +VA++ I + +  +   +  ++ + LL  L H NI+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 245 RLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
            L     S     C  L+++F  K  L K LD  E  + + D   ++  +  + +G+ + 
Sbjct: 83  SLIDVIHSE---RCLTLVFEFMEKD-LKKVLD--ENKTGLQDSQIKI-YLYQLLRGVAHC 135
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           H        I+HR+L  + +LI+      +AD GL +      V S       + Y AP+
Sbjct: 136 HQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPD 189
Query: 364 YVT-TGRFTERSDIFAFGVIILQILTGS 390
            +  + +++   DI++ G I  +++TG 
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 209 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 262
Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 319
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 320 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRL 246
           V +LGKG+F  V K   R      A++ IN  S K+++ +  ++ + LL  L H NI++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             F         +++ +    G+L   + + +  S          II  +  GI Y+H  
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSGITYMH-- 138
Query: 307 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
              K  IVHR+L  E +L++   +  +  I D GL      +      K    +G   Y+
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYI 190
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGS 390
           APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 98  CIGV--SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 152
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 153 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 263
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 98  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 152
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 153 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 263
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 207 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 260
Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 317
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 318 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 200 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 253
Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 310
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 311 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 202 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 255
Query: 356 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 312
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AE 227
           +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++ + 
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
            ++ + LL  L H NI++L  F         +++ +    G+L   + + +  S      
Sbjct: 68  ILREVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----H 121
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLAD 344
               II  +  GI Y+H     K  IVHR+L  E +L++   +  +  I D GL      
Sbjct: 122 DAARIIKQVFSGITYMH-----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 345 DIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           +      K    +G   Y+APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 177 NT-----KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 90  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 144
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 145 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 199
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 255
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 256 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AE 227
           +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++ + 
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
            ++ + LL  L H NI++L  F         +++ +    G+L   + + +  S      
Sbjct: 68  ILREVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----H 121
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLAD 344
               II  +  GI Y+H     K  IVHR+L  E +L++   +  +  I D GL      
Sbjct: 122 DAARIIKQVFSGITYMH-----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 345 DIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           +      K    +G   Y+APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 177 NT-----KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 170
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           +S    +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  +  + 
Sbjct: 202 ISYSFQVARGMEFLSSRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDY- 255
Query: 350 VLK--TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI--LTGSLVLTSSMRLAAESAT 405
           V K  T   + ++APE +    ++ +SD++++GV++ +I  L GS      M        
Sbjct: 256 VRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQM-----DED 310
Query: 406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           F + +   ++ +  E    ++ ++ L C H DP+ RP    ++E+L
Sbjct: 311 FCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 65  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 119
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 120 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 173
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 66  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 121 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 174
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F     L K++D    +   L      S +  + +G+ + 
Sbjct: 72  VKLLDVIHTENK--LYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 127 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWY 170
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F     L K++D    +   L      S +  + +G+ + 
Sbjct: 69  VKLLDVIHTENK--LYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 124 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 177
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 105 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 159
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 160 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 270
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 271 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 115 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 169
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 170 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 224
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 280
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 281 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRDG-TLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 241
           Q + ++  +G+G + +V+K   R+   +VA++ + +    +   +  ++ + LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL     S  +    L+++F  +  L KY D   G    LD     S +  + KG+G
Sbjct: 62  NIVRLHDVLHSDKK--LTLVFEFCDQD-LKKYFDSCNGD---LDPEIVKSFLFQLLKGLG 115
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
           + HS  V     +HR+L  + +LI++     +AD GL +
Sbjct: 116 FCHSRNV-----LHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 125 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 179
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 355
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 180 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 290
Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               ++    + ++   C    PE+RP    ++E +
Sbjct: 291 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F  + +LG G FS V+    R  G L A++ I   S    ++     + +L  ++HEN
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHEN 67
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+ L     S      +L+      G+L   +  E G     D S    +I  +   + Y
Sbjct: 68  IVTLEDIYESTTH--YYLVMQLVSGGELFDRI-LERGVYTEKDASL---VIQQVLSAVKY 121
Query: 303 LHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           LH +      IVHR+L  E +L    ++    +I D GL K+  + I+ +   T    GY
Sbjct: 122 LHEN-----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP---GY 173
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           +APE +    +++  D ++ GVI   +L G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/277 (20%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 116 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 170
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 357
             YL  +       +HR+++    L+       +A  G   + A DI  +    K   AM
Sbjct: 171 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGM-ARDIYRAGYYRKGGCAM 224
Query: 358 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
               ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGG 280
Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    ++    + ++   C    PE+RP    ++E +
Sbjct: 281 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F  +  L  ++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKDFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 48/287 (16%)
Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVXLLASLNHQYVV 65
Query: 245 RL-------RGFC----CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           R        R F       + +   F+  ++     L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW---RLF 122
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 343
             I + + Y+HS       I+HRNL    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 344 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 395
            ++  S    ++A+G   Y+A E +  TG + E+ D ++ G+I  + +    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNI 237
Query: 396 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
             +L + S  F    D N K K  +       K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDN-KXKVEK-------KIIRLLIDHDPNKRP 276

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/277 (20%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 192 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 299
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 139 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 193
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 357
             YL  +       +HR+++    L+       +A  G   + A DI  +    K   AM
Sbjct: 194 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGM-ARDIYRAGYYRKGGCAM 247
Query: 358 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
               ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGG 303
Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    ++    + ++   C    PE+RP    ++E +
Sbjct: 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 26/231 (11%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VA++ I+ T       +   + + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 81  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 133
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYVTTG 368
              IVHR+L  E +L+D   N  IAD G         V + L T   +  Y APE     
Sbjct: 134 --YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT---VGNKLDTFCGSPPYAAPELFQGK 188
Query: 369 RFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           ++     D+++ GVI+  +++GSL          +    +   +R L+GK+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKY 231

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 233
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 234 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 289
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 350 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 50/288 (17%)
Query: 186 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVV 65
Query: 245 R-----------LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           R           ++     + +   F+  ++     L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW---RLF 122
Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 343
             I + + Y+HS       I+HR+L    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 344 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 395
            ++  S    ++A+G   Y+A E +  TG + E+ D+++ G+I  +++    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 396 SMRLAAESATF-ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
             +L + S  F  +F D  +K +          K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRP 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 32/225 (14%)
Query: 179 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 230
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
            + LL  L H NI +L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 76  EVQLLKQLDHPNIXKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 129
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIV 347
            II  +  GI Y H     K  IVHR+L  E +L++   +  N  I D GL         
Sbjct: 130 RIIRQVLSGITYXH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---- 180
Query: 348 FSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            +  K    +G   Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 181 -ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA+  I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA+  I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++   +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEHVDQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 233
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 234 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 289
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 350 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 233
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 234 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 289
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 350 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 387
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L  ++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFL-HQDLKTFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 186 FSEVNLLGKGNF---SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++++  +G+G +   SS Y    +  T VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           +I +R    +       + +++ D   +  L K L  ++ S++ + +      +  I +G
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICY-----FLYQILRG 156
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD---DIVFSVLKTSAA 356
           + Y+HS+ V     +HR+L    +LI+   +  I D GL + +AD   D    + +  A 
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVAT 210
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 388
             Y APE +   + +T+  DI++ G I+ ++L+
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L  ++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 97  I--QEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 147
Query: 310 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 148 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 203
Query: 367 TGRFTERSDIFAFGVIILQILTG 389
              +++  DI+A GVI+  +L G
Sbjct: 204 KDPYSKPVDIWACGVILYILLVG 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 72
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 73  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 124
Query: 310 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 180
Query: 367 TGRFTERSDIFAFGVIILQILTG 389
              +++  DI+A GVI+  +L G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 72
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 73  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 124
Query: 310 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 180
Query: 367 TGRFTERSDIFAFGVIILQILTG 389
              +++  DI+A GVI+  +L G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 71
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 72  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 123
Query: 310 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 124 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 179
Query: 367 TGRFTERSDIFAFGVIILQILTG 389
              +++  DI+A GVI+  +L G
Sbjct: 180 KDPYSKPVDIWACGVILYILLVG 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 239
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NI++L     +  +   +L+++F     L  ++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 360 LAPEYVTTGRFTERS-DIFAFGVIILQILT 388
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 17/138 (12%)
Query: 259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 318
           FL++D   KG+L  YL ++   S   +  TR SI+  + + + +LH++      IVHR+L
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALS---EKETR-SIMRSLLEAVSFLHANN-----IVHRDL 226
Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV------TTGRFTE 372
             E +L+D      ++D G    L        L      GYLAPE +      T   + +
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--CGTPGYLAPEILKCSMDETHPGYGK 284
Query: 373 RSDIFAFGVIILQILTGS 390
             D++A GVI+  +L GS
Sbjct: 285 EVDLWACGVILFTLLAGS 302

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 241
           Q + ++  +G+G + +V+K   R+   +VA++ + +    +   +  ++ + LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL     S  +    L+++F  +  L KY D   G    LD     S +  + KG+G
Sbjct: 62  NIVRLHDVLHSDKK--LTLVFEFCDQD-LKKYFDSCNGD---LDPEIVKSFLFQLLKGLG 115
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
           + HS  V     +HR+L  + +LI++     +A+ GL +
Sbjct: 116 FCHSRNV-----LHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 243
           F  + +LGKG+F  V    +++ G L A++ +      + ++ E       + SL   + 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
              + FCC +     F + +F   G L  ++ +    S   D +        I   + +L
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFL 140
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           H        I++R+L ++ VL+D + +  +AD G+ K    + + + + T+   G   Y+
Sbjct: 141 HDK-----GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVTTATFCGTPDYI 191
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE +    +    D +A GV++ ++L G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR--- 239
            +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR   
Sbjct: 23  EILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 240 -HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
            H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + +
Sbjct: 82  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLE 135
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTSAAM 357
            I  LH     K  IVHR+L  E +L+D   N  + D G   +L   + + SV  T +  
Sbjct: 136 VICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPS-- 188
Query: 358 GYLAPEYVTTGR------FTERSDIFAFGVIILQILTGS 390
            YLAPE +          + +  D+++ GVI+  +L GS
Sbjct: 189 -YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 103/244 (42%), Gaps = 29/244 (11%)
Query: 184 QCFSEVNLLGKGNFSSVYK-------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +CF  + +LGKG +  V++        T +   +  ++   +     + A       +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            ++H  I+ L      +  G+ +LI ++   G+L   L++E     +    T    +  I
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEI 130
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSA 355
           +  +G+LH        I++R+L  E ++++ Q +  + D GL K  + D  V        
Sbjct: 131 SMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CG 183
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + Y+APE +         D ++ G ++  +LTG+   T   R        +  ID+ LK
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILK 235
Query: 416 GKFS 419
            K +
Sbjct: 236 CKLN 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 28/243 (11%)
Query: 178 EVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-----KG 231
           +V+S  + + +++ LG+G F++VYK   ++   +VAI+ I +   +SE  + +     + 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH-RSEAKDGINRTALRE 62
Query: 232 LYLLTSLRHENIIRLRGFCCSRG-RGECFLIYDFAPKGKLSKYLDQE---EGSSNVLDWS 287
           + LL  L H NII   G   + G +    L++DF          D E   + +S VL  S
Sbjct: 63  IKLLQELSHPNII---GLLDAFGHKSNISLVFDFMET-------DLEVIIKDNSLVLTPS 112
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
              + ++   +G+ YLH        I+HR+L    +L+D+     +AD GL K       
Sbjct: 113 HIKAYMLMTLQGLEYLHQH-----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167
Query: 348 FSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 406
            +         Y APE +   R +    D++A G I+ ++L     L     L   +  F
Sbjct: 168 -AYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226
Query: 407 ENF 409
           E  
Sbjct: 227 ETL 229

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 103/244 (42%), Gaps = 29/244 (11%)
Query: 184 QCFSEVNLLGKGNFSSVYK-------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
           +CF  + +LGKG +  V++        T +   +  ++   +     + A       +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
            ++H  I+ L      +  G+ +LI ++   G+L   L++E     +    T    +  I
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEI 130
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSA 355
           +  +G+LH        I++R+L  E ++++ Q +  + D GL K  + D  V        
Sbjct: 131 SMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF--CG 183
Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
            + Y+APE +         D ++ G ++  +LTG+   T   R        +  ID+ LK
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILK 235
Query: 416 GKFS 419
            K +
Sbjct: 236 CKLN 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/211 (20%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + F  +  LG+G++ SVYK   ++ G +VAI+ + V   +S+  E +K + ++      +
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSPH 85
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +++  G        + +++ ++   G +S  +      +  L      +I+    KG+ Y
Sbjct: 86  VVKYYGSYFK--NTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEY 140
Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           LH         +HR++    +L++ + +  +AD G+   L D +     K +  +G   +
Sbjct: 141 LHFMRK-----IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA----KRNXVIGTPFW 191
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           +APE +    +   +DI++ G+  +++  G 
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 190 NLLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR--- 239
            +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR   
Sbjct: 23  EILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 240 -HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
            H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + +
Sbjct: 82  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLE 135
Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
            I  LH     K  IVHR+L  E +L+D   N  + D G    L  D    + +      
Sbjct: 136 VICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 188
Query: 359 YLAPEYVTTGR------FTERSDIFAFGVIILQILTGS 390
           YLAPE +          + +  D+++ GVI+  +L GS
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 69  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 120
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMG 358
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      
Sbjct: 121 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 173
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           YLAPE +    +    D +  GV++ +++ G L
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 358
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      
Sbjct: 118 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 170
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           YLAPE +    +    D +  GV++ +++ G L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 191 LLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR---- 239
           +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR    
Sbjct: 11  ILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 69
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + + 
Sbjct: 70  HPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLEV 123
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           I  LH     K  IVHR+L  E +L+D   N  + D G    L  D    + +      Y
Sbjct: 124 ICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 176
Query: 360 LAPEYVTTGR------FTERSDIFAFGVIILQILTGS 390
           LAPE +          + +  D+++ GVI+  +L GS
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 166 REHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKS 223
           R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    +
Sbjct: 49  RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 108
Query: 224 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS-- 281
              + ++ L +L       I+   G               F   G++S  ++  +G S  
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGA--------------FYSDGEISICMEHMDGGSLD 154
Query: 282 NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
            VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + D
Sbjct: 155 QVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCD 210
Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 211 FGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 66  FLTALKYAFQTHDR-LCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-YL 360
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YL
Sbjct: 120 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYL 172
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           APE +    +    D +  GV++ +++ G L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++   +  L  ++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEHVHQD-LKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 364 YVTTGRFTERS-DIFAFGVIILQILT 388
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 100
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  + C +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 101 KL--YFCFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 154
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 155 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 207
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 165 SREHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCK 222
            R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72
Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS- 281
           +   + ++ L +L       I+   G               F   G++S  ++  +G S 
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYG--------------AFYSDGEISICMEHMDGGSL 118
Query: 282 -NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 334
             VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + 
Sbjct: 119 DQVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           D G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 175 DFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 70  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 122
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 123 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGEL 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV--KGLYLLTSLRHENIIRLRG 248
           LG+G+F  V   T  +    VA++ I+    K  +      + +  L  LRH +II+L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
              +    +  ++ ++A  G+L  Y+ +++  +   D   R      I   I Y H  + 
Sbjct: 77  VITTPT--DIVMVIEYA-GGELFDYIVEKKRMTE--DEGRR--FFQQIICAIEYCHRHK- 128
Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYVTT 367
               IVHR+L  E +L+D   N  IAD GL  ++ D    + LKTS  +  Y APE +  
Sbjct: 129 ----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVING 181
Query: 368 GRFT-ERSDIFAFGVIILQILTGSL 391
             +     D+++ G+++  +L G L
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRL 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 169 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS- 223
           +++FR   E+VE   +   E   LG G F+ V     KGT ++     I+   ++S +  
Sbjct: 2   MSTFRQ--EDVEDHYEMGEE---LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG 56
Query: 224 -EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 282
               E  + + +L  +RH NII L        + +  LI +    G+L  +L ++E  + 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE 114
Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL 338
             D +T+   +  I  G+ YLHS       I H +L  E + L+D+   NP I   D G+
Sbjct: 115 --DEATQ--FLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 339 -HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
            HK+ A +   ++  T     ++APE V        +D+++ GVI   +L+G+
Sbjct: 166 AHKIEAGNEFKNIFGTPE---FVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 111
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 168
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 169 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 220
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 103
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 160
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 161 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 212
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 109
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 166
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 167 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 218
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 111/252 (44%), Gaps = 34/252 (13%)
Query: 166 REHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKS 223
           R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    +
Sbjct: 6   RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 65
Query: 224 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS-- 281
              + ++ L +L       I+   G               F   G++S  ++  +G S  
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYG--------------AFYSDGEISICMEHMDGGSLD 111
Query: 282 NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
            VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + D
Sbjct: 112 QVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCD 167
Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 395
            G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G   + S
Sbjct: 168 FGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224
Query: 396 SMRLAAESATFE 407
               +   A FE
Sbjct: 225 G---SGSMAIFE 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 113
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 170
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 171 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 222
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 109
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 166
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 167 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 218
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 240
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 241 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 291
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 352 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 154
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 211
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 212 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 358 GYL------APEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 88
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 145
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 146 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 358 GYL------APEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 80
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 137
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 138 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 358 GYL------APEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 71  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 122
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        Y
Sbjct: 123 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEY 176
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        Y
Sbjct: 118 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEY 171
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        Y
Sbjct: 118 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEY 171
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 83
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 140
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 141 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 192
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 300
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 212 FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 264
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGY 359
            YLHS +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      Y
Sbjct: 265 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEY 318
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 350

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 87
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 144
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 145 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 196
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    +LI       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADS-GNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 94
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 151
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 152 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 203
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 300
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 209 FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 261
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGY 359
            YLHS +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      Y
Sbjct: 262 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEY 315
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 87
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 144
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 355
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 145 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 196
Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVL 393
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKG 299
            +  L+    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSA 117
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        Y
Sbjct: 118 LEYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEY 171
Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 76
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 133
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 134 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 186
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/253 (21%), Positives = 107/253 (42%), Gaps = 19/253 (7%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +G+G +  VYK   +DG      ++             + + LL  L+H N+I L+    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 252 SRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKGIGYLHSSE 307
           S    + +L++D+A      + K+    + +   +     +  S++  I  GI YLH++ 
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 308 VNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLA 361
           V     +HR+L    +L+     ++    IAD G  +L    +  +  +        Y A
Sbjct: 149 V-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 362 PEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMR-LAAESATFENFIDR--NLKGK 417
           PE +   R +T+  DI+A G I  ++LT   +       +   +    + +DR  N+ G 
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 418 FSESEAAKLGKMA 430
            ++ +   + KM 
Sbjct: 264 PADKDWEDIKKMP 276

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 358 GYL------APEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T     + +S  +++  +  +      E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGD---SPDSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 79
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 136
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 137 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 189
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 358 GYL------APEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 240
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 75
Query: 241 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 291
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 128
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 129 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 177
Query: 352 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 178 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + Y+HS       I HR++  + +L+D        D  + KL        +++    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLD-------PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 358 GYL------APEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
            Y+      APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 192 LGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V     KGT ++     I+   ++S +      E  + + +L  +RH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        + +  LI +    G+L  +L ++E  +   D +T+   +  I  G+ YLHS
Sbjct: 73  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE--DEATQ--FLKQILDGVHYLHS 126
Query: 306 SEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL-HKLLADDIVFSVLKTSAAMGYL 360
                  I H +L  E + L+D+   NP I   D G+ HK+ A +   ++  T     ++
Sbjct: 127 KR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE---FV 178
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGS 390
           APE V        +D+++ GVI   +L+G+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGA 208

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 128 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 LARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 240
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 241 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 291
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 352 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 128 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 LARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 128 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 LARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 186 FSEVNLLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSL 238
           +  +  LG+G +  VYK   T+ + T VAI+ I +      E E V G     + LL  L
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRL----EHEEEGVPGTAIREVSLLKEL 90
Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGI 296
           +H NII L+       R    LI+++A +  L KY+D+        D S RV  S +  +
Sbjct: 91  QHRNIIELKSVIHHNHR--LHLIFEYA-ENDLKKYMDKNP------DVSMRVIKSFLYQL 141
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPL--IADCGLHKLLADDIVFSVL 351
             G+ + HS        +HR+L  + +L+   D    P+  I D GL +     I     
Sbjct: 142 INGVNFCHSRRC-----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFT 195
Query: 352 KTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQIL 387
                + Y  PE +   R ++   DI++   I  ++L
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 52/247 (21%)
Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQ 276
           SEE E      LL   +H NII L+      G+   +L+ +    G+L       K+  +
Sbjct: 68  SEEIEI-----LLRYGQHPNIITLKD-VYDDGK-HVYLVTELMRGGELLDKILRQKFFSE 120
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNP---L 332
            E S           ++  I K + YLHS       +VHR+L    +L +D+  NP    
Sbjct: 121 REASF----------VLHTIGKTVEYLHSQ-----GVVHRDLKPSNILYVDESGNPECLR 165
Query: 333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 392
           I D G  K L  +    ++       ++APE +    + E  DI++ G+++  +L G   
Sbjct: 166 ICDFGFAKQLRAENGL-LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
Query: 393 LTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTHEDPENRP 442
             +       S T E  + R   GKF        + SE AK  + KM     H DP  R 
Sbjct: 225 FAN-----GPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML----HVDPHQRL 275
Query: 443 TMEAVIE 449
           T + V++
Sbjct: 276 TAKQVLQ 282

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 300
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 71  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 123
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 358
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 124 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 171
Query: 359 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 209

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 300
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 70  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 122
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 358
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 123 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 170
Query: 359 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +A +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANAFVGTAQYVS 200
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 300
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 69  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 121
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 358
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 122 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 169
Query: 359 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  + E +  L+ D+ P    +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 52/247 (21%)
Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQ 276
           SEE E      LL   +H NII L+      G+   +L+ +    G+L       K+  +
Sbjct: 68  SEEIEI-----LLRYGQHPNIITLKD-VYDDGK-HVYLVTELMRGGELLDKILRQKFFSE 120
Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNP---L 332
            E S           ++  I K + YLHS       +VHR+L    +L +D+  NP    
Sbjct: 121 REASF----------VLHTIGKTVEYLHSQ-----GVVHRDLKPSNILYVDESGNPECLR 165
Query: 333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 392
           I D G  K L  +    ++       ++APE +    + E  DI++ G+++  +L G   
Sbjct: 166 ICDFGFAKQLRAENGL-LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
Query: 393 LTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTHEDPENRP 442
             +       S T E  + R   GKF        + SE AK  + KM     H DP  R 
Sbjct: 225 FAN-----GPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML----HVDPHQRL 275
Query: 443 TMEAVIE 449
           T + V++
Sbjct: 276 TAKQVLQ 282

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 114/247 (46%), Gaps = 26/247 (10%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHE 241
           F  + ++GKG+F  V     + +    A++ +    +   K E+    +   LL +++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
            ++ L      +   + + + D+   G+L  +L +E      L+   R      IA  +G
Sbjct: 100 FLVGLH--FSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARF-YAAEIASALG 153
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLHS       IV+R+L  E +L+D Q + ++ D GL K   ++I  +   TS   G   
Sbjct: 154 YLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNS-TTSTFCGTPE 204
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           YLAPE +    +    D +  G ++ ++L G     S  R  AE   ++N +++ L+ K 
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAE--MYDNILNKPLQLKP 260
Query: 419 SESEAAK 425
           + + +A+
Sbjct: 261 NITNSAR 267

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 369
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 370 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 428
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 269
Query: 429 MALVCTHEDPENR 441
           + L    ++PENR
Sbjct: 270 VVLKALAKNPENR 282

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 192 LGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V     KGT ++     I+   + S +      E  + + +L  +RH NII 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        + +  LI +    G+L  +L ++E  +   D +T+   +  I  G+ YLHS
Sbjct: 94  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE--DEATQ--FLKQILDGVHYLHS 147
Query: 306 SEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL-HKLLADDIVFSVLKTSAAMGYL 360
                  I H +L  E + L+D+   NP I   D G+ HK+ A +   ++  T     ++
Sbjct: 148 KR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE---FV 199
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGS 390
           APE V        +D+++ GVI   +L+G+
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGA 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG+G    V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 248 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 365
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 366 TTGRF-TERSDIFAFGVIILQILTGSL 391
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F  ++ LG GN   V K   R  G ++A + I++    +   + ++ L +L       I+
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 78  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 124 LRGLAYLR----EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 178
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y+APE +    ++ +SDI++ G+ ++++  G
Sbjct: 179 --YMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 243
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 244 IRLRGFCCSRGRGECF----LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           +RLR F  S G  +      L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 356
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 357 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 296
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 71  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D++    + T + 
Sbjct: 117 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS- 171
Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 172 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 105/245 (42%), Gaps = 28/245 (11%)
Query: 162 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS 220
           +GF R+ +      +  V      + ++  +G G + +V      R G  VAI+ +    
Sbjct: 9   SGFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRP 61
Query: 221 CKSE--EAEFVKGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIYDFAP--KGKLSKYLD 275
            +SE       + L LL  +RHEN+I L   F       +    Y   P     L K + 
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
            E+   + + +     ++  + KG+ Y+H++      I+HR+L    + +++     I D
Sbjct: 122 HEKLGEDRIQF-----LVYQMLKGLRYIHAA-----GIIHRDLKPGNLAVNEDCELKILD 171
Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLT 394
            GL +    ++   V+       Y APE +    R+T+  DI++ G I+ +++TG  +  
Sbjct: 172 FGLARQADSEMXGXVV----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 395 SSMRL 399
            S  L
Sbjct: 228 GSDHL 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDAG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + +  V  LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATCDHPY 69
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIII-GIAKGI 300
           I++L G     G+   +++ +F P G +    L+ + G +       ++ ++   + + +
Sbjct: 70  IVKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTE-----PQIQVVCRQMLEAL 122
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 358
            +LHS       I+HR+L    VL+  + +  +AD G    ++   + ++ K  + +G  
Sbjct: 123 NFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTP 173
Query: 359 -YLAPEYVTTGRFTE-----RSDIFAFGVIILQI 386
            ++APE V      +     ++DI++ G+ ++++
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 22/230 (9%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 280
              A+   + L LL  ++HEN+I L   F  +R   E   +Y       +   L+    S
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKS 119
Query: 281 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
             + D   +  +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL +
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELKILDFGLCR 173
Query: 341 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
              D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 174 HTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 108/235 (45%), Gaps = 23/235 (9%)
Query: 163 GFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTS 220
           G S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 221 CKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLD 275
                A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  + 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK 129
Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
            ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D
Sbjct: 130 CQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELKILD 179
Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 180 FGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 180 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTS 237
           +S  Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   
Sbjct: 21  QSMYQLFEE---LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL 77
Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           L+H NI+RL       G    +LI+D    G+L + +   E  S   D S  +  I+   
Sbjct: 78  LKHPNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILE-- 132
Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 354
                LH  ++    +VHR+L  E +L+  +       +AD GL  +  +    +    +
Sbjct: 133 ---AVLHCHQM---GVVHRDLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFA 185
Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
              GYL+PE +    + +  D++A GVI+  +L G
Sbjct: 186 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 125
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 126 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELKILDFG 175
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 176 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + +  V  LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATCDHPY 77
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIII-GIAKGI 300
           I++L G     G+   +++ +F P G +    L+ + G +       ++ ++   + + +
Sbjct: 78  IVKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTE-----PQIQVVCRQMLEAL 130
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 358
            +LHS       I+HR+L    VL+  + +  +AD G    ++   + ++ K  + +G  
Sbjct: 131 NFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTP 181
Query: 359 -YLAPEYVTTGRFTE-----RSDIFAFGVIILQI 386
            ++APE V      +     ++DI++ G+ ++++
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 96
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 97  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 150
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + ++ +G   Y++
Sbjct: 151 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVS 203
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGXV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-----AEFVKGLYLLTSLRHENIIR 245
           LG G F+ V K   +  G   A + I     ++        E  + + +L  + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS 390
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 161 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 218
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 76
Query: 219 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKY 273
                  A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 135
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I
Sbjct: 136 VKCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKI 185
Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 186 LDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 240
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 241 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 291
           EN++ L   C       +R +   +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 352 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 393
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 161 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 218
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 219 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKY 273
                  A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 136
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I
Sbjct: 137 VKCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKI 186
Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 187 LDFGLARHTDDEMXGXV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 23/240 (9%)
Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG+G+FS   K   +         I     ++   + +  L L     H NI++L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVF- 75
Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII-GIAKGIGYLHSSEVNK 310
              +   FL+ +    G+L + + +++  S      T  S I+  +   + ++H      
Sbjct: 76  -HDQLHTFLVMELLNGGELFERIKKKKHFS-----ETEASYIMRKLVSAVSHMHDV---- 125
Query: 311 PAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVT 366
             +VHR+L  E +L   + + L   I D G  +L   D     LKT    + Y APE + 
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLN 182
Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ESEAAK 425
              + E  D+++ GVI+  +L+G +   S  R    ++  E  + +  KG FS E EA K
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSFEGEAWK 241

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 318
           LI D+   G+L  +L Q E  +        V I +G I   + +LH     K  I++R++
Sbjct: 136 LILDYINGGELFTHLSQRERFTE-----HEVQIYVGEIVLALEHLH-----KLGIIYRDI 185
Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 376
            +E +L+D   + ++ D GL K    D           + Y+AP+ V  G     +  D 
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 377 FAFGVIILQILTGS 390
           ++ GV++ ++LTG+
Sbjct: 246 WSLGVLMYELLTGA 259

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 161 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 218
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 77
Query: 219 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKY 273
                  A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 136
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I
Sbjct: 137 VKCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKI 186
Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 187 LDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 32/226 (14%)
Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F  +  LG+G F  V++   + D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW------------STRVSI 292
           R       +   E   +   +PK  L   + Q     N+ DW            S  + I
Sbjct: 67  RYFNAWLEKNTTE--KLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVL 351
            + IA+ + +LHS       ++HR+L    +         + D GL   +  D+   +VL
Sbjct: 124 FLQIAEAVEFLHSK-----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 352 KTSAAMG----------YLAPEYVTTGRFTERSDIFAFGVIILQIL 387
               A            Y++PE +    ++ + DIF+ G+I+ ++L
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 5   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 58
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 117
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 118 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 167
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 6   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 59
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 60  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 118
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 119 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 168
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 169 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDYG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 161 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 218
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 76
Query: 219 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKY 273
                  A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 135
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I
Sbjct: 136 VKCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKI 185
Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 186 LDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S +   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPI---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 125
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 126 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELKILDFG 175
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 176 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 161 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 218
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 219 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKY 273
                  A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 136
Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I
Sbjct: 137 VKCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKI 186
Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 187 LDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 108/235 (45%), Gaps = 23/235 (9%)
Query: 163 GFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTS 220
           G S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 221 CKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLD 275
                A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  + 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK 129
Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
            ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D
Sbjct: 130 CQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILD 179
Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
            GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 180 FGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS 73
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 132
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 133 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 182
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 183 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHEN 242
           F  +  +GKG+F  V      D   + A++ +N   C  ++E     K L ++  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII-GIAKGIG 301
           ++ L  +   +   + F++ D    G L  +L Q     NV      V + I  +   + 
Sbjct: 77  LVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALD 129
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YL +       I+HR++  + +L+D+  +  I D  +  +L  +   + +  +    Y+A
Sbjct: 130 YLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMA 182
Query: 362 PEYVTTGR---FTERSDIFAFGVIILQILTG 389
           PE  ++ +   ++   D ++ GV   ++L G
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 122
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 123 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELKILDFG 172
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 122
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 123 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 172
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 57
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 116
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 117 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 166
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 167 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 132
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 133 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 182
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 183 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 132
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 133 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 182
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 183 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 200
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 175 NLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGT--LVAIRSIN---VTSCKSEEAEFV 229
           NL+ V+     F+ + +LGKG+F  V     R GT  L AI+ +    V      E   V
Sbjct: 12  NLDRVKLTD--FNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWS 287
           +   L    +   + +L    C +     + + ++   G L  ++ Q  +      + ++
Sbjct: 69  EKRVLALLDKPPFLTQLHS--CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 126
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             +SI      G+ +LH     K  I++R+L ++ V++D + +  IAD G+ K    D V
Sbjct: 127 AEISI------GLFFLH-----KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV 175
Query: 348 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 407
            +  +      Y+APE +    + +  D +A+GV++ ++L G            E   F+
Sbjct: 176 -TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE----DEDELFQ 230
Query: 408 NFIDRNLKGKFSESEAA 424
           + ++ N+    S S+ A
Sbjct: 231 SIMEHNVSYPKSLSKEA 247

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 5   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 58
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 117
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 118 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 167
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 200
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 128 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 92
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 93  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 146
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + ++ +G   Y++
Sbjct: 147 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVS 199
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 31  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 85  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 143
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 144 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 193
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 194 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 72
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 73  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 126
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 127 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 179
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 116
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 117 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 166
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 167 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 126
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 127 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 176
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 177 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 122
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 123 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 172
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 241
           Q F E   LGKG FS V +   +  T   A + IN     + + +   +   +   L+H 
Sbjct: 34  QLFEE---LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 91  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIHQILESVN 144
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 358
           ++H  +     IVHR+L  E +L+  +       +AD GL  +       +    +   G
Sbjct: 145 HIHQHD-----IVHRDLKPENLLLASKCKGAAVKLADFGL-AIEVQGEQQAWFGFAGTPG 198
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           YL+PE +    + +  DI+A GVI+  +L G
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 126
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 127 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELKILDFG 176
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 177 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 96
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 97  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 150
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 151 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 203
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 125
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 126 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 175
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 176 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 7   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 60
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 61  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 119
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 120 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 169
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 170 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 126
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 127 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 176
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 177 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 67
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 126
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 127 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 176
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 177 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 73
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 74  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 127
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 128 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 180
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
           PE +T     + SD++A G II Q++ G        R   E   F+  I
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAG----LPPFRAGNEYLIFQKII 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 122
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 123 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 172
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 241
           Q F E   LGKG FS V +   +  G   A   IN     + + +   +   +   L+H 
Sbjct: 14  QLFEE---LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL       G    +LI+D    G+L + +   E  S   D S  +  I+       
Sbjct: 71  NIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILE-----A 122
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 358
            LH  ++    +VHRNL  E +L+  +       +AD GL  +  +    +    +   G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFAGTPG 178
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDGG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 125
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 126 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 175
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 176 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDRG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 98
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 99  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 152
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 153 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 205
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I   + YLH        I+HR+L  E +L+++  +  I D G  K+L+ +      + ++
Sbjct: 141 IVSALEYLHGK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANS 193
Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            +G   Y++PE +T    ++ SD++A G II Q++ G
Sbjct: 194 FVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 71
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 72  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 126 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 178
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G + SV K   +  G ++A++ I  T  + E+ + +  L ++  +R  +   +  F 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV--MRSSDCPYIVQFY 87
Query: 251 CSRGR-GECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            +  R G+C++  +       K  KY+       +V+       I +   K + +L  + 
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYV--YSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                I+HR++    +L+D+  N  + D G+   L D I  +  + +    Y+APE +  
Sbjct: 146 ----KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT--RDAGCRPYMAPERIDP 199
Query: 368 GR----FTERSDIFAFGVIILQILTG 389
                 +  RSD+++ G+ + ++ TG
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATG 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 192 LGKGNFSSVY----KGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G  S VY    KGT +   L V  ++++    ++E       + +L  L H NII+L
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE-------IGVLLRLSHPNIIKL 113
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +         E  L+ +    G+L   +  E+G  +  D +  V  I+   + + YLH +
Sbjct: 114 KEIF--ETPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQIL---EAVAYLHEN 167
Query: 307 EVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
                 IVHR+L  E +L        PL IAD GL K++   ++   +      GY APE
Sbjct: 168 -----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPE 220
Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +    +    D+++ G+I   +L G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 70
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 71  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 124
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 125 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 177
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAIR I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 31  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 85  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 143
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 144 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 193
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 194 LARHTDDEMXGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 116
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 117 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 166
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 167 LARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K    + ++  + T  
Sbjct: 451 IAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKX 501
Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
             G   Y+APE +    + +  D +AFGV++ ++L G            E   F++ ++ 
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH 557
Query: 413 NLKGKFSESEAA 424
           N+    S S+ A
Sbjct: 558 NVAYPKSMSKEA 569

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 77
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 78  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 131
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 132 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 184
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVV 357
Query: 366 TTGRFTERSDIFAFGVIILQILTGS 390
              R+T   D +A G ++ +++ G 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 190 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 244
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 92
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 93  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 146
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 147 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 199
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE +T     + SD++A G II Q++ G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
            ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVV 357
Query: 366 TTGRFTERSDIFAFGVIILQILTGS 390
              R+T   D +A G ++ +++ G 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L + RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L + RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 190 NLLGKGNFSS-VYKGTLRDGTLVAIRSINVTSC-KSEEAEFV-KGLYLLTSLRHENIIRL 246
            +LG+G+FS+ V    L      AI+ +      K  +  +V +   +++ L H   ++L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH  
Sbjct: 96  --YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLHGK 149
Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++PE
Sbjct: 150 -----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVSPE 202
Query: 364 YVTTGRFTERSDIFAFGVIILQILTG 389
            +T     + SD++A G II Q++ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/246 (21%), Positives = 103/246 (41%), Gaps = 26/246 (10%)
Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
           F+ + +LGKG+F  V     KGT     +  ++   V      E   V+   L    +  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
            + +L    C +     + + ++   G L  ++ Q             V     IA G+ 
Sbjct: 82  FLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLF 135
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           +L S       I++R+L ++ V++D + +  IAD G+ K    + ++  + T    G   
Sbjct: 136 FLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPD 186
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           Y+APE +    + +  D +AFGV++ ++L G            E   F++ ++ N+    
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEHNVAYPK 242
Query: 419 SESEAA 424
           S S+ A
Sbjct: 243 SMSKEA 248

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  + V   G G + SV      + G  VA++ ++     
Sbjct: 18  FYRQELNK---TIWEVPERYQNLAPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 71
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 72  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 130
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D G
Sbjct: 131 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 180
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 181 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 241
           Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   L+H 
Sbjct: 7   QLFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 64  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIQQILESVN 117
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 358
           + H +      IVHR+L  E +L+  +       +AD GL   +  D   +    +   G
Sbjct: 118 HCHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPG 171
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 156
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 144
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 145 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/225 (16%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 215
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 266
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 267 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 321
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
             +    DI++ G+++++++ G     +   L A     +N   R
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 366

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 184 QCFSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 241
           Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   L+H 
Sbjct: 7   QLFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 64  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIQQILESVN 117
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 358
           + H +      IVHR+L  E +L+  +       +AD GL   +  D   +    +   G
Sbjct: 118 HCHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPG 171
Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/209 (19%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 81
Query: 245 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 82  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 133
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS++V     +HRN+  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 134 HSNQV-----IHRNIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 184
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/106 (22%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
            + + I K + YL      K  ++HR++    +L+D++    + D G+   L DD     
Sbjct: 128 KMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD- 182
Query: 351 LKTSAAMGYLAPEYV-----TTGRFTERSDIFAFGVIILQILTGSL 391
            +++    Y+APE +     T   +  R+D+++ G+ ++++ TG  
Sbjct: 183 -RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 141
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 142 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 142
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 143 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 133
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 134 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +  + +  A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 141
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +  + +  A  
Sbjct: 142 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG+G +  V K   +  G ++A++ I  T    E+   +  L +  S+R  +      F 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI--SMRTVDCPFTVTFY 72
Query: 251 CSRGR-GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
            +  R G+ ++  +      L K+  Q       +       I + I K + +LHS    
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---- 127
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV---- 365
           K +++HR++    VLI+      + D G+   L DD+   +   +    Y+APE +    
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPERINPEL 185
Query: 366 TTGRFTERSDIFAFGVIILQI 386
               ++ +SDI++ G+ ++++
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 88
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 139
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 140 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 194
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 253
Query: 426 LGKMALVCTHEDPENRPT 443
           L ++ +     DP  R T
Sbjct: 254 LDRLLV----RDPAQRAT 267

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 138
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 189
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 190 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 244
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 303
Query: 426 LGKMALVCTHEDPENRPT 443
           L ++ +     DP  R T
Sbjct: 304 LDRLLV----RDPAQRAT 317

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 95
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 146
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 147 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 201
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 260
Query: 426 LGKMALVCTHEDPENRPT 443
           L ++ +     DP  R T
Sbjct: 261 LDRLLV----RDPAQRAT 274

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 134
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 135 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 93
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 144
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 145 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 199
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 258
Query: 426 LGKMALVCTHEDPENRPT 443
           L ++ +     DP  R T
Sbjct: 259 LDRLLV----RDPAQRAT 272

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 134
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 135 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 135
Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 367
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 190
Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 425
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 249
Query: 426 LGKMALVCTHEDPENRPT 443
           L ++ +     DP  R T
Sbjct: 250 LDRLLV----RDPAQRAT 263

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 223
           F R+ LN     + EV    Q  S V     G+  S Y   ++ G  +A++ ++      
Sbjct: 37  FYRQELNK---TIWEVPERYQTLSPVGSGAYGSVCSSYD--VKSGLKIAVKKLSRPFQSI 91
Query: 224 EEAEFV-KGLYLLTSLRHENIIRLRGFCCSRGRGECF---LIYDFAPKGKLSKYLDQEEG 279
             A+   + L LL  ++HEN+I L          E F    +        L+  +  ++ 
Sbjct: 92  IHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 280 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 339
           + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL 
Sbjct: 152 TDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLA 201
Query: 340 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           +   D++   V    A   Y APE +     +    DI++ G I+ ++LTG
Sbjct: 202 RHTDDEMTGYV----ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 31/240 (12%)
Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSIN 217
           +   GF ++ +N     L       + +     +G G + SV      R G  VAI+ ++
Sbjct: 23  IRKKGFYKQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS 76
Query: 218 VTSCKSE--EAEFVKGLYLLTSLRHENIIRLRGFCCS----RGRGECFLIYDFAPKGKLS 271
               +SE       + L LL  ++HEN+I L          R   + +L+  F  +  L 
Sbjct: 77  -RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQ 134
Query: 272 KYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP 331
           K +  E     +        ++  + KG+ Y+HS+      +VHR+L    + +++    
Sbjct: 135 KIMGMEFSEEKI------QYLVYQMLKGLKYIHSA-----GVVHRDLKPGNLAVNEDCEL 183
Query: 332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGS 390
            I D GL +    ++   V+       Y APE + +   + +  DI++ G I+ ++LTG 
Sbjct: 184 KILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICY-----FLYQILRG 140
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 249
           +GKG FS V +   L  G   A + IN     + + +   +   +   L+H NI+RL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
               G    +L++D    G+L + +   E  S   D S  +  I+        LH  ++ 
Sbjct: 72  ISEEGFH--YLVFDLVTGGELFEDIVAREYYSEA-DASHCIQQILE-----AVLHCHQM- 122
Query: 310 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              +VHR+L  E +L+  +       +AD GL   +  D   +    +   GYL+PE + 
Sbjct: 123 --GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPEVLR 179
Query: 367 TGRFTERSDIFAFGVIILQILTG 389
              + +  DI+A GVI+  +L G
Sbjct: 180 KEAYGKPVDIWACGVILYILLVG 202

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ L      + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELAK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 272
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K +K
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 273 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 332
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 118 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 161
Query: 333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 162 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 186 FSEVNLLGKGNFSS-VYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F   ++LG G   + VY+G   D   VA++ I +  C S     V+   L  S  H N+I
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRI-LPECFSFADREVQ--LLRESDEHPNVI 81
Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           R   FC  + R   ++  +      L +Y++Q++ +   L+    ++++     G+ +LH
Sbjct: 82  RY--FCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 305 SSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIADCGLHKLLA-DDIVFSVLK-TSAAM 357
           S       IVHR+L    +LI       +   +I+D GL K LA     FS         
Sbjct: 136 SLN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 358 GYLAPEYVTTG---RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRN 413
           G++APE ++       T   DIF+ G +   +++ GS     S++  A        +D  
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250
Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
              K  +  A +L +  +     DP+ RP+ + V++
Sbjct: 251 HPEKHEDVIARELIEKMIAM---DPQKRPSAKHVLK 283

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 317
            +++ ++AP G++  +L +    S          I++       YLHS +     +++R+
Sbjct: 117 LYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLHSLD-----LIYRD 167
Query: 318 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIF 377
           L  E +LIDQQ    +AD G  K +                YLAPE + +  + +  D +
Sbjct: 168 LKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 378 AFGVIILQILTG 389
           A GV+I ++  G
Sbjct: 224 ALGVLIYEMAAG 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 47/235 (20%)
Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWS 287
           LL   +H NII L+      G+   +++ +    G+L       K+  + E S+      
Sbjct: 69  LLRYGQHPNIITLKD-VYDDGK-YVYVVTELMKGGELLDKILRQKFFSEREASA------ 120
Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNP---LIADCGLHKLLA 343
               ++  I K + YLH+       +VHR+L    +L +D+  NP    I D G  K L 
Sbjct: 121 ----VLFTITKTVEYLHAQ-----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            +    ++       ++APE +    +    DI++ GV++  +LTG     +        
Sbjct: 172 AENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN-----GPD 225
Query: 404 ATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTHEDPENRPTMEAVI 448
            T E  + R   GKF        S S+ AK  + KM     H DP  R T   V+
Sbjct: 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKM----LHVDPHQRLTAALVL 276

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 186 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 243 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           II +     +       + +L+        L K L  +  S++ + +      +  I +G
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY-----FLYQILRG 156
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 357
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 358 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 399
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/209 (19%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 245 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 183
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I   G
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILGFG 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     +++R+L  E +LIDQQ    +AD G  K +                YLA
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLA 206
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +  + +  D +A GV+I ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     +++R+L  E +LIDQQ    +AD G  K +                YLA
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLA 206
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +  + +  D +A GV+I ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/209 (19%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 245 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSXMVGTPYWM 183
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     +++R+L  E +LIDQQ    +AD G  K +                YLA
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLA 206
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +  + +  D +A GV+I ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/209 (19%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 81
Query: 245 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 82  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 133
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 134 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSXMVGTPYWM 184
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/201 (21%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG+G +  V K   +  G ++A++ I  T    E+   +  L +  S+R  +      F 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI--SMRTVDCPFTVTFY 116
Query: 251 CSRGR-GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
            +  R G+ ++  +      L K+  Q       +       I + I K + +LHS    
Sbjct: 117 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---- 171
Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-- 367
           K +++HR++    VLI+      + D G+   L D +  ++   +    Y+APE +    
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTI--DAGCKPYMAPERINPEL 229
Query: 368 --GRFTERSDIFAFGVIILQI 386
               ++ +SDI++ G+ ++++
Sbjct: 230 NQKGYSVKSDIWSLGITMIEL 250

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 164 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 222
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 223 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGE---CFLIYDFAPKGKLSKYLDQE 277
              A+   + L LL  ++HEN+I L   F  +R   E    +L+        L+  +  +
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 120
Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           + + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D  
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFY 170
Query: 338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
           L +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 LARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     +++R+L  E +LIDQQ    + D G  K +                YLA
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLA 206
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +  + +  D +A GV+I Q+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLR 239
           + ++  +G+G++  V+K   RD G +VAI+       +SE+   +K + L     L  L+
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLK 60
Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H N++ L      R +    L++++     L +    + G    L      SI     + 
Sbjct: 61  HPNLVNL--LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL----VKSITWQTLQA 114
Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVFSVLKT 353
           + + H     K   +HR++  E +LI +     + D G  +LL       DD V      
Sbjct: 115 VNFCH-----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV------ 163
Query: 354 SAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 389
            A   Y +PE  V   ++    D++A G +  ++L+G
Sbjct: 164 -ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/209 (19%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 245 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 360
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSEMVGTPYWM 183
Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTG 389
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           FS   ++G+G F  VY     D G + A++ ++    K ++ E        T   +E I+
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--------TLALNERIM 241
Query: 245 RLRGFCCSRGRGECFLI----YDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSI 292
                      G+C  I    Y F    KLS  LD   G           V   +     
Sbjct: 242 -----LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 296
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I  G+ ++H+       +V+R+L    +L+D+  +  I+D G    LA D  FS  K
Sbjct: 297 AAEIILGLEHMHNR-----FVVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKK 345
Query: 353 TSAAM---GYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
             A++   GY+APE +  G  +   +D F+ G ++ ++L G
Sbjct: 346 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           FS   ++G+G F  VY     D G + A++ ++    K ++ E        T   +E I+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--------TLALNERIM 242
Query: 245 RLRGFCCSRGRGECFLI----YDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSI 292
                      G+C  I    Y F    KLS  LD   G           V   +     
Sbjct: 243 -----LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I  G+ ++H+       +V+R+L    +L+D+  +  I+D G    LA D  FS  K
Sbjct: 298 AAEIILGLEHMHNR-----FVVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKK 346
Query: 353 TSAAM---GYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
             A++   GY+APE +  G  +   +D F+ G ++ ++L G
Sbjct: 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           FS   ++G+G F  VY     D G + A++ ++    K ++ E        T   +E I+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--------TLALNERIM 242
Query: 245 RLRGFCCSRGRGECFLI----YDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSI 292
                      G+C  I    Y F    KLS  LD   G           V   +     
Sbjct: 243 -----LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I  G+ ++H+       +V+R+L    +L+D+  +  I+D G    LA D  FS  K
Sbjct: 298 AAEIILGLEHMHNR-----FVVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKK 346
Query: 353 TSAAM---GYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
             A++   GY+APE +  G  +   +D F+ G ++ ++L G
Sbjct: 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           FS   ++G+G F  VY     D G + A++ ++    K ++ E        T   +E I+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--------TLALNERIM 242
Query: 245 RLRGFCCSRGRGECFLI----YDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSI 292
                      G+C  I    Y F    KLS  LD   G           V   +     
Sbjct: 243 -----LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I  G+ ++H+       +V+R+L    +L+D+  +  I+D G    LA D  FS  K
Sbjct: 298 AAEIILGLEHMHNR-----FVVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKK 346
Query: 353 TSAAM---GYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 389
             A++   GY+APE +  G  +   +D F+ G ++ ++L G
Sbjct: 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +L +G F+ VY+   +  G   A++ +     +   A   +  ++     H NI++   F
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---F 91
Query: 250 CCS---------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
           C +          G+ E  L+ +   KG+L ++L + E S   L   T + I     + +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAV 149
Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----------- 349
            ++H     KP I+HR+L VE +L+  Q    + D G    ++    +S           
Sbjct: 150 QHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 350 -VLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVII 383
            + + +  M Y  PE +   +     E+ DI+A G I+
Sbjct: 207 EITRNTTPM-YRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           YLHS +     +++R+L  E +LIDQQ    + D G  K +           +    YLA
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEYLA 206
Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTG 389
           PE + +  + +  D +A GV+I ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 317
            +++ ++AP G++  +L +    S          I++       YLHS +     +++R+
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLHSLD-----LIYRD 166
Query: 318 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIF 377
           L  E ++IDQQ    + D GL K +                YLAPE + +  + +  D +
Sbjct: 167 LKPENLMIDQQGYIQVTDFGLAKRVKG----RTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 378 AFGVIILQILTG 389
           A GV+I ++  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 317
            +++ ++AP G++  +L +    S          I++       YLHS +     +++R+
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLHSLD-----LIYRD 166
Query: 318 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIF 377
           L  E ++IDQQ    + D GL K +                YLAPE + +  + +  D +
Sbjct: 167 LKPENLMIDQQGYIKVTDFGLAKRVKG----RTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 378 AFGVIILQILTG 389
           A GV+I ++  G
Sbjct: 223 ALGVLIYEMAAG 234

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	464
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-82
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-75
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-42
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-21
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-21
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-19
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-12
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-11
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-11
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-10
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-09
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-09
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  255 bits (653), Expect = 7e-82
 Identities = 94/295 (31%), Positives = 165/295 (55%), Gaps = 21/295 (7%)

Query: 173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 232
           R +L E++ A+  FS  N+LG+G F  VYKG L DGTLVA++ +     +  E +F   +
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 233 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW  R  I
Sbjct: 79  EMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
            +G A+G+ YLH  +   P I+HR++    +L+D++F  ++ D GL KL+      + + 
Sbjct: 137 ALGSARGLAYLH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVT 192

Query: 353 TSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-------------SLVLTSSM 397
           T+    +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L   +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 398 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
           +   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L 
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  237 bits (606), Expect = 5e-75
 Identities = 93/298 (31%), Positives = 145/298 (48%), Gaps = 24/298 (8%)

Query: 168 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE 227
              S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E E
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-E 81

Query: 228 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 287
           F   +  L+  RH +++ L GFC    R E  LIY +   G L ++L   +  +  + W 
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
            R+ I IG A+G+ YLH       AI+HR++    +L+D+ F P I D G+ K   +   
Sbjct: 140 QRLEICIGAARGLHYLH-----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194

Query: 348 FSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------- 397
             +  ++      GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+       
Sbjct: 195 THL--STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 398 ----RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                 +  +   E  +D NL  K       K G  A+ C     E+RP+M  V+ +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  215 bits (551), Expect = 6e-67
 Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 41/308 (13%)

Query: 168 HLNSFRLNLEEVESATQCFSE------VNLLGKGNFSSVYKGTLRDGTLVAI----RSIN 217
             +SF  +  E+++ T  F E       N +G+G F  VYKG + + T VA+      ++
Sbjct: 11  RFHSF--SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67

Query: 218 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 277
           +T+ + ++ +F + + ++   +HEN++ L GF       +  L+Y + P G L   L   
Sbjct: 68  ITTEELKQ-QFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCL 124

Query: 278 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           +G+   L W  R  I  G A GI +LH         +HR++    +L+D+ F   I+D G
Sbjct: 125 DGTP-PLSWHMRCKIAQGAANGINFLHE-----NHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 338 LHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG----- 389
           L +         +  TS  +G   Y+APE +  G  T +SDI++FGV++L+I+TG     
Sbjct: 179 LARASEKFAQTVM--TSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 390 ------SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
                  L+      +  E  T E++ID+ +      +    +  +A  C HE    RP 
Sbjct: 236 EHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 444 MEAVIEEL 451
           ++ V + L
Sbjct: 294 IKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (506), Expect = 4e-60
 Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 42/319 (13%)

Query: 165 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE 224
              H +   L  E +   +     + +  +G F  V+K  L     VA++   +   +S 
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW 63

Query: 225 EAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 282
           + E+   +Y L  ++HENI++  G     +    + +LI  F  KG LS +L      +N
Sbjct: 64  QNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KAN 116

Query: 283 VLDWSTRVSIIIGIAKGIGYLHS-----SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 337
           V+ W+    I   +A+G+ YLH       + +KPAI HR++  + VL+       IAD G
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 338 LHKLLADDIVFSVLKTSAAMG---YLAPEYV-----TTGRFTERSDIFAFGVIILQILTG 389
           L          S   T   +G   Y+APE +            R D++A G+++ ++ + 
Sbjct: 177 LALKFEAGK--SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

Query: 390 SLVLTSSMR--------LAAESATFENFIDRNLKGK---------FSESEAAKLGKMALV 432
                  +            +  + E+  +  +  K            +  A L +    
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294

Query: 433 CTHEDPENRPTMEAVIEEL 451
           C   D E R +   V E +
Sbjct: 295 CWDHDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  172 bits (438), Expect = 4e-50
 Identities = 72/316 (22%), Positives = 125/316 (39%), Gaps = 49/316 (15%)

Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 236
            E          + L+G+G + +VYKG+L     VA++  +  + ++   E  K +Y + 
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE--KNIYRVP 62

Query: 237 SLRHENIIRLRGFC---CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
            + H+NI R         + GR E  L+ ++ P G L KYL     S +  DW +   + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLA 117

Query: 294 IGIAKGIGYLHSSEVN----KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             + +G+ YLH+        KPAI HR+L+   VL+      +I+D GL   L  + +  
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 350 VLKTSAAM-------GYLAPEY-------VTTGRFTERSDIFAFGVIILQILTGSLVLTS 395
             +   A         Y+APE               ++ D++A G+I  +I      L  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 396 S-----MRLAAESA-----TFENFIDRNLKGKF----------SESEAAKLGKMALVCTH 435
                  ++A ++      TFE+      + K           +      L +    C  
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 436 EDPENRPTMEAVIEEL 451
           +D E R T +   E +
Sbjct: 298 QDAEARLTAQXAEERM 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (389), Expect = 3e-43
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 40/294 (13%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +  +GKG +  V++G+ + G  VA++  +    KS   E    LY    LRHENI+    
Sbjct: 13  LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69

Query: 249 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
                 R    + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 306 ---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
                  KPAI HR+L  + +L+ +     IAD GL  + +       +  +  +G   Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 360 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 406
           +APE       V      +R DI+AFG+++ ++    +              +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 407 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           E+                  FS+     L K+   C +++P  R T   + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  154 bits (390), Expect = 4e-43
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 40/294 (13%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  +GKG +  V+ G  R G  VA++    T   S   E    +Y    +RHENI+    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98

Query: 249 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
               +G G   + +LI D+   G L  YL      S  LD  + + +      G+ +LH+
Sbjct: 99  -ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 306 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
                  KPAI HR+L  + +L+ +     IAD GL      D     +  +  +G   Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 360 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 406
           + PE           +    +D+++FG+I+ ++    +              L     ++
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 407 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           E+  +    + L         S+    ++GK+   C   +P +R T   V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  150 bits (382), Expect = 3e-42
 Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 34/277 (12%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           + E+ +   +G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H N
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPN 62

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I++L G C +       L+ ++A  G L   L   E        +  +S  +  ++G+ Y
Sbjct: 63  IVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA--MGY 359
           LHS +    A++HR+L    +L+      L I D G    +          T+      +
Sbjct: 118 LHSMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAW 169

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL----VLTSSMRLAAESATFENFIDRNLK 415
           +APE      ++E+ D+F++G+I+ +++T       +   + R+          +    +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-------VHNGTR 222

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
               ++    +  +   C  +DP  RP+ME +++ +T
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  150 bits (381), Expect = 8e-42
 Identities = 70/341 (20%), Positives = 120/341 (35%), Gaps = 43/341 (12%)

Query: 142 PLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ-CFSEVNLLGKGNFSSV 200
           P +   +      L D +     S     S    L +   A      E   +GKG F  V
Sbjct: 3   PSLDRPFISEGTTLKDLIYDMTTS--GSGSGLPLLVQRTIARTIVLQES--IGKGRFGEV 58

Query: 201 YKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGEC 258
           ++G  R G  VA++  +    +S   E    +Y    LRHENI+         +    + 
Sbjct: 59  WRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS---SEVNKPAIVH 315
           +L+ D+   G L  YL     +   +     + + +  A G+ +LH        KPAI H
Sbjct: 116 WLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170

Query: 316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE------YVT 366
           R+L  + +L+ +     IAD GL            +  +  +G   Y+APE       + 
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATFENFID----RNL- 414
                +R+DI+A G++  +I     +             L     + E        + L 
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290

Query: 415 ----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                   S      + K+   C + +   R T   + + L
Sbjct: 291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (373), Expect = 2e-41
 Identities = 58/282 (20%), Positives = 117/282 (41%), Gaps = 41/282 (14%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 241
           F ++N    L + +   ++KG  + G  + ++ + V    +    +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   + +A+G+ 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMA 125

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           +LH+    +P I    L+   V+ID+     I+   +             ++   M    
Sbjct: 126 FLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPA 173

Query: 359 YLAPEYVTTGR----FTERSDIFAFGVIILQILTGS-----LVLTSSMRLAAESATFENF 409
           ++APE     +        +D+++F V++ +++T       L   S+M +  + A     
Sbjct: 174 WVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL---SNMEIGMKVAL---- 225

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               L+       +  + K+  +C +EDP  RP  + ++  L
Sbjct: 226 --EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 6e-41
 Identities = 66/286 (23%), Positives = 129/286 (45%), Gaps = 48/286 (16%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 241
           + ++N+   +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+   G           ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ 
Sbjct: 95  NIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLH+     P IVHRNL    +L+D+++   + D GL +L A   +     + +A G   
Sbjct: 152 YLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL----SSKSAAGTPE 204

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-------------VLTSSMRLAAESAT 405
           ++APE +      E+SD+++FGVI+ ++ T                V     RL      
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------ 258

Query: 406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                      +   +   ++  +   C   +P  RP+   +++ L
Sbjct: 259 -----------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (365), Expect = 5e-40
 Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 49/292 (16%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE------AEFVKGLYLL 235
            +E+     +GKG F  V+KG L  D ++VAI+S+ +   + E        EF + ++++
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
           ++L H NI++L G           ++ +F P G L   L  +   ++ + WS ++ +++ 
Sbjct: 78  SNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLD 130

Query: 296 IAKGIGYLHSSEVNKPAIVHR-----NLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           IA GI Y+ +     P IVHR     N+ ++ +  +      +AD GL +          
Sbjct: 131 IALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----- 182

Query: 351 LKTSAAMG---YLAPEYVTTGR---FTERSDIFAFGVIILQILTGSL----VLTSSMRLA 400
              S  +G   ++APE         +TE++D ++F +I+  ILTG           ++  
Sbjct: 183 --VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239

Query: 401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
                     +  L+    E    +L  +  +C   DP+ RP    +++EL+
Sbjct: 240 NM------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (360), Expect = 2e-39
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAI---RSINVTSCKSEEAEFVKGLYLLTSLR 239
           F+E+ L   +G G F  VY+     G  VA+   R               +   L   L+
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H NII LRG C         L+ +FA  G L++ L  +      +     V+  + IA+G
Sbjct: 65  HPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARG 117

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVL 351
           + YLH        I+HR+L    +LI Q+            I D GL +        S  
Sbjct: 118 MNYLHDE--AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENF 409
              A   ++APE +    F++ SD++++GV++ ++LTG +       + +A   A     
Sbjct: 176 GAYA---WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               L      +      K+   C + DP +RP+   ++++L
Sbjct: 228 -MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  138 bits (350), Expect = 9e-38
 Identities = 54/276 (19%), Positives = 117/276 (42%), Gaps = 25/276 (9%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 241
             ++ +   +G G+F +VYKG    G  VA++ +NVT+   +    F   + +L   RH 
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+   G   +  +    ++  +     L  +L   E      +    + I    A+G+ 
Sbjct: 81  NILLFMG-YSTAPQ--LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMD 134

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYL 360
           YLH+      +I+HR+L    + + +     I D GL    +        +  +  + ++
Sbjct: 135 YLHA-----KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 361 APE---YVTTGRFTERSDIFAFGVIILQILTGSL--VLTSSMRLAAESATFENFIDRNLK 415
           APE      +  ++ +SD++AFG+++ +++TG L     ++     E     +       
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL--SPDL 247

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            K   +   ++ ++   C  +  + RP+   ++ E+
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  138 bits (350), Expect = 1e-37
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 34/277 (12%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LGKG F    K T R+ G ++ ++ +     +  +  F+K + ++  L H N+++  G  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
               R     I ++   G L   +   +       WS RVS    IA G+ YLHS     
Sbjct: 77  YKDKR--LNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMN--- 128

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----------VLKTSAAMG-- 358
             I+HR+L+    L+ +  N ++AD GL +L+ D+                K    +G  
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 359 -YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV---LTSSMRLAAESATFENFIDRNL 414
            ++APE +    + E+ D+F+FG+++ +I+                  +  F   +   L
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR------TMDFGLNVRGFL 240

Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                 +       + + C   DPE RP+   +   L
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (328), Expect = 2e-34
 Identities = 67/284 (23%), Positives = 109/284 (38%), Gaps = 36/284 (12%)

Query: 186 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 241
           F ++ +   +GKG F  VY G    G  VAIR I++    + +   F + +      RHE
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++   G C S       +I        L   +   +    VLD +    I   I KG+G
Sbjct: 90  NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMG 144

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMG-- 358
           YLH+       I+H++L  + V  D     +I D GL  +           K     G  
Sbjct: 145 YLHA-----KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 359 -YLAPEYVTTGR---------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 408
            +LAPE +             F++ SD+FA G I  ++         +    A       
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-WPFKTQPAEAIIWQ--- 254

Query: 409 FIDRNLKGKFSESEA-AKLGKMALVCTHEDPENRPTMEAVIEEL 451
            +   +K   S+     ++  + L C   + E RPT   +++ L
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  122 bits (307), Expect = 2e-31
 Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 27/277 (9%)

Query: 192 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G+F  V            G +VA++++   +     + + + + +L +L HE+II+ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C   G     L+ ++ P G L  YL       + +  +  +     I +G+ YLH+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 364
                  +HR+L+   VL+D      I D GL K + +   +  ++        + APE 
Sbjct: 154 H-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 365 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           +   +F   SD+++FGV + ++LT   S     +  L              L       E
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268

Query: 423 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                    A++  +   C   +   RPT E +I  L
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  122 bits (309), Expect = 2e-31
 Identities = 63/290 (21%), Positives = 128/290 (44%), Gaps = 18/290 (6%)

Query: 106 RYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFS 165
            + R +  +             D   + +            E  +       +++ +  +
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 166 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSC 221
            E + + +  +    S    F+EV  +G+G+F  VY GTL D        A++S+N  + 
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130

Query: 222 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 281
             E ++F+    ++    H N++ L G  C R  G   ++  +   G L  ++  E  + 
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 189

Query: 282 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 341
            V D    +   + +AKG+ +L  +       VHR+L+    ++D++F   +AD GL + 
Sbjct: 190 TVKD---LIGFGLQVAKGMKFL--ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 342 LADDIVFSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           + D    SV   + A     ++A E + T +FT +SD+++FGV++ +++T
Sbjct: 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (305), Expect = 3e-31
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 192 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LG+G+F  V            G  VA++S+   S  +  A+  K + +L +L HENI++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C   G     LI +F P G L +YL + +     ++   ++   + I KG+ YL S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 364
           +      VHR+L+   VL++ +    I D GL K +  D  +  +K        + APE 
Sbjct: 146 Q-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 365 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           +   +F   SD+++FGV + ++LT   S     ++ L     T        L     E +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260

Query: 423 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                     ++ ++   C    P NR + + +IE  
Sbjct: 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (304), Expect = 3e-31
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 190 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            ++GKG+F  VY G   D        AI+S++  +   +   F++   L+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G       G   ++  +   G L +++   + +  V D    +S  + +A+G+ YL  
Sbjct: 87  LIG-IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL-- 140

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 362
               K   VHR+L+    ++D+ F   +AD GL + + D   +SV +   A     + A 
Sbjct: 141 -AEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 363 EYVTTGRFTERSDIFAFGVIILQILT 388
           E + T RFT +SD+++FGV++ ++LT
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (303), Expect = 4e-31
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 27/278 (9%)

Query: 192 LGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV            G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D  F  +K        + APE 
Sbjct: 134 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 421
           +T  +F+  SD+++FGV++ ++ T      S                 I  +L      +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248

Query: 422 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                      ++  +   C + +   RP+   +   +
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 6e-31
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)

Query: 192 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKGNF SV            G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 364
                  +HR+L+   +L++ +    I D GL K+L  D  +  +K        + APE 
Sbjct: 165 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 421
           +T  +F+  SD+++FGV++ ++ T      S                 I  +L      +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279

Query: 422 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                      ++  +   C + +   RP+   +   +
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  119 bits (300), Expect = 1e-30
 Identities = 62/240 (25%), Positives = 119/240 (49%), Gaps = 22/240 (9%)

Query: 158 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAI 213
           +++ +  + E + + +  +    S    F+EV  +G+G+F  VY GTL D        A+
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 58

Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G  C R  G   ++  +   G L  +
Sbjct: 59  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 117

Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +  V D    +   + +AKG+ YL  +       VHR+L+    ++D++F   +
Sbjct: 118 IRNETHNPTVKD---LIGFGLQVAKGMKYL--ASKK---FVHRDLAARNCMLDEKFTVKV 169

Query: 334 ADCGLHKLLADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
           AD GL + + D   +SV   + A   L     A E + T +FT +SD+++FGV++ +++T
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAK--LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (302), Expect = 9e-30
 Identities = 66/360 (18%), Positives = 134/360 (37%), Gaps = 55/360 (15%)

Query: 107 YRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEY-CHGWDPLGDYLNGTGFS 165
           YR +    G    SS+ + +T   L    +      + +L Y     +    Y     + 
Sbjct: 154 YRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYD 213

Query: 166 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE 224
           +  +    + ++              LG G +  VY+G  +     VA++++   +   E
Sbjct: 214 KWEMERTDITMKHK------------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--ME 259

Query: 225 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 284
             EF+K   ++  ++H N+++L G  C+R     ++I +F   G L  YL +       +
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLG-VCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--V 315

Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                + +   I+  + YL          +HRNL+    L+ +     +AD GL +L+  
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370

Query: 345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
           D   +       + + APE +   +F+ +SD++AFGV++ +I T  +     +       
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------- 423

Query: 405 TFENFIDRNLKGKFSESEAAKLGKMA-------------LVCTHEDPENRPTMEAVIEEL 451
                 +   K            +M                C   +P +RP+   + +  
Sbjct: 424 DLSQVYELLEKD----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  118 bits (298), Expect = 3e-29
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
              LG+G F  V+ GT    T VAI+++   +       F++   ++  LRHE +++L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                     +++ ++  KG L  +L  E G    L     V +   IA G+ Y+     
Sbjct: 247 VVSEEPI---YIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN- 300

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    G
Sbjct: 301 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
           RFT +SD+++FG+++ ++ T   V    M         +  ++R  +          L  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 412

Query: 429 MALVCTHEDPENRPTMEAVIEEL 451
           +   C  ++PE RPT E +   L
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFL 435

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (294), Expect = 3e-29
 Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 46/277 (16%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 251 CSRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
               + +  +++ +    G    +L  E      L   T + ++   A G+ YL S    
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC- 234

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APEY 364
               +HR+L+    L+ ++    I+D G+ +  AD +  +    S  +  +     APE 
Sbjct: 235 ----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA----SGGLRQVPVKWTAPEA 286

Query: 365 VTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDRNL 414
           +  GR++  SD+++FG+++ +           L+                    F+++  
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--------------EFVEKGG 332

Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    E     + ++   C   +P  RP+   + +EL
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  115 bits (290), Expect = 5e-29
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 40/288 (13%)

Query: 189 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           ++ LGKGNF SV            G LVA++ +  +    +  +F + + +L +L  + I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFI 86

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLA 361
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++        + A
Sbjct: 144 GSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAESATFENFIDRNL 414
           PE ++   F+ +SD+++FGV++ ++ T        S      M    +       ++   
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 415 KGKFSESEAAKLGKMA----------LVCTHEDPENRPTMEAVIEELT 452
           +G+       +L               +C    P++RP+  A+  +L 
Sbjct: 259 EGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  118 bits (296), Expect = 9e-29
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
              LG+G F  V+ GT    T VAI+++   +       F++   ++  LRHE +++L  
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                     +++ ++  KG L  +L  E G    L     V +   IA G+ Y+     
Sbjct: 330 VVSEEPI---YIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN- 383

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    G
Sbjct: 384 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 428
           RFT +SD+++FG+++ ++ T   V    M         +  ++R  +          L  
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 495

Query: 429 MALVCTHEDPENRPTMEAVIEEL 451
           +   C  ++PE RPT E +   L
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFL 518

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  112 bits (283), Expect = 5e-28
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           + +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
            RL G C +       LI    P G L  Y+ + + +   +     ++  + IAKG+ YL
Sbjct: 80  CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 360
              +     +VHR+L+   VL+    +  I D GL KLL  +                ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT 388
           A E +    +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  111 bits (280), Expect = 5e-28
 Identities = 50/282 (17%), Positives = 113/282 (40%), Gaps = 28/282 (9%)

Query: 180 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTS 237
            S  + +  +  +G G++    K     DG ++  + ++  S    E + +   + LL  
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           L+H NI+R       R     +++ ++   G L+  + +       LD    + ++  + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
             +   H        ++HR+L    V +D + N  + D GL ++L  D  F        +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKTFV 177

Query: 358 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
           G   Y++PE +    + E+SDI++ G ++ ++                + + +    +  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIR 229

Query: 415 KGKFSE-----SEAAKLGKMALV--CTHEDPENRPTMEAVIE 449
           +GKF       S+        ++    +    +RP++E ++E
Sbjct: 230 EGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 267

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  114 bits (287), Expect = 8e-28
 Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 12/200 (6%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
              LG G F  V+  T    T VA++++   S       F+    ++ +L+H+ +++L  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                     ++I +F  KG L  +L  +EGS         +     IA+G+ ++     
Sbjct: 251 VVTKEP---IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRN- 304

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
                +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G
Sbjct: 305 ----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 369 RFTERSDIFAFGVIILQILT 388
            FT +SD+++FG+++++I+T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (272), Expect = 4e-27
 Identities = 47/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +G G F  V+ G   +   VAI++I   +    E +F++   ++  L H  +++L G  C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYG-VC 72

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
                   L+ +F   G LS YL  + G        T + + + + +G+ YL   E    
Sbjct: 73  LEQA-PICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL--EEAC-- 124

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
            ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  R++
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 372 ERSDIFAFGVIILQILT 388
            +SD+++FGV++ ++ +
Sbjct: 184 SKSDVWSFGVLMWEVFS 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (272), Expect = 7e-27
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G +  VY+G  +  +L VA++++   +   E  EF+K   ++  ++H N+++L G  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG-V 77

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
           C+R     ++I +F   G L  YL +       +     + +   I+  + YL       
Sbjct: 78  CTRE-PPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 370
              +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +   +F
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 371 TERSDIFAFGVIILQILT 388
           + +SD++AFGV++ +I T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  107 bits (270), Expect = 9e-27
 Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  +    VA++ I   S    E EF +    +  L H  +++  G  C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYG-VC 72

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
           S+     +++ ++   G L  YL         L+ S  + +   + +G+ +L S +    
Sbjct: 73  SKEY-PIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L+D+     ++D G+ + + DD   S + T   + + APE     +++
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 372 ERSDIFAFGVIILQILT 388
            +SD++AFG+++ ++ +
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (273), Expect = 9e-27
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           + +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
            RL G C +       LI    P G L  Y+ + + +   +     ++  + IAKG+ YL
Sbjct: 80  CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 360
              +     +VHR+L+   VL+    +  I D GL KLL  +                ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT 388
           A E +    +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  108 bits (271), Expect = 1e-26
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           V  LG G F  V+ G     T VA++S+   S       F+    L+  L+H+ ++RL  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                     ++I ++   G L  +L    G    L  +  + +   IA+G+ ++     
Sbjct: 76  VVTQEPI---YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNY 130

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 363
                +HR+L    +L+    +  IAD GL +L+ D+       T+           APE
Sbjct: 131 -----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-----TAREGAKFPIKWTAPE 180

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +  G FT +SD+++FG+++ +I+T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  107 bits (269), Expect = 2e-26
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +  +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                 +G  +++ ++  KG L  YL     S   L     +   + + + + YL  +  
Sbjct: 82  -VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 363
                VHR+L+   VL+ +     ++D GL      +       ++   G L     APE
Sbjct: 139 -----VHRDLAARNVLVSEDNVAKVSDFGL----TKEAS-----STQDTGKLPVKWTAPE 184

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F+ +SD+++FG+++ +I +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (269), Expect = 2e-26
 Identities = 59/258 (22%), Positives = 103/258 (39%), Gaps = 19/258 (7%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRG 248
            +G+G+F +VYKG        VA   +      KSE   F +   +L  L+H NI+R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 249 FCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
              S  +G+  +  + +    G L  YL +      V+      S    I KG+ +LH+ 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
               P I+HR+L  + + I      + I D GL  L       +V+ T   M   APE  
Sbjct: 148 --RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM---APEMY 202

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
               + E  D++AFG+ +L++ T              +  +           F +    +
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 426 LGKMALVCTHEDPENRPT 443
           + ++   C  ++ + R +
Sbjct: 259 VKEIIEGCIRQNKDERYS 276

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (271), Expect = 2e-26
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 192 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G G+   V  G LR        VAI+++     + +  +F+    ++    H NIIRL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G   +RGR    ++ ++   G L  +L   +G          V ++ G+  G+ YL  S+
Sbjct: 117 G-VVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--SD 169

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL--APEYV 365
           +     VHR+L+   VL+D      ++D GL ++L DD   +   T   +     APE +
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 366 TTGRFTERSDIFAFGVIILQILT 388
               F+  SD+++FGV++ ++L 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  107 bits (268), Expect = 4e-26
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           + +LG G F +V+KG            V I+ I   S +         +  + SL H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +RL G C         L+  + P G L  ++ Q  G+   L     ++  + IAKG+ YL
Sbjct: 78  VRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL 131

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 360
              E     +VHRNL+   VL+       +AD G+  LL  D        S A     ++
Sbjct: 132 --EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL--LYSEAKTPIKWM 184

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT 388
           A E +  G++T +SD++++GV + +++T
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  110 bits (276), Expect = 5e-26
 Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 32/294 (10%)

Query: 99  TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 158
            G    F  R  K+  G  +  S  +L+ +       +    S   + +Y    D    Y
Sbjct: 322 NGATQSFIIRPQKE--GERALPSIPKLANNEKQGVRSH--TVSVSETDDYAEIIDEEDTY 377

Query: 159 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIR 214
              +    E +   R+ L               +G+G F  V++G           VAI+
Sbjct: 378 TMPSTRDYE-IQRERIELGRC------------IGEGQFGDVHQGIYMSPENPAMAVAIK 424

Query: 215 SINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL 274
           +    +  S   +F++    +    H +I++L G          ++I +    G+L  +L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFL 481

Query: 275 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 334
              + S   LD ++ +     ++  + YL          VHR+++   VL+       + 
Sbjct: 482 QVRKFS---LDLASLILYAYQLSTALAYL--ESKR---FVHRDIAARNVLVSSNDCVKLG 533

Query: 335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
           D GL + + D   +   K    + ++APE +   RFT  SD++ FGV + +IL 
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (265), Expect = 5e-26
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G  C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYG-VC 88

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
           ++ R   F+I ++   G L  YL +             + +   + + + YL        
Sbjct: 89  TKQR-PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL--ESKQ-- 140

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 372 ERSDIFAFGVIILQILT 388
            +SDI+AFGV++ +I +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (265), Expect = 7e-26
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 192 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL   E 
Sbjct: 78  VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 129

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 363
           N    VHR+L+   VL+  +    I+D GL K L  D       T+ + G       APE
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 183

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F+ RSD++++GV + + L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (271), Expect = 8e-26
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG-VI 255

Query: 252 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 311
              +G  +++ ++  KG L  YL     S   L     +   + + + + YL  +     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNN---- 309

Query: 312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 371
             VHR+L+   VL+ +     ++D GL      +   +       + + APE +   +F+
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 372 ERSDIFAFGVIILQILT 388
            +SD+++FG+++ +I +
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  104 bits (263), Expect = 1e-25
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 192 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           LG+G F  VY+G   +       VA+++         + +F+    ++ +L H +I++L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +  P G+L  YL++ + S   L   T V   + I K + YL    
Sbjct: 80  GIIE---EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL--ES 131

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
           +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE +  
Sbjct: 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188

Query: 368 GRFTERSDIFAFGVIILQILT 388
            RFT  SD++ F V + +IL+
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (263), Expect = 1e-25
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 192 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL    
Sbjct: 83  GVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 134

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 135 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191

Query: 368 GRFTERSDIFAFGVIILQILT 388
            RFT  SD++ FGV + +IL 
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (264), Expect = 2e-25
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 192 LGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           +G G F  VYKG L+  +      VAI+++     + +  +F+    ++    H NIIRL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G   S+ +    +I ++   G L K+L +++G          V ++ GIA G+ YL  +
Sbjct: 112 EG-VISKYK-PMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--A 164

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YL 360
            +N    VHR+L+   +L++      ++D GL ++L DD       T    G      + 
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TYTTSGGKIPIRWT 217

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILT 388
           APE ++  +FT  SD+++FG+++ +++T
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (263), Expect = 2e-25
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 189 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           +  LG G F  VY+G +           VA++++     + +E +F+    +++   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 299
           I+R  G    +     F++ +    G L  +L          + L     + +   IA G
Sbjct: 95  IVRCIG-VSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 356
             YL   E N    +HR+++    L+          I D G    +A DI  +       
Sbjct: 153 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGG 203

Query: 357 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
              L      PE    G FT ++D ++FGV++ +I +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (270), Expect = 2e-25
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 192 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL   E 
Sbjct: 404 VCQAE---ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 455

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 363
           N    VHRNL+   VL+  +    I+D GL K L  D       T+ + G       APE
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 509

Query: 364 YVTTGRFTERSDIFAFGVIILQILT 388
            +   +F+ RSD++++GV + + L+
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALS 534

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  105 bits (264), Expect = 3e-25
 Identities = 48/203 (23%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 192 LGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +G G F  V  G L    +    VAI+++ V   + +  +F+    ++    H NIIRL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G   ++ +    ++ ++   G L  +L + +           V ++ GIA G+ YL  S+
Sbjct: 113 G-VVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--SD 165

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL--APEYV 365
           +     VHR+L+   +LI+      ++D GL ++L DD   +       +     +PE +
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 366 TTGRFTERSDIFAFGVIILQILT 388
              +FT  SD++++G+++ ++++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (261), Expect = 4e-25
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 192 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRL 246
           LGKG F SV +  L+        VA++ +       S+  EF++    +    H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 247 RGFCCSRGRGEC-----FLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 299
            G    R R +       +I  F   G L  +L   +   +   L   T V  ++ IA G
Sbjct: 91  VG-VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-- 357
           + YL S        +HR+L+    ++ +     +AD GL + +     +   +  A+   
Sbjct: 150 MEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKLP 202

Query: 358 -GYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
             +LA E +    +T  SD++AFGV + +I+T
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  103 bits (260), Expect = 5e-25
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)

Query: 189 VNLLGKGNFSSVYKGTLRDG----TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 243
             +LG+G F SV +G L+        VA++++ +  S + E  EF+     +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 244 IRLRGFCC---SRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAK 298
           IRL G C    S+G  +  +I  F   G L  YL   + E     +   T +  ++ IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 358
           G+ YL  S  N    +HR+L+    ++       +AD GL K +     +   +   A  
Sbjct: 159 GMEYL--SNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAK- 210

Query: 359 YL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
            +     A E +    +T +SD++AFGV + +I T
Sbjct: 211 -MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (261), Expect = 8e-25
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 189 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           +  LG G F  VY+G +           VA++++     + +E +F+    +++   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 299
           I+R  G    +     F++ +    G L  +L          + L     + +   IA G
Sbjct: 136 IVRCIG-VSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 356
             YL   E N    +HR+++    L+          I D G    +A DI  +       
Sbjct: 194 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGG 244

Query: 357 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
              L      PE    G FT ++D ++FGV++ +I +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  102 bits (257), Expect = 2e-24
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G+F  VY+G  +        T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSSNVLDWSTRVSIIIGIAKG 299
           L G   S+G     +I +   +G L  YL                  S  + +   IA G
Sbjct: 93  LLG-VVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YL++   NK   VHR+L+    ++ + F   I D G+ + + +   +   K    +  
Sbjct: 151 MAYLNA---NK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGL-- 201

Query: 360 L-----APEYVTTGRFTERSDIFAFGVIILQILT 388
           L     +PE +  G FT  SD+++FGV++ +I T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  102 bits (256), Expect = 2e-24
 Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 39/288 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  +  LG+G FS V     L DG   A++ I     + +  E  +   +     H NI+
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNIL 89

Query: 245 RLRGFCC--SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           RL  +C      + E +L+  F  +G L   +++ +   N L     + +++GI +G+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----VLKTSAA-- 356
           +H+         HR+L    +L+  +  P++ D G        +  S     L+  AA  
Sbjct: 150 IHA-----KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 357 --MGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-NFI 410
             + Y APE  +        ER+D+++ G ++  ++ G            +    + + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG--------EGPYDMVFQKGDSV 256

Query: 411 DRNLKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              ++ + S        S   +L    +     DP  RP +  ++ +L
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMT---VDPHQRPHIPLLLSQL 301

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  102 bits (256), Expect = 2e-24
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LG+G  ++V++G  +  G L AI+  N  S        ++   +L  L H+NI++L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                     LI +F P G L   L +E  ++  L  S  + ++  +  G+ +L  +   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 310 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 364
              IVHRN+    ++     D Q    + D G  + L DD       +      YL P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186

Query: 365 VTTG--------RFTERSDIFAFGVIILQILTGSL 391
                       ++    D+++ GV      TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (254), Expect = 3e-24
 Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 43/290 (14%)

Query: 189 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 241
              LG+G F  V +              VA++ +   +  SE    +  L +L  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTR 289
           N++ L G  C++  G   +I +F   G LS YL              E+   + L     
Sbjct: 92  NVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           +     +AKG+ +L S +      +HR+L+   +L+ ++    I D GL    A DI   
Sbjct: 151 ICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL----ARDIYKD 201

Query: 350 VLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
                     L     APE +    +T +SD+++FGV++ +I +        +++  E  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259

Query: 405 TFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
               F  R  +G    +      ++ +  L C H +P  RPT   ++E L
Sbjct: 260 ----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  101 bits (253), Expect = 5e-24
 Identities = 61/310 (19%), Positives = 108/310 (34%), Gaps = 74/310 (23%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHEN 242
             +L +G F+ VY+   +  G   A++ +     +       E  F+K L       H N
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPN 87

Query: 243 IIRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
           I++              G+ E  L+ +    G+L ++L + E S   L   T + I    
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQT 145

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 356
            + + ++H     KP I+HR+L VE +L+  Q    + D G    ++    +S      A
Sbjct: 146 CRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 357 MG-----------YLAPEYVTTGR---FTERSDIFAFGVI---------------ILQIL 387
           +            Y  PE +         E+ DI+A G I                L+I+
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262

Query: 388 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 447
            G   +        +   F + I   L+                     +PE R ++  V
Sbjct: 263 NGKYSIPPHDT---QYTVFHSLIRAMLQ--------------------VNPEERLSIAEV 299

Query: 448 IEELTVAAPV 457
           + +L   A  
Sbjct: 300 VHQLQEIAAA 309

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  101 bits (254), Expect = 8e-24
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LG+G  ++V++G  +  G L AI+  N  S        ++   +L  L H+NI++L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                     LI +F P G L   L +E  ++  L  S  + ++  +  G+ +L  +   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 310 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 364
              IVHRN+    ++     D Q    + D G  + L DD       +      YL P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186

Query: 365 VTTG--------RFTERSDIFAFGVIILQILTGSL 391
                       ++    D+++ GV      TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 51/285 (17%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENI 243
           F E+ L+G G F  V+K     DG    I+ +   + K+E E +       L  L H NI
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK------ALAKLDHVNI 66

Query: 244 IRLRGF--------------CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
           +   G                        F+  +F  KG L +++++  G    LD    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           + +   I KG+ Y+HS    K  +++R+L    + +       I D GL   L +D    
Sbjct: 125 LELFEQITKGVDYIHS---KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---G 176

Query: 350 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 406
               S   G   Y++PE +++  + +  D++A G+I+ ++L                  F
Sbjct: 177 KRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------CDTAF 222

Query: 407 E--NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           E   F      G  S+    K   +      + PE+RP    ++ 
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (253), Expect = 2e-23
 Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 36/277 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           F   ++LG G   ++    + D   VA++ I        + E V+   L  S  H N+IR
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE-VQ--LLRESDEHPNVIR 82

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
              FC  + R   ++  +      L +Y++Q++ +   L+    ++++     G+ +LHS
Sbjct: 83  Y--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS 136

Query: 306 SEVNKPAIVHRNLSVEKVLI-----DQQFNPLIADCGLHKLLADDIV-FSVLKTSAA-MG 358
                  IVHR+L    +LI       +   +I+D GL K LA     FS         G
Sbjct: 137 LN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 359 YLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDR 412
           ++APE +        T   DIF+ G +   +++        +   +              
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251

Query: 413 NLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAV 447
             K    E   A+  + KM       DP+ RP+ + V
Sbjct: 252 PEK---HEDVIARELIEKM----IAMDPQKRPSAKHV 281

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 46/289 (15%)

Query: 192 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V + T            VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------DQEEGSSNVLDWSTRV 290
            L G  C+ G G   +I ++   G L  +L                 E     LD    +
Sbjct: 91  NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  +  
Sbjct: 149 SFSYQVAKGMAFLAS---KN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-- 201

Query: 351 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 405
           +    A   L     APE +    +T  SD++++G+ + ++ +        M        
Sbjct: 202 VVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PV 253

Query: 406 FENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
              F     +G    S     A++  +   C   DP  RPT + +++ +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  102 bits (255), Expect = 2e-23
 Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 18/209 (8%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 247
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 248 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
            G           L  ++   G L KYL  +  +   L      +++  I+  + YLH +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSA-AMGYLAP 362
                 I+HR+L  E +++      L   I D G  K L       +       + YLAP
Sbjct: 141 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAP 192

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSL 391
           E +   ++T   D ++FG +  + +TG  
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 2e-23
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)

Query: 189 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 239
              LG+G F  V                  VA++ +   + + + ++ V  + ++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 287
           H+NII L G  C++  G  ++I ++A KG L +YL            D        + + 
Sbjct: 146 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             VS    +A+G+ YL S    K   +HR+L+   VL+ +     IAD GL + + +   
Sbjct: 204 DLVSCTYQLARGMEYLAS---QK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 348 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 402
           +   KT+     L     APE +    +T +SD+++FGV++ +I T          L   
Sbjct: 259 Y--KKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 304

Query: 403 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                  E       +G   +  A    +L  M   C H  P  RPT + ++E+L
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 52/274 (18%), Positives = 103/274 (37%), Gaps = 34/274 (12%)

Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-RH 240
           Q F  ++ LG G++  V+K     DG L A++          + A  +  +     + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
              +RL         G  +L  +      L ++  +  G+S  L  +     +      +
Sbjct: 117 PCCVRLEQ--AWEEGGILYLQTELC-GPSLQQHC-EAWGAS--LPEAQVWGYLRDTLLAL 170

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK-TSAAMGY 359
            +LHS       +VH ++    + +  +    + D GL   L       V +       Y
Sbjct: 171 AHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RY 222

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
           +APE +  G +   +D+F+ G+ IL++          M L      ++      L  +F+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACN-------MELPHGGEGWQQLRQGYLPPEFT 274

Query: 420 E--SEAAKLGKMALV--CTHEDPENRPTMEAVIE 449
              S   +    +++      DP+ R T EA++ 
Sbjct: 275 AGLSSELR----SVLVMMLEPDPKLRATAEALLA 304

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 50/292 (17%)

Query: 189 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 241
              LG G F  V + T            VA++ +  T+   E+   +  L +++ L +HE
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL----------DQEEGSSNVLDWSTRVS 291
           NI+ L G  C+ G G   +I ++   G L  +L               +++       + 
Sbjct: 111 NIVNLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
               +A+G+ +L          +HR+++   VL+       I D GL + + +D  +  +
Sbjct: 169 FSSQVAQGMAFL---ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--I 221

Query: 352 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---- 402
               A   L     APE +    +T +SD++++G+++ +I +          L       
Sbjct: 222 VKGNAR--LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----------LGLNPYPG 269

Query: 403 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                 F      G      A     +  +   C   +P +RPT + +   L
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 49/293 (16%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F  +  LG+G F  V++     D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 245 RLRGFCC----------SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           R                S  +   ++      K  L  +++         + S  + I +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHIFL 125

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            IA+ + +LHS       ++HR+L    +         + D GL   +  D     + T 
Sbjct: 126 QIAEAVEFLHS---KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 355 AAMG-----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
                          Y++PE +    ++ + DIF+ G+I+ ++L               +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----------PFST 229

Query: 404 ATFENFIDRNLK-GKFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                    +++  KF             + +         P  RP    +IE
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD---MLSPSPMERPEAINIIE 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 192 LGKGNFSSVYKGTLRDG---TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           LG GNF +V KG  +       VA++ +    +  + + E +    ++  L +  I+R+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           G C +       L+ + A  G L+KYL Q       +     + ++  ++ G+ YL   E
Sbjct: 85  GICEAESW---MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL--EE 135

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----AP 362
            N    VHR+L+   VL+  Q    I+D GL K L  D        +   G       AP
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAP 189

Query: 363 EYVTTGRFTERSDIFAFGVIILQILT 388
           E +   +F+ +SD+++FGV++ +  +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)

Query: 189 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 239
              LG+G F  V                  VA++ +   + + + ++ V  + ++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 287
           H+NII L G  C++  G  ++I ++A KG L +YL            D        + + 
Sbjct: 100 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + +   
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 348 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 402
           +   KT+     L     APE +    +T +SD+++FGV++ +I T          L   
Sbjct: 213 YK--KTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 258

Query: 403 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                  E       +G   +  A    +L  M   C H  P  RPT + ++E+L
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 52/288 (18%)

Query: 192 LGKGNFSSVYKGTLR----DGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG G+F  V +G           VA++ +  +V S      +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G   +       ++ + AP G L   L + +G        T     + +A+G+GYL  
Sbjct: 86  LYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL-- 137

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY--LAPE 363
                   +HR+L+   +L+  +    I D GL + L  +    V++    + +   APE
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 364 YVTTGRFTERSDIFAFGVIILQILTG--------------SLVLTSSMRLAA-ESATFEN 408
            + T  F+  SD + FGV + ++ T                 +     RL   E      
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 251

Query: 409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 456
                            +  + + C    PE+RPT  A+ + L  A P
Sbjct: 252 ---------------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 189 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           +  LG+  F  VYKG L           VAI+++   +      EF     L   L+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           ++ L G   ++ +    +I+ +   G L ++L            D +    + L+    V
Sbjct: 74  VVCLLG-VVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
            ++  IA G+ YL  S  +   +VH++L+   VL+  + N  I+D G    L  ++  + 
Sbjct: 132 HLVAQIAAGMEYL--SSHH---VVHKDLATRNVLVYDKLNVKISDLG----LFREVYAAD 182

Query: 351 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
                    L     APE +  G+F+  SDI+++GV++ ++ +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 189 VNLLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
            +++G+GNF  V K  ++        AI+ +   + K +  +F   L +L  L  H NII
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 292
            L G  C    G  +L  ++AP G L  +L                 +++ L     +  
Sbjct: 90  NLLG-ACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              +A+G+ YL  S+      +HR+L+   +L+ + +   IAD GL +    ++      
Sbjct: 148 AADVARGMDYL--SQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEV-----Y 195

Query: 353 TSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
               MG L     A E +    +T  SD++++GV++ +I++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V K T          T VA++ +   +  SE  + +    +L  + H ++I+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSNVLD 285
           L G  CS+  G   LI ++A  G L  +L                      +      L 
Sbjct: 91  LYG-ACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 345
               +S    I++G+ YL  +E+    +VHR+L+   +L+ +     I+D GL + + ++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 346 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 400
             +   K S     +     A E +    +T +SD+++FGV++ +I+T          L 
Sbjct: 204 DSYV--KRSQGR--IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------LG 249

Query: 401 A---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                    E   +    G   E       ++ ++ L C  ++P+ RP    + ++L
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 35/220 (15%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
           LG+G F  V+     +        LVA++++   +  +   +F +   LLT+L+HE+I++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVK 81

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 293
             G  C  G     +++++   G L+K+L             Q   +   L  S  + I 
Sbjct: 82  FYG-VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             IA G+ YL  +  +    VHR+L+    L+       I D G+ + +     +     
Sbjct: 140 SQIASGMVYL--ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VG 192

Query: 354 SAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
              M  L      PE +   +FT  SD+++FGVI+ +I T
Sbjct: 193 GHTM--LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 58/300 (19%)

Query: 189 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
           V  +G+G F  V++            T+VA++ +   +    +A+F +   L+    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSN 282
           I++L G  C+ G     L++++   G L+++L                            
Sbjct: 112 IVKLLG-VCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 342
            L  + ++ I   +A G+ YL      K   VHR+L+    L+ +     IAD G    L
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE---RK--FVHRDLATRNCLVGENMVVKIADFG----L 220

Query: 343 ADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM 397
           + +I  +    +     +      PE +   R+T  SD++A+GV++ +I +         
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------- 271

Query: 398 RLAA---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                       E  I     G           +L  +  +C  + P +RP+  ++   L
Sbjct: 272 -YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 53/292 (18%)

Query: 192 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 242
           LG+G F  V                T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 290
           II L G  C++  G  ++I ++A KG L +YL            +        L     V
Sbjct: 137 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           S    +A+G+ YL      K   +HR+L+   VL+ +     IAD GL + +     +  
Sbjct: 195 SCAYQVARGMEYL---ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248

Query: 351 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE--- 402
            KT+     L     APE +    +T +SD+++FGV++ +I T          L      
Sbjct: 249 -KTTNGR--LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----------LGGSPYP 295

Query: 403 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
               E       +G   +  +    +L  M   C H  P  RPT + ++E+L
Sbjct: 296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 56/278 (20%), Positives = 123/278 (44%), Gaps = 41/278 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 243
           +  +  +G+G+F          DG    I+ IN++   S+E E  +  + +L +++H NI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 299
           ++ R      G    +++ D+   G L K ++ ++G       +LDW       + I   
Sbjct: 86  VQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 358
           + ++H     K  I+HR++  + + + +     + D G+ ++L   +        A +G 
Sbjct: 138 LKHVHD---RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL----ARACIGT 188

Query: 359 --YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
             YL+PE      +  +SDI+A G ++ ++ T         + A E+ + +N + + + G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTL--------KHAFEAGSMKNLVLKIISG 240

Query: 417 KFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            F       S   +   +       +P +RP++ +++E
Sbjct: 241 SFPPVSLHYSYDLR--SLVSQLFKRNPRDRPSVNSILE 276

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 53/288 (18%), Positives = 115/288 (39%), Gaps = 61/288 (21%)

Query: 192 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 243
           LG+G F+ ++KG  R+         T V ++ ++       E  F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSHKHL 74

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +   G  C  G  E  L+ +F   G L  YL + +     ++   ++ +   +A  + +L
Sbjct: 75  VLNYG-VCVCGD-ENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVLKTSA 355
              E     ++H N+  + +L+ ++ +          ++D G+   +             
Sbjct: 130 --EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---------- 174

Query: 356 AMGYL-------APEYVTTGR-FTERSDIFAFGVIILQILTGSLV----LTSSMRLAAES 403
               L        PE +   +     +D ++FG  + +I +G       L S  +L    
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---- 228

Query: 404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                F +     +    +AA+L  +   C   +P++RP+  A+I +L
Sbjct: 229 ----QFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 52/279 (18%), Positives = 110/279 (39%), Gaps = 37/279 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           F     +G+G FS VY+   L DG  VA++ + +      +A  + +K + LL  L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 243 IIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           +I+               I  + A  G LS+ +   +    ++   T     + +   + 
Sbjct: 94  VIKYYASFIEDN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           ++HS    +  ++HR++    V I       + D GL +  +     +   +    G   
Sbjct: 151 HMHS---RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLV--GTPY 201

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA--AESATFENFIDRNLKG 416
           Y++PE +    +  +SDI++ G ++ ++           +     +     +   +  + 
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAAL--------QSPFYGDKMNLYSLCKKIEQC 253

Query: 417 KFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            +        SE  +  ++  +C + DPE RP +  V +
Sbjct: 254 DYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYVYD 290

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 34/222 (15%)

Query: 189 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 242
              LG+G F  V+     +        LVA++++   S +S   +F +   LLT L+H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQH 104

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----------DQEEGSSNVLDWSTRVS 291
           I+R  G  C+ GR    +++++   G L+++L             E+ +   L     ++
Sbjct: 105 IVRFFG-VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           +   +A G+ YL  + ++    VHR+L+    L+ Q     I D G+    + DI  +  
Sbjct: 163 VASQVAAGMVYL--AGLH---FVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDY 213

Query: 352 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 388
                   L      PE +   +FT  SD+++FGV++ +I T
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 59/298 (19%)

Query: 192 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG G F  V   T            VA++ +   +  SE    +  L ++T L  HENI+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEGSSNVLD 285
            L G  C+   G  +LI+++   G L  YL                    +EE   NVL 
Sbjct: 113 NLLG-ACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 345
           +   +     +AKG+ +L          VHR+L+   VL+       I D GL + +  D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 346 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 400
             +  +    A   L     APE +  G +T +SD++++G+++ +I +          L 
Sbjct: 226 SNY--VVRGNAR--LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----------LG 271

Query: 401 A----ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
                      NF      G   +       ++  +   C   D   RP+   +   L
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 43/273 (15%)

Query: 190 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHEN 242
             LGKG F +VY     +   ++A++ +     K++  +A     L     + + LRH N
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLF----KAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+RL G+     R   +LI ++AP G + + L Q+       D     + I  +A  + Y
Sbjct: 71  ILRLYGYFHDATR--VYLILEYAPLGTVYREL-QKLSK---FDEQRTATYITELANALSY 124

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLA 361
            HS  V     +HR++  E +L+       IAD G           S        + YL 
Sbjct: 125 CHSKRV-----IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLP 175

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-- 419
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227

Query: 420 ---ESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                 A  L    L     +P  RP +  V+E
Sbjct: 228 DFVTEGARDLISRLLK---HNPSQRPMLREVLE 257

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 48/284 (16%), Positives = 107/284 (37%), Gaps = 49/284 (17%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 246
             +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + IIRL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +         +++ +      L+ +L +++ S   +D   R S    + + +  +H  
Sbjct: 94  YDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 146

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 IVH +L     LI       + D G+   +  D    V  +   +G   Y+ PE
Sbjct: 147 G-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ--VGTVNYMPPE 198

Query: 364 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 409
                        +  + + +SD+++ G I+  +  G      + + +      +     
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 252

Query: 410 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           ID N + +F +   +  +  L    L     DP+ R ++  ++ 
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCC-LK---RDPKQRISIPELLA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 48/284 (16%), Positives = 106/284 (37%), Gaps = 49/284 (17%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 246
             +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + IIRL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
             +         +++ +      L+ +L +++ S   +D   R S    + + +  +H  
Sbjct: 75  YDY--EITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 127

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
                 IVH +L     LI       + D G+   +  D    V  +    G   Y+ PE
Sbjct: 128 -----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPE 179

Query: 364 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 409
                        +  + + +SD+++ G I+  +  G      + + +      +     
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 233

Query: 410 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           ID N + +F +   +  +  L      C   DP+ R ++  ++ 
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRISIPELLA 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 41/297 (13%), Positives = 98/297 (32%), Gaps = 42/297 (14%)

Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 230
            E +  ++     +LLG+G F+ VY+ T  D           ++     +   E     +
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQ 116

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-EEGSSNVLDWSTR 289
            +  L        ++         +    L+ +    G L   ++  +     V+     
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----------IADCGL 338
           +S  + +   I  +H  E     I+H ++  +  ++   F              + D G 
Sbjct: 175 ISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 339 ---HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 394
               KL     +F +  +TS   G+   E ++   +  + D F     +  +L G+    
Sbjct: 230 SIDMKLFPKGTIFTAKCETS---GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY--- 283

Query: 395 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               +  ++   E   +   +         +   + L     D  + P+++ + ++L
Sbjct: 284 ----MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML--NIPDCHHLPSLDLLRQKL 334

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 247
            LGKG F+  ++ +      + A + +  +              + +  SL H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           GF         F++ +   +  L +   +   +  + +   R   +  I  G  YLH + 
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 161

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 364
           V     +HR+L +  + +++     I D GL   +  D      K     G   Y+APE 
Sbjct: 162 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 212

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 420
           ++    +   D+++ G I+  +L G        +   E++  +    R  K ++S     
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 264

Query: 421 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           +  A   + KM L     DP  RPT+  ++ 
Sbjct: 265 NPVAASLIQKM-LQ---TDPTARPTINELLN 291

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 43/272 (15%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 243
            LGKG F +VY    +    ++A++ +     KS+  +      L     + + LRH NI
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLF----KSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +R+  +   R R   +L+ +FAP+G+L K L Q+ G  +  +  +  + +  +A  + Y 
Sbjct: 77  LRMYNYFHDRKR--IYLMLEFAPRGELYKEL-QKHGRFD--EQRSA-TFMEELADALHYC 130

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAP 362
           H  +V     +HR++  E +L+  +    IAD G              +T    + YL P
Sbjct: 131 HERKV-----IHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPP 181

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 419
           E +      E+ D++  GV+  + L G            +S +      R +        
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG--------MPPFDSPSHTETHRRIVNVDLKFPP 233

Query: 420 --ESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                +  L    L      P  R  ++ V+E
Sbjct: 234 FLSDGSKDLISKLLR---YHPPQRLPLKGVME 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 89.8 bits (223), Expect = 7e-20
 Identities = 40/301 (13%), Positives = 99/301 (32%), Gaps = 60/301 (19%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSIN------------VTSCKSEEAEFVKGLY----LL 235
           L +G F+ +     +D    A++                 + K               ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVS 291
           T +++E  +   G   +      ++IY++     + K+ +     ++  +  +       
Sbjct: 98  TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           II  +     Y+H+    +  I HR++    +L+D+     ++D G  + + D      +
Sbjct: 156 IIKSVLNSFSYIHN----EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKI 207

Query: 352 KTSAAMG---YLAPEYVTTGRFT--ERSDIFAFGVIILQILTGSL--------------V 392
           K S   G   ++ PE+ +        + DI++ G+ +  +    +              +
Sbjct: 208 KGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265

Query: 393 LTSSMRLAAESATFENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVI 448
            T ++    +   F   +        +   S      L          +P  R T E  +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK----NPAERITSEDAL 321

Query: 449 E 449
           +
Sbjct: 322 K 322

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 90.3 bits (224), Expect = 7e-20
 Identities = 49/288 (17%), Positives = 109/288 (37%), Gaps = 49/288 (17%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--EN 242
           +S +  +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           IIRL  +         +++ +      L+ +L +++ S   +D   R S    + + +  
Sbjct: 118 IIRLYDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHT 170

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 359
           +H        IVH +L     LI       + D G+   +  D    V  +    G   Y
Sbjct: 171 IHQHG-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GAVNY 222

Query: 360 LAPE-----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESAT 405
           + PE             +  + + +SD+++ G I+  +  G      + + +      + 
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SK 276

Query: 406 FENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
               ID N + +F +   +  +  L    L     DP+ R ++  ++ 
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCC-LK---RDPKQRISIPELLA 320

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 247
            LGKG F+  ++ +      + A + +  +              + +  SL H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
           GF         F++ +   +  L +   +   +  + +   R   +  I  G  YLH + 
Sbjct: 82  GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 135

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 364
           V     +HR+L +  + +++     I D GL   +  D      K     G   Y+APE 
Sbjct: 136 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 186

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 420
           ++    +   D+++ G I+  +L G        +   E++  +    R  K ++S     
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 238

Query: 421 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           +  A   + KM L     DP  RPT+  ++ 
Sbjct: 239 NPVAASLIQKM-LQ---TDPTARPTINELLN 265

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 64/291 (21%), Positives = 103/291 (35%), Gaps = 47/291 (16%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
            +LG G+  +V       G  VA++ + +  C     E +K   L  S  H N+IR   +
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME-IK--LLTESDDHPNVIRY--Y 75

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR---VSIIIGIAKGIGYLHSS 306
           C        ++  +      L   ++ +  S   L        +S++  IA G+ +LHS 
Sbjct: 76  CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133

Query: 307 EVNKPAIVHRNLSVEKVLID-------------QQFNPLIADCGLHKLLADDIVFSVLKT 353
              K  I+HR+L  + +L+              +    LI+D GL K L           
Sbjct: 134 --LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 354 SAAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
           +   G   + APE         T  R T   DIF+ G +   IL+         + + ES
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRES 248

Query: 404 ATFE---NFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIE 449
                  +  +       S    A      L+      DP  RPT   V+ 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEAT----DLISQMIDHDPLKRPTAMKVLR 295

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 44/274 (16%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 243
           LLGKG+F+ VY+   +  G  VAI+ I+    K    +A  V+ +     +   L+H +I
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMID----KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           + L  +         +L+ +    G++++YL          +   R   +  I  G+ YL
Sbjct: 74  LELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKP--FSENEAR-HFMHQIITGMLYL 128

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTS-AAMGYLA 361
           HS  +     +HR+L++  +L+ +  N  IAD GL  +L           T      Y++
Sbjct: 129 HSHGI-----LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTPNYIS 180

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE- 420
           PE  T       SD+++ G +   +L G        R   ++ T +N +++ +   +   
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG--------RPPFDTDTVKNTLNKVVLADYEMP 232

Query: 421 ---SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
              S  AK  + ++ L     +P +R ++ +V++
Sbjct: 233 SFLSIEAKDLIHQL-LR---RNPADRLSLSSVLD 262

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 36/230 (15%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F E+ +LG+G F  V K     D    AI+ I  T  + + +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVV 65

Query: 245 RLRGFCCSRGRGEC-----------FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           R       R                F+  ++   G L   +  E  +           + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYWRLF 122

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             I + + Y+HS       I+HR+L    + ID+  N  I D GL K +   +    L +
Sbjct: 123 RQILEALSYIHS---QG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 354 SAAMG-------------YLAPEYVT-TGRFTERSDIFAFGVIILQILTG 389
               G             Y+A E +  TG + E+ D+++ G+I  +++  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 36/297 (12%), Positives = 69/297 (23%), Gaps = 51/297 (17%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN----- 242
            L  G+ S V+     +     A++   + +  S        +  +    L  E+     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 243 -------------------IIRLRGFCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSS 281
                                +L             L+   A      L   LD      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 282 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 341
                     +   + +    L S       +VH + + + + I      ++ D     L
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG-----LVHGHFTPDNLFIMPDGRLMLGDVSA--L 241

Query: 342 LADDIVFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSL-----VLT 394
                            Y   E++   T  FT   + +  G+ I ++    L        
Sbjct: 242 WKVGTRGPASSVPVT--YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 395 SSMRLAAESATFENFIDRNLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
                   S                  +  K  +G+  L     D   R      +E
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-LNF---DRRRRLLPLEAME 352

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 51/284 (17%), Positives = 100/284 (35%), Gaps = 43/284 (15%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-R 239
           T  F E+  +G G F SV+K     DG + AI+        S +E   ++ +Y    L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H +++R              +  ++   G L+  + +     +    +    +++ + +G
Sbjct: 70  HSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 300 IGYLHSSEVNKPAIVHR-----N--LSVEKVLIDQQFNPLIADCGLHKL---LAD-DIVF 348
           + Y+HS       +VH      N  +S   +           D   +K+   + D   V 
Sbjct: 128 LRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 349 SVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
            +       G   +LA E +        ++DIFA  + ++              L     
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-------EPLPRNGD 235

Query: 405 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPT 443
            +        +G+        S+     ++  V  H DPE RP+
Sbjct: 236 QWHEIR----QGRLPRIPQVLSQEFT--ELLKVMIHPDPERRPS 273

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 44/302 (14%), Positives = 85/302 (28%), Gaps = 65/302 (21%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE---------------------- 227
           +LG+ +  +  + T    G    +     T      A                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 228 -----FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA--PKGKLSKYLDQEEGS 280
                F+    L+   + + +IR+R           F +Y           + L     +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 281 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
              L    R+ + + + + +  LH        +VH  L    +++DQ+    +       
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 341 LLADDIVFSVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTG 389
                +V SV     + G+  PE                  T   D +A G++I  I   
Sbjct: 255 RDGARVVSSV-----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 390 SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAV 447
            L +T      A     E       +   +  +  +    AL+        E+R      
Sbjct: 310 DLPITKD----AALGGSE----WIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQA 357

Query: 448 IE 449
           +E
Sbjct: 358 ME 359

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 38/301 (12%), Positives = 77/301 (25%), Gaps = 64/301 (21%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA----------------------- 226
           +LG+ +  +  + T    G    +     T      A                       
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 227 ----EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGS 280
                F+    L+   + + +IR+R           F +Y           + L     +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 281 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
              L    R+ + + + + +  LH        +VH  L    +++DQ+    +       
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 341 LLADDIVFSVLKTSAAMGYLAPEYVT----------TGRFTERSDIFAFGVIILQILTGS 390
                 V     +    G+  PE                 T   D +  G+ I  I    
Sbjct: 260 RDGASAV-----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA- 313

Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVI 448
                   L           +   +   +  +  +    AL+        E+R      +
Sbjct: 314 -------DLPNTDDAALGGSEWIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQAM 362

Query: 449 E 449
           E
Sbjct: 363 E 363

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 64/285 (22%), Positives = 107/285 (37%), Gaps = 65/285 (22%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LG G +  V     +      AI+ I  TS  +     +   + +L  L H NI++L  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 250 C------------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
                           G GE  L  +   + K +     E  ++          II  + 
Sbjct: 105 FEDKRNYYLVMECYK-G-GE--LFDEIIHRMKFN-----EVDAAV---------IIKQVL 146

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            G+ YLH        IVHR+L  E +L+   ++     I D GL  +  +         +
Sbjct: 147 SGVTYLHKH-----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201

Query: 355 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 414
           A   Y+APE V   ++ E+ D+++ GVI+  +L G            +       +    
Sbjct: 202 A--YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILRK-V---E 250

Query: 415 KGKF--------SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           KGK+        + SE AK  + +M L     D + R + +  +E
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQM-LQ---FDSQRRISAQQALE 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 75/318 (23%), Positives = 121/318 (38%), Gaps = 81/318 (25%)

Query: 167 EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE 225
            H +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 226 AEFVKG-LYLLTSLRHENIIRLRGFC------------CSRGRGECFLIYDFAPKGKLSK 272
              +   + LL  L H NI++L                 + G GE  L  +   + + S 
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT-G-GE--LFDEIIKRKRFS- 119

Query: 273 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQF 329
               E  ++          II  +  GI Y+H        IVHR+L  E +L+   ++  
Sbjct: 120 ----EHDAAR---------IIKQVFSGITYMHKH-----NIVHRDLKPENILLESKEKDC 161

Query: 330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           +  I D GL      +        +A   Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 162 DIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

Query: 390 SLVLTSSMRLAAESATFENFIDRNLKGKFSE----------------SEAAK--LGKMAL 431
           +                  F  +N                       S+ AK  + KM L
Sbjct: 219 TP----------------PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM-L 261

Query: 432 VCTHEDPENRPTMEAVIE 449
                 P  R T    +E
Sbjct: 262 TF---HPSLRITATQCLE 276

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 59/268 (22%), Positives = 120/268 (44%), Gaps = 37/268 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +   +       + ++I ++   G     L+        LD +   +I+  I KG+ YLH
Sbjct: 84  KY--YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH 136

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S        +HR++    VL+ +     +AD G+   L D    + +K +  +G   ++A
Sbjct: 137 SE-----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFWMA 187

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENFIDRN----LK 415
           PE +    +  ++DI++ G+  +++  G         M+       F   I +N    L+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLF--LIPKNNPPTLE 240

Query: 416 GKFSESEAAKLGKMALVCTHEDPENRPT 443
           G +S+     L +    C +++P  RPT
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPT 264

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 243
           LG G    V     R     VAIR I+        + EA+    +     +L  L H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           I+++ F  +    + +++ +    G+L      +K L +                   + 
Sbjct: 203 IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 249

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 354
             + YLH +      I+HR+L  E VL+  Q       I D G  K+L +    S+++T 
Sbjct: 250 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 301

Query: 355 A-AMGYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
                YLAPE    V T  +    D ++ GVI+   L+G    +                
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 354

Query: 411 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           D+   GK++         SE A   + K+ +V    DP+ R T E  + 
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 399

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 51/276 (18%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYL----LTSLRHENI 243
           LG G F  V+          V ++ I    V      E   +  + L    L+ + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGK-LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I++     ++G     L+ +    G  L  ++D+       LD      I   +   +GY
Sbjct: 92  IKVLDIFENQG--FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLA 361
           L         I+HR++  E ++I + F   + D G    L       +  T    + Y A
Sbjct: 146 LRLK-----DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCA 197

Query: 362 PEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
           PE V  G        ++++ GV +  ++                  F    +  ++    
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN-------------PFCEL-EETVEAAIH 242

Query: 420 E----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
                S+     +  +        PE R T+E ++ 
Sbjct: 243 PPYLVSKELMSLVSGLLQP----VPERRTTLEKLVT 274

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 42/271 (15%)

Query: 192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           +GKGNF+ V     +  G  VAI+ I+ T       + +   + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                    +LI ++A  G++  YL         +      S    I   + Y H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK--- 133

Query: 310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 366
              IVHR+L  E +L+D   N  IAD G             L      G   Y APE + 
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC--GAPPYAAPE-LF 185

Query: 367 TGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 420
            G+  +    D+++ GVI+  +++GSL          +    +   +R L+GK+      
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYM 237

Query: 421 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           S   +  L +  ++    +P  R T+E +++
Sbjct: 238 STDCENLLKRFLVL----NPIKRGTLEQIMK 264

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 61/283 (21%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LGKG+F  V K   R      A++ IN  S K+++   +   + LL  L H NI++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                    +++ +    G+L    D+  +    +  D +    II  +  GI Y+H   
Sbjct: 90  LED--SSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141

Query: 308 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                IVHR+L  E +L+   ++  +  I D GL      +        +A   Y+APE 
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE- 193

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--------LKG 416
           V  G + E+ D+++ GVI+  +L+G                   F  +N          G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG----------------TPPFYGKNEYDILKRVETG 237

Query: 417 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           K+          S+ AK  + KM L      P  R T    +E
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKM-LTF---HPSLRITATQCLE 276

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 25/207 (12%)

Query: 190 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
             +G+G+F  V++    + G   A++ + +   + EE      L     L    I+ L G
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSPRIVPLYG 117

Query: 249 FCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                  G    I+ +    G L + + ++ G    L     +  +    +G+ YLH+  
Sbjct: 118 AVRE---GPWVNIFMELLEGGSLGQLI-KQMGC---LPEDRALYYLGQALEGLEYLHTRR 170

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAM-G---YLAP 362
                I+H ++  + VL+    +   + D G    L  D +   L T   + G   ++AP
Sbjct: 171 -----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTG 389
           E V       + DI++   ++L +L G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 35/295 (11%)

Query: 168 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA 226
           H +S R NL    +    F     LG G F  V+    R  G    I++IN    +    
Sbjct: 6   HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65

Query: 227 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           +    + +L SL H NII++            +++ +    G+L + +   +     L  
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLA 343
                ++  +   + Y HS       +VH++L  E +L           I D GL +L  
Sbjct: 124 GYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
            D   +    +A   Y+APE V     T + DI++ GV++  +LTG L  T +    +  
Sbjct: 179 SDEHSTNAAGTA--LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT----SLE 231

Query: 404 ATFENFIDRNLKGKF---SE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
              +         +     E    +  A   L +M L     DPE RP+   V+ 
Sbjct: 232 EVQQKA----TYKEPNYAVECRPLTPQAVDLLKQM-LTK---DPERRPSAAQVLH 278

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 52/279 (18%)

Query: 192 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA-EFVKG-LYLLTSLRHENIIRLRG 248
           LGKG+F  V     +  G   A++ I+    K +   E +   + LL  L H NI++L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQ-----EEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           F   +G    +L+ +    G+L   +       E  ++          II  +  GI Y+
Sbjct: 94  FFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAAR---------IIRQVLSGITYM 142

Query: 304 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 360
           H +      IVHR+L  E +L+    +  N  I D GL               +A   Y+
Sbjct: 143 HKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA--YYI 195

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 418
           APE V  G + E+ D+++ GVI+  +L+G      +     E    +  +    KGK+  
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKK-V---EKGKYTF 246

Query: 419 ------SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
                   SE+AK  + KM L      P  R +    ++
Sbjct: 247 ELPQWKKVSESAKDLIRKM-LT---YVPSMRISARDALD 281

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 66/288 (22%), Positives = 110/288 (38%), Gaps = 71/288 (24%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LG G FS V+    R  G L A++ I  +    + +     + +L  ++HENI+ L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-LENEIAVLKKIKHENIVTLEDI 74

Query: 250 CCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
             S      +L+      G+L         Y   E+ +S          +I  +   + Y
Sbjct: 75  YESTT--HYYLVMQLVSGGELFDRILERGVY--TEKDASL---------VIQQVLSAVKY 121

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGY 359
           LH +      IVHR+L  E +L         + I D GL K+  + I+ +   T    GY
Sbjct: 122 LHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT---PGY 173

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN------ 413
           +APE +    +++  D ++ GVI   +L G                +  F +        
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG----------------YPPFYEETESKLFE 217

Query: 414 --LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
              +G +   S      SE+AK  +  + L     DP  R T E  + 
Sbjct: 218 KIKEGYYEFESPFWDDISESAKDFICHL-LEK---DPNERYTCEKALS 261

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 85/294 (28%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLRHE--N 242
           LLG G F SVY G  + D   VAI+ +                    + LL  +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 243 IIRLRGFCCSR-----------GRGECFLIYDF-APKGKLS-----KYLDQEEGSSNVLD 285
           +IRL  +                  + F   DF   +G L       +  Q         
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLF---DFITERGALQEELARSFFWQ--------- 157

Query: 286 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD 344
                     + + + + H+       ++HR++  E +LID     L + D G   LL D
Sbjct: 158 ----------VLEAVRHCHNC-----GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202

Query: 345 DIVFSVLKTSAAMG---YLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 400
               +V       G   Y  PE++   R+    + +++ G+++  ++ G +         
Sbjct: 203 ----TVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--------- 247

Query: 401 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                FE+  +  ++G+        SE   L +  L      P +RPT E +  
Sbjct: 248 ----PFEH-DEEIIRGQVFFRQRVSSECQHLIRWCLA---LRPSDRPTFEEIQN 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 20/206 (9%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LGKG +  VY G  L +   +AI+ I             + + L   L+H+NI++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 250 CCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
                      I+ +  P G LS  L  + G     + +        I +G+ YLH ++ 
Sbjct: 88  FSEN---GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ- 142

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD--DIVFSVLKTSAAMGYLAPEYV 365
               IVHR++  + VLI+     L I+D G  K LA       +   T   M   APE +
Sbjct: 143 ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM---APEII 195

Query: 366 TTGR--FTERSDIFAFGVIILQILTG 389
             G   + + +DI++ G  I+++ TG
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATG 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 53/294 (18%), Positives = 96/294 (32%), Gaps = 83/294 (28%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG---------LYLLTSLRH 240
           LLGKG F +V+ G  L D   VAI+ I                          +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 241 ENIIRLRGFCCSRGR-----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNV 283
             +IRL  +  ++              + F   D+   KG L       +  Q       
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLF---DYITEKGPLGEGPSRCFFGQ------- 147

Query: 284 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 342
                       +   I + HS       +VHR++  E +LID +     + D G   LL
Sbjct: 148 ------------VVAAIQHCHSR-----GVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

Query: 343 ADDIVFSVLKTSA-AMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 400
            D               Y  PE+++  ++    + +++ G+++  ++ G +         
Sbjct: 191 HD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI--------- 237

Query: 401 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                FE      L+ +         +   L +  L      P +RP++E ++ 
Sbjct: 238 ----PFER-DQEILEAELHFPAHVSPDCCALIRRCLA---PKPSSRPSLEEILL 283

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 76.0 bits (187), Expect = 8e-15
 Identities = 47/302 (15%), Positives = 91/302 (30%), Gaps = 89/302 (29%)

Query: 191 LLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHEN 242
            +  G    +Y       +G  V ++ +  +           E +F      L  + H +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF------LAEVVHPS 140

Query: 243 IIRLRGFCCSRGRGECFLIYDF----APKGKLSKYLDQE--EGSS------NVLDWSTRV 290
           I++               I++F       G    Y+  E   G S        L  +  +
Sbjct: 141 IVQ---------------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
           + ++ I   + YLHS       +V+ +L  E +++ ++    + D G         V  +
Sbjct: 186 AYLLEILPALSYLHSI-----GLVYNDLKPENIMLTEE-QLKLIDLG--------AVSRI 231

Query: 351 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL--------VLTSSMRL 399
                  G   + APE +     T  +DI+  G  +  +              L     +
Sbjct: 232 NSFGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV 290

Query: 400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL-TVAAPV 457
                ++   + R                        DP  R  T E +  +L  V   V
Sbjct: 291 LKTYDSYGRLLRR--------------------AIDPDPRQRFTTAEEMSAQLTGVLREV 330

Query: 458 MA 459
           +A
Sbjct: 331 VA 332

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 243
           LG G    V     R     VAI+ I+        + EA+    +     +L  L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           I+++ F  +    + +++ +    G+L      +K L +                   + 
Sbjct: 78  IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 124

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 354
             + YLH +      I+HR+L  E VL+  Q       I D G  K+L +    S+++T 
Sbjct: 125 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 176

Query: 355 AAM-GYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
                YLAPE    V T  +    D ++ GVI+   L+G    +                
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 229

Query: 411 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           D+   GK++         SE A   + K+ +V    DP+ R T E  + 
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + + + ++    +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 250 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
              +     +L++D    G+L       ++  + + S            I  I + I Y 
Sbjct: 74  I--QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 121

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 360
           HS+      IVHRNL  E +L+  +     + +AD GL   + D   +     +   GYL
Sbjct: 122 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 174

Query: 361 APEYVTTGRFTERSDIFAFGVI--IL 384
           +PE +    +++  DI+A GVI  IL
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYIL 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 67/301 (22%), Positives = 106/301 (35%), Gaps = 82/301 (27%)

Query: 190 NLLGKGNFSSVYKGTLR-DGTLVAIRSIN------------VTSCKSEEAEFVKGLYLLT 236
             LG G +  V     +   +  AI+ I               + +    E    + LL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTR 289
           SL H NII+L      +     +L+ +F   G+L        K+   E  ++N       
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKF--DECDAAN------- 150

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDI 346
             I+  I  GI YLH        IVHR++  E +L+   +   N  I D GL    + D 
Sbjct: 151 --IMKQILSGICYLHKH-----NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 406
                  +A   Y+APE V   ++ E+ D+++ GVI+  +L G                 
Sbjct: 204 KLRDRLGTA--YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP--------------- 245

Query: 407 ENFIDRNLKGKFSE----------------SEAAK--LGKMALVCTHEDPENRPTMEAVI 448
             F  +N +    +                S+ AK  +  M L     D   R T E  +
Sbjct: 246 -PFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM-LT---YDYNKRCTAEEAL 300

Query: 449 E 449
            
Sbjct: 301 N 301

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 58/226 (25%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--------EAEFVKGLYLLTSLRHE 241
            LG G  S+VY          VAI++I +   + E        E          + L H+
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS------SQLSHQ 71

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGK-------------LSKYLDQEEGSSNVLDWST 288
           NI+                + D   +               LS+Y+ +  G    L   T
Sbjct: 72  NIVS---------------MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP---LSVDT 112

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 348
            ++    I  GI + H        IVHR++  + +LID      I D G+ K L++    
Sbjct: 113 AINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET--- 164

Query: 349 SVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           S+ +T+  +G   Y +PE        E +DI++ G+++ ++L G  
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 63/283 (22%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
            LG G F  V  G     G  VA++ +N    K    + V  +      L   RH +II+
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L  +       + F++ ++   G+L  Y+ +       ++      +   I   + Y H 
Sbjct: 76  L--YQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHR 129

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 362
                  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS   G   Y AP
Sbjct: 130 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 179

Query: 363 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 414
           E V +GR       DI++ GVI+  +L G+L                 F D ++      
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTL----------------PFDDEHVPTLFKK 222

Query: 415 --KGKFSE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
              G F      + +    L  M  V    DP  R T++ + E
Sbjct: 223 IRGGVFYIPEYLNRSVATLLMHMLQV----DPLKRATIKDIRE 261

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 51/305 (16%), Positives = 116/305 (38%), Gaps = 26/305 (8%)

Query: 162 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS 220
             F  +      L  ++ E       +++ LG GN   V+K + +  G ++A + I++  
Sbjct: 18  EAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70

Query: 221 CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG- 279
             +   + ++ L +L       I+   G       GE  +  +    G L + L +    
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYG--AFYSDGEISICMEHMDGGSLDQVLKKAGRI 128

Query: 280 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 339
              +L       + I + KG+ YL      K  I+HR++    +L++ +    + D G+ 
Sbjct: 129 PEQIL-----GKVSIAVIKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 399
             L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G   +      
Sbjct: 180 GQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

Query: 400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 459
             E            +         +      + +         ++ ++ E     P + 
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE---PPPKLP 293

Query: 460 TFLFS 464
           + +FS
Sbjct: 294 SGVFS 298

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 59/272 (21%), Positives = 105/272 (38%), Gaps = 40/272 (14%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LG G F  V++ T R  G   A + +        + E V+  +  ++ LRH  ++ L   
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                  E  +IY+F   G+L + +  E    +  +    V  +  + KG+ ++H +   
Sbjct: 223 FEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHENN-- 275

Query: 310 KPAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
               VH +L  E ++   ++ N L + D GL   L       V   +A   + APE    
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEG 330

Query: 368 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---SE---- 420
                 +D+++ GV+   +L+G     S      +  T  N         +         
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG----LSPFGGENDDETLRNV----KSCDWNMDDSAFSG 382

Query: 421 -SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
            SE  K  + K+ L+    DP  R T+   +E
Sbjct: 383 ISEDGKDFIRKL-LL---ADPNTRMTIHQALE 410

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 69/300 (23%), Positives = 106/300 (35%), Gaps = 83/300 (27%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS-----LR----HE 241
           LG+G  S V +   +      A++ I+VT   S  AE V+ L   T      LR    H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIG 295
           NII+L+    +      FL++D   KG+L         L ++E             I+  
Sbjct: 85  NIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRK----------IMRA 132

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + + I  LH        IVHR+L  E +L+D   N  + D G    L        +  + 
Sbjct: 133 LLEVICALHKL-----NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 356 AMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFE 407
              YLAPE            + +  D+++ GVI   L  L G                  
Sbjct: 188 --SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAG----------------SP 227

Query: 408 NFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
            F  R         + G +   S      S+  K  + +  +V     P+ R T E  + 
Sbjct: 228 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV----QPQKRYTAEEALA 283

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 57/301 (18%), Positives = 97/301 (32%), Gaps = 91/301 (30%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 246
           LLG+G++  V +          A++ +    +    + EA   K + LL  LRH+N+I+L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 247 RGFC--------------CSRGRGECFLIYDFAPKGKLS-----KYLDQEEGSSNVLDWS 287
                             C  G  E     D  P+ +        Y  Q           
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQ----------- 117

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
               +I G+     YLHS       IVH+++    +L+       I+  G+ + L     
Sbjct: 118 ----LIDGLE----YLHSQ-----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 348 FSVLKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAE 402
               +TS   G   +  PE           + DI++ GV +  I TG             
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY----------- 211

Query: 403 SATFENFIDRNL--------KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVI 448
                 F   N+        KG ++         + L   M       +P  R ++  + 
Sbjct: 212 -----PFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEY----EPAKRFSIRQIR 262

Query: 449 E 449
           +
Sbjct: 263 Q 263

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LGKG FS V +   +  G   A + IN     + + + ++    +   L+H NI+RL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 250 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
                    +L++D    G+L       ++  + + S            I  I + I Y 
Sbjct: 97  IQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 144

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 360
           HS+      IVHRNL  E +L+  +     + +AD GL   + D   +     +   GYL
Sbjct: 145 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 197

Query: 361 APEYVTTGRFTERSDIFAFGVI--IL 384
           +PE +    +++  DI+A GVI  IL
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYIL 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 34/217 (15%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK------SEEAEFVKGLYL----LTSLR 239
           +LG G  S V+    LRD   VA+        K      + +  F            +L 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAV--------KVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 240 HENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           H  I+ +   G   +      +++ ++     L   +   EG    +     + +I    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP---MTPKRAIEVIADAC 126

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
           + + + H +      I+HR++    ++I       + D G+ + +AD    SV +T+A +
Sbjct: 127 QALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVI 180

Query: 358 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
           G   YL+PE         RSD+++ G ++ ++LTG  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 45/278 (16%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LG G    V +   R  G   A++ +  +    +E +     +   +    +I+ +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD-----HHWQASGGPHIVCILDV 90

Query: 250 CCSRGRGEC--FLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYL 303
             +   G+    +I +    G+L       QE G      ++ R    I+  I   I +L
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQA---FTEREAAEIMRDIGTAIQFL 144

Query: 304 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 360
           HS       I HR++  E +L    ++     + D G  K    + + +   T     Y+
Sbjct: 145 HSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP---YYV 196

Query: 361 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 418
           APE +   ++ +  D+++ GVI+  +L G     S+       A       R   G++  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN----TGQAISPGMKRRIRLGQYGF 252

Query: 419 -SE-----SEAAK-LGKMALVCTHEDPENRPTMEAVIE 449
            +      SE AK L ++ L     DP  R T+   + 
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKT---DPTERLTITQFMN 287

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 79/292 (27%)

Query: 191 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRG 248
            LG+G  S VY+   +      A++ +     K+ + + V+  + +L  L H NII+L+ 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 249 FCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
              +    E  L+ +    G+L         Y   E  +++          +  I + + 
Sbjct: 116 IFETPT--EISLVLELVTGGELFDRIVEKGYY--SERDAAD---------AVKQILEAVA 162

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AM 357
           YLH +      IVHR+L  E +L        PL IAD GL K++       ++KT     
Sbjct: 163 YLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTP 214

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN-- 413
           GY APE +    +    D+++ G+I  IL  L G                FE F D    
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYIL--LCG----------------FEPFYDERGD 256

Query: 414 -------LKGKF---SE-----SEAAK-LGKMALVCTHEDPENRPTMEAVIE 449
                  L  ++   S      S  AK L +  +V    DP+ R T    ++
Sbjct: 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL---DPKKRLTTFQALQ 305

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 64/276 (23%), Positives = 121/276 (43%), Gaps = 29/276 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +    ++G G  + V           VAI+ IN+  C++   E +K +  ++   H NI+
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLS----KYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
               +     + E +L+      G +       + + E  S VLD ST  +I+  + +G+
Sbjct: 77  SY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-G- 358
            YLH +       +HR++    +L+ +  +  IAD G+   LA     +  K      G 
Sbjct: 135 EYLHKN-----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 359 --YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS--LVLTSSMR---LAAESAT---FE 407
             ++APE +   R +  ++DI++FG+  +++ TG+        M+   L  ++       
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
              D+ +  K+ +S      KM  +C  +DPE RPT
Sbjct: 250 GVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPT 281

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 41/277 (14%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 246
           +GKG FS V +   R+ G   A++ ++V    S      + L     +   L+H +I+ L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 306
                S   G  +++++F     L   + +   +  V   +     +  I + + Y H +
Sbjct: 92  LETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 307 EVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGL-HKLLADDIVFSVLKTSAAMGYLAP 362
                 I+HR++    VL+  + N  P+ +   G+  +L    +V      +    ++AP
Sbjct: 150 N-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP--HFMAP 202

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---S 419
           E V    + +  D++  GVI+  +L+G L    +     +   FE  I   +KGK+    
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEG-I---IKGKYKMNP 253

Query: 420 E-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
                 SE+AK  + +M L+    DP  R T+   + 
Sbjct: 254 RQWSHISESAKDLVRRM-LML---DPAERITVYEALN 286

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 52/284 (18%), Positives = 95/284 (33%), Gaps = 65/284 (22%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G+G++  V     +      A + I     +  +  F + + ++ SL H NIIRL    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYETF 75

Query: 251 ------------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
                       C+ G GE F       K         E  ++          I+  +  
Sbjct: 76  EDNTDIYLVMELCT-G-GELF--ERVVHKRVFR-----ESDAAR---------IMKDVLS 117

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
            + Y H        + HR+L  E  L           + D GL        +      + 
Sbjct: 118 AVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 415
              Y++P+ V  G +    D ++ GV++  +L G    ++      +S      I    +
Sbjct: 173 --YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP----TDSEVMLK-I---RE 221

Query: 416 GKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           G F    +     S  A+  + ++ L      P+ R T    +E
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRRL-LTK---SPKQRITSLQALE 261

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 74/283 (26%), Positives = 110/283 (38%), Gaps = 63/283 (22%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
            LG G F  V  G     G  VA++ +N    K    + V  +      L   RH +II+
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L  +       + F++ ++   G+L  Y+ +       LD      +   I  G+ Y H 
Sbjct: 81  L--YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHR 134

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 362
                  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS   G   Y AP
Sbjct: 135 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 184

Query: 363 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 414
           E V +GR       DI++ GVI+  +L G+L                 F D ++      
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTL----------------PFDDDHVPTLFKK 227

Query: 415 --KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 449
              G F            L   M  V    DP  R T++ + E
Sbjct: 228 ICDGIFYTPQYLNPSVISLLKHMLQV----DPMKRATIKDIRE 266

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
            LG+G +  V           VA++ ++         +  + +     +   L HEN+++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 246 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 289
             G                 GE F   D   P   +      ++  Q             
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
              ++    G+ YLH        I HR++  E +L+D++ N  I+D GL  +   +    
Sbjct: 114 ---LMA---GVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 350 VLKTSAAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSL 391
           +L      G   Y+APE +   R    E  D+++ G+++  +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 63/330 (19%), Positives = 118/330 (35%), Gaps = 79/330 (23%)

Query: 192 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 244
           LG+G F  V +              VA++ +   +  SE    +  L +L  +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL---------------DQEEGSSNV------ 283
            L G  C++  G   +I +F   G LS YL                  +G   V      
Sbjct: 90  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148

Query: 284 ------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN-------------------- 317
                    S++ S   G  +        E   P  ++++                    
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 318 ----------LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAPEY 364
                     L+   +L+ ++    I D GL + +  D  +  ++   A     ++APE 
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPET 266

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---RNLKGKFSES 421
           +    +T +SD+++FGV++ +I +        +++  E   F   +    R     ++  
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTP 323

Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           E  +   M L C H +P  RPT   ++E L
Sbjct: 324 EMYQT--M-LDCWHGEPSQRPTFSELVEHL 350

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
            LG+G +  V           VA++ ++         +  + +     +   L HEN+++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 246 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 289
             G                 GE F   D   P   +      ++  Q             
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
             ++ G+     YLH        I HR++  E +L+D++ N  I+D GL  +   +    
Sbjct: 114 --LMAGVV----YLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 350 VLKTSAAMG---YLAPEYVTTGRF--TERSDIFAFGVIILQILTGSL 391
           +L      G   Y+APE +   R    E  D+++ G+++  +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 61/286 (21%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 245
           LG G F+ V K   +  G   A + I     ++      +         L  + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           L     +R   +  LI +    G+L       + L +EE +S           I  I  G
Sbjct: 80  LHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEATS----------FIKQILDG 127

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSA 355
           + YLH+ +     I H +L  E +++  +  P+    + D GL   + D + F  +  + 
Sbjct: 128 VNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              ++APE V        +D+++ GVI  IL  L+G     S      +  T  N I   
Sbjct: 183 --EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I--- 230

Query: 414 LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
               +    E     SE AK  + K+ LV    +   R T++  + 
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKL-LVK---ETRKRLTIQEALR 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 51/281 (18%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 245
           LG G F+ V K   +  G   A + I     ++      +         L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 304
           L     +R   +  LI +    G+L  +L Q+E  S         +  I  I  G+ YLH
Sbjct: 80  LHDVYENRT--DVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLH 132

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYL 360
           + +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++
Sbjct: 133 TKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFV 185

Query: 361 APEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           APE V        +D+++ GVI  IL  L+G     S      +  T  N I       +
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I---TSVSY 235

Query: 419 ---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
               E     SE AK  + K+ LV   ++   R T++  + 
Sbjct: 236 DFDEEFFSHTSELAKDFIRKL-LV---KETRKRLTIQEALR 272

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 94/298 (31%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 245
            LG+G+F  V   T  +    VA++ I+      ++++    +      L  LRH +II+
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 246 LRGFCCSRGR---------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTRV 290
           L     +            GE F   D+   K +++     ++  Q              
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELF---DYIVEKKRMTEDEGRRFFQQ-------------- 116

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
                I   I Y H        IVHR+L  E +L+D   N  IAD GL  ++ D    + 
Sbjct: 117 -----IICAIEYCHRH-----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NF 163

Query: 351 LKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 405
           LKTS   G   Y APE V  G+       D+++ G+++  +L G L              
Sbjct: 164 LKTSC--GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRL-------------- 206

Query: 406 FENFIDRNL--------KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 449
              F D  +           +         A  L  +M +     DP  R T++ +  
Sbjct: 207 --PFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA----DPMQRITIQEIRR 258

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 56/271 (20%), Positives = 106/271 (39%), Gaps = 38/271 (14%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G F  V++   +  G +   + IN      +       + ++  L H  +I L    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117

Query: 251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 310
             +   E  LI +F   G+L   +  E+   +  +    ++ +    +G+ ++H      
Sbjct: 118 EDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEHS--- 169

Query: 311 PAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 368
             IVH ++  E ++   ++ + + I D GL   L  D +  V   +A   + APE V   
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDRE 225

Query: 369 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSE------ 420
                +D++A GV+   +L+G     S      +  T +N      +    F E      
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG----LSPFAGEDDLETLQNV----KRCDWEFDEDAFSSV 277

Query: 421 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           S  AK  +  + L    ++P  R T+   +E
Sbjct: 278 SPEAKDFIKNL-LQ---KEPRKRLTVHDALE 304

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 67/291 (23%), Positives = 106/291 (36%), Gaps = 75/291 (25%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LGKG FS V +      G   A   IN     + + + ++    +   L+H NI+RL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 250 CCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
                 G  +LI+D    G+L         Y   E  +S+          I  I + + +
Sbjct: 79  ISE--EGHHYLIFDLVTGGELFEDIVAREYY--SEADASH---------CIQQILEAVLH 125

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AMG 358
            H        +VHRNL  E +L+  +     + +AD GL   +  +         A   G
Sbjct: 126 CHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178

Query: 359 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN--- 413
           YL+PE +    + +  D++A GVI  IL  L G                +  F D +   
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYIL--LVG----------------YPPFWDEDQHR 220

Query: 414 -----LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
                  G +   S      +  AK  + KM L     +P  R T    ++
Sbjct: 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKM-LTI---NPSKRITAAEALK 267

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 60/227 (26%)

Query: 191 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCK------SEEAEFVKGL----YLLTS 237
           L+G+G    VY+    D      VA+        K      S +  F   +         
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVAL--------KLMSETLSSDPVFRTRMQREARTAGR 90

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EGSS--------NVLDWS 287
           L+  +++                I+DF        Y+D     G            L   
Sbjct: 91  LQEPHVVP---------------IHDFGEIDGQL-YVDMRLINGVDLAAMLRRQGPLAPP 134

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             V+I+  I   +   H++        HR++  E +L+       + D G+     D+  
Sbjct: 135 RAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187

Query: 348 FSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
             + +    +G   Y+APE  +    T R+DI+A   ++ + LTGS 
Sbjct: 188 -KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 43/327 (13%), Positives = 92/327 (28%), Gaps = 72/327 (22%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F  +  +G+G F  V++     D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 245 RLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           R    +  +        + +   K + + +        +      R          +G L
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 304 HSSEVN---------------KPAIVHRNLSVEK-------------------------- 322
             S                  K  +  R    ++                          
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187

Query: 323 -------VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----------YLAPEY 364
                  +         + D GL   +  D     + T                Y++PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SE 422
           +    ++ + DIF+ G+I+ ++L      T   R         +  +      F++   +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--FSTQMER----VRIITDVRNLKFPLLFTQKYPQ 301

Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIE 449
              + +         P  RP    +IE
Sbjct: 302 EHMMVQD---MLSPSPTERPEATDIIE 325

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 88/302 (29%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS----LR----HEN 242
           +G+G  S V +   R  G   A++ + VT+ +    +  +           LR    H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGI 296
           II L     S      FL++D   KG+L         L ++E            SI+  +
Sbjct: 162 IITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSL 209

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--- 353
            + + +LH++      IVHR+L  E +L+D      ++D G    L        L+    
Sbjct: 210 LEAVSFLHAN-----NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCG 261

Query: 354 SAAMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESAT 405
           +   GYLAPE        T   + +  D++A GVI   L  L G                
Sbjct: 262 TP--GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--LAG---------------- 301

Query: 406 FENFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAV 447
              F  R         ++G++   S      S   K  + ++ L     DPE R T E  
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRL-LQV---DPEARLTAEQA 357

Query: 448 IE 449
           ++
Sbjct: 358 LQ 359

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 42/204 (20%), Positives = 84/204 (41%), Gaps = 23/204 (11%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 249
           LG+G F  V++            + +     K  +   VK  + +L   RH NI+ L   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
             S    E  +I++F     + + ++      N  +    VS +  + + + +LHS    
Sbjct: 70  FESME--ELVMIFEFISGLDIFERINTSAFELNERE---IVSYVHQVCEALQFLHSHN-- 122

Query: 310 KPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 367
              I H ++  E ++   ++ + + I + G  + L     F +L T+    Y APE    
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP--EYYAPEVHQH 177

Query: 368 GRFTERSDIFAFGVI--ILQILTG 389
              +  +D+++ G +  +L  L+G
Sbjct: 178 DVVSTATDMWSLGTLVYVL--LSG 199

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 52/314 (16%), Positives = 98/314 (31%), Gaps = 73/314 (23%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 246
           +G+G++  V          + AI+ +N    +    + V+ +     L+  L H NI RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 247 RGF------------CCS----------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 284
                           C                         K ++    +  E + N  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 285 DWSTRV------------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFN 330
               R             +I+  I   + YLH+       I HR++  E  L   ++ F 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208

Query: 331 PLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTG--RFTERSDIFAFGVIILQ 385
             + D GL K             +   G   ++APE + T    +  + D ++ GV++  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 386 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTH 435
           +L G++          ++ T        L  K           S  A+  L  + L    
Sbjct: 269 LLMGAVPFPGV----NDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNL-LNR-- 317

Query: 436 EDPENRPTMEAVIE 449
            + + R      ++
Sbjct: 318 -NVDERFDAMRALQ 330

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
            S+  +LG G F  V+K      G  +A + I     K +E E    + ++  L H N+I
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTR--VSIIIGIAKGI 300
           +L     S  + +  L+ ++   G+L    D+  +E  +     +    +  +  I +GI
Sbjct: 150 QLYDAFES--KNDIVLVMEYVDGGEL---FDRIIDESYN----LTELDTILFMKQICEGI 200

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG 358
            ++H        I+H +L  E +L +++    + I D GL +         V   +    
Sbjct: 201 RHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP--E 253

Query: 359 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTG 389
           +LAPE V     +  +D+++ GVI  +L  L+G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYML--LSG 284

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 49/307 (15%), Positives = 101/307 (32%), Gaps = 82/307 (26%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---------------------VTSCKSEEAEF 228
            +GKG++  V       D T  A++ ++                           +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 229 VKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 284
           ++ +Y    +L  L H N+++L            +++++   +G + +       +   L
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPL 134

Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                      + KGI YLH     K  I+HR++    +L+ +  +  IAD G+      
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY---QK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 345 DIVFSVLKTSAAMG---YLAPEYVTTGRFT---ERSDIFAFGVIILQILTGSLVLTSSMR 398
                 L  +   G   ++APE ++  R     +  D++A GV +   + G         
Sbjct: 190 SDAL--LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC------- 238

Query: 399 LAAESATFENFIDRNL--------KGKFS------ESEAAK--LGKMALVCTHEDPENRP 442
                     F+D  +                    +E  K  + +M       +PE+R 
Sbjct: 239 ---------PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK----NPESRI 285

Query: 443 TMEAVIE 449
            +  +  
Sbjct: 286 VVPEIKL 292

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 66/282 (23%), Positives = 107/282 (37%), Gaps = 53/282 (18%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 245
           LG G F+ V K   +  G   A + I      S      +         L  +RH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           L     +  + +  LI +    G+L    D   E+ S    + +     +  I  G+ YL
Sbjct: 73  LHDIFEN--KTDVVLILELVSGGEL---FDFLAEKESLTEDEAT---QFLKQILDGVHYL 124

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGY 359
           HS       I H +L  E +++  +  P     + D G+   +     F  +  +    +
Sbjct: 125 HSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--EF 177

Query: 360 LAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
           +APE V        +D+++ GVI  IL  L+G     S      +  T  N I       
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGETKQETLTN-I---SAVN 227

Query: 418 F---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           +    E     SE AK  + ++ LV   +DP+ R T+   +E
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRL-LV---KDPKRRMTIAQSLE 265

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 65/289 (22%), Positives = 109/289 (37%), Gaps = 72/289 (24%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           +G G++S   +   +      A++ I+ +     E   +    LL   +H NII L+   
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNIITLKDVY 85

Query: 251 CSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
                   +++ +    G+L       K+  + E S+          ++  I K + YLH
Sbjct: 86  DDGKY--VYVVTELMKGGELLDKILRQKFFSEREASA----------VLFTITKTVEYLH 133

Query: 305 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL---IADCGLHKLLADDIVFSVLKT---SAAM 357
           +       +VHR+L    +L +D+  NP    I D G  K L  +    +L T   +A  
Sbjct: 134 AQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTA-- 184

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-------AAESATFENFI 410
            ++APE +    +    DI++ GV +L  +           L            T E  +
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGV-LLYTM-----------LTGYTPFANGPDDTPEEIL 232

Query: 411 DRNLKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
            R   GKF          S+ AK  + KM L     DP  R T   V+ 
Sbjct: 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKM-LHV---DPHQRLTAALVLR 277

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 67/313 (21%), Positives = 117/313 (37%), Gaps = 64/313 (20%)

Query: 180 ESATQCFSEV-----NLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF--VKG 231
           +S +  F +V     ++LG+G  + V            A++ I           F  V+ 
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63

Query: 232 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR 289
           LY      H N++ L  F     R   +L+++    G +   L    +    N L+ S  
Sbjct: 64  LYQCQG--HRNVLELIEFFEEEDR--FYLVFEKMRGGSI---LSHIHKRRHFNELEAS-- 114

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDI 346
             ++  +A  + +LH+       I HR+L  E +L +      P+ I D  L   +  + 
Sbjct: 115 -VVVQDVASALDFLHN-----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 347 VFSVLKTSAAM------GYLAPE-----YVTTGRFTERSDIFAFGVI--ILQILTG---- 389
             S + T   +       Y+APE           + +R D+++ GVI  IL  L+G    
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPF 226

Query: 390 ---SLVLTSSMRLAAESATFENFIDRNLKGKF---SE-----SEAAK--LGKMALVCTHE 436
                      R  A  A      +   +GK+    +     S AAK  + K+ LV    
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL-LVR--- 282

Query: 437 DPENRPTMEAVIE 449
           D + R +   V++
Sbjct: 283 DAKQRLSAAQVLQ 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 53/282 (18%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 245
           LG G F+ V K   +  G   A + I     KS      +         L  ++H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           L     ++   +  LI +    G+L    D   E+ S    + +     +  I  G+ YL
Sbjct: 79  LHEVYENKT--DVILILELVAGGEL---FDFLAEKESLTEEEAT---EFLKQILNGVYYL 130

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGY 359
           HS +     I H +L  E +++  +  P     I D GL   +     F  +  +    +
Sbjct: 131 HSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP--EF 183

Query: 360 LAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
           +APE V        +D+++ GVI  IL  L+G     S      +  T  N +       
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-V---SAVN 233

Query: 418 --FSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
             F +      S  AK  + ++ LV   +DP+ R T++  ++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRL-LV---KDPKKRMTIQDSLQ 271

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 63/287 (21%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  +G GNF             LVA++ I   +   E  +  + +    SLRH NI+R +
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFK 82

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----------IIIGIA 297
               +       +I ++A  G+L + +            + R S          ++ G++
Sbjct: 83  EVILTPT--HLAIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVS 130

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSA 355
               Y HS ++      HR+L +E  L+D    P   I D G  K        S  K++ 
Sbjct: 131 ----YCHSMQI-----CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTV 178

Query: 356 AMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 410
             G   Y+APE V   +  +   +D+++ GV +  +L G+           E   +   I
Sbjct: 179 --GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPRDYRKTI 231

Query: 411 DRNLKGKFSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
            R L  K+S       S      + ++ +     DP  R ++  +  
Sbjct: 232 QRILSVKYSIPDDIRISPECCHLISRIFVA----DPATRISIPEIKT 274

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 47/278 (16%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH-ENIIRLRG 248
           LG+G F+ V +   +  G   A + +       +    +   + +L   +    +I L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR--VSIIIGIAKGIGYLHSS 306
              +    E  LI ++A  G++      E         S    + +I  I +G+ YLH +
Sbjct: 97  VYENTS--EIILILEYAAGGEIFSLCLPELAEM----VSENDVIRLIKQILEGVYYLHQN 150

Query: 307 EVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
                 IVH +L  + +L+   +    + I D G+ + +        +  +    YLAPE
Sbjct: 151 N-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP--EYLAPE 203

Query: 364 YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FS 419
            +     T  +D++  G+I  +L  LT     TS         T+ N I    +    +S
Sbjct: 204 ILNYDPITTATDMWNIGIIAYML--LTH----TSPFVGEDNQETYLN-I---SQVNVDYS 253

Query: 420 E------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           E      S+ A   +  + LV   ++PE RPT E  + 
Sbjct: 254 EETFSSVSQLATDFIQSL-LV---KNPEKRPTAEICLS 287

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 21/159 (13%)

Query: 192 LGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           +G+G +  VYK   +D       A++ I  T          + + LL  L+H N+I L+ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN-----VLDWSTRVSIIIGIAKGIGYL 303
              S    + +L++D+A    L   +     S        L      S++  I  GI YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGL 338
           H+   N   ++HR+L    +L+  +        IAD G 
Sbjct: 145 HA---NW--VLHRDLKPANILVMGEGPERGRVKIADMGF 178

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 49/218 (22%), Positives = 96/218 (44%), Gaps = 31/218 (14%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE-----EAEFVKG-LYLLT 236
           + F    +LG+G+FS+V            AI+ +     K       +  +V     +++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMS 85

Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG- 295
            L H   ++L        +   +    +A  G+L KY+ ++ GS     +    +     
Sbjct: 86  RLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYI-RKIGS-----FDETCTRFYTA 137

Query: 296 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            I   + YLH        I+HR+L  E +L+++  +  I D G  K+L+ +   +  + +
Sbjct: 138 EIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RAN 190

Query: 355 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           + +G   Y++PE +T     + SD++A G II Q++ G
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 57/329 (17%), Positives = 112/329 (34%), Gaps = 92/329 (27%)

Query: 154 PLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVA 212
             G     TG+       ++  + ++E        +  +G G    V+K    + G ++A
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLE-------NLGEMGSGTCGQVWKMRFRKTGHVIA 54

Query: 213 IRSINVTSCKSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS 271
           ++ +  +  K E    +  L  +L S     I++      +           F     + 
Sbjct: 55  VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGT-----------FITNTDVF 100

Query: 272 ---KYLDQEEGSSNVLDWSTRVSI---IIG-----IAKGIGYLHSSEVNKPAIVHRNLSV 320
              + +      +  L    +  I   I+G     I K + YL      K  ++HR++  
Sbjct: 101 IAMELMG---TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE----KHGVIHRDVKP 153

Query: 321 EKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE-----YVTTGRFTE 372
             +L+D++    + D G+   L D       K  +A G   Y+APE       T   +  
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVD----DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDI 208

Query: 373 RSDIFAFGVIILQILTG--------------SLVLTSSM-RLAAE---SATFENFIDRNL 414
           R+D+++ G+ ++++ TG              + VL      L      S  F++F+    
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD-- 266

Query: 415 KGKFSESEAAKLGKMALVCTHEDPENRPT 443
                             C  +D   RP 
Sbjct: 267 ------------------CLTKDHRKRPK 277

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 56/283 (19%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G    V +   +      A++ +        E E         + +  +I+R+    
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 124

Query: 251 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 304
                GR    ++ +    G+L       Q+ G      ++ R    I+  I + I YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 178

Query: 305 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMG 358
           S       I HR++  E +L   ++ N +  + D G  K        + L T   +    
Sbjct: 179 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTP--Y 228

Query: 359 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           Y+APE +   ++ +  D+++ GVI  IL  L G     S+  LA           R   G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGYPPFYSNHGLAISPGMKT----RIRMG 282

Query: 417 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           ++   +      SE  K  +  + L     +P  R T+   + 
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNL-LKT---EPTQRMTITEFMN 321

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 58/299 (19%), Positives = 112/299 (37%), Gaps = 65/299 (21%)

Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV 229
           S  +  +++E        +  LG+G +  V K      G ++A++ I  T    E+   +
Sbjct: 1   SMEVKADDLE-------PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53

Query: 230 KGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
             L   + ++     +   G       G+ ++  +      L K+  Q       +    
Sbjct: 54  MDLDISMRTVDCPFTVTFYG--ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 348
              I + I K + +LHS    K +++HR++    VLI+      + D G+   L D    
Sbjct: 111 LGKIAVSIVKALEHLHS----KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---- 162

Query: 349 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTGS----------- 390
            V K   A G   Y+APE     +    ++ +SDI++ G+ ++++               
Sbjct: 163 DVAKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221

Query: 391 ----LVLTSSMRLAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
               +V   S +L A+  SA F +F  +                    C  ++ + RPT
Sbjct: 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQ--------------------CLKKNSKERPT 260

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 52/282 (18%), Positives = 114/282 (40%), Gaps = 58/282 (20%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
            + F  +  LG+G++ SVYK      G +VAI+ + V   +S+  E +K + ++      
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSP 84

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           ++++  G    +   + +++ ++   G +S   D     +  L      +I+    KG+ 
Sbjct: 85  HVVKYYG-SYFKN-TDLWIVMEYCGAGSVS---DIIRLRNKTLTEDEIATILQSTLKGLE 139

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLH         +HR++    +L++ + +  +AD G+   L D    ++ K +  +G   
Sbjct: 140 YLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD----TMAKRNTVIGTPF 190

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 402
           ++APE +    +   +DI++ G+  +++  G            + +  +           
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250

Query: 403 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
            S  F +F+ +                    C  + PE R T
Sbjct: 251 WSDNFTDFVKQ--------------------CLVKSPEQRAT 272

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 43/237 (18%), Positives = 88/237 (37%), Gaps = 21/237 (8%)

Query: 165 SREHLNSFRLNLEEVESATQCFSEVNLLGKG--NFSSVYKGT-LRDGTLVAIRSINVTSC 221
                N +   +        C+  + ++GKG  +  +V        G  V +R IN+ +C
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65

Query: 222 KSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 280
            +E   F++G L++     H NI+            E +++  F   G     +      
Sbjct: 66  SNEMVTFLQGELHVSKLFNHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLI--CTHF 121

Query: 281 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 340
            + ++      I+ G+ K + Y+H         VHR++    +LI       ++    + 
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGY-----VHRSVKASHILISVDGKVYLSGLRSNL 176

Query: 341 LLADDI-----VFSVLKTSAAMGY-LAPEYVTTGR--FTERSDIFAFGVIILQILTG 389
            +         V    K S  +   L+PE +      +  +SDI++ G+   ++  G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 46/278 (16%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGF 249
           LG+G+FS   K   +      A++ I+    K  EA   K +  L     H NI++L   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 250 CCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
              +     FL+ +    G+L    +  +++   +  + S    I+  +   + ++H   
Sbjct: 75  FHDQLH--TFLVMELLNGGEL---FERIKKKKHFSETEAS---YIMRKLVSAVSHMHDVG 126

Query: 308 VNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMGYLA 361
                +VHR+L  E +L  D+  N    I D G  +L   D     LKT   +    Y A
Sbjct: 127 -----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTL--HYAA 177

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 418
           PE +    + E  D+++ GVI+  +L+G +   S  R    ++  E    +  KG F   
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSFE 236

Query: 419 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
            E     S+ AK  +  + L     DP  R  M  +  
Sbjct: 237 GEAWKNVSQEAKDLIQGL-LTV---DPNKRLKMSGLRY 270

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 32/164 (19%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHENI 243
           ++   ++G G+F  V++  L +   VAI+ +       ++  F K   L ++  ++H N+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV------LQDKRF-KNRELQIMRIVKHPNV 94

Query: 244 IRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           + L+ F  S G  +      L+ ++ P+  + +           +        +  + + 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 342
           + Y+HS       I HR++  + +L+D     L + D G  K+L
Sbjct: 154 LAYIHSI-----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 63/303 (20%)

Query: 173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG 231
            ++L  +      F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQE 70

Query: 232 LYLLTSL-RHENIIRLRG----FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 286
           + +L     H NI    G            + +L+ +F   G ++  +   +G  N L  
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKE 128

Query: 287 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 346
                I   I +G+ +LH  +V     +HR++  + VL+ +     + D G+   L    
Sbjct: 129 EWIAYICREILRGLSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-- 181

Query: 347 VFSVLKTSAAMG---YLAPEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSS 396
             +V + +  +G   ++APE +      +     +SD+++ G+  +++  G+  L     
Sbjct: 182 --TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

Query: 397 MR------------LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 442
           MR            L ++  S  F++FI+                     C  ++   RP
Sbjct: 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIES--------------------CLVKNHSQRP 279

Query: 443 TME 445
             E
Sbjct: 280 ATE 282

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 237
           + +  + L+G+G++  V K   +D G +VAI+        S++ + VK      + LL  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE----SDDDKMVKKIAMREIKLLKQ 80

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           LRHEN++ L   C  + +   +L+++F     +   L+      N LD+      +  I 
Sbjct: 81  LRHENLVNLLEVC--KKKKRWYLVFEFVDH-TILDDLEL---FPNGLDYQVVQKYLFQII 134

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
            GIG+ HS   +   I+HR++  E +L+ Q     + D G 
Sbjct: 135 NGIGFCHS---HN--IIHRDIKPENILVSQSGVVKLCDFGF 170

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 58/302 (19%), Positives = 115/302 (38%), Gaps = 67/302 (22%)

Query: 171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV 229
            +    E+++       ++  +G+G + SV K      G ++A++ I  T  + E+ + +
Sbjct: 16  HWDFTAEDLK-------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68

Query: 230 KGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
             L  ++ S     I++  G    R  G+C++  +         Y        +V+    
Sbjct: 69  MDLDVVMRSSDCPYIVQFYG-ALFRE-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 348
              I +   K + +L         I+HR++    +L+D+  N  + D G+   L D    
Sbjct: 127 LGKITLATVKALNHLKE----NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---- 178

Query: 349 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTG------------ 389
           S+ KT  A G   Y+APE      +   +  RSD+++ G+ + ++ TG            
Sbjct: 179 SIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

Query: 390 --SLVLTSSM-RLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR 441
             + V+     +L+       S +F NF++                     C  +D   R
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNL--------------------CLTKDESKR 277

Query: 442 PT 443
           P 
Sbjct: 278 PK 279

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 33/188 (17%)

Query: 165 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS 223
             +   S  ++     ++   +  +  LG+G +  VYK         VAI+ I +     
Sbjct: 15  QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL----E 70

Query: 224 EEAEFVKGL--------YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 275
            E E   G+         LL  L+H NII L+       R    LI+++A    L KY+D
Sbjct: 71  HEEE---GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAEN-DLKKYMD 124

Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 332
                +  +      S +  +  G+ + HS    +   +HR+L  + +L+          
Sbjct: 125 ----KNPDVSMRVIKSFLYQLINGVNFCHS---RR--CLHRDLKPQNLLLSVSDASETPV 175

Query: 333 --IADCGL 338
             I D GL
Sbjct: 176 LKIGDFGL 183

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 24/170 (14%)

Query: 178 EVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL---- 232
           +V+S  + + +++ LG+G F++VYK        +VAI+ I +       +E   G+    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH----RSEAKDGINRTA 59

Query: 233 ----YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
                LL  L H NII L      +      L++DF     L   +     +S VL  S 
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETD-LEVIIKD---NSLVLTPSH 113

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
             + ++   +G+ YLH    +   I+HR+L    +L+D+     +AD GL
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HW--ILHRDLKPNNLLLDENGVLKLADFGL 158

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 21/168 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHEN 242
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F K   L ++  L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRF-KNRELQIMRKLDHCN 108

Query: 243 IIRLRGFCCSRG--RGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 298
           I+RLR F  S G  + E +L  + D+ P+  + +       +   L        +  + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 299 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADD 345
            + Y+HS       I HR++  + +L+D     L + D G  K L   
Sbjct: 168 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 32/161 (19%), Positives = 68/161 (42%), Gaps = 21/161 (13%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 237
           + + ++  +G+G++  V+K   RD G +VAI+        SE+   +K      + +L  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE----SEDDPVIKKIALREIRMLKQ 58

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           L+H N++ L      R +    L++++     +   LD+       +      SI     
Sbjct: 59  LKHPNLVNLLEVF--RRKRRLHLVFEYCDH-TVLHELDR---YQRGVPEHLVKSITWQTL 112

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           + + + H    +    +HR++  E +LI +     + D G 
Sbjct: 113 QAVNFCHK---HN--CIHRDVKPENILITKHSVIKLCDFGF 148

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 19/169 (11%)

Query: 181 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEF-------VKGL 232
            AT  +  V  +G G + +VYK      G  VA++S+ V +               V  L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 233 YLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 289
             L +  H N++RL   C +          L+++   +  L  YLD+       L   T 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETI 122

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
             ++    +G+ +LH+   N   IVHR+L  E +L+       +AD GL
Sbjct: 123 KDLMRQFLRGLDFLHA---NC--IVHRDLKPENILVTSGGTVKLADFGL 166

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 9e-10
 Identities = 33/198 (16%), Positives = 56/198 (28%), Gaps = 44/198 (22%)

Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF------------- 228
            T+       +G+G F  V++    D T VAI+ I +                       
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 229 ---VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI--YDFAPKGKLSKY---------- 273
              +  L      R E  I L    C +G     L+  +D     K S            
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 274 -----------LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 322
                      +D E+  + +   +T  SI+  +   +              HR+L    
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE----ASLRFEHRDLHWGN 192

Query: 323 VLIDQQFNPLIADCGLHK 340
           VL+ +     +      K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 27/246 (10%)

Query: 153 DPLGDYLNGTGFSREHLNSFRLNLEEVESAT-QCFSEVNLLGKGNFSSVYKGTLRD-GTL 210
           D    ++    F+R        N+E     T   FS   ++G+G F  VY     D G +
Sbjct: 160 DVFQKFIESDKFTRFC---QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216

Query: 211 VAIRSINVTSCKS-EEAEFVKG----LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 265
            A++ ++    K  +           L L+++     I+ +          +   I D  
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS--YAFHTPDKLSFILDLM 274

Query: 266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVL 324
             G L  +L Q    S        +      I  G+ ++H+       +V+R+L    +L
Sbjct: 275 NGGDLHYHLSQHGVFSE-----ADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANIL 324

Query: 325 IDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVII 383
           +D+  +  I+D GL    +     + + T    GY+APE +  G  +   +D F+ G ++
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGT---HGYMAPEVLQKGVAYDSSADWFSLGCML 381

Query: 384 LQILTG 389
            ++L G
Sbjct: 382 FKLLRG 387

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 58.3 bits (142), Expect = 1e-09
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 26/167 (15%)

Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL------- 232
           +   + + ++  +G+G +  VYK     G +VA++ I + +    E E   G+       
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDE---GIPSTAIRE 69

Query: 233 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
             LL  L H NI+ L     S       L+++F  K  L K LD+   +   L  S    
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKD-LKKVLDE---NKTGLQDSQIKI 123

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
            +  + +G+ + H    ++  I+HR+L  + +LI+      +AD GL
Sbjct: 124 YLYQLLRGVAHCHQ---HR--ILHRDLKPQNLLINSDGALKLADFGL 165

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 48/282 (17%), Positives = 112/282 (39%), Gaps = 58/282 (20%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
            + ++    +G+G   +VY    +  G  VAIR +N+   + ++   +  + ++   ++ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNP 77

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           NI+            E +++ ++   G L+  + +       +D     ++     + + 
Sbjct: 78  NIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           +LHS++     ++HR++  + +L+    +  + D G    +         K S  +G   
Sbjct: 131 FLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPY 181

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 402
           ++APE VT   +  + DI++ G++ ++++ G            L L ++     L     
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 403 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
            SA F +F++R                    C   D E R +
Sbjct: 242 LSAIFRDFLNR--------------------CLEMDVEKRGS 263

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 41/164 (25%), Positives = 79/164 (48%), Gaps = 28/164 (17%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL--------YL 234
           + + +++ LG+G +++VYKG  +    LVA++ I +   + EE     G          L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL---EHEE-----GAPCTAIREVSL 53

Query: 235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           L  L+H NI+ L     +       L++++  K  L +YLD      N+++       + 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKS--LTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLF 107

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
            + +G+ Y H     K  ++HR+L  + +LI+++    +AD GL
Sbjct: 108 QLLRGLAYCHR---QK--VLHRDLKPQNLLINERGELKLADFGL 146

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 57.5 bits (140), Expect = 2e-09
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 26/163 (15%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL--------YLL 235
           + +  +  +G+G +  VYK     G   A++ I +     +E E   G+         +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL----EKEDE---GIPSTTIREISIL 54

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             L+H NI++L     ++ R    L+++   +  L K LD        L+  T  S ++ 
Sbjct: 55  KELKHSNIVKLYDVIHTKKR--LVLVFEHLDQD-LKKLLDV---CEGGLESVTAKSFLLQ 108

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
           +  GI Y H     +  ++HR+L  + +LI+++    IAD GL
Sbjct: 109 LLNGIAYCHD---RR--VLHRDLKPQNLLINREGELKIADFGL 146

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 67/278 (24%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 250
           LG G    V +   +      A++ +        E E         + +  +I+R+    
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 80

Query: 251 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 304
                GR    ++ +    G+L       Q+ G      ++ R    I+  I + I YLH
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 134

Query: 305 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           S       I HR++  E +L   ++ N +  + D G                       A
Sbjct: 135 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FA 167

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 418
            E  T  ++ +  D+++ GVI+  +L G     S+  LA           R   G++   
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEFP 222

Query: 419 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 449
           +      SE  K  +  +       +P  R T+   + 
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMN 256

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 61/284 (21%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  V  LG G F  VYK      G L A + I   S + E  +++  + +L +  H  I+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIV 79

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L G       G+ +++ +F P G +             L       +   + + + +LH
Sbjct: 80  KLLG--AYYHDGKLWIMIEFCPGGAVD---AIMLELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S  +     +HR+L    VL+  + +  +AD G+          ++ K  + +G   ++A
Sbjct: 135 SKRI-----IHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----TLQKRDSFIGTPYWMA 185

Query: 362 PEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSSMR------------LAAE 402
           PE V      +     ++DI++ G+ ++++          + MR            L   
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245

Query: 403 ---SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
              S  F +F+                         ++PE RP+
Sbjct: 246 SKWSVEFRDFLKI--------------------ALDKNPETRPS 269

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 27/169 (15%)

Query: 181 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL------- 232
           S++  F ++  LG G +++VYKG     G  VA++ + +    SEE     G        
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---DSEE-----GTPSTAIRE 53

Query: 233 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV- 290
             L+  L+HENI+RL     +  +    L+++F     L KY+D     +        + 
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110

Query: 291 -SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
                 + +G+ + H    NK  I+HR+L  + +LI+++    + D GL
Sbjct: 111 KYFQWQLLQGLAFCHE---NK--ILHRDLKPQNLLINKRGQLKLGDFGL 154

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 41/282 (14%), Positives = 103/282 (36%), Gaps = 58/282 (20%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 241
                    +G+G+   V        G  VA++ +++   +         + ++   +H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           N++ +          E +++ +F   G L+  + Q       L+     ++   + + + 
Sbjct: 103 NVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALA 155

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLH+       ++HR++  + +L+       ++D G    ++ D    V K  + +G   
Sbjct: 156 YLHAQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKSLVGTPY 206

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 402
           ++APE ++   +    DI++ G+++++++ G            +         +L     
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266

Query: 403 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
            S    +F++R                        DP+ R T
Sbjct: 267 VSPVLRDFLER--------------------MLVRDPQERAT 288

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 17/190 (8%)

Query: 165 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI--NVTSC 221
           S   LN+     E        F    + G+G F +V  G  +  G  VAI+ +  +    
Sbjct: 4   SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR 63

Query: 222 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE-----CFLIYDFAPKGKLSKYLDQ 276
             E       +  L  L H NI++L+ +  + G  +       ++ ++ P   L +    
Sbjct: 64  NRELQI----MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118

Query: 277 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IAD 335
                           +  + + IG LH   VN   + HR++    VL+++    L + D
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD 175

Query: 336 CGLHKLLADD 345
            G  K L+  
Sbjct: 176 FGSAKKLSPS 185

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 55.6 bits (135), Expect = 8e-09
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 26/164 (15%)

Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 234
           + F +V  +G+G +  VYK      G +VA++ I +      E E   G+         L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL----DTETE---GVPSTAIREISL 55

Query: 235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           L  L H NI++L     +  +   +L+++F  +  L K++D    +   +      S + 
Sbjct: 56  LKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLF 110

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
            + +G+ + HS   ++  ++HR+L  + +LI+ +    +AD GL
Sbjct: 111 QLLQGLAFCHS---HR--VLHRDLKPQNLLINTEGAIKLADFGL 149

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 55.6 bits (135), Expect = 9e-09
 Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 27/164 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 234
           Q + ++  +G+G + +V+K        +VA++ + +     ++ E   G+         L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDE---GVPSSALREICL 54

Query: 235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           L  L+H+NI+RL     S  +    L+++F  +  L KY D     +  LD     S + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLF 108

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
            + KG+G+ HS       ++HR+L  + +LI++     +A+ GL
Sbjct: 109 QLLKGLGFCHS---RN--VLHRDLKPQNLLINRNGELKLANFGL 147

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 78/290 (26%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 242
           FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
            I+ RG  C       +L+ ++          D  E     L      ++  G  +G+ Y
Sbjct: 116 TIQYRG--CYLREHTAWLVMEYCLGS----ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---- 358
           LHS       ++HR++    +L+ +         GL K L D   F     ++ M     
Sbjct: 170 LHSHN-----MIHRDVKAGNILLSEP--------GLVK-LGD---FGS---ASIMAPANS 209

Query: 359 ------YLAPEYVTT---GRFTERSDIFAFGVIILQILTGS--LVLTSSMR--------- 398
                 ++APE +     G++  + D+++ G+  +++      L   ++M          
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269

Query: 399 ---LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 443
              L +   S  F NF+D                     C  + P++RPT
Sbjct: 270 SPALQSGHWSEYFRNFVDS--------------------CLQKIPQDRPT 299

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 32/216 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 239
           +  +  +G G    V           VAI+ +     N T  K    E V    L+  + 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 82

Query: 240 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
           H+NII L      +   E F    ++ +      L + +  E      LD      ++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQ 135

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS- 354
           +  GI +LHS+ +     +HR+L    +++       I D G    LA     S + T  
Sbjct: 136 MLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPY 186

Query: 355 -AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
                Y APE +    + E  DI++ G I+ +++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 32/219 (14%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 236
            + +  +  +G G    V           VAI+ +     N T  K    E V    L+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116

Query: 237 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            + H+NII L      +   E F    L+ +      L + +  E      LD      +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYL 169

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--V 350
           +  +  GI +LHS+ +     +HR+L    +++       I D GL +      + +  V
Sbjct: 170 LYQMLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 351 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
                   Y APE +    + E  DI++ G I+ +++  
Sbjct: 225 ----VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 49/254 (19%), Positives = 92/254 (36%), Gaps = 42/254 (16%)

Query: 153 DPLGDYLNGTGFSR----EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD- 207
            P  ++L+   F R    + L +  +  +        F +  +LG+G F  V+   ++  
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFACQMKAT 209

Query: 208 GTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 258
           G L A + +N               E+        +L  +    I+ L        + + 
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKK-------ILAKVHSRFIVSL--AYAFETKTDL 260

Query: 259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 318
            L+      G +  ++   +  +        +     I  G+ +LH        I++R+L
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDL 315

Query: 319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSD 375
             E VL+D   N  I+D GL   L         KT    G   ++APE +    +    D
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVD 371

Query: 376 IFAFGVIILQILTG 389
            FA GV + +++  
Sbjct: 372 YFALGVTLYEMIAA 385

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 42/223 (18%)

Query: 184 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSI---------NVTSCKSEEAEFVK 230
             F+ + +LGKG+F  V     KGT     L A++ +         +V     E+     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR---- 393

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
              L    +   + +L    C +     + + ++   G L  ++ Q              
Sbjct: 394 --VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHA 444

Query: 291 SIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
                 IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K   ++I   
Sbjct: 445 VFYAAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 496

Query: 350 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           V  T    G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 497 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 31/218 (14%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 236
            + +     +G G + SV      R G  VAI+ +     +    K    E    L LL 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLK 78

Query: 237 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            ++HEN+I L            F    L+  F     L K +  +              +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQYL 131

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
           +  + KG+ Y+HS+ V     VHR+L    + +++     I D GL +    ++   V  
Sbjct: 132 VYQMLKGLKYIHSAGV-----VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-- 184

Query: 353 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 389
                 Y APE + +   + +  DI++ G I+ ++LTG
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 33/170 (19%)

Query: 185 CFSEVNLLGKGNFSSVYKGT-LRDGTLVA---IR------SINVTSCKSEEAEFVKGLYL 234
            + ++  +G+G F  V+K    + G  VA   +          +T+        ++ + +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--------LREIKI 69

Query: 235 LTSLRHENIIRLRGFCCSRG------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
           L  L+HEN++ L   C ++       +G  +L++DF     L+  L            S 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSE 125

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
              ++  +  G+ Y+H    NK  I+HR++    VLI +     +AD GL
Sbjct: 126 IKRVMQMLLNGLYYIHR---NK--ILHRDMKAANVLITRDGVLKLADFGL 170

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 36/222 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 233
             F  + LLGKG F  V     +  G   A++ +          V    +E         
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR------- 200

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           +L + RH  +  L      +       + ++A  G+L  +L +E   S       R    
Sbjct: 201 VLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-----DRARFY 253

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I   + YLHS    +  +V+R+L +E +++D+  +  I D GL K   + I      
Sbjct: 254 GAEIVSALDYLHS----EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA-T 305

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
                G   YLAPE +    +    D +  GV++ +++ G L
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 23/170 (13%)

Query: 181 SATQCFSEVNLLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKSEEAEF-------VKG 231
            A Q +  V  +G+G +  V+K       G  VA++ + V   ++ E          V  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAV 64

Query: 232 LYLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWST 288
           L  L +  H N++RL   C            L+++   +  L+ YLD+       +   T
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG--VPTET 121

Query: 289 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
              ++  + +G+ +LHS   ++  +VHR+L  + +L+       +AD GL
Sbjct: 122 IKDMMFQLLRGLDFLHS---HR--VVHRDLKPQNILVTSSGQIKLADFGL 166

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 45/212 (21%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 242
           F  +  +GKG+F  V      D   + A++ +N   C +  E   V   L ++  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 301
           ++ L      +   + F++ D    G L  +L Q             V + I  +   + 
Sbjct: 77  LVNLW--YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE-----ETVKLFICELVMALD 129

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYL 360
           YL +       I+HR++  + +L+D+  +  I D  +  +L  +   + + T +    Y+
Sbjct: 130 YLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYM 181

Query: 361 APEYVTTGRFTERS---DIFAFGVIILQILTG 389
           APE  ++ +    S   D ++ GV   ++L G
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 42/303 (13%)

Query: 103 IFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSL--EYCHGWDPLGDYLN 160
           +   +  H               +    L +   ++    L  L  EY     P  DYL+
Sbjct: 105 LTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV-APFADYLD 163

Query: 161 GTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN-- 217
              F+R  L    L  + V      F +  +LGKG F  V    +R  G + A + +   
Sbjct: 164 SIYFNR-FLQWKWLERQPV--TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220

Query: 218 -------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 270
                       +E+        +L  +    ++ L        +    L+      G L
Sbjct: 221 RIKKRKGEAMALNEKQ-------ILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDL 271

Query: 271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 330
             ++            +  V     I  G+  LH        IV+R+L  E +L+D   +
Sbjct: 272 KFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGH 324

Query: 331 PLIADCGLHKLLADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQI 386
             I+D GL   + +       +T        GY+APE V   R+T   D +A G ++ ++
Sbjct: 325 IRISDLGLAVHVPEG------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

Query: 387 LTG 389
           + G
Sbjct: 379 IAG 381

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 239
           + ++  +G G + +V      R G  VAI+ +     +    K    E    L LL  +R
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82

Query: 240 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
           HEN+I L          + F    L+  F     L K +         L       ++  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHEKLGEDRIQFLVYQ 136

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + KG+ Y+H++ +     +HR+L    + +++     I D GL +    ++   V     
Sbjct: 137 MLKGLRYIHAAGI-----IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----V 187

Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 389
              Y APE +    R+T+  DI++ G I+ +++TG
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 236
            + +  ++ +G G + SV      + G  VA++ +     ++   K    E    L LL 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83

Query: 237 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 292
            ++HEN+I L          E F    L+        L+  +         L       +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-----KCQKLTDDHVQFL 137

Query: 293 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
           I  I +G+ Y+HS+++     +HR+L    + +++     I D GL +  AD++   V  
Sbjct: 138 IYQILRGLKYIHSADI-----IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190

Query: 353 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 389
             A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 43/211 (20%), Positives = 85/211 (40%), Gaps = 26/211 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 242
           F  +  LG G+F  V     ++ G   A++ ++     K ++ E       +L ++    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 301
           +++L            +++ ++   G++  +L +    S               I     
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSE-----PHARFYAAQIVLTFE 155

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLHS +     +++R+L  E +LIDQQ    + D G  K +         +T    G   
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTPE 203

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            LAPE + +  + +  D +A GV+I ++  G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI----NVTSCKSEEAEFVKGLYLLTSLRH 240
           ++ ++ +G+G +  V       +   VAI+ I    + T C+    E    + +L   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84

Query: 241 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           ENII +     +       + +++ D      L K L      +  L        +  I 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQHLSNDHICYFLYQIL 138

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--A 355
           +G+ Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A
Sbjct: 139 RGLKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 356 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 389
              Y APE +  +  +T+  DI++ G I+ ++L+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 56/298 (18%), Positives = 111/298 (37%), Gaps = 47/298 (15%)

Query: 167 EHLNSFRLNLEEVESAT---QCFSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSIN-V 218
           E+L   +    +V+      + F  + ++G+G F  V     K       + A++ +N  
Sbjct: 54  EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKW 110

Query: 219 TSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 277
              K  E    +    +L +   + I  L      +     +L+ D+   G L   L + 
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168

Query: 278 EGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 336
           E     L         +  +   I  +H         VHR++  + +L+D   +  +AD 
Sbjct: 169 ED---RLP-EEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADF 219

Query: 337 GLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERS-----DIFAFGVIILQILT 388
           G    L +D     +++S A+G   Y++PE +      +       D ++ GV + ++L 
Sbjct: 220 GSCLKLMED---GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 389 GSLVLTSSMRLAAESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 441
           G     +     +   T+   ++   + +F       SE AK     L+C     E+R
Sbjct: 277 GETPFYAE----SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC---SREHR 327

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 27/220 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI---NVTSCKSEEAEFVKGLYLLTSLRHE 241
           + ++  LG G    V+          VAI+ I   +  S K    E    + ++  L H+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EG------SSNVLDWSTRVSII 293
           NI+++       G      +        +  Y+ QE  E           L        +
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSV--YIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLK 352
             + +G+ Y+HS+ V     +HR+L    + I+ +   L I D GL +++          
Sbjct: 127 YQLLRGLKYIHSANV-----LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 353 TS--AAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 389
           +       Y +P   ++   +T+  D++A G I  ++LTG
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 47.2 bits (113), Expect = 6e-06
 Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 40/222 (18%)

Query: 184 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVK 230
           + F    +LGKG+F  V    +K T       AI+++          V     E+     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKR---- 69

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 290
              L  +  H  +  +  FC  + +   F + ++   G L  ++          D S   
Sbjct: 70  --VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRAT 121

Query: 291 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
                I  G+ +LHS       IV+R+L ++ +L+D+  +  IAD G+ K   ++++   
Sbjct: 122 FYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDA 173

Query: 351 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            KT+   G   Y+APE +   ++    D ++FGV++ ++L G
Sbjct: 174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 40/220 (18%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 233
           Q F  + ++G+G+++ V    L+    + A+R +         ++   ++E+        
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH------V 105

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
              +  H  ++ L    C +     F + ++   G L  ++ ++                
Sbjct: 106 FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 158

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I+  + YLH        I++R+L ++ VL+D + +  + D G+ K   + +      
Sbjct: 159 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 209

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           TS   G   Y+APE +    +    D +A GV++ +++ G
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 37/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 233
             F  + LLGKG F  V     +  G   A++ +          V    +E         
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR------- 57

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           +L + RH  +  L      +       + ++A  G+L  +L +E   +       R    
Sbjct: 58  VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFY 110

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I   + YLHS +     +V+R++ +E +++D+  +  I D GL K   + I      
Sbjct: 111 GAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA-T 161

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
                G   YLAPE +    +    D +  GV++ +++ G
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 233
             F+ + +LGKG+F  V     +    L A++ +         +V     E+        
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR------V 73

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           L    +   + +L    C +     + + ++   G L  ++ Q                 
Sbjct: 74  LALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFY 126

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K   ++I   V  
Sbjct: 127 AAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV-T 177

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           T    G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 27/219 (12%)

Query: 184 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG-LYLLT 236
           +CF  + +LGKG +  V+   K T  + G + A++ +   +    +++    K    +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG- 295
            ++H  I+ L      +  G+ +LI ++   G+L   L++E                +  
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-----EDTACFYLAE 129

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           I+  +G+LH        I++R+L  E ++++ Q +  + D GL K    D       T  
Sbjct: 130 ISMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHT 180

Query: 356 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
             G   Y+APE +         D ++ G ++  +LTG+ 
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 43/272 (15%), Positives = 102/272 (37%), Gaps = 56/272 (20%)

Query: 143 LVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVY- 201
           L +L Y   +  L    N   F   +       + ++    + +  V ++G+G F  V  
Sbjct: 29  LDALVYDLDFPALRKNKNIDNFLSRY-KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87

Query: 202 ---KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLLTSLRHENIIRLRGFCCS 252
              K T     + A++ ++    K E     ++ F      ++       +++L  F   
Sbjct: 88  VRHKST---RKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAF 138

Query: 253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK--------GIGYLH 304
           +     +++ ++ P G L   +   +                  A+         +  +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-------------ARFYTAEVVLALDAIH 185

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 361
           S        +HR++  + +L+D+  +  +AD G    +  +    +++   A+G   Y++
Sbjct: 186 SMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE---GMVRCDTAVGTPDYIS 237

Query: 362 PEYVTT----GRFTERSDIFAFGVIILQILTG 389
           PE + +    G +    D ++ GV + ++L G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 31/277 (11%), Positives = 74/277 (26%), Gaps = 51/277 (18%)

Query: 191 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIR 245
             G       ++    D  L   VA+  ++      ++   E +     L+ +    + R
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           +        R    ++ ++   G L +  D              +  +  +A      H 
Sbjct: 96  V--LDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR 147

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
           +      +        +V +                  D  V  VL   A    +     
Sbjct: 148 A-----GVALSIDHPSRVRVS----------------IDGDV--VL---AYPATMPDA-- 179

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GKFSESEAA 424
                  + DI   G  +  +L     L  +   +  +    +   + ++          
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 425 KLGKMALVCTHEDPENRP--TMEAVIEELTVAAPVMA 459
           ++  +A      D   R   T+  ++++ T  A    
Sbjct: 235 QISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTE 271

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 30/162 (18%), Positives = 69/162 (42%), Gaps = 23/162 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 239
           +   +L+G G++  V +     +  +VAI+ I     ++  CK    E    + +L  L 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110

Query: 240 HENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 296
           H++++++      +      E +++ + A      K       +   L      +++  +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLTELHIKTLLYNL 165

Query: 297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
             G+ Y+HS+ +     +HR+L     L++Q  +  + D GL
Sbjct: 166 LVGVKYVHSAGI-----LHRDLKPANCLVNQDCSVKVCDFGL 202

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 59/387 (15%), Positives = 108/387 (27%), Gaps = 89/387 (22%)

Query: 122 DWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGF-----SR-EHLNSFRLN 175
            + L + +   K   R  +            D L  Y +   F     SR +     R  
Sbjct: 92  KF-LMSPI---KTEQRQPSMMTRMYIEQR--DRL--YNDNQVFAKYNVSRLQPYLKLRQA 143

Query: 176 LEEVESATQCFSEVNLLGKGNF--SSVYKGTLRDGTLVAIRS-----INVTSCKSEEA-- 226
           L E+  A      V + G      + V         +          +N+ +C S E   
Sbjct: 144 LLELRPA----KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199

Query: 227 EFVKGLYL-----LTSL--RHENII--------RLRGFCCSRGRGECFLIYDFAPKGKLS 271
           E ++ L        TS      NI          LR    S+    C L+       K  
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 272 KYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE---KVL-IDQ 327
              +    S  +L  +TR   +          H S  +    +  +       K L    
Sbjct: 260 NAFN---LSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 328 Q--------FNPL-IADCGLHKLLADDI-------------VFSVLKTSAAMGYLAPEYV 365
           Q         NP  ++     + + D +             + +++++S  +  L P   
Sbjct: 316 QDLPREVLTTNPRRLSIIA--ESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEY 371

Query: 366 TTGRFTERSDIFAFGVII----LQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
               F   S +F     I    L ++   ++ +  M +  +          +L  K  + 
Sbjct: 372 RK-MFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNK------LHKYSLVEKQPKE 423

Query: 422 EAAKLGKMALVCTHEDPENRPTMEAVI 448
               +  + L       EN   +   I
Sbjct: 424 STISIPSIYLE-LKVKLENEYALHRSI 449

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 7e-05
 Identities = 66/517 (12%), Positives = 138/517 (26%), Gaps = 161/517 (31%)

Query: 5   EALKRLNGGFQFQNNP-----GLCGDGIASLRACTVYDNTQINPVKPFGSH----SNDTT 55
           +AL  L      +        G+ G G   + A  V  + ++     F        N  +
Sbjct: 142 QALLEL------RPAKNVLIDGVLGSGKTWV-ALDVCLSYKVQCKMDFKIFWLNLKNCNS 194

Query: 56  PIDISEP-SGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKI 114
           P  + E         + +  S S     I        + +      +    + + ++   
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNI-------KLRIHSIQAELRRLLKSKPYEN-- 245

Query: 115 GNTSESS----D--WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREH 168
                              +      FN      L++  +      + D+L+    +   
Sbjct: 246 ------CLLVLLNVQ----NAKAWNAFN-LSCKILLTTRF----KQVTDFLSAATTTHIS 290

Query: 169 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSE 224
           L+   + L   E         +LL K  +       L           +  I        
Sbjct: 291 LDHHSMTLTPDEV-------KSLLLK--YLDCRPQDLPREVLTTNPRRLSII-------- 333

Query: 225 EAEFVK-GLYLLTSLRHENIIRLRGFCCSRGRGECF----------LIYDFA-------- 265
            AE ++ GL    + +H N  +L     +                 +    +        
Sbjct: 334 -AESIRDGLATWDNWKHVNCDKL-----TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 266 PKGKLSKY---LDQEEGSSNVLDWSTRVSIIIGIAK-GIGYLHS------SEVNKPAIVH 315
           P   LS     + + +    V++   + S++    K     + S       ++     +H
Sbjct: 388 PTILLSLIWFDVIKSD-VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446

Query: 316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSD 375
           R++ V+   I + F+       L     D   +S +      G+    ++      ER  
Sbjct: 447 RSI-VDHYNIPKTFDSD----DLIPPYLDQYFYSHI------GH----HLKNIEHPERMT 491

Query: 376 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH 435
           +F                            F +F  R L+ K      A     +++ T 
Sbjct: 492 LF-------------------------RMVFLDF--RFLEQKIRHDSTAWNASGSILNTL 524

Query: 436 ED--------PENRPTMEAVIEELTVAAPVMATFLFS 464
           +          +N P  E ++  +         FL  
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAIL-------DFLPK 554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 39/220 (17%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 233
           Q F  + ++G+G+++ V    L+    + A++ +         ++   ++E+        
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH------V 62

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
              +  H  ++ L    C +     F + ++   G L  ++ ++                
Sbjct: 63  FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 115

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I+  + YLH        I++R+L ++ VL+D + +  + D G+ K   + +      
Sbjct: 116 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 166

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           TS   G   Y+APE +    +    D +A GV++ +++ G
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 19/156 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 243
           +  V  LG+G +S V++   + +   V ++ +     K  + E +K   +L +LR   NI
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-IK---ILENLRGGPNI 93

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           I L             L+++        +           L        +  I K + Y 
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 146

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGL 338
           HS       I+HR++    V+ID +   L + D GL
Sbjct: 147 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGL 177

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 36/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 233
             F  + +LGKG+F  V    +++ G L A++ +         +V    +E+        
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR------I 76

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           L  +  H  + +L  FCC +     F + +F   G L  ++ +            R    
Sbjct: 77  LSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFY 129

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              I   + +LH        I++R+L ++ VL+D + +  +AD G+ K   + I   V  
Sbjct: 130 AAEIISALMFLHDK-----GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGV-T 180

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           T+   G   Y+APE +    +    D +A GV++ ++L G
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 54/282 (19%), Positives = 99/282 (35%), Gaps = 54/282 (19%)

Query: 186 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLL 235
           F  + ++G+G FS V     K T   G + A++ +N    K +     E    +    +L
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMN----KWDMLKRGEVSCFREERDVL 115

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
            +     I +L      +     +L+ ++   G L   L +                 + 
Sbjct: 116 VNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA----EMARFYLA 169

Query: 296 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            I   I  +H         VHR++  + +L+D+  +  +AD G    L  D     +++ 
Sbjct: 170 EIVMAIDSVHRL-----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---GTVRSL 221

Query: 355 AAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 404
            A+G   YL+PE          TG +    D +A GV   ++  G     +     + + 
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAE 277

Query: 405 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 441
           T+   +                E A+     L+C    PE R
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC---PPETR 316

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 53/256 (20%), Positives = 104/256 (40%), Gaps = 29/256 (11%)

Query: 184 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG--LYLL 235
           + F  + +LG G +  V+   K +  D G L A++ +       K++  E  +     L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
              +   ++ L      +   +  LI D+   G+L  +L Q E  +        V I +G
Sbjct: 114 HIRQSPFLVTLH--YAFQTETKLHLILDYINGGELFTHLSQRERFTE-----HEVQIYVG 166

Query: 296 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
            I   + +LH        I++R++ +E +L+D   + ++ D GL K   + +     +  
Sbjct: 167 EIVLALEHLHKL-----GIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAY 218

Query: 355 AAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
              G   Y+AP+ V  G     +  D ++ GV++ ++LTG+   T      +++      
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

Query: 410 IDRNLKGKFSESEAAK 425
           +          S  AK
Sbjct: 279 LKSEPPYPQEMSALAK 294

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 242
           F  +  LG G+F  V+    R  G   A++ +      + ++ E       +L+ + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 301
           IIR+ G      +   F+I D+   G+L   L + +   N              +   + 
Sbjct: 68  IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPN-----PVAKFYAAEVCLALE 120

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 358
           YLHS +     I++R+L  E +L+D+  +  I D G  K + D        T    G   
Sbjct: 121 YLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPD 168

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           Y+APE V+T  + +  D ++FG++I ++L G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 44/231 (19%), Positives = 83/231 (35%), Gaps = 51/231 (22%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINV----TSCKSEEAEFVKGLYLLTSLRH 240
           F   +LLG+G +  V   T    G +VAI+ I              E    + +L   +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKH 68

Query: 241 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           ENII +             E ++I +      L + +     S+ +L        I    
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLSDDHIQYFIYQTL 122

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-------ADDIVFSV 350
           + +  LH S V     +HR+L    +LI+       ++C L K+         D+     
Sbjct: 123 RAVKVLHGSNV-----IHRDLKPSNLLIN-------SNCDL-KVCDFGLARIIDESAADN 169

Query: 351 LKTSAAMGYLAPEYVTT------------GRFTERSDIFAFGVIILQILTG 389
            + +     +  E+V T             +++   D+++ G I+ ++   
Sbjct: 170 SEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 42/230 (18%), Positives = 75/230 (32%), Gaps = 49/230 (21%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY---------LL 235
           ++    +  G++ +V  G   +G  VAI+ +  T                        LL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 236 TSLRHENIIRLRGFCCSRGRG---ECFLIYDF----------APKGKLSKYLDQEEGSSN 282
               H NI+ LR            + +L+ +             +  +S    Q      
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ------ 137

Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 342
                     +  I  G+  LH + V     VHR+L    +L+    +  I D  L +  
Sbjct: 138 --------YFMYHILLGLHVLHEAGV-----VHRDLHPGNILLADNNDITICDFNLARED 184

Query: 343 ADDIVFS--VLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 389
             D   +  V        Y APE V     FT+  D+++ G ++ ++   
Sbjct: 185 TADANKTHYV----THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)

Query: 184 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSI--------NVTSCKSEEAEFVKG 231
             F  + +LG+G+F  V+   K +  D   L A++ +        +    K E       
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER------ 77

Query: 232 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
             +L  + H  I++L      +  G+ +LI DF   G L   L +E   +        V 
Sbjct: 78  -DILVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVK 129

Query: 292 IIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 350
             +  +A  + +LHS       I++R+L  E +L+D++ +  + D GL K   D      
Sbjct: 130 FYLAELALALDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 181

Query: 351 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
            K  +  G   Y+APE V     T+ +D ++FGV++ ++LTG+L
Sbjct: 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 184 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 233
             F  + ++GKG+F  V     +      A++ +               SE         
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN------V 91

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           LL +++H  ++ L      +   + + + D+   G+L  +L Q E          R    
Sbjct: 92  LLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLE----PRARFY 144

Query: 294 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 352
              IA  +GYLHS       IV+R+L  E +L+D Q + ++ D GL K   ++I  +   
Sbjct: 145 AAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNS-T 195

Query: 353 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 389
           TS   G   YLAPE +    +    D +  G ++ ++L G
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 34/204 (16%), Positives = 71/204 (34%), Gaps = 49/204 (24%)

Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTS 237
           E++++ +S    LG G+F  V +    + G   A++ +      K+ E      L ++  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE------LDIMKV 56

Query: 238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR-------- 289
           L H NII+L  +  + G  E           KL    +        +  +          
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 290 -------VSIIIG--------------------IAKGIGYLHSSEVNKPAIVHRNLSVEK 322
                  +  ++                     + + +G++HS  +      HR++  + 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI-----CHRDIKPQN 171

Query: 323 VLIDQQFNPL-IADCGLHKLLADD 345
           +L++ + N L + D G  K L   
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPS 195

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	464
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.99
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.96
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.79
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.6
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.14
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.04
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	97.02
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.88
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.52
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	96.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.17
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.06
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.27
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.79
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.38
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.64
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	84.65

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.3e-60  Score=457.58  Aligned_cols=262  Identities=23%  Similarity=0.392  Sum_probs=216.1

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||+||+|++.      ++..||||+++... ....++|.+|+.+|++++|||||+++|+|  .+.+.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVC--VEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEE--eeCCE
Confidence            45667789999999999999874      47889999998654 45567899999999999999999999999  44677


Q ss_pred             EEEEEecCCCCCHHHHhhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEE---------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      .+||||||++|||.++|+...         .....++|.+++.|+.|||+||+|||+++     ||||||||+||||+++
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGG
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccCHhhEEECCC
Confidence            999999999999999997642         22345999999999999999999999988     9999999999999999


Q ss_pred             CCeEEeeCCccccccCCceeee-eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhH
Q 012392          329 FNPLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  406 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~  406 (464)
                      +.+||+|||+++.......... ....+|+.|||||++.++.|+.++|||||||+||||+| |+.||......     .+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-----~~  239 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EV  239 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HH
Confidence            9999999999987654433222 22347889999999999999999999999999999999 89999754321     22


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ...+........+..+++++.+|+.+||+.||++||||+||++.|+.+....
T Consensus       240 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          240 IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            2233334445567778889999999999999999999999999998775543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.4e-60  Score=458.28  Aligned_cols=257  Identities=23%  Similarity=0.390  Sum_probs=214.3

Q ss_pred             CccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      +...+.||+|+||+||+|++.      +++.||||+++........++|.+|+.+|++++|||||+++|+|  ...+..+
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~--~~~~~~~  105 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV--TKDQPLS  105 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE--EECCEEE
Confidence            455688999999999999973      46789999998765555567899999999999999999999999  4466789


Q ss_pred             EEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      ||||||++|||.++|......            ...++|.+++.|+.|||+||+|||+.+     ||||||||+||||++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYD  180 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCccccceEECC
Confidence            999999999999999754311            235999999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhh
Q 012392          328 QFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  405 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~  405 (464)
                      ++++||+|||+++........ ......+|++|||||++.++.|+.++|||||||+||||+| |..||.+...     ..
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~  255 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QD  255 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HH
Confidence            999999999999876543322 2334467889999999999999999999999999999999 7888875432     12


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +...+........+..++..+.+|+.+||+.||++||||+||+++|+..
T Consensus       256 ~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2333444445556778889999999999999999999999999999854

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-59  Score=459.46  Aligned_cols=263  Identities=22%  Similarity=0.376  Sum_probs=212.1

Q ss_pred             cCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...++||+|+||+||+|+++      +++.||||.++... ....++|.+|+.+|++++|||||+++|+|  .+.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVC--TEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence            34566788999999999999875      47899999998654 55567899999999999999999999999  44677


Q ss_pred             EEEEEecCCCCCHHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      .+||||||++|+|.++|+....           ...+++|.+++.|+.|||+||+|||+.+     ||||||||+||||+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLKp~NILl~  192 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVG  192 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHhhEEEC
Confidence            9999999999999999976432           1245999999999999999999999988     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      +++.+||+|||+++....... .......+|+.|||||++.+..|+.++|||||||+||||+| |+.||......     
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-----  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----  267 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-----
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-----
Confidence            999999999999987654322 22334568899999999999999999999999999999999 89998754321     


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      .+...+....+...+..+++++.+|+.+||+.||++||||+||+++|+.+.+..+
T Consensus       268 ~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          268 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            1222333344556677788899999999999999999999999999998765443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-58  Score=446.04  Aligned_cols=257  Identities=20%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +++...+.||+|+||+||+|++++  .||||.++... .....++|.+|+.+|++++|||||+++|+|.   .+..+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---~~~~~iVm  110 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT---KDNLAIVT  110 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE---CCeEEEEE
Confidence            456677899999999999999754  59999987543 2344578999999999999999999999873   24589999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      |||++|+|.++|+...   ..++|.+++.|+.|||+||+|||+.+     ||||||||+||||++++++||+|||+|+..
T Consensus       111 Ey~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~-----IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             ECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9999999999997643   34999999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCc-eeeeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC---
Q 012392          343 ADDI-VFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK---  415 (464)
Q Consensus       343 ~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  415 (464)
                      .... ........||+.|||||++..   +.|+.++|||||||+||||+||+.||.......    .+...+.....   
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~~~~~~p~  258 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVGRGYASPD  258 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHTTCCCCC
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCC
Confidence            5322 222334568999999999853   468999999999999999999999997532211    11122222211   


Q ss_pred             -CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          416 -GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       416 -~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                       ...+..+++.+.+|+.+||+.||++||||.||+++|+.+...
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence             223456778899999999999999999999999999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.1e-58  Score=452.68  Aligned_cols=274  Identities=22%  Similarity=0.381  Sum_probs=228.4

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC-CCcee
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIR  245 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H-~niv~  245 (464)
                      .+..++++...++|...+.||+|+||+||+|++..      ++.||||.++........++|.+|+.+|++++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            45566777778889999999999999999998642      368999999877656667789999999999965 99999


Q ss_pred             eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 012392          246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI  313 (464)
Q Consensus       246 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~i  313 (464)
                      ++|+|.. ..+..+||||||++|+|.++|+....            ....++|.+++.|+.|||+||+|||+++     |
T Consensus       133 l~g~~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-----i  206 (353)
T 4ase_A          133 LLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----C  206 (353)
T ss_dssp             EEEEECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred             EEEEEEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-----e
Confidence            9999843 24568999999999999999976432            1245899999999999999999999998     9


Q ss_pred             eecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCC
Q 012392          314 VHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSL  391 (464)
Q Consensus       314 vH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~  391 (464)
                      |||||||+|||+++++.+||+|||+|+....+.. .......+|+.|||||++.++.|+.++|||||||+||||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999997754332 22333457889999999999999999999999999999998 899


Q ss_pred             CCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          392 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       392 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ||.+...    ...+...+....+...+..+++++.+++..||+.||++||||.||+++|+.+.+
T Consensus       287 Pf~~~~~----~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          287 PYPGVKI----DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             SSTTCCC----SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCH----HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            9865321    122334444555666777788899999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-55  Score=421.59  Aligned_cols=253  Identities=23%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             ccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--CCCeEEEEE
Q 012392          187 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLIY  262 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~lv~  262 (464)
                      ...++||+|+||+||+|+.. ++..||||.+.... .....+.|.+|+.+|++++|||||++++++...  ....++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34467999999999999976 68899999987543 334456799999999999999999999988542  234689999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~~  341 (464)
                      |||++|+|.++|....    .+++..+..|+.||+.||+|||+++   ++||||||||+||||+ +++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~---~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999998653    4899999999999999999999876   5699999999999998 479999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ......   ....||+.|||||++. +.|+.++|||||||+||||+||+.||........   ....+.........+..
T Consensus       182 ~~~~~~---~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~~  254 (290)
T 3fpq_A          182 KRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             CCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGC
T ss_pred             CCCCcc---CCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---HHHHHHcCCCCCCCCcc
Confidence            544322   2346899999999886 4699999999999999999999999965322111   11111111111122333


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .++++.+++.+||+.||++|||++|+++|-+.
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            45678999999999999999999999998664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-55  Score=433.04  Aligned_cols=256  Identities=18%  Similarity=0.354  Sum_probs=207.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|..++.||+|+||+||+|+.. +|+.||||.+..... ......|.+|+.+|++++|||||++++++.  +.+..|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~--~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE--ENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEE
Confidence            46889999999999999999975 799999999976542 334567999999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||||++|+|.++|.....  ..+++.+++.|+.||+.||+|||+++     ||||||||+||||++++.+||+|||+++.
T Consensus       102 mEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             EECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             EeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCCEEEccccccee
Confidence            999999999999976432  34789999999999999999999998     99999999999999999999999999997


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...... ......||+.|||||++.+..|+.++|||||||+||||+||+.||......    ..+..+.... ....+..
T Consensus       175 ~~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~-~~~~~~~  248 (350)
T 4b9d_A          175 LNSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----NLVLKIISGS-FPPVSLH  248 (350)
T ss_dssp             CCHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTC-CCCCCTT
T ss_pred             ecCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcCC-CCCCCcc
Confidence            654221 112235899999999999999999999999999999999999999765322    1222332222 2234455


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+.++.+|+.+||+.||++|||++|++++-+..
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence            677899999999999999999999999886543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-55  Score=426.96  Aligned_cols=265  Identities=21%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC--CeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~lv~  262 (464)
                      +|...+.||+|+||+||+|++ +|+.||||+++...  .....+..|+..+.+++|||||+++|+|.+...  ..++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            456678999999999999998 58999999987532  222223446666778999999999999976433  2689999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---NKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||++|+|.++|+..     .++|..+++|+.|+|.||+|||+...   .+++||||||||+||||++++++||+|||++
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999753     38999999999999999999998620   1346999999999999999999999999999


Q ss_pred             ccccCCcee---eeeccCCCCccCcccccccC------CCCCcchhHHHHHHHHHHHhCCCCCcchHH----------HH
Q 012392          340 KLLADDIVF---SVLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTGSLVLTSSMR----------LA  400 (464)
Q Consensus       340 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvll~el~tg~~p~~~~~~----------~~  400 (464)
                      +........   ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+.....          ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876443211   12234589999999998654      467899999999999999999776532110          00


Q ss_pred             -HhhhhHHHhhhhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          401 -AESATFENFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       401 -~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                       ........+....+++..+     ...++.+.+|+.+||+.||++||||.||++.|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence             0011112223334444443     24667899999999999999999999999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-55  Score=430.46  Aligned_cols=254  Identities=16%  Similarity=0.325  Sum_probs=211.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ...|+..+.||+|+||+||+|+.. +|+.||||.++.... .....+.+|+.+|++++|||||++++++.+  .+.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence            356888999999999999999976 799999999976542 234568899999999999999999999844  6789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||||++|+|.+++...     .+++.++..|+.||+.||+|||+++     ||||||||+||||++++.+||+|||+++.
T Consensus       150 mEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~  219 (346)
T 4fih_A          150 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQ  219 (346)
T ss_dssp             ECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEECCCCCEEEecCcCcee
Confidence            9999999999999752     3899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--CCCC
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKFS  419 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  419 (464)
                      +..... ......||+.|||||++.+..|+.++|||||||+||||+||..||.+.....    .+..+.. ...  ....
T Consensus       220 ~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~-~~~~~~~~~  293 (346)
T 4fih_A          220 VSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRD-NLPPRLKNL  293 (346)
T ss_dssp             CCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHH-SSCCCCSCG
T ss_pred             cCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHc-CCCCCCCcc
Confidence            754322 1223468999999999999999999999999999999999999997643221    1222222 121  1223


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...++++.+++.+||+.||++|||++|+++|-+...
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            456788999999999999999999999999876543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-55  Score=425.92  Aligned_cols=253  Identities=17%  Similarity=0.206  Sum_probs=205.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|...++||+|+||.||+|+.. +|+.||||.++....      +.+|+.+|++++|||||++++++.  +.+..||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~--~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVR--EGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEE
Confidence            45677789999999999999975 689999999976432      246999999999999999999984  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~~  341 (464)
                      |||++|+|.++|....    .+++.++..|+.||+.||+|||+++     ||||||||+||||+.++ .+||+|||+++.
T Consensus       130 Ey~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            9999999999998653    3999999999999999999999998     99999999999999987 699999999997


Q ss_pred             ccCCcee----eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC-C
Q 012392          342 LADDIVF----SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-G  416 (464)
Q Consensus       342 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~  416 (464)
                      +..+...    ......||+.|||||++.+..|+.++|||||||+||||+||+.||......    ..+..+...... .
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~~  276 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PLCLKIASEPPPIR  276 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CCHHHHHHSCCGGG
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHHcCCCCch
Confidence            7543221    112235899999999999999999999999999999999999999754221    112222221111 1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+...+..+.+++.+||+.||++|||+.|++++|..+.+.
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            24456678899999999999999999999999998766443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.7e-54  Score=431.18  Aligned_cols=254  Identities=15%  Similarity=0.318  Sum_probs=211.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .+.|+..+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.+|++++|||||++++++..  .+.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence            467999999999999999999976 69999999997654 2334568899999999999999999999854  6789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||||++|+|.+++...     .+++.++..|+.||+.||+|||+++     ||||||||+||||+.++.+||+|||+++.
T Consensus       227 mEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~-----IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             EECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEecCccceE
Confidence            9999999999999653     2899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-CCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  420 (464)
                      +..... ......||+.|||||++.+..|+.++|||||||+||||++|..||.+.....    .+..+..... ......
T Consensus       297 ~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~~~~  371 (423)
T 4fie_A          297 VSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPRLKNLH  371 (423)
T ss_dssp             CCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCCCSCTT
T ss_pred             CCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCCCCcccc
Confidence            754322 1223458899999999999999999999999999999999999997643221    1122221111 112234


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+..+.+|+.+||+.||++|||++|+++|-+..
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence            5567899999999999999999999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-53  Score=404.56  Aligned_cols=251  Identities=22%  Similarity=0.360  Sum_probs=196.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||+||+|+.. +|+.||||.++....  ......|.+|+.+|++++|||||++++++  .+.+..|+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI--KSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE--EECCEEEE
Confidence            46889999999999999999965 799999999975432  22345789999999999999999999998  45678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+ +|+|.+++....    .+++.+...++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+|+
T Consensus        91 vmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCChHHeEECCCCCEEEeecCCCe
Confidence            99999 789999997643    4999999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......  .....||+.|||||++.+..+ +.++||||+||+||||+||+.||......    ..+..+...  ....+
T Consensus       161 ~~~~~~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i~~~--~~~~p  232 (275)
T 3hyh_A          161 IMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNISNG--VYTLP  232 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHT--CCCCC
T ss_pred             ecCCCCc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcC--CCCCC
Confidence            7654322  223458999999999988876 57999999999999999999999764321    112222222  12344


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...++++.+++.+||+.||++|||++|+++|-|..
T Consensus       233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence            55677899999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-54  Score=415.11  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=207.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||+||+|+.. +|+.||||.+....  .......+.+|+.+|++++|||||++++++  ++.+..||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~yi  109 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLYF  109 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEEEE
Confidence            35889999999999999999975 78999999997532  122346789999999999999999999998  45778999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.++|....    .+++.+...++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+++
T Consensus       110 vmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            999999999999998653    3899999999999999999999998     9999999999999999999999999999


Q ss_pred             cccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .+..+. ........||+.|||||++.+..|+.++||||+||+||||+||+.||......    ..+..+...  ...++
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~--~~~~p  254 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKL--EYDFP  254 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHT--CCCCC
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcC--CCCCC
Confidence            775432 12233446899999999999999999999999999999999999999764322    122233222  22345


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVI  448 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl  448 (464)
                      ...+.++.+++.+||+.||++|||++|++
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            55677899999999999999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.9e-53  Score=409.39  Aligned_cols=254  Identities=20%  Similarity=0.328  Sum_probs=195.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC-------
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-------  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-------  255 (464)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.++........+.|.+|+.+|++++|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999975 7899999999876655556789999999999999999999998865332       


Q ss_pred             ---CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          256 ---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       256 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                         ...|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||+++     ||||||||+|||++.++.+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~-----IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc-----CccccCcHHHeEECCCCcEE
Confidence               247999999999999999976432 223667788999999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceee-----------eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH
Q 012392          333 IADCGLHKLLADDIVFS-----------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA  401 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~  401 (464)
                      |+|||+++.........           .....||+.|||||++.+..|+.++|||||||+||||++   ||....... 
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-  234 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-  234 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-
Confidence            99999998765432111           122358899999999999999999999999999999997   665433211 


Q ss_pred             hhhhHHHhhhhhcCCCCCH---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          402 ESATFENFIDRNLKGKFSE---SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ..+..+    .....+.   .....+.+++.+||+.||++|||+.|++++-+.
T Consensus       235 --~~~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          235 --RTLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             --HHHHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             --HHHHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence              111111    1223332   334567889999999999999999999987553

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.3e-54  Score=412.73  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|+..+.||+|+||+||+|+..    .++.||||.++.... ......+.+|+.+|++++|||||++++++.  +.+..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ--TEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE--ETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEE
Confidence            45888999999999999999863    478999999875431 122346888999999999999999999984  46789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |||||||++|+|.++|....    .+++.++..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            99999999999999998653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      |+....... ......||+.|||||.+.+..|+.++|||||||+||||+||+.||.+.....    .+..+...  ....
T Consensus       173 a~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~--~~~~  245 (304)
T 3ubd_A          173 SKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMILKA--KLGM  245 (304)
T ss_dssp             EEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCC
T ss_pred             ceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHHHcC--CCCC
Confidence            986543221 1223458999999999999999999999999999999999999997653321    22222222  2234


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      +...+.++.+++.+||+.||++|||     ++|+++|-+.
T Consensus       246 p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence            5566788999999999999999998     5799987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=396.70  Aligned_cols=261  Identities=17%  Similarity=0.298  Sum_probs=203.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeC----CCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~----~~~~  257 (464)
                      ++|...+.||+|+||+||+|+.. +|+.||||.++.... ....+.+++|+.+|++++|||||++++++...    +.+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46889999999999999999975 799999999975432 33446789999999999999999999987432    2357


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      +|||||||+ |+|.+++...    ..+++..+..|+.||+.||+|||+++     ||||||||+|||++.++.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ-----VIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc-----CcCCCcCccccccCCCCCEEEeecc
Confidence            899999995 7899999753    34999999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCce---eeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh--
Q 012392          338 LHKLLADDIV---FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--  411 (464)
Q Consensus       338 l~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~--  411 (464)
                      +++.+.....   .......||+.|||||++.+. .++.++||||+||++|||++|+.||.+................  
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9987643321   112234688999999998775 4689999999999999999999999764332211111110000  


Q ss_pred             ----------------hhcCCC--CC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          412 ----------------RNLKGK--FS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       412 ----------------~~~~~~--~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                      ..+...  .+     ...+.++.+|+.+||+.||++|||++|+++|-+..
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence                            000000  00     12346788999999999999999999999997754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-49  Score=388.25  Aligned_cols=281  Identities=33%  Similarity=0.665  Sum_probs=232.8

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      .++..++....++|...+.||+|+||.||+|+..+++.||||.+...........|.+|+.++++++||||+++++++  
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--   96 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC--   96 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE--
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE--
Confidence            678899999999999999999999999999998889999999997654333344689999999999999999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ......++||||+++|+|.+++.........++|..+..++.|++.||+|||+..  .++|+||||||+|||+++++.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS--SSCEECCCCSGGGEEECTTCCEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCchhhEEECCCCCEE
Confidence            4566789999999999999999876655566999999999999999999999981  12299999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh----------
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----------  402 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~----------  402 (464)
                      |+|||+++..............+|..|+|||.+.+..++.++||||||+++|||+||+.||.........          
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999876544333334445888999999998888999999999999999999999999643211111          


Q ss_pred             ---hhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          403 ---SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       403 ---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                         ........+.......+...+..+.+++..||+.||++|||+.||+++|+.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence               1122333344445566788899999999999999999999999999999875443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-48  Score=382.45  Aligned_cols=280  Identities=33%  Similarity=0.593  Sum_probs=229.7

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      .++..++..++++|...+.||+|+||.||+|++++++.||||.+.... ......|.+|+.++++++||||+++++++  
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--  104 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFC--  104 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEEC--
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            455566777889999999999999999999998889999999987654 34566799999999999999999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ...+..++||||+++|+|.+++.........++|..++.++.||+.||+|||+.+     |+||||||+|||++.++.+|
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-----IIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCSTTEEECTTCCEE
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-----eecCCCCHHHEEECCCCCEE
Confidence            4567789999999999999999765544446999999999999999999999988     99999999999999999999


Q ss_pred             EeeCCccccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH-----------H
Q 012392          333 IADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----------A  400 (464)
Q Consensus       333 l~DfGl~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~-----------~  400 (464)
                      |+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||+||+.|+......           .
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998654321 11112233678899999999889999999999999999999999998643211           0


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccc
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT  460 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~  460 (464)
                      .....+...+++..........+..+.+++.+||+.||++|||+.|++++|+.+...+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence            011122233344445556788899999999999999999999999999999988766543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-48  Score=387.00  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=199.8

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      .+....+.|...+.||+|+||+||+|+.+    .++.||||.+....   ...++.+|+.+|+.+ +|||||++++++. 
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-   90 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFR-   90 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEE-
Confidence            34456688999999999999999999853    46789999986543   234678999999998 6999999999884 


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCe
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNP  331 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~  331 (464)
                       ..+..++||||+++|+|.+++.       .+++.++..++.||+.||+|||+++     |+||||||+|||++.+ +.+
T Consensus        91 -~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g-----IiHRDiKPeNiLl~~~~~~~  157 (361)
T 4f9c_A           91 -KNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG-----IVHRDVKPSNFLYNRRLKKY  157 (361)
T ss_dssp             -ETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEE
T ss_pred             -ECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCcCCHHHeEEeCCCCeE
Confidence             4678999999999999999984       2899999999999999999999998     9999999999999877 799


Q ss_pred             EEeeCCccccccCCce---------------------------eeeeccCCCCccCcccccccC-CCCCcchhHHHHHHH
Q 012392          332 LIADCGLHKLLADDIV---------------------------FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVII  383 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll  383 (464)
                      ||+|||+|+...+...                           .......||+.|+|||++.+. .|+.++||||+||++
T Consensus       158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence            9999999986543210                           011223588999999999775 589999999999999


Q ss_pred             HHHHhCCCCCcchHHHHHhhhhH-------------------------------HHhhhhhcC-----------------
Q 012392          384 LQILTGSLVLTSSMRLAAESATF-------------------------------ENFIDRNLK-----------------  415 (464)
Q Consensus       384 ~el~tg~~p~~~~~~~~~~~~~~-------------------------------~~~~~~~~~-----------------  415 (464)
                      |||+||+.||............+                               .........                 
T Consensus       238 ~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  317 (361)
T 4f9c_A          238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT  317 (361)
T ss_dssp             HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred             HHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence            99999999995432111000000                               000000000                 


Q ss_pred             -CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          416 -GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       416 -~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       .......+++..+|+.+|++.||++|||++|+++|-+.
T Consensus       318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence             00011234668899999999999999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.5e-48  Score=406.04  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=211.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|.+.+.||+|+||.||+|+.+ +|+.||||.+.... ......+.+|+.+|+.++|||||++++++  .+...++|||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDNEMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEE--ECSSEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCEEEEEE
Confidence            57899999999999999999976 79999999997654 44556788999999999999999999998  5578899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC--CCeEEeeCCccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIADCGLHK  340 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfGl~~  340 (464)
                      |||++|+|.++|....   ..+++.++..++.||+.||+|||+++     |+||||||+|||++.+  +.+||+|||+++
T Consensus       234 E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          234 EFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             ECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             eecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhccccCCCCCCEEEeecccee
Confidence            9999999999996533   24899999999999999999999998     9999999999999854  899999999999


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--CCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKF  418 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~  418 (464)
                      .+......  ....||+.|||||++.+..|+.++||||+||+||||++|..||.+....    ..+..+......  ...
T Consensus       306 ~~~~~~~~--~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~  379 (573)
T 3uto_A          306 HLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSCDWNMDDSA  379 (573)
T ss_dssp             ECCTTSEE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCCCSGG
T ss_pred             EccCCCce--eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHhCCCCCCccc
Confidence            87654332  2345889999999999999999999999999999999999999765332    112222221111  111


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....++.+.+|+.+||+.||++|||+.|+++|-+..
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~  415 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  415 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence            234567789999999999999999999999987643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-47  Score=400.32  Aligned_cols=253  Identities=19%  Similarity=0.235  Sum_probs=205.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-----chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...++||+|+||+||+|+.. +|+.||||.++....     .....+...++.+++.++|||||++++++  .+.+.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--~~~~~  266 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDK  266 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECSSE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--EECCE
Confidence            67999999999999999999976 699999999964321     11112233456778888999999999988  55788


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      +|||||||++|+|.++|....    .+++.....++.||+.||+|||+++     ||||||||+||||++++.+||+|||
T Consensus       267 lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g-----IiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHeEEeCCCCEEecccc
Confidence            999999999999999998653    3899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +|+.......   ....||+.|||||++.. ..|+.++||||+||+||||++|..||........ .........  ...
T Consensus       338 lA~~~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~--~~~  411 (689)
T 3v5w_A          338 LACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT--MAV  411 (689)
T ss_dssp             TCEECSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHH--CCC
T ss_pred             eeeecCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcC--CCC
Confidence            9987765432   23468999999999975 5799999999999999999999999975421100 111112211  223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      .++...+.++.+|+..||+.||.+|++     ++||++|-+.
T Consensus       412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF  453 (689)
T 3v5w_A          412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  453 (689)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence            455566788999999999999999998     7999988664

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-47  Score=383.80  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=215.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|++. +++.||||.++.........+|.+|+.+|++++||||++++|+|  ...+..++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE--CSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--ecCCCcEEE
Confidence            456778899999999999999986 78999999998655444556799999999999999999999998  446678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus       191 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKC-----CIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            999999999999986432   3899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeee-ccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          342 LADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       342 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......... ...++..|+|||.+..+.++.++|||||||++|||+| |..||.....     ......+....+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  337 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVEKGGRLPCP  337 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHHTTCCCCCC
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            5543322111 1123567999999998899999999999999999999 8888865432     1223334444455566


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..+++.+.+++..||+.||++|||++++++.|+.+..
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            6678889999999999999999999999999987753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.6e-47  Score=378.02  Aligned_cols=262  Identities=24%  Similarity=0.408  Sum_probs=215.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  253 (464)
                      .++|...+.||+|+||.||+|+..        ++..||||.++.........+|.+|+.+++++ +||||++++++|  .
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--T  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--C
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--c
Confidence            356788899999999999999862        35679999998765555667899999999999 899999999998  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCC
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  321 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~  321 (464)
                      ..+..++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||+.+     |+||||||+
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~  232 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR  232 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGG
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchh
Confidence            56779999999999999999986532            1234899999999999999999999998     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHH
Q 012392          322 KVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL  399 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~  399 (464)
                      |||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... 
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            99999999999999999986644321 11223345678999999999999999999999999999999 8888865321 


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                          ..+...+........+..++..+.+++..||+.||++||++.|++++|+.+..
T Consensus       312 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          312 ----EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ----GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                12223333344445566777889999999999999999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=369.91  Aligned_cols=259  Identities=22%  Similarity=0.415  Sum_probs=213.2

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||.||+|++.    .+..||||.++.........+|.+|+.++++++||||+++++++  ...+..+
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~  126 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRGRLAM  126 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CGGGCCE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCccE
Confidence            56788899999999999999984    35569999998765556667899999999999999999999998  4466789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       127 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEECCCCCEEECCCCcc
Confidence            9999999999999997543   24999999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +.......  .......+|..|+|||.+.+..++.++||||||+++|||++ |..||......     .+...+......
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~~~~~  273 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSVEEGYRL  273 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHTTCCC
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHcCCCC
Confidence            87654321  22223345668999999998899999999999999999999 99998654321     122223333444


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+...+..+.+++..||+.||++|||+.+|++.|+.+...
T Consensus       274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            55566778899999999999999999999999999877443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.1e-47  Score=378.15  Aligned_cols=259  Identities=23%  Similarity=0.437  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ..+|...+.||+|+||.||+|++.    ++..||||.++........++|.+|+.++++++||||++++|++  ...+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--eeCCce
Confidence            356888999999999999999875    57789999998765455667899999999999999999999998  446778


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            99999999999999997543   24899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ++.......  .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....     ..+...+.....
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~i~~~~~  268 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYR  268 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHHHHTTEE
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            987654321  12222334667999999999999999999999999999998 9999865432     122233333444


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+..++..+.+++..||+.||++||++.+|++.|+.+..
T Consensus       269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            44555677889999999999999999999999999987743

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.9e-47  Score=390.90  Aligned_cols=261  Identities=23%  Similarity=0.431  Sum_probs=217.8

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++...++|...+.||+|+||.||+|++.++..||||.++...  ....+|.+|+.+|++++||||+++++++.   ....
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~  257 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPI  257 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCcc
Confidence            344566788889999999999999999888999999998654  23568999999999999999999999873   3468


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++.....  ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999986432  13889999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++..............++..|+|||.+..+.++.++|||||||+||||+| |+.||......     .+...+....+..
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~  405 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALERGYRMP  405 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHHTCCCC
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCC
Confidence            98765433222233445678999999998999999999999999999999 99998654321     1222333344455


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+..+++.+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            566778899999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.1e-46  Score=355.88  Aligned_cols=258  Identities=21%  Similarity=0.399  Sum_probs=215.9

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .++|...+.||+|+||.||+|+.+++..||||.++....  ...++.+|+.++.+++||||+++++++  ......++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCceEEEE
Confidence            456888899999999999999999888999999976542  345789999999999999999999998  5567799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++...
T Consensus        83 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             ECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             EccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCcceEEECCCCCEEEccCccceec
Confidence            99999999999976532   3899999999999999999999998     999999999999999999999999999877


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ............++..|+|||.+.+..++.++||||||+++|||+| |+.||.......     ....+........+..
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGHRLYRPHL  229 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTCCCCCCTT
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHcCCCCCCCCc
Confidence            6655444445556678999999998889999999999999999999 888886543211     1111222223334445


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .++.+.+++..||+.||++|||+.+++++|+.+...
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            567899999999999999999999999999987653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-46  Score=366.76  Aligned_cols=268  Identities=22%  Similarity=0.391  Sum_probs=208.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      +++.....+|...+.||+|+||.||+|+. +++.||||.+..... .....+|.+|+.++++++||||+++++++  ...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV--TQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EEC
Confidence            34444556788999999999999999987 588999999876542 33446799999999999999999999998  456


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+   ++|+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN---PPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS---SCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC---CCEECCCCChhhEEEeCCCcEEECC
Confidence            678999999999999999975321 123899999999999999999999876   5699999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ||+++....... ......+|..|+|||.+.+..++.++||||||+++|||+||+.||.......    ...........
T Consensus       183 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~  257 (309)
T 3p86_A          183 FGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKCKR  257 (309)
T ss_dssp             CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHHHSCCC
T ss_pred             CCCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCC
Confidence            999986543221 2223457888999999999999999999999999999999999997543211    11122222233


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            44556677889999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-46  Score=364.19  Aligned_cols=266  Identities=24%  Similarity=0.414  Sum_probs=212.4

Q ss_pred             cCCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|+..+.||+|+||.||+|++     .+++.||||.+.... ....+.|.+|+.++++++||||+++++++...+....
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5678889999999999999985     268899999987654 4455789999999999999999999999865445568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++.+++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHhhEEEcCCCeEEEccCcc
Confidence            99999999999999997643   23899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----------hhh
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------SAT  405 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----------~~~  405 (464)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|||+||..|+.........           ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987654321  1122234556799999999999999999999999999999999888654322110           012


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ....+........+..+++.+.+++..||+.||++|||++|+++.|+.+...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            22233333344556677889999999999999999999999999999876544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-46  Score=357.99  Aligned_cols=256  Identities=22%  Similarity=0.439  Sum_probs=213.7

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|+..+++.||||.+.....  ...+|.+|+.++++++||||+++++++  ...+..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCCceEEEEE
Confidence            45788899999999999999998899999999986542  345799999999999999999999998  45677999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++...
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             eCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCcchheEEEcCCCCEEecccccccccc
Confidence            999999999997543   34899999999999999999999998     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..||......     .....+........+...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCCCCCCTTS
T ss_pred             ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhcCccCCCCCcC
Confidence            443333334445677999999998999999999999999999999 88888654321     111222222334445556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..+.+++..||+.||++|||+.+++++|+.+..
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            7789999999999999999999999999998753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.7e-47  Score=376.40  Aligned_cols=277  Identities=22%  Similarity=0.386  Sum_probs=224.8

Q ss_pred             ccccCHHHHHHhhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCc
Q 012392          171 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENI  243 (464)
Q Consensus       171 ~~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~ni  243 (464)
                      ...+...+++...++|...+.||+|+||.||+|++.      +++.||||.++........+.|.+|+.++.++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            345667778888899999999999999999999842      46799999998766555667899999999999 79999


Q ss_pred             eeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC-------------------------------------------
Q 012392          244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------------------------------------------  280 (464)
Q Consensus       244 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------------  280 (464)
                      +++++++.. .....++||||+++|+|.+++......                                           
T Consensus        89 v~~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           89 VNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             CCEEEEECS-TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeec-CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            999999844 234589999999999999999865321                                           


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          281 -------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       281 -------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                                         ...+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCcEEEEeccceee
Confidence                               122899999999999999999999998     99999999999999999999999999986


Q ss_pred             ccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          342 LADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       342 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ..... ........+|..|+|||++.+..++.++|||||||++|||+| |..||.....    ...+...+........+
T Consensus       243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  318 (359)
T 3vhe_A          243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCRRLKEGTRMRAP  318 (359)
T ss_dssp             TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHHHHHHHTCCCCCC
T ss_pred             ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHHHHHHcCCCCCCC
Confidence            64332 222233446778999999999999999999999999999999 9999865321    11222333333344455


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ...+..+.+++..||+.||++|||+.|++++|+.+.+.
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            56677899999999999999999999999999987543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=365.09  Aligned_cols=259  Identities=24%  Similarity=0.420  Sum_probs=209.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+.... ......|.+|+.++++++||||+++++++..  .+..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEE
Confidence            45778899999999999999975 68999999886543 4556789999999999999999999999854  57799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....   ..++|.+++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++..
T Consensus        87 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN-----IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             ECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999998643   34999999999999999999999998     999999999999999999999999999876


Q ss_pred             cCCceee-------------eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH-hhhhHHH
Q 012392          343 ADDIVFS-------------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-ESATFEN  408 (464)
Q Consensus       343 ~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~-~~~~~~~  408 (464)
                      .......             .....+|..|+|||.+.+..++.++||||||+++|||++|..|+........ .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            4432111             0133578889999999999999999999999999999999988764321110 0111222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+..    .+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       239 ~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          239 FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            22222    2334456789999999999999999999999999877543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-46  Score=359.45  Aligned_cols=255  Identities=16%  Similarity=0.309  Sum_probs=210.9

Q ss_pred             hhcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+. .+++.||||.+..... .....+.+|+.++++++||||+++++++..  .+..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence            346788999999999999999986 4789999999876542 334568899999999999999999999854  567999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus        95 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            99999999999999753     3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh-hhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-RNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  419 (464)
                      ....... ......+|..|+|||.+.+..++.++|||||||++|||+||..||........    ...... .......+
T Consensus       165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~  239 (297)
T 3fxz_A          165 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQNP  239 (297)
T ss_dssp             ECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHHCSCCCSCG
T ss_pred             ecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCCc
Confidence            7654322 12234578889999999999999999999999999999999999975432211    111111 11222334


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++.+||+.||++|||++|++++.+..
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            56678899999999999999999999999986654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-46  Score=389.28  Aligned_cols=260  Identities=22%  Similarity=0.420  Sum_probs=219.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ....+|...+.||+|+||.||+|++.+ +..||||.++....  ...+|.+|+.+|++++||||++++|+|  ......+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~  292 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFY  292 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEE--ecCCcEE
Confidence            345668888999999999999999874 88999999976542  356799999999999999999999998  4466789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++.....  ..+++..++.|+.||+.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus       293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChhhEEECCCCcEEEeecccc
Confidence            99999999999999986432  34899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      +..............++..|+|||.+..+.++.++|||||||+||||+| |..||....     ...+.+.+....+...
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~~~  440 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKDYRMER  440 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHTTCCCCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCCCCC
Confidence            9776544333334445678999999998899999999999999999999 888886532     1223344445555566


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            67778899999999999999999999999999987754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=360.58  Aligned_cols=265  Identities=21%  Similarity=0.290  Sum_probs=214.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.++++++||||+++++++........++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46888899999999999999986 58999999997654444456788999999999999999999998766556789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE----cCCCCeEEeeCCc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGL  338 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfGl  338 (464)
                      ||+++|+|.+++...... ..+++.+++.++.||+.||+|||+.+     |+||||||+|||+    +.++.+||+|||+
T Consensus        89 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            999999999999865432 23899999999999999999999998     9999999999999    8888899999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVT--------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      ++.......  .....+|..|+|||.+.        +..++.++|||||||++|||+||+.||............+..++
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            987654332  12345788899999986        56789999999999999999999999864221111111122222


Q ss_pred             hhh-----------------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          411 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       411 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...                       .....+......+.+++..||+.||++|||++|++++.++.+-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            111                       1113456788899999999999999999999999999987643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=368.17  Aligned_cols=270  Identities=20%  Similarity=0.356  Sum_probs=218.4

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEE
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC  250 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~  250 (464)
                      ..+....++|...+.||+|+||.||+|+..      +++.||||.++..........|.+|+.++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344556788999999999999999999974      34789999998765555567899999999999999999999998


Q ss_pred             EeCCCCeEEEEEecCCCCCHHHHhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012392          251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  310 (464)
Q Consensus       251 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  310 (464)
                        ...+..++||||+++|+|.+++......                    ...+++.+++.++.||+.||+|||+.+   
T Consensus       120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---  194 (343)
T 1luf_A          120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  194 (343)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence              4467789999999999999999864311                    145899999999999999999999998   


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-  388 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-  388 (464)
                        |+||||||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| 
T Consensus       195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence              99999999999999999999999999986643322 12233456778999999998899999999999999999999 


Q ss_pred             CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          389 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       389 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      |..||......     .+...+........+...+..+.+++..||+.||++||++.+++++|+.+....
T Consensus       273 g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          273 GLQPYYGMAHE-----EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TCCTTTTSCHH-----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCcCCCCChH-----HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            88888754321     111122222223345566778999999999999999999999999999886654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.4e-46  Score=357.07  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=211.6

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      .++|...+.||+|+||.||+|+..++..||||.+.....  ...+|.+|+.++.+++||||+++++++  ...+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEE--ecCCCeEEEE
Confidence            356788899999999999999999888999999986542  346799999999999999999999998  5567799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999976432   3899999999999999999999998     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ............++..|+|||.+.+..++.++||||||+++|||+| |+.||......     .....+........+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~  245 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLYRPHL  245 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCCCCCCTT
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHHhcccCCCCCCc
Confidence            5443333334445678999999998899999999999999999999 99888754321     11122223334444555


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .++.+.+++..||+.||++|||+++++++|+.+..
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            66789999999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.7e-46  Score=365.55  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=205.0

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC--CCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG--RGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~--~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.. ++.||||.+....  .....+..|+.++++++||||+++++++....  ....++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            56888899999999999999886 7899999987542  33445667999999999999999999986543  2357999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCCCeeecCCCCCceEEcCCCCe
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS----------EVNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                      |||+++|+|.+++...     .++|..+..++.|++.||+|||+.          +     |+||||||+|||++.++.+
T Consensus       101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-----ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-----ISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-----EECSCCSGGGEEECTTCCE
T ss_pred             EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-----EEeCCCChHhEEECCCCeE
Confidence            9999999999999753     389999999999999999999987          6     9999999999999999999


Q ss_pred             EEeeCCccccccCCcee-eeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH-----
Q 012392          332 LIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----  400 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~-----  400 (464)
                      ||+|||+++........ ......+|..|+|||.+.+     ..++.++|||||||++|||+||+.||.......     
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999876543221 2223457889999999876     356678999999999999999999886421100     


Q ss_pred             ---H---hhhhHH-HhhhhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          401 ---A---ESATFE-NFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       401 ---~---~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                         .   ....+. ...........+     ...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               0   001111 111222222222     2456779999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-45  Score=360.33  Aligned_cols=266  Identities=16%  Similarity=0.311  Sum_probs=217.0

Q ss_pred             ccCHHHHHHhhcC----------CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCC
Q 012392          173 RLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE  241 (464)
Q Consensus       173 ~~~~~~~~~~~~~----------f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~  241 (464)
                      .++.+++..+++.          |+..+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.++++++||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence            5677888777764          667789999999999999986 79999999997654 33456789999999999999


Q ss_pred             CceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCC
Q 012392          242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  321 (464)
Q Consensus       242 niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~  321 (464)
                      ||+++++++..  .+..++||||+++|+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+
T Consensus       103 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~  170 (321)
T 2c30_A          103 NVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG-----VIHRDIKSD  170 (321)
T ss_dssp             TBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGG
T ss_pred             CcceEEEEEEE--CCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHH
Confidence            99999999854  56799999999999999998642     3899999999999999999999988     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH
Q 012392          322 KVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA  401 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~  401 (464)
                      |||++.++.+||+|||+++....... ......+|..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~  249 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA  249 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999987654321 12234578899999999999999999999999999999999999975432211


Q ss_pred             hhhhHHHhhhhhc-CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          402 ESATFENFIDRNL-KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       402 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                          ...+..... ........+..+.+++.+||+.||++|||+.|++++.+....
T Consensus       250 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          250 ----MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             ----HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ----HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                111111111 111223456789999999999999999999999998776544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.9e-46  Score=382.22  Aligned_cols=259  Identities=24%  Similarity=0.431  Sum_probs=210.1

Q ss_pred             HhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...++|...+.||+|+||.||+|++.++..||||.++....  ...+|.+|+.+|++++||||+++++++.  . +..++
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~-~~~~i  255 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EPIYI  255 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSCEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEc--C-CceEE
Confidence            34566788899999999999999998888899999986542  3457999999999999999999999983  3 56899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....+  ..+++.+++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus       256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEECCCCCEEECCCccce
Confidence            9999999999999986432  23899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ..............++..|+|||.+..+.++.++|||||||++|||+| |+.||......     .+...+....+...+
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~~~  403 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMPCP  403 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCC
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCC
Confidence            765443323333446678999999999999999999999999999999 88888654321     122223334445556


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..+++.+.+++..||+.||++|||++++++.|+.+..
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            6778899999999999999999999999999987754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-46  Score=366.95  Aligned_cols=258  Identities=24%  Similarity=0.439  Sum_probs=206.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|++. +++    .||+|.+..........+|.+|+.++++++||||++++++|..   +..
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---SSE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---CCe
Confidence            45788899999999999999964 444    4688888755444556789999999999999999999999854   347


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCChheEEECCCCCEEEccCcc
Confidence            89999999999999998643   34899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++...... ........+|..|+|||.+.+..++.++|||||||++|||+| |+.||....     ...+...+......
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~~~~~  238 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGERL  238 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHHTTCCC
T ss_pred             eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHHcCCCC
Confidence            98764432 222233445778999999999999999999999999999999 999986532     12233444444455


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+..++..+.+++.+||+.||++||++.+++++|+.+...
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            55666778899999999999999999999999999887553

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=372.51  Aligned_cols=262  Identities=19%  Similarity=0.374  Sum_probs=213.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|...+.||+|+||.||+|++.      ++..||||.++.........+|.+|+.++++++||||+++++++  ....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCC
Confidence            356888899999999999999953      46789999997665566667899999999999999999999998  4466


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC---C
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~  330 (464)
                      ..++||||+++|+|.+++......   ...+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++   .
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEEecCCCCce
Confidence            789999999999999999875422   235899999999999999999999998     99999999999999554   5


Q ss_pred             eEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHH
Q 012392          331 PLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  408 (464)
                      +||+|||+++....... .......+|..|+|||.+.+..++.++|||||||++|||+| |..||.....     ..+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~  297 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLE  297 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            99999999975532211 11222345778999999999999999999999999999998 8888865432     12223


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+........+...+..+.+++..||+.||++|||+.+|+++|+.+..
T Consensus       298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            333333344455667789999999999999999999999999987754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-44  Score=352.28  Aligned_cols=273  Identities=28%  Similarity=0.533  Sum_probs=222.8

Q ss_pred             cccCHHHHHHhhcCCccc------cccccCCceEEEEEEECCCcEEEEEEeccCC---CchHHHHHHHHHHHHhcCCCCC
Q 012392          172 FRLNLEEVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHEN  242 (464)
Q Consensus       172 ~~~~~~~~~~~~~~f~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~f~~e~~~l~~l~H~n  242 (464)
                      ..++.+++..++++|...      +.||+|+||.||+|+. +++.||||.+....   .......|.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            468899999999999988      8999999999999987 58899999986532   2334567999999999999999


Q ss_pred             ceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       243 iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      |+++++++  ...+..++||||+++|+|.+++..... ...++|..++.++.||+.||+|||+.+     |+||||||+|
T Consensus        92 i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~N  163 (307)
T 2nru_A           92 LVELLGFS--SDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH-----HIHRDIKSAN  163 (307)
T ss_dssp             BCCEEEEE--CSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGG
T ss_pred             eEEEEEEE--ecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHH
Confidence            99999998  446678999999999999999975432 235999999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH-
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~-  400 (464)
                      |++++++.+||+|||+++...... ........++..|+|||.+.+ .++.++||||||+++|||+||..|+....... 
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            999999999999999998664322 112223457889999998764 58899999999999999999999986532110 


Q ss_pred             ---------HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          401 ---------AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       401 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                               .....+...+++.+ ...+...+..+.+++..||+.||.+|||+.+|+++|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                     00111223333222 2346678889999999999999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=370.33  Aligned_cols=263  Identities=24%  Similarity=0.396  Sum_probs=217.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      ..++|...+.||+|+||.||+|+..        ++..||||.++.........++.+|+.+++++ +||||+++++++  
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence            3457888899999999999999862        34679999998766556667899999999999 899999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCC
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV  320 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~  320 (464)
                      ...+..++||||+++|+|.+++......            ...+++.+++.++.||+.||+|||+.+     |+||||||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp  219 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA  219 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCc
Confidence            4567789999999999999999865421            234899999999999999999999998     99999999


Q ss_pred             CceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHH
Q 012392          321 EKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR  398 (464)
Q Consensus       321 ~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~  398 (464)
                      +|||+++++.+||+|||+++....... .......+|..|+|||.+.+..++.++|||||||++|||+| |..|+.....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986643221 12223345678999999999999999999999999999999 8888865432


Q ss_pred             HHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                           ..+...+........+...+..+.+++..||+.||++|||++||+++|+.+..
T Consensus       300 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          300 -----EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -----HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 12223333344444556677889999999999999999999999999987743

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-45  Score=377.58  Aligned_cols=254  Identities=23%  Similarity=0.428  Sum_probs=211.8

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..++|...+.||+|+||.||+|.+. ++.||||.++...   ..++|.+|+.+|++++||||+++++++... ....++|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv  265 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV  265 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEE
Confidence            3456888899999999999999985 7899999997643   346799999999999999999999998543 3468999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus       266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            999999999999987542  34789999999999999999999998     99999999999999999999999999985


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....    .....++..|+|||.+.+..++.++|||||||+||||+| |..||.....     ..+...+....+...+.
T Consensus       339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~~~~~~~p~  409 (450)
T 1k9a_A          339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAPD  409 (450)
T ss_dssp             CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHHHHTTCCCCCCT
T ss_pred             cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCC
Confidence            4332    112245678999999999999999999999999999998 9988865321     12223333444555667


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .++..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            778899999999999999999999999999987653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-45  Score=354.57  Aligned_cols=257  Identities=21%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+...    +..||||.+...........|.+|+.++++++||||+++++++  . .+..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--C-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--c-cCcc
Confidence            3568888999999999999998742    4579999988665455567899999999999999999999987  3 3467


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHEEECCCCCEEECcccc
Confidence            89999999999999997643   24899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++..............++..|+|||.+....++.++||||||+++|||++ |..||......     .....+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~~~~~~~  237 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLP  237 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTCCCC
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHHcCCCCC
Confidence            98765543333333445678999999998899999999999999999997 88888653221     1112222223334


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .+...+..+.+++..||+.||++|||+.+++++|+.+.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            55567788999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-45  Score=359.21  Aligned_cols=262  Identities=22%  Similarity=0.403  Sum_probs=216.0

Q ss_pred             hhcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ..++|...+.||+|+||.||+|+.      .++..||||.+.........+.+.+|+.++++++||||+++++++  ...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC--SQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE--ecC
Confidence            345688889999999999999986      245889999998765555667899999999999999999999998  456


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH  315 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH  315 (464)
                      +..++||||+++|+|.+++.....                    ....+++.+++.++.||+.||+|||+.+     |+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH  173 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVH  173 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-----EEC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-----Ccc
Confidence            778999999999999999986532                    1134889999999999999999999998     999


Q ss_pred             cCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 012392          316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVL  393 (464)
Q Consensus       316 ~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~  393 (464)
                      |||||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987644322 22223345678999999998889999999999999999999 88888


Q ss_pred             cchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .....     ..+...+........+...++.+.+++..||+.||++||++.+++++|+.+.
T Consensus       254 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          254 PGIPP-----ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TTCCG-----GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCH-----HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            65432     1222333333344455667788999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-45  Score=356.31  Aligned_cols=257  Identities=23%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--CCCCCceeeeeEEEeC--CCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSR--GRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~--l~H~niv~l~g~~~~~--~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+. +++.||||.+...    ....+..|.+++..  ++||||+++++++...  .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            45688899999999999999988 6889999998643    34456667776666  7999999999987543  23468


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--------SSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      ++||||+++|+|.++++..     .+++..++.++.||+.||+|||        +.+     |+||||||+|||++.++.
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-----IAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-----EECSCCCGGGEEECTTSC
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-----eecCCCChHhEEEcCCCC
Confidence            9999999999999999542     3999999999999999999999        666     999999999999999999


Q ss_pred             eEEeeCCccccccCCceee---eeccCCCCccCcccccccC------CCCCcchhHHHHHHHHHHHhC----------CC
Q 012392          331 PLIADCGLHKLLADDIVFS---VLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTG----------SL  391 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvll~el~tg----------~~  391 (464)
                      +||+|||+++.........   .....+|..|+|||.+.+.      .++.++|||||||++|||+||          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            9999999998664432211   1223578899999999876      455799999999999999999          77


Q ss_pred             CCcchHHHHHhhhhHHHhh-hhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          392 VLTSSMRLAAESATFENFI-DRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       392 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ||............+.... ........+     ...+..+.+++..||+.||++|||+.+|++.|+.+
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            7754321111111111211 111122222     35778999999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-45  Score=361.68  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=209.4

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+|+. .+|+.||||.+.... .......+.+|+.+|+.++||||+++++++  ...+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECCEEEE
Confidence            35688889999999999999997 479999999987643 234456788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        92 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR-----IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             EECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            999999999999997653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ......  ......+|..|+|||.+.+..+. .++|||||||++|||+||+.||........    ...+...  ....+
T Consensus       163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~--~~~~p  234 (328)
T 3fe3_A          163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRG--KYRIP  234 (328)
T ss_dssp             GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHC--CCCCC
T ss_pred             ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhC--CCCCC
Confidence            665432  12234578889999999887765 789999999999999999999976532211    1122221  12334


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++.+||+.||++|||++|++++.+..
T Consensus       235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence            45567889999999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.4e-45  Score=356.06  Aligned_cols=260  Identities=23%  Similarity=0.396  Sum_probs=216.6

Q ss_pred             CccccccccCCceEEEEEEEC-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      |...+.||+|+||.||++.+.     +++.||||.++..........|.+|+.++++++||||+++++++........++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            477899999999999998753     688999999987655556678999999999999999999999997766678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++...     .+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEEcCCCCEEECCccccc
Confidence            99999999999999753     2899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH----------HhhhhHHH
Q 012392          341 LLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA----------AESATFEN  408 (464)
Q Consensus       341 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~----------~~~~~~~~  408 (464)
                      .......  .......++..|+|||.+.+..++.++||||||+++|||+||+.|+.......          .....+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            7654322  12223446677999999998889999999999999999999999987543221          11122344


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .+........+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            44445555566677889999999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.2e-45  Score=354.93  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=211.3

Q ss_pred             cCCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      +.|...+.||+|+||.||+|++     .+++.||||.+...........+.+|+.++++++||||+++++++........
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3477789999999999999984     36889999999865544455789999999999999999999999976555678


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCchheEEEcCCCCEEECcccc
Confidence            99999999999999997644   23899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH----------HhhhhH
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA----------AESATF  406 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~----------~~~~~~  406 (464)
                      ++.......  .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.......          .....+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987654332  12223446677999999998899999999999999999999998865432211          011222


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+........+...++.+.+++..||+.||++|||+.++++.|+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            233333344445666778899999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-45  Score=354.10  Aligned_cols=261  Identities=21%  Similarity=0.351  Sum_probs=205.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.....  ......|.+|+.++++++||||+++++++  ...+..++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~--~~~~~~~l   88 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD--EEDDCYYL   88 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE--ECSSEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee--eeCCeEEE
Confidence            56888899999999999999965 689999999865432  23346789999999999999999999998  45678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        89 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            999999999999997653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..............+|..|+|||.+.+..++.++||||||+++|||+||+.||............+..... ........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NVTTDVRK  238 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CHHHHSCT
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-Ccchhccc
Confidence            76544333333445788999999999999999999999999999999999999765432211111111000 00011223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhcC
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAP  456 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~~  456 (464)
                      ..+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus       239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            3567899999999999999998 89999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-45  Score=358.65  Aligned_cols=253  Identities=19%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC-------
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-------  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-------  255 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++........+.+.+|+.++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56888899999999999999986 7999999999866555566789999999999999999999998865432       


Q ss_pred             ------------------------------------------------CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHH
Q 012392          256 ------------------------------------------------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS  287 (464)
Q Consensus       256 ------------------------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~  287 (464)
                                                                      ...++||||+++|+|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                            138999999999999999986543 2346778


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-----------eeeeccCCC
Q 012392          288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-----------FSVLKTSAA  356 (464)
Q Consensus       288 ~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-----------~~~~~~~~~  356 (464)
                      .++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.......           .......+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             HHHHHHHHHHHHHHHHHhCC-----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            89999999999999999998     99999999999999999999999999987654321           111233578


Q ss_pred             CccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC---HHHHHHHHHHHHHh
Q 012392          357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS---ESEAAKLGKMALVC  433 (464)
Q Consensus       357 ~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~C  433 (464)
                      ..|+|||.+.+..++.++|||||||++|||++|..|+......      ...    ......+   ......+.+++..|
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~------~~~----~~~~~~~~~~~~~~~~~~~li~~~  309 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI------ITD----VRNLKFPLLFTQKYPQEHMMVQDM  309 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH------HHH----HHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH------HHH----hhccCCCcccccCChhHHHHHHHH
Confidence            8899999999999999999999999999999987665332211      111    1112222   34456789999999


Q ss_pred             hhcCCCCCCCHHHHHHHHh
Q 012392          434 THEDPENRPTMEAVIEELT  452 (464)
Q Consensus       434 ~~~dp~~RPs~~evl~~L~  452 (464)
                      |+.||++|||++|++++.+
T Consensus       310 l~~~p~~Rps~~~~l~~~~  328 (332)
T 3qd2_B          310 LSPSPTERPEATDIIENAI  328 (332)
T ss_dssp             HCSSGGGSCCHHHHHHSTT
T ss_pred             ccCCCCcCCCHHHHhhchh
Confidence            9999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.3e-45  Score=347.86  Aligned_cols=256  Identities=20%  Similarity=0.356  Sum_probs=211.0

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.+ ++.||||.+..... ....+.|.+|+.++++++||||+++++++........++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            45778899999999999999985 88999999986542 33456799999999999999999999998554447789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++.....  ..+++..++.++.||+.||+|||+.+   ++|+||||||+||++++++.++|+|||++...
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE---PLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS---SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC---CceecCCCccceEEEcCCcceeEEeccceeee
Confidence            99999999999986432  24899999999999999999999865   56999999999999999999999998887643


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCC---cchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTE---RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ...      ...+|..|+|||.+.+..++.   ++||||||+++|||+||+.||......    ...............+
T Consensus       164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----EIGMKVALEGLRPTIP  233 (271)
T ss_dssp             SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----HHHHHHHHSCCCCCCC
T ss_pred             ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----HHHHHHHhcCCCCCCC
Confidence            322      234678899999998765544   799999999999999999999754322    1222333334445556


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++..||+.||++|||++++++.|+.+.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            667788999999999999999999999999998875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=389.49  Aligned_cols=261  Identities=25%  Similarity=0.429  Sum_probs=216.6

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++...++|...+.||+|+||.||+|++.++..||||.++....  ...+|.+|+.+|++++||||+++++++.  . ...
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~--~-~~~  336 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EPI  336 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSC
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEe--e-ccc
Confidence            3445566788899999999999999998888899999986542  3457999999999999999999999983  3 568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      +|||||+++|+|.++|.....  ..+++.+++.|+.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             eEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEEcCCCcEEEccccc
Confidence            999999999999999986432  23899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++..............++..|+|||.+..+.++.++|||||||+||||+| |+.||......     .+...+....+..
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~  484 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMP  484 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHHHHTTCCCC
T ss_pred             ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCC
Confidence            98765433222233445678999999999999999999999999999999 88888654221     1222333344445


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+..+++.+.+|+..||+.||++|||+++|++.|+.+..
T Consensus       485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            566778889999999999999999999999999987754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-45  Score=348.59  Aligned_cols=256  Identities=22%  Similarity=0.430  Sum_probs=212.1

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|+..+++.||||.+.....  ...++.+|+.++++++||||+++++++  ...+..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCCeEEEEe
Confidence            45778899999999999999998889999999986542  235789999999999999999999998  44667899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             CCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEECCCCCEEEcccccccccc
Confidence            999999999997643   24899999999999999999999998     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..|+.......     ....+........+...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~  230 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTGFRLYKPRLA  230 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTCCCCCCTTS
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHHhcCCcCCCCccC
Confidence            433222233445677999999998889999999999999999999 888886543211     11112222333344556


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..+.+++.+||+.||++|||+++++++|+.+..
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7789999999999999999999999999988753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=362.57  Aligned_cols=268  Identities=24%  Similarity=0.378  Sum_probs=213.0

Q ss_pred             HhhcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  253 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  253 (464)
                      ...++|...+.||+|+||.||+|+.      .++..||||.+...........+.+|+.++.++ +||||+++++++  .
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--T  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--e
Confidence            3457788999999999999999996      245689999998654444556799999999999 899999999998  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCee
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGS-------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV  314 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~iv  314 (464)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.||+.||+|||+.+     |+
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----iv  194 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CV  194 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EE
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Confidence            467799999999999999999865321                   134899999999999999999999998     99


Q ss_pred             ecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCC
Q 012392          315 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLV  392 (464)
Q Consensus       315 H~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p  392 (464)
                      ||||||+|||++.++.+||+|||++........ .......+|..|+|||.+.+..++.++||||||+++|||+| |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999986644322 12223345678999999998899999999999999999998 8888


Q ss_pred             CcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          393 LTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      |.....    ...+...+........+...++.+.+++..||+.||++|||+.+++++|+.+.....
T Consensus       275 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          275 YPGIPV----DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             STTCCC----SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cccCCc----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            865321    122333344444445556667889999999999999999999999999998765543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-45  Score=354.09  Aligned_cols=259  Identities=21%  Similarity=0.417  Sum_probs=217.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+.. ++..||||.+....  ....+|.+|+.++++++||||+++++++  ......++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCCEEE
Confidence            4566888899999999999999986 48899999987543  3556799999999999999999999998  55677999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++.....  ..+++..++.++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        87 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT-----CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC-----ccCCCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999976432  34899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     ......+........+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRMERP  234 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTCCCCCC
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhccCCCCCC
Confidence            776544333334445678999999998899999999999999999999 8888865321     2223333344445556


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...++.+.+++..||+.||++|||+.++++.|+.+..
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            6677889999999999999999999999999987644

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.3e-45  Score=349.44  Aligned_cols=258  Identities=23%  Similarity=0.395  Sum_probs=208.4

Q ss_pred             hcCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+..+    +..||||.+...........|.+|+.++++++||||+++++++.  . +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE--E-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--S-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--C-CCC
Confidence            3567888999999999999998642    34699999987654556678999999999999999999999873  2 346


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             EEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEECCCCcEEeCccCC
Confidence            89999999999999997653   24899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +...............++..|+|||.+.+..++.++||||||+++|||+| |+.||.....     ......+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~~~~~~~~  234 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVLEKGDRLP  234 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHHHHTCCCC
T ss_pred             CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHHhcCCCCC
Confidence            98765543333334456778999999988899999999999999999998 9999864321     11222222333334


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+...++.+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            455567789999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.9e-45  Score=355.22  Aligned_cols=265  Identities=23%  Similarity=0.397  Sum_probs=216.6

Q ss_pred             hhcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      ..++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.+++++ +||||+++++++  ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE--ec
Confidence            345688889999999999999985      256799999998765455667899999999999 899999999998  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCC
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGS--------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV  320 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~  320 (464)
                      .+..++||||+++|+|.+++......              ...+++..++.++.||+.||+|||+.+     |+||||||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp  173 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAA  173 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCcc
Confidence            66789999999999999999865421              124899999999999999999999998     99999999


Q ss_pred             CceEEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHH
Q 012392          321 EKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR  398 (464)
Q Consensus       321 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~  398 (464)
                      +||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..|+.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99999999999999999998765433211 222335667999999998899999999999999999999 8888865321


Q ss_pred             HHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                          ...+...+........+...+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       254 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          254 ----DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ----SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                1122333333444444556678899999999999999999999999999876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.1e-45  Score=356.96  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=218.0

Q ss_pred             cCCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|++     .+++.||||.+.... ....+.|.+|+.++++++||||+++++++........
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4578889999999999999984     368899999997654 4455679999999999999999999999876667789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChhhEEECCCCCEEEccccc
Confidence            999999999999999986432   3899999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCcee--eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh----------hhhH
Q 012392          339 HKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----------SATF  406 (464)
Q Consensus       339 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~----------~~~~  406 (464)
                      ++........  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........          ...+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9876543221  222334667799999999888999999999999999999999998754432111          1223


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+........+...++.+.+++..||+.||++|||++|++++|+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            33344444555666778889999999999999999999999999987643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=357.04  Aligned_cols=262  Identities=24%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  253 (464)
                      .++|...+.||+|+||.||+|+..        ++..||||.++.........++.+|+.+++++ +||||+++++++  .
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--T  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE--c
Confidence            456888899999999999999863        46789999998765555667899999999999 899999999998  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCC
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  321 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~  321 (464)
                      ..+..++||||+++|+|.+++......            ...+++.+++.++.||+.||+|||+.+     |+||||||+
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~  186 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR  186 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGG
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCccc
Confidence            467789999999999999999865421            124899999999999999999999998     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHH
Q 012392          322 KVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL  399 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~  399 (464)
                      |||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |..|+......
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999987654322 22223345678999999988889999999999999999999 88888654221


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                           .+...+........+...+..+.+++..||+.||++|||+.|++++|+.+..
T Consensus       267 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 -----ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 1222223333344555667889999999999999999999999999987754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=352.67  Aligned_cols=255  Identities=18%  Similarity=0.271  Sum_probs=201.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-------------------------hHHHHHHHHHHHHhc
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------------------------SEEAEFVKGLYLLTS  237 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~f~~e~~~l~~  237 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+......                         ....+|.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            56888899999999999999975 6889999998754311                         112468899999999


Q ss_pred             CCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecC
Q 012392          238 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN  317 (464)
Q Consensus       238 l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~d  317 (464)
                      ++||||+++++++........++||||+++|+|.+++..     ..+++..+..++.||+.||+|||+.+     |+|||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~D  162 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK-----IIHRD  162 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccC
Confidence            999999999999865556789999999999999886542     34899999999999999999999998     99999


Q ss_pred             CCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCC---CCCcchhHHHHHHHHHHHhCCCCCc
Q 012392          318 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLT  394 (464)
Q Consensus       318 lk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvll~el~tg~~p~~  394 (464)
                      |||+|||++.++.+||+|||+++....... ......+|..|+|||.+.+..   ++.++|||||||++|||++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987654321 123345788999999997655   3778999999999999999999997


Q ss_pred             chHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          395 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .......    ...+.............++.+.+++.+||+.||++|||+.|++++.+.
T Consensus       242 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          242 DERIMCL----HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             CSSHHHH----HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             CccHHHH----HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            6432111    111112222222223456789999999999999999999999988654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-45  Score=350.75  Aligned_cols=257  Identities=24%  Similarity=0.439  Sum_probs=212.5

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..++|...+.||+|+||.||+|+..++..||||.+.....  ....|.+|+.++++++||||+++++++.   .+..++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEEE
Confidence            4467888999999999999999998888999999876542  3467999999999999999999999873   3458899


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.....  ..+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            999999999999975432  13899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+......     .....+........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~  233 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMVRPD  233 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCT
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHHHhcccCCCCcc
Confidence            76544333334445678999999988889999999999999999999 88888654321     1112222233334455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            66788999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.7e-45  Score=359.67  Aligned_cols=258  Identities=19%  Similarity=0.313  Sum_probs=206.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.+++.++||||+++++++  ...+..++||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGNIQYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCCeEEEEE
Confidence            56888899999999999999976 78999999987654444446788999999999999999999998  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++...    ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++..
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           85 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999999753    24899999999999999999999998     999999999999999999999999999865


Q ss_pred             cCCce-eeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          343 ADDIV-FSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       343 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..... .......+|..|+|||++.+..+ +.++|||||||++|||++|+.||.......   .................
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  232 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWK  232 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHTTCTTSTTGG
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcccccCCccc
Confidence            43221 12233457888999999987765 778999999999999999999997543211   11122222222222224


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence            45677899999999999999999999999887653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-45  Score=352.94  Aligned_cols=270  Identities=18%  Similarity=0.314  Sum_probs=215.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+++.. +++.||+|.+..... ....+.|.+|+.++++++||||+++++++........++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            356888899999999999999976 789999999976542 344567899999999999999999999887666678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||+.+....+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999875544455999999999999999999999875223449999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+......     .+...+........+.
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCCCCCCT
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----HHHHHHhhcccccCCc
Confidence            66432211 11234678899999999889999999999999999999999998764321     1111222222233445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+..+.+++.+||+.||++||++.|++++++..++..
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            66788999999999999999999999999998877654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-45  Score=361.46  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=208.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.+...........+.+|+.++++++||||+++++++  . ....
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC--P-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE--C-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--c-CCcc
Confidence            35778899999999999999965 444    38888876544333445678899999999999999999988  3 3458


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT-----CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCccchheEEECCCCeEEECCCCc
Confidence            89999999999999997642   24889999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++....... .......++..|+|||.+.++.++.++||||||+++|||+| |..||.....     ..+...+......
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~  236 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEKGERL  236 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHTTCBC
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCCCC
Confidence            987644321 12223446678999999998999999999999999999999 9999875321     2223333333344


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+..++..+.+++..||+.||++||++.+++++|+.+....
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            445556677899999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-44  Score=356.93  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=207.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||+||+|+.. +|+.||||.++...  .......+.+|+.++++++||||+++++++  ...+..++
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~--~~~~~~~l   82 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE--EeCCEEEE
Confidence            56888899999999999999976 68999999987532  122345688999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        83 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCCHHHEEECCCCCEEEeeccchh
Confidence            999999999999997653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......+|..|+|||.+.+..++.++|||||||++|||++|..||.......    ....+...  ...++.
T Consensus       154 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~--~~~~p~  226 (337)
T 1o6l_A          154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILME--EIRFPR  226 (337)
T ss_dssp             CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCCCT
T ss_pred             hcccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----HHHHHHcC--CCCCCC
Confidence            6432211 1223346788999999999999999999999999999999999997643221    12222222  223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      ..+..+.+++..||+.||++||     +++|+++|.+.
T Consensus       227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence            5677899999999999999999     99999988654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.4e-44  Score=346.37  Aligned_cols=255  Identities=26%  Similarity=0.493  Sum_probs=206.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHH------HHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.........      +.|.+|+.++++++||||+++++++  ....
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPP   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE--TTTT
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee--cCCC
Confidence            45778899999999999999975 7899999998654322211      5789999999999999999999988  3333


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC-----e
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----P  331 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~-----~  331 (464)
                        ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||||||+|||++.++.     +
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQN---PPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCC---CCeecCCCCcceEEEeccCCCCceeE
Confidence              69999999999999987543   34899999999999999999999876   55999999999999988776     9


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCccccc--ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHh
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV--TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  409 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  409 (464)
                      ||+|||+++.....    .....++..|+|||.+  ....++.++||||||+++|||++|+.||.......  .......
T Consensus       169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~  242 (287)
T 4f0f_A          169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMI  242 (287)
T ss_dssp             EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHHH
T ss_pred             EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHHH
Confidence            99999999865442    2334578889999998  34567899999999999999999999996432111  1112222


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .........+...+..+.+++..||+.||++|||++|+++.|+.+
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            333444556667788899999999999999999999999999763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=385.74  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=205.1

Q ss_pred             ccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          191 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       191 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      .||+|+||.||+|.++   ++..||||.++.........+|.+|+.+|++++|||||+++|+|..   +..++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCC
Confidence            7999999999999874   4678999999876555567789999999999999999999999843   458999999999


Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  347 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~  347 (464)
                      |+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.......
T Consensus       420 g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          420 GPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             CBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             CcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999997542   34999999999999999999999998     99999999999999999999999999987643321


Q ss_pred             e--eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHH
Q 012392          348 F--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  424 (464)
Q Consensus       348 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (464)
                      .  ......+++.|+|||++.++.++.++|||||||+||||+| |+.||.....     ..+...+....+...+..++.
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~p~~~~~  566 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMECPPECPP  566 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHHHHHTTCCCCCCTTCCH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCCcCCH
Confidence            1  1122234578999999999999999999999999999998 9999875432     123333444445556677888


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          425 KLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       425 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+.+++..||+.||++||++.+|++.|+..
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999999998865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=354.27  Aligned_cols=253  Identities=18%  Similarity=0.246  Sum_probs=208.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+...  ......+.+|+.+++.++||||+++++++..  .+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEE
Confidence            457888999999999999999976 6889999998754  3445678899999999999999999999844  6789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--CCCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGl~  339 (464)
                      |||+++|+|.+++....   ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.  ++.+||+|||++
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g-----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           80 FEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            99999999999997532   24899999999999999999999998     999999999999997  789999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +........  ....+|+.|+|||.+.+..++.++|||||||++|||++|..||......    ..+..+......  .+
T Consensus       152 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~--~~  223 (321)
T 1tki_A          152 RQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEYT--FD  223 (321)
T ss_dssp             EECCTTCEE--EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCC--CC
T ss_pred             eECCCCCcc--ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHcCCCC--CC
Confidence            877544322  2234678899999999888999999999999999999999999764322    122222222111  12


Q ss_pred             H----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 E----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .    ..+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            1    34577899999999999999999999999887543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=364.88  Aligned_cols=257  Identities=23%  Similarity=0.431  Sum_probs=198.3

Q ss_pred             CCccccccccCCceEEEEEEEC--CC--cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR--DG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .|...+.||+|+||.||+|++.  ++  ..||||.++.........+|.+|+.++++++||||++++++|.. ..+..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCCCeEE
Confidence            3566789999999999999864  22  46899998765555667889999999999999999999998743 3456789


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus       169 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCccchheEEECCCCCEEEeeccccc
Confidence            999999999999997543   24889999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCcee---eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          341 LLADDIVF---SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       341 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ........   ......++..|+|||.+.+..++.++|||||||++|||+|| ..||.....     ......+......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~~~~~~~~  315 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGRRL  315 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHHHHTTCCC
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHHHHcCCCC
Confidence            66443221   12233456789999999999999999999999999999995 555543211     1111222222333


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+..++..+.+++..||+.||++|||+.|++++|+.+.
T Consensus       316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            445566788999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=354.82  Aligned_cols=258  Identities=23%  Similarity=0.464  Sum_probs=205.4

Q ss_pred             cCCccccccccCCceEEEEEEECC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .+|...+.||+|+||.||+|+...     +..||||.++.........+|.+|+.++++++||||+++++++  ...+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--ecCCCc
Confidence            456777999999999999998652     2469999998765455567899999999999999999999998  556789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChheEEECCCCcEEECCCCc
Confidence            99999999999999997643   24899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......     .+...+.....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~~~~~~~~  268 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFR  268 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCC
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHCCCc
Confidence            987654321  12222335678999999998899999999999999999999 99998653221     11222222333


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            34455667889999999999999999999999999987643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-45  Score=355.26  Aligned_cols=276  Identities=22%  Similarity=0.383  Sum_probs=222.0

Q ss_pred             cccCHHHHHHhhcCCccccccccCCceEEEEEEE------CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCce
Q 012392          172 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII  244 (464)
Q Consensus       172 ~~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv  244 (464)
                      ..+...++....++|...+.||+|+||.||+|+.      .+++.||||.+...........+.+|+.++.++ +||||+
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence            3456667777788999999999999999999984      256899999998765555667899999999999 799999


Q ss_pred             eeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCC
Q 012392          245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPA  312 (464)
Q Consensus       245 ~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~  312 (464)
                      ++++++.. .....++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+.+     
T Consensus        95 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----  168 (316)
T 2xir_A           95 NLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----  168 (316)
T ss_dssp             CEEEEECC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-----
T ss_pred             eEEEEEec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-----
Confidence            99999843 234589999999999999999865421            123889999999999999999999998     


Q ss_pred             eeecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CC
Q 012392          313 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GS  390 (464)
Q Consensus       313 ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~  390 (464)
                      |+||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |.
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986644322 22223345678999999999999999999999999999998 88


Q ss_pred             CCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       391 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .||......    ..+...+........+...+..+.+++..||+.||++|||+.+++++|+.+.+.
T Consensus       249 ~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          249 SPYPGVKID----EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CSSTTCCCS----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccchh----HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            888653211    112222223333344455667899999999999999999999999999877543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.1e-45  Score=361.33  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=207.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .+.|...+.||+|+||.||+|+.. +|+.||||.++......     ....+.+|+.+|++++||||+++++++  ....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY--ENRT   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSS
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE--EeCC
Confidence            456888899999999999999976 68999999997654221     246789999999999999999999998  4467


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeE
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPL  332 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~k  332 (464)
                      ..++||||+++|+|.+++...    ..+++..+..++.||+.||.|||+.+     |+||||||+|||+++++    .+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeCCCCCccCEE
Confidence            899999999999999999753    24899999999999999999999998     99999999999998877    799


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |+|||+++.......  .....+|+.|+|||++.+..++.++|||||||++|||++|..||......    ..+..+...
T Consensus       160 l~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~  233 (361)
T 2yab_A          160 LIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITAV  233 (361)
T ss_dssp             ECCCSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTT
T ss_pred             EEecCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc
Confidence            999999987654321  22345788999999999889999999999999999999999999764321    112222211


Q ss_pred             hcCCCCCH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                        ...++.    ..+..+.+++..||+.||++|||+.|+++|.+..
T Consensus       234 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          234 --SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             --CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             --CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence              111222    2356789999999999999999999999887653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.1e-45  Score=355.46  Aligned_cols=269  Identities=22%  Similarity=0.376  Sum_probs=216.5

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeE
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF  249 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~  249 (464)
                      .++++...++|...+.||+|+||.||+|+..      +++.||||.+..........+|.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444556678999999999999999999864      3678999999866555566789999999999999999999999


Q ss_pred             EEeCCCCeEEEEEecCCCCCHHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCce
Q 012392          250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV  323 (464)
Q Consensus       250 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Ni  323 (464)
                      +  ...+..++||||+++|+|.+++.....      ....+++..++.++.||+.||.|||+.+     |+||||||+||
T Consensus        97 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NI  169 (322)
T 1p4o_A           97 V--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNC  169 (322)
T ss_dssp             E--CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGE
T ss_pred             E--ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCccceE
Confidence            8  446678999999999999999976321      1234789999999999999999999998     99999999999


Q ss_pred             EEcCCCCeEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHH
Q 012392          324 LIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAA  401 (464)
Q Consensus       324 ll~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~  401 (464)
                      |++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..|+......  
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  247 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--  247 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--
Confidence            99999999999999998664432221 112234677999999998899999999999999999999 77887653221  


Q ss_pred             hhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          402 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                         .....+........+...+..+.+++..||+.||++|||+.|++++|+....
T Consensus       248 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 ---QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               1111121222223445567789999999999999999999999999987644

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-44  Score=345.18  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=198.4

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCc---hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. ++.||||.++.....   .....+.+|+.+++.++||||+++++++  ...+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC--LKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--ecCCceEE
Confidence            46788899999999999999985 889999998754322   2235788999999999999999999998  44667899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--------CCCeE
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--------QFNPL  332 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--------~~~~k  332 (464)
                      ||||+++++|.+++...     .+++..+..++.|++.||+|||+.+  ..+|+||||||+|||++.        ++.+|
T Consensus        84 v~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~--~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEA--IVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSS--SSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999999999632     3899999999999999999999976  234889999999999986        77899


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |+|||+++.......   ....++..|+|||.+.+..++.++||||||+++|||+||+.||.......    ........
T Consensus       157 l~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~  229 (271)
T 3dtc_A          157 ITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAYGVAMN  229 (271)
T ss_dssp             ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHHTS
T ss_pred             EccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHhhhcC
Confidence            999999986654322   23357788999999998899999999999999999999999997543221    12222233


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+...++.+.+++.+||+.||++|||+.|++++|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            334445566778899999999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.2e-45  Score=356.55  Aligned_cols=268  Identities=24%  Similarity=0.358  Sum_probs=199.8

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEECCC----cEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      ++....++|...+.||+|+||.||+|+....    ..||||.++... ......+|.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3444566799999999999999999987533    279999987643 23456789999999999999999999999854


Q ss_pred             CCCC----eEEEEEecCCCCCHHHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          253 RGRG----ECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       253 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      ....    ..++|+||+++|+|.+++......  ...+++.+++.++.||+.||+|||+.+     |+||||||+|||++
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dikp~NIli~  171 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLA  171 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEC
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCcceEEEc
Confidence            3221    238999999999999999765422  224899999999999999999999998     99999999999999


Q ss_pred             CCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  404 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~  404 (464)
                      +++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....     .
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~  246 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----A  246 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----H
Confidence            999999999999987644322 12223345678999999999999999999999999999999 8888865322     1


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .....+........+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          247 EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            122222222333445566788999999999999999999999999888764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=347.55  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             cCCcccc-ccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVN-LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+ .||+|+||.||+|+..   ++..||||.++.........++.+|+.++++++||||+++++++.   .+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCcE
Confidence            3445555 8999999999999864   578899999987655556678999999999999999999999982   34589


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||++
T Consensus        86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCchheEEEcCCCCEEECcccce
Confidence            9999999999999997532   34899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +.........  .....++..|+|||.+.+..++.++||||||+++|||+| |..||.....     ......+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~i~~~~~~  232 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRM  232 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTCCC
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHhcCCcC
Confidence            8765432211  222335678999999988889999999999999999999 9999865432     1122223333344


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+...+..+.+++..||+.||++||++.+++++|+.+
T Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            45666778999999999999999999999999999876

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=353.84  Aligned_cols=250  Identities=18%  Similarity=0.253  Sum_probs=198.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...++||+|+||+||+|+.. +++.||||++..... .....++..|+..+.++ +||||++++++|.  ..+..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEEEE
Confidence            56889999999999999999986 799999998865432 23344566677666665 8999999999984  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+ +|+|.+++....   ..++|..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++.
T Consensus       135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEccceeee
Confidence            99999 779999997754   24999999999999999999999988     9999999999999999999999999988


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......  ......+|.+|+|||++.+ .++.++|||||||++|||++|..++......       ..+.........+.
T Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~~~~~~~~~~  275 (311)
T 3p1a_A          206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-------QQLRQGYLPPEFTA  275 (311)
T ss_dssp             ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-------HHHTTTCCCHHHHT
T ss_pred             ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHhccCCCccccc
Confidence            765432  2223457889999998875 7899999999999999999997776543221       11111111111122


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..++.+.+++.+||+.||++|||++|++++.+..
T Consensus       276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            3457899999999999999999999999887654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-44  Score=358.65  Aligned_cols=257  Identities=19%  Similarity=0.312  Sum_probs=207.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .+.|...+.||+|+||.||+|+.. +++.||||.+....    .......+.+|+.++++++||||+++++++..  .+.
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~  100 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM  100 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence            346888999999999999999875 68999999986421    11234678999999999999999999999854  678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC---eEEe
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIA  334 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~  334 (464)
                      .++||||+++|+|.+++.........+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.   +||+
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChHHeEEecCCCCCcEEEe
Confidence            99999999999999988765433345899999999999999999999998     999999999999986654   9999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      |||+++....... ......+|..|+|||.+.+..++.++|||||||++|||++|..||......     .+..+.....
T Consensus       176 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~i~~~~~  249 (351)
T 3c0i_A          176 GFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGKY  249 (351)
T ss_dssp             CCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----HHHHHHHTCC
T ss_pred             cCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----HHHHHHcCCC
Confidence            9999987654322 122345788999999999989999999999999999999999999764321     1222222111


Q ss_pred             CCCCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 KGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .  ..    ...+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       250 ~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          250 K--MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             C--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             C--CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            1  11    12356789999999999999999999999876643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-44  Score=359.97  Aligned_cols=257  Identities=19%  Similarity=0.255  Sum_probs=199.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+++.. +++.||||.+.....  ....+.+|+.++++++||||+++++++.  .....++||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~   95 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIIM   95 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEe--eCCEEEEEE
Confidence            46888899999999999999986 789999999976432  2346889999999999999999999984  467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC--eEEeeCCccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLIADCGLHK  340 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfGl~~  340 (464)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.  +||+|||+++
T Consensus        96 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~-----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           96 EYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            9999999999997643    3899999999999999999999998     999999999999987766  9999999997


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCc-chhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTER-SDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ......  ......+|..|+|||.+.+..++.+ +|||||||++|||++|+.||............+..+..........
T Consensus       167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (361)
T 3uc3_A          167 SSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD  244 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred             cccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence            543221  1223457889999999988887666 8999999999999999999976432211122223333222222222


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            235678899999999999999999999999977643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-45  Score=372.59  Aligned_cols=267  Identities=17%  Similarity=0.260  Sum_probs=214.8

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEE
Q 012392          174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFC  250 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~  250 (464)
                      ....++....++|...++||+|+||+||+|+.. +++.||||.++....  ......+.+|..++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566677889999999999999999999987 578999999875221  11123488999999999999999999998


Q ss_pred             EeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       251 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                        .+....++||||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.
T Consensus       144 --~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          144 --QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             --ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSC
T ss_pred             --eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeeEcCCCC
Confidence              45678999999999999999997632   24899999999999999999999998     999999999999999999


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  405 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~  405 (464)
                      +||+|||+++..............+|..|+|||++.     .+.++.++|||||||++|||++|+.||.......    .
T Consensus       214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~----~  289 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----T  289 (437)
T ss_dssp             EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H
T ss_pred             EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH----H
Confidence            999999999876554433334456889999999987     5678999999999999999999999997653321    1


Q ss_pred             HHHhhhhhcCCCCC---HHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhhh
Q 012392          406 FENFIDRNLKGKFS---ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTVA  454 (464)
Q Consensus       406 ~~~~~~~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~~  454 (464)
                      +..++.......++   ...++.+.+++.+|+..+|++  ||+++|+++|.+..
T Consensus       290 ~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            22222211111122   235677899999999888887  99999999987754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=355.66  Aligned_cols=259  Identities=24%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.+..........++.+|+.++++++||||+++++++..   ...
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---SSE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---CCc
Confidence            56888899999999999999964 444    3688888665545566789999999999999999999999854   347


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             eEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC-----CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            89999999999999998643   24899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....     ..+...+......
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~~~~  238 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERL  238 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCC
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCC
Confidence            98764332 122223345678999999999999999999999999999999 9999865422     2233444444445


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+...+..+.+++..||+.||++||++.|+++.|+.+....
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            556667788999999999999999999999999999886544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-45  Score=369.25  Aligned_cols=263  Identities=13%  Similarity=0.241  Sum_probs=213.6

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      +.++....++|...+.||+|+||+||+|+.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++  
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--  138 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  138 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            4455666788999999999999999999986 688999999864210  11123478899999999999999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      .+....++||||+++|+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+|
T Consensus       139 ~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          139 QDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeeECCCCCEE
Confidence            4567899999999999999999753     2889999999999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      |+|||+++..............+|+.|+|||++....    ++.++|||||||++|||+||..||.......    .+..
T Consensus       209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~  284 (410)
T 3v8s_A          209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSK  284 (410)
T ss_dssp             ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH
T ss_pred             EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----HHHH
Confidence            9999999877655443344556889999999997655    7899999999999999999999997654321    2223


Q ss_pred             hhhhh--cCCCCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhhh
Q 012392          409 FIDRN--LKGKFSESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTVA  454 (464)
Q Consensus       409 ~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~~  454 (464)
                      ++...  +........+..+.+++.+||+.+|.+  ||+++||++|.+..
T Consensus       285 i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          285 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            32221  111222245678999999999999988  99999999987754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-44  Score=352.56  Aligned_cols=263  Identities=21%  Similarity=0.381  Sum_probs=193.2

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++..........+.+|+.++++++||||+++++++  ...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI--HTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE--CCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE--EECCeEEEE
Confidence            356888899999999999999875 68999999997655444446788999999999999999999998  556789999


Q ss_pred             EecCCCCCHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||++ |+|.+++.....  ....+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCChHHeEEcCCCCEEECcCccc
Confidence            99997 699999976532  1234899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh-------
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-------  411 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-------  411 (464)
                      +....... ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||..................       
T Consensus       156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          156 RAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             EETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             eecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            87643211 1223456788999999876 46899999999999999999999999764332111111100000       


Q ss_pred             ---------hhc------------CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          412 ---------RNL------------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       412 ---------~~~------------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                               ...            ........+..+.+++.+||+.||++|||++|++++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                     000            0001112356799999999999999999999999886644

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=354.95  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      +.|...+.||+|+||.||+|+.. +++.||||.+......     ....++.+|+.++++++||||+++++++  .....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~   88 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKTD   88 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCE
Confidence            45888899999999999999976 6899999998764322     1356789999999999999999999998  44678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeEE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI  333 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl  333 (464)
                      .++||||+++|+|.+++...    ..+++..+..++.||+.||.|||+.+     |+||||||+|||++.++    .+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC-----eEcCCCCHHHEEEecCCCCCCCEEE
Confidence            99999999999999999753    24899999999999999999999998     99999999999999887    7999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      +|||+++.......  .....+|..|+|||++....++.++|||||||++|||++|..||.......    .+..+... 
T Consensus       160 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~-  232 (326)
T 2y0a_A          160 IDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAV-  232 (326)
T ss_dssp             CCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHT-
T ss_pred             EECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHhc-
Confidence            99999987653321  223457889999999998899999999999999999999999997543211    11111111 


Q ss_pred             cCCCCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 LKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ....+    ...+..+.+++..||+.||++|||+.|++++.+..
T Consensus       233 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          233 -NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             -CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence             11122    13356789999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-44  Score=348.04  Aligned_cols=257  Identities=22%  Similarity=0.415  Sum_probs=197.5

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+..+  .||||.++.... ....+.|.+|+.++++++||||+++++++  . ....++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~-~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--T-APQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--C-SSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec--c-CCccEEE
Confidence            4568888999999999999998653  599999976543 33456799999999999999999999976  2 3457899


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++....   ..+++.+++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS-----IIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCccceEEECCCCCEEEccceeccc
Confidence            99999999999997543   34899999999999999999999998     99999999999999999999999999976


Q ss_pred             ccCCc-eeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcC-
Q 012392          342 LADDI-VFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLK-  415 (464)
Q Consensus       342 ~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~-  415 (464)
                      ..... ........++..|+|||.+.   ...++.++||||||+++|||++|+.||.......    .+...+.. ... 
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~  245 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGRGSLSP  245 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHHTSCCC
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcccccCc
Confidence            54311 11222345788899999986   5678889999999999999999999997532211    11111111 111 


Q ss_pred             --CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          416 --GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       416 --~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                        ......++..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence              12234567889999999999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-44  Score=356.57  Aligned_cols=256  Identities=20%  Similarity=0.378  Sum_probs=208.5

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ...|...+.||+|+||.||+|+. .+++.||||.+......  ....+|.+|+.++++++||||+++++++..  .+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence            34588889999999999999996 47899999998765422  233578999999999999999999999854  57899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||++ |+|.+++....   ..+++.++..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus       131 lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            9999996 78998886543   24899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +.....     ....+|..|+|||.+.   .+.++.++|||||||++|||+||+.|+.......    .+..+.......
T Consensus       202 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----~~~~~~~~~~~~  272 (348)
T 1u5q_A          202 SIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPA  272 (348)
T ss_dssp             BSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCC
T ss_pred             eecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCC
Confidence            876532     2345788899999984   5678999999999999999999999987543221    122222222222


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ..+...++.+.+++..||+.||++|||+++++++.+......
T Consensus       273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            233455678999999999999999999999999887665443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=350.43  Aligned_cols=255  Identities=23%  Similarity=0.393  Sum_probs=198.9

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|+.. ++.||||.+...   .....|.+|+.++++++||||++++|++  .  +..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~--~~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGAC--L--NPVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBC--T--TTTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEE--c--CCcEEEEE
Confidence            45777899999999999999985 788999998643   3456799999999999999999999987  3  34789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC-eEEeeCCccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-PLIADCGLHKLL  342 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~-~kl~DfGl~~~~  342 (464)
                      |+++|+|.+++..... ...+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++. +||+|||++...
T Consensus        80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ--PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             CCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCS--SSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             cCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            9999999999976432 224788999999999999999999831  112999999999999998886 799999999765


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||+||+.||........   ..................
T Consensus       157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (307)
T 2eva_A          157 QTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVHNGTRPPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHHTTCCCCCBTTC
T ss_pred             ccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHhcCCCCCccccc
Confidence            432    1233478889999999999999999999999999999999999864321110   111111222233344456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            6789999999999999999999999999987754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4e-44  Score=356.80  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=208.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+.++++++||||+++++++  ...+..++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~l  105 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYL  105 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEEEE
Confidence            467899999999999999999976 689999999976542 33446788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG  337 (464)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.+   +.+||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEeecC
Confidence            99999999999999753    24899999999999999999999998     9999999999999865   459999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++........  .....+|..|+|||++.+..++.++|||||||++|||++|..||......    ..+..+........
T Consensus       177 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~  250 (362)
T 2bdw_A          177 LAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYP  250 (362)
T ss_dssp             TCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCC
T ss_pred             cceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCC
Confidence            9987654321  22345788999999999989999999999999999999999999764321    11222222212111


Q ss_pred             C--CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          418 F--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       418 ~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .  ....+..+.+++.+||+.||++||++.|++++.+.
T Consensus       251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            1  13456789999999999999999999999988664

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-45  Score=358.93  Aligned_cols=266  Identities=21%  Similarity=0.369  Sum_probs=215.2

Q ss_pred             HHhhcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe
Q 012392          180 ESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  252 (464)
Q Consensus       180 ~~~~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  252 (464)
                      +...++|...+.||+|+||.||+|+...      ...||||.+...........+.+|+.+++++ +||||+++++++  
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC--  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence            3445678889999999999999999742      2479999998765555667899999999999 899999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEG----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      ...+..++||||+++|+|.+++.....          ....+++..++.++.||+.||+|||+.+     |+||||||+|
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~N  194 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN  194 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCcccce
Confidence            456678999999999999999976431          1234899999999999999999999988     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |..|+.....  
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--  272 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV--  272 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS--
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch--
Confidence            9999999999999999986643322 11222335667999999998899999999999999999999 8888865321  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                        ...+...+........+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       273 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          273 --NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             --SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence              112233333344444455567789999999999999999999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.9e-44  Score=349.47  Aligned_cols=259  Identities=19%  Similarity=0.316  Sum_probs=201.3

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+..+++.||||.+..... ......+.+|+.++++++||||+++++++  ......++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI--HSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE--CCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE--ccCCEEEEE
Confidence            356888899999999999999998899999999875432 22346788999999999999999999998  556789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||++ |+|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           98 FEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             EECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCchHhEEECCCCCEEEccCcCcee
Confidence            99997 58988887543   34899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--------  412 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  412 (464)
                      ...... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........... +......        
T Consensus       169 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          169 FGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQ  246 (311)
T ss_dssp             TTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGG
T ss_pred             cCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhh
Confidence            643221 2223456888999999876 5689999999999999999999999965332111111 1010000        


Q ss_pred             ----------hcC--CC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 ----------NLK--GK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ----------~~~--~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ...  ..     .....+.++.+++.+||+.||++|||++|++++.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                      000  00     0112346788999999999999999999999986643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-44  Score=349.70  Aligned_cols=270  Identities=23%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC--CCCCceeeeeEEEeCCC-
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL--RHENIIRLRGFCCSRGR-  255 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l--~H~niv~l~g~~~~~~~-  255 (464)
                      -....++|...+.||+|+||.||+|+.. ++.||||.+...    ....+..|.+++..+  +||||+++++++..... 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3445578999999999999999999986 899999998643    234455566666554  89999999999865432 


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCCeeecCCCCCceEEcCCCCe
Q 012392          256 -GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE---VNKPAIVHRNLSVEKVLIDQQFNP  331 (464)
Q Consensus       256 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~~~~ivH~dlk~~Nill~~~~~~  331 (464)
                       ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||+..   ..++.|+||||||+|||++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             5789999999999999999653     3899999999999999999999871   001239999999999999999999


Q ss_pred             EEeeCCccccccCCceee---eeccCCCCccCcccccccCCCCCc------chhHHHHHHHHHHHhC----------CCC
Q 012392          332 LIADCGLHKLLADDIVFS---VLKTSAAMGYLAPEYVTTGRFTER------SDIFAFGVIILQILTG----------SLV  392 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------sDv~s~Gvll~el~tg----------~~p  392 (464)
                      ||+|||+++.........   .....+|..|+|||.+.+...+.+      +|||||||++|||+||          ..|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997664432211   123357889999999987766655      9999999999999999          555


Q ss_pred             CcchHHHHHhhhhHHHh-hhhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          393 LTSSMRLAAESATFENF-IDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       393 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      +................ .........+     ..++..+.+++.+||+.||++|||+.+|+++|+.+....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            54321111111111111 1122233333     367889999999999999999999999999999886654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=349.91  Aligned_cols=269  Identities=20%  Similarity=0.351  Sum_probs=212.4

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--CCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~  259 (464)
                      .++|...+.||+|+||.||+++. .+++.||||.+.... ......+.+|+.++++++||||+++++++...  .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            46788999999999999999997 478999999987643 45567799999999999999999999998532  334789


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++|+|.+++.........+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-----YAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            999999999999999875444456999999999999999999999998     999999999999999999999999998


Q ss_pred             ccccCCcee--------eeeccCCCCccCcccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          340 KLLADDIVF--------SVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       340 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      .........        ......++..|+|||.+....   ++.++||||||+++|||++|+.||......   ......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~  258 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVAL  258 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhH
Confidence            765321100        001223578899999987543   688999999999999999999998643211   111222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccc
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT  460 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~  460 (464)
                      .+............+..+.+++.+||+.||++|||+++++++|+.+.+....
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            2222222333345567899999999999999999999999999988776543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-44  Score=346.42  Aligned_cols=260  Identities=23%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             cCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .+|...+.||+|+||.||+|+..+    ...||||.+...........|.+|+.++++++||||++++++|.. ..+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCceE
Confidence            457778999999999999998642    236899998876555666789999999999999999999998743 345688


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus       104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEECCCCCEEECccccc
Confidence            9999999999999997533   34899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCce---eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          340 KLLADDIV---FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       340 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      +.......   .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.....    .......+......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~  251 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLLQGRRL  251 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC----TTTHHHHHHTTCCC
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC----HHHHHHHHhcCCCC
Confidence            87654322   122334456789999999999999999999999999999996554433211    11112222222333


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..+...++.+.+++..||+.||++|||++|+++.|+.+..
T Consensus       252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            3445566789999999999999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.7e-45  Score=349.98  Aligned_cols=254  Identities=19%  Similarity=0.389  Sum_probs=202.6

Q ss_pred             cCCccccccccCCceEEEEEEEC-CC-------cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DG-------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ++|...+.||+|+||.||+|+.. ++       ..||+|.+.... ......|.+|+.++++++||||+++++++  ...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVC--VCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEE--CCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEE--EeC
Confidence            45788899999999999999865 23       579999987544 34556799999999999999999999998  446


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC-----
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----  330 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~-----  330 (464)
                      +..++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.     
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEEECCBGGGTB
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC-----eECCCcCcceEEEecCCcccccc
Confidence            67899999999999999998643   23899999999999999999999998     999999999999998887     


Q ss_pred             ---eEEeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          331 ---PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       331 ---~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                         +||+|||++.......     ...++..|+|||.+.+ ..++.++||||||+++|||+||+.|+.........    
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~----  227 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK----  227 (289)
T ss_dssp             CCEEEECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----
T ss_pred             cceeeeccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH----
Confidence               9999999997654321     2235677999999987 67899999999999999999976655443221111    


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      .....  .....+...+..+.+++..||+.||++|||+++++++|+.+..+-+
T Consensus       228 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          228 LQFYE--DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHH--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHHhh--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            11111  1222333345678999999999999999999999999998866543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=352.72  Aligned_cols=266  Identities=24%  Similarity=0.415  Sum_probs=213.8

Q ss_pred             hcCCccccccccCCceEEEEEEE-----CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      .++|...+.||+|+||.||+|++     .+++.||||.+.... ....+.|.+|+.++++++||||+++++++.......
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            34578889999999999999984     368899999997654 455678999999999999999999999986554457


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++||||+++|+|.+++....   ..+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEEcCCCcEEEecCc
Confidence            899999999999999998643   24899999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH-----------hhh
Q 012392          338 LHKLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-----------ESA  404 (464)
Q Consensus       338 l~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~-----------~~~  404 (464)
                      +++.........  .....++..|+|||.+.+..++.++||||||+++|||+||..|+........           ...
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            998765433211  1223355679999999888899999999999999999999988764322110           011


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .+.+.+........+...+..+.+++..||+.||++|||+.|+++.|+.+...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            22233333333445566778899999999999999999999999999887543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-44  Score=360.18  Aligned_cols=263  Identities=15%  Similarity=0.210  Sum_probs=203.9

Q ss_pred             hhcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchH----------HHHHHHHHHHHhcCCCCCcee
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSE----------EAEFVKGLYLLTSLRHENIIR  245 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~f~~e~~~l~~l~H~niv~  245 (464)
                      ..++|...+.||+|+||.||+|++.+      ++.||||.+........          ...++.|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578889999999999999999864      47899999876431100          013445666778889999999


Q ss_pred             eeeEEEeCCC--CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCce
Q 012392          246 LRGFCCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV  323 (464)
Q Consensus       246 l~g~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Ni  323 (464)
                      +++++.....  ...++||||+ +|+|.+++....   ..+++.+++.|+.||+.||+|||+.+     |+||||||+||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDlkp~Ni  183 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE-----YVHGDIKASNL  183 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEEecCCHHHE
Confidence            9999865433  4589999999 999999997642   34999999999999999999999998     99999999999


Q ss_pred             EEc--CCCCeEEeeCCccccccCCceeee------eccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          324 LID--QQFNPLIADCGLHKLLADDIVFSV------LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       324 ll~--~~~~~kl~DfGl~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                      |++  .++.+||+|||+++..........      ....+|..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999  889999999999987654321111      123378899999999999999999999999999999999999975


Q ss_pred             hHHHHH--------hhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          396 SMRLAA--------ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       396 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ......        ....+..++++.+.   ....+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             GTTCHHHHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            321111        11122333333221   12335679999999999999999999999999887643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=350.31  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=208.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +|+.||+|.++....  ......+.+|..+++.++||||+++++++  .+....++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~~l   83 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQIFM   83 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE--EeCCEEEE
Confidence            46888899999999999999976 789999999875321  12345678899999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        84 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             EECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChheEEEcCCCCEEEeecCcce
Confidence            999999999999997643    3899999999999999999999988     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .....    .....+|..|+|||.+.+..++.++|||||||++|||++|..||......    ..+..+....  ..++.
T Consensus       155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~--~~~p~  224 (318)
T 1fot_A          155 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAE--LRFPP  224 (318)
T ss_dssp             ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCC--CCCCT
T ss_pred             ecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCC--CCCCC
Confidence            76542    22345788999999999999999999999999999999999999764322    2223333322  23445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      ..+..+.+++.+||+.||++||     +++++++|-+.
T Consensus       225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence            5667899999999999999999     99999987664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.9e-44  Score=345.24  Aligned_cols=259  Identities=19%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||+||+|+.. +++.||||.+..... ......+.+|+.++++++||||+++++++..  .+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence            46888899999999999999976 689999999976542 3344678899999999999999999999844  6789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++ +|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~-----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             EECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            999965 6777665433   34899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC-----
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-----  415 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  415 (464)
                      ...... ......+|..|+|||.+.+.. ++.++|||||||++|||+||+.|+............+.........     
T Consensus       151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            643221 122345678899999997765 7999999999999999999988864332211111111111100000     


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 -------------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 -------------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                         .......+..+.+++..||+.||++|||++|+++|-+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence                               011123567789999999999999999999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-44  Score=349.99  Aligned_cols=273  Identities=24%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeE
Q 012392          175 NLEEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGF  249 (464)
Q Consensus       175 ~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~  249 (464)
                      .++++....++|...+.||+|+||.||+|+..    .+..||||.++.... ......|.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            34445556677889999999999999999864    345899999876542 3345679999999999999999999999


Q ss_pred             EEeCCCC---eEEEEEecCCCCCHHHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceE
Q 012392          250 CCSRGRG---ECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL  324 (464)
Q Consensus       250 ~~~~~~~---~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nil  324 (464)
                      +......   ..++||||+++|+|.+++....  .....+++..++.++.||+.||.|||+.+     |+||||||+|||
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIl  179 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCM  179 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCSGGGEE
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEE
Confidence            8654332   4599999999999999995432  22345999999999999999999999988     999999999999


Q ss_pred             EcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHh
Q 012392          325 IDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAE  402 (464)
Q Consensus       325 l~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~  402 (464)
                      ++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....    
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  255 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----  255 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH----
Confidence            99999999999999986644321 12223345678999999999999999999999999999999 7778764322    


Q ss_pred             hhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          403 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                       ......+........+...+..+.+++..||+.||++|||+.+++++|+.+...
T Consensus       256 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          256 -HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             -GGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             111222222333444556678899999999999999999999999999987543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-44  Score=344.36  Aligned_cols=258  Identities=23%  Similarity=0.388  Sum_probs=208.0

Q ss_pred             CccccccccCCceEEEEEEEC-C---CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-D---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      |...++||+|+||.||+|+.. +   +..||+|.+...........|.+|+.++++++||||+++++++... ....++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v  101 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEEE
Confidence            455688999999999999863 2   2379999998665555667899999999999999999999998432 3345899


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+.+|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus       102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999997633   34899999999999999999999998     99999999999999999999999999986


Q ss_pred             ccCCce---eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          342 LADDIV---FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       342 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ......   .......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....    ...+...+........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~  249 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLAQGRRLPQ  249 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHHHHHTTCCCCC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHHHhhcCCCCCC
Confidence            644321   112233456789999999999999999999999999999997766543321    1222333333334444


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +...++.+.+++..||+.||++|||++++++.|+.+..
T Consensus       250 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            55667789999999999999999999999999987744

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-44  Score=358.33  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=208.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+|++++||||+++++++  ......++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEE--EeCCEEEEE
Confidence            356889999999999999999976 68999999987654 34456789999999999999999999998  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--CCCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGl~  339 (464)
                      |||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.  ++.+||+|||++
T Consensus       127 ~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccchHHeEEecCCCCceEEEecccc
Confidence            99999999999997542   24899999999999999999999998     999999999999974  477999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh--cCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGK  417 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  417 (464)
                      +........  ....+|..|+|||++.+..++.++|||||||++|||+||..||.......    .+..+....  ....
T Consensus       199 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~  272 (387)
T 1kob_A          199 TKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDED  272 (387)
T ss_dssp             EECCTTSCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCCCCCCSS
T ss_pred             eecCCCcce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCcc
Confidence            877544322  22357889999999999899999999999999999999999997643221    111221111  1112


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .....+..+.+++..||+.||++|||+.|++++.+.
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence            223456789999999999999999999999998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=354.82  Aligned_cols=256  Identities=18%  Similarity=0.323  Sum_probs=205.8

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCC--CCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||++...+++.||||.+..... ......|.+|+.++.+++|  |||+++++++.  .....+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCEEE
Confidence            356888899999999999999998899999999876542 3344678999999999976  99999999984  467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|||| .+|+|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++ ++.+||+|||++
T Consensus        86 lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EEEeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEE-CCcEEEeecccc
Confidence            99995 5889999998643    4899999999999999999999998     99999999999997 568999999999


Q ss_pred             ccccCCcee-eeeccCCCCccCccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH
Q 012392          340 KLLADDIVF-SVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       340 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~  407 (464)
                      +........ ......+|..|+|||++..           ..++.++|||||||++|||++|+.||......   ...+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~  231 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLH  231 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHH
Confidence            876543221 1223457889999999864           67899999999999999999999999753221   22344


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..++.......+...+..+.+++..||+.||++|||+.|++++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            44555555555556667899999999999999999999999988765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-44  Score=351.94  Aligned_cols=261  Identities=23%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcE--EEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||.||+|+.. ++..  ||||.++..........+.+|+.++.++ +||||+++++++..  .+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceE
Confidence            45778899999999999999875 5654  4999987654445556799999999999 89999999999844  67899


Q ss_pred             EEEecCCCCCHHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +||||+++|+|.+++....            .....+++..++.++.||+.||+|||+.+     |+||||||+|||++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  177 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCccceEEEcC
Confidence            9999999999999997643            22345899999999999999999999998     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  406 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~  406 (464)
                      ++.+||+|||+++.....  .......++..|+|||.+....++.++||||||+++|||+| |+.||......     .+
T Consensus       178 ~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~  250 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL  250 (327)
T ss_dssp             GGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred             CCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HH
Confidence            999999999998744321  11122345678999999988889999999999999999998 99998654321     11


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                      ...+........+...+..+.+++.+||+.||++|||+++++++|+.+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            2222233333445566788999999999999999999999999998765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-44  Score=353.27  Aligned_cols=267  Identities=16%  Similarity=0.229  Sum_probs=206.9

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      ++....++|...+.||+|+||.||+|+.. ++..||||.+....    .......+.+|+.++++++||||+++++++  
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--   97 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--   97 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--
Confidence            34566778999999999999999999975 68899999986532    234456799999999999999999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCC------------------------------------CCCCCHHHHHHHHHHH
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGS------------------------------------SNVLDWSTRVSIIIGI  296 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i  296 (464)
                      ...+..++||||+++|+|.+++......                                    ...+++..+..++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            4467899999999999999999521100                                    1124567788999999


Q ss_pred             HHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC--CeEEeeCCccccccC---CceeeeeccCCCCccCccccccc--CC
Q 012392          297 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF--NPLIADCGLHKLLAD---DIVFSVLKTSAAMGYLAPEYVTT--GR  369 (464)
Q Consensus       297 a~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~--~~kl~DfGl~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~--~~  369 (464)
                      +.||+|||+.+     |+||||||+|||++.++  .+||+|||+++....   ..........+|..|+|||.+..  ..
T Consensus       178 ~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          178 FSALHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHTT-----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHCC-----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            99999999998     99999999999998776  899999999986533   11222334557888999999865  67


Q ss_pred             CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC--CHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 012392          370 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--SESEAAKLGKMALVCTHEDPENRPTMEAV  447 (464)
Q Consensus       370 ~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~ev  447 (464)
                      ++.++||||||+++|||++|+.||......    .....+.........  ....+..+.+++..||+.||++||++.++
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDA----DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChH----HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            899999999999999999999999764332    122233322222211  12356789999999999999999999999


Q ss_pred             HHHHhhhc
Q 012392          448 IEELTVAA  455 (464)
Q Consensus       448 l~~L~~~~  455 (464)
                      +++.+...
T Consensus       329 l~hp~~~~  336 (345)
T 3hko_A          329 LQHPWISQ  336 (345)
T ss_dssp             HHSHHHHT
T ss_pred             hcChhhcc
Confidence            99876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4e-44  Score=345.27  Aligned_cols=258  Identities=21%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+..+++.||||.+...... .....+.+|+.++++++||||+++++++.  ..+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc--cCCeEEEEE
Confidence            468888999999999999999988999999998754322 22357889999999999999999999984  456799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++ +|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++..
T Consensus        80 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             ECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            99964 9999987543   24899999999999999999999998     999999999999999999999999999865


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh----------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID----------  411 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~----------  411 (464)
                      ..... ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||..................          
T Consensus       151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             Ccccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence            43211 1223356788999999875 45899999999999999999999999754322111111110000          


Q ss_pred             ------hhcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          412 ------RNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       412 ------~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                            +....       ......+..+.+++.+||+.||++|||++|++++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                  00000       0112345778999999999999999999999988654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.7e-44  Score=363.12  Aligned_cols=256  Identities=21%  Similarity=0.275  Sum_probs=207.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..++|...+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.++++++||||+++++++  ...+..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI--SEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE--ECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE--EECCEEE
Confidence            3456889999999999999999865 7899999998765422 3346789999999999999999999998  4567899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCCeEEeeC
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADC  336 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Df  336 (464)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++   .++.+||+||
T Consensus        87 lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g-----ivHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEeccCCCCcEEEccC
Confidence            9999999999999997643    3899999999999999999999998     99999999999998   5678999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |+++....... ......+|+.|+|||++.+..++.++|||||||++|||++|..||.......    .+..+.......
T Consensus       158 G~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~  232 (444)
T 3soa_A          158 GLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQIKAGAYDF  232 (444)
T ss_dssp             SSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCC
T ss_pred             ceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhCCCCC
Confidence            99987654321 1223457889999999999899999999999999999999999997643221    122222221111


Q ss_pred             --CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          417 --KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       417 --~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ......+..+.+++..||+.||++|||+.|++++.+.
T Consensus       233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence              1123456789999999999999999999999987653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-44  Score=344.95  Aligned_cols=257  Identities=22%  Similarity=0.324  Sum_probs=201.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+++.. ++..||+|.+...........+.+|+.++++++||||+++++++  ......++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF--EDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe--ecCCeEEEEE
Confidence            45788899999999999999975 68899999998765455567899999999999999999999998  4467899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCCcc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLH  339 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl~  339 (464)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||+.+     |+||||||+|||+   +.++.+||+|||++
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            999999999999765333345999999999999999999999998     9999999999999   45688999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +......  ......++..|+|||.+. +.++.++||||||+++|||++|+.||............  ........ ...
T Consensus       175 ~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~-~~~  248 (285)
T 3is5_A          175 ELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYA-VEC  248 (285)
T ss_dssp             CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCC-C--
T ss_pred             eecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh--ccCCcccc-ccc
Confidence            8664432  122345788899999875 56899999999999999999999999764322111100  00001010 111


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...++.+.+++..||+.||++|||+.|++++-+.
T Consensus       249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence            1245678899999999999999999999987653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=365.76  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=212.7

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEE
Q 012392          174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFC  250 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~  250 (464)
                      +.+.++....++|...+.||+|+||+||+++.+ +|+.||||.++....  ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345666677889999999999999999999985 789999999874321  11223478899999999999999999988


Q ss_pred             EeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          251 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       251 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                        .+.+..++||||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.
T Consensus       131 --~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          131 --QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG-----YVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSC
T ss_pred             --eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccCHHHeeecCCCC
Confidence              45678999999999999999998643   23899999999999999999999998     999999999999999999


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      +||+|||+++..............+|..|+|||++.       ...++.++|||||||++|||++|+.||.......   
T Consensus       201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---  277 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---  277 (412)
T ss_dssp             EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---
T ss_pred             EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---
Confidence            999999999877554333333446889999999987       4578999999999999999999999997653321   


Q ss_pred             hhHHHhhhhh--cC-CCCCHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHHHhh
Q 012392          404 ATFENFIDRN--LK-GKFSESEAAKLGKMALVCTHEDPENR---PTMEAVIEELTV  453 (464)
Q Consensus       404 ~~~~~~~~~~--~~-~~~~~~~~~~l~~l~~~C~~~dp~~R---Ps~~evl~~L~~  453 (464)
                       .+..++...  .. .......+..+.+++.+||. +|++|   |+++|+++|-+.
T Consensus       278 -~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          278 -TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             -HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             -HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence             122222211  11 11223456789999999999 99998   699999988765

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-44  Score=346.04  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             HhhcCCcccc-ccccCCceEEEEEEEC---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          181 SATQCFSEVN-LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       181 ~~~~~f~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ...++|...+ .||+|+||.||+|.+.   +++.||||.++.... .....+|.+|+.++++++||||+++++++  . .
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~   89 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--E-A   89 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--E-S
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--C-C
Confidence            3345677777 9999999999999653   468899999876532 33356799999999999999999999998  2 3


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      +..++||||+++++|.+++....    .+++..++.++.||+.||+|||+.+     |+||||||+||+++.++.+||+|
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEcCCCCcceEEEeCCCcEEEcc
Confidence            56889999999999999997642    3899999999999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhh
Q 012392          336 CGLHKLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       336 fGl~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      ||+++.........  .....++..|+|||.+.+..++.++||||||+++|||+| |..||......     .+...+..
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~  235 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEK  235 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHT
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc
Confidence            99998765432211  222335678999999988889999999999999999999 99998754321     12223333


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ......+...+..+.+++..||+.||++||++.++++.|+.+-
T Consensus       236 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3344455667788999999999999999999999999998763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=361.06  Aligned_cols=265  Identities=21%  Similarity=0.290  Sum_probs=213.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.++++++||||+++++++........++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46788899999999999999986 58999999997654444456788999999999999999999998765555789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE----cCCCCeEEeeCCc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGL  338 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfGl  338 (464)
                      ||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+     |+||||||+|||+    +.++.+||+|||+
T Consensus        89 e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             ecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999865432 23899999999999999999999998     9999999999999    7888899999999


Q ss_pred             cccccCCceeeeeccCCCCccCccccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTT--------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      ++.......  .....+|..|+|||.+..        ..++.++|||||||++|||+||+.||............+..++
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             CEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             ceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            987654332  123457888999999864        5678899999999999999999999864221111111112221


Q ss_pred             hhh-----------------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          411 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       411 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...                       .....+......+.+++..||+.||++||++.|++++++.+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            111                       0112346788899999999999999999999999999987644

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=356.82  Aligned_cols=253  Identities=19%  Similarity=0.275  Sum_probs=204.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++...  .......+.+|..++..+ +||||+++++++  ...+..
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~~~   99 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF--QTPDRL   99 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE--EeCCEE
Confidence            357888999999999999999976 68999999987532  122335678899999988 699999999988  456789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCHHHEEECCCCCEEEccccc
Confidence            99999999999999998653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++....... ......+|..|+|||++.+..++.++|||||||++|||++|..||......    ..+..+...  ...+
T Consensus       171 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~--~~~~  243 (353)
T 3txo_A          171 CKEGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILND--EVVY  243 (353)
T ss_dssp             CBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CCCC
T ss_pred             eeecccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----HHHHHHHcC--CCCC
Confidence            985432211 222345788999999999888999999999999999999999999765332    122222222  2234


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV  453 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~  453 (464)
                      +...+..+.+++..||+.||++||++      +|+++|.+.
T Consensus       244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f  284 (353)
T 3txo_A          244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF  284 (353)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred             CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence            45566789999999999999999998      889887654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=357.68  Aligned_cols=250  Identities=19%  Similarity=0.250  Sum_probs=199.4

Q ss_pred             cccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecCC
Q 012392          188 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  266 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~~  266 (464)
                      ..+.||+|+||.||+|+.. +|+.||||.++... .....+|.+|+.++++++||||+++++++  ...+..++||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCEEEEEEeCCC
Confidence            3568999999999999975 68999999998654 34556799999999999999999999998  44678999999999


Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE--cCCCCeEEeeCCccccccC
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFNPLIADCGLHKLLAD  344 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill--~~~~~~kl~DfGl~~~~~~  344 (464)
                      +|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||+  +.++.+||+|||+++....
T Consensus       170 ~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          170 GGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             TCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            999999997543   23899999999999999999999998     9999999999999  5678999999999987654


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC--CCCHHH
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSESE  422 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  422 (464)
                      ...  .....+|..|+|||++....++.++|||||||++|||++|..||......    ..+..+.......  ......
T Consensus       242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCSCSGGGTTS
T ss_pred             ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCCChhhhccC
Confidence            322  12335788999999999889999999999999999999999999765332    1222222221111  111234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++..||+.||++|||+.|++++.+..
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            67899999999999999999999999986643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.6e-44  Score=350.08  Aligned_cols=263  Identities=19%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|...+.||+|+||.||+|++.      ++..||||.+..........+|.+|+.++++++||||+++++++  ....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE--cCCC
Confidence            456888899999999999999842      57789999997655556667899999999999999999999998  4466


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFN  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~  330 (464)
                      ..++||||+++|+|.+++......   ...+++..++.++.||+.||.|||+.+     |+||||||+|||++   ++..
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eecCcCCHhHEEEecCCCcce
Confidence            789999999999999999875422   134899999999999999999999998     99999999999999   4456


Q ss_pred             eEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHH
Q 012392          331 PLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  408 (464)
                      +||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |..|+......     .+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~  256 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLE  256 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----HHHH
Confidence            99999999976543221 12223345778999999988899999999999999999999 88888654321     1222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .+........+...+..+.+++..||+.||++||++.+++++|+.+...
T Consensus       257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            2223333344556677899999999999999999999999999977543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.1e-44  Score=353.69  Aligned_cols=250  Identities=18%  Similarity=0.275  Sum_probs=208.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +|+.||||.+.....  ......+.+|+.+++.++||||+++++++  ......++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~l  118 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCCEEEE
Confidence            46888899999999999999976 689999999865321  12345788999999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       119 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCccceEEECCCCCEEEcccccce
Confidence            999999999999998653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......    ....+|..|+|||.+.+..++.++|||||||++|||++|..||......    ..+..+...  ....+.
T Consensus       190 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~--~~~~p~  259 (350)
T 1rdq_E          190 RVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSG--KVRFPS  259 (350)
T ss_dssp             ECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CCCCCT
T ss_pred             eccCCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHHHHHcC--CCCCCC
Confidence            765432    2234678899999999999999999999999999999999999764322    122222222  223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~~  454 (464)
                      ..+..+.+++.+||+.||++||+     ++++++|.+..
T Consensus       260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            56778999999999999999998     99999887643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.3e-44  Score=357.63  Aligned_cols=257  Identities=17%  Similarity=0.257  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...++||+|+||+||+|+.. +++.||||.++.....  .....+..|..++.++ +||||+++++++  ......
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTESRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE--EECCEE
Confidence            356888999999999999999976 6789999999764322  2224577899999887 899999999988  456789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEECCCCCEEEeecce
Confidence            99999999999999998653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH-----hhhhHHHhhhhh
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-----ESATFENFIDRN  413 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~  413 (464)
                      ++....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........     .......+..  
T Consensus       200 a~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--  276 (396)
T 4dc2_A          200 CKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--  276 (396)
T ss_dssp             CBCCCCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--
T ss_pred             eeecccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--
Confidence            985322111 22334578899999999999999999999999999999999999964211100     0111122222  


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV  453 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~  453 (464)
                      ....++...+..+.+++..||+.||++||++      +|+++|.+.
T Consensus       277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            2233455667789999999999999999984      788887654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-43  Score=345.46  Aligned_cols=264  Identities=19%  Similarity=0.328  Sum_probs=201.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .+|...+.||+|+||.||+|+.. +|+.||||.+....  ......++.+|+.++++++||||+++++++..  .+..++
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l  109 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI  109 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEEE
Confidence            45888899999999999999974 78999999987532  23445678999999999999999999999854  568999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++.........+++..++.++.||+.||.|||+.+     |+||||||+||+++.++.+||+|||+++
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            99999999999999764433455899999999999999999999998     9999999999999999999999999988


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........  .....+...........
T Consensus       185 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  261 (310)
T 2wqm_A          185 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSD  261 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHHHHTTCSCCCCTT
T ss_pred             eecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHHhhcccCCCCccc
Confidence            6643221 12233467889999999999999999999999999999999999865321100  11111111112222224


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+..+.+++..||+.||++|||+++|++.|+.+.+.
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            5567899999999999999999999999999887543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-43  Score=340.20  Aligned_cols=253  Identities=22%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|+.. ++..||||.+......  .....+.+|+.++++++||||+++++++  ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   85 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVY   85 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE--ecCCEEE
Confidence            456888899999999999999876 5779999998643211  1245688999999999999999999998  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        86 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----CEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHhEEEcCCCCEEEEecccc
Confidence            9999999999999997653    3899999999999999999999988     999999999999999999999999998


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++|..||........    ...+.  ......+
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~--~~~~~~~  227 (279)
T 3fdn_A          157 VHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRIS--RVEFTFP  227 (279)
T ss_dssp             SCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHH--HTCCCCC
T ss_pred             ccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH----HHHHH--hCCCCCC
Confidence            6554332   1234567889999999998999999999999999999999999975432111    11111  1223344


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++..||+.||++|||++|++++.+...
T Consensus       228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence            556678999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-43  Score=338.73  Aligned_cols=256  Identities=22%  Similarity=0.313  Sum_probs=208.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++  ...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE--EcCCEEEE
Confidence            467888999999999999999976 689999999876442 33446788999999999999999999998  44677899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC---eEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG  337 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.   +||+|||
T Consensus        83 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            999999999999987653    3899999999999999999999998     999999999999986655   9999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--  415 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  415 (464)
                      ++........  .....++..|+|||.+.+..++.++||||||+++|||++|..||........    ...+......  
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~  227 (284)
T 3kk8_A          154 LAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYP  227 (284)
T ss_dssp             TCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCC
T ss_pred             eeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH----HHHHHhccccCC
Confidence            9986654322  2234578889999999999999999999999999999999999976433211    1121111111  


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .......+..+.+++..||+.||++|||+.|++++.+...
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence            1112345677999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-43  Score=348.75  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             cCCccccccccCCceEEEEEEE----CCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      ++|...+.||+|+||.||+++.    .+++.||||.++....   ......+.+|+.++++++||||+++++++.  ..+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   94 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--TGG   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--cCC
Confidence            5688889999999999999987    4789999999976431   223456788999999999999999999984  467


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG-----IIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEcccCCHHHeEECCCCcEEEEeC
Confidence            7999999999999999997643    3889999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |+++....... ......+|..|+|||.+.+..++.++||||||+++|||++|..||.......    .+..+...  ..
T Consensus       166 g~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~--~~  238 (327)
T 3a62_A          166 GLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKC--KL  238 (327)
T ss_dssp             SCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHT--CC
T ss_pred             CcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhC--CC
Confidence            99875432211 1223457889999999998899999999999999999999999997643221    12222222  22


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      ..+...+..+.+++.+||+.||++||     ++.|+++|.+.
T Consensus       239 ~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          239 NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            34445667899999999999999999     88999988764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.5e-44  Score=341.44  Aligned_cols=251  Identities=24%  Similarity=0.441  Sum_probs=206.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe---------
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS---------  252 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~---------  252 (464)
                      ..+|...+.||+|+||.||+|+.. +++.||||.+....     ..+.+|+.++++++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            356888999999999999999986 78999999987543     246789999999999999999998743         


Q ss_pred             -----CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          253 -----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       253 -----~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                           ......++||||+++|+|.+++.....  ..+++..++.++.||+.||.|||+.+     |+||||||+|||+++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHEEEcC
Confidence                 113458999999999999999976532  34899999999999999999999998     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~  407 (464)
                      ++.+||+|||+++.......  .....++..|+|||.+.+..++.++||||||+++|||++|..|+.....      ...
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~~  229 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------FFT  229 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------HHH
T ss_pred             CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------HHH
Confidence            99999999999987654321  2234577889999999998999999999999999999999988754321      111


Q ss_pred             HhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          408 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ....    ...+...+..+.+++..||+.||++|||+.|++++|+.....
T Consensus       230 ~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          230 DLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             Hhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            1111    223334456789999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.6e-44  Score=357.47  Aligned_cols=261  Identities=16%  Similarity=0.312  Sum_probs=202.0

Q ss_pred             cCCccccccccC--CceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|  +||.||+|+.. +++.||||.+....... ....+.+|+.++++++||||+++++++..  .+..+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  102 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELW  102 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEEE
Confidence            458888999999  99999999986 78999999997654333 34567889999999999999999999854  67899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            99999999999999986532  24899999999999999999999998     999999999999999999999999998


Q ss_pred             ccccCCcee------eeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH----
Q 012392          340 KLLADDIVF------SVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----  407 (464)
Q Consensus       340 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~----  407 (464)
                      .........      ......+|..|+|||.+.+  ..++.++|||||||++|||++|+.||............+.    
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            654322110      1112356778999999987  5789999999999999999999999965321111000000    


Q ss_pred             Hhhhhh------------------------------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 012392          408 NFIDRN------------------------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  451 (464)
Q Consensus       408 ~~~~~~------------------------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L  451 (464)
                      ...+..                                    .....+...+..+.+++.+||+.||++|||++|++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            000000                                    00011223456799999999999999999999999885


Q ss_pred             hh
Q 012392          452 TV  453 (464)
Q Consensus       452 ~~  453 (464)
                      +.
T Consensus       336 ~f  337 (389)
T 3gni_B          336 FF  337 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            53

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-43  Score=357.31  Aligned_cols=255  Identities=19%  Similarity=0.331  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCC--CCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..|...+.||+|+||.||+|...+++.||||.+..... ......|.+|+.+|.+++  ||||+++++++..  .+..++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEE
Confidence            45888999999999999999988899999999876542 344567999999999996  5999999998844  567999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||| +.+|+|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++ ++.+||+|||+++
T Consensus       134 v~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             EEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            999 56899999998643    4889999999999999999999988     99999999999996 5789999999998


Q ss_pred             cccCCcee-eeeccCCCCccCccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          341 LLADDIVF-SVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       341 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      ........ ......+|..|+|||++..           ..++.++|||||||+||||++|..||......   ...+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~  279 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHA  279 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHH
Confidence            76543211 1233458889999999864           46889999999999999999999999653211   123344


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +++.......+...+..+.+++..||+.||++|||+.|++++.+..
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            4554444444555567899999999999999999999999987754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=353.12  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=194.1

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++...   ....+.+|+.++++++||||+++++++  ......++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIF--ETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeE--ecCCeEEE
Confidence            4567888999999999999999986 57899999987543   345688999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG  337 (464)
                      ||||+++|+|.+++...    ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.   ++.+||+|||
T Consensus       126 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCcccEEEecCCCCCCEEEccCc
Confidence            99999999999999753    24899999999999999999999998     999999999999975   8899999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--  415 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  415 (464)
                      +++.......  .....+|..|+|||++.+..++.++|||||||++|||++|..||.......   ..+..+......  
T Consensus       197 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~~~~~~~~  271 (349)
T 2w4o_A          197 LSKIVEHQVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRILNCEYYFI  271 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHHTTCCCCC
T ss_pred             cccccCcccc--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHHhCCCccC
Confidence            9986644321  123447888999999999899999999999999999999999996543211   112222222111  


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .......+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            1122345678999999999999999999999999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.8e-44  Score=343.59  Aligned_cols=258  Identities=16%  Similarity=0.182  Sum_probs=204.9

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+. .+++.||||.+....   ....+.+|+.++.++ +|+|++++++++.  .....++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeEEE
Confidence            5688889999999999999996 478999999986543   223577899999999 7999999999884  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC-----eEEeeC
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----PLIADC  336 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Df  336 (464)
                      |||+ +++|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.     +||+||
T Consensus        85 ~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             EEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            9999 999999998643   24899999999999999999999988     999999999999987776     999999


Q ss_pred             CccccccCCce------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          337 GLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       337 Gl~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      |+++.......      .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~  234 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIG  234 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-cHHHHHHHH
Confidence            99987654321      11233457889999999999999999999999999999999999997521100 001111111


Q ss_pred             hhhcCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          411 DRNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       411 ~~~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .......   .....++.+.+++..||+.||++||++++|++.|+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            1111111   112345789999999999999999999999999987653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-43  Score=343.52  Aligned_cols=253  Identities=21%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.++++++||||+++++++..  ....++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence            45888899999999999999875 6899999999876555566789999999999999999999999854  56799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++++|.+++..     ..+++..+..++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||++...
T Consensus       100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChheEEECCCCCEEEeecccceec
Confidence            99999999999964     24899999999999999999999998     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......     ....+........+...
T Consensus       170 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  243 (303)
T 3a7i_A          170 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIPKNNPPTLEGNY  243 (303)
T ss_dssp             BTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCCSSC
T ss_pred             Ccccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhhcCCCCCCcccc
Confidence            54321 1223457788999999999999999999999999999999999987543211     11112222233344456


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+++..||+.||++|||+.+++++.+..
T Consensus       244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            67899999999999999999999999987654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.2e-44  Score=378.35  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=204.3

Q ss_pred             cccccCCceEEEEEEEC---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      +.||+|+||.||+|.+.   .++.||||.++.... .....+|.+|+.+|++++|||||+++++|..   ...++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence            47999999999999753   467899999976432 2345789999999999999999999999832   3578999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .+++..++.|+.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus       452 ~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          452 ELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             TTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            9999999997532    3899999999999999999999998     999999999999999999999999999876543


Q ss_pred             ce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..  .......+|..|+|||++....++.++|||||||+||||+| |+.||.....     ..+...+........+..+
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~p~~~  597 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGERMGCPAGC  597 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCCCC
Confidence            21  12222345678999999999999999999999999999998 9999975432     2233344444555566778


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      +..+.+++..||+.||++||++.+|++.|+...
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            889999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.5e-44  Score=349.47  Aligned_cols=256  Identities=18%  Similarity=0.181  Sum_probs=203.0

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....   ..++.+|+.+++++ +||||+++++++..  ....++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence            5688889999999999999996 4789999999875432   23588999999999 89999999999854  5678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC-----eEEeeC
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----PLIADC  336 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Df  336 (464)
                      |||+ +|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.     +||+||
T Consensus        84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN-----LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             EEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            9999 999999998642   34999999999999999999999998     999999999999998887     999999


Q ss_pred             CccccccCCcee------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          337 GLHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       337 Gl~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      |+++........      ......+|..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+.
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~  233 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIG  233 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHH
Confidence            999876432211      1234457889999999999999999999999999999999999997531100 001111111


Q ss_pred             hhhcCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          411 DRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       411 ~~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ........   ....+ .+.+++..||+.||.+||++++|++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            11111000   11123 8999999999999999999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-43  Score=349.36  Aligned_cols=256  Identities=16%  Similarity=0.264  Sum_probs=206.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.++....  ......+.+|..++.++ +||||+++++++  ......+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~~~~   86 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTESRLF   86 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE--EeCCEEE
Confidence            45788899999999999999986 688999999976432  23345688899999988 899999999998  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        87 lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999997643    3899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH-----HHhhhhHHHhhhhhc
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESATFENFIDRNL  414 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~  414 (464)
                      +....... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......     .........+...  
T Consensus       158 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--  234 (345)
T 3a8x_A          158 KEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--  234 (345)
T ss_dssp             BCSCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--
T ss_pred             ccccCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--
Confidence            86432211 122345788999999999999999999999999999999999999642110     0011111222221  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV  453 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~  453 (464)
                      ....+...+..+.+++.+||+.||++||++      .|+++|.+.
T Consensus       235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            223455667789999999999999999995      788887654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=352.60  Aligned_cols=266  Identities=16%  Similarity=0.185  Sum_probs=200.5

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCch----------HHHHHHHHHHHHhcCCCCCceeeeeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKS----------EEAEFVKGLYLLTSLRHENIIRLRGF  249 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~f~~e~~~l~~l~H~niv~l~g~  249 (464)
                      ++|...+.||+|+||.||+|+..    ++..||||.+.......          ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888899999999999999975    57889999987653211          11246788899999999999999999


Q ss_pred             EEeC--CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          250 CCSR--GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       250 ~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +...  .....++||||+ +++|.+++....    .+++.+++.++.||+.||+|||+.+     |+||||||+|||++.
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE-----YVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEES
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCcCHHHEEEcc
Confidence            8652  256799999999 999999998654    4899999999999999999999998     999999999999998


Q ss_pred             CC--CeEEeeCCccccccCCceee------eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH
Q 012392          328 QF--NPLIADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL  399 (464)
Q Consensus       328 ~~--~~kl~DfGl~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~  399 (464)
                      ++  .+||+|||+++.........      .....+|..|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  99999999998764322111      12335788999999999989999999999999999999999999642211


Q ss_pred             HHhhhhHHHhhhhhcCC-----CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCccc
Q 012392          400 AAESATFENFIDRNLKG-----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  459 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~  459 (464)
                      .................     ......+..+.+++..||+.||++||++++|++.|+.+.....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            11111111111111100     0011345689999999999999999999999999998765443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-43  Score=353.14  Aligned_cols=257  Identities=18%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.++++++||||+++++++..  .+..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEEE
Confidence            56888899999999999999986 7899999999876545556789999999999999999999999854  57799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+. +     |+||||||+|||++.++.+||+|||++..
T Consensus       111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999998653    389999999999999999999985 6     99999999999999999999999999976


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh------------------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------------  403 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~------------------  403 (464)
                      .....   .....++..|+|||.+.+..++.++||||||+++|||+||+.||..........                  
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          182 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            53321   123357888999999999999999999999999999999999986532211000                  


Q ss_pred             --------------------hhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          404 --------------------ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       404 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                          ...................+..+.+++..||+.||++|||++|+++|.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                                000111111111111223466799999999999999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=355.48  Aligned_cols=254  Identities=18%  Similarity=0.299  Sum_probs=204.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||||.+....  .......+.+|+.+|++++||||+++++++  ......++
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~~l   92 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF--QDEEDMFM   92 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCEEEE
Confidence            45788899999999999999976 68899999986532  122345788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        93 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEECCCCCEEEeccceee
Confidence            999999999999997532    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ......  ......+|..|+|||++..   ..++.++|||||||++|||++|..||........ ......+.  .....
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~--~~~~~  238 (384)
T 4fr4_A          164 MLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFE--TTVVT  238 (384)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHH--HCCCC
T ss_pred             eccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHh--hcccC
Confidence            765432  2233457889999999864   4589999999999999999999999964321100 11111111  12233


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELTV  453 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~~  453 (464)
                      ++...+..+.+++..||+.||++||+ +++++++.+.
T Consensus       239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f  275 (384)
T 4fr4_A          239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM  275 (384)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence            45566788999999999999999998 8888876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-43  Score=351.00  Aligned_cols=263  Identities=19%  Similarity=0.263  Sum_probs=207.7

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-----CCCceee
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----HENIIRL  246 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-----H~niv~l  246 (464)
                      .+++.+.....++|...+.||+|+||.||+|+.. +++.||||.++..  ......+..|+.+++.++     ||||+++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            4555666667788999999999999999999974 7899999998743  344566788999999986     9999999


Q ss_pred             eeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc
Q 012392          247 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  326 (464)
Q Consensus       247 ~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~  326 (464)
                      ++++..  .+..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||++
T Consensus       102 ~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~  171 (360)
T 3llt_A          102 HGKFMY--YDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS-----LTHTDLKPENILLD  171 (360)
T ss_dssp             EEEEEE--TTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEES
T ss_pred             cceeeE--CCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCcccEEEc
Confidence            999854  56899999999 9999999986543  24899999999999999999999998     99999999999997


Q ss_pred             C-------------------------CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHH
Q 012392          327 Q-------------------------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGV  381 (464)
Q Consensus       327 ~-------------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gv  381 (464)
                      +                         ++.+||+|||+++.....    .....+|..|+|||++.+..++.++|||||||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  247 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC  247 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence            6                         789999999999865432    12345788899999999999999999999999


Q ss_pred             HHHHHHhCCCCCcchHHHHHhhhhHHHhhhh---------------------hcCCCCC--------------------H
Q 012392          382 IILQILTGSLVLTSSMRLAAESATFENFIDR---------------------NLKGKFS--------------------E  420 (464)
Q Consensus       382 ll~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~--------------------~  420 (464)
                      ++|||+||+.||......... ..+.....+                     ......+                    .
T Consensus       248 il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          248 VLAELYTGSLLFRTHEHMEHL-AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHH-HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHHHCCCCCCCCcHHHHH-HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999999754321110 000000000                     0000000                    0


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ...+.+.+++..||+.||++|||++|++++.+
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence            11256789999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.9e-44  Score=365.55  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=200.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+....  .......+.+|+.++++++||||+++++++..  .+..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~  224 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC  224 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence            356888999999999999999975 78999999987532  23334568899999999999999999999844  67799


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+ .+     |+||||||+|||++.++.+||+|||+
T Consensus       225 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC-----CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             EEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC-----EEECCCCHHHEEECCCCCEEEccCCC
Confidence            9999999999999997653    38999999999999999999998 77     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++....... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.......    ....+...  ...+
T Consensus       296 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~--~~~~  368 (446)
T 4ejn_A          296 CKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILME--EIRF  368 (446)
T ss_dssp             CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCC
T ss_pred             ceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHHhC--CCCC
Confidence            986433221 2233457889999999999999999999999999999999999997643221    11222221  2234


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  454 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~  454 (464)
                      +...+..+.+++..||+.||++||     +++|+++|.+..
T Consensus       369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence            455667899999999999999999     999999886654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-44  Score=353.22  Aligned_cols=251  Identities=21%  Similarity=0.321  Sum_probs=204.3

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....  ......+.+|+.+++.++||||+++++++  ......++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~l   86 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI--TTPTDIVM   86 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEEEE
Confidence            4688889999999999999997 4789999999864321  11124688999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+ +|+|.+++....    .+++.++..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|||++.
T Consensus        87 v~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK-----IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT-----CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            99999 789999997653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......  .....+|..|+|||.+.+..+ +.++|||||||++|||++|..||......     .+...+. ......+
T Consensus       157 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~-~~~~~~p  228 (336)
T 3h4j_B          157 IMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NLFKKVN-SCVYVMP  228 (336)
T ss_dssp             TTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TCBCCCC-SSCCCCC
T ss_pred             eccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HHHHHHH-cCCCCCc
Confidence            7654322  123457889999999988776 68999999999999999999999753211     0000000 0112234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++.+||+.||.+|||++|++++.+..
T Consensus       229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            45667899999999999999999999999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.5e-44  Score=353.75  Aligned_cols=255  Identities=18%  Similarity=0.274  Sum_probs=206.5

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  256 (464)
                      ...++|...+.||+|+||.||+|+.+ +++.||||.++....  ......+..|..++..+ +||||+++++++  ....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~--~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE--EeCC
Confidence            34567889999999999999999986 689999999975321  12335677899999877 899999999988  4567


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCChhhEEECCCCCEEEeEC
Confidence            8999999999999999998653    3899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |+++....... ......+|..|+|||.+.+..++.++|||||||++|||++|..||......    ..+..+...  ..
T Consensus       163 G~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~--~~  235 (345)
T 1xjd_A          163 GMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMD--NP  235 (345)
T ss_dssp             TTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CC
T ss_pred             hhhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHhC--CC
Confidence            99986432211 123345788999999999999999999999999999999999999764322    112222211  22


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTME-AVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~-evl~~L~~  453 (464)
                      .++...+..+.+++.+||+.||++||++. ++++|.+.
T Consensus       236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f  273 (345)
T 1xjd_A          236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  273 (345)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence            34455667899999999999999999998 88766543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.5e-44  Score=341.01  Aligned_cols=252  Identities=23%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||.||+|+.. |+.||||.++...   ..+.|.+|+.++++++||||+++++++.. ..+..++|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCceEEEEe
Confidence            56788899999999999999885 8899999987543   45678999999999999999999998743 3346899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            9999999999976432  23789999999999999999999998     9999999999999999999999999988654


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||+| |..|+.....     ......+........+...
T Consensus       169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~  239 (278)
T 1byg_A          169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAPDGC  239 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCCCCCCTTC
T ss_pred             ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCCCCcccC
Confidence            321    12345678999999998899999999999999999998 8888865321     1122222233334455667


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            7889999999999999999999999999988754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=343.36  Aligned_cols=263  Identities=21%  Similarity=0.345  Sum_probs=200.6

Q ss_pred             hhcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCC----chHHHHHHHHHHHHhcC---CCCCceeeeeEEEeC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSL---RHENIIRLRGFCCSR  253 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~  253 (464)
                      ..++|...+.||+|+||.||+|+. .+++.||||.+.....    ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            356899999999999999999996 4789999999874321    11123566677766665   599999999998654


Q ss_pred             CCC---eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          254 GRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       254 ~~~---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      ...   ..++||||+. |+|.+++.....  ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCC
Confidence            322   5799999996 699999986543  23899999999999999999999998     999999999999999999


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      +||+|||+++......  ......+|..|+|||.+.+..++.++|||||||++|||++|+.||.................
T Consensus       159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (308)
T 3g33_A          159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  236 (308)
T ss_dssp             EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999998665332  12234578889999999999999999999999999999999999976543222111111100


Q ss_pred             hhh--------------cCCC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          411 DRN--------------LKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       411 ~~~--------------~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+.              ....       .....++.+.+++.+||+.||++|||+.|+++|.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~  301 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  301 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence            000              0000       0113456789999999999999999999999986643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-43  Score=340.94  Aligned_cols=252  Identities=18%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.... ......++.+|+..+.++ +||||+++++++..  .+..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence            456888999999999999999986 78999999987643 234556789999999999 89999999999854  66899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC------------
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ------------  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~------------  327 (464)
                      +||||+++|+|.+++.........+++..+..++.||+.||+|||+.+     |+||||||+|||++.            
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEC-------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecCCCHHHEEEcCCCCCcccccccc
Confidence            999999999999999875433345899999999999999999999998     999999999999984            


Q ss_pred             -------CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHH
Q 012392          328 -------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRL  399 (464)
Q Consensus       328 -------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~  399 (464)
                             ...+||+|||++.......     ...++..|+|||.+.+. .++.++||||||+++|||++|..++..... 
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred             cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence                   4479999999998765432     23477889999999765 567899999999999999999887654322 


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                            +..+. .......+...+..+.+++..||+.||++|||+.|++++.+..
T Consensus       237 ------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          237 ------WHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             ------HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             ------HHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence                  11111 1222334445667899999999999999999999999886643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.8e-43  Score=346.34  Aligned_cols=266  Identities=20%  Similarity=0.315  Sum_probs=207.9

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--CCCCCceeeeeEEEeCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSRG  254 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~--l~H~niv~l~g~~~~~~  254 (464)
                      ..-....++|...+.||+|+||.||+|+. +++.||||.+...    ....+.+|.+++..  ++||||+++++++....
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            33344567899999999999999999998 4899999998643    34567888888887  78999999999986543


Q ss_pred             C--CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCCCeeecCCCCCceE
Q 012392          255 R--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--------SSEVNKPAIVHRNLSVEKVL  324 (464)
Q Consensus       255 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~ivH~dlk~~Nil  324 (464)
                      .  ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.+     |+||||||+|||
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~NIl  179 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-----IAHRDLKSKNIL  179 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-----EECSCCSGGGEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-----eeeCCCCHHHEE
Confidence            2  2789999999999999999753     3899999999999999999999        666     999999999999


Q ss_pred             EcCCCCeEEeeCCccccccCCcee---eeeccCCCCccCcccccccC------CCCCcchhHHHHHHHHHHHhC------
Q 012392          325 IDQQFNPLIADCGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTG------  389 (464)
Q Consensus       325 l~~~~~~kl~DfGl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvll~el~tg------  389 (464)
                      ++.++.+||+|||+++........   ......++..|+|||.+...      .++.++||||||+++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999866543211   12234578889999998765      234689999999999999999      


Q ss_pred             ----CCCCcchHHHHHhhhhH-HHhhhhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          390 ----SLVLTSSMRLAAESATF-ENFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       390 ----~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                          ..||............+ ..+.....+...+     ...++.+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                66765432110011111 1222233333333     36778899999999999999999999999999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-43  Score=343.10  Aligned_cols=259  Identities=17%  Similarity=0.259  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....  ......+.+|+.++++++||||+++++++..  .+..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~  110 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY  110 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence            367888999999999999999976 788999999875432  2234678999999999999999999999854  67899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|+||+++++|.+++....    .+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       111 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             EEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc-----CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            9999999999999998643    3899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--CC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GK  417 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  417 (464)
                      ...............++..|+|||.+.+..++.++||||||+++|||+||+.||......     .+...+.....  ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHINQAIPRPST  256 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHHSCCCCGGG
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhccCCCCccc
Confidence            876544332333445778899999999999999999999999999999999999765432     11111111111  11


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhcCc
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAPV  457 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~~~  457 (464)
                      .+...+..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            2344566799999999999999999 999999999876544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-43  Score=338.50  Aligned_cols=260  Identities=19%  Similarity=0.313  Sum_probs=209.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.+++.++||||+++++++..  .+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence            356888899999999999999976 7899999999765545556789999999999999999999999844  6778999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+++++|.+++...    ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            9999999999998643    24899999999999999999999998     99999999999999999999999999986


Q ss_pred             ccCCce-eeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          342 LADDIV-FSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       342 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ...... .......++..|+|||.+.+..+ +.++||||||+++|||++|..||........   .+.............
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~  231 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPW  231 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHHHTTCTTSTTG
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhhhcccccCch
Confidence            543221 11223457788999999987665 7789999999999999999999975432111   111222111111122


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+..+.+++..||+.||++|||++|++++.+...+
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            3456788999999999999999999999998765443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.4e-44  Score=342.36  Aligned_cols=259  Identities=17%  Similarity=0.294  Sum_probs=194.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHH-HHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF-VKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f-~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++.........++ .++...++.++||||+++++++.  ..+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCCEEE
Confidence            456888999999999999999974 7899999999765444444444 44555588889999999999984  4667999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      ||||++ |+|.+++.........+++..+..++.|++.||+|||+. +     |+||||||+||+++.++.+||+|||++
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-----VIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-----CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeecCCc
Confidence            999996 699888876433344599999999999999999999997 7     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYV----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      +.......  .....++..|+|||.+    ....++.++||||||+++|||+||+.|+......   ...+...+.....
T Consensus       158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~  232 (290)
T 3fme_A          158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQVVEEPSP  232 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---HHHHHHHHHSCCC
T ss_pred             cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---HHHHHHHhccCCC
Confidence            87654322  2223577889999996    5567899999999999999999999999753221   1122233333333


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .......+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence            333345667899999999999999999999999976643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.2e-43  Score=335.85  Aligned_cols=250  Identities=18%  Similarity=0.275  Sum_probs=204.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+.. ++..||+|.+.... ......|.+|+.++++++||||+++++++  ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETF--EDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCCeEEEE
Confidence            456888999999999999999976 57799999987654 23356799999999999999999999998  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCCc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl  338 (464)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+   +.++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            99999999999997653    3899999999999999999999998     9999999999999   7889999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      +........  .....++..|+|||.+.+ .++.++||||||+++|||++|..||.......    ....+...  ....
T Consensus       156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~--~~~~  226 (277)
T 3f3z_A          156 AARFKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREG--TFTF  226 (277)
T ss_dssp             CEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCC
T ss_pred             ceeccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhC--CCCC
Confidence            987654322  223457888999998865 48999999999999999999999997643211    11122111  1122


Q ss_pred             CH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          419 SE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       419 ~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      +.    ..+..+.+++..||+.||++|||+.+++++.+.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  265 (277)
T 3f3z_A          227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF  265 (277)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence            22    346789999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-43  Score=356.20  Aligned_cols=256  Identities=17%  Similarity=0.220  Sum_probs=194.7

Q ss_pred             CCccc-cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHh-cCCCCCceeeeeEEEe--CCCCeEE
Q 012392          185 CFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLT-SLRHENIIRLRGFCCS--RGRGECF  259 (464)
Q Consensus       185 ~f~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~-~l~H~niv~l~g~~~~--~~~~~~~  259 (464)
                      +|... ++||+|+||.||+|+.. +++.||||.++..      ..+.+|+.++. ..+||||+++++++..  .+....+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            34444 68999999999999976 6899999998632      24667888774 4589999999998743  2345689


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEeeC
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADC  336 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df  336 (464)
                      +||||+++|+|.+++.....  ..+++.++..|+.||+.||.|||+.+     |+||||||+|||++.   ++.+||+||
T Consensus       136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCcceEEEecCCCCccEEEEec
Confidence            99999999999999976432  34899999999999999999999988     999999999999998   789999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |+++......  ......+|..|+|||++.+..++.++|||||||++|||++|..||...............+.......
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            9998664322  12234467889999999999999999999999999999999999975432111001111111111111


Q ss_pred             --CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          417 --KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       417 --~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                        ......+..+.+++..||+.||++|||+.|++++.+...
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence              111345678999999999999999999999999987653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.9e-44  Score=347.53  Aligned_cols=256  Identities=18%  Similarity=0.273  Sum_probs=197.1

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC--eE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG--EC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~--~~  258 (464)
                      ++|...+.||+|+||.||+|+. .+++.||||.++....  ......|.+|+.++++++||||+++++++......  ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5688889999999999999996 4789999999976532  23345789999999999999999999988554332  35


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....    .+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             EEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            89999999999999998653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|||+||+.||.........    ..........
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~  238 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIP  238 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHCCCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHhcCCCCC
Confidence            986644321  1222334788999999999999999999999999999999999999764332111    1111111000


Q ss_pred             --CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          417 --KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       417 --~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                        ......+..+.+++.+||+.||++||++.+++++..
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence              001224567999999999999999998777776543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-43  Score=349.88  Aligned_cols=253  Identities=19%  Similarity=0.267  Sum_probs=207.2

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++...  .......+..|..++..+ +||||+++++++  ...+..
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~~~   96 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRL   96 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE--ECSSEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE--EcCCEE
Confidence            356888999999999999999986 47899999987532  112345678899999988 799999999988  456789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            99999999999999998653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++....... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......    ..+..+...  ...+
T Consensus       168 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~--~~~~  240 (353)
T 2i0e_A          168 CKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEH--NVAY  240 (353)
T ss_dssp             CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CCCC
T ss_pred             ccccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhC--CCCC
Confidence            986432211 122345788999999999999999999999999999999999999764322    122233322  2234


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      +...+..+.+++..||+.||++||+     ++++++|.+.
T Consensus       241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence            5566778999999999999999994     6899887653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=347.22  Aligned_cols=262  Identities=25%  Similarity=0.446  Sum_probs=194.8

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHH--HhcCCCCCceeeeeEEEe---CCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYL--LTSLRHENIIRLRGFCCS---RGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~--l~~l~H~niv~l~g~~~~---~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|+. +++.||||.+....    ...+..|.++  +..++||||+++++.+..   ......
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            4678889999999999999987 68999999987432    3344444444  556899999999985532   233467


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCCCeeecCCCCCceEEcCCCCeEEe
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV----NKPAIVHRNLSVEKVLIDQQFNPLIA  334 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~~~ivH~dlk~~Nill~~~~~~kl~  334 (464)
                      ++||||+++|+|.+++....     .++..+..++.||+.||+|||+...    .++.|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999996532     6899999999999999999998800    00129999999999999999999999


Q ss_pred             eCCccccccCCce-------eeeeccCCCCccCccccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH
Q 012392          335 DCGLHKLLADDIV-------FSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLA  400 (464)
Q Consensus       335 DfGl~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~  400 (464)
                      |||+++.......       .......+|..|+|||.+.+       ..++.++|||||||++|||+||..|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987653221       11223357889999999876       456778999999999999999987764321100


Q ss_pred             H-------------hhhhHHHhh-hhhcCCCC------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          401 A-------------ESATFENFI-DRNLKGKF------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       401 ~-------------~~~~~~~~~-~~~~~~~~------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .             ........+ ....+...      ....+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            0             000011111 11112222      2346778999999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-43  Score=353.88  Aligned_cols=260  Identities=22%  Similarity=0.348  Sum_probs=195.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~  258 (464)
                      ..++|...+.||+|+||.||+|+.. +|+.||||.+.... .......+.+|+.++.++. ||||+++++++........
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3467899999999999999999975 78999999986442 2344567889999999997 9999999999866555679


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|||||+ |+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            99999996 6999999753     3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCc--------------------eeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchH
Q 012392          339 HKLLADDI--------------------VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSM  397 (464)
Q Consensus       339 ~~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~  397 (464)
                      ++......                    ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98653210                    011122357888999999876 678999999999999999999999997643


Q ss_pred             HHHHhhhhHHHhhh-----------------------h-------hcCCC------------CCHHHHHHHHHHHHHhhh
Q 012392          398 RLAAESATFENFID-----------------------R-------NLKGK------------FSESEAAKLGKMALVCTH  435 (464)
Q Consensus       398 ~~~~~~~~~~~~~~-----------------------~-------~~~~~------------~~~~~~~~l~~l~~~C~~  435 (464)
                      ........+ ..+.                       .       .....            .....+..+.+++.+||+
T Consensus       236 ~~~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          236 TMNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            321111111 0000                       0       00000            001235678999999999


Q ss_pred             cCCCCCCCHHHHHHHHhh
Q 012392          436 EDPENRPTMEAVIEELTV  453 (464)
Q Consensus       436 ~dp~~RPs~~evl~~L~~  453 (464)
                      .||++|||++|+++|.+.
T Consensus       315 ~dP~~R~t~~e~l~Hp~~  332 (388)
T 3oz6_A          315 FNPNKRISANDALKHPFV  332 (388)
T ss_dssp             SSGGGSCCHHHHTTSTTT
T ss_pred             cCcccCCCHHHHhCCHHH
Confidence            999999999999998663

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-43  Score=346.15  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=206.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+.......     ...++.+|+.++++++||||+++++++  ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY--ENRT   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCC
Confidence            345888899999999999999976 68999999987644221     356799999999999999999999998  4467


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeE
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPL  332 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~k  332 (464)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++    .+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~-----ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChHHEEEecCCCCcCCEE
Confidence            899999999999999999753    24899999999999999999999998     99999999999999888    799


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |+|||+++.......  .....++..|+|||.+.+..++.++||||||+++|||+||..||.......    .+..+...
T Consensus       160 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~  233 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANITSV  233 (321)
T ss_dssp             ECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTT
T ss_pred             EccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhc
Confidence            999999987654321  223457888999999998899999999999999999999999997543211    11111111


Q ss_pred             hcCCCCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 NLKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 ~~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ....+    ...+..+.+++..||+.||++|||+.|++++.+.
T Consensus       234 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          234 --SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             --CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             --ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence              11112    2345678999999999999999999999988664

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-43  Score=346.79  Aligned_cols=248  Identities=21%  Similarity=0.340  Sum_probs=182.6

Q ss_pred             cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEecCCC
Q 012392          190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      +.||+|+||.||+|+.. +++.||||.+...    ....+.+|+.++..+. ||||+++++++  ......++||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~--~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVF--HDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEE--EcCCEEEEEEEccCC
Confidence            78999999999999986 6899999998643    3456789999999997 99999999998  446789999999999


Q ss_pred             CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC---CeEEeeCCccccccC
Q 012392          268 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADCGLHKLLAD  344 (464)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfGl~~~~~~  344 (464)
                      |+|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++.++   .+||+|||+++....
T Consensus        91 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           91 GELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             CBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999997643    4899999999999999999999998     99999999999997665   899999999986543


Q ss_pred             CceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC--C---
Q 012392          345 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--S---  419 (464)
Q Consensus       345 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~---  419 (464)
                      ... ......+|..|+|||.+.+..++.++|||||||++|||++|..||........ .....+.......+..  +   
T Consensus       162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          162 DNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCccc
Confidence            321 12233467889999999999999999999999999999999999975432111 0111122222222221  1   


Q ss_pred             -HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 -ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 -~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ...++.+.+++..||+.||++|||++|++++.+..
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence             23467899999999999999999999999887754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-43  Score=337.00  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=201.8

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--CCCeEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLI  261 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~lv  261 (464)
                      |...+.||+|+||.||+|... ++..||+|.+.... .....+.|.+|+.++++++||||+++++++...  .....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            566678999999999999875 68899999987543 234456789999999999999999999987542  24568999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~  340 (464)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||+.+   ++|+||||||+|||++ +++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC---CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999997643    3899999999999999999999875   4599999999999998 88999999999997


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .......   ....++..|+|||.+. +.++.++||||||+++|||++|+.||........   ..............+.
T Consensus       181 ~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  253 (290)
T 1t4h_A          181 LKRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDK  253 (290)
T ss_dssp             GCCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGG
T ss_pred             ccccccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHHHHhccCCccccCC
Confidence            6544322   2335788899999876 4689999999999999999999999965322111   1111111111111223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+..+.+++..||+.||++|||++|++++.+.
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            344679999999999999999999999988654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-44  Score=355.17  Aligned_cols=258  Identities=19%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             cCCccccccccCCceEEEEEEE----CCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  255 (464)
                      ++|...+.||+|+||.||+++.    .+++.||||.++....   ......+.+|+.+++++ +||||+++++++..  .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~  131 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E  131 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--C
Confidence            5688899999999999999997    3789999999875321   12234577899999999 69999999998844  5


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESC
T ss_pred             ceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCcEEEee
Confidence            67999999999999999998653    3899999999999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      ||+++..............+|..|+|||++.+  ..++.++|||||||++|||+||+.||..................  
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  280 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  280 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--
Confidence            99998664332222233457889999999975  34789999999999999999999999643211111111111111  


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~  454 (464)
                      .....+...+..+.+++.+||+.||++||     +++|++++++..
T Consensus       281 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            12334556677899999999999999999     999999988754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=341.03  Aligned_cols=258  Identities=17%  Similarity=0.276  Sum_probs=199.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+...... .....+.+|+.++++++||||+++++++..  .+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence            56888999999999999999986 5899999988665433 234668899999999999999999999844  6779999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN-----CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            99999999999886532    3899999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh---------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---------  411 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~---------  411 (464)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|||+||..||........... +.....         
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL-IRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHH
T ss_pred             ccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhcccccccccc
Confidence            653221 1123356788999999875 6689999999999999999999999976432211110 000000         


Q ss_pred             ---h----hcCCC-----C-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          412 ---R----NLKGK-----F-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       412 ---~----~~~~~-----~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                         .    .....     .     ....+..+.+++..||+.||++|||++|++++.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence               0    00000     0     023456689999999999999999999999886543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-43  Score=368.57  Aligned_cols=260  Identities=20%  Similarity=0.314  Sum_probs=212.0

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ..++|...+.||+|+||.||+|+.. +|+.||||.+.....  ......+.+|+.+|++++||||+++++++  ......
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE--eeCCEE
Confidence            3467899999999999999999986 789999999865321  12345688999999999999999999988  446789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCchheEEEeCCCCeEEEeccc
Confidence            999999999999999976432  34899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++.......  .....+|+.|+|||++.+..++.++|||||||++|||++|..||......... ..+...+. .....+
T Consensus       333 a~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~-~~~~~~  408 (576)
T 2acx_A          333 AVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVK-EVPEEY  408 (576)
T ss_dssp             CEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHH-HCCCCC
T ss_pred             ceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhh-cccccC
Confidence            987654332  22346889999999999989999999999999999999999999764211111 11112111 123344


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  454 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~  454 (464)
                      +...+..+.+++..||+.||++||     +++||++|.+..
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence            556678899999999999999999     899999886643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=349.31  Aligned_cols=250  Identities=20%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcCCCCCceeeeeEEEeC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR  253 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~  253 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+......       .....+.+|+.++++++||||+++++++  .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--~   99 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--E   99 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--E
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--e
Confidence            4567999999999999999999864 7899999998765321       1233577899999999999999999998  4


Q ss_pred             CCCeEEEEEecCCCC-CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          254 GRGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       254 ~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ..+..++||||+..| +|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+|
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEEeccCHHHEEEcCCCcEE
Confidence            467899999999777 9999997543    3899999999999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |+|||+++........  ....+|..|+|||.+.+..+ +.++|||||||++|||++|..||.....          ...
T Consensus       171 L~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~  238 (335)
T 3dls_A          171 LIDFGSAAYLERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVE  238 (335)
T ss_dssp             ECCCTTCEECCTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTT
T ss_pred             EeecccceECCCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHh
Confidence            9999999876543321  22347889999999988776 7899999999999999999999975321          111


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       412 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..  ...+...+..+.+++..||+.||++|||+++++++.+...+
T Consensus       239 ~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 AA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             TC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             hc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            11  11223355679999999999999999999999999776443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-42  Score=336.26  Aligned_cols=256  Identities=17%  Similarity=0.304  Sum_probs=209.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.++++++||||+++++++  ...+..++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~l   92 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFV   92 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee--ccCCEEEE
Confidence            56788899999999999999986 57899999987543  233456788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....    .+++.++..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        93 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            999999999999987643    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+||..||.......    ....+...  ....+.
T Consensus       164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~--~~~~~~  236 (294)
T 2rku_A          164 KVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKN--EYSIPK  236 (294)
T ss_dssp             ECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTT--CCCCCT
T ss_pred             ecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhc--cCCCcc
Confidence            6643221 1223447788999999998889999999999999999999999997643211    11122111  123344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ..+..+.+++.+||+.||++|||++|++++.+.....
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            5567899999999999999999999999987765433

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.9e-43  Score=374.11  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=210.0

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      ...++|...+.||+|+||.||+|++.    .+..||||.++..........|.+|+.++++++||||++++|++  . .+
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~-~~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T-EN  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C-SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--e-cC
Confidence            34567888999999999999999874    24679999987655455567899999999999999999999987  3 24


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchHhEEEeCCCCEEEEec
Confidence            5899999999999999997643   24899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      |+++..............++..|+|||.+....++.++|||||||++|||++ |..||......     .....+.....
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~i~~~~~  610 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGER  610 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHHTCC
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcCCC
Confidence            9998775544333334446678999999998899999999999999999997 88888654321     11122222333


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            4455667788999999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=344.26  Aligned_cols=261  Identities=19%  Similarity=0.348  Sum_probs=192.9

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEe------C
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS------R  253 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~------~  253 (464)
                      ...+|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++.++. ||||+++++++..      .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3456888899999999999999975 78999999986553 445567899999999996 9999999998842      2


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      .....++|+||+. |+|.+++..... ...+++.+++.++.||+.||+|||+.+   ++|+||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK---PPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEEccCCcccEEECCCCCEEE
Confidence            3445899999995 899999976432 235999999999999999999999875   45999999999999999999999


Q ss_pred             eeCCccccccCCceee-----------eeccCCCCccCccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH
Q 012392          334 ADCGLHKLLADDIVFS-----------VLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL  399 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~  399 (464)
                      +|||+++.........           .....++..|+|||.+   .+..++.++||||||+++|||+||+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432111           1123467789999998   5667899999999999999999999999653221


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                              ..................+.+++..||+.||++|||+.|++++|+.+..
T Consensus       260 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 --------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    1122222222233344568899999999999999999999999987754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=347.46  Aligned_cols=258  Identities=19%  Similarity=0.357  Sum_probs=196.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.++++++||||+++++++.  ..+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe--eCCEEEEEe
Confidence            46888899999999999999976 789999999876543333335668999999999999999999984  467799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||++ |+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++..
T Consensus        80 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK-----VLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             ECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             cccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            9996 69999997643   34899999999999999999999998     999999999999999999999999999865


Q ss_pred             cCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC----
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK----  417 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  417 (464)
                      ..... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||............. ..........    
T Consensus       151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          151 SIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF-RILGTPTEETWPGI  228 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTSTTG
T ss_pred             cCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCChHhchhh
Confidence            43221 1223346788999999876 568999999999999999999999997643321111111 1100000000    


Q ss_pred             ---------------------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          418 ---------------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       418 ---------------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                           .....+..+.+++.+||+.||++|||++|++++.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence                                 0112346788999999999999999999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.1e-43  Score=335.22  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. ++..||||.+.....  ......+.+|+.++++++||||+++++++.  ..+..++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l   91 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH--DRKRIYL   91 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE--cCCEEEE
Confidence            45788899999999999999976 678999999864321  122457889999999999999999999984  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            999999999999998653    3899999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......   .....++..|+|||.+.+..++.++||||||+++|||++|..||........    ...+..  .....+.
T Consensus       163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~--~~~~~~~  233 (284)
T 2vgo_A          163 HAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVN--VDLKFPP  233 (284)
T ss_dssp             ECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHT--TCCCCCT
T ss_pred             cCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhc--cccCCCC
Confidence            654321   1234567889999999998999999999999999999999999975432211    112222  1223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..+..+.+++..||+.||++||++++++++.+..
T Consensus       234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            5667899999999999999999999999876643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-43  Score=337.99  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             cCCccccccccCCceEEEEEEEC--CCc--EEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--DGT--LVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||.||+|++.  +++  .||||.++...  .....++|.+|+.++++++||||+++++++..  . .
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~   94 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--P-P   94 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S-S
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--C-C
Confidence            45788899999999999999863  333  68999887543  23455789999999999999999999999843  3 3


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++|+||+++|+|.+++....   ..+++..+..++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEEcCCCCEEEcccc
Confidence            789999999999999998653   23899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCcee--eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          338 LHKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       338 l~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||......    .....+.....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~  242 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGE  242 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCC
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHHccCC
Confidence            99876543221  1222345667999999988889999999999999999999 99998654321    12222222223


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ....+...+..+.+++..||+.||++|||+.++++.|+.+.+.
T Consensus       243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            3334456678899999999999999999999999999987654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=335.17  Aligned_cols=256  Identities=24%  Similarity=0.333  Sum_probs=202.6

Q ss_pred             CccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |....+||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++..  .+..++||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEe
Confidence            455568999999999999974 68899999987654 3445679999999999999999999999854  5679999999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEEeeCCcccccc
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLA  343 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGl~~~~~  343 (464)
                      +++++|.+++..... ...+++..+..++.||+.||+|||+.+     |+||||||+||+++. ++.+||+|||+++...
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC-----EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999986532 234678899999999999999999988     999999999999997 8999999999998664


Q ss_pred             CCceeeeeccCCCCccCcccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .... ......++..|+|||.+..+.  ++.++||||||+++|||++|+.||.........   .............+..
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~  250 (295)
T 2clq_A          175 GINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMFKVHPEIPES  250 (295)
T ss_dssp             C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHHCCCCCCCTT
T ss_pred             CCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhcccccccccccc
Confidence            3211 122345778899999987643  789999999999999999999999653221111   1111111223344556


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+.+++.+||+.||++||++.+++++-+..
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            677899999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.1e-43  Score=336.18  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.++.....     .....|.+|+.++++++||||+++++++.  ....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~   82 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE--NKTD   82 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec--CCCe
Confidence            45888899999999999999986 6899999998764322     13567999999999999999999999984  4678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeEE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI  333 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl  333 (464)
                      .++||||+++++|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+||+++.++    .+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChHHEEEecCCCCCCceEE
Confidence            999999999999999997643    3899999999999999999999998     99999999999999877    8999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      +|||++........  .....++..|+|||.+....++.++||||||+++|||++|..||.......    .+..+... 
T Consensus       154 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-  226 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTNISAV-  226 (283)
T ss_dssp             CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTT-
T ss_pred             EecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHhHhc-
Confidence            99999987644321  223347788999999998899999999999999999999999997643211    11111111 


Q ss_pred             cCCCCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          414 LKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       414 ~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       ....+    ...+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       227 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          227 -NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             -CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             -ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence             11112    2235678999999999999999999999987653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.9e-43  Score=338.77  Aligned_cols=253  Identities=23%  Similarity=0.396  Sum_probs=205.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+++.. +|+.||||.++... ......+.+|+.++++++||||+++++++  ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIY--ESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhc--ccCCEEEEE
Confidence            456888899999999999999976 78999999998643 23345688999999999999999999998  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCCc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl  338 (464)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+.+     |+||||||+||++   ++++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           85 MQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            99999999999997653    3899999999999999999999998     9999999999999   7889999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--CC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KG  416 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~  416 (464)
                      ++......   .....++..|+|||.+.+..++.++||||||+++|||++|..||.......    ....+.....  ..
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~  228 (304)
T 2jam_A          156 SKMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LFEKIKEGYYEFES  228 (304)
T ss_dssp             TCCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHCCCCCCT
T ss_pred             ceecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCc
Confidence            87654321   112346788999999999899999999999999999999999997543211    1122222111  11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......+..+.+++..||+.||++|||+.|++++.+..
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            22345567899999999999999999999999987654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-44  Score=360.64  Aligned_cols=249  Identities=15%  Similarity=0.179  Sum_probs=192.2

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCC--CchHHHHHHHHH---HHHhcCCCCCceeee-------eE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS--CKSEEAEFVKGL---YLLTSLRHENIIRLR-------GF  249 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~e~---~~l~~l~H~niv~l~-------g~  249 (464)
                      .++|...+.||+|+||.||+|+. .+|+.||||.+....  .....+.|.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45688889999999999999996 479999999987432  234456789999   555666899999998       55


Q ss_pred             EEeCCC----------C-----eEEEEEecCCCCCHHHHhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 012392          250 CCSRGR----------G-----ECFLIYDFAPKGKLSKYLDQEEGSS---NVLDWSTRVSIIIGIAKGIGYLHSSEVNKP  311 (464)
Q Consensus       250 ~~~~~~----------~-----~~~lv~E~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  311 (464)
                      +.....          +     ..++||||+ +|+|.+++.......   ..++|..++.|+.||+.||+|||+.+    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC----
Confidence            432211          0     278999999 689999998643211   23556888999999999999999998    


Q ss_pred             CeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-----------CCCCcchhHHHH
Q 012392          312 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----------RFTERSDIFAFG  380 (464)
Q Consensus       312 ~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDv~s~G  380 (464)
                       |+||||||+|||++.++.+||+|||+++....    ......+ ..|+|||++.+.           .++.++||||||
T Consensus       227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             -eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence             99999999999999999999999999986443    2223345 789999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          381 VIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       381 vll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      |++|||+||+.||......    .....+..      .....+..+.+++.+||+.||++|||+.|++++.+
T Consensus       301 ~il~elltg~~Pf~~~~~~----~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  362 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAAL----GGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  362 (377)
T ss_dssp             HHHHHHHHSSCCC----------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred             HHHHHHHHCCCCCcccccc----cchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence            9999999999999654321    11111111      11234567899999999999999999999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.7e-43  Score=365.35  Aligned_cols=260  Identities=17%  Similarity=0.267  Sum_probs=210.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+.....  ......+.+|+.++++++||||+++++++  ......++
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~l~l  262 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTDLCL  262 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE--eeCCEEEE
Confidence            67888899999999999999986 699999999965321  12245788999999999999999999988  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++.........+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-----IvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-----CcccCCChHHEEEeCCCCEEEeecceee
Confidence            99999999999999865443456999999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ........ .....+|+.|+|||++.+..++.++|||||||++|||+||..||...............+...  ...++.
T Consensus       338 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~  414 (543)
T 3c4z_A          338 ELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPD  414 (543)
T ss_dssp             ECCTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCT
T ss_pred             eccCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCc
Confidence            76543211 223358889999999999999999999999999999999999997642111111112222221  223455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~L~~  453 (464)
                      ..+..+.+++..||+.||++||++     +++++|.+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff  452 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF  452 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence            667889999999999999999964     788876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-42  Score=356.77  Aligned_cols=258  Identities=17%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  256 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.... .......+.+|+.+|+.++||||+++++++....    ..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467889999999999999999865 68999999997542 2344567889999999999999999999984432    24


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+++ +|.+.+..      .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChHhEEEeCCCCEEEEEE
Confidence            67999999965 57777642      2889999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH----------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~----------  406 (464)
                      |+++.......  .....+|..|+|||++.+..++.++|||||||++|||++|+.||.+..........+          
T Consensus       209 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          209 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CCC-----CCC--C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EeeeecCCCcc--cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99987654321  223457888999999999999999999999999999999999997643221111111          


Q ss_pred             --------HHhhhhhcC-CCC-----------------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 --------ENFIDRNLK-GKF-----------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 --------~~~~~~~~~-~~~-----------------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                              ...+..... ...                 ....+..+.+|+.+||+.||++|||++|+++|.+..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                    111110000 000                 011256789999999999999999999999987653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-43  Score=359.38  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=206.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+.....  ......+.+|+.+++.++||||+++++++  ......++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~~~~~~l   93 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI--STPSDIFM   93 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEEE
Confidence            45778899999999999999976 799999999865321  12245688999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcccccHHHEEEecCCCeEEEeccchh
Confidence            99999999999999753    24899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......  .....+|..|+|||.+.+..+ +.++|||||||++|||++|..||......    .....+.+..  ...+
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~--~~~p  236 (476)
T 2y94_A          165 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKICDGI--FYTP  236 (476)
T ss_dssp             ECCTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHHTTC--CCCC
T ss_pred             hcccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCC--cCCC
Confidence            7654322  223457888999999988765 68999999999999999999999754321    1122222221  1233


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++..||+.||++|||++|++++.+..
T Consensus       237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence            44567799999999999999999999999987654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-42  Score=342.46  Aligned_cols=255  Identities=17%  Similarity=0.304  Sum_probs=209.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.++++++||||+++++++.  ..+..+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~  117 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF  117 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEE
Confidence            356888899999999999999976 57899999987543  2334567889999999999999999999984  467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++++|.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       118 lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CEecCCCchhEEEcCCCCEEEeeccCc
Confidence            9999999999999987643    3899999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......    .+..+...  ....+
T Consensus       189 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~--~~~~~  261 (335)
T 2owb_A          189 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKN--EYSIP  261 (335)
T ss_dssp             EECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHT--CCCCC
T ss_pred             eecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHhcC--CCCCC
Confidence            87643221 1223457788999999998889999999999999999999999997543211    11111111  12234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++.+||+.||++|||++|++++.+...
T Consensus       262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            455677899999999999999999999999876544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.6e-43  Score=350.10  Aligned_cols=251  Identities=20%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHH-HhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||.||+|+.+ +++.||||.++....  ......+.+|..+ ++.++||||+++++++  ...+..+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~--~~~~~~~  115 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLY  115 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE--ECSSEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EeCCEEE
Confidence            46888899999999999999986 688999999976532  2233456677776 5778999999999988  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus       116 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEeeCccc
Confidence            9999999999999998653    3888999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....... ......+|..|+|||++.+..++.++|||||||++|||++|..||......    ..+..++...  ...+
T Consensus       187 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~--~~~~  259 (373)
T 2r5t_A          187 KENIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNKP--LQLK  259 (373)
T ss_dssp             GGGBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHHHSC--CCCC
T ss_pred             cccccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcc--cCCC
Confidence            86432211 222345788999999999999999999999999999999999999764322    1222333222  2234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCH----HHHHHHHh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTM----EAVIEELT  452 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~----~evl~~L~  452 (464)
                      ...+..+.+++..||+.||.+||++    .++++|.+
T Consensus       260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~  296 (373)
T 2r5t_A          260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF  296 (373)
T ss_dssp             SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred             CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence            4566789999999999999999997    46665543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=349.58  Aligned_cols=259  Identities=14%  Similarity=0.143  Sum_probs=202.7

Q ss_pred             cCCccccccccCCceEEEEEEECC---------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCcee---------
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD---------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR---------  245 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~---------  245 (464)
                      ++|...+.||+|+||.||+|+...         ++.||||.+...      ..+.+|+.++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            568888999999999999999763         789999998753      35788999999999999998         


Q ss_pred             ------eeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCC
Q 012392          246 ------LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  319 (464)
Q Consensus       246 ------l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk  319 (464)
                            +++++.. .....++||||+ +|+|.+++.....  ..+++.+++.++.||+.||+|||+.+     |+|||||
T Consensus       116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dik  186 (352)
T 2jii_A          116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENE-----YVHGNVT  186 (352)
T ss_dssp             TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCC
T ss_pred             ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCC
Confidence                  5677644 356789999999 9999999986421  34999999999999999999999998     9999999


Q ss_pred             CCceEEcCCC--CeEEeeCCccccccCCceee------eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 012392          320 VEKVLIDQQF--NPLIADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL  391 (464)
Q Consensus       320 ~~Nill~~~~--~~kl~DfGl~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~  391 (464)
                      |+|||++.++  .+||+|||+++.........      .....+|..|+|||.+.+..++.++|||||||++|||+||+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  99999999998765432111      122357789999999999899999999999999999999999


Q ss_pred             CCcchHHHHHhhhhHHHhhhhhcCCC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          392 VLTSSMRLAAESATFENFIDRNLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       392 p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ||........................     .....+..+.+++..||+.||++|||++++++.|+.+...
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            99764311111111111111111100     0113357899999999999999999999999999877543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.3e-43  Score=344.80  Aligned_cols=260  Identities=20%  Similarity=0.323  Sum_probs=195.3

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++...... ....+.+|+.++++++||||+++++++..  ....+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence            3457889999999999999999865 78999999997654222 24568899999999999999999999844  67899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE-----cCCCCeEEe
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI-----DQQFNPLIA  334 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill-----~~~~~~kl~  334 (464)
                      +||||++ |+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+     ++++.+||+
T Consensus       110 lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR-----CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EECCCCCHHHEEEecCCCCccceEEEC
Confidence            9999997 59999997643    3899999999999999999999998     9999999999999     455569999


Q ss_pred             eCCccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          335 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       335 DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      |||+++....... ......+|..|+|||.+.+. .++.++|||||||++|||++|..||..................+.
T Consensus       180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            9999986643221 22233467889999999764 489999999999999999999999976543222111111100000


Q ss_pred             ------------cCCC------------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 ------------LKGK------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ------------~~~~------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                  ....            .....+..+.+++.+||+.||++|||++|++++.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                        0000            0011456789999999999999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=343.64  Aligned_cols=266  Identities=21%  Similarity=0.376  Sum_probs=205.9

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeC
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  253 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  253 (464)
                      +.++....++|...+.||+|+||.||+|+.. +++.||||.+....  ....++.+|+.+++++ +||||+++++++...
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3444556778999999999999999999974 78999999987653  2345788999999999 799999999998654


Q ss_pred             C----CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          254 G----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       254 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      .    ....++||||+++|+|.+++.....  ..+++..+..++.||+.||.|||+.+     |+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCcHHHEEEcCCC
Confidence            3    4578999999999999999986432  24889999999999999999999998     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  404 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~  404 (464)
                      .+||+|||++........ ......++..|+|||.+.     ...++.++||||||+++|||+||..|+........   
T Consensus       167 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---  242 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---  242 (326)
T ss_dssp             CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred             CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---
Confidence            999999999886543211 112234678899999986     56789999999999999999999999865432211   


Q ss_pred             hHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          405 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                       ...+.............+..+.+++.+||+.||++||++.+++++.+...
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          243 -LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             -HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             -HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence             11111111222223345678999999999999999999999999866543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=344.17  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=199.0

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch----HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ...++|...+.||+|+||.||+|+.. +|+.||||.+.......    ....+.+|+.++++++||||+++++++  ...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~   84 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHK   84 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE--eeC
Confidence            34567899999999999999999975 68999999987543211    124688999999999999999999998  456


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++||||+++ +|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEEcCCCCEEEEe
Confidence            778999999975 8999987533   34888999999999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      ||+++....... ......+|..|+|||.+.+. .++.++|||||||++|||++|..|+............+.....+..
T Consensus       156 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          156 FGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             CGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999987643221 12234568889999998654 5889999999999999999999988765432221111111100000


Q ss_pred             ---C--------------CCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          415 ---K--------------GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       415 ---~--------------~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                         .              ...+     ...+..+.+++..||+.||++|||+.|++++.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence               0              0001     233578999999999999999999999999987653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.5e-43  Score=340.99  Aligned_cols=257  Identities=18%  Similarity=0.291  Sum_probs=197.4

Q ss_pred             cCCccc-cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +.|... +.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++.++ +||||+++++++..  .+..++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEE
Confidence            345553 68999999999999964 78999999997654 33456789999999985 79999999999854  678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC---eEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG  337 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.   +||+|||
T Consensus        89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            999999999999998653    3899999999999999999999998     999999999999998776   9999999


Q ss_pred             ccccccCCce------eeeeccCCCCccCccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH------
Q 012392          338 LHKLLADDIV------FSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLA------  400 (464)
Q Consensus       338 l~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~------  400 (464)
                      +++.......      .......+|..|+|||.+..     ..++.++|||||||++|||++|+.||.......      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            9876532211      11122347888999999865     568899999999999999999999986532100      


Q ss_pred             -----HhhhhHHHhhhhhcCCCCCH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          401 -----AESATFENFIDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       401 -----~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                           ........+....  ...+.    ..+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       240 ~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             ccchhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence                 0011111221111  12222    2456799999999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.1e-43  Score=348.52  Aligned_cols=271  Identities=17%  Similarity=0.261  Sum_probs=206.3

Q ss_pred             ccCHHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCc----------hHHHHHHHHHHHHhcCCCCC
Q 012392          173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK----------SEEAEFVKGLYLLTSLRHEN  242 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~f~~e~~~l~~l~H~n  242 (464)
                      +....++....++|...+.||+|+||.||+|+..+|..||||.+......          ...+.+.+|+.++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            34567888999999999999999999999999888999999998653321          12367999999999999999


Q ss_pred             ceeeeeEEEeCC---CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCC
Q 012392          243 IIRLRGFCCSRG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  319 (464)
Q Consensus       243 iv~l~g~~~~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk  319 (464)
                      |+++++++....   ....++||||++ |+|.+++....   ..+++..+..++.||+.||.|||+.+     |+|||||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlk  161 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLH  161 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCC
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc-----CEecCCC
Confidence            999999886532   346899999997 79999887533   34899999999999999999999998     9999999


Q ss_pred             CCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHH
Q 012392          320 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMR  398 (464)
Q Consensus       320 ~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~  398 (464)
                      |+|||++.++.+||+|||+++......  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999998554322  1223346778999999876 6789999999999999999999999976432


Q ss_pred             HHHhhhhH-------------------HHhhhhhcCCC-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          399 LAAESATF-------------------ENFIDRNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       399 ~~~~~~~~-------------------~~~~~~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ........                   ...+.......       .....+..+.+++..||+.||++|||+.|++++.+
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            21111110                   01111111100       01123567899999999999999999999999876


Q ss_pred             hh
Q 012392          453 VA  454 (464)
Q Consensus       453 ~~  454 (464)
                      ..
T Consensus       320 f~  321 (362)
T 3pg1_A          320 FE  321 (362)
T ss_dssp             GT
T ss_pred             hh
Confidence            43

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.5e-43  Score=336.89  Aligned_cols=262  Identities=15%  Similarity=0.206  Sum_probs=202.9

Q ss_pred             hhcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+. .+++.||||.+....   ...++.+|+.+++.++|+|++..++++.. .....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEE
Confidence            346789999999999999999996 478999999876543   22357889999999999998888877654 3567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG  337 (464)
                      ||||+ +|+|.+++....   ..+++..+..++.||+.||.|||+.+     |+||||||+|||+   ++++.+||+|||
T Consensus        83 v~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             EEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            99999 999999997543   24899999999999999999999998     9999999999999   788999999999


Q ss_pred             ccccccCCce------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          338 LHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       338 l~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      +++.......      .......+|..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  232 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISE  232 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh-hhhhhhhhhc
Confidence            9987654321      11223457788999999999999999999999999999999999996532110 0011111111


Q ss_pred             hhcCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          412 RNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       412 ~~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ......   .....++.+.+++..||+.||++|||++++++.|+.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            111111   0122356799999999999999999999999999877543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-43  Score=354.16  Aligned_cols=256  Identities=13%  Similarity=0.062  Sum_probs=185.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHH---HHHhcCCCCCceeee-------eEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGL---YLLTSLRHENIIRLR-------GFC  250 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~---~~l~~l~H~niv~l~-------g~~  250 (464)
                      ..|...+.||+|+||.||+|+.. +++.||||.+......  .....+.+|+   ..|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            44778899999999999999975 7899999999875532  2334567774   45555 799988754       444


Q ss_pred             EeCCC---------------CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 012392          251 CSRGR---------------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR------VSIIIGIAKGIGYLHSSEVN  309 (464)
Q Consensus       251 ~~~~~---------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~  309 (464)
                      .....               ...++||||++ |+|.+++.....   .+++..+      ..++.||+.||+|||+.+  
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            32221               34899999998 899999987532   2455566      788899999999999998  


Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHH
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQIL  387 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~  387 (464)
                         |+||||||+|||++.++.+||+|||+++.....    .....++..|+|||.+.+  ..++.++|||||||+||||+
T Consensus       215 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          215 ---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             ---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             ---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence               999999999999999999999999999876532    123446688999999987  67999999999999999999


Q ss_pred             hCCCCCcchHHHHHhhhh---HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          388 TGSLVLTSSMRLAAESAT---FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       388 tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ||+.||............   .................+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            999999765221110000   000001111111223557789999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=336.21  Aligned_cols=255  Identities=21%  Similarity=0.365  Sum_probs=186.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.....  ......+.+|+.++++++||||+++++++  ...+..++
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~l   88 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF--EDSNYVYL   88 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE--ECSSEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE--ccCCeEEE
Confidence            56888899999999999999974 789999999864321  11235788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG-----ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            999999999999997542   34899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......    ..+......  ....+.
T Consensus       161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~--~~~~~~  233 (278)
T 3cok_A          161 QLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----NTLNKVVLA--DYEMPS  233 (278)
T ss_dssp             ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSS--CCCCCT
T ss_pred             eccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----HHHHHHhhc--ccCCcc
Confidence            6643211 112334678899999999888999999999999999999999998653211    111111111  112334


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+..+.+++.+||+.||++|||+++++++.+...
T Consensus       234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            45678999999999999999999999998866543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-43  Score=351.25  Aligned_cols=261  Identities=18%  Similarity=0.261  Sum_probs=198.8

Q ss_pred             HHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----
Q 012392          180 ESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----  254 (464)
Q Consensus       180 ~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----  254 (464)
                      +...++|...+.||+|+||.||+|+.. +|+.||||.+.....     .+.+|+.+|+.++||||+++++++....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            445678999999999999999999874 789999999865431     2236999999999999999999885432    


Q ss_pred             --------------------------------CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 012392          255 --------------------------------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY  302 (464)
Q Consensus       255 --------------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  302 (464)
                                                      ....++||||++ |+|.+.+.........+++..+..++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            234889999997 69888887543334459999999999999999999


Q ss_pred             HhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHH
Q 012392          303 LHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFG  380 (464)
Q Consensus       303 LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~G  380 (464)
                      ||+.+     |+||||||+|||++ .++.+||+|||+++.......  .....++..|+|||.+.+. .++.++||||||
T Consensus       157 LH~~g-----i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          157 IHSLG-----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHTTT-----EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHCc-----CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            99988     99999999999998 688999999999987644321  2233467889999998764 489999999999


Q ss_pred             HHHHHHHhCCCCCcchHHHHHhhhhHHH--------hh--hhhc-------------CCCCCHHHHHHHHHHHHHhhhcC
Q 012392          381 VIILQILTGSLVLTSSMRLAAESATFEN--------FI--DRNL-------------KGKFSESEAAKLGKMALVCTHED  437 (464)
Q Consensus       381 vll~el~tg~~p~~~~~~~~~~~~~~~~--------~~--~~~~-------------~~~~~~~~~~~l~~l~~~C~~~d  437 (464)
                      |++|||++|+.||............+..        +.  .+..             ....+...+..+.+++.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999764332211111100        00  0000             00022335567999999999999


Q ss_pred             CCCCCCHHHHHHHHhh
Q 012392          438 PENRPTMEAVIEELTV  453 (464)
Q Consensus       438 p~~RPs~~evl~~L~~  453 (464)
                      |++|||+.|+++|-+.
T Consensus       310 P~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFF  325 (383)
T ss_dssp             GGGSCCHHHHHTSGGG
T ss_pred             hhhCCCHHHHhcCHHH
Confidence            9999999999987553

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-42  Score=339.01  Aligned_cols=253  Identities=16%  Similarity=0.241  Sum_probs=201.3

Q ss_pred             cCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+. .+++.||||.++..    ....+.+|+.++++++ ||||+++++++........++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            5688889999999999999986 47899999998743    2457889999999997 9999999999866556778999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~  340 (464)
                      |||+++++|.+++..       +++..+..++.||+.||+|||+.+     |+||||||+|||++.++ .+||+|||+++
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            999999999999853       888999999999999999999998     99999999999999776 89999999998


Q ss_pred             cccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh---------hhhHHHhh
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---------SATFENFI  410 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~---------~~~~~~~~  410 (464)
                      .......  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........         .......+
T Consensus       180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            6654322  223346778999999876 67899999999999999999999998532111000         00111111


Q ss_pred             hhh-----------------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          411 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       411 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..                       .........+..+.+++..||+.||++|||++|+++|.+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            110                       00111122467899999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-42  Score=334.79  Aligned_cols=261  Identities=15%  Similarity=0.206  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||.||+|+. .+++.||||.+......   .++.+|+.+++.++|+|++..++++.. .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEE
Confidence            45788899999999999999997 57899999998765422   358899999999999988887777644 35678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCCc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl  338 (464)
                      |||+ +++|.+++....   ..+++..++.++.||+.||+|||+.+     |+||||||+|||+   ++++.+||+|||+
T Consensus        84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            9999 999999997533   24899999999999999999999998     9999999999999   4889999999999


Q ss_pred             cccccCCcee------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          339 HKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       339 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      ++........      ......++..|+|||.+.+..++.++|||||||++|||+||+.||...... .....+..+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  233 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEK  233 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch-hhhhhhhhhccc
Confidence            9876543221      123345788899999999999999999999999999999999999752110 000111111111


Q ss_pred             hcCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          413 NLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       413 ~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      .....   .....+..+.+++..||+.||++|||+++|++.|+.+...
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            11111   1123456799999999999999999999999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-42  Score=353.45  Aligned_cols=257  Identities=21%  Similarity=0.292  Sum_probs=196.8

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-------chHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      ...++|...+.||+|+||.||+|... +++.||||.+.....       ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            34678999999999999999999875 689999999875321       111235889999999999999999999873 


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---C
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---F  329 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~  329 (464)
                        ....++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.+   +
T Consensus       211 --~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          211 --AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             --SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSSSC
T ss_pred             --cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCCCcc
Confidence              34589999999999999998753    24899999999999999999999998     9999999999999754   4


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      .+||+|||+++.......  .....+|..|+|||++.   ...++.++|||||||++|||+||..||.....    ...+
T Consensus       280 ~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~  353 (419)
T 3i6u_A          280 LIKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSL  353 (419)
T ss_dssp             CEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCH
T ss_pred             eEEEeecccceecCCCcc--ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHH
Confidence            599999999987654321  22345788999999985   36788899999999999999999999965321    1111


Q ss_pred             HHhhhhhcCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          407 ENFIDRNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       407 ~~~~~~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+........+   ...++.+.+++.+||+.||++|||++|++++.+...
T Consensus       354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            1222111111111   124577999999999999999999999999877643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-42  Score=353.97  Aligned_cols=261  Identities=16%  Similarity=0.280  Sum_probs=187.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC---CCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~  258 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.... .....+.+.+|+.+|++++||||+++++++....   ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            56889999999999999999875 78999999986543 2334567999999999999999999999884332   2468


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |+||||+ +|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+||||+.++.+||+|||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cCCCCCChhhEEECCCCCEeeccccc
Confidence            9999998 67999999753    24899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce--------------------------eeeeccCCCCccCccccc-ccCCCCCcchhHHHHHHHHHHHh---
Q 012392          339 HKLLADDIV--------------------------FSVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILT---  388 (464)
Q Consensus       339 ~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvll~el~t---  388 (464)
                      ++.......                          .......+|..|+|||++ ....++.++|||||||+||||+|   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            987642210                          012233568889999986 45679999999999999999999   


Q ss_pred             --------CCCCCcchHHHH----------------HhhhhHHHhhhh----------------------hcCC------
Q 012392          389 --------GSLVLTSSMRLA----------------AESATFENFIDR----------------------NLKG------  416 (464)
Q Consensus       389 --------g~~p~~~~~~~~----------------~~~~~~~~~~~~----------------------~~~~------  416 (464)
                              |+++|.+.....                .....+..+.+.                      .+..      
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    555553321000                000000000000                      0000      


Q ss_pred             -CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 -~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ......+..+.+|+.+||+.||++|||++|+++|.+..
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~  401 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK  401 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence             00112356789999999999999999999999997754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.4e-42  Score=334.13  Aligned_cols=259  Identities=21%  Similarity=0.379  Sum_probs=200.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--------
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--------  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--------  253 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+...  ......+.+|+.++++++||||+++++++...        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456888999999999999999975 7899999998653  34456789999999999999999999987543        


Q ss_pred             ---CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          254 ---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       254 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                         .....++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHhEEEcCCCC
Confidence               2356899999999999999997533   24788999999999999999999998     999999999999999999


Q ss_pred             eEEeeCCccccccCCc-------------eeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcch
Q 012392          331 PLIADCGLHKLLADDI-------------VFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSS  396 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~  396 (464)
                      +||+|||+++......             ........++..|+|||.+.+. .++.++||||||+++|||++   |+...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            9999999998664321             0111233467789999998754 78999999999999999998   44432


Q ss_pred             HHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          397 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .........+.. .........+...+..+.+++..||+.||++|||+++++++.+...
T Consensus       232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          232 MERVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hhHHHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            221111111111 1112233345566678999999999999999999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=343.82  Aligned_cols=252  Identities=13%  Similarity=0.201  Sum_probs=200.5

Q ss_pred             hhcCCccccccccCCceEEEEEE------ECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCS  252 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~  252 (464)
                      ..++|...+.||+|+||.||+|+      ..+++.||||.+....    ..+|..|+.++.+++   |+||+++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            44678888999999999999994      3468899999987542    446778888888886   9999999999844


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC----
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ----  327 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~----  327 (464)
                        .+..++||||+++|+|.+++..... ....++|..++.|+.||+.||+|||+.+     |+||||||+|||++.    
T Consensus       139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-----ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECGGGTC
T ss_pred             --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEecccccC
Confidence              5678999999999999999986432 2345999999999999999999999988     999999999999998    


Q ss_pred             -------CCCeEEeeCCccccccCC-ceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH
Q 012392          328 -------QFNPLIADCGLHKLLADD-IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL  399 (464)
Q Consensus       328 -------~~~~kl~DfGl~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~  399 (464)
                             ++.+||+|||+++..... .........+|..|+|||++.+..++.++|||||||++|||+||+.|+......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   899999999999765321 112333456889999999999999999999999999999999999998654221


Q ss_pred             HHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHhhh
Q 012392          400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR-PTMEAVIEELTVA  454 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~R-Ps~~evl~~L~~~  454 (464)
                      .   ..    +...... .  ...+.+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       292 ~---~~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          292 E---CK----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             E---EE----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             c---ee----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            0   00    1111111 1  235678899999999999998 6788887777654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=331.56  Aligned_cols=258  Identities=18%  Similarity=0.238  Sum_probs=204.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC---CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||++... +++.||||.+....   .......+.+|+.++++++||||+++++++........
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367899999999999999999975 68899999987532   12345679999999999999999999999866556679


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||++++ |.+++.....  ..+++..+..++.||+.||.|||+.+     |+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEcCCCcEEeecccc
Confidence            9999999876 8787765432  34899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCc-eeeeeccCCCCccCcccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          339 HKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      +....... ........++..|+|||.+.+..  ++.++||||||+++|||++|..||.......    ....+...  .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~--~  229 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKG--S  229 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHC--C
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcC--C
Confidence            98664321 11223345788899999987643  4779999999999999999999997643211    11111111  1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+...+..+.+++.+||+.||++|||++|++++.+..
T Consensus       230 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            233445667899999999999999999999999987654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-42  Score=340.74  Aligned_cols=263  Identities=18%  Similarity=0.305  Sum_probs=202.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC------C
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~------~  255 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+...... .....+.+|+.++++++||||+++++++....      .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            46888899999999999999984 7899999998654422 23457889999999999999999999986543      3


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      +..++||||++ |+|.+.+....   ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECC
T ss_pred             ceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCCEEEcc
Confidence            46899999996 58888876543   24899999999999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCc---eeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          336 CGLHKLLADDI---VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       336 fGl~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      ||+++......   ........+|..|+|||.+.+ ..++.++|||||||++|||+||+.||.......... .+.....
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~  246 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA-LISQLCG  246 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhC
Confidence            99998664221   112223456788999999876 458999999999999999999999997643321111 1111100


Q ss_pred             hhcCCCC--------------------C--H-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          412 RNLKGKF--------------------S--E-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       412 ~~~~~~~--------------------~--~-----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .......                    .  .     ..+..+.+++.+||+.||++|||++|++++-+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            0000000                    0  0     013568899999999999999999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.4e-42  Score=342.48  Aligned_cols=258  Identities=23%  Similarity=0.368  Sum_probs=206.4

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcC-CCCCceeeeeE
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSL-RHENIIRLRGF  249 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~f~~e~~~l~~l-~H~niv~l~g~  249 (464)
                      .....++|...+.||+|+||.||+|+.. +|+.||||.+......       .....+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445677999999999999999999986 7999999998764321       1134678899999999 79999999999


Q ss_pred             EEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       250 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      +.  .....++||||+++|+|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||++.++
T Consensus       169 ~~--~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g-----i~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          169 YE--SSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN-----IVHRDLKPENILLDDNM  237 (365)
T ss_dssp             EE--BSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTC
T ss_pred             Ee--eCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCC
Confidence            84  4678999999999999999997643    3899999999999999999999998     99999999999999999


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      .+||+|||++.......  ......+|..|+|||++.+      ..++.++|||||||++|||+||..||.......   
T Consensus       238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---  312 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---  312 (365)
T ss_dssp             CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---
Confidence            99999999998765432  1223457888999999853      358889999999999999999999997543211   


Q ss_pred             hhHHHhhhhhcCCCCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          404 ATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       404 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                       .+..+.........+  ...+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       313 -~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          313 -MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             -HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             -HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence             111111111111100  1234678999999999999999999999987653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.3e-43  Score=342.46  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             HHHHhhcCCccc-cccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCC-CCCceeeeeEEEeC
Q 012392          178 EVESATQCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  253 (464)
Q Consensus       178 ~~~~~~~~f~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~  253 (464)
                      ..+...+.|... +.||+|+||.||+|+.. +++.||||.+..... .....++.+|+.++.++. ||||+++++++  .
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--~   99 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY--E   99 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE--E
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE--E
Confidence            344455667776 88999999999999976 689999999875432 233567899999999995 69999999998  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCC
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFN  330 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~  330 (464)
                      .....++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.+     |+||||||+|||++.   ++.
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g-----ivH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN-----IVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESCBTTBCC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCChHHEEEecCCCCCc
Confidence            5678999999999999999986532  234899999999999999999999998     999999999999998   789


Q ss_pred             eEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          331 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      +||+|||+++.......  .....++..|+|||.+.+..++.++||||||+++|||++|+.||........    ...+.
T Consensus       173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~  246 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET----YLNIS  246 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH
T ss_pred             EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHH
Confidence            99999999987654321  2234578889999999999999999999999999999999999976432211    11111


Q ss_pred             hh--hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          411 DR--NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       411 ~~--~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..  ..........+..+.+++..||+.||++|||+++++++.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence            11  112222345667899999999999999999999999987643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=344.84  Aligned_cols=257  Identities=21%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----C
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  256 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+.... .......+.+|+.+++.++||||+++++++.....    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            356888999999999999999975 78999999986543 23345678999999999999999999999844321    3


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+ +++|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCHHHEEEcCCCCEEEEee
Confidence            469999999 88999999752     3899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH---------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~---------  406 (464)
                      |+++.....    .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...........         
T Consensus       173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~  248 (367)
T 1cm8_A          173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  248 (367)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999876432    223456788999999876 679999999999999999999999997643221111110         


Q ss_pred             ----------HHhhhhh--c-CC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ----------ENFIDRN--L-KG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ----------~~~~~~~--~-~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ..++...  . ..   ......+..+.+++.+||+.||++|||++|+++|.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence                      0000000  0 00   01123456789999999999999999999999986643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=334.74  Aligned_cols=256  Identities=19%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..+.|...+.||+|+||.||+|+.. +|+.||||.+....   ...++.+|+.++.+++||||+++++++..  .+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence            4567889999999999999999976 58999999987643   23568899999999999999999999854  567999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++..+..++.||+.||.|||+.+     |+|+||||+||+++.++.+||+|||++.
T Consensus       102 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCcCHHHEEECCCCCEEEeecccch
Confidence            999999999999997533   24899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  419 (464)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|..||........    ....... ......+
T Consensus       174 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~  248 (314)
T 3com_A          174 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----IFMIPTNPPPTFRKP  248 (314)
T ss_dssp             ECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCCSSG
T ss_pred             hhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhcCCCcccCCc
Confidence            6644321 12234577889999999998999999999999999999999999975432111    1111111 1111223


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ...+..+.+++..||+.||++|||+.+++++.+...
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            445678999999999999999999999998876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.6e-43  Score=344.81  Aligned_cols=255  Identities=18%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+.....     .+.+|++++.++ +||||+++++++  .+....+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVY--DDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEE--ECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEE--EcCCEEE
Confidence            3456889999999999999999976 688999999976432     234678888887 799999999998  4567899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC----CCeEEee
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIAD  335 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~D  335 (464)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+.++    +.+||+|
T Consensus        93 lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g-----ivHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            9999999999999997532    4899999999999999999999998     9999999999998543    3599999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ||+++....... ......+|..|+|||++.+..++.++|||||||++|||++|..||...... .....+..+......
T Consensus       164 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          164 FGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIGSGKFS  241 (342)
T ss_dssp             CTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHHHCCCC
T ss_pred             CCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHccCCcc
Confidence            999987644321 122345678899999998888899999999999999999999999753210 011111222211111


Q ss_pred             --CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 --GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 --~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                        .......++.+.+++..||+.||++||++.+++++.+..
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence              112245667899999999999999999999999987753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.1e-42  Score=357.22  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc------------hHHHHHHHHHHHHhcCCCCCceeeee
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK------------SEEAEFVKGLYLLTSLRHENIIRLRG  248 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~f~~e~~~l~~l~H~niv~l~g  248 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+......            .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3567899999999999999999976 6789999998754321            23457889999999999999999999


Q ss_pred             EEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC
Q 012392          249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  328 (464)
Q Consensus       249 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~  328 (464)
                      ++  ......++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.+
T Consensus       114 ~~--~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          114 VF--EDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN-----IVHRDIKPENILLENK  182 (504)
T ss_dssp             EE--ECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESST
T ss_pred             EE--EcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCcHHHEEEecC
Confidence            98  45678999999999999999997653    3899999999999999999999998     9999999999999877


Q ss_pred             C---CeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh
Q 012392          329 F---NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  405 (464)
Q Consensus       329 ~---~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~  405 (464)
                      +   .+||+|||+++......  ......+|+.|+|||++. +.++.++|||||||++|||++|..||.......    .
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~  255 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----I  255 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H
T ss_pred             CCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----H
Confidence            5   69999999998765432  222345788999999886 568999999999999999999999997643211    1


Q ss_pred             HHHhhhhhcCCCCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 FENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 ~~~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.........+  ...+..+.+++..||+.||.+|||++|++++.+..
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            22222111111100  12357799999999999999999999999987653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.8e-42  Score=329.80  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+.++++++||||+++++++.  ..+..++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l   88 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS--TPTDFFM   88 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCCeEEE
Confidence            46788899999999999999986 78999999986532  1122457889999999999999999999984  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC-----SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChhhEEECCCCCEEEeeccccc
Confidence            999999999999997653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      .......  .....++..|+|||.+.+..+ +.++||||||+++|||++|..||.......    ....+ ... ....+
T Consensus       160 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~-~~~-~~~~~  231 (276)
T 2h6d_A          160 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKI-RGG-VFYIP  231 (276)
T ss_dssp             CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH-HHC-CCCCC
T ss_pred             ccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHh-hcC-cccCc
Confidence            7654321  123346788999999987765 689999999999999999999997543211    11111 111 12234


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~  266 (276)
T 2h6d_A          232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK  266 (276)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence            44567799999999999999999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-42  Score=356.38  Aligned_cols=253  Identities=21%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .+.|...+.||+|+||.||+|+.. ++..||||.+..... ......+.+|+.+++.++||||+++++++  ......++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF--EDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEEEE
Confidence            346888999999999999999976 788999999875431 22346788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG  337 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.+   +.+||+|||
T Consensus       114 v~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN-----IVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            999999999999987653    3899999999999999999999998     9999999999999764   559999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +++.......  .....+|..|+|||++. +.++.++|||||||++|||++|..||.......    .+..+........
T Consensus       185 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~  257 (494)
T 3lij_A          185 LSAVFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEKGKYTFD  257 (494)
T ss_dssp             TCEECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred             CCeECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCC
Confidence            9987654321  22345788999999876 569999999999999999999999997643321    1222222211111


Q ss_pred             C--CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          418 F--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       418 ~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .  ....+..+.+++..||+.||++|||+.|++++.+.
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  295 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI  295 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence            1  12346779999999999999999999999987654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-42  Score=336.91  Aligned_cols=257  Identities=19%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+.. ++..||+|.+.... ......|.+|+.++++++||||+++++++..  .+..++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence            3456888999999999999999986 58999999987654 3345679999999999999999999999854  567999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++....   ..+++..+..++.||+.||.|||+.+     |+||||||+||+++.++.+||+|||++.
T Consensus        94 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             EEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             EEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            999999999999987643   23899999999999999999999998     9999999999999999999999999976


Q ss_pred             cccCCceeeeeccCCCCccCccccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYV-----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-  414 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  414 (464)
                      ....... ......++..|+|||.+     ....++.++||||||+++|||++|..|+........    ......... 
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~  240 (302)
T 2j7t_A          166 KNLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKSDPP  240 (302)
T ss_dssp             HHHHHHH-C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCC
T ss_pred             ccccccc-ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----HHHHhccCCc
Confidence            4322111 11223467889999998     356789999999999999999999999875432111    111111111 


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....+...+..+.+++..||+.||++|||+.+++++.+..
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            1122345567899999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.3e-42  Score=356.40  Aligned_cols=254  Identities=21%  Similarity=0.337  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.... .......+.+|+.++++++||||+++++++  ......++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~~l   98 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL--EDSSSFYI   98 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE--EcCCEEEE
Confidence            356888999999999999999976 78999999986432 122356789999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG  337 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||++   .++.+||+|||
T Consensus        99 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            999999999999997653    3899999999999999999999998     99999999999995   55679999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +++......  ......+|+.|+|||++.+ .++.++|||||||++|||++|..||.......    .+..+........
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~  242 (486)
T 3mwu_A          170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFD  242 (486)
T ss_dssp             CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCSC
T ss_pred             cCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCC
Confidence            998765432  2233457889999999875 58999999999999999999999997653221    1222222222111


Q ss_pred             C--CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          418 F--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       418 ~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .  ....++.+.+++..||+.||++|||+.|++++.+..
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred             CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence            1  134567899999999999999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.9e-42  Score=344.95  Aligned_cols=261  Identities=20%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC---CCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~  258 (464)
                      ..+|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.++.+++||||+++++++....   ....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            456888999999999999999975 788999999986554555578999999999999999999999984322   1468


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++|+||++ |+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999996 6999999753     3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceee--eeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH---------
Q 012392          339 HKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  406 (464)
Q Consensus       339 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~---------  406 (464)
                      ++.........  .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.............         
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            98765432211  123357888999998754 458999999999999999999999996543211111000         


Q ss_pred             ----------HHhhhhhc-CCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ----------ENFIDRNL-KGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ----------~~~~~~~~-~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ........ ....     ....+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                      00000000 0001     122356789999999999999999999999987654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-43  Score=340.77  Aligned_cols=262  Identities=21%  Similarity=0.348  Sum_probs=187.2

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+..........++.+|+.++++++||||+++++++..  .+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   90 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL   90 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence            3467888999999999999999864 6889999998765544555678999999999999999999999844  567899


Q ss_pred             EEecCCCCCHHHHhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          261 IYDFAPKGKLSKYLDQEE----GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ||||+++|+|.+++....    .....+++..+..++.||+.||+|||+.+     |+||||||+||+++.++.+||+||
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-----QIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCCChhhEEEcCCCCEEEEec
Confidence            999999999999997521    12345899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCce----eeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          337 GLHKLLADDIV----FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       337 Gl~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      |++........    .......++..|+|||.+.. ..++.++||||||+++|||+||+.||........    ......
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~  241 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LMLTLQ  241 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHT
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----HHHHhc
Confidence            99876543211    11122347788999999875 5689999999999999999999999875432111    111111


Q ss_pred             hhc--------CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          412 RNL--------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       412 ~~~--------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...        ........+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  292 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ  292 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence            100        0111223456789999999999999999999999876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-42  Score=341.25  Aligned_cols=258  Identities=18%  Similarity=0.366  Sum_probs=184.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHH-HHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+..........++..|+. +++.++||||+++++++.  ..+..++|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~~~lv   99 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWIC   99 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCceEEE
Confidence            56778899999999999999985 789999999987654455566777776 777889999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||++ |+|.+++.... .....+++..+..++.|++.||.|||+. +     |+||||||+|||++.++.+||+|||++
T Consensus       100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A          100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-----IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-----CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-----EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            99997 58888876421 1234589999999999999999999997 7     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCccccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh---
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYV----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---  412 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~---  412 (464)
                      +.......  .....++..|+|||.+    .+..++.++||||||+++|||++|+.||........   .+......   
T Consensus       174 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~  248 (327)
T 3aln_A          174 GQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVVKGDPP  248 (327)
T ss_dssp             CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCC
T ss_pred             eecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHhcCCCC
Confidence            87654321  1223577889999998    456789999999999999999999999975322111   11111111   


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+........+..+.+++..||+.||++|||+.+++++.+..
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            111111234567899999999999999999999999876654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-42  Score=357.98  Aligned_cols=254  Identities=21%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....  ......+.+|+.++++++||||+++++++  ...+..+
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF--EDKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCEEE
Confidence            356888899999999999999976 789999999865432  23456799999999999999999999998  4467899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeC
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADC  336 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Df  336 (464)
                      +|+||+.+|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+   +.++.+||+||
T Consensus       103 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             EEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            9999999999999997543    3899999999999999999999998     9999999999999   56789999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      |+++......  ......+|+.|+|||.+.+ .++.++|||||||++|||++|..||.......    .+..+.......
T Consensus       174 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~  246 (484)
T 3nyv_A          174 GLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD----ILKKVEKGKYTF  246 (484)
T ss_dssp             THHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCC
T ss_pred             eeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCC
Confidence            9998765432  1223457889999999865 68999999999999999999999997653221    122222222221


Q ss_pred             CC--CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KF--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..  ....+..+.+++..||+.||++|||+.|+++|.+..
T Consensus       247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            11  134567899999999999999999999999987654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-42  Score=351.41  Aligned_cols=257  Identities=18%  Similarity=0.236  Sum_probs=201.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC------CCCCceeeeeEEEeCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL------RHENIIRLRGFCCSRGR  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l------~H~niv~l~g~~~~~~~  255 (464)
                      ..+|...+.||+|+||.||+|+.. +++.||||.++..  .....++.+|+.+++.+      +|+||+++++++..  .
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--R  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--T
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--C
Confidence            356888999999999999999876 5899999998753  34446677888888777      57899999999854  5


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC--eEE
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLI  333 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl  333 (464)
                      ...++||||+. |+|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.  +||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR-----IIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT-----EECSCCSGGGEEESSTTSCCEEE
T ss_pred             CeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEccCCCcceEE
Confidence            78999999995 799999986543  34899999999999999999999988     999999999999999987  999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH-------
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-------  406 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~-------  406 (464)
                      +|||++......    .....+|..|+|||++.+..++.++|||||||++|||+||..||.............       
T Consensus       244 ~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          244 IDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999765432    223457788999999999999999999999999999999999987543221111000       


Q ss_pred             ----------HHhhhhhcC----------------------------CC--------CCHHHHHHHHHHHHHhhhcCCCC
Q 012392          407 ----------ENFIDRNLK----------------------------GK--------FSESEAAKLGKMALVCTHEDPEN  440 (464)
Q Consensus       407 ----------~~~~~~~~~----------------------------~~--------~~~~~~~~l~~l~~~C~~~dp~~  440 (464)
                                ..+++....                            ..        ........+.+++.+||+.||++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence                      000000000                            00        00112467899999999999999


Q ss_pred             CCCHHHHHHHHhhhc
Q 012392          441 RPTMEAVIEELTVAA  455 (464)
Q Consensus       441 RPs~~evl~~L~~~~  455 (464)
                      |||++|+++|.+...
T Consensus       400 Rpta~e~L~Hpw~~~  414 (429)
T 3kvw_A          400 RMTPGQALRHPWLRR  414 (429)
T ss_dssp             SCCHHHHHTSTTTC-
T ss_pred             CCCHHHHhCChhhcc
Confidence            999999999877543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.1e-42  Score=338.79  Aligned_cols=260  Identities=22%  Similarity=0.381  Sum_probs=200.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...... .....+.+|+.++++++||||+++++++.  ..+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv  102 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK--KKKRWYLV  102 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee--cCCEEEEE
Confidence            45788899999999999999986 5899999998655433 33456889999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++++|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            99999999998876432    3899999999999999999999998     99999999999999999999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH----------Hhh
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------NFI  410 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~----------~~~  410 (464)
                      ...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..............          ...
T Consensus       174 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          174 LAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             ecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            543221 12234577889999999775 789999999999999999999999976433211111000          000


Q ss_pred             h----------hhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          411 D----------RNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       411 ~----------~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .          +......+     ...++.+.+++.+||+.||++|||++|++++.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            0          00000001     134678999999999999999999999999876543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.6e-42  Score=340.20  Aligned_cols=261  Identities=19%  Similarity=0.277  Sum_probs=202.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC---CCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~---~~~~~  258 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+...........+.+|+.++++++||||+++++++...   .....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            356888899999999999999976 68999999997655455567789999999999999999999987432   12568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||++ |+|.+++...     .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999996 6999998752     3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCcee---------eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh---
Q 012392          339 HKLLADDIVF---------SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---  405 (464)
Q Consensus       339 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~---  405 (464)
                      ++........         ......+|..|+|||.+.. ..++.++|||||||++|||++|+.||............   
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9876432211         1112346788999998764 67899999999999999999999999764321111000   


Q ss_pred             -----------------HHHhhhhhcCCC-C-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 -----------------FENFIDRNLKGK-F-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 -----------------~~~~~~~~~~~~-~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                       ..+.+....... .     ....+..+.+++.+||+.||++|||++|++++.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                             001110000000 0     123456789999999999999999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-41  Score=329.11  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=206.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--------chHHHHHHHHHHHHhcCC-CCCceeeeeEEEe
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--------KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS  252 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~  252 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....        ......+.+|+.+++++. ||||+++++++  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   93 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence            456888899999999999999986 689999999875431        122356889999999996 99999999998  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ......++||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+||+++.++.+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEE
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEcCCCcEE
Confidence            44678999999999999999998643    3899999999999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      |+|||++.......  ......++..|+|||.+.      ...++.++||||||+++|||++|..|+.......    ..
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~  238 (298)
T 1phk_A          165 LTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----ML  238 (298)
T ss_dssp             ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH
T ss_pred             EecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HH
Confidence            99999998765432  122345678899999885      4568899999999999999999999987543221    11


Q ss_pred             HHhhhhhcCCC--CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          407 ENFIDRNLKGK--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       407 ~~~~~~~~~~~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+........  .....+..+.+++.+||+.||++|||+.|++++-+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence            22222222211  12356678999999999999999999999998766543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-41  Score=339.66  Aligned_cols=258  Identities=17%  Similarity=0.277  Sum_probs=195.2

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  256 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.... .......+.+|+.+++.++||||+++++++....    ..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            356888999999999999999875 68899999987543 2334567889999999999999999999985432    13


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||++ |+|.+++..      .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEEEe
Confidence            6899999996 588888852      2889999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH----------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~----------  406 (464)
                      |+++......  ......+|..|+|||.+.+..++.++|||||||++|||++|+.||............+          
T Consensus       172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998664332  1223457788999999999899999999999999999999999997643221111100          


Q ss_pred             --------HHhhhhh---------------cCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 --------ENFIDRN---------------LKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 --------~~~~~~~---------------~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                              .......               .....   ....+..+.+++.+||+.||++|||++|++++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                    0000000               00000   112367899999999999999999999999987643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.3e-42  Score=339.71  Aligned_cols=268  Identities=18%  Similarity=0.239  Sum_probs=194.8

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  255 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  255 (464)
                      ++.....++|...+.||+|+||.||+|+.. +++.||||.+....  .....+.+++..++.++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            456667788999999999999999999985 68999999886543  222356778888999999999999999865322


Q ss_pred             -----CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCCCeeecCCCCCceEEcC-
Q 012392          256 -----GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--SSEVNKPAIVHRNLSVEKVLIDQ-  327 (464)
Q Consensus       256 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~~ivH~dlk~~Nill~~-  327 (464)
                           ...++||||+++ +|...+.........+++..+..++.|++.||.|||  +.+     |+||||||+|||++. 
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-----ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-----VCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-----CBCSCCCGGGEEEETT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eecCcCCHHHEEEeCC
Confidence                 137899999975 666655543333445899999999999999999999  777     999999999999997 


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      ++.+||+|||+++.......  .....+|..|+|||++.+. .++.++|||||||++|||+||+.||.............
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            89999999999987654321  2234568889999998654 48999999999999999999999997643321111111


Q ss_pred             HH-------h---hhhh----------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 EN-------F---IDRN----------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ~~-------~---~~~~----------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..       .   +.+.                .........+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  319 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD  319 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence            10       0   0000                00111222567899999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6e-42  Score=366.79  Aligned_cols=254  Identities=19%  Similarity=0.267  Sum_probs=208.7

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCe
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  257 (464)
                      ..++|...++||+|+||.||+|+.. +++.||||.++...  .......+..|..++..+ +||||+++++++  ...+.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCCE
Confidence            3467889999999999999999976 68899999987532  122335678899999988 799999999887  55778


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .|+||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+||||+.++.+||+|||
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS-----EECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeccCChhhEEEcCCCcEEEeecc
Confidence            999999999999999998653    3899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +++....... ......+|+.|+|||++.+..++.++|||||||+||||++|..||......    ..+..++..  ...
T Consensus       488 la~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~--~~~  560 (674)
T 3pfq_A          488 MCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEH--NVA  560 (674)
T ss_dssp             TCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHSS--CCC
T ss_pred             eeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----HHHHHHHhC--CCC
Confidence            9986432211 223345789999999999999999999999999999999999999765322    222333322  233


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTM-----EAVIEELTV  453 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~L~~  453 (464)
                      ++...+.++.+|+..||+.||++||++     +||++|.+.
T Consensus       561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence            555677889999999999999999997     888876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-42  Score=349.27  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=195.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~~  259 (464)
                      .|...+.||+|+||.||+|+.. +|+.||||.+....     ..+.+|+.+|++++||||+++++++....    ....+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4778899999999999999986 68999999986542     12346999999999999999999885422    12367


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-CCeEEeeCCc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGL  338 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGl  338 (464)
                      +||||+++ +|.+.+.........+++..+..++.||++||+|||+.+     |+||||||+|||++.+ +.+||+|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999975 777776543323345999999999999999999999988     9999999999999965 6789999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH-------hh
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-------FI  410 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-------~~  410 (464)
                      ++.......  .....+|..|+|||++.+. .++.++|||||||++|||++|+.||............+..       .+
T Consensus       204 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          204 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             CEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            987643321  1234567889999998764 7899999999999999999999999764322111111110       00


Q ss_pred             ---hhhcC-CC------------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          411 ---DRNLK-GK------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       411 ---~~~~~-~~------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                         .+... ..            ++...+..+.+|+.+||+.||++|||+.|+++|.+.
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence               00000 00            112345789999999999999999999999988765

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-42  Score=341.74  Aligned_cols=257  Identities=16%  Similarity=0.359  Sum_probs=205.3

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCch----------------HHHHHHHHHHHHhcCCCCCceee
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS----------------EEAEFVKGLYLLTSLRHENIIRL  246 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~f~~e~~~l~~l~H~niv~l  246 (464)
                      .++|...+.||+|+||.||+|+. +++.||||.+.......                ....|.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35688899999999999999999 89999999987532111                11679999999999999999999


Q ss_pred             eeEEEeCCCCeEEEEEecCCCCCHHHH------hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCC
Q 012392          247 RGFCCSRGRGECFLIYDFAPKGKLSKY------LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLS  319 (464)
Q Consensus       247 ~g~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk  319 (464)
                      ++++.  ..+..++||||+++|+|.++      +....  ...+++..+..++.||+.||+|||+ .+     |+|||||
T Consensus       109 ~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dl~  179 (348)
T 2pml_X          109 EGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN-----ICHRDVK  179 (348)
T ss_dssp             SEEEE--SSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC-----EECCCCC
T ss_pred             EEEEe--eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC-----EeecCCC
Confidence            99984  46789999999999999999      54321  3459999999999999999999998 77     9999999


Q ss_pred             CCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCcchH
Q 012392          320 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTE-RSDIFAFGVIILQILTGSLVLTSSM  397 (464)
Q Consensus       320 ~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDv~s~Gvll~el~tg~~p~~~~~  397 (464)
                      |+||+++.++.+||+|||++......   ......++..|+|||.+.+. .++. ++||||||+++|||++|..||....
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876543   23345578889999999877 6666 9999999999999999999997543


Q ss_pred             HHHHhhhhHHHhhhhhcCCCC-----------------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          398 RLAAESATFENFIDRNLKGKF-----------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..   ......+.........                 ....+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       257 ~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          257 SL---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             CS---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cH---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            21   1111111111111110                 1345678999999999999999999999999876543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-41  Score=332.33  Aligned_cols=261  Identities=18%  Similarity=0.320  Sum_probs=205.8

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCC--CCCceeeeeEEEeCCC
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR  255 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~  255 (464)
                      +....++|...+.||+|+||.||+++..+++.||||.+..... ......|.+|+.++.+++  ||||+++++++.  ..
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--CS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--cC
Confidence            3344567889999999999999999998899999999876442 334567899999999997  599999999984  46


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      +..++||| +.+++|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+|||+++ +.+||+|
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEET-TEEEECC
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEEEC-CeEEEee
Confidence            67999999 55889999998643    4899999999999999999999998     999999999999975 7999999


Q ss_pred             CCccccccCCce-eeeeccCCCCccCccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          336 CGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       336 fGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      ||+++....... .......++..|+|||.+..           ..++.++||||||+++|||++|+.||......   .
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---I  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---H
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---H
Confidence            999987644321 11223357888999999865           46888999999999999999999999653221   1


Q ss_pred             hhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ..+...++.......+...+..+.+++.+||+.||++||++.|++++.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            2233444444444455555678999999999999999999999999877554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-41  Score=346.51  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=196.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC---Ce
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~  257 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.... .....+.+.+|+.+|++++||||+++++++.....   ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            356888999999999999999975 68899999997543 23345679999999999999999999998854321   56


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++||||++ |+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999995 6999999753    24899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCcee---------------------eeeccCCCCccCccccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCc-
Q 012392          338 LHKLLADDIVF---------------------SVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVLT-  394 (464)
Q Consensus       338 l~~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvll~el~tg~~p~~-  394 (464)
                      +++........                     ......+|..|+|||++ ....++.++|||||||++|||++|..|+. 
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            99876433211                     12334578889999986 55679999999999999999998544332 


Q ss_pred             ----------chHH-------------HHHhhhhH-----------------------HHhhhhhc-CCCCC-----HHH
Q 012392          395 ----------SSMR-------------LAAESATF-----------------------ENFIDRNL-KGKFS-----ESE  422 (464)
Q Consensus       395 ----------~~~~-------------~~~~~~~~-----------------------~~~~~~~~-~~~~~-----~~~  422 (464)
                                +...             .......+                       ...+.... ....+     ...
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                      1100             00000000                       11110000 00000     124


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +..+.+|+.+||+.||++|||++|+++|.+..
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            56789999999999999999999999987644

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.3e-42  Score=334.03  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=196.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-------chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  254 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  254 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....       ......|.+|+.++++++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            456889999999999999999975 688999999865421       1122458899999999999999999998843  


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC---e
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---P  331 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~---~  331 (464)
                      . ..++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.   +
T Consensus        87 ~-~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 E-DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             S-SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSSSCCE
T ss_pred             C-ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEecCCCCCeE
Confidence            3 389999999999999999753    24899999999999999999999998     999999999999987654   9


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  408 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  408 (464)
                      ||+|||+++.......  .....++..|+|||.+.   ...++.++|||||||++|||++|..||......    ..+..
T Consensus       157 kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~  230 (322)
T 2ycf_A          157 KITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD  230 (322)
T ss_dssp             EECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHH
T ss_pred             EEccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHH
Confidence            9999999987654321  11234678899999974   567899999999999999999999999653211    11111


Q ss_pred             hhhhhcCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          409 FIDRNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       409 ~~~~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+........+   ...+..+.+++.+||+.||++||++.+++++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence            11111111111   1245778999999999999999999999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.9e-42  Score=344.44  Aligned_cols=257  Identities=19%  Similarity=0.264  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC--------CCCceeeeeEEEeC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR--------HENIIRLRGFCCSR  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~--------H~niv~l~g~~~~~  253 (464)
                      .++|...+.||+|+||.||+|+.. +++.||||.++..  ......+.+|+.++++++        |+||+++++++...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            367889999999999999999865 6889999998743  344567889999999985        78899999988532


Q ss_pred             --CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCC-
Q 012392          254 --GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQF-  329 (464)
Q Consensus       254 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~-  329 (464)
                        .....++||||+ +|+|.+++.....  ..+++..+..++.||+.||+|||++ +     |+||||||+|||++.++ 
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g-----ivHrDikp~NIll~~~~~  185 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR-----IIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECCCCSGGGEEECCCHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHeeEeccch
Confidence              345789999999 6777777765432  3489999999999999999999998 7     99999999999999775 


Q ss_pred             ------------------------------------------------CeEEeeCCccccccCCceeeeeccCCCCccCc
Q 012392          330 ------------------------------------------------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLA  361 (464)
Q Consensus       330 ------------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~a  361 (464)
                                                                      .+||+|||+++.....    .....+|..|+|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a  261 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence                                                            8999999999876542    223457888999


Q ss_pred             ccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHH-----HHhhhhHHHhhhh------------------------
Q 012392          362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESATFENFIDR------------------------  412 (464)
Q Consensus       362 PE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~------------------------  412 (464)
                      ||++.+..++.++|||||||++|||+||+.||......     ......+.+....                        
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999998642100     0000000000000                        


Q ss_pred             -------------hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 -------------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 -------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                   ......+...+..+.+|+.+||+.||++|||++|+++|.+.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence                         00112356778889999999999999999999999988653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.4e-42  Score=334.47  Aligned_cols=262  Identities=19%  Similarity=0.356  Sum_probs=201.9

Q ss_pred             hhcCCccccccccCCceEEEEEEE--CCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcC---CCCCceeeeeEEEe---
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTL--RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCS---  252 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~---  252 (464)
                      +.++|...+.||+|+||.||+|+.  .+++.||||.++..... .....+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456789999999999999999997  36889999998754321 1123456677666655   89999999999852   


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeE
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  332 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~k  332 (464)
                      ......++||||++ |+|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g-----i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHHHeEEcCCCCEE
Confidence            13457899999997 799999976542  24899999999999999999999998     99999999999999999999


Q ss_pred             EeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          333 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       333 l~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      |+|||+++......  ......++..|+|||.+.+..++.++||||||+++|||+||+.||..................+
T Consensus       161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999998665332  1223456788999999999899999999999999999999999997654322111111110000


Q ss_pred             --------------hcC-------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 --------------NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 --------------~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                    ...       .......+..+.+++.+||+.||++|||+.|++++-+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence                          000       01122356778999999999999999999999987554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=339.21  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      +++...++|...+.||+|+||.||+|+..+  .||||.++.... ......|.+|+.++++++||||+++++++..  ..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~  102 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PP  102 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SS
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CC
Confidence            333445678889999999999999999864  499999875432 2223457889999999999999999999854  56


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+++++|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++ ++.+||+||
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG-----ILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCSTTEEEC---CCEECCC
T ss_pred             ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChhhEEEe-CCCEEEeec
Confidence            7999999999999999997543   34899999999999999999999998     99999999999998 679999999


Q ss_pred             CccccccCCc----eeeeeccCCCCccCccccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhh
Q 012392          337 GLHKLLADDI----VFSVLKTSAAMGYLAPEYVTT---------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  403 (464)
Q Consensus       337 Gl~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~  403 (464)
                      |+++......    ........++..|+|||.+..         ..++.++||||||+++|||++|+.||.......   
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---  250 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---  250 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            9987543211    111122346778999999864         457889999999999999999999997543211   


Q ss_pred             hhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcc
Q 012392          404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  458 (464)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~  458 (464)
                       ....+.............+..+.+++..||+.||++|||+.++++.|+.+....
T Consensus       251 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          251 -IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             111111111111222245567999999999999999999999999999876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=343.17  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=188.5

Q ss_pred             Ccc-ccccccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          186 FSE-VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       186 f~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      |.. .++||+|+||.||+|+..   +++.||||.+.....   ...+.+|+.+|++++||||+++++++........++|
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            444 457999999999999975   578999999975432   2468899999999999999999999977667789999


Q ss_pred             EecCCCCCHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE----cCCCCeE
Q 012392          262 YDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPL  332 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill----~~~~~~k  332 (464)
                      |||++ |+|.+++.....     ....+++..+..|+.||+.||+|||+.+     |+||||||+|||+    +.++.+|
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99995 689888864321     1224899999999999999999999998     9999999999999    7789999


Q ss_pred             EeeCCccccccCCce--eeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHh-----hh
Q 012392          333 IADCGLHKLLADDIV--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----SA  404 (464)
Q Consensus       333 l~DfGl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~-----~~  404 (464)
                      |+|||+++.......  .......+|..|+|||++.+ ..++.++|||||||++|||+||..||.........     ..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987653211  12233457888999999987 45899999999999999999999999643211000     00


Q ss_pred             hHHHhhhh------------------------hcC---CCCC---------HHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 012392          405 TFENFIDR------------------------NLK---GKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVI  448 (464)
Q Consensus       405 ~~~~~~~~------------------------~~~---~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~evl  448 (464)
                      .+..++..                        ...   ....         ...+..+.+|+..||+.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            00010000                        000   0000         01145688999999999999999999999


Q ss_pred             HHHhhhcCc
Q 012392          449 EELTVAAPV  457 (464)
Q Consensus       449 ~~L~~~~~~  457 (464)
                      +|.+.....
T Consensus       333 ~hp~f~~~~  341 (405)
T 3rgf_A          333 QDPYFLEDP  341 (405)
T ss_dssp             TSGGGTSSS
T ss_pred             cChhhccCC
Confidence            998876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-41  Score=331.60  Aligned_cols=253  Identities=17%  Similarity=0.245  Sum_probs=201.3

Q ss_pred             cCCccccccccCCceEEEEEEE-C-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCC------CceeeeeEEEeCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTL-R-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE------NIIRLRGFCCSRGR  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~------niv~l~g~~~~~~~  255 (464)
                      ++|...+.||+|+||.||+|.. . +++.||||.++..  ......+.+|+.+++.++|+      +++++++++..  .
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~   89 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H   89 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence            5688889999999999999987 3 6889999998743  34456788899999988665      49999999844  6


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--------
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--------  327 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--------  327 (464)
                      +..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.        
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK-----LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCCCEEEEEC
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEEEeccccccccC
Confidence            7899999999 8999999976542  34889999999999999999999998     999999999999987        


Q ss_pred             -----------CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcch
Q 012392          328 -----------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS  396 (464)
Q Consensus       328 -----------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~  396 (464)
                                 ++.+||+|||+++.....    .....+|..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                       678999999999865432    12345788899999999989999999999999999999999998754


Q ss_pred             HHHHHhhhhHHHhhh----------------------------------hh-----cCCCCCHHHHHHHHHHHHHhhhcC
Q 012392          397 MRLAAESATFENFID----------------------------------RN-----LKGKFSESEAAKLGKMALVCTHED  437 (464)
Q Consensus       397 ~~~~~~~~~~~~~~~----------------------------------~~-----~~~~~~~~~~~~l~~l~~~C~~~d  437 (464)
                      ...... ..+.....                                  ..     .........++.+.+++.+||+.|
T Consensus       238 ~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          238 DSKEHL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             CHHHHH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             ChHHHH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            321110 00100000                                  00     001123456788999999999999


Q ss_pred             CCCCCCHHHHHHHHhh
Q 012392          438 PENRPTMEAVIEELTV  453 (464)
Q Consensus       438 p~~RPs~~evl~~L~~  453 (464)
                      |++|||+.|++++.+.
T Consensus       317 P~~Rpt~~ell~hp~f  332 (339)
T 1z57_A          317 PAKRITLREALKHPFF  332 (339)
T ss_dssp             TTTSCCHHHHTTSGGG
T ss_pred             cccccCHHHHhcCHHH
Confidence            9999999999988554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=329.67  Aligned_cols=259  Identities=18%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe----------
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS----------  252 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~----------  252 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.... .....++.+|+.++++++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            56888899999999999999986 58999999987654 4456789999999999999999999998732          


Q ss_pred             --CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCC
Q 012392          253 --RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQF  329 (464)
Q Consensus       253 --~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~  329 (464)
                        ......++||||++ |+|.+++..     ..+++..+..++.||+.||+|||+.+     |+||||||+|||++ +++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCC
Confidence              22357899999997 699999964     23889999999999999999999998     99999999999997 577


Q ss_pred             CeEEeeCCccccccCCcee--eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH
Q 012392          330 NPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  406 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~  406 (464)
                      .+||+|||+++........  ......++..|+|||.+.. ..++.++||||||+++|||+||+.||.............
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999876432111  1122345778999998865 678999999999999999999999997643221111110


Q ss_pred             HH------------------hhhhhcC-CCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 EN------------------FIDRNLK-GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ~~------------------~~~~~~~-~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..                  .+..... ...     ....+..+.+++.+||+.||++|||++|++++.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            00                  0000000 001     123457799999999999999999999999987654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.7e-42  Score=341.80  Aligned_cols=257  Identities=21%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  256 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+.... .......+.+|+.+++.++||||+++++++....    ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            367889999999999999999864 78999999986543 2334567889999999999999999999984321    24


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++|+||+ +++|.+++..     ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHhhEEECCCCCEEEeec
Confidence            579999999 7899999864     23899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH---------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~---------  406 (464)
                      |+++.....    .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...........         
T Consensus       177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865432    223457788999999876 678999999999999999999999997643221111110         


Q ss_pred             ----------HHhhhhhcC-CCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ----------ENFIDRNLK-GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ----------~~~~~~~~~-~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ..++..... ....     ...+..+.+|+.+||+.||++|||+.|++++.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                      111110000 0000     12346789999999999999999999999986643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-42  Score=344.33  Aligned_cols=258  Identities=17%  Similarity=0.274  Sum_probs=194.7

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----CeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----GECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~~~~  259 (464)
                      .+|...+.||+|+||.||+|+..++..||+|.+.....     ...+|+.+++.++||||+++++++.....    ...+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            45888899999999999999998777799998764331     12368999999999999999999865332    2378


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGL  338 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl  338 (464)
                      +||||++++ +.+.+.........+++..+..++.||+.||+|||+.+     |+||||||+|||++ .++.+||+|||+
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            999999764 44444332222345999999999999999999999998     99999999999999 799999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH---------
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN---------  408 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~---------  408 (464)
                      ++.......  .....+|..|+|||.+.+. .++.++|||||||++|||++|+.||...............         
T Consensus       189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            987643321  2234567889999998764 5899999999999999999999999764322111111100         


Q ss_pred             -hhhhhc-CCC------------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          409 -FIDRNL-KGK------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       409 -~~~~~~-~~~------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ...+.. ...            ++...+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence             000000 000            1122456899999999999999999999999986643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-41  Score=324.79  Aligned_cols=256  Identities=21%  Similarity=0.334  Sum_probs=204.1

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ...++|...+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+.++++++||||+++++++.  .....
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   96 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSF   96 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe--CCCeE
Confidence            34467999999999999999999986 789999999865432 234567899999999999999999999984  46789


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC---CCeEEee
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIAD  335 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~D  335 (464)
                      ++|+||+++++|.+++....    .+++..+..++.||+.||.|||+.+     |+||||||+||+++.+   +.+||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             EEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChhhEEEecCCCcccEEEec
Confidence            99999999999999987653    3899999999999999999999998     9999999999999754   4799999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ||++........  .....++..|+|||.+.+ .++.++||||||+++|||++|..||.......    ....+......
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~  240 (287)
T 2wei_A          168 FGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYA  240 (287)
T ss_dssp             TTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCC
T ss_pred             cCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCC
Confidence            999986643321  112235677999998865 58999999999999999999999997643221    11222221111


Q ss_pred             CCCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+  ...+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence            1111  23467899999999999999999999999976543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-41  Score=337.23  Aligned_cols=256  Identities=19%  Similarity=0.300  Sum_probs=197.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC----
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG----  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~----  256 (464)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+..... ......+.+|+.++++++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            457888899999999999999975 689999999976432 33356789999999999999999999998432221    


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||++ |+|.+++..      .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCcCHHHeEECCCCCEEEEec
Confidence            2399999996 799888742      2899999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhH---------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  406 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~---------  406 (464)
                      |+++.....    .....+|..|+|||.+.+ ..++.++|||||||++|||+||+.||.............         
T Consensus       189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            999865432    223456888999999877 678999999999999999999999997643221111110         


Q ss_pred             ----------HHhhhhhcCCCC------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          407 ----------ENFIDRNLKGKF------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       407 ----------~~~~~~~~~~~~------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ............      ....+..+.+++..||+.||++|||++|++++.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                      000100000000      112357899999999999999999999999987653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.4e-41  Score=346.17  Aligned_cols=258  Identities=17%  Similarity=0.230  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCceEEEEEEE-CCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCce-eeeeEEEeCCCCeEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII-RLRGFCCSRGRGECFL  260 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv-~l~g~~~~~~~~~~~l  260 (464)
                      .++|...++||+|+||.||+|+. .+++.||||.+......   .++.+|+.++..++|++.+ .+..++  ......+|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~--~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFG--VEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEE--EETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEE--eeCCEEEE
Confidence            35688899999999999999996 47899999988754422   3578899999999875544 444444  23567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---cCCCCeEEeeCC
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCG  337 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG  337 (464)
                      ||||+ +++|.+++....   ..+++.+++.|+.||+.||+|||+.+     |+||||||+||||   +.++.+||+|||
T Consensus        81 vme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             EEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             EEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCcceEEEecCCCCCeEEEEeCC
Confidence            99999 999999997543   24999999999999999999999998     9999999999999   688999999999


Q ss_pred             ccccccCCcee------eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          338 LHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       338 l~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      +++........      ......+|..|+|||.+.+..++.++|||||||+||||++|+.||....... ....+..+..
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~  230 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISE  230 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHHHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHHHHhh
Confidence            99876543211      1124457889999999999999999999999999999999999997532100 0111111111


Q ss_pred             hhcCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          412 RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       412 ~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .......   ...++.++.+++..||+.||++||++.+|++.|+.+.
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1111110   1233568999999999999999999999999988763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4e-41  Score=335.90  Aligned_cols=258  Identities=19%  Similarity=0.294  Sum_probs=202.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-----------CCCceeeeeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----------HENIIRLRGFCC  251 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-----------H~niv~l~g~~~  251 (464)
                      .+|...+.||+|+||.||+|+.. +++.||||.+...  ......+.+|+.++.+++           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46888899999999999999974 7899999998743  334567888999998886           899999999986


Q ss_pred             eCCC--CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEc--
Q 012392          252 SRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLID--  326 (464)
Q Consensus       252 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~--  326 (464)
                      ....  ...++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+. +     |+||||||+|||++  
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~-----ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCChHHeEEecc
Confidence            5322  2689999999 9999999986443  2389999999999999999999997 7     99999999999994  


Q ss_pred             ----CCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH--
Q 012392          327 ----QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA--  400 (464)
Q Consensus       327 ----~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~--  400 (464)
                          ..+.+||+|||+++.....    .....+|..|+|||.+.+..++.++|||||||++|||+||..||.......  
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                4458999999999876542    223457888999999999999999999999999999999999997432110  


Q ss_pred             HhhhhHHHhhhh----------------------------------------hcCCCCCHHHHHHHHHHHHHhhhcCCCC
Q 012392          401 AESATFENFIDR----------------------------------------NLKGKFSESEAAKLGKMALVCTHEDPEN  440 (464)
Q Consensus       401 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~  440 (464)
                      .....+..++..                                        ......+...+..+.+++..||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence            000011111100                                        0112345677889999999999999999


Q ss_pred             CCCHHHHHHHHhhhc
Q 012392          441 RPTMEAVIEELTVAA  455 (464)
Q Consensus       441 RPs~~evl~~L~~~~  455 (464)
                      |||++|++++.+...
T Consensus       325 Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          325 RADAGGLVNHPWLKD  339 (373)
T ss_dssp             CBCHHHHHTCGGGTT
T ss_pred             cCCHHHHhhChhhhc
Confidence            999999999876543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-41  Score=344.80  Aligned_cols=254  Identities=23%  Similarity=0.305  Sum_probs=187.8

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEEEEec
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      |...+.||+|+||+||.+...+|+.||||++...    ....+.+|+.++.++ +||||+++++++  ......++||||
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~--~~~~~~~lv~E~   90 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSE--TTDRFLYIALEL   90 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEE--ECSSEEEEEECC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEE--ecCCeEEEEEec
Confidence            4455789999999998776678999999998653    234578899999886 899999999987  456789999999


Q ss_pred             CCCCCHHHHhhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC-------------
Q 012392          265 APKGKLSKYLDQEEGSSNV---LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-------------  328 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~-------------  328 (464)
                      ++ |+|.+++.........   .++..++.++.||+.||+|||+.+     |+||||||+|||++.+             
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCcccccccccCCCc
Confidence            95 7999999865432211   133356789999999999999998     9999999999999754             


Q ss_pred             CCeEEeeCCccccccCCcee---eeeccCCCCccCccccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCcchH
Q 012392          329 FNPLIADCGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILT-GSLVLTSSM  397 (464)
Q Consensus       329 ~~~kl~DfGl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~  397 (464)
                      +.+||+|||+++........   ......+|..|+|||++.+       ..++.++|||||||++|||+| |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            58999999999876543211   1223457889999999865       678999999999999999999 888886542


Q ss_pred             HHHHhhhhHHHhhh-hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          398 RLAAESATFENFID-RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       398 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...  ......... ...........+..+.+++.+||+.||++|||+.+|+++.+.
T Consensus       245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            211  111111111 111122245677899999999999999999999999986543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.4e-41  Score=332.31  Aligned_cols=257  Identities=16%  Similarity=0.211  Sum_probs=177.0

Q ss_pred             hcCCccc-cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC--CCeE
Q 012392          183 TQCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG--RGEC  258 (464)
Q Consensus       183 ~~~f~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~--~~~~  258 (464)
                      .++|... ++||+|+||.||+|+.. +++.||||.+...  .....   +....+..++||||+++++++....  ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            3456764 46999999999999986 6899999998653  22222   2223456679999999999885422  3458


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEee
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD  335 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  335 (464)
                      ++||||+++|+|.+++.....  ..+++.++..++.||+.||+|||+.+     |+||||||+|||++.   ++.+||+|
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEEecCCCceEEEec
Confidence            999999999999999986432  35999999999999999999999998     999999999999986   45599999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh--h
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--N  413 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~  413 (464)
                      ||+++......   .....+|..|+|||.+....++.++||||||+++|||++|..||...............+...  .
T Consensus       175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            99998664332   123346788999999988889999999999999999999999997543221111111111111  1


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .........+..+.+++..||+.||++|||++|++++.+..
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            11112234567899999999999999999999999987754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-40  Score=333.35  Aligned_cols=260  Identities=18%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             HhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CC-----CceeeeeEEEeC
Q 012392          181 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HE-----NIIRLRGFCCSR  253 (464)
Q Consensus       181 ~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~-----niv~l~g~~~~~  253 (464)
                      ...++|...+.||+|+||.||+|+.. +++.||||.++..  .....++..|+.+++.++ |+     +|+++++++.. 
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence            34567899999999999999999976 6889999999743  334566788888888885 55     49999998854 


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc--CCCCe
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNP  331 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~--~~~~~  331 (464)
                       .+..++||||++ |+|.+++.....  ..+++..+..++.|++.||.|||+..   .+|+||||||+|||++  .++.+
T Consensus       128 -~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          128 -RNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             -TTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT---TCEECCCCSGGGEEESSTTSCCE
T ss_pred             -CCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC---CCEEcCCCCcccEEEecCCCCcE
Confidence             578999999995 699999986542  24899999999999999999999531   2399999999999994  57889


Q ss_pred             EEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH----
Q 012392          332 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----  407 (464)
Q Consensus       332 kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~----  407 (464)
                      ||+|||+++.....    .....+|..|+|||++.+..++.++|||||||++|||+||+.||..............    
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999999876542    2234577889999999999999999999999999999999999975432211111100    


Q ss_pred             -------------HhhhhhcC-----------------------------------------CCCCHHHHHHHHHHHHHh
Q 012392          408 -------------NFIDRNLK-----------------------------------------GKFSESEAAKLGKMALVC  433 (464)
Q Consensus       408 -------------~~~~~~~~-----------------------------------------~~~~~~~~~~l~~l~~~C  433 (464)
                                   .+++....                                         ..........+.+++.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence                         00000000                                         001123446889999999


Q ss_pred             hhcCCCCCCCHHHHHHHHhhh
Q 012392          434 THEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       434 ~~~dp~~RPs~~evl~~L~~~  454 (464)
                      |+.||++|||++|++++.+..
T Consensus       357 L~~dP~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGC
T ss_pred             cCCChhhCCCHHHHhcCcccc
Confidence            999999999999999987643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=331.54  Aligned_cols=255  Identities=19%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC----Ce
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----GE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~~  257 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+..... ......+.+|+.++++++||||+++++++.....    ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            56888899999999999999975 689999999876432 3335678999999999999999999999844221    13


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++||||++ |+|.+++..      .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEeECCCCcEEEeecc
Confidence            599999996 698887742      2899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH---------
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------  407 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~---------  407 (464)
                      +++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............         
T Consensus       172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99865432    223356788999999876 6789999999999999999999999975432111110000         


Q ss_pred             ----------Hhhhh---hcCC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          408 ----------NFIDR---NLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       408 ----------~~~~~---~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                ..+..   ....   ......+..+.+++.+||+.||++|||++|++++.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                      00000   0000   11234567899999999999999999999999987643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-41  Score=333.63  Aligned_cols=252  Identities=20%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhcCC--CCCceeeee
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLR--HENIIRLRG  248 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~f~~e~~~l~~l~--H~niv~l~g  248 (464)
                      .+.....++|...+.||+|+||.||+|+.. +++.||||.+.......     ....+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344456678999999999999999999864 78999999987643221     2245678999999996  599999999


Q ss_pred             EEEeCCCCeEEEEEecCCC-CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-
Q 012392          249 FCCSRGRGECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-  326 (464)
Q Consensus       249 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-  326 (464)
                      ++.  ..+..++|+||+.. ++|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++ 
T Consensus       116 ~~~--~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          116 WFE--RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDL  184 (320)
T ss_dssp             EEE--CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEET
T ss_pred             EEe--cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeCCCCHHHEEEeC
Confidence            984  46789999999976 89999998643    3899999999999999999999998     99999999999999 


Q ss_pred             CCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  405 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~  405 (464)
                      +++.+||+|||+++.......   ....++..|+|||.+.+..+ +.++||||||+++|||+||+.||.......     
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----  256 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-----  256 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSCB---CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-----
T ss_pred             CCCCEEEeeCccccccccccc---cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh-----
Confidence            789999999999987654321   23457888999999987665 678999999999999999999997543211     


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                           ..  ....+...+..+.+++.+||+.||++|||++|++++.+..
T Consensus       257 -----~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          257 -----RG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             -----HC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             -----cc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence                 11  1112334456789999999999999999999999886644

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=329.11  Aligned_cols=251  Identities=20%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhcC----CCCCceeeee
Q 012392          179 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSL----RHENIIRLRG  248 (464)
Q Consensus       179 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~f~~e~~~l~~l----~H~niv~l~g  248 (464)
                      .+...++|...+.||+|+||.||+|+.. +++.||||.+.......     ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445577999999999999999999864 78899999987553221     223466789999888    8999999999


Q ss_pred             EEEeCCCCeEEEEEec-CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-
Q 012392          249 FCCSRGRGECFLIYDF-APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-  326 (464)
Q Consensus       249 ~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-  326 (464)
                      ++.  ..+..++|+|| +.+++|.+++....    .+++..++.++.||+.||+|||+.+     |+||||||+||+++ 
T Consensus       106 ~~~--~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A          106 WFE--TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG-----VVHRDIKDENILIDL  174 (312)
T ss_dssp             EC-------CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT-----EECCCCSGGGEEEET
T ss_pred             EEe--cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChhhEEEeC
Confidence            884  45678999999 78999999998643    3899999999999999999999988     99999999999999 


Q ss_pred             CCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhh
Q 012392          327 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  405 (464)
Q Consensus       327 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~  405 (464)
                      +++.+||+|||+++.......   ....++..|+|||.+.+..+. .++||||||+++|||++|+.||......      
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------  245 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------  245 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------
T ss_pred             CCCeEEEEEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------
Confidence            889999999999987654322   234477889999998776664 5899999999999999999999754321      


Q ss_pred             HHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          406 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                          ...  ....+...+..+.+++.+||+.||++|||++|++++.+...
T Consensus       246 ----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~  289 (312)
T 2iwi_A          246 ----LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT  289 (312)
T ss_dssp             ----HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred             ----hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence                111  12233455677899999999999999999999999866543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.5e-40  Score=327.33  Aligned_cols=255  Identities=15%  Similarity=0.233  Sum_probs=200.3

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CC-cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC------ceeeeeEEEeCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN------IIRLRGFCCSRG  254 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n------iv~l~g~~~~~~  254 (464)
                      .++|...+.||+|+||.||+|+.. ++ +.||||.++..  ......+.+|+.++++++|+|      ++.+.+++..  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence            356888999999999999999975 34 78999998743  344567888999999997766      8999888844  


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEE---------
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---------  325 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill---------  325 (464)
                      .+..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+.+     |+||||||+|||+         
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ-----LTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEESCCCEEEEE
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecccccccc
Confidence            66899999999 7788888876432  34899999999999999999999988     9999999999999         


Q ss_pred             ----------cCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          326 ----------DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       326 ----------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                                +.++.+||+|||+++......    ....+|..|+|||.+.+..++.++|||||||++|||+||..||..
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                      678899999999998654321    234578889999999999999999999999999999999999975


Q ss_pred             hHHHHHhhhhHHHhhh----------------------------------hhc-----CCCCCHHHHHHHHHHHHHhhhc
Q 012392          396 SMRLAAESATFENFID----------------------------------RNL-----KGKFSESEAAKLGKMALVCTHE  436 (464)
Q Consensus       396 ~~~~~~~~~~~~~~~~----------------------------------~~~-----~~~~~~~~~~~l~~l~~~C~~~  436 (464)
                      ........ .+.....                                  ...     ........+..+.+++.+||+.
T Consensus       242 ~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          242 HENREHLV-MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             SSHHHHHH-HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCHHHHHH-HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            43211100 0000000                                  000     0011234567899999999999


Q ss_pred             CCCCCCCHHHHHHHHhhh
Q 012392          437 DPENRPTMEAVIEELTVA  454 (464)
Q Consensus       437 dp~~RPs~~evl~~L~~~  454 (464)
                      ||++|||+.|++++-+..
T Consensus       321 dP~~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          321 DPAQRITLAEALLHPFFA  338 (355)
T ss_dssp             STTTSCCHHHHTTSGGGG
T ss_pred             ChhhCcCHHHHhcChhhc
Confidence            999999999999886654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=325.14  Aligned_cols=253  Identities=17%  Similarity=0.318  Sum_probs=181.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHH-HHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~-~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+..........++. ++..+++.++||||+++++++.  ..+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~lv  102 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIA  102 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCcEEEE
Confidence            45788899999999999999986 78999999998665444444444 4455688889999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||+ ++.+..+.....   ..+++..+..++.|++.||.|||+. +     |+||||||+||+++.++.+||+|||++.
T Consensus       103 ~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG-----VIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             Eecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            9999 556655554322   2489999999999999999999985 7     9999999999999999999999999997


Q ss_pred             cccCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      .......  .....++..|+|||.+.     ...++.++||||||+++|||++|+.||.......   ..+....... .
T Consensus       174 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-~  247 (318)
T 2dyl_A          174 RLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTKVLQEE-P  247 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHHSC-C
T ss_pred             hccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHHHhccC-C
Confidence            6644321  22334778899999984     4568899999999999999999999987532111   1112222111 1


Q ss_pred             CCC--CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          416 GKF--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       416 ~~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...  ....+..+.+++.+||+.||++||++++++++.+.
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (318)
T 2dyl_A          248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI  287 (318)
T ss_dssp             CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence            111  12356779999999999999999999999987553

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=337.01  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=187.4

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ...+|...++||+|+||+||.....+++.||||++......    .+.+|+.+|+++ +||||+++++++.  .....++
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~l   95 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEK--DRQFQYI   95 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEE
Confidence            34567888999999999976655668999999998754322    356799999999 7999999999884  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-----CCCeEEee
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIAD  335 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~D  335 (464)
                      ||||++ |+|.+++......   +.+..++.++.||+.||+|||+.+     |+||||||+|||++.     ...+||+|
T Consensus        96 v~E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLN-----IVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTT-----CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EEECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCc-----CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            999995 6999999865422   444456789999999999999998     999999999999953     34688999


Q ss_pred             CCccccccCCce--eeeeccCCCCccCcccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHh
Q 012392          336 CGLHKLLADDIV--FSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENF  409 (464)
Q Consensus       336 fGl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  409 (464)
                      ||+++.......  .......+|..|+|||++.   ...++.++|||||||++|||+| |..|+........     ...
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-----~~~  241 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-----NIL  241 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-----HHH
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-----HHH
Confidence            999987653321  1223345889999999997   4567889999999999999999 8888854322111     111


Q ss_pred             hhh-hcC-CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          410 IDR-NLK-GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       410 ~~~-~~~-~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ... ... ..........+.+++.+||+.||++|||+.+|++|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~  286 (432)
T 3p23_A          242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF  286 (432)
T ss_dssp             TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred             hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence            111 111 1112345667889999999999999999999997654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-40  Score=349.26  Aligned_cols=257  Identities=21%  Similarity=0.284  Sum_probs=200.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEe----CCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS----RGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~----~~~~~~  258 (464)
                      ++|...+.||+|+||.||+|... +|+.||||.+...........|.+|+.++++++||||+++++++..    ...+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            56889999999999999999875 6899999998766555566789999999999999999999998632    125668


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC---eEEee
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIAD  335 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  335 (464)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.   +||+|
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g-----IVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT-----BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEeecCCCceeEEEcc
Confidence            999999999999999986442 234889999999999999999999988     999999999999997665   99999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH------Hh
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE------NF  409 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~------~~  409 (464)
                      ||+++.......  .....++..|+|||.+.+..++.++||||||+++|||++|..||............+.      ..
T Consensus       168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            999987654322  1234578889999999999999999999999999999999999965422211100000      00


Q ss_pred             hhhh------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 012392          410 IDRN------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI  448 (464)
Q Consensus       410 ~~~~------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl  448 (464)
                      ....            .........+..+.+++..||+.||++|||+.+++
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000            01123456788999999999999999999998854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-39  Score=349.50  Aligned_cols=240  Identities=18%  Similarity=0.256  Sum_probs=191.1

Q ss_pred             cCCccccccccCCceEEEEEEEC--CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC---eE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---EC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~---~~  258 (464)
                      ++|...+.||+|+||.||+|+..  +++.||||.+...........|.+|+.++++++||||+++++++......   ..
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67889999999999999999975  68999999987655445566799999999999999999999998654321   16


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ||||||+++++|.+++..      .++|.+++.|+.||+.||.|||+.+     |+||||||+|||++++ .+||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g-----iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG-----LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccChHHeEEeCC-cEEEEeccc
Confidence            999999999999988753      3899999999999999999999998     9999999999999986 899999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  418 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  418 (464)
                      ++.....     ....+|.+|+|||++.++ ++.++|||||||++|||++|..|+.....            +.......
T Consensus       228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~~~~~~~~  289 (681)
T 2pzi_A          228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV------------DGLPEDDP  289 (681)
T ss_dssp             CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC------------SSCCTTCH
T ss_pred             chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc------------cccccccc
Confidence            9876543     234578899999998765 48899999999999999999887753210            00000011


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPT-MEAVIEELTV  453 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~~  453 (464)
                      .......+.+++.+||+.||++||+ ++++.+.|..
T Consensus       290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            1223467899999999999999995 5555555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5e-39  Score=311.38  Aligned_cols=233  Identities=17%  Similarity=0.243  Sum_probs=180.6

Q ss_pred             cCCccc-cccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHH-hcCCCCCceeeeeEEEe--CCCCeE
Q 012392          184 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLL-TSLRHENIIRLRGFCCS--RGRGEC  258 (464)
Q Consensus       184 ~~f~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l-~~l~H~niv~l~g~~~~--~~~~~~  258 (464)
                      ++|... +.||+|+||.||+|+.. +++.||||.++..      ..+.+|+.++ +..+||||+++++++..  ......
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            345555 77999999999999974 7899999998642      3466788887 55689999999998743  224568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEee
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD  335 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  335 (464)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.   ++.+||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEecCCCCCcEEEec
Confidence            999999999999999986432  34899999999999999999999998     999999999999998   78999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ||++....                       +..++.++|||||||++|||+||..||..................  ..
T Consensus       164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~  218 (299)
T 3m2w_A          164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--GQ  218 (299)
T ss_dssp             CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT--TC
T ss_pred             cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh--cc
Confidence            99986432                       134677999999999999999999999754322111000000000  00


Q ss_pred             CCCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          416 GKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       416 ~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ...+    ...+..+.+++..||+.||++|||+.|++++.+..
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            1112    23467899999999999999999999999987654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.6e-39  Score=311.61  Aligned_cols=231  Identities=11%  Similarity=0.086  Sum_probs=181.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.....  ......|.+|+.++++++||||+++++++..  .+..|+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l  108 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV  108 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence            46888899999999999999986 589999999976543  2334679999999999999999999999854  577999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++++|.+++...      ....+...|+.|++.||+|||+.+     |+||||||+|||+++++.+||+++|   
T Consensus       109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG-----VALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC-----CccCCCCcccEEEcCCCCEEEEecc---
Confidence            99999999999999531      344568889999999999999998     9999999999999999999998543   


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC--CC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KF  418 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  418 (464)
                                        |++|       ++.++|||||||++|||+||+.||.......... .....+......  ..
T Consensus       175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADI  228 (286)
T ss_dssp             ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECCBCTTSCBCCHHHH
T ss_pred             ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHHHHhccCCCChhhc
Confidence                              4443       5889999999999999999999997542210000 000000000000  01


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                      ....+..+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            12345679999999999999999 999999999987544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-39  Score=329.51  Aligned_cols=248  Identities=15%  Similarity=0.147  Sum_probs=183.4

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCch--HHHHHHHHHHHHhcCCC-CCceeee----------
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRH-ENIIRLR----------  247 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~f~~e~~~l~~l~H-~niv~l~----------  247 (464)
                      .+..|...++||+|+||.||+|+.. +|+.||||.+.......  ..+.|.+|+.+++.++| +|.....          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3445677789999999999999964 78999999987443222  24678999999999987 3221111          


Q ss_pred             -----------eEEEeCC---CCeEEEEEecCCCCCHHHHhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012392          248 -----------GFCCSRG---RGECFLIYDFAPKGKLSKYLDQE---EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  310 (464)
Q Consensus       248 -----------g~~~~~~---~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  310 (464)
                                 .++....   ....+++|+++ +++|.+++...   ......++|..++.++.||+.||+|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                       1111101   22467777766 78999998532   122334888999999999999999999998   


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCccccc----------ccCCCCCcchhHHHH
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV----------TTGRFTERSDIFAFG  380 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDv~s~G  380 (464)
                        |+||||||+|||++.++.+||+|||+++.....    .....+ ..|+|||++          ....++.++||||||
T Consensus       232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             --cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence              999999999999999999999999998865442    223345 889999999          555688899999999


Q ss_pred             HHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          381 VIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       381 vll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      |++|||+||+.||......    ......    ....  ...++.+.+++..||+.||++||++.+++++
T Consensus       305 vil~elltg~~Pf~~~~~~----~~~~~~----~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAAL----GGSEWI----FRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGG----SCSGGG----GSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHCCCCCCCcchh----hhHHHH----Hhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999999754321    111111    1111  1234679999999999999999998888754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.9e-38  Score=308.93  Aligned_cols=244  Identities=17%  Similarity=0.202  Sum_probs=187.4

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-------chHHHHHHHHHHHHhcCC---------CCCceee
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLR---------HENIIRL  246 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~f~~e~~~l~~l~---------H~niv~l  246 (464)
                      .++|...+.||+|+||+||+|+. +|+.||||.+.....       ......+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34577889999999999999998 689999999986531       223367888998888885         8888888


Q ss_pred             eeEEEeC----------------------------CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHH
Q 012392          247 RGFCCSR----------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK  298 (464)
Q Consensus       247 ~g~~~~~----------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  298 (464)
                      .+.++..                            .....++||||+++|++.+.+..     ..+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            7765421                            25679999999999987777643     23899999999999999


Q ss_pred             HHHHHh-cCCCCCCCeeecCCCCCceEEcCCC--------------------CeEEeeCCccccccCCceeeeeccCCCC
Q 012392          299 GIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQF--------------------NPLIADCGLHKLLADDIVFSVLKTSAAM  357 (464)
Q Consensus       299 gL~yLH-~~~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~~~~  357 (464)
                      ||+||| +.+     |+||||||+|||++.++                    .+||+|||+++......      ..+|.
T Consensus       173 aL~~lH~~~~-----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~------~~gt~  241 (336)
T 2vuw_A          173 SLAVAEASLR-----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI------VVFCD  241 (336)
T ss_dssp             HHHHHHHHHC-----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE------EECCC
T ss_pred             HHHHHHHhCC-----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc------EEEee
Confidence            999999 888     99999999999999887                    89999999998765431      24778


Q ss_pred             ccCcccccccCCCCCcchhHHHHHH-HHHHHhCCCCCcchHHHHHhhhhHHHhhhhh-cCC----CCCHHHHHHHHHHHH
Q 012392          358 GYLAPEYVTTGRFTERSDIFAFGVI-ILQILTGSLVLTSSMRLAAESATFENFIDRN-LKG----KFSESEAAKLGKMAL  431 (464)
Q Consensus       358 ~y~aPE~~~~~~~~~~sDv~s~Gvl-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~l~~l~~  431 (464)
                      .|+|||.+.+.. +.++||||++++ .+++++|..|+........   ....+.... ...    ......+.++.+++.
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            899999998665 889999998777 7778899988854321111   111111111 111    113457889999999


Q ss_pred             HhhhcCCCCCCCHHHHH-HHHh
Q 012392          432 VCTHEDPENRPTMEAVI-EELT  452 (464)
Q Consensus       432 ~C~~~dp~~RPs~~evl-~~L~  452 (464)
                      +||+.|     |++|++ +|-+
T Consensus       318 ~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HGGGSS-----SHHHHHHHCGG
T ss_pred             HHhccC-----CHHHHHhcCCC
Confidence            999976     999999 7754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.2e-30  Score=273.74  Aligned_cols=183  Identities=12%  Similarity=0.031  Sum_probs=125.4

Q ss_pred             cccCCceEEEEEE-ECCCcEEEEEEeccCCC---------chHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEEE
Q 012392          192 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSC---------KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       192 lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~---------~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .+.|++|.+..++ ..-|+.||||.+.....         +...++|.+|+++|+++ .|+||+++++++  ++.+..||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~yL  319 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSGWL  319 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEEEE
Confidence            4566666666544 33578899999875421         12335799999999999 699999999998  55788999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||++||+|.++|....    +++..   +|+.||+.||+|||+++     ||||||||+||||++++.+||+|||+++
T Consensus       320 VMEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G-----IIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG-----FWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT-----CEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EEecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC-----ceeccCchHhEEECCCCCEEEeecccCe
Confidence            999999999999997643    36543   58999999999999999     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS  390 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~  390 (464)
                      ....+.. ......+|++|||||.+.+ .+..++|+||+|++++++.++.
T Consensus       388 ~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          388 TTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             eCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            7654322 1223347788999999865 4677899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.1e-28  Score=254.02  Aligned_cols=185  Identities=14%  Similarity=0.144  Sum_probs=141.2

Q ss_pred             ccccccccCCceEEEEEEECCCcEEEEEEeccCCCc-h------HHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          187 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-S------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ...++||+|+||.||+|+. .+..+++|........ .      ..+.|.+|+.++++++||||+++..++..  ....+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccE
Confidence            3457899999999999954 5778899986543211 1      13458999999999999999966666644  34569


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +||||+++|+|.+++..            +..++.|+++||+|||+.+     |+||||||+|||+++  .+||+|||++
T Consensus       416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g-----IiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND-----VIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT-----EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc-----CccCCCCHHHEEECC--eEEEEECccC
Confidence            99999999999999974            4579999999999999998     999999999999999  9999999999


Q ss_pred             ccccCCceee------eeccCCCCccCccccccc--CCCCCcchhHHHHHHHHHHHhCCCCC
Q 012392          340 KLLADDIVFS------VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVL  393 (464)
Q Consensus       340 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvll~el~tg~~p~  393 (464)
                      +.........      .....+|..|||||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9775432111      112346788999999976  66888899999998888887776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=7.5e-25  Score=209.90  Aligned_cols=154  Identities=14%  Similarity=0.085  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCc-----------------hHHHHHHHHHHHHhcC
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------SEEAEFVKGLYLLTSL  238 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~f~~e~~~l~~l  238 (464)
                      +..+......|...+.||+|+||.||+|+..+|+.||||.++.....                 .....|.+|+.+|+++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34444555667778999999999999999977999999998653211                 1345689999999999


Q ss_pred             CCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCC
Q 012392          239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  318 (464)
Q Consensus       239 ~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dl  318 (464)
                      +  | +++.+++..   +..++||||+++|+|.+ +..          .....++.|++.||.|||+.+     |+||||
T Consensus       162 ~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g-----iiHrDl  219 (282)
T 1zar_A          162 Q--G-LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG-----IVHGDL  219 (282)
T ss_dssp             T--T-SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT-----EECSCC
T ss_pred             c--C-CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC-----CEeCCC
Confidence            9  5 666665422   34689999999999998 421          123469999999999999998     999999


Q ss_pred             CCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccc
Q 012392          319 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT  366 (464)
Q Consensus       319 k~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~  366 (464)
                      ||+|||++ ++.+||+|||+++...              .++|||++.
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~~~--------------~~~a~e~l~  252 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVEVG--------------EEGWREILE  252 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEETT--------------STTHHHHHH
T ss_pred             CHHHEEEE-CCcEEEEECCCCeECC--------------CCCHHHHHH
Confidence            99999999 9999999999987432              378999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.1e-20  Score=176.57  Aligned_cols=138  Identities=15%  Similarity=0.159  Sum_probs=106.4

Q ss_pred             CCccccccccCCceEEEEEEE-CCCcE--EEEEEeccCCCc-----------------------hHHHHHHHHHHHHhcC
Q 012392          185 CFSEVNLLGKGNFSSVYKGTL-RDGTL--VAIRSINVTSCK-----------------------SEEAEFVKGLYLLTSL  238 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~f~~e~~~l~~l  238 (464)
                      .|...+.||+|+||.||+|.. .+|+.  ||||.++.....                       .....+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999998 68888  999987543211                       1123678899999999


Q ss_pred             CCCCc--eeeeeEEEeCCCCeEEEEEecCCC-C----CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCC
Q 012392          239 RHENI--IRLRGFCCSRGRGECFLIYDFAPK-G----KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH-SSEVNK  310 (464)
Q Consensus       239 ~H~ni--v~l~g~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~  310 (464)
                      +|+|+  ..++++      ...+|||||+.+ |    +|.++...       .++.....++.|++.||.||| +.+   
T Consensus       128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---  191 (258)
T 1zth_A          128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---  191 (258)
T ss_dssp             HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred             HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence            88764  334332      235899999942 4    77776532       223456789999999999999 888   


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                        |+||||||+|||+++  .++|+|||++...
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence              999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.4e-17  Score=164.26  Aligned_cols=145  Identities=12%  Similarity=0.127  Sum_probs=100.9

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-----c--------hHHHH--------HHHHHHHHh
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----K--------SEEAE--------FVKGLYLLT  236 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~--------~~~~~--------f~~e~~~l~  236 (464)
                      .+..-..-|.+.+.||+|+||.||+|...+|+.||||.++....     +        .....        ..+|...|.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            33333344888999999999999999998999999998764210     0        00111        234556666


Q ss_pred             cCCCCCceeeeeEEEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeec
Q 012392          237 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  316 (464)
Q Consensus       237 ~l~H~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~  316 (464)
                      ++.+.++....-+...    ..+|||||+++++|.++...          .....++.|++.+|.|||+.+     ||||
T Consensus       169 rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g-----IVHr  229 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG-----LIHG  229 (397)
T ss_dssp             HHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT-----EECS
T ss_pred             HHHhcCCCCCeeeecc----CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC-----CcCC
Confidence            6644433211111111    13699999999888654321          123568899999999999988     9999


Q ss_pred             CCCCCceEEcCCC----------CeEEeeCCcccc
Q 012392          317 NLSVEKVLIDQQF----------NPLIADCGLHKL  341 (464)
Q Consensus       317 dlk~~Nill~~~~----------~~kl~DfGl~~~  341 (464)
                      ||||.|||+++++          .+.|+||+-+..
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999876          388999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.29  E-value=7.4e-12  Score=117.84  Aligned_cols=146  Identities=14%  Similarity=0.057  Sum_probs=109.1

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  260 (464)
                      .-..|.....++.|+.+.||+.... +..+++|....... .....+.+|..+++.+. |.++.++++++..  .+..|+
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l   87 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL   87 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence            3356777778888888999998754 67899999865321 11235778999998884 6778889988743  567899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--------------------------------  308 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--------------------------------  308 (464)
                      ||||+++.+|.+.+..         ......++.+++.+|..||+...                                
T Consensus        88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999999876421         11234688999999999998210                                


Q ss_pred             ----------------------CCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          309 ----------------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       309 ----------------------~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                                            ..+.++|+|+++.|||++++..+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  11458999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=3.9e-11  Score=112.31  Aligned_cols=130  Identities=12%  Similarity=0.148  Sum_probs=94.4

Q ss_pred             ccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC--ceeeeeEEEeCCCCeEEEEEecCCCCCH
Q 012392          193 GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPKGKL  270 (464)
Q Consensus       193 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~~~lv~E~~~~gsL  270 (464)
                      +.|..+.||+....+|..+++|......    ...+..|+.+++.+.+.+  +.+++++..  ..+..++||||+++.+|
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSEET
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCCEEEEEecCCccc
Confidence            3555699999987778889999876431    234678888888885444  456887763  34568999999999888


Q ss_pred             HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC------------------------------------------
Q 012392          271 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV------------------------------------------  308 (464)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~------------------------------------------  308 (464)
                      .  ...       .+   ...++.+++..|..||+...                                          
T Consensus       103 ~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          103 L--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             T--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             C--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            4  211       12   23577888888888886430                                          


Q ss_pred             -----------CCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          309 -----------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       309 -----------~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                                 ..+.++|+|++|.|||++++..+.|.||+.+.
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       11239999999999999887667799999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2.1e-10  Score=113.15  Aligned_cols=148  Identities=14%  Similarity=0.207  Sum_probs=105.3

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEec--cCCCchHHHHHHHHHHHHhcCC--CCCceeeeeEEEeCCC-CeEEEEE
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR-GECFLIY  262 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~-~~~~lv~  262 (464)
                      .++.|+.|.++.||+....+ ..+++|...  ..........+.+|..+++.+.  +.++.++++++..... +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45678899999999988764 578888765  3321222346778999999886  4567888888733211 4578999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------------------------------
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN---------------------------------  309 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------------------------------  309 (464)
                      ||+++..+.+..      ...++..++..++.+++..|+.||+....                                 
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999987774321      12267788889999999999999973110                                 


Q ss_pred             --------------------CCCeeecCCCCCceEEcCCCC--eEEeeCCccccc
Q 012392          310 --------------------KPAIVHRNLSVEKVLIDQQFN--PLIADCGLHKLL  342 (464)
Q Consensus       310 --------------------~~~ivH~dlk~~Nill~~~~~--~kl~DfGl~~~~  342 (464)
                                          .+.++|+|+++.|||++.++.  +.|.||+.+..-
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                256999999999999997753  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=4.4e-09  Score=101.07  Aligned_cols=192  Identities=16%  Similarity=0.135  Sum_probs=120.6

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCC--ceeeeeEEEeCC-CCeEEEEEec
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HEN--IIRLRGFCCSRG-RGECFLIYDF  264 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~n--iv~l~g~~~~~~-~~~~~lv~E~  264 (464)
                      ++.++.|....||+..    ..+++|....   ......+.+|..+|+.+. +..  +.++++...... ....|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3568899999999863    4588887542   233456888999998873 332  344544431111 1134789999


Q ss_pred             CCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 012392          265 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE-------------------------------------  307 (464)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  307 (464)
                      +++.+|......      .++..++..++.+++..|+.||+..                                     
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888754321      1666777788888888888888621                                     


Q ss_pred             ----------------CCCCCeeecCCCCCceEEcC--CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccc---
Q 012392          308 ----------------VNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT---  366 (464)
Q Consensus       308 ----------------~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~---  366 (464)
                                      ...+.++|+|+++.||++++  +..+.|.||+.+..........  .......-..|+...   
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~--~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI--SLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH--TTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH--HHHhhccccCHHHHHHHH
Confidence                            11356899999999999998  5567899999886542211000  000000001222110   


Q ss_pred             --cCC---------CCCcchhHHHHHHHHHHHhCCCCCcc
Q 012392          367 --TGR---------FTERSDIFAFGVIILQILTGSLVLTS  395 (464)
Q Consensus       367 --~~~---------~~~~sDv~s~Gvll~el~tg~~p~~~  395 (464)
                        .+.         .....+.|+++.++|.+.+|..++..
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence              011         11236899999999999999876643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=1e-06  Score=84.68  Aligned_cols=139  Identities=22%  Similarity=0.161  Sum_probs=92.8

Q ss_pred             ccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCC---CceeeeeEEEeCCCCeEEEEEecC
Q 012392          189 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE---NIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~---niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++.++.|....||+.    |..+++|.-..   ......+.+|..+|..+.+.   .+.+.+.++. ...+..++||||+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEecc
Confidence            356778888899987    45678887421   23345788999999998642   3556666653 2345678999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV-------------------------------------  308 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-------------------------------------  308 (464)
                      ++..|......      .++..++..++.+++..|+.||+...                                     
T Consensus        96 ~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           96 QGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             CCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            99888763211      13444445555555555555554220                                     


Q ss_pred             ------------------CCCCeeecCCCCCceEEcC---CCC-eEEeeCCcccc
Q 012392          309 ------------------NKPAIVHRNLSVEKVLIDQ---QFN-PLIADCGLHKL  341 (464)
Q Consensus       309 ------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~DfGl~~~  341 (464)
                                        ..+.++|+|+++.|||++.   ++. +.|.||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              2345799999999999997   455 47999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.9e-06  Score=80.77  Aligned_cols=135  Identities=14%  Similarity=0.152  Sum_probs=92.0

Q ss_pred             cccCCce-EEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNFS-SVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      +..|..| .||+.... ++..+.+|.-..    ....++..|...|+.+. +-.+.++++++..  .+..++|||++++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCc
Confidence            4445544 68987754 466788897653    23456788999888774 3346678887743  56789999999998


Q ss_pred             CHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 012392          269 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE-----------------------------------------  307 (464)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------  307 (464)
                      ++.+.....        ......++.+++..|.-||+..                                         
T Consensus       106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            887754321        1112345556666666666421                                         


Q ss_pred             ------------CCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          308 ------------VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       308 ------------~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                                  ...+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        012347999999999999988777799998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.99  E-value=2.3e-05  Score=76.56  Aligned_cols=82  Identities=12%  Similarity=0.023  Sum_probs=51.5

Q ss_pred             ccc-ccCCceEEEEEEEC-------CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCC-C--CCceeeeeEEEeCC-C
Q 012392          190 NLL-GKGNFSSVYKGTLR-------DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-H--ENIIRLRGFCCSRG-R  255 (464)
Q Consensus       190 ~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~-H--~niv~l~g~~~~~~-~  255 (464)
                      +.| +.|....+|+....       ++..+++|.......  ......+.+|..+++.+. +  -.+.++++++.... .
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999988764       266788887653220  000134567777777763 2  35667777763221 1


Q ss_pred             CeEEEEEecCCCCCHH
Q 012392          256 GECFLIYDFAPKGKLS  271 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~  271 (464)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.96  E-value=2.8e-05  Score=77.27  Aligned_cols=76  Identities=9%  Similarity=-0.066  Sum_probs=47.5

Q ss_pred             ccccccCCceEEEEEEEC-CCcEEEEEEeccCCC------chHHHHHHHHHHHHhcCCC--C-CceeeeeEEEeCCCCeE
Q 012392          189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC------KSEEAEFVKGLYLLTSLRH--E-NIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~f~~e~~~l~~l~H--~-niv~l~g~~~~~~~~~~  258 (464)
                      .+.||.|.++.||+++.. ++..|+||.......      ......+..|..++..+..  + .+.+++.+.  .  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence            467899999999999764 467899997653211      0112345678888877632  3 344565442  2  235


Q ss_pred             EEEEecCCCC
Q 012392          259 FLIYDFAPKG  268 (464)
Q Consensus       259 ~lv~E~~~~g  268 (464)
                      ++||||+++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=7.7e-05  Score=72.08  Aligned_cols=30  Identities=13%  Similarity=0.284  Sum_probs=26.8

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      +.++|+|+++.|||++.++.+.|.||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            459999999999999888889999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=0.00011  Score=69.41  Aligned_cols=78  Identities=15%  Similarity=0.183  Sum_probs=55.0

Q ss_pred             CccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-C--CCceeeeeEEEeCCCCeEEEEE
Q 012392          186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-H--ENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       186 f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H--~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ...++.+|.|..+.||+.++.||+.|.||+-.... ......|..|...|+.+. .  -.+.+++++.  .    -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence            44557789999999999999999999999865443 222345778888888774 2  2345555542  2    37899


Q ss_pred             ecCCCCCH
Q 012392          263 DFAPKGKL  270 (464)
Q Consensus       263 E~~~~gsL  270 (464)
                      ||++.+..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.79  E-value=0.00017  Score=69.11  Aligned_cols=141  Identities=19%  Similarity=0.194  Sum_probs=90.2

Q ss_pred             cccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEEEEEec
Q 012392          188 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFLIYDF  264 (464)
Q Consensus       188 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~lv~E~  264 (464)
                      ..+.|+.|....+|+... ++..+++|.....    ....|..|...|+.+.   ...+.++++++.  ..+..++||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~--~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGN--SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE--CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee--cCCceEEEEEe
Confidence            346788899999999876 4667888976532    2456788888888773   356778888773  34678999999


Q ss_pred             CCCCCHH--------H---HhhhhcC-C-----------------CCCCCHHHHH---HHH----------------HHH
Q 012392          265 APKGKLS--------K---YLDQEEG-S-----------------SNVLDWSTRV---SII----------------IGI  296 (464)
Q Consensus       265 ~~~gsL~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~i  296 (464)
                      +++..+.        .   .||.... .                 ...-+|....   ++.                ..+
T Consensus       113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l  192 (312)
T 3jr1_A          113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI  192 (312)
T ss_dssp             CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred             ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence            9987642        1   2232211 0                 0012454321   111                111


Q ss_pred             HHH-HHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          297 AKG-IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       297 a~g-L~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      +.- ...|.... .+|.++|+|+.+.|++++.++ +.|.|+.
T Consensus       193 ~~~l~~~L~~~~-~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          193 VQIVADTLSKHN-PKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHTTCC-CCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHhccCC-CCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 23443222 367899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.60  E-value=0.00029  Score=70.49  Aligned_cols=78  Identities=13%  Similarity=0.101  Sum_probs=46.6

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccC---CCCCcchhHHHHHHHHHHH
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQIL  387 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDv~s~Gvll~el~  387 (464)
                      +.++|+|+++.|||++.++ ++|.||+.+..-.........-..-...|.+|+.....   ......++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4599999999999999876 99999998875432110000000001235666554311   1122345567788888877


Q ss_pred             hC
Q 012392          388 TG  389 (464)
Q Consensus       388 tg  389 (464)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.18  E-value=0.0027  Score=60.72  Aligned_cols=163  Identities=13%  Similarity=0.042  Sum_probs=84.9

Q ss_pred             cCHHHHHHhhcCCcc-----ccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC--ceee
Q 012392          174 LNLEEVESATQCFSE-----VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRL  246 (464)
Q Consensus       174 ~~~~~~~~~~~~f~~-----~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n--iv~l  246 (464)
                      ++.+++...-..|..     .+.|+.|....+|+....+| .+++|........   .++..|+.++..+....  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence            455666665555654     23456677789999987666 5778887652111   23345566655553111  2333


Q ss_pred             eeEE----EeCCCCeEEEEEecCCCCCHHH--------------Hhhhhc-CCC-------CCCCHHHHHH---------
Q 012392          247 RGFC----CSRGRGECFLIYDFAPKGKLSK--------------YLDQEE-GSS-------NVLDWSTRVS---------  291 (464)
Q Consensus       247 ~g~~----~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~-~~~-------~~l~~~~~~~---------  291 (464)
                      +...    .....+..++|++|+++..+..              .+|... ...       ....|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3210    0011245789999998754311              122211 000       0012433111         


Q ss_pred             ---HHHHHHHHHHHHhcCC--CCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          292 ---IIIGIAKGIGYLHSSE--VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       292 ---i~~~ia~gL~yLH~~~--~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                         +...+...+++++...  .....++|+|+.+.|||++++..+.|.||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               0112344555555321  123568999999999999987666899998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.14  E-value=0.0011  Score=62.85  Aligned_cols=31  Identities=23%  Similarity=0.156  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      .+.++|+|+.+.||+ .+++.+.|.||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456899999999999 5666789999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.04  E-value=0.0062  Score=58.51  Aligned_cols=33  Identities=21%  Similarity=0.168  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCceEEcCC----CCeEEeeCCccccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQ----FNPLIADCGLHKLL  342 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~----~~~kl~DfGl~~~~  342 (464)
                      .+.++|+|+.+.|||++.+    ..+.|.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3569999999999999874    67899999987654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=97.02  E-value=0.00088  Score=43.18  Aligned_cols=28  Identities=18%  Similarity=0.218  Sum_probs=12.1

Q ss_pred             eehhHHH-HHHHHHHHHHHHHHHhhhccc
Q 012392           85 VLAAVTS-VTVILAGTGILIFFRYRRHKQ  112 (464)
Q Consensus        85 ii~~~~~-~~~~~~~~~~~~~~~~rr~~~  112 (464)
                      +++++++ ++++++++++++|+++||+++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            3444443 444444444444444444443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.99  E-value=0.011  Score=56.63  Aligned_cols=163  Identities=10%  Similarity=0.092  Sum_probs=85.3

Q ss_pred             cCHHHHHHhhcCCc-----cccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC--CCceee
Q 012392          174 LNLEEVESATQCFS-----EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRL  246 (464)
Q Consensus       174 ~~~~~~~~~~~~f~-----~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l  246 (464)
                      ++.+++...-..|.     ....++ |....||+....+|+.+++|.......  ....+..|..++..+..  -.++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecce
Confidence            44455544444342     223466 777899998777777899998864321  12345567776666531  123444


Q ss_pred             eeE---EEeCCCCeEEEEEecCCCCCHH-----H------H---hhhhcC-----CCCCCCHHHH----HHHH-------
Q 012392          247 RGF---CCSRGRGECFLIYDFAPKGKLS-----K------Y---LDQEEG-----SSNVLDWSTR----VSII-------  293 (464)
Q Consensus       247 ~g~---~~~~~~~~~~lv~E~~~~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----~~i~-------  293 (464)
                      +..   ......+..++|+||+++..+.     .      .   +|....     ....+++...    ..++       
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            332   0001134568899999874431     1      1   121110     0112233211    0010       


Q ss_pred             --------HHHHHHHHHHhcCC--CCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          294 --------IGIAKGIGYLHSSE--VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       294 --------~~ia~gL~yLH~~~--~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                              ..+...++.+...-  ...+.++|+|+++.|||++ + .+.|.||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    01111222222110  1235589999999999999 4 899999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.88  E-value=0.0029  Score=63.39  Aligned_cols=72  Identities=17%  Similarity=0.249  Sum_probs=47.3

Q ss_pred             ccccccCCceEEEEEEECC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCc-eeeeeEEEeCCCCeEE
Q 012392          189 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECF  259 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~  259 (464)
                      .+.|+.|-...+|+....+        +..+++|+.....   ....+..|..++..+...++ .++++.+  .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIF--SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----C
Confidence            3567778889999998753        4788999874311   11345678888887743333 5677765  32    3


Q ss_pred             EEEecCCCCC
Q 012392          260 LIYDFAPKGK  269 (464)
Q Consensus       260 lv~E~~~~gs  269 (464)
                      +|+||+++.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998633

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.72  E-value=0.0014  Score=42.13  Aligned_cols=28  Identities=11%  Similarity=0.172  Sum_probs=12.1

Q ss_pred             eehhHHH-HHHHHHHHHHHHHHHhhhccc
Q 012392           85 VLAAVTS-VTVILAGTGILIFFRYRRHKQ  112 (464)
Q Consensus        85 ii~~~~~-~~~~~~~~~~~~~~~~rr~~~  112 (464)
                      +++++++ ++++++++++++++++||+++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3344443 444444444444444444443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.71  E-value=0.01  Score=52.92  Aligned_cols=105  Identities=13%  Similarity=0.038  Sum_probs=67.3

Q ss_pred             CCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCCc
Q 012392          267 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  346 (464)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~  346 (464)
                      .-||.+.|...+   .++++.+++.++.|.++.|.-+-.....    ..+=+.|..|++..+|.+...+ ..+..     
T Consensus        32 ~vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~----~~~i~~~~~i~l~~dG~V~f~~-~~s~~-----   98 (229)
T 2yle_A           32 ALSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQP----RHRVRSAAQIRVWRDGAVTLAP-AADDA-----   98 (229)
T ss_dssp             EEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCC----CCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred             cccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccC----CceecCCcceEEecCCceeccc-ccccc-----
Confidence            448999998765   4599999999999999998766211100    1222456899999999988774 22110     


Q ss_pred             eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 012392          347 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL  393 (464)
Q Consensus       347 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~  393 (464)
                              ....+.|||... ...+.+.=|||+|+++|..+--+.+-
T Consensus        99 --------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           99 --------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             --------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                    011267888753 34467888999999999988755443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.52  E-value=0.015  Score=57.06  Aligned_cols=143  Identities=13%  Similarity=0.136  Sum_probs=80.8

Q ss_pred             cccccCCceEEEEEEEC--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEE
Q 012392          190 NLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +.|..|-...+|+....        ++..+.+|+....  ......+.+|..+++.+. +.-..++++++  .+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----cc
Confidence            45666777889998874        2478899875322  122345668888887774 33235677765  32    28


Q ss_pred             EEecCCCCCHHH--------------H---hhhhcC-CCCCCC--HHHHHHHHHHHH-------------------HHHH
Q 012392          261 IYDFAPKGKLSK--------------Y---LDQEEG-SSNVLD--WSTRVSIIIGIA-------------------KGIG  301 (464)
Q Consensus       261 v~E~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~gL~  301 (464)
                      |+||+++..|..              .   ||.... ......  |.++.++..++.                   ..+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998755431              1   121110 011122  344444443331                   1222


Q ss_pred             ----HHhcCCCCCCCeeecCCCCCceEEcCC----CCeEEeeCCcccc
Q 012392          302 ----YLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIADCGLHKL  341 (464)
Q Consensus       302 ----yLH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfGl~~~  341 (464)
                          +|.... ....++|+|+.+.|||++.+    +.+.|.||..+..
T Consensus       208 ~L~~~L~~~~-~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTP-SPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSC-CCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcC-CCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                333322 34569999999999999876    7899999987753

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=96.17  E-value=0.0048  Score=39.55  Aligned_cols=30  Identities=13%  Similarity=0.293  Sum_probs=13.3

Q ss_pred             eeeehhHHHHHHHHHHHHHHHHHHhhhccc
Q 012392           83 IAVLAAVTSVTVILAGTGILIFFRYRRHKQ  112 (464)
Q Consensus        83 ~~ii~~~~~~~~~~~~~~~~~~~~~rr~~~  112 (464)
                      ..++++++++++++++.++++++++||+.+
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            334555555443333333434444444443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.17  E-value=0.0048  Score=60.27  Aligned_cols=72  Identities=13%  Similarity=0.086  Sum_probs=40.9

Q ss_pred             cccccCCceEEEEEEECC---------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCC-ceeeeeEEEeCCCCeEE
Q 012392          190 NLLGKGNFSSVYKGTLRD---------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGRGECF  259 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~~~  259 (464)
                      +.|+.|....+|+....+         +..+++|...... . ...+...|..++..+...+ ..++++..  .  +  +
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-D-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--G  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-G-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-c-ceecHHHHHHHHHHHHhcCCCCceEEec--C--C--c
Confidence            456778788999988754         2678888765422 1 1112345666776664223 44666543  2  2  6


Q ss_pred             EEEecCCCCC
Q 012392          260 LIYDFAPKGK  269 (464)
Q Consensus       260 lv~E~~~~gs  269 (464)
                      +||||+++..
T Consensus       111 ~v~e~i~G~~  120 (369)
T 3c5i_A          111 RIEEWLYGDP  120 (369)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEecCCc
Confidence            8999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.06  E-value=0.026  Score=54.37  Aligned_cols=32  Identities=22%  Similarity=0.281  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          310 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       310 ~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45699999999999999888899999987664

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.88  E-value=0.058  Score=54.25  Aligned_cols=73  Identities=15%  Similarity=0.049  Sum_probs=44.9

Q ss_pred             cccccCCceEEEEEEECC-CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCc-eeeeeEEEeCCCCeEEEEEecCCC
Q 012392          190 NLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECFLIYDFAPK  267 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~lv~E~~~~  267 (464)
                      +.|+.|-...+|+....+ +..+++|...... .. ..+...|..++..+...++ .++++.+  . .   .+|+||+++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~-~---G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFF--T-N---GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--T-T---EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--C-C---eEEEEeeCC
Confidence            567777788999998865 4778888764322 11 1112467778887764444 5677765  2 2   259999987


Q ss_pred             CCH
Q 012392          268 GKL  270 (464)
Q Consensus       268 gsL  270 (464)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.79  E-value=0.19  Score=49.83  Aligned_cols=74  Identities=11%  Similarity=-0.020  Sum_probs=44.7

Q ss_pred             ccccccCCceEEEEEEECC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEE
Q 012392          189 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++.+..|-...+|+....+        +..+++|...... . ...+..+|..+++.+. +.-..++++.+  .  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYDSKVELDVFRYLSNINIAPNIIADF--P--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--C
Confidence            3456667778899988763        5788998864322 1 1112235666666663 22245666543  2  2  6


Q ss_pred             EEEecCCCCCH
Q 012392          260 LIYDFAPKGKL  270 (464)
Q Consensus       260 lv~E~~~~gsL  270 (464)
                      +|+||+++..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.92  E-value=0.077  Score=33.00  Aligned_cols=27  Identities=22%  Similarity=0.169  Sum_probs=12.4

Q ss_pred             eeeehhHHHHHHHHHHHHHHHHHHhhh
Q 012392           83 IAVLAAVTSVTVILAGTGILIFFRYRR  109 (464)
Q Consensus        83 ~~ii~~~~~~~~~~~~~~~~~~~~~rr  109 (464)
                      -++++++++.++.+++++.+.|+++||
T Consensus        11 GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           11 GEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CceeeeehHHHHHHHHHHHHHHHHeec
Confidence            344445555544444444444444444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.38  E-value=0.43  Score=46.93  Aligned_cols=30  Identities=10%  Similarity=0.265  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEE------cCCCCeEEeeCCcccc
Q 012392          312 AIVHRNLSVEKVLI------DQQFNPLIADCGLHKL  341 (464)
Q Consensus       312 ~ivH~dlk~~Nill------~~~~~~kl~DfGl~~~  341 (464)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999988764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.64  E-value=0.029  Score=56.64  Aligned_cols=61  Identities=10%  Similarity=0.117  Sum_probs=17.9

Q ss_pred             ccccccCCceEEEEEEECC-CcEEEE------EEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEe
Q 012392          189 VNLLGKGNFSSVYKGTLRD-GTLVAI------RSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  252 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~~-~~~vav------K~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  252 (464)
                      .+.||   ||.||+|.+.. ...|||      |..+.... ......|.+|..++..++|||+++.++|...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45665   99999999864 467898      77664332 2233568899999999999999999987643

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=84.65  E-value=0.21  Score=30.19  Aligned_cols=25  Identities=24%  Similarity=0.287  Sum_probs=10.4

Q ss_pred             eehhHHHHHHHHHHHHHHHHHHhhh
Q 012392           85 VLAAVTSVTVILAGTGILIFFRYRR  109 (464)
Q Consensus        85 ii~~~~~~~~~~~~~~~~~~~~~rr  109 (464)
                      ++++++++++++++.+.+.++++||
T Consensus        10 IaagVvglll~vii~l~~~~~iRRr   34 (35)
T 1iij_A           10 IIATVVGVLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred             eHHHHHHHHHHHHHHHHhheEEeec
Confidence            4444444333333333333444444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	464
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-54
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-37
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-13

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 62/266 (23%), Positives = 120/266 (45%), Gaps = 16/266 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
              V  LG G F  V+ G     T VA++S+   S   +   F+    L+  L+H+ ++R
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVR 72

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L            ++I ++   G L  +L    G    L  +  + +   IA+G+ ++  
Sbjct: 73  LYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                   +HR+L    +L+    +  IAD GL +L+ D+   +       + + APE +
Sbjct: 128 -----RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
             G FT +SD+++FG+++ +I+T   +    M         +N ++R  +    ++   +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMVRPDNCPEE 238

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           L ++  +C  E PE+RPT + +   L
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-53
 Identities = 51/271 (18%), Positives = 112/271 (41%), Gaps = 18/271 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENII 244
            +    +G G+F +VYKG       VA++ +NVT+   ++   F   + +L   RH NI+
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
              G+  +    +  ++  +     L  +L   E      +    + I    A+G+ YLH
Sbjct: 68  LFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPE 363
                  +I+HR+L    + + +     I D GL  + +        +  + ++ ++APE
Sbjct: 122 -----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 364 YVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
            +       ++ +SD++AFG+++ +++TG L  ++                     K   
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           +    + ++   C  +  + RP    ++  +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 56/266 (21%), Positives = 121/266 (45%), Gaps = 16/266 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            + V  +G G F  V+ G   +   VAI++I        E +F++   ++  L H  +++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G C  +      L+++F   G LS YL  +     +    T + + + + +G+ YL  
Sbjct: 65  LYGVCLEQA--PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE- 118

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
               +  ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  
Sbjct: 119 ----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
           +  R++ +SD+++FGV++ ++ +   +   +      S   E+ I    +       +  
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED-ISTGFRLYKPRLASTH 230

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           + ++   C  E PE+RP    ++ +L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 8e-52
 Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 16/278 (5%)

Query: 174 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLY 233
           L  +  E   +       LG+G F  V+ GT    T VAI+++   +   E   F++   
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQ 64

Query: 234 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 293
           ++  LRHE +++L            +++ ++  KG L  +L  E G          V + 
Sbjct: 65  VMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMA 119

Query: 294 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 353
             IA G+ Y+      +   VHR+L    +L+ +     +AD GL +L+ D+   +    
Sbjct: 120 AQIASGMAYVE-----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 354 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 413
              + + APE    GRFT +SD+++FG+++ ++ T   V    M     +    + ++R 
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERG 230

Query: 414 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            +          L  +   C  ++PE RPT E +   L
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 60/266 (22%), Positives = 116/266 (43%), Gaps = 16/266 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
            + +  LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G C  +     F+I ++   G L  YL +             + +   + + + YL  
Sbjct: 64  LYGVCTKQR--PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE- 117

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                   +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +
Sbjct: 118 ----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
              +F+ +SDI+AFGV++ +I +   +          ++     I + L+       + K
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQGLRLYRPHLASEK 229

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           +  +   C HE  + RPT + ++  +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  172 bits (438), Expect = 4e-51
 Identities = 58/280 (20%), Positives = 125/280 (44%), Gaps = 16/280 (5%)

Query: 173 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG 231
             N ++ E      +  + LG G +  VY+G  +     VA++++   + + EE  F+K 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63

Query: 232 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 291
             ++  ++H N+++L G C        ++I +F   G L  YL   E +   +     + 
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLY 119

Query: 292 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 351
           +   I+  + YL          +HR+L+    L+ +     +AD GL +L+  D   +  
Sbjct: 120 MATQISSAMEYLEK-----KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

Query: 352 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 411
                + + APE +   +F+ +SD++AFGV++ +I T  +     + L    +     ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE 230

Query: 412 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           ++ + +  E    K+ ++   C   +P +RP+   + +  
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 21/279 (7%)

Query: 180 ESATQCFSEVNLLGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYL 234
           E    C +   ++G G F  VYKG L+  +      VAI+++     + +  +F+    +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 235 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 294
           +    H NIIRL G           +I ++   G L K+L +++G          V ++ 
Sbjct: 63  MGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLR 117

Query: 295 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 354
           GIA G+ YL +        VHR+L+   +L++      ++D GL ++L DD   +   + 
Sbjct: 118 GIAAGMKYLAN-----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 355 AA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
               + + APE ++  +FT  SD+++FG+++ +++T              +      I+ 
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG----ERPYWELSNHEVMKAIND 228

Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
             +        + + ++ + C  ++   RP    ++  L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 6e-50
 Identities = 50/273 (18%), Positives = 115/273 (42%), Gaps = 22/273 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 243
           +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L+H NI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +R       R     +++ ++   G L+  + +       LD    + ++  +   +   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLA 361
           H        ++HR+L    V +D + N  + D GL ++L  D  F  + + T     Y++
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT---PYYMS 182

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE- 420
           PE +    + E+SDI++ G ++ ++                + + +    +  +GKF   
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIREGKFRRI 234

Query: 421 ----SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
               S+     ++     +    +RP++E ++E
Sbjct: 235 PYRYSDELN--EIITRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-50
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 20/265 (7%)

Query: 192 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 248
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 308
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL     
Sbjct: 77  VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE---- 126

Query: 309 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYVT 366
            +   VHR+L+   VL+  +    I+D GL K L  D  +   +++    + + APE + 
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 426
             +F+ RSD++++GV + + L+        M    +      FI++  + +       +L
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKRMECPPECPPEL 241

Query: 427 GKMALVCTHEDPENRPTMEAVIEEL 451
             +   C     E+RP    V + +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRM 266

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 61/293 (20%), Positives = 121/293 (41%), Gaps = 31/293 (10%)

Query: 176 LEEVESATQCFSE---------VNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCK 222
            E+   A + F++           ++G G F  V  G L+        VAI+++     +
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 223 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 282
            +  +F+    ++    H N+I L G           +I +F   G L  +L Q +G   
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 342
                  V ++ GIA G+ YL          VHR+L+   +L++      ++D GL + L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA-----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 343 ADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
            DD       ++        + APE +   +FT  SD++++G+++ ++++        M 
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM- 237

Query: 399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
               +    N I+++ +        + L ++ L C  +D  +RP    ++  L
Sbjct: 238 ---TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-48
 Identities = 66/302 (21%), Positives = 136/302 (45%), Gaps = 22/302 (7%)

Query: 158 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAI 213
           +++ +  + E + + +  +    S    F+EV  +G+G+F  VY GTL D        A+
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 214 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 273
           +S+N  +   E ++F+    ++    H N++ L G  C R  G   ++  +   G L  +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 274 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 333
           +  E  +         +   + +AKG+ +L          VHR+L+    ++D++F   +
Sbjct: 120 IRNETHN---PTVKDLIGFGLQVAKGMKFLA-----SKKFVHRDLAARNCMLDEKFTVKV 171

Query: 334 ADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGS 390
           AD GL + + D    SV   + A     ++A E + T +FT +SD+++FGV++ +++T  
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231

Query: 391 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 450
                 +           ++ +  +    E     L ++ L C H   E RP+   ++  
Sbjct: 232 APPYPDVNTFD----ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 451 LT 452
           ++
Sbjct: 288 IS 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-47
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 33/290 (11%)

Query: 168 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSE 224
           +L+   L LE+             LG GNF +V KG  +       VA++ +   +    
Sbjct: 2   YLDRKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 50

Query: 225 -EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV 283
            + E +    ++  L +  I+R+ G C         L+ + A  G L+KYL Q       
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRH---- 103

Query: 284 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 343
           +     + ++  ++ G+ YL  S       VHR+L+   VL+  Q    I+D GL K L 
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158

Query: 344 DDIVFSVLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 401
            D  +   +T     + + APE +   +F+ +SD+++FGV++ +  +        M    
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---- 214

Query: 402 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           + +     +++  +         ++  +  +C   D ENRP   AV   L
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-47
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 20/266 (7%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 245
              +  +GKG F  V  G  R G  VA++ I      +    F+    ++T LRH N+++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 246 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 305
           L G      +G  +++ ++  KG L  YL     S  VL     +   + + + + YL  
Sbjct: 65  LLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121

Query: 306 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                   VHR+L+   VL+ +     ++D GL K  +             + + APE +
Sbjct: 122 -----NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEAL 172

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
              +F+ +SD+++FG+++ +I +   V    + L          +++  K    +     
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA 228

Query: 426 LGKMALVCTHEDPENRPTMEAVIEEL 451
           + ++   C H D   RP+   + E+L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-47
 Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 37/293 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 238
                +LG G F  V   T            VA++ +   +  SE    +  L ++T L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEG 279
            HENI+ L G C   G    +LI+++   G L  YL                    +EE 
Sbjct: 99  SHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 280 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 339
             NVL +   +     +AKG+ +L        + VHR+L+   VL+       I D GL 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-----KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 340 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 398
           + +  D  + V   +   + ++APE +  G +T +SD++++G+++ +I +  +     + 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                A F   I    K         ++  +   C   D   RP+   +   L
Sbjct: 272 ---VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-46
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 38/291 (13%)

Query: 192 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 251
           +GKG F  V++G  R G  VA++  +    +S   E    +Y    LRHENI+       
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67

Query: 252 SRGRG--ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 309
                  + +L+ D+   G L  YL++       +     + + +  A G+ +LH   V 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 310 ---KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 363
              KPAI HR+L  + +L+ +     IAD GL            +  +  +G   Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 364 YVTT------GRFTERSDIFAFGVIILQILTGS---------------LVLTSSMRLAAE 402
            +            +R+DI+A G++  +I                   LV +        
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 403 SATFENFIDRNLKGKFSESEAAK-LGKMALVCTHEDPENRPTMEAVIEELT 452
               E  +  N+  ++   EA + + K+   C + +   R T   + + L+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (407), Expect = 1e-46
 Identities = 61/303 (20%), Positives = 120/303 (39%), Gaps = 38/303 (12%)

Query: 176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFV 229
           L  +E        V  +G+G F  V++            T+VA++ +   +    +A+F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 230 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN------- 282
           +   L+    + NI++L G C         L++++   G L+++L      +        
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 283 -------------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 329
                         L  + ++ I   +A G+ YL          VHR+L+    L+ +  
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-----RKFVHRDLATRNCLVGENM 177

Query: 330 NPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 388
              IAD GL + +     +      A  + ++ PE +   R+T  SD++A+GV++ +I +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 389 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 448
             L     M   A         D N+     E+   +L  +  +C  + P +RP+  ++ 
Sbjct: 238 YGLQPYYGM---AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 449 EEL 451
             L
Sbjct: 294 RIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-46
 Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 32/288 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 238
            S    LG G F  V + T            VA++ +  ++  +E    +  L +L+ L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 239 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--------------EGSSNVL 284
            H NI+ L G C   G     +I ++   G L  +L ++              E     L
Sbjct: 85  NHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
           D    +S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-----KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 345 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
           D  + V   +   + ++APE +    +T  SD++++G+ + ++ +        M      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---VD 254

Query: 404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           + F   I    +    E   A++  +   C   DP  RPT + +++ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-45
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 14/207 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           F +++ LG GN   V+K + +  G ++A + I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
              G   S G  E  +  +    G L + L +       +       + I + KG+ YL 
Sbjct: 68  GFYGAFYSDG--EISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLR 121

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                K  I+HR++    +L++ +    + D G+   L D +  S + T     Y++PE 
Sbjct: 122 E----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT---RSYMSPER 174

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSL 391
           +    ++ +SDI++ G+ ++++  G  
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-45
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 22/275 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 239
              +  LG G+F  V +G           VA++ +        EA  +F++ +  + SL 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H N+IRL G   +       ++ + AP G L   L + +G        T     + +A+G
Sbjct: 70  HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 123

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--M 357
           +GYL S        +HR+L+   +L+  +    I D GL + L  +    V++       
Sbjct: 124 MGYLES-----KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 358 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 417
            + APE + T  F+  SD + FGV + ++ T        +     S           +  
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLP 235

Query: 418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 452
             E     +  + + C    PE+RPT  A+ + L 
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 6e-45
 Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 19/263 (7%)

Query: 192 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +G+G+F +VYKG   +    VA   +      KSE   F +   +L  L+H NI+R    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 250 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                +G+    L+ +    G L  YL +      V+      S    I KG+ +LH+  
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT-- 130

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 366
              P I+HR+L  + + I      + I D GL  L       +V+ T     ++APE   
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT---PEFMAPEMYE 186

Query: 367 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 426
             ++ E  D++AFG+ +L++ T     +        +  +           F +    ++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 427 GKMALVCTHEDPENRPTMEAVIE 449
            ++   C  ++ + R +++ ++ 
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 6e-45
 Identities = 60/282 (21%), Positives = 122/282 (43%), Gaps = 29/282 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 241
               +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE------------EGSSNVLDWSTR 289
           NII L G C    RG  +L  ++AP G L  +L +               +++ L     
Sbjct: 72  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 290 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 349
           +     +A+G+ YL          +HR+L+   +L+ + +   IAD GL +     +  +
Sbjct: 130 LHFAADVARGMDYLSQ-----KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 350 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
           + +    + ++A E +    +T  SD++++GV++ +I++        M  A     +E  
Sbjct: 185 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK- 238

Query: 410 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
           + +  + +   +   ++  +   C  E P  RP+   ++  L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-44
 Identities = 59/272 (21%), Positives = 114/272 (41%), Gaps = 21/272 (7%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 240
           F ++ +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
            ++ RL G C +       LI    P G L   LD      + +     ++  + IAKG+
Sbjct: 71  PHVCRLLGICLT---STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGY 359
            YL         +VHR+L+   VL+    +  I D GL KLL  +      +     + +
Sbjct: 125 NYLE-----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
           +A E +    +T +SD++++GV + +++T        +  +       + +++  +    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQP 235

Query: 420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                 +  + + C   D ++RP    +I E 
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 55/273 (20%), Positives = 117/273 (42%), Gaps = 26/273 (9%)

Query: 183 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 239
            + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           H N I+ RG          +L+ ++            ++     L      ++  G  +G
Sbjct: 74  HPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQG 127

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + YLHS       ++HR++    +L+ +     + D G   ++A    F          +
Sbjct: 128 LAYLHSH-----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYW 177

Query: 360 LAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
           +APE +     G++  + D+++ G+  +++      L +   ++A     +N       G
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            +SE            C  + P++RPT E +++
Sbjct: 238 HWSE-YFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 31/271 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN 242
           F     LGKG F +VY    +    ++A++ +     +    E    + + + + LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           I+RL G+     R   +LI ++AP G + + L +     +  D     + I  +A  + Y
Sbjct: 68  ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSY 121

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
            HS       ++HR++  E +L+       IAD G           ++  T   + YL P
Sbjct: 122 CHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT---LDYLPP 173

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-- 420
           E +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+   
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPD 225

Query: 421 --SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             +E A+   +       +P  RP +  V+E
Sbjct: 226 FVTEGAR--DLISRLLKHNPSQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-42
 Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 19/268 (7%)

Query: 189 VNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
              +G+G F  V++G           VAI++    +  S   +F++    +    H +I+
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL 
Sbjct: 72  KLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE 125

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
           S        VHR+++   VL+       + D GL + + D   +   K    + ++APE 
Sbjct: 126 S-----KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +   RFT  SD++ FGV + +IL   +     ++           I+   +     +   
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNCPP 236

Query: 425 KLGKMALVCTHEDPENRPTMEAVIEELT 452
            L  +   C   DP  RP    +  +L+
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 9e-42
 Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 17/267 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  V  LG+G +  V     R     VA++ +++           K + +   L HEN++
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +  G    R     +L  ++   G+L   ++ + G    +           +  G+ YLH
Sbjct: 67  KFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 363
                   I HR++  E +L+D++ N  I+D GL  +   +    +L      + Y+APE
Sbjct: 121 G-----IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 364 YVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
            +    F  E  D+++ G+++  +L G L          E + ++         K  +S 
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235

Query: 423 AAKLGKMALVCTHEDPENRPTMEAVIE 449
              L         E+P  R T+  + +
Sbjct: 236 PLALLHK---ILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-41
 Identities = 58/285 (20%), Positives = 116/285 (40%), Gaps = 27/285 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 239
                 LG+G F  V +              VA++ +   +  SE    +  L +L  + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWS 287
           H   +      C++  G   +I +F   G LS YL              E+   + L   
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 288 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 347
             +     +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  
Sbjct: 135 HLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 348 FSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 406
           +     +   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 246

Query: 407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
              +    + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 8e-41
 Identities = 60/291 (20%), Positives = 123/291 (42%), Gaps = 30/291 (10%)

Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVK 230
           +E E A +  +    LG+G+F  VY+G  +        T VAI+++N  +   E  EF+ 
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 231 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVL 284
              ++      +++RL G           +I +   +G L  YL                
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
             S  + +   IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

Query: 345 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
              +         + +++PE +  G FT  SD+++FGV++ +I T             + 
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-------AEQPYQG 238

Query: 404 ATFENFIDRNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            + E  +   ++G      ++    L ++  +C   +P+ RP+   +I  +
Sbjct: 239 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 47/270 (17%), Positives = 102/270 (37%), Gaps = 27/270 (10%)

Query: 189 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           +  LG G F  VYK   ++   L A + I+  S + E  +++  + +L S  H NI++L 
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLL 75

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                      +++ +F   G +   + + E     L  S    +       + YLH + 
Sbjct: 76  DAFYYENN--LWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDN- 129

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 364
                I+HR+L    +L     +  +AD G+       I     +  + +G   ++APE 
Sbjct: 130 ----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RRDSFIGTPYWMAPEV 181

Query: 365 V-----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
           V         +  ++D+++ G+ ++++            +       ++      +    
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241

Query: 420 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            S      K    C  ++ + R T   +++
Sbjct: 242 SSNFKDFLKK---CLEKNVDARWTTSQLLQ 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 5e-39
 Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 33/288 (11%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 237
                 LG+G F  V                T VA++ +   + + + ++ +  + ++  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 238 L-RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVL 284
           + +H+NII L G C   G    ++I ++A KG L +YL            +        L
Sbjct: 75  IGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 285 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 344
                VS    +A+G+ YL S        +HR+L+   VL+ +     IAD GL + +  
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS-----KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 345 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 403
              +         + ++APE +    +T +SD+++FGV++ +I T        + +    
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245

Query: 404 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
                 +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 3e-38
 Identities = 41/265 (15%), Positives = 103/265 (38%), Gaps = 18/265 (6%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIV 80

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
                       E +++ ++   G L+  + +       +D     ++     + + +LH
Sbjct: 81  NYLDSYLVGD--ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH 133

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
           S+      ++HR++  + +L+    +  + D G    +  +             ++APE 
Sbjct: 134 SN-----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEV 187

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           VT   +  + DI++ G++ ++++ G     +   L A      N        +   +   
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 425 KLGKMALVCTHEDPENRPTMEAVIE 449
                   C   D E R + + +++
Sbjct: 248 DFLNR---CLDMDVEKRGSAKELLQ 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  139 bits (350), Expect = 8e-38
 Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
              LG G F  V++ T    G   A + +       +E    K +  ++ LRH  ++ L 
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLH 89

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                    E  +IY+F   G+L + +  E      +     V  +  + KG+ ++H + 
Sbjct: 90  DAFEDDN--EMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENN 144

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                 VH +L  E ++   + +  +   D GL   L      SV  T+    + APE  
Sbjct: 145 -----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVA 197

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
                   +D+++ GV+   +L+G            +  T  N   ++      +S  + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNV--KSCDWNMDDSAFSG 251

Query: 426 LGKMA--LV--CTHEDPENRPTMEAVIE 449
           + +     +      DP  R T+   +E
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 21/264 (7%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           F    +LG+G+FS+V     L      AI+ +       E       +   +++ L H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
            ++L      +   + +    +A  G+L KY+ +        D +        I   + Y
Sbjct: 70  FVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEY 123

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYLA 361
           LH        I+HR+L  E +L+++  +  I D G  K+L+ +   +   +      Y++
Sbjct: 124 LHG-----KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 362 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 421
           PE +T     + SD++A G II Q++ G     +      E   F+  I   L+  F E 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKII--KLEYDFPEK 232

Query: 422 EAAKLGKMALVCTHEDPENRPTME 445
              K   +       D   R   E
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCE 256

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (343), Expect = 9e-37
 Identities = 50/269 (18%), Positives = 100/269 (37%), Gaps = 22/269 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +  +  LG G F  V++      G +   + IN      ++      + ++  L H  +I
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLI 89

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L      +      LI +F   G+L   +  E+     +  +  ++ +    +G+ ++H
Sbjct: 90  NLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
                  +IVH ++  E ++ + +    +   D GL   L  D +  V   +A   + AP
Sbjct: 145 EH-----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAP 197

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E V        +D++A GV+   +L+G         L           + +     S S 
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 423 AAKLGKMALV--CTHEDPENRPTMEAVIE 449
            AK      +     ++P  R T+   +E
Sbjct: 258 EAK----DFIKNLLQKEPRKRLTVHDALE 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 48/276 (17%), Positives = 100/276 (36%), Gaps = 23/276 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           +    +LG G  S V+    LR    VA++ +     +       F +      +L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 243 IIRLRGFCCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
           I+ +     +        +++ ++     L   +  E      +     + +I    + +
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQAL 124

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MG 358
            + H +      I+HR++    ++I       + D G+ + +AD         +      
Sbjct: 125 NFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDRNLKG 416
           YL+PE         RSD+++ G ++ ++LTG    T  S + +A +    +         
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 417 KFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL 451
             S      L  + L    ++PENR  T   +  +L
Sbjct: 240 GLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (334), Expect = 7e-36
 Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 19/277 (6%)

Query: 177 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 235
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
             ++H NI+ L     S G    +LI      G+L   + ++              +I  
Sbjct: 62  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 115

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLK 352
           +   + YLH        IVHR+L  E +L    D+    +I+D GL K+     V S   
Sbjct: 116 VLDAVKYLH-----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170

Query: 353 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 412
            +   GY+APE +    +++  D ++ GVI   +L G                 +   + 
Sbjct: 171 GTP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228

Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           +       S++AK          +DPE R T E  ++
Sbjct: 229 DSPYWDDISDSAK--DFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 49/268 (18%), Positives = 103/268 (38%), Gaps = 27/268 (10%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
              LG+G F  V++            + + V    +++    K + +L   RH NI+ L 
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLH 67

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
               S    E  +I++F     + + ++        L+    VS +  + + + +LHS  
Sbjct: 68  ESFESME--ELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSHN 122

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 365
                I H ++  E ++   + +    I + G  + L     F +L T+    Y APE  
Sbjct: 123 -----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--PEYYAPEVH 175

Query: 366 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 425
                +  +D+++ G ++  +L+G     +           EN +  N +  F E    +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIM--NAEYTFDEEAFKE 229

Query: 426 LGKMA--LV--CTHEDPENRPTMEAVIE 449
           +   A   V     ++ ++R T    ++
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 4e-33
 Identities = 49/269 (18%), Positives = 96/269 (35%), Gaps = 26/269 (9%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 249
           +LG G    V +    R     A++ +        E E         + +  +I+R+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73

Query: 250 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
                 GR    ++ +    G+L   +  ++             I+  I + I YLHS  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                I HR++  E +L   +       + D G  K        +    +    Y+APE 
Sbjct: 132 -----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--PYYVAPEV 184

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           +   ++ +  D+++ GVI+  +L G     S+  LA           R  + +F   E +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFPNPEWS 242

Query: 425 KLGKMA--LV--CTHEDPENRPTMEAVIE 449
           ++ +    L+      +P  R T+   + 
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  124 bits (313), Expect = 2e-32
 Identities = 50/274 (18%), Positives = 103/274 (37%), Gaps = 25/274 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLR 239
           FS   ++G+G F  VY     D G + A++ ++    K ++ E         L L+++  
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 240 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
              I+ +     +  +     I D    G L  +L Q          +        I  G
Sbjct: 66  CPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           + ++H+       +V+R+L    +L+D+  +  I+D GL    +     + + T    GY
Sbjct: 120 LEHMHN-----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT---HGY 171

Query: 360 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 418
           +APE +  G  +   +D F+ G ++ ++L G        +   +       +   ++   
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD 230

Query: 419 SESEAAKLGKMALVCTHEDPENRPT-MEAVIEEL 451
           S S   +   +       D   R   +    +E+
Sbjct: 231 SFSPELR--SLLEGLLQRDVNRRLGCLGRGAQEV 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (306), Expect = 2e-32
 Identities = 65/284 (22%), Positives = 107/284 (37%), Gaps = 39/284 (13%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLT 236
           +    +LG+G  S V +          A++ I+VT   S  AE V+ L         +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 237 SLR-HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
            +  H NII+L+    +      FL++D   KG+L  YL ++      L       I+  
Sbjct: 65  KVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + + I  LH        IVHR+L  E +L+D   N  + D G    L        +  + 
Sbjct: 119 LLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT- 172

Query: 356 AMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 409
              YLAPE +          + +  D+++ GVI+  +L GS           +       
Sbjct: 173 -PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMI 227

Query: 410 IDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
           +  N +    E    S+  K   +        P+ R T E  + 
Sbjct: 228 MSGNYQFGSPEWDDYSDTVK--DLVSRFLVVQPQKRYTAEEALA 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-31
 Identities = 54/294 (18%), Positives = 104/294 (35%), Gaps = 43/294 (14%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           +++  ++G G+F  VY+  L D G LVAI+ +       ++    + L ++  L H NI+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76

Query: 245 RLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
           RLR F  S G  +      L+ D+ P+    +       +   L        +  + + +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGY 359
            Y+HS       I HR++  + +L+D     L + D G  K L             +  Y
Sbjct: 136 AYIHS-----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYY 188

Query: 360 LAP-EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS------MRLAAESATFENFIDR 412
            AP        +T   D+++ G ++ ++L G  +          + +     T      R
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 413 NLKGKFSESEAAKLGKMALV-----------------CTHEDPENRPTMEAVIE 449
            +   ++E +  ++                            P  R T      
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (295), Expect = 1e-30
 Identities = 44/279 (15%), Positives = 87/279 (31%), Gaps = 33/279 (11%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
              +G G+F  +Y GT +  G  VAI+   V   K++  +      +   ++    I   
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            +C + G     ++ +           D     S      T + +   +   I Y+HS  
Sbjct: 69  RWCGAEG-DYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK- 122

Query: 308 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVL---KTSAAMG--- 358
                 +HR++  +  L+    +     I D GL K   D      +   +     G   
Sbjct: 123 ----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 359 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL------TSSMRLAAESATFENFIDR 412
           Y +         + R D+ + G +++    GSL        T   +    S    +    
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 451
            L   +              C     +++P    + +  
Sbjct: 239 VLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 51/269 (18%), Positives = 92/269 (34%), Gaps = 35/269 (13%)

Query: 191 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-----AEFVKGLYLLTSLR--HEN 242
           LLG G F SVY G  + D   VAI+ +                    + LL  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +IRL  +          LI +     +       E G+   L      S    + + + +
Sbjct: 71  VIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLA 361
            H+       ++HR++  E +LID     L + D G   LL D +      T     Y  
Sbjct: 126 CHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT---RVYSP 177

Query: 362 PEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 420
           PE++   R+    + +++ G+++  ++ G +       +      F   +    +     
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ----- 232

Query: 421 SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                   +   C    P +RPT E +  
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQN 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-30
 Identities = 44/295 (14%), Positives = 99/295 (33%), Gaps = 34/295 (11%)

Query: 182 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAE----FVKGLYLL 235
           A Q +  V  +G+G +  V+K       G  VA++ + V + +          V  L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 236 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 295
            +  H N++RL   C          +               ++     +   T   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 296 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 355
           + +G+ +LHS       +VHR+L  + +L+       +AD GL ++ +  +  + +  + 
Sbjct: 125 LLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT- 178

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMR 398
            + Y APE +    +    D+++ G I  ++                     ++      
Sbjct: 179 -LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 399 LAAESATFENFIDRNLKGKFSESEAAKLGKMALV----CTHEDPENRPTMEAVIE 449
                         +   +  E     + ++       C   +P  R +  + + 
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 35/288 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENII 244
           +  +  +G+G +  VYK     G   A++ I +        +  ++ + +L  L+H NI+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
           +L     ++ R    ++        L K LD  EG    L+  T  S ++ +  GI Y H
Sbjct: 64  KLYDVIHTKKR---LVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                   ++HR+L  + +LI+++    IAD GL +     +     +            
Sbjct: 118 D-----RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 365 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 424
           + + +++   DI++ G I  +++ G+ +             F      N K   + +E  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 425 KLGKMALV-----------------------CTHEDPENRPTMEAVIE 449
           K      V                           DP  R T +  +E
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-30
 Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 26/269 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE---EAEFVKGLYLLTSLRHE 241
           F    +LGKG+F  V+    +      AI+++       +   E   V+   L  +  H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 242 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
            +  +     ++     F + ++   G L  ++          D S        I  G+ 
Sbjct: 64  FLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGY 359
           +LH        IV+R+L ++ +L+D+  +  IAD G+ K     D    +   T     Y
Sbjct: 118 FLH-----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT---PDY 169

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 419
           +APE +   ++    D ++FGV++ ++L G            E   F +    N      
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNPFYPRW 225

Query: 420 ESEAAKLGKMALVCTHEDPENRPTMEAVI 448
             + AK   + +     +PE R  +   I
Sbjct: 226 LEKEAK--DLLVKLFVREPEKRLGVRGDI 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-30
 Identities = 46/289 (15%), Positives = 103/289 (35%), Gaps = 35/289 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 243
           F +V  +G+G +  VYK   +  G +VA++ I + +         ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           ++L     +  +   +L+++F  +                +      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           HS       ++HR+L  + +LI+ +    +AD GL +     +     +           
Sbjct: 119 HS-----HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSL------------VLTSSMRLAAESATFENFID 411
            +    ++   DI++ G I  +++T                +  ++    E         
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 412 RNLKGKFSESEAAKLGKMALVCTHE-----------DPENRPTMEAVIE 449
            + K  F +       K+      +           DP  R + +A + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 59/298 (19%), Positives = 111/298 (37%), Gaps = 38/298 (12%)

Query: 162 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 220
           T F +E+++ +             +     LG G F+ V K      G   A + I    
Sbjct: 1   TVFRQENVDDY-------------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRR 47

Query: 221 CKSEE-----AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 275
            KS        +  + + +L  ++H N+I L        + +  LI +    G+L  +L 
Sbjct: 48  TKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLA 105

Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 332
           ++E     L        +  I  G+ YLHS       I H +L  E +++  +  P    
Sbjct: 106 EKES----LTEEEATEFLKQILNGVYYLHS-----LQIAHFDLKPENIMLLDRNVPKPRI 156

Query: 333 -IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
            I D GL   +     F  +  +    ++APE V        +D+++ GVI   +L+G+ 
Sbjct: 157 KIIDFGLAHKIDFGNEFKNIFGT--PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214

Query: 392 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
                 +    +       +   +   + S  AK          +DP+ R T++  ++
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRMTIQDSLQ 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 29/272 (10%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 242
           F  +  LG G+F  V+    R +G   A++ +        +          +L+ + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           IIR+ G      +   F+I D+   G+L   L +    S              +   + Y
Sbjct: 66  IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEY 119

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
           LHS       I++R+L  E +L+D+  +  I D G  K + D              Y+AP
Sbjct: 120 LHS-----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E V+T  + +  D ++FG++I ++L G      S        T+E  ++  L+     +E
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPFFNE 226

Query: 423 AAKLGKMALV--CTHEDPENRPT-MEAVIEEL 451
             K     L+      D   R   ++   E++
Sbjct: 227 DVK----DLLSRLITRDLSQRLGNLQNGTEDV 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-28
 Identities = 44/210 (20%), Positives = 90/210 (42%), Gaps = 16/210 (7%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 244
           ++ ++ +G+G +  V       +   VAI+ I+    ++     ++ + +L   RHENII
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 245 RLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
            +     +    + +   +        L K L  +      L        +  I +G+ Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKY 124

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYL 360
           +HS+      ++HR+L    +L++   +  I D GL ++   D   +   T   A   Y 
Sbjct: 125 IHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 361 APEYVTTGRFTERS-DIFAFGVIILQILTG 389
           APE +   +   +S DI++ G I+ ++L+ 
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSN 209

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 4e-27
 Identities = 64/291 (21%), Positives = 105/291 (36%), Gaps = 46/291 (15%)

Query: 190 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENII 244
           + LG+G F++VYK   +    +VAI+ I +      +    +       LL  L H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 245 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 304
            L      +      L++DF          D     S VL  S   + ++   +G+ YLH
Sbjct: 64  GLLDAFGHKS--NISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 305 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 364
                   I+HR+L    +L+D+     +AD GL K        +         Y APE 
Sbjct: 118 Q-----HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPEL 171

Query: 365 VTTGR-FTERSDIFAFGVIILQILTGSLVLTSS-----------------------MRLA 400
           +   R +    D++A G I+ ++L     L                          M   
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 401 AESATFENFIDRNLKGKFSE--SEAAKLGKMALVCTHEDPENRPTMEAVIE 449
            +  TF++F    L   FS    +   L +   +    +P  R T    ++
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF---NPCARITATQALK 279

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 5e-27
 Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 28/235 (11%)

Query: 162 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 220
           +GF R+ +      +  V      + ++  +G G + +V      R G  VAI+ +    
Sbjct: 2   SGFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF 55

Query: 221 CKSEEAE-FVKGLYLLTSLRHENIIRLRGFCCSRGR----GECFLIYDFAPKGKLSKYLD 275
                A+   + L LL  +RHEN+I L              + +L+  F   G     L 
Sbjct: 56  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM 113

Query: 276 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 335
           + E     L       ++  + KG+ Y+H+       I+HR+L    + +++     I D
Sbjct: 114 KHEK----LGEDRIQFLVYQMLKGLRYIHA-----AGIIHRDLKPGNLAVNEDCELKILD 164

Query: 336 CGLHKLLADDIVFSVLKTSAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 389
            GL +    ++   V+       Y APE  +   R+T+  DI++ G I+ +++TG
Sbjct: 165 FGLARQADSEMTGYVVTR----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (269), Expect = 5e-27
 Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 29/278 (10%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
              +G+G+F  +++GT L +   VAI+       +S+  +          L     I   
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 307
            +    G     L+ D           D  +         T       +   +  +H   
Sbjct: 67  YYFGQEG-LHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 308 VNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTSAA------ 356
                +V+R++  +  LI +  +       + D G+ K   D +    +           
Sbjct: 122 -----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 357 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 416
             Y++         + R D+ A G + +  L GSL     ++ A     +E   ++    
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQST 235

Query: 417 KFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 451
              E  A    +  K      +   +  P  + +    
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 26/272 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 242
           F  + LLGKG F  V        G   A++ +      +++  A  V    +L + RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +  L      +       + ++A  G+L  +L +E     V            I   + Y
Sbjct: 67  LTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEY 120

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
           LHS       +V+R++ +E +++D+  +  I D GL K    D             YLAP
Sbjct: 121 LHS-----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-PEYLAP 174

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E +    +    D +  GV++ +++ G L   +          FE  +   ++   + S 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILMEEIRFPRTLSP 230

Query: 423 AAKLGKMALV--CTHEDPENRPTM-EAVIEEL 451
            AK    +L+     +DP+ R     +  +E+
Sbjct: 231 EAK----SLLAGLLKKDPKQRLGGGPSDAKEV 258

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-25
 Identities = 51/302 (16%), Positives = 106/302 (35%), Gaps = 47/302 (15%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENI 243
           + ++  +G+G F  V+K   R  G  VA++ + + + K       ++ + +L  L+HEN+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 244 IRLRGFCCS------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 297
           + L   C +      R +G  +L++DF          +           S    ++  + 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 127

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 357
            G+ Y+H ++     I+HR++    VLI +     +AD GL +  +        + +  +
Sbjct: 128 NGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 358 G---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTS------------------ 395
               Y  PE +   R +    D++  G I+ ++ T S ++                    
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 396 -------SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV-CTHEDPENRPTMEAV 447
                        E         R +K +             +      DP  R   +  
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 448 IE 449
           + 
Sbjct: 303 LN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.3 bits (246), Expect = 6e-24
 Identities = 43/290 (14%), Positives = 100/290 (34%), Gaps = 37/290 (12%)

Query: 186 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 243
           + ++  +G+G + +V+K   R    +VA++ + +           ++ + LL  L+H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           +RL     S    +  L+++F  +          +  +  LD     S +  + KG+G+ 
Sbjct: 64  VRLHDVLHSDK--KLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 363
           H        ++HR+L  + +LI++     +A+ GL +     +     +           
Sbjct: 118 H-----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 364 YVTTGRFTERSDIFAFGVIILQILTGSLVL------------------------TSSMRL 399
                 ++   D+++ G I  ++      L                          SM  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 400 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 449
             +   +  +              A    +       +P  R + E  ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.5 bits (247), Expect = 1e-23
 Identities = 43/270 (15%), Positives = 93/270 (34%), Gaps = 25/270 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 242
           F  +  LG G+F  V        G   A++ ++       +     +    +L ++    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 243 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 302
           +++L            +++ ++   G++  +L +                   I     Y
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156

Query: 303 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
           LHS +     +++R+L  E +LIDQQ    + D G     A  +             LAP
Sbjct: 157 LHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGF----AKRVKGRTWTLCGTPEALAP 207

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 422
           E + +  + +  D +A GV+I ++  G     +          +E  +   ++     S 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGKVRFPSHFSS 263

Query: 423 AAKLGKMALVCTHEDPENR-PTMEAVIEEL 451
             K   +       D   R   ++  + ++
Sbjct: 264 DLK--DLLRNLLQVDLTKRFGNLKNGVNDI 291

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 5e-22
 Identities = 53/294 (18%), Positives = 109/294 (37%), Gaps = 33/294 (11%)

Query: 170 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE 225
           ++ ++ +E        F  + +LG G +  V+          G L A++ +   +   + 
Sbjct: 17  HAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 226 ---AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 282
                      +L  +R    +    +   +   +  LI D+   G+L  +L Q E    
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTETKLHLILDYINGGELFTHLSQRER--- 125

Query: 283 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 342
                     +  I   + +LH     K  I++R++ +E +L+D   + ++ D GL K  
Sbjct: 126 -FTEHEVQIYVGEIVLALEHLH-----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 343 ADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLA 400
             D           + Y+AP+ V  G     +  D ++ GV++ ++LTG+   T      
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

Query: 401 AESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTM-EAVIEEL 451
           +++      +          S  AK     L+     +DP+ R        +E+
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAK----DLIQRLLMKDPKKRLGCGPRDADEI 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 87.6 bits (216), Expect = 1e-19
 Identities = 36/207 (17%), Positives = 76/207 (36%), Gaps = 20/207 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 243
           +  V  LG+G +S V++   + +   V ++ +       ++ +  + + +L +LR   NI
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNI 92

Query: 244 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 303
           I L             L+++        +           L        +  I K + Y 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 145

Query: 304 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAP 362
           HS       I+HR++    V+ID +   L + D GL +       ++V   S        
Sbjct: 146 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPE 199

Query: 363 EYVTTGRFTERSDIFAFGVIILQILTG 389
             V    +    D+++ G ++  ++  
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFR 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.9 bits (214), Expect = 2e-19
 Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 20/210 (9%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 243
           +  +  +G G    V           VAI+ ++        A+   + L L+  + H+NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 244 IRLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 299
           I L      +   E     +L+ +            +        D      ++  +  G
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCG 131

Query: 300 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 359
           I +LHS       I+HR+L    +++       I D GL +      + +    +    Y
Sbjct: 132 IKHLHS-----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT--RYY 184

Query: 360 LAPEYVTTGRFTERSDIFAFGVIILQILTG 389
            APE +    + E  DI++ G I+ +++  
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 3e-19
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 18/209 (8%)

Query: 186 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 243
           +  ++ +G G + SV      + G  VA++ ++        A+   + L LL  ++HEN+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 244 IRLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 301
           I L               +       G     + + +     L       +I  I +G+ 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLK 135

Query: 302 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 361
           Y+HS       I+HR+L    + +++     I D GL    A      +    A   Y A
Sbjct: 136 YIHS-----ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATRWYRA 186

Query: 362 PE-YVTTGRFTERSDIFAFGVIILQILTG 389
           PE  +    + +  DI++ G I+ ++LTG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.5 bits (205), Expect = 4e-18
 Identities = 37/216 (17%), Positives = 77/216 (35%), Gaps = 19/216 (8%)

Query: 189 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 247
           V  LG G+FS+V+    + + T VA++ +      +E AE    + LL  +   +  +  
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADNTKED 75

Query: 248 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----------DWSTRVSIIIGIA 297
               +             P G     + +  G + +                  I   + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 298 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL-LADDIVFSVLKTSA 355
            G+ Y+H     +  I+H ++  E VL++       +    +  L  A         +  
Sbjct: 136 LGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 356 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 391
              Y +PE +    +   +DI++   +I +++TG  
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.3 bits (161), Expect = 2e-13
 Identities = 23/158 (14%), Positives = 50/158 (31%), Gaps = 24/158 (15%)

Query: 190 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE---------EAEFVKGLYLLTSLRH 240
            L+G+G  S+V+           ++   V     +         +  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 241 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 300
             + +L+G    +       +Y +     L + +D +E     ++      ++  I + +
Sbjct: 66  RALQKLQGLAVPK-------VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEV 116

Query: 301 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 338
              +        IVH +LS   VL+  +    I D   
Sbjct: 117 AKFYH-----RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	464
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.49
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.63
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.93
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.62

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=429.11  Aligned_cols=256  Identities=21%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|...+.||+|+||+||+|++.+++.||||.++...  ...++|.+|+.++++++|||||+++|+|  ...+..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~--~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCccccccee--ccCCceEEEEE
Confidence            3577789999999999999999989999999997654  2346799999999999999999999999  44667899999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++....   ..++|..++.|+.|||.||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             ecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc-----eeecccchhheeecCCCCeEecccchheecc
Confidence            999999999987543   34899999999999999999999988     9999999999999999999999999998776


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...........+|..|+|||++.++.++.++|||||||++|||+|++.|+......    ..+.+.+....+...+..++
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHHHHHHHTCCCCCCTTSC
T ss_pred             CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHHHHHHHhcCCCCCccccC
Confidence            54443444456788999999999999999999999999999999965555432211    12223333444555666778


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      +++.+++..||+.||++||||+||+++|+.+.
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            89999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=431.14  Aligned_cols=257  Identities=24%  Similarity=0.431  Sum_probs=215.5

Q ss_pred             hhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ..++|...+.||+|+||+||+|++++++.||||.++...  ...++|.+|+.+|++++|||||+++|+|.  + +..++|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~-~~~~iv   85 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT--Q-EPIYII   85 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSCEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeec--c-CCeEEE
Confidence            345678889999999999999999988999999997654  23467999999999999999999999873  2 457899


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.....  ..++|..++.|+.|||+||.|||+.+     |+||||||+||||++++.+||+|||+++.
T Consensus        86 ~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccchhheeeecccceeeccccceEE
Confidence            999999999998875542  23899999999999999999999988     99999999999999999999999999998


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      .............+|+.|+|||++.++.++.++|||||||++|||+||+.|+......    ..+...+....+...+..
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTT
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhcCCCCCccc
Confidence            7665544444556788999999999999999999999999999999977666543221    112223334445556667


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .++.+.+++.+||+.||++||||++|++.|+..
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            788899999999999999999999999988753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-57  Score=432.34  Aligned_cols=259  Identities=21%  Similarity=0.417  Sum_probs=220.7

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||+||+|++. +++.||||.++.+.  ...++|.+|+.+|++++|||||+++|+|  ...+..++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~iv   91 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYII   91 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccE--eeCCeeEEE
Confidence            456788899999999999999986 58899999987654  3346799999999999999999999998  456778999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.....  ..++|..++.|+.|||.||+|||+++     |+||||||+||||++++.+||+|||+++.
T Consensus        92 ~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC-----cccCccccCeEEECCCCcEEEccccceee
Confidence            999999999999976432  35999999999999999999999988     99999999999999999999999999998


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ...+.........++..|+|||++.++.++.++|||||||++|||+||+.|+.....    ...+.+.+....+...+..
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHHTTCCCCCCTT
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHHHhcCCCCCCCcc
Confidence            766544444445577889999999999999999999999999999998877654332    1223344555566666777


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .++.+.+|+..||+.||++||||+||++.|+.+..
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            88899999999999999999999999999987654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=429.91  Aligned_cols=258  Identities=21%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             hcCCccccccccCCceEEEEEEECCCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|...+.||+|+||+||+|++++  .||||.++... .....++|.+|+.+|++++|||||+++|++.   .+..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEEEEE
Confidence            4568888999999999999998753  59999997543 3445678999999999999999999999873   2457999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++....   ..++|.+++.|+.|||+||+|||+++     ||||||||+||||++++.+||+|||+++.
T Consensus        82 ~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~-----ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC-----EeccccCHHHEEEcCCCCEEEccccceee
Confidence            99999999999997543   24999999999999999999999988     99999999999999999999999999987


Q ss_pred             ccCCce-eeeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--
Q 012392          342 LADDIV-FSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--  415 (464)
Q Consensus       342 ~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  415 (464)
                      ...... .......+|+.|||||++.+   +.|+.++|||||||+||||+||+.||.......    .+...+.....  
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~p  229 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYLSP  229 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSCCC
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCC
Confidence            654322 22334568899999999864   358999999999999999999999997532211    11122222211  


Q ss_pred             --CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCc
Q 012392          416 --GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  457 (464)
Q Consensus       416 --~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~  457 (464)
                        ...+..+++.+.+++.+||+.||++||||+||+++|+.+...
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence              123445678899999999999999999999999999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-56  Score=429.02  Aligned_cols=258  Identities=24%  Similarity=0.471  Sum_probs=205.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CC---cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...++||+|+||+||+|+++ ++   ..||||.+.........++|.+|+.+|++++|||||+++|+|  ...+..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~--~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV--TKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE--eeCCEEE
Confidence            34566789999999999999975 22   369999988766566677899999999999999999999998  4467799


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +|||||++|+|.+++....   ..++|.+++.++.|||+||+|||+.+     |+||||||+||||++++++||+|||++
T Consensus       104 iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC-----CccCccccceEEECCCCcEEECCcccc
Confidence            9999999999999987643   34999999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCcee----eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          340 KLLADDIVF----SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       340 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +........    ......+|+.|||||.+.++.++.++|||||||+||||+| |+.||.....     ..+...+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~~~i~~~~  250 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAIEQDY  250 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTC
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC
Confidence            876543221    1222346788999999999999999999999999999998 7888865432     12223344445


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +...+..+++.+.+++.+||+.||++||||.||++.|+.+.+
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            555667788899999999999999999999999999987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=415.36  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=217.0

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|+..+.||+|+||+||+|++++++.||||.++....  ...+|.+|+.++++++||||++++|+|  ...+..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~--~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEE--CCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEE--eeCCceEEEEE
Confidence            56888899999999999999999899999999986543  346899999999999999999999998  45678999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.+++.....   .+++..+.+++.|||+||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus        80 y~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~-----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             CCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT-----BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             ccCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC-----cccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999876542   4889999999999999999999988     9999999999999999999999999998776


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...........+|..|+|||.+.+..++.++|||||||++|||+| |+.||......     .+...+....+...+...
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~  226 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLYRPHLA  226 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHTTCCCCCCTTC
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHHHHhCCCCCCcccc
Confidence            554444445567888999999999999999999999999999998 78888654321     122333344555667777


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ++.+.+++.+||+.||++|||+++++++|..
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            8899999999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=419.21  Aligned_cols=259  Identities=22%  Similarity=0.451  Sum_probs=210.0

Q ss_pred             cCCccccccccCCceEEEEEEECCC-----cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      ++|+..++||+|+||.||+|.+++.     ..||||.++....+....+|.+|+.+|++++|||||+++|+|  ...+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~--~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE--ecCCce
Confidence            4577789999999999999997632     479999998766566667899999999999999999999998  446778


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+.+|+|.+++....   ..++|.+++.++.||+.||+|||+.+     |+||||||+||||++++.+||+|||+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc-----cccCccccceEEECCCCeEEEcccch
Confidence            99999999999999887643   34999999999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCc--eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCC
Q 012392          339 HKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  416 (464)
Q Consensus       339 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (464)
                      ++......  ........+|+.|||||++.++.++.++|||||||++|||+||+.|+......    ..+...+....+.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~~~~~  232 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRL  232 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCC
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHHHhccCCC
Confidence            98765432  22233445788999999999999999999999999999999987766543221    2233344455566


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..+..++..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            6677788899999999999999999999999999987644

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-56  Score=421.16  Aligned_cols=263  Identities=18%  Similarity=0.318  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.+..... +...+.|.+|+.+|++++|||||++++++.+...+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46888999999999999999975 789999999976543 3345678999999999999999999999876656678999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+++|+|.+++.........+++.+++.++.||+.||+|||+.+....+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999997644334469999999999999999999998653334599999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ....... .....+|+.|||||.+.+..++.++|||||||++|||+||+.||.......    ....+.. ......+..
T Consensus       164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~-~~~~~~~~~  237 (269)
T d2java1         164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIRE-GKFRRIPYR  237 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH-TCCCCCCTT
T ss_pred             cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHc-CCCCCCCcc
Confidence            7543221 223457889999999999999999999999999999999999997543211    1222222 222234556


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .++++.+++.+||+.||++|||++|+++|.+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            6778999999999999999999999998743

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=418.53  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=211.7

Q ss_pred             CCccccc-cccCCceEEEEEEEC---CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          185 CFSEVNL-LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       185 ~f~~~~~-lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +|...+. ||+|+||.||+|.++   ++..||||.++....+...++|.+|+.+|++++|||||+++|+|..   +..++
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEEE
Confidence            3445564 999999999999864   4568999999876656667889999999999999999999999842   35899


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....   ..+++.+++.|+.|||.||+|||+++     |+||||||+|||++.++.+||+|||+++
T Consensus        86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCcCchhheeeccCCceeeccchhhh
Confidence            999999999999986533   34999999999999999999999988     9999999999999999999999999999


Q ss_pred             cccCCceee--eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          341 LLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       341 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      .........  .....+|+.|+|||++..+.++.++|||||||++|||+| |+.||.....     ..+...+....+..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~i~~~~~~~  232 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRME  232 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTCCCC
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCC
Confidence            775433222  223346788999999999999999999999999999998 8999865321     12233344445556


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+..+++++.+|+..||+.||++||||.+|++.|+..
T Consensus       233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            6777888999999999999999999999999988754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=413.81  Aligned_cols=259  Identities=19%  Similarity=0.314  Sum_probs=207.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.++........++|.+|+.+|++++|||||++++++.+  .+..+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEE
Confidence            45888899999999999999975 7899999999765544445679999999999999999999999854  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++...    ..+++.++..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+++..
T Consensus        83 Ey~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~-----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          83 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999999643    34999999999999999999999998     999999999999999999999999999876


Q ss_pred             cCCce-eeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          343 ADDIV-FSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       343 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ..... .......||+.|||||++.+..+ +.++|||||||+||||+||+.||.......   ..+..............
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  230 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWK  230 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHHHHHHTTCTTSTTGG
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCccc
Confidence            43322 22334568999999999988776 578999999999999999999996543211   11112222222222223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ..++++.+++.+||+.||++|||++|+++|-+...+
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            456788999999999999999999999998776544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=410.20  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             cccccCCceEEEEEEECC---CcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRD---GTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||+||+|.+++   ++.||||.++... .....++|.+|+.+|++++|||||+++|+|.  . +..+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--A-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--S-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--c-CCEEEEEEcC
Confidence            579999999999998753   4689999997543 2344568999999999999999999999983  2 3478999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....    .++|.+++.|+.|||.||+|||+.+     |+||||||+||||+.++.+||+|||+++.....
T Consensus        90 ~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~-----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          90 ELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             TTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC-----cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            9999999997643    3999999999999999999999988     999999999999999999999999999876543


Q ss_pred             ce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ..  .......+|+.|||||.+.++.++.++|||||||++|||+| |+.||.....     ..+...+....+...+..+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~~~~~~~~p~~~  235 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGERMGCPAGC  235 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCccc
Confidence            22  22233457889999999999999999999999999999998 8889875432     1233344445555667778


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ++++.+|+.+||+.||++||||++|++.|+..
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            88999999999999999999999998887653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=415.96  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|+..+.||+|+||+||+|++++++.||||.++....  ..++|.+|+.+|++++|||||+++|+|.  + +..++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~--~-~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSCEEEEC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe--c-CCeEEEEE
Confidence            46888899999999999999999888999999976542  3467999999999999999999999883  2 45789999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|..++.....  ..++|.+++.|+.|||.||+|||+.+     |+||||||+||||++++++||+|||+++...
T Consensus        92 y~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~-----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          92 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             CCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh-----eecccccceEEEECCCCcEEEcccchhhhcc
Confidence            9999999999986542  24999999999999999999999988     9999999999999999999999999998775


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  423 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (464)
                      ...........+|..|+|||++..+.++.++|||||||++|||+||+.|+......    ..+...+....+...+...+
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTSC
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHHhcCCCCCCcccC
Confidence            54444444456788999999999999999999999999999999987776543321    11223333444555677778


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          424 AKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       424 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      +++.+++.+||+.||++||||++|++.|+..-
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            89999999999999999999999999887643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=422.90  Aligned_cols=261  Identities=25%  Similarity=0.407  Sum_probs=212.6

Q ss_pred             hhcCCccccccccCCceEEEEEEECC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      ..++|...++||+|+||+||+|++..      ...||||.+...........|.+|+.+|.++ +|||||+++|+|  ..
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TL  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE--ee
Confidence            34568888999999999999998752      2369999987655455567899999999998 899999999998  55


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeee
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEGS-------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH  315 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH  315 (464)
                      .+..++||||+++|+|.++|+.....                   ...++|..++.|+.||++||+|||+++     |||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-----IiH  187 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVH  187 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEE
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eee
Confidence            67799999999999999999764321                   235899999999999999999999988     999


Q ss_pred             cCCCCCceEEcCCCCeEEeeCCccccccCCcee-eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 012392          316 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVL  393 (464)
Q Consensus       316 ~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~  393 (464)
                      |||||+|||++.++.+||+|||+++........ ......+|+.|||||++.++.++.++|||||||+||||+| |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543222 2223346888999999999999999999999999999998 78888


Q ss_pred             cchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          394 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+...    ...+..++....+...+...++.+.+|+.+||+.||++||||+||+++|.-
T Consensus       268 ~~~~~----~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         268 PGIPV----DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TTCCC----SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCH----HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            65321    223344555556666677788899999999999999999999999999963

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=409.24  Aligned_cols=252  Identities=16%  Similarity=0.312  Sum_probs=210.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||+||+|+.. +|+.||||.++.... ...+.+.+|+.+|++++|||||++++++..  .+..++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEE
Confidence            46899999999999999999964 799999999876542 334679999999999999999999999854  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++...     .+++.++..++.||+.||+|||+++     |+||||||+|||++.++.+||+|||+++..
T Consensus        97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCcHHHeEECCCCcEeeccchhheee
Confidence            999999999988652     3899999999999999999999998     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-hcCCCCCHH
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFSES  421 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  421 (464)
                      ..+.. ......||+.|+|||.+.++.++.++|||||||++|||+||..||........    +...... ......+..
T Consensus       167 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~  241 (293)
T d1yhwa1         167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQNPEK  241 (293)
T ss_dssp             CSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHHCSCCCSSGGG
T ss_pred             ccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCCCCCCCccc
Confidence            54322 22334588999999999999999999999999999999999999975432211    1122211 112234456


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .++.+.+++.+||+.||++|||++|+++|-+.
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            67889999999999999999999999998664

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=404.87  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||+||+|+.+ +++.||||.+.....  ......+.+|+.++++++|||||++++++  .+.+..++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE--EECCEEEE
Confidence            35888899999999999999986 689999999864321  22345788999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+++     ||||||||+|||+++++.+||+|||+++
T Consensus        84 vmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeeeeccccceecCCCCEeecccceee
Confidence            999999999999998653    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      .......   ....||+.|||||++.+..++.++|||||||+||||+||+.||......    ..+..+..  .....+.
T Consensus       155 ~~~~~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~--~~~~~p~  225 (263)
T d2j4za1         155 HAPSSRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISR--VEFTFPD  225 (263)
T ss_dssp             CCCCCCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHT--TCCCCCT
T ss_pred             ecCCCcc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHc--CCCCCCc
Confidence            7654422   2345788999999999999999999999999999999999999754321    11222222  1233455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ..++++.+++.+||+.||++|||++|+++|.+..
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            6678899999999999999999999999987643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-54  Score=413.16  Aligned_cols=267  Identities=21%  Similarity=0.361  Sum_probs=217.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEE
Q 012392          177 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC  250 (464)
Q Consensus       177 ~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~  250 (464)
                      .+++...++|+..+.||+|+||+||+|+++      +++.||||+++.........+|.+|+.+|++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556778999999999999999999864      45789999998766555667899999999999999999999998


Q ss_pred             EeCCCCeEEEEEecCCCCCHHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012392          251 CSRGRGECFLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  310 (464)
Q Consensus       251 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  310 (464)
                        ...+..++||||+++|+|.+++.....                    ....++|..++.|+.|+|.||+|||+.+   
T Consensus        86 --~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---  160 (301)
T d1lufa_          86 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  160 (301)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             --ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence              446778999999999999999975321                    1234899999999999999999999988   


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhC
Q 012392          311 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG  389 (464)
Q Consensus       311 ~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg  389 (464)
                        ||||||||+||||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|
T Consensus       161 --ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         161 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence              99999999999999999999999999986644322 222334567889999999999999999999999999999999


Q ss_pred             CC-CCcchHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          390 SL-VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       390 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .. |+......     .+...+........+...+.++.+|+.+||+.||++||||.||++.|+.+-
T Consensus       239 ~~~p~~~~~~~-----e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         239 GLQPYYGMAHE-----EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TCCTTTTSCHH-----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCCHH-----HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            75 55443221     111222333344556677788999999999999999999999999998763

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=402.08  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             ccccccccCCceEEEEEEEC-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC--CCCeEEEEE
Q 012392          187 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLIY  262 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~lv~  262 (464)
                      ...+.||+|+||+||+|+.. +++.||||.+.... .....+.|.+|+++|++++|||||++++++...  .....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34467999999999999976 68899999987653 334456799999999999999999999988542  245689999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc-CCCCeEEeeCCcccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKL  341 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl~~~  341 (464)
                      ||+++|+|.+++....    .+++.++..++.||++||+|||+++   ++|+||||||+|||++ +++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~---~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC---CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999999999997653    3899999999999999999999875   5699999999999996 578999999999986


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHH
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  421 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (464)
                      ......   ....||+.|||||++.+ .++.++|||||||++|||+||+.||........   ....+.........+..
T Consensus       165 ~~~~~~---~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~~  237 (270)
T d1t4ha_         165 KRASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKV  237 (270)
T ss_dssp             CCTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGC
T ss_pred             ccCCcc---CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---HHHHHHcCCCCcccCcc
Confidence            544322   23468899999998865 699999999999999999999999964321111   11122111111122333


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          422 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       422 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      .++++.+++.+||+.||++|||++|+++|-+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence            4567899999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=406.24  Aligned_cols=257  Identities=21%  Similarity=0.389  Sum_probs=203.0

Q ss_pred             hcCCccccccccCCceEEEEEEECC----CcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  258 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  258 (464)
                      .++|...+.||+|+||.||+|++..    +..||||.++..........|.+|+.+|++++|||||+++|++.   .+..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeE
Confidence            3568888999999999999998752    45799999876665566678999999999999999999999983   3568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      ++||||+++|+|.+++....   ..+++..++.++.||++||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC-----eeccccchhheeecCCCcEEEccchh
Confidence            99999999999999987543   34899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      ++..............+|+.|+|||.+.++.++.++|||||||++|||+| |..|+.....     ..+...+.......
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~~~~~~~  229 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLP  229 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCCC
T ss_pred             heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCC
Confidence            98776544434445567889999999999999999999999999999998 7777765322     11222233334445


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      .+...++.+.+++..||+.||++|||++||+++|+.+.
T Consensus       230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            66777889999999999999999999999999998763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=416.81  Aligned_cols=258  Identities=18%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             hhcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          182 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       182 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..++|+..+.||+|+||+||+|+.. +|+.||||.++.........++.+|+.+|++++|||||+++++|.  +.+..++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEE
Confidence            3467899999999999999999975 789999999987655556678999999999999999999999994  4678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+. +     |+||||||+|||+++++.+||+|||+|
T Consensus        82 VmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999999998653    389999999999999999999974 6     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh---------------
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---------------  404 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~---------------  404 (464)
                      +.......   ....||..|+|||++.+..|+.++||||+||++|||+||+.||...........               
T Consensus       153 ~~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         153 GQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHHHHTC------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             cccCCCcc---ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            87644322   234588999999999999999999999999999999999999964321100000               


Q ss_pred             -------------------hHHHhhhh---hcCCCC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          405 -------------------TFENFIDR---NLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       405 -------------------~~~~~~~~---~~~~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                         ...+..+.   ...... ....+.++.+++.+||+.||++|||++|+++|.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~  301 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI  301 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence                               00000000   000111 11234678999999999999999999999998554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=408.39  Aligned_cols=254  Identities=18%  Similarity=0.281  Sum_probs=208.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|+..+.||+|+||+||+|+.. +++.||||.++... ....+.|.+|+++|++++|||||++++++..  .+..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEE
Confidence            35788899999999999999975 68999999997654 4445679999999999999999999999854  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+++|+|.+++....   ..+++.++..++.||+.||.|||+++     |+||||||+|||++.++.+||+|||+++..
T Consensus        89 Ey~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEeecChhheeECCCCCEEEEechhhhcc
Confidence            9999999999987643   24999999999999999999999998     999999999999999999999999999765


Q ss_pred             cCCceeeeeccCCCCccCcccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc-CC
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KG  416 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  416 (464)
                      ..... ......||+.|+|||++.     ...|+.++|||||||++|||+||+.||......    ..+..+..... ..
T Consensus       161 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~~~i~~~~~~~~  235 (288)
T d2jfla1         161 TRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVLLKIAKSEPPTL  235 (288)
T ss_dssp             HHHHH-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHHHHSCCCCC
T ss_pred             CCCcc-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCC
Confidence            43211 122345788999999984     456899999999999999999999999754321    12222222211 12


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..+...++++.+++.+||+.||++|||++|+++|-+.
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            2345667889999999999999999999999988654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=410.59  Aligned_cols=256  Identities=24%  Similarity=0.446  Sum_probs=208.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      +|+..++||+|+||+||+|++. +|+    .||||.++........++|.+|+.+|++++|||||+++|+|.+   +..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCee
Confidence            4888899999999999999875 443    6899998765555566789999999999999999999999854   3467


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      +++||+.+|+|.+++....   ..+++..+++++.|||.||+|||+++     ||||||||+||||++++.+||+|||++
T Consensus        87 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             EEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC-----cccCcchhhcceeCCCCCeEeeccccc
Confidence            8899999999999987643   34999999999999999999999988     999999999999999999999999999


Q ss_pred             ccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          340 KLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       340 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      +....... .......+|..|+|||++.++.++.++|||||||+||||+| |..||....     ...+...+....+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~~~~~~  233 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGERLP  233 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHHTCCCC
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCCCCC
Confidence            87754332 22333457889999999999999999999999999999999 667765432     223344555555666


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      .+..++..+.+++.+||+.||++|||+.||+++|+.+..
T Consensus       234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            677788899999999999999999999999999987643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-53  Score=408.18  Aligned_cols=251  Identities=19%  Similarity=0.354  Sum_probs=207.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ..|+..+.||+|+||+||+|+.. +++.||||.++.....  ...++|.+|+.+|++++|||||++++++.+  .+..++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence            34888999999999999999965 7899999999765433  233579999999999999999999999854  678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||||++|+|..++...    ..+++.++..++.||+.||.|||+++     ||||||||+|||+++++.+||+|||+++
T Consensus        93 v~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             EEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEECCCCCEEEeeccccc
Confidence            99999999998776543    24999999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  417 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (464)
                      .....     ....||+.|||||++.+   +.|+.++|||||||++|||++|..||......    ..+..+........
T Consensus       164 ~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~i~~~~~~~~  234 (309)
T d1u5ra_         164 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPAL  234 (309)
T ss_dssp             SSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCC
T ss_pred             ccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCC
Confidence            76542     23458899999999853   46899999999999999999999999754322    12223333333333


Q ss_pred             CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          418 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       418 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      .+...++.+.+++.+||+.||++|||++|+++|.+..
T Consensus       235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence            3445677899999999999999999999999876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=400.79  Aligned_cols=251  Identities=23%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      ++|+..+.||+|+||.||+|+++ |+.||||.++.+.   ..++|.+|++++++++||||++++|+|.+. .+..++|||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~e   81 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE   81 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEe
Confidence            34667789999999999999985 7889999997543   346799999999999999999999988543 345799999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+++|+|.++|.....  ..++|..+++|+.|||.||.|||+.+     |+||||||+|||++.++.+||+|||+++...
T Consensus        82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc-----eeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999976432  24899999999999999999999988     9999999999999999999999999998764


Q ss_pred             CCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...    ....++..|+|||++.++.++.++|||||||++|||+| |+.|+....     ...+...+....+...+...
T Consensus       155 ~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i~~~~~~~~~~~~  225 (262)
T d1byga_         155 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYKMDAPDGC  225 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHHTTTCCCCCCTTC
T ss_pred             CCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCCCCCCCccC
Confidence            422    22346778999999999999999999999999999999 566665432     12223334444556667777


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      +.++.+++.+||+.||++||||.+++++|+.+.
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            889999999999999999999999999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=408.86  Aligned_cols=270  Identities=22%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeee
Q 012392          176 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRG  248 (464)
Q Consensus       176 ~~~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g  248 (464)
                      ..+++...++|...+.||+|+||.||+|++.      +++.||||.++........++|.+|...+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3445555577899999999999999999864      34689999998766566667888999888887 6899999999


Q ss_pred             EEEeCCCCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeec
Q 012392          249 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  316 (464)
Q Consensus       249 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~  316 (464)
                      ++.+ .....++|||||++|+|.++|+....            ....++|.+++.++.||++||+|||+.+     ||||
T Consensus        85 ~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----ivHr  158 (299)
T d1ywna1          85 ACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHR  158 (299)
T ss_dssp             EECS-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-----CCCS
T ss_pred             eecc-CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----CcCC
Confidence            8754 34568999999999999999976432            1234899999999999999999999988     9999


Q ss_pred             CCCCCceEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCC-CCc
Q 012392          317 NLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLT  394 (464)
Q Consensus       317 dlk~~Nill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~-p~~  394 (464)
                      ||||+||||++++.+||+|||+++....... .......+|+.|+|||.+.++.++.++|||||||++|||+||.. ||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986643322 12223457889999999999999999999999999999999865 554


Q ss_pred             chHHHHHhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          395 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ....    ...+...+....+...+...++++.+++.+||+.||++|||++||+++|+.+.
T Consensus       239 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         239 GVKI----DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             TCCC----SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCH----HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3211    12233444445555666777888999999999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=403.28  Aligned_cols=253  Identities=23%  Similarity=0.439  Sum_probs=207.8

Q ss_pred             cccccCCceEEEEEEECCC----cEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEecC
Q 012392          190 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  265 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E~~  265 (464)
                      ++||+|+||+||+|++.++    ..||||.++.........+|.+|+++|++++||||++++|+|... .+..++|||||
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~~  111 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEECC
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEEe
Confidence            6799999999999997532    369999998655566668899999999999999999999998543 45789999999


Q ss_pred             CCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccccCC
Q 012392          266 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  345 (464)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~~~  345 (464)
                      ++|+|.+++....   ..+++..++.++.|+|+||.|||+.+     |+||||||+||||++++.+||+|||+++.....
T Consensus       112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~-----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC-----cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999987643   34788999999999999999999988     999999999999999999999999999876543


Q ss_pred             cee---eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCHHH
Q 012392          346 IVF---SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  422 (464)
Q Consensus       346 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (464)
                      ...   ......+|..|+|||.+..+.++.++||||||+++|||+||+.|+.......    .+...+....+...+..+
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~i~~g~~~~~p~~~  259 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQGRRLLQPEYC  259 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTTC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCCCCCcccC
Confidence            221   1222456788999999999999999999999999999999888876543221    122222233444556667


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          423 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       423 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ++.+.+|+.+||+.||++||+|.||+++|+.+.
T Consensus       260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         260 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            788999999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-53  Score=407.09  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .+.|...+.||+|+||+||+|+.+ +++.||||.+...........|.+|+.+|++++|||||++++++  .+.+..+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY--ESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEEEE
Confidence            456888999999999999999976 68999999998665444456788999999999999999999998  456789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCCeEEeeCCc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGL  338 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGl  338 (464)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+     |+||||||+|||+.   +++.+||+|||+
T Consensus        86 mE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          86 MQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             ECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhce-----eeeEEecccceeecccCCCceEEEeccce
Confidence            9999999999999753    24999999999999999999999998     99999999999995   578999999999


Q ss_pred             cccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--C
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--G  416 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  416 (464)
                      ++.......  .....||+.|||||++.+..++.++|||||||+||||+||..||.......    ....+......  .
T Consensus       157 a~~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~  230 (307)
T d1a06a_         157 SKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILKAEYEFDS  230 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHTTCCCCCT
T ss_pred             eEEccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCCCCC
Confidence            987654322  223458899999999999999999999999999999999999997643221    12222222222  2


Q ss_pred             CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          417 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       417 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ......++.+.+++.+||+.||++|||++|+++|.+..
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            22345667899999999999999999999999986543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=403.38  Aligned_cols=259  Identities=23%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCc--EEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|+..++||+|+||.||+|+++ +|.  .||||.++....+...++|.+|+.+|+++ +|||||+++|+|..  .+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeE
Confidence            45677789999999999999976 443  57889887655455567899999999999 79999999999954  67899


Q ss_pred             EEEecCCCCCHHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC
Q 012392          260 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  327 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~  327 (464)
                      +||||+++|+|.++|+...            .....++|..+++++.|||.||.|||+.+     |+||||||+|||++.
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-----iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----ccccccccceEEEcC
Confidence            9999999999999997541            22345999999999999999999999988     999999999999999


Q ss_pred             CCCeEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCC-CcchHHHHHhhhhH
Q 012392          328 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV-LTSSMRLAAESATF  406 (464)
Q Consensus       328 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p-~~~~~~~~~~~~~~  406 (464)
                      ++.+||+|||+++......  ......+|..|+|||.+.++.++.++|||||||++|||++|..| +....     ...+
T Consensus       163 ~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~  235 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAEL  235 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHH
T ss_pred             CCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHH
Confidence            9999999999998654322  12233477889999999999999999999999999999998764 54322     1122


Q ss_pred             HHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          407 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...+....+...+...++++.+|+.+||+.||++||||+||+++|+.+..
T Consensus       236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            23333344555666778899999999999999999999999999987643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=399.75  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||+||+|+.. +|+.||||.++...  .......+.+|+.+|++++||||+++++++  .+.+..|+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE--ECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE--EECCEEEE
Confidence            35888899999999999999975 78999999986432  122345789999999999999999999998  44678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        86 vmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc-----EEcCcCCccccccCCCceEEecccccce
Confidence            999999999999988654    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          341 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       341 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      ....... .......||+.|+|||++.+..++.++|||||||+||||+||..||.......    .+..+...  ...++
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~--~~~~p  230 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKL--EYDFP  230 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTT--CCCCC
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcC--CCCCC
Confidence            7754322 22233458899999999999999999999999999999999999997643221    12222221  22345


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  450 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~  450 (464)
                      ...++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            5667789999999999999999999987543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=401.91  Aligned_cols=262  Identities=21%  Similarity=0.373  Sum_probs=214.5

Q ss_pred             hcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  256 (464)
                      .++|...+.||+|+||.||+|++.      +++.||||+++..........|.+|+.++++++|||||+++|+|  ....
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~--~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--CSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE--ecCC
Confidence            456778899999999999999874      35789999998766566667899999999999999999999998  4466


Q ss_pred             eEEEEEecCCCCCHHHHhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEE------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  330 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~  330 (464)
                      ..++||||+++|+|.+++....      .....++|..+.+++.|+|+||.|||+.+     |+||||||+|||++++++
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-----ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEECTTCC
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeceEcCCceeecCCce
Confidence            7899999999999999987532      12234799999999999999999999988     999999999999999999


Q ss_pred             eEEeeCCccccccCCceee-eeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCC-CCCcchHHHHHhhhhHHH
Q 012392          331 PLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFEN  408 (464)
Q Consensus       331 ~kl~DfGl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~  408 (464)
                      +||+|||+++......... .....+|+.|+|||.+.++.++.++||||||+++|||+||+ .|+.....    ...+..
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----~~~~~~  247 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRF  247 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            9999999998765433222 22334678899999999999999999999999999999996 45543221    122222


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          409 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      +. .......+...+..+.+++.+||+.||++||||++|+++|+....
T Consensus       248 i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 VM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22 233444556677889999999999999999999999999987644

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=394.60  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             cCCccccccccCCceEEEEEEEC--C--CcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR--D--GTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|+..+.||+|+||.||+|++.  +  ...||||.++...  .....++|.+|+.+|++++|||||+++|+|.  + +.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~--~-~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--T-PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--e-cc
Confidence            45788899999999999999864  2  2478999987543  2334568999999999999999999999983  3 35


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++||||+++|+|.+++.....   .+++..++.++.|||.||.|||+++     |+||||||+||||+.++++||+|||
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             hheeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC-----EeeeeecHHHhccccccceeeccch
Confidence            6899999999999999876542   4999999999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCcee--eeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHHHhhhhHHHhhhhhc
Q 012392          338 LHKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  414 (464)
Q Consensus       338 l~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  414 (464)
                      +++........  ......++..|+|||.+.+..++.++|||||||++|||+| |..||.....    ......+.....
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~~~~i~~~~~  232 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDKEGE  232 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTSCC
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----HHHHHHHHhCCC
Confidence            99977543221  2223346678999999999999999999999999999998 7888865432    122334444444


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      +...+...+..+.+|+..||+.||++||||+||++.|..+
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            5555667778899999999999999999999999988765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=395.97  Aligned_cols=254  Identities=21%  Similarity=0.315  Sum_probs=207.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-----chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|...+.||+|+||+||+|+.+ +|+.||||.++....     ....+.|.+|+.+|++++|||||++++++  .+.+.
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~   87 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKTD   87 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence            56889999999999999999975 789999999875432     12356799999999999999999999998  45678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC----CeEE
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI  333 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl  333 (464)
                      .+||||||++|+|.+++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++    .+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~-----ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc-----eeecccccceEEEecCCCcccceEe
Confidence            999999999999999998653    3999999999999999999999998     99999999999998776    4999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      +|||+++.......  .....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+....    ..+..+....
T Consensus       159 ~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~  232 (293)
T d1jksa_         159 IDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVN  232 (293)
T ss_dssp             CCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTC
T ss_pred             cchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHHHHHhcC
Confidence            99999987654322  22345778899999999999999999999999999999999999764321    1122222211


Q ss_pred             cCCC--CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 LKGK--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....  .....+..+.+++.+||+.||++|||++|+++|-+..
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            1111  1123456789999999999999999999999886543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.7e-51  Score=402.84  Aligned_cols=253  Identities=20%  Similarity=0.276  Sum_probs=209.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+.+|++++|||||++++++.+  .+..+|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence            46888999999999999999975 78999999997654 4455678999999999999999999999844  67899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC--CCCeEEeeCCccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHK  340 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGl~~  340 (464)
                      |||++|+|.+++....   ..+++..+..|+.||+.||+|||+++     ||||||||+|||++.  ++.+||+|||+++
T Consensus       103 E~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2         103 EFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             CCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC-----CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            9999999999996533   24999999999999999999999998     999999999999964  6789999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC--CCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKF  418 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~  418 (464)
                      ........  ....+|+.|||||++.+..++.++|||||||++|||+||+.||.+....    ..+..+......  ...
T Consensus       175 ~~~~~~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         175 HLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             ECCTTSCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCCGG
T ss_pred             eccccccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCccc
Confidence            77654322  2345788999999999999999999999999999999999999754321    122222222211  112


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ....++.+.+++.+||+.||++|||++|+++|-+.
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~  283 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL  283 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            23456789999999999999999999999998553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=397.94  Aligned_cols=262  Identities=23%  Similarity=0.385  Sum_probs=218.4

Q ss_pred             hcCCccccccccCCceEEEEEEEC------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCCC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  255 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  255 (464)
                      .++|...+.||+|+||.||+|++.      +++.||||+++.........+|.+|+.+++++ +|||||+++|+|  ...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE--eeC
Confidence            356778899999999999999863      45789999998776666677899999999999 699999999999  456


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCC
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEG--------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  321 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~  321 (464)
                      ...++|||||++|+|.++++....              ....+++.++..++.|||.||+|||+++     ||||||||+
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-----ivHrDLKp~  174 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAAR  174 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccccc
Confidence            778999999999999999976432              1235899999999999999999999998     999999999


Q ss_pred             ceEEcCCCCeEEeeCCccccccCCc-eeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHH
Q 012392          322 KVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA  400 (464)
Q Consensus       322 Nill~~~~~~kl~DfGl~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~  400 (464)
                      |||++.++.+||+|||+++...... ........+|+.|+|||++.++.++.++|||||||++|||+|++.|+.....  
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--  252 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--  252 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--
Confidence            9999999999999999998765432 2223334567889999999999999999999999999999996655443221  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                       ....+..++....+...+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus       253 -~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 -VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             12234455666666667777788999999999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=394.76  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             cCCccccccccCCceEEEEEEECC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEeCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  254 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  254 (464)
                      ++|...+.||+|+||.||+|+...        +..||||.++.+.......+|.+|...+.++ +|||||+++|+|  ..
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--TQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--cc
Confidence            457778999999999999998632        3579999998776666668899999999888 799999999999  44


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCc
Q 012392          255 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  322 (464)
Q Consensus       255 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  322 (464)
                      .+..++||||+++|+|.++|.....            ....+++.+++.++.|||.||+|||+.+     ||||||||+|
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-----ivHrDiKp~N  165 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  165 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGG
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-----EEeeeecccc
Confidence            6779999999999999999976532            1245899999999999999999999998     9999999999


Q ss_pred             eEEcCCCCeEEeeCCccccccCCce-eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcchHHHH
Q 012392          323 VLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  400 (464)
Q Consensus       323 ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~t-g~~p~~~~~~~~  400 (464)
                      ||++.++.+||+|||+++....... .......+++.|+|||.+.++.|+.++|||||||++|||+| |..|+.....  
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--  243 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  243 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence            9999999999999999987754322 12233456788999999999999999999999999999998 5667654322  


Q ss_pred             HhhhhHHHhhhhhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          401 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                         ..+.+.+....+...+...++.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       244 ---~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 ---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence               1233444455566666777888999999999999999999999999998763

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-51  Score=400.32  Aligned_cols=252  Identities=20%  Similarity=0.300  Sum_probs=209.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      +.|+..+.||+|+||.||+|+.. +|+.||||.++... ......+.+|+.+|++++|||||++++++  .+.+..||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEEEEE
Confidence            45888999999999999999975 79999999987654 34456788999999999999999999998  4567899999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc--CCCCeEEeeCCccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLHK  340 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfGl~~  340 (464)
                      ||+++|+|.+++....   ..+++.++..|+.||+.||+|||+.+     |+||||||+||||+  .++.+||+|||+++
T Consensus       106 E~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         106 EFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             ECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccccccccccCCCeEEEeecccce
Confidence            9999999999886533   34999999999999999999999998     99999999999998  67899999999999


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--CCCC
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGKF  418 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  418 (464)
                      ........  ....+|..|+|||++.+..++.++|||||||+||||+||..||.+.....    .+..+.....  ....
T Consensus       178 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         178 KLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             ECCTTSCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCCCCCCSST
T ss_pred             ecCCCCce--eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCccc
Confidence            87654322  23457888999999999999999999999999999999999997643321    1222222111  2222


Q ss_pred             CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          419 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       419 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ....+.++.+++.+||+.||.+|||++|+++|-+
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            3456678999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-50  Score=390.81  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=207.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.++...  .....+.+.+|+.+|++++|||||++++++  .+.+..++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE--eeCCeeee
Confidence            45888999999999999999975 69999999987432  122346789999999999999999999998  45678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      ||||+++|+|..++....    .+++..+..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+++
T Consensus        82 vmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc-----EEccccCchheeEcCCCCEEEecCccce
Confidence            999999999999987654    3788888999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......    ....||+.|||||++.+..|+.++|||||||+||||+||+.||.......    ....+...  ....+.
T Consensus       153 ~~~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~--~~~~p~  222 (316)
T d1fota_         153 YVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNA--ELRFPP  222 (316)
T ss_dssp             ECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHC--CCCCCT
T ss_pred             Eecccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HHHHHHcC--CCCCCC
Confidence            775432    23568899999999999999999999999999999999999997643221    12222222  223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~  452 (464)
                      ..+.++.+++.+||+.||++|+     |++++++|.+
T Consensus       223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence            5667899999999999999996     9999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=388.41  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=198.3

Q ss_pred             CCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC--CeEEEEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFLIY  262 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~lv~  262 (464)
                      .|...+.||+|+||.||+|++ +|+.||||.++...  .....+..|+..+.+++|||||+++|+|.....  ...++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            456668899999999999997 58899999986432  122223345556678899999999999976543  2689999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---NKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||++|+|.++|+..     .++|..+++++.|+|.||+|||+...   ..++||||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999753     39999999999999999999997411   1245999999999999999999999999999


Q ss_pred             ccccCCce---eeeeccCCCCccCcccccccCC------CCCcchhHHHHHHHHHHHhCCCCCcchHHH-----------
Q 012392          340 KLLADDIV---FSVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRL-----------  399 (464)
Q Consensus       340 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~sDv~s~Gvll~el~tg~~p~~~~~~~-----------  399 (464)
                      +.......   .......+|+.|+|||++....      ++.++|||||||+||||+||..|+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            87644321   1223346889999999987542      577999999999999999998766321100           


Q ss_pred             HHhhhhHHHhhhhhcCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcC
Q 012392          400 AAESATFENFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  456 (464)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~  456 (464)
                      ...........+...++..+     ......+.+++.+||+.||++||||.||+++|+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            00011112222333333332     2456779999999999999999999999999987653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=391.09  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=209.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|...+.||+|+||.||+|+.+ +|+.||||.++...  .......+.+|+.+|++++||||+++++++  .+.+..++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee--cccccccc
Confidence            45888999999999999999975 79999999987532  122346788999999999999999999998  55778999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |||||++|+|.+++....    .+++.....++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+++
T Consensus        83 v~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC-----ccccccCHHHeEecCCCCEEEeeccccc
Confidence            999999999999998754    3888999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ....... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.......    .+..+...  ...++.
T Consensus       154 ~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~~~--~~~~p~  226 (337)
T d1o6la_         154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILME--EIRFPR  226 (337)
T ss_dssp             CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCCCT
T ss_pred             ccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHHHhcC--CCCCCc
Confidence            6543221 1223457889999999999999999999999999999999999997654321    12222221  234455


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHh
Q 012392          421 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELT  452 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~  452 (464)
                      ..+.++.+++..||+.||++||+     ++|+++|-+
T Consensus       227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence            66778999999999999999994     899998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.6e-50  Score=380.28  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=208.2

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc--------hHHHHHHHHHHHHhcCC-CCCceeeeeEEEeC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--------SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  253 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~  253 (464)
                      ++|+..+.||+|+||+||+|+.. +|+.||||.++.....        .....+.+|+.+|++++ ||||+++++++  .
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--~   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--E   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--E
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--c
Confidence            56888999999999999999974 7899999998764321        12246889999999997 99999999998  4


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      +++..||||||+++|||.++|....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEE
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEcCCCCeEE
Confidence            5788999999999999999997643    3999999999999999999999998     999999999999999999999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  407 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~  407 (464)
                      +|||+++.......  .....+|..|+|||.+..      ..++.++||||+||+||||+||+.||.......    ...
T Consensus       152 ~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~~~  225 (277)
T d1phka_         152 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLR  225 (277)
T ss_dssp             CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred             ccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----HHH
Confidence            99999987755332  223457888999999853      346889999999999999999999998654322    222


Q ss_pred             HhhhhhcC--CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          408 NFIDRNLK--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       408 ~~~~~~~~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .+......  .......++++.+++.+||+.||++|||++||++|-+.
T Consensus       226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence            23322222  22334667889999999999999999999999987553

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.1e-50  Score=381.32  Aligned_cols=258  Identities=18%  Similarity=0.258  Sum_probs=203.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC--CeE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GEC  258 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~  258 (464)
                      ++|...+.||+|+||+||+|+.. +|+.||||.++....  ......|.+|+.+|++++||||+++++++.....  ...
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            56888999999999999999974 799999999976542  2344679999999999999999999998865433  348


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCc
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  338 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl  338 (464)
                      |+||||+++|+|.+++....    .+++.+++.++.||+.||+|||+.+     |+||||||+|||++.++..+|+|||.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCccccCcccccCccccceeehhhh
Confidence            89999999999999987653    3899999999999999999999998     99999999999999999999999999


Q ss_pred             cccccCCce--eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC-
Q 012392          339 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-  415 (464)
Q Consensus       339 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  415 (464)
                      +........  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........    +...+..... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~~~~~~~~~  233 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----AYQHVREDPIP  233 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHCCCCC
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH----HHHHHhcCCCC
Confidence            876543221  222334578899999999999999999999999999999999999976432211    1122211111 


Q ss_pred             -CCCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhh
Q 012392          416 -GKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVA  454 (464)
Q Consensus       416 -~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~  454 (464)
                       .......++.+.+++.+||+.||++|| |++++++.|..+
T Consensus       234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence             112234567899999999999999999 899999988765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-49  Score=390.33  Aligned_cols=249  Identities=18%  Similarity=0.269  Sum_probs=208.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  260 (464)
                      ++|+.++.||+|+||.||+|+.+ +|+.||||.+....  .......+.+|+.+|++++|||||++++++  ......++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc--cccccccc
Confidence            36888999999999999999975 79999999986432  122345689999999999999999999998  45678999


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      |+||+.+|+|.+++....    .+++..+..++.||+.||.|||+++     ||||||||+|||++.++.+||+|||+++
T Consensus       119 v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCcCCHHHcccCCCCCEEeeeceeee
Confidence            999999999999997654    3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCCH
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  420 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (464)
                      ......    ....||+.|||||++.+..++.++|||||||+||||+||..||.......    .+..+...  ....+.
T Consensus       190 ~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~--~~~~p~  259 (350)
T d1rdqe_         190 RVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSG--KVRFPS  259 (350)
T ss_dssp             ECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC--CCCCCT
T ss_pred             eccccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHhcC--CCCCCc
Confidence            775432    23457888999999999999999999999999999999999997653221    12222222  223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          421 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       421 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      ..+.++.+++.+||+.||.+|+     |++++++|-+.
T Consensus       260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence            5677899999999999999994     99999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=383.25  Aligned_cols=251  Identities=18%  Similarity=0.250  Sum_probs=206.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      .++|.+.+.||+|+||+||+|+.. +++.||||.++...  .....+.+|+.+|++++|||||++++++.  +.+..|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFE--SMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEE
Confidence            356888999999999999999975 68899999997653  34456889999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCC--CCeEEeeCCcc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIADCGLH  339 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfGl~  339 (464)
                      ||||++|+|.+++....   ..+++.++..|+.||+.||+|||+.+     |+||||||+|||++.+  ..+||+|||++
T Consensus        80 mE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~-----iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          80 FEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC-----CCcccccccceeecCCCceEEEEcccchh
Confidence            99999999999997543   24899999999999999999999998     9999999999999854  58999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +........  ....+++.|+|||.+.+..++.++||||+||++|||++|..||......    ..+..+.....  ..+
T Consensus       152 ~~~~~~~~~--~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~~i~~~~~--~~~  223 (321)
T d1tkia_         152 RQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEY--TFD  223 (321)
T ss_dssp             EECCTTCEE--EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCC--CCC
T ss_pred             hccccCCcc--cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC--CCC
Confidence            876543322  2234678899999999999999999999999999999999999765432    12222222211  122


Q ss_pred             H----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          420 E----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       420 ~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      .    ..+.++.+++..||+.||++|||++|+++|-+.
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            2    245678999999999999999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-49  Score=389.83  Aligned_cols=251  Identities=20%  Similarity=0.251  Sum_probs=201.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC--chHHHHHH---HHHHHHhcCCCCCceeeeeEEEeCCCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFV---KGLYLLTSLRHENIIRLRGFCCSRGRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~---~e~~~l~~l~H~niv~l~g~~~~~~~~~  257 (464)
                      ++|.+.++||+|+||.||+|+.. +|+.||||.+.....  ......+.   .++.+++.++|||||++++++  ...+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~--~~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDK   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECSSE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE--EECCE
Confidence            46888999999999999999976 699999999864321  11122333   457778888999999999998  44678


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .|+||||+++|+|.++|....    .+++..+..++.||+.||+|||+.+     ||||||||+|||+++++.+||+|||
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~-----iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC-----ccceeeccceeEEcCCCcEEEeeec
Confidence            999999999999999998653    3889999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh--c
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--L  414 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~  414 (464)
                      +++......   .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......     ....+....  .
T Consensus       153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~~  224 (364)
T d1omwa3         153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTM  224 (364)
T ss_dssp             TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHHSSSC
T ss_pred             eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcccC
Confidence            998775542   234468899999999975 46899999999999999999999999753211     111111111  1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhh
Q 012392          415 KGKFSESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  453 (464)
Q Consensus       415 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~  453 (464)
                      ....+...++++.+++.+||+.||++|||     ++|+++|-+.
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence            22334556778999999999999999999     7999987553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=385.38  Aligned_cols=250  Identities=18%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCC--CchHHHHHHHHHHHHh-cCCCCCceeeeeEEEeCCCCeEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLT-SLRHENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~e~~~l~-~l~H~niv~l~g~~~~~~~~~~~  259 (464)
                      ++|...+.||+|+||+||+|+.. +++.||||.++...  .......+..|..++. .++|||||++++++  .+.+..|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~--~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE--ccCCcee
Confidence            46888899999999999999976 78999999997532  1223345667777665 68999999999998  4577899


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  339 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~  339 (464)
                      |||||+++|+|.+++....    .+++.++..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||++
T Consensus        80 ivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~-----iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCcccceeecCCCceeccccchh
Confidence            9999999999999998654    3889999999999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcCCCCC
Q 012392          340 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  419 (464)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (464)
                      +....... ......||..|+|||++.+..++.++|||||||++|||+||+.||.+......    +..+..  -....+
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~--~~~~~p  223 (320)
T d1xjda_         151 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRM--DNPFYP  223 (320)
T ss_dssp             BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHH--CCCCCC
T ss_pred             hhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHc--CCCCCC
Confidence            86543322 22334588899999999999999999999999999999999999976432211    112211  123345


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHH
Q 012392          420 ESEAAKLGKMALVCTHEDPENRPTME-AVIEEL  451 (464)
Q Consensus       420 ~~~~~~l~~l~~~C~~~dp~~RPs~~-evl~~L  451 (464)
                      ...+.++.+|+.+||+.||++||++. ++++|-
T Consensus       224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence            55677899999999999999999995 787653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=385.39  Aligned_cols=255  Identities=17%  Similarity=0.228  Sum_probs=199.1

Q ss_pred             cCCcccc-ccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcC-CCCCceeeeeEEEe--CCCCeE
Q 012392          184 QCFSEVN-LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS--RGRGEC  258 (464)
Q Consensus       184 ~~f~~~~-~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~--~~~~~~  258 (464)
                      ++|.+.+ .||+|+||.||+|+.. +++.||||.++..      ..+.+|+.++.++ +|||||++++++..  ......
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            4577664 6999999999999974 7899999998642      3466899887655 89999999998743  234568


Q ss_pred             EEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC---CCCeEEee
Q 012392          259 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD  335 (464)
Q Consensus       259 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  335 (464)
                      |+|||||++|+|.++|.....  ..+++.++..|+.||+.||+|||+.+     |+||||||+|||+++   ++.+||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~-----iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC-----Cccccccccccccccccccccccccc
Confidence            999999999999999975432  34999999999999999999999998     999999999999985   56799999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhcC
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  415 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  415 (464)
                      ||+++......  ......||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.............+......
T Consensus       158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             cceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            99998765433  2234568899999999999999999999999999999999999997643211111111111111111


Q ss_pred             CCCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          416 GKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       416 ~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ...+  ...++++.+++.+||+.||++|||+.|+++|-+.
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence            1111  2456789999999999999999999999998554

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=377.11  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=194.3

Q ss_pred             ccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchH----HHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEEe
Q 012392          189 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE----EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  263 (464)
Q Consensus       189 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E  263 (464)
                      +++||+|+||+||+|+.. +|+.||||+++.......    ...+.+|+.+|++++|||||++++++  ...+..+||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivmE   80 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee--ccCCceeehhh
Confidence            578999999999999975 689999999875432211    24688999999999999999999998  55677999999


Q ss_pred             cCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccccc
Q 012392          264 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  343 (464)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~~  343 (464)
                      |+.++++..+....    ..+++.++..++.||+.||+|||+++     |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          81 FMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             CCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             hhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc-----eecccCCcceEEecCCCccccccCccccccC
Confidence            99887777665432    34888899999999999999999998     9999999999999999999999999998765


Q ss_pred             CCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhhc--------
Q 012392          344 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--------  414 (464)
Q Consensus       344 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  414 (464)
                      .... ......+|..|+|||.+..+ .++.++|||||||++|||+||..||.............+....+..        
T Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         152 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             CCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence            4322 22234578889999998654 5799999999999999999999998754332211111111000000        


Q ss_pred             ---------CCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          415 ---------KGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       415 ---------~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                               ....+     ...++.+.+++.+||+.||++|||++|+++|-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence                     00001     12356789999999999999999999999986543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=373.03  Aligned_cols=258  Identities=21%  Similarity=0.384  Sum_probs=197.3

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|+.++.||+|+||+||+|+.. +|+.||||.++..... ....++.+|+.+|++++|||||++++++.  +.+..++|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~--~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc--cccceeEE
Confidence            46888999999999999999974 7899999999754322 22467899999999999999999999984  46789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      |||+.+ ++.+++....  ...+++..+..++.||+.||+|||+.+     ||||||||+|||++.++.+||+|||+++.
T Consensus        80 ~e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~-----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             EECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             EeecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC-----EEccccCchheeecccCcceeccCCccee
Confidence            999964 5555554432  234999999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh---------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---------  411 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~---------  411 (464)
                      ...... ......+|..|+|||.+.... ++.++|||||||++|||++|+.||..................         
T Consensus       152 ~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         152 FGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             HCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            644321 222345788899999887655 578999999999999999999999754322111111110000         


Q ss_pred             ---hhcCCCC-----------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          412 ---RNLKGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       412 ---~~~~~~~-----------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                         .......           ....+.++.+++.+||+.||++|||++|+++|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence               0000000           0123467899999999999999999999999844

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=371.84  Aligned_cols=244  Identities=20%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhcCC--CCCceeeeeEEEeCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~  255 (464)
                      ++|...++||+|+||.||+|+.. +|+.||||.++.....     ....++.+|+.+|++++  |||||++++++  ...
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--~~~   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--ERP   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--ECS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE--eeC
Confidence            56888899999999999999975 7899999998754211     11234678999999996  99999999998  456


Q ss_pred             CeEEEEEecCCC-CCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-CCCeEE
Q 012392          256 GECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLI  333 (464)
Q Consensus       256 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl  333 (464)
                      +..++||||+.+ +++.+++....    .+++.++..++.||+.||+|||+.+     |+||||||+|||++. ++.+||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEE
T ss_pred             CeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCcccceEEecCCCeEEE
Confidence            789999999975 68888887643    3899999999999999999999998     999999999999985 479999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  412 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  412 (464)
                      +|||+++......   .....||..|+|||++.+..+ +.++|||||||++|||+||+.||......          ...
T Consensus       153 ~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----------~~~  219 (273)
T d1xwsa_         153 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRG  219 (273)
T ss_dssp             CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------HHC
T ss_pred             Cccccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----------hhc
Confidence            9999998765432   223458889999999987765 56789999999999999999999764321          111


Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                        ....+...+.++.+++.+||+.||++|||++|+++|-+.
T Consensus       220 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         220 --QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             --CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             --ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence              112333455778999999999999999999999998654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.6e-48  Score=368.59  Aligned_cols=257  Identities=19%  Similarity=0.318  Sum_probs=198.9

Q ss_pred             cCCccccccccCCceEEEEEEECCCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|...+.||+|+||+||+|+.++|+.||||.++.... +.....|.+|+.+|++++|||||++++++.  ..+..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCceeEEE
Confidence            46888999999999999999999999999999976542 222467999999999999999999999984  467799999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccccc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  342 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~~  342 (464)
                      ||+.++++..+....    ..+++..+..|+.||+.||+|||+.+     ||||||||+|||++.++.+||+|||++...
T Consensus        80 e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             ECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc-----EEecCCCCceeeEcCCCCEEecccccceec
Confidence            999877666665432    34999999999999999999999988     999999999999999999999999999876


Q ss_pred             cCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh---------
Q 012392          343 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---------  412 (464)
Q Consensus       343 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------  412 (464)
                      ..... ......++..|+|||.+... .++.++|||||||++|||++|+.||..................+         
T Consensus       151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence            54322 22233467789999998754 56899999999999999999999997543221111111000000         


Q ss_pred             -------hcC-------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          413 -------NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       413 -------~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                             ...       .......+..+.+++.+||+.||++|||++|+++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                   000       0011234567899999999999999999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=370.23  Aligned_cols=261  Identities=18%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEEC--CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcC---CCCCceeeeeEEEeC---
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSR---  253 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~---  253 (464)
                      .++|+.++.||+|+||+||+|+..  +++.||||.++..... .....+.+|+.+|+.+   +||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            467999999999999999999974  3678999998754322 1223455677666555   899999999988532   


Q ss_pred             CCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEE
Q 012392          254 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  333 (464)
Q Consensus       254 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  333 (464)
                      .....++++||+++|++.......   ...+++..+..++.||+.||+|||+++     ||||||||+|||+++++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecCCCccEEEEcCCCCeee
Confidence            234689999999887766554432   234899999999999999999999998     999999999999999999999


Q ss_pred             eeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhh-
Q 012392          334 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-  412 (464)
Q Consensus       334 ~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-  412 (464)
                      +|||+++......  ......||+.|+|||++.+..|+.++||||+||++|||+||+.||..................+ 
T Consensus       158 ~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         158 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            9999998664432  2234558899999999999999999999999999999999999997643221111111100000 


Q ss_pred             -------------hcC-------CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          413 -------------NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       413 -------------~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                   ...       .......++.+.+|+.+||+.||++|||++|+++|.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                         000       00122345678899999999999999999999998553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=363.26  Aligned_cols=268  Identities=18%  Similarity=0.266  Sum_probs=199.7

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC------C
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~------~  255 (464)
                      ++|+.++.||+|+||+||+|+.. +|+.||||++..... +....++.+|+.+|++++||||+++++++....      .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            56889999999999999999975 799999999865432 233467899999999999999999999885422      3


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      +..++||||++++++..+....    ..++...+..++.||+.||.|||+.+     |+||||||+|||+++++.+||+|
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~-----ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC-----EEecCcCchheeecCCCcEEeee
Confidence            4589999999887776554432    23888899999999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCcee---eeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhh
Q 012392          336 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  411 (464)
Q Consensus       336 fGl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  411 (464)
                      ||+++........   ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..................
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999866533221   11223478899999998765 6899999999999999999999999754322211111110000


Q ss_pred             --hh-----------------cCCCCCH-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhcCcccc
Q 012392          412 --RN-----------------LKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT  460 (464)
Q Consensus       412 --~~-----------------~~~~~~~-------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~  460 (464)
                        ..                 .......       .....+.+|+.+||+.||++|||++|+++|-+....++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~  315 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  315 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence              00                 0000000       1134567899999999999999999999998876555443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=367.40  Aligned_cols=259  Identities=20%  Similarity=0.288  Sum_probs=196.1

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCC--CeEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFL  260 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~l  260 (464)
                      .+|..++.||+|+||+||+|+.. +|+.||||.++..........+++|+.+|++++||||+++++++.....  ...++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46888999999999999999864 8999999999866545566789999999999999999999999843221  12344


Q ss_pred             EEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          261 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       261 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                      +++|+.+|+|.+++...     .+++..+..++.||+.||+|||+++     ||||||||+|||++.++.+||+|||+++
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~-----iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCcceEEECCCCCEEEcccCcee
Confidence            45666799999999653     3899999999999999999999998     9999999999999999999999999998


Q ss_pred             cccCCcee--eeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH----------
Q 012392          341 LLADDIVF--SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------  407 (464)
Q Consensus       341 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~----------  407 (464)
                      ........  ......+|..|+|||.+.. ..++.++||||+||++|||++|+.||..............          
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            76443221  1223447788999999854 5678899999999999999999999965432111111000          


Q ss_pred             ---------Hhhhhh-cCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          408 ---------NFIDRN-LKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       408 ---------~~~~~~-~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                               ...... .....+     ...+.++.+++.+||+.||++|||++|+++|-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                     000000 000011     122356889999999999999999999999854

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-46  Score=357.31  Aligned_cols=257  Identities=15%  Similarity=0.209  Sum_probs=196.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  262 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~  262 (464)
                      ++|+..+.||+|+||.||+|+.. +|+.||||.+.....   ..++..|++++++++|+|++..++.+.. ..+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEEE
Confidence            45888999999999999999974 689999999876432   2357889999999998887776665543 356789999


Q ss_pred             ecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEc---CCCCeEEeeCCcc
Q 012392          263 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH  339 (464)
Q Consensus       263 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGl~  339 (464)
                      ||+ +|+|...+....   ..+++..+..++.|++.||+|||+++     |+||||||+|||++   .+..+||+|||++
T Consensus        83 e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHhhccccccCCCceeeeeccCcc
Confidence            999 667777765533   34999999999999999999999998     99999999999986   4567999999999


Q ss_pred             ccccCCce------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          340 KLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       340 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      +.......      .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... .........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~  232 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKK  232 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhccc
Confidence            87654321      12233458899999999999999999999999999999999999996532211111 111111111


Q ss_pred             cCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          414 LKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       414 ~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                      ....   .....++++.+++..||+.||++||+++++.+.|+..
T Consensus       233 ~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1111   1223457799999999999999999999888777654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=363.69  Aligned_cols=256  Identities=21%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCC----CC
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  256 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  256 (464)
                      .++|..++.||+|+||+||+|+.. +|+.||||.++.... ....+.+.+|+.+|++++|||||+++++|...+    ..
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            457899999999999999999975 699999999975432 334567899999999999999999999985432    12


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeC
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  336 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  336 (464)
                      ..++||||+ +++|..++...     .+++..+..++.||+.||+|||+++     |+||||||+|||++.++.+||+||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCcchhhcccccccccccc
Confidence            579999999 66888877542     3999999999999999999999998     999999999999999999999999


Q ss_pred             CccccccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH--------
Q 012392          337 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------  407 (464)
Q Consensus       337 Gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~--------  407 (464)
                      |+++......    ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||..............        
T Consensus       166 g~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         166 GLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             TTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence            9998765432    334578889999998764 568999999999999999999999975432211100000        


Q ss_pred             ----------HhhhhhcCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          408 ----------NFIDRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       408 ----------~~~~~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                ......+..       ......+..+.+|+.+||+.||++|||++|+++|-+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                      000000000       0112345678899999999999999999999998553

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=364.59  Aligned_cols=255  Identities=20%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCCCCceeeeeEEEeC----CCCeEE
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGECF  259 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~----~~~~~~  259 (464)
                      .|+..++||+|+||+||+|+.. +|+.||||.+.....     .+.+|+.+|++++||||+++++++...    +....+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4677789999999999999986 689999999976432     234699999999999999999988543    233578


Q ss_pred             EEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCc
Q 012392          260 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGL  338 (464)
Q Consensus       260 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl  338 (464)
                      |||||+++|. .+.+.........+++.++..++.||+.||+|||+.+     |+||||||+|||++.++ .+||+|||+
T Consensus        96 lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-----IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          96 LVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCcceEEEecCCCceeEecccc
Confidence            9999997654 4444322223345999999999999999999999998     99999999999999764 899999999


Q ss_pred             cccccCCceeeeeccCCCCccCccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHH-------Hhh
Q 012392          339 HKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------NFI  410 (464)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~-------~~~  410 (464)
                      ++.......  .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||............+.       +.+
T Consensus       170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            987654332  223457788999998765 5689999999999999999999999965432211111100       000


Q ss_pred             hhh----cCC------------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 012392          411 DRN----LKG------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  452 (464)
Q Consensus       411 ~~~----~~~------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~  452 (464)
                      ...    ...            ......++.+.+|+.+||+.||++|||++|+++|-+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            000    000            011234567899999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=353.29  Aligned_cols=258  Identities=17%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|+.++.||+|+||+||+|+.. +++.||||+++.... ......+.+|+.+|+.++||||+++++++  ......++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc--ccccceeEE
Confidence            46889999999999999999975 789999999976542 34457899999999999999999999998  446789999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+.+++|..++...    ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||.++.
T Consensus        80 ~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~-----IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          80 FEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             EECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC-----EeeecccCcccccccCCceeeeecchhhc
Confidence            9999999998887643    24889999999999999999999998     99999999999999999999999999987


Q ss_pred             ccCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh-------
Q 012392          342 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-------  413 (464)
Q Consensus       342 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  413 (464)
                      ....... .....++..|+|||.+.... ++.++|||||||++|||++|+.|+............+.......       
T Consensus       151 ~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         151 FGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCSCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ccCCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            6543221 12233556799999987655 68999999999999999999999754322111111111111000       


Q ss_pred             -----------------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          414 -----------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       414 -----------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                                       .........+..+.+++.+||+.||.+|||++|+++|-+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence                             0001122345678899999999999999999999998654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-45  Score=359.87  Aligned_cols=252  Identities=16%  Similarity=0.232  Sum_probs=198.4

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|..+++||+|+||+||+|+.. +|+.||||+++..    ..+++.+|+.+|++++ ||||+++++++........++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            46899999999999999999974 7899999998743    2456889999999995 9999999999866556679999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC-CeEEeeCCccc
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHK  340 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl~~  340 (464)
                      |||+++|+|..+.+       .+++..+..++.||+.||+|||+++     |+||||||+|||++.++ .+||+|||+++
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g-----IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc-----cccccccccceEEcCCCCeeeecccccce
Confidence            99999999977642       3899999999999999999999998     99999999999998654 69999999998


Q ss_pred             cccCCceeeeeccCCCCccCcccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH---------hh
Q 012392          341 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN---------FI  410 (464)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~---------~~  410 (464)
                      .......  .....+|..|+|||.+.+. .++.++||||+||++|||++|+.||............+..         ..
T Consensus       179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         179 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             eccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence            7654322  2234467889999998765 4799999999999999999999998643211110000000         00


Q ss_pred             hh-----------------------hcCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 012392          411 DR-----------------------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  453 (464)
Q Consensus       411 ~~-----------------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~  453 (464)
                      ..                       ..........+.++.+|+.+||+.||++|||++|+++|-+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            00                       00001112345678999999999999999999999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=363.60  Aligned_cols=257  Identities=19%  Similarity=0.297  Sum_probs=203.8

Q ss_pred             cCCccccccccCCceEEEEEEEC----CCcEEEEEEeccCCC---chHHHHHHHHHHHHhcCCC-CCceeeeeEEEeCCC
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGR  255 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~f~~e~~~l~~l~H-~niv~l~g~~~~~~~  255 (464)
                      ++|+..+.||+|+||+||+|+..    +|+.||||.++....   ....+.+.+|+.+|++++| |||+++++++.  ..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--~~  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TE  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--ET
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec--cC
Confidence            45888999999999999999852    578999999865321   1223568899999999976 89999999884  46


Q ss_pred             CeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEee
Q 012392          256 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  335 (464)
Q Consensus       256 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  335 (464)
                      ...++|+||+.+|+|.+++.....    +.......++.||+.||+|||+.+     |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESC
T ss_pred             CceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcCC-----EEeccCCccceeecCCCCEEEee
Confidence            789999999999999999986543    677888899999999999999998     99999999999999999999999


Q ss_pred             CCccccccCCceeeeeccCCCCccCcccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhhhhh
Q 012392          336 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  413 (464)
Q Consensus       336 fGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  413 (464)
                      ||+++..............++..|+|||.+...  .++.++|||||||+||||+||+.||..................  
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--  250 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  250 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--
Confidence            999987654433333445677889999999754  4688999999999999999999999754321111111122111  


Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhh
Q 012392          414 LKGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  453 (464)
Q Consensus       414 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~  453 (464)
                      .....+...+.++.+++.+||+.||++||     |++|+++|-+.
T Consensus       251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence            22334556788999999999999999999     58999987553

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.5e-45  Score=348.63  Aligned_cols=257  Identities=16%  Similarity=0.174  Sum_probs=199.5

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC-CCceeeeeEEEeCCCCeEEEE
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLI  261 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lv  261 (464)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||.+.....   ...+.+|++.++.++| +|++.+++++.  .....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEE
Confidence            56888999999999999999975 689999998865432   2346678888888865 89999998884  46778999


Q ss_pred             EecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcC-----CCCeEEeeC
Q 012392          262 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIADC  336 (464)
Q Consensus       262 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Df  336 (464)
                      |||+ +|+|.+++....   ..+++.++..++.|++.||+|||+.+     |+||||||+|||++.     ++.+||+||
T Consensus        80 me~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g-----iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             EEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeecCcccccCCceEEccc
Confidence            9999 789999987643   24899999999999999999999998     999999999999974     567999999


Q ss_pred             CccccccCCce------eeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHHhh
Q 012392          337 GLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  410 (464)
Q Consensus       337 Gl~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  410 (464)
                      |+++.......      .......||+.|||||.+.+..++.++|||||||++|||+||+.||......... .....+.
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~i~  229 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIG  229 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HHHHHHH
Confidence            99987643221      1122345889999999999999999999999999999999999999642211000 0111111


Q ss_pred             hhhcCC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhc
Q 012392          411 DRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  455 (464)
Q Consensus       411 ~~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~  455 (464)
                      ......   ......++++.+++..||+.+|++||+++.+.+.|+.+.
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111000   011234567999999999999999999999888777653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=355.81  Aligned_cols=257  Identities=18%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             cCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeC----CCCe
Q 012392          184 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGE  257 (464)
Q Consensus       184 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~----~~~~  257 (464)
                      ++|+..++||+|+||+||+|+.. +|+.||||+++.... ......+.+|+.++++++||||+++++++...    ....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56889999999999999999976 699999999976543 33445788999999999999999999998543    2367


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .|+||||+.+ ++.+.+..      .+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~-~l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g-----iiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccch-HHHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCccccccccccceeeechh
Confidence            8999999965 55555532      3899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhh-------------
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-------------  404 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~-------------  404 (464)
                      +++......  ......+|..|+|||++.+..++.++||||+||++|||++|+.||...........             
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            988665432  22233467889999999999999999999999999999999999864322111110             


Q ss_pred             -----hHHHhhhhhc---------------CCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          405 -----TFENFIDRNL---------------KGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       405 -----~~~~~~~~~~---------------~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                           ..........               ....   ....+..+.+++.+|++.||++|||++|+++|-+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~  315 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  315 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence                 0111111110               0000   123467889999999999999999999999986543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=355.17  Aligned_cols=258  Identities=19%  Similarity=0.267  Sum_probs=195.6

Q ss_pred             hcCCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcCCCCCceeeeeEEEeC---CCCe
Q 012392          183 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGE  257 (464)
Q Consensus       183 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~---~~~~  257 (464)
                      .++|...+.||+|+||+||+|+.. +|+.||||.++.... ......+.+|+.+|++++|||||++++++...   +...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            457899999999999999999964 799999999976542 23445788999999999999999999987432   1223


Q ss_pred             EEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCC
Q 012392          258 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  337 (464)
Q Consensus       258 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  337 (464)
                      .++|+||+.+|+|.+++...     .+++.++..++.||+.||+|||+++     |+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g-----iiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCccccccccccccccccc
Confidence            45667778899999999642     3999999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCceeeeeccCCCCccCcccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcchHHHHHhhhhHHH--------
Q 012392          338 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN--------  408 (464)
Q Consensus       338 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~--------  408 (464)
                      ++.......    ....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.+.............        
T Consensus       167 ~a~~~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         167 LARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             ---CCTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhcccCccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            997654321    2334667799999876654 688999999999999999999999754322111111100        


Q ss_pred             -----------hhhhhcCC-CC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 012392          409 -----------FIDRNLKG-KF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  454 (464)
Q Consensus       409 -----------~~~~~~~~-~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~  454 (464)
                                 ........ ..     ....+..+.+|+.+||+.||++|||++|+++|-+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                       00000000 00     012346788999999999999999999999986543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8e-40  Score=323.31  Aligned_cols=258  Identities=19%  Similarity=0.271  Sum_probs=193.4

Q ss_pred             CCccccccccCCceEEEEEEEC-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-----------CCCceeeeeEEEe
Q 012392          185 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----------HENIIRLRGFCCS  252 (464)
Q Consensus       185 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-----------H~niv~l~g~~~~  252 (464)
                      +|..+++||+|+||+||+|+.. +|+.||||+++..  ......+.+|+.+++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4888999999999999999975 7999999999754  233456778888888775           5789999998866


Q ss_pred             CCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeeecCCCCCceEEcCCCC-
Q 012392          253 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN-  330 (464)
Q Consensus       253 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivH~dlk~~Nill~~~~~-  330 (464)
                      ......+++++++..+.......... ....+++..+..++.||+.||+|||+ .+     |+||||||+|||++.++. 
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~-----IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEETT
T ss_pred             ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC-----cccccCChhHeeeeccCcc
Confidence            55667777888776654433333222 23458889999999999999999997 66     999999999999986653 


Q ss_pred             -----eEEeeCCccccccCCceeeeeccCCCCccCcccccccCCCCCcchhHHHHHHHHHHHhCCCCCcchHHHHH--hh
Q 012392          331 -----PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--ES  403 (464)
Q Consensus       331 -----~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvll~el~tg~~p~~~~~~~~~--~~  403 (464)
                           ++++|||.+......    .....+|..|+|||.+....++.++||||+||+++||++|+.||........  ..
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                 899999999865432    2334577889999999999999999999999999999999999863211000  00


Q ss_pred             hhH---------------------HHhhh-------------------hhcCCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 012392          404 ATF---------------------ENFID-------------------RNLKGKFSESEAAKLGKMALVCTHEDPENRPT  443 (464)
Q Consensus       404 ~~~---------------------~~~~~-------------------~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs  443 (464)
                      ..+                     ....+                   ...........+..+.+++.+|++.||++|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            000                     00000                   00112234567888999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 012392          444 MEAVIEELTVA  454 (464)
Q Consensus       444 ~~evl~~L~~~  454 (464)
                      ++|+++|-+..
T Consensus       322 a~e~L~Hp~f~  332 (362)
T d1q8ya_         322 AGGLVNHPWLK  332 (362)
T ss_dssp             HHHHHTCGGGT
T ss_pred             HHHHhcCcccC
Confidence            99999986643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1.9e-24  Score=192.83  Aligned_cols=164  Identities=13%  Similarity=0.089  Sum_probs=118.9

Q ss_pred             ccccccccCCceEEEEEEECCCcEEEEEEeccCCCc-----------------hHHHHHHHHHHHHhcCCCCCceeeeeE
Q 012392          187 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------SEEAEFVKGLYLLTSLRHENIIRLRGF  249 (464)
Q Consensus       187 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~f~~e~~~l~~l~H~niv~l~g~  249 (464)
                      ...+.||+|+||.||+|+..+|+.||||.++.....                 .....+.+|...+.++.|.|++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            345789999999999999989999999987542110                 011235568889999999999998765


Q ss_pred             EEeCCCCeEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCC
Q 012392          250 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  329 (464)
Q Consensus       250 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~  329 (464)
                      .  .    .+++|||++++.+.+           ++......++.|++.+|+|||+.+     |+||||||+|||++++ 
T Consensus        83 ~--~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g-----iiHrDiKP~NILv~~~-  139 (191)
T d1zara2          83 E--G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             E--T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEETT-
T ss_pred             c--C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC-----EEEccCChhheeeeCC-
Confidence            3  2    268999998765432           333345679999999999999998     9999999999999976 


Q ss_pred             CeEEeeCCccccccCCceeeeeccCCCCccCcc--cc---cccCCCCCcchhHHHHHH
Q 012392          330 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP--EY---VTTGRFTERSDIFAFGVI  382 (464)
Q Consensus       330 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~~y~aP--E~---~~~~~~~~~sDv~s~Gvl  382 (464)
                      .++|+|||++.........         .|...  +.   ...+.|+.++|+||..--
T Consensus       140 ~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            5899999998765432110         01110  00   113567889999998543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.37  E-value=1.2e-06  Score=79.49  Aligned_cols=150  Identities=16%  Similarity=0.112  Sum_probs=93.5

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCC
Q 012392          178 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG  256 (464)
Q Consensus       178 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~  256 (464)
                      ++...-..|...+..+-+....||+... ++..+.+|+..... ......+.+|...+..+. +--+.+++.+.  ...+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~   83 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDG   83 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETT
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEE--ecCC
Confidence            4444445565555443344468998865 45566778765432 112224566777776663 43356677665  3356


Q ss_pred             eEEEEEecCCCCCHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----------------------------
Q 012392          257 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV----------------------------  308 (464)
Q Consensus       257 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----------------------------  308 (464)
                      ..++||+++++.++.+.....      ..   ...++.++++.|+.||+...                            
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             ceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            789999999998886654211      11   23345566666666664320                            


Q ss_pred             --------------------------CCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          309 --------------------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       309 --------------------------~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                                                ..+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      12237999999999999987767799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=5.3e-06  Score=74.66  Aligned_cols=73  Identities=12%  Similarity=0.103  Sum_probs=48.2

Q ss_pred             cccCCc-eEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC--CCCceeeeeEEEeCCCCeEEEEEecCCCC
Q 012392          192 LGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFLIYDFAPKG  268 (464)
Q Consensus       192 lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~lv~E~~~~g  268 (464)
                      +..|.. ..||+...+++..+.+|.-.....    .++..|...++.+.  .-.+.++++++  ...+..++||||+++-
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCSSE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEeeecc
Confidence            334443 579999888888889997654431    23456666666553  33456777765  3456789999999876


Q ss_pred             CH
Q 012392          269 KL  270 (464)
Q Consensus       269 sL  270 (464)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.49  E-value=0.00028  Score=67.54  Aligned_cols=76  Identities=12%  Similarity=-0.032  Sum_probs=45.4

Q ss_pred             cccccCCceEEEEEEECC-CcEEEEEEeccC------CCchHHHHHHHHHHHHhcCC---CCCceeeeeEEEeCCCCeEE
Q 012392          190 NLLGKGNFSSVYKGTLRD-GTLVAIRSINVT------SCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECF  259 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~  259 (464)
                      +.||.|....||+....+ ++.|+||.-...      ...........|...|..+.   ...+.+++.+.  .+  ..+
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~--~~~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MAV  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TTE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC--CCE
Confidence            568999999999998654 678999964321      11111122335666666552   24566776654  32  347


Q ss_pred             EEEecCCCCC
Q 012392          260 LIYDFAPKGK  269 (464)
Q Consensus       260 lv~E~~~~gs  269 (464)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.63  E-value=0.0025  Score=58.89  Aligned_cols=140  Identities=10%  Similarity=0.115  Sum_probs=74.7

Q ss_pred             eEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCCC-----CCceeeeeEEEeCCCCeEEEEEecCCCCCH--
Q 012392          198 SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-----ENIIRLRGFCCSRGRGECFLIYDFAPKGKL--  270 (464)
Q Consensus       198 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~H-----~niv~l~g~~~~~~~~~~~lv~E~~~~gsL--  270 (464)
                      -.||+.+..+|+.|++|..+....  ...++..|...+..|..     +..+..-|-......+..+.|++++++..+  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            579999999999999999876532  23456677777766632     211222110001123567889999976322  


Q ss_pred             ---HHH---------hhhh----c-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHhcC--CCCCCC
Q 012392          271 ---SKY---------LDQE----E-GSSNVLDWST-------------------RVSIIIGIAKGIGYLHSS--EVNKPA  312 (464)
Q Consensus       271 ---~~~---------l~~~----~-~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~~--~~~~~~  312 (464)
                         ..+         ++..    . .....+++..                   +..+...+...++.+...  ......
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111         1110    0 0011122211                   111222222233333221  112345


Q ss_pred             eeecCCCCCceEEcCCCCeEEeeCCcccc
Q 012392          313 IVHRNLSVEKVLIDQQFNPLIADCGLHKL  341 (464)
Q Consensus       313 ivH~dlk~~Nill~~~~~~kl~DfGl~~~  341 (464)
                      +||+|+.+.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899987753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.93  E-value=0.013  Score=55.43  Aligned_cols=72  Identities=18%  Similarity=0.207  Sum_probs=46.5

Q ss_pred             cccccCCceEEEEEEECCC--------cEEEEEEeccCCCchHHHHHHHHHHHHhcCC-CCCceeeeeEEEeCCCCeEEE
Q 012392          190 NLLGKGNFSSVYKGTLRDG--------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  260 (464)
Q Consensus       190 ~~lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  260 (464)
                      +.|+.|-.-.+|+....++        ..|.++.... . .. ..+..+|..+++.+. +.=..++++++  .+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ET-ESHLVAESVIFTLLSERHLGPKLYGIF--SG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----ce
Confidence            5677777889999987543        4567766542 2 22 234557888888774 43344788776  32    57


Q ss_pred             EEecCCCCCH
Q 012392          261 IYDFAPKGKL  270 (464)
Q Consensus       261 v~E~~~~gsL  270 (464)
                      |+||+++-.|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.62  E-value=0.034  Score=50.46  Aligned_cols=163  Identities=11%  Similarity=-0.006  Sum_probs=82.8

Q ss_pred             ccCHHHHHHhhcCCccccccc-----cCCceEEEEEEECCCcEEEEEEeccCCCchHHHHHHHHHHHHhcCC-----CCC
Q 012392          173 RLNLEEVESATQCFSEVNLLG-----KGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----HEN  242 (464)
Q Consensus       173 ~~~~~~~~~~~~~f~~~~~lg-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~e~~~l~~l~-----H~n  242 (464)
                      .++.+|++.....|...+...     .|---+.|+.+..+|+ +++|.........   +...|+.+|..+.     -|.
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhccccccc
Confidence            356788888888887644433     4545678998887765 7888875432222   2223444554442     122


Q ss_pred             ceeee-eEEEeCCCCeEEEEEecCCCCCHHH--------------HhhhhcCC------CCCCC----------------
Q 012392          243 IIRLR-GFCCSRGRGECFLIYDFAPKGKLSK--------------YLDQEEGS------SNVLD----------------  285 (464)
Q Consensus       243 iv~l~-g~~~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~~------~~~l~----------------  285 (464)
                      .+... |.....-......++.+..+.....              .++.....      .....                
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            22211 1000011234566677766533211              11110000      00000                


Q ss_pred             -HHHHHHHHHHHHHHHHHHhcCCCCCCCeeecCCCCCceEEcCCCCeEEeeCCccc
Q 012392          286 -WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  340 (464)
Q Consensus       286 -~~~~~~i~~~ia~gL~yLH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl~~  340 (464)
                       .......+..+...+.-.+... -+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~-L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKD-LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCS-SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccc-cccccccCCcchhhhhcccccceeEecccccc
Confidence             0112233333444444444332 24458999999999999998777899999764